data_2mp1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mp1 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.478 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 25.7 p . . . . . 0 N--CA 1.44 -0.956 0 N-CA-C 112.959 0.726 . . . . 72.05 112.959 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.39 -171.04 3.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.966 -0.561 . . . . 71.44 109.659 -175.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.28 -64.02 1.09 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.06 -0.348 . . . . 70.24 110.06 -176.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -175.03 153.39 1.63 Allowed 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.307 -1.368 . . . . 71.14 107.307 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.96 150.53 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 C-N-CA 119.862 -0.735 . . . . 64.24 109.59 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.439 ' CG2' ' HA ' ' A' ' 16' ' ' PRO . 10.0 t -91.74 177.65 6.14 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.286 -1.005 . . . . 73.5 108.286 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -44.87 -63.49 0.91 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.388 0.675 . . . . 72.31 110.912 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -142.55 91.91 7.41 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 106.9 -1.518 . . . . 74.34 106.9 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.551 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.0 Cg_endo -46.98 -87.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.507 3.472 . . . . 62.43 118.321 -172.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.412 HD11 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -131.59 160.87 65.47 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 109.628 -0.508 . . . . 75.22 109.628 -173.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 21' ' ' ILE . 51.2 Cg_exo -60.16 128.41 26.33 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.181 1.921 . . . . 73.31 110.719 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.49 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -76.24 -0.88 67.49 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 116.023 -0.535 . . . . 72.32 113.454 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -95.67 -3.75 45.54 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 113.149 0.796 . . . . 75.03 113.149 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 18' ' ' PRO . 40.8 pt -103.74 9.79 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.539 0.685 . . . . 74.52 110.538 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -93.96 132.42 38.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.683 -0.689 . . . . 70.11 111.794 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -84.32 -47.99 10.17 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.657 1.183 . . . . 74.33 111.479 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.412 ' O ' ' HB ' ' A' ' 42' ' ' THR . 28.0 t-20 -150.39 156.57 41.75 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.6 -0.889 . . . . 64.45 108.6 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.404 ' CZ ' HG22 ' A' ' 62' ' ' ILE . 34.9 p90 -129.14 159.98 34.32 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.016 0.436 . . . . 64.41 109.896 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.51 ' HB2' HG21 ' A' ' 40' ' ' VAL . 3.7 m170 -127.16 125.67 41.55 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 104.907 -2.257 . . . . 74.31 104.907 175.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -95.88 100.61 12.29 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.981 -0.377 . . . . 73.04 109.981 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.478 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.4 mm? -97.99 120.28 38.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.066 0.546 . . . . 64.35 111.375 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.7 mt -130.0 176.03 8.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.069 0.461 . . . . 74.05 110.719 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.6 mt -73.52 -22.13 18.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.268 -1.012 . . . . 72.23 108.268 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -58.38 -42.59 87.37 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.623 -1.171 . . . . 64.11 108.781 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.79 -48.03 60.66 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.984 -1.007 . . . . 75.44 108.586 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.74 87.85 0.4 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 115.104 -0.953 . . . . 50.01 112.469 175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 46.9 t -171.12 161.93 6.89 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.928 -1.138 . . . . 64.2 107.928 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -87.54 -25.92 23.41 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.928 0.394 . . . . 62.24 110.388 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.6 109.2 58.09 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-O 121.123 0.487 . . . . 74.13 111.371 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -81.86 129.73 6.38 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 121.401 1.401 . . . . 72.44 109.752 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.49 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -166.49 147.76 6.36 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.164 -0.471 . . . . 75.14 110.091 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.33 128.24 51.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 107.577 -1.268 . . . . 64.55 107.577 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 26' ' ' HIS . 11.9 m -93.37 129.71 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 C-N-CA 119.42 -0.912 . . . . 75.24 109.378 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 14.7 m-85 -99.76 113.47 25.99 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.419 -0.81 . . . . 70.55 111.312 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 24' ' ' ASN . 99.4 m -83.03 104.49 13.28 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.383 -0.969 . . . . 72.14 108.383 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.5 p -72.64 178.47 4.1 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 112.321 0.489 . . . . 73.34 112.321 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.435 HD21 ' HG2' ' A' ' 23' ' ' ARG . 77.0 mt -60.69 -31.74 70.98 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.807 0.843 . . . . 74.32 110.947 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -75.93 -14.55 60.25 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.711 -0.677 . . . . 73.34 111.01 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.66 16.2 43.38 Favored Glycine 0 CA--C 1.506 -0.471 0 C-N-CA 120.571 -0.823 . . . . 71.11 112.243 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -100.54 130.49 46.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 110.379 -0.23 . . . . 74.42 110.379 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.515 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -95.67 144.03 26.43 Favored 'General case' 0 N--CA 1.426 -1.649 0 C-N-CA 120.173 -0.611 . . . . 75.11 111.412 175.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -139.42 146.33 39.99 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.445 -1.317 . . . . 63.52 107.445 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.515 ' N ' HD12 ' A' ' 49' ' ' LEU . 3.7 m -80.71 126.19 30.98 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.148 0.28 . . . . 60.23 110.286 -175.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.551 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.12 156.27 74.73 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 122.016 -0.427 . . . . 53.14 110.877 175.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HG3' ' OE1' ' A' ' 55' ' ' GLN . 90.3 Cg_endo -72.93 116.8 4.85 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.758 2.305 . . . . 73.43 113.961 -172.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.6 Cg_endo -74.38 -9.74 21.82 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.255 1.97 . . . . 65.45 112.57 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -89.94 -38.04 13.95 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.915 -0.314 . . . . 74.24 111.192 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.49 ' OE1' ' HG3' ' A' ' 52' ' ' PRO . 52.0 mt-30 -63.99 137.73 97.19 Favored Pre-proline 0 C--O 1.239 0.523 0 N-CA-C 113.535 0.939 . . . . 74.15 113.535 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 68.5 Cg_exo -57.27 -34.53 98.0 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.9 3.067 . . . . 71.5 114.245 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -61.02 -31.95 71.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.246 0.546 . . . . 73.02 110.579 -176.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 62' ' ' ILE . 70.9 t -76.65 -38.85 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 115.434 -0.803 . . . . 71.53 111.641 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.575 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.303 0.2 OUTLIER -66.83 -24.65 66.18 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 113.815 1.042 . . . . 41.55 113.815 -175.63 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -74.22 -50.77 17.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.037 0.446 . . . . 75.34 111.345 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.49 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 10.4 pt -64.15 -32.2 56.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.567 0.58 . . . . 75.43 112.567 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 58' ' ' VAL . 58.8 mt -58.09 -47.1 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.375 -0.375 . . . . 73.23 110.195 172.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 85.5 mm-40 -58.71 -42.59 89.0 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.809 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -59.59 -46.32 89.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.583 -0.735 . . . . 74.44 110.593 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.92 -34.92 74.12 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.658 -0.417 . . . . 74.32 111.24 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 27.3 mt-30 -61.88 -46.09 90.9 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 121.059 -0.256 . . . . 74.54 111.225 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 . . . . . 0 C--N 1.313 -1.014 0 N-CA-C 113.542 0.942 . . . . 70.25 113.542 -178.594 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.402 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 47.7 t . . . . . 0 N--CA 1.425 -1.71 0 N-CA-C 106.602 -1.629 . . . . 74.44 106.602 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 10' ' ' LEU . 40.4 t -117.33 177.25 4.8 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 119.848 -0.741 . . . . 74.12 110.415 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 2.5 mm? -95.85 -54.2 3.42 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.913 -1.143 . . . . 75.15 107.913 175.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 p -178.05 164.17 1.81 Allowed 'General case' 0 C--O 1.251 1.141 0 N-CA-C 109.304 -0.628 . . . . 74.3 109.304 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 13' ' ' THR . 2.0 m -109.46 163.22 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 N-CA-C 105.723 -1.955 . . . . 74.53 105.723 174.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 12' ' ' VAL . 9.7 t -102.84 177.15 4.93 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.689 -1.226 . . . . 72.21 107.689 175.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -50.64 -49.17 57.54 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 123.222 0.326 . . . . 75.43 110.761 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 41.1 ttmt -144.91 97.65 4.87 Favored Pre-proline 0 N--CA 1.433 -1.314 0 N-CA-C 109.943 -0.392 . . . . 74.14 109.943 167.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.516 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 3.2 Cg_endo -48.65 -69.66 0.07 OUTLIER 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.955 3.103 . . . . 75.34 115.669 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.58 165.41 17.47 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 109.754 -0.462 . . . . 72.33 109.754 -176.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.518 ' O ' HG12 ' A' ' 21' ' ' ILE . 42.9 Cg_exo -61.15 128.83 26.35 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.966 1.778 . . . . 52.13 109.061 171.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.495 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -74.66 1.2 53.78 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 115.761 1.064 . . . . 71.34 115.761 -172.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.64 -1.22 38.59 Favored 'General case' 0 C--N 1.287 -2.136 0 O-C-N 121.826 -0.808 . . . . 75.2 112.689 176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.543 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 38.1 pt -98.21 7.06 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 121.57 0.7 . . . . 75.05 109.885 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG22 ' CD1' ' A' ' 41' ' ' PHE . 3.5 p -92.18 138.3 20.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.564 -0.744 . . . . 64.43 111.421 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.46 -56.79 2.9 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.921 -1.036 . . . . 72.13 109.205 -173.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -139.92 173.6 11.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.473 -0.936 . . . . 73.5 108.473 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -149.68 165.66 31.7 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.632 -0.427 . . . . 71.24 110.513 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.408 ' HB2' HG21 ' A' ' 40' ' ' VAL . 39.4 m170 -128.02 116.18 19.63 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.114 -1.439 . . . . 70.24 107.114 170.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -88.23 120.61 29.75 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.393 -0.595 . . . . 73.22 109.393 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 7.5 tt -132.5 133.78 44.21 Favored 'General case' 0 N--CA 1.407 -2.608 0 O-C-N 123.366 0.417 . . . . 55.1 110.281 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.426 HD13 ' HE3' ' A' ' 31' ' ' LYS . 80.8 mt -131.33 -173.3 3.07 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.309 -0.997 . . . . 73.22 108.309 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.0 mt -68.53 -29.0 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.569 -0.53 . . . . 73.13 109.569 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' A' ' 32' ' ' ASP 0.263 0.0 OUTLIER -64.72 -20.44 66.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.226 0.824 . . . . 72.13 113.226 176.168 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.447 ' N ' ' HD2' ' A' ' 31' ' ' LYS . 7.5 m-20 -80.82 -8.8 59.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.433 0.635 . . . . 75.42 109.644 174.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.71 79.13 1.39 Allowed Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.281 -0.872 . . . . 74.25 113.593 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.4 t -178.82 148.51 0.42 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.215 -1.402 . . . . 63.44 107.215 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -73.26 -31.03 63.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.508 0.559 . . . . 62.21 112.508 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.48 106.57 46.75 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-O 121.32 0.581 . . . . 70.42 111.519 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.55 129.43 4.25 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.107 1.871 . . . . 73.44 110.836 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.73 145.96 6.66 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.991 -0.549 . . . . 73.1 110.122 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.51 125.47 53.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.402 -0.962 . . . . 72.24 108.402 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.646 HG13 ' SG ' ' A' ' 50' ' ' CYS . 5.3 m -88.73 124.78 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 C-N-CA 119.409 -0.916 . . . . 75.11 109.537 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 10.6 m-85 -96.32 121.76 38.46 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.287 -0.87 . . . . 75.42 111.353 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.9 m -87.7 105.79 17.6 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.577 -1.268 . . . . 70.53 107.577 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.4 p -74.81 172.76 11.61 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.735 -0.211 . . . . 75.14 110.959 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 88.4 mt -63.98 -25.71 68.25 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.437 0.637 . . . . 75.23 109.74 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -61.02 -33.74 73.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.71 -1.132 . . . . 74.31 109.953 174.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.3 -0.14 40.63 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.643 -0.708 . . . . 54.33 111.857 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -95.44 153.19 17.82 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.06 -1.089 . . . . 73.51 108.06 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 41.4 mt-30 -110.5 138.79 46.42 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.482 -0.562 . . . . 70.35 109.482 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 47.1 tp -139.75 132.56 29.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.116 -1.068 . . . . 73.31 108.116 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.646 ' SG ' HG13 ' A' ' 40' ' ' VAL . 9.8 m -82.08 142.95 31.85 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 120.175 -0.61 . . . . 71.52 112.166 -174.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.516 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.78 158.35 68.48 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 115.465 -0.789 . . . . 54.55 110.144 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 88.3 Cg_endo -73.69 109.59 2.89 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.495 2.13 . . . . 74.04 113.281 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.45 -11.24 30.81 Favored 'Trans proline' 0 N--CA 1.482 0.799 0 C-N-CA 122.697 2.265 . . . . 73.01 112.594 -176.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -95.61 -5.8 41.68 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.479 -0.782 . . . . 75.32 111.21 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -98.06 128.69 32.91 Favored Pre-proline 0 N--CA 1.443 -0.805 0 C-N-CA 120.548 -0.461 . . . . 73.41 111.407 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.23 -34.0 23.27 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 124.28 3.32 . . . . 74.34 115.449 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -62.85 -33.32 75.01 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.135 -0.626 . . . . 74.4 109.988 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 62' ' ' ILE . 89.7 t -77.53 -40.16 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.709 -0.678 . . . . 73.33 110.275 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.04 -27.3 69.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.133 0.492 . . . . 72.4 111.422 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -72.03 -44.01 64.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.706 -0.679 . . . . 74.34 110.575 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.495 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 16.5 pt -80.32 -30.65 12.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.396 0.888 . . . . 72.33 113.396 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 58' ' ' VAL . 65.2 mt -55.34 -44.84 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 110.389 -0.226 . . . . 72.42 110.389 174.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -60.02 -40.91 90.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.079 0.466 . . . . 74.31 110.105 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.86 -42.05 88.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.258 -0.883 . . . . 75.24 109.814 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.433 HD12 ' CG1' ' A' ' 22' ' ' VAL . 82.4 mt -76.25 -35.97 58.72 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.446 0.536 . . . . 73.44 112.446 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -64.72 -25.75 68.07 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 120.467 -0.493 . . . . 72.22 111.836 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.538 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--N 1.297 -1.714 0 C-N-CA 120.073 -0.651 . . . . 72.11 111.421 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.469 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 73.0 m . . . . . 0 N--CA 1.409 -2.482 0 N-CA-C 106.922 -1.51 . . . . 71.23 106.922 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.475 ' SG ' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -95.06 175.61 6.56 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.94 -0.704 . . . . 72.23 112.705 -169.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 tt -88.2 -66.11 0.95 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.643 -0.873 . . . . 72.44 108.643 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -175.92 153.12 1.3 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.778 -1.193 . . . . 63.12 107.778 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 13' ' ' THR . 1.4 m -98.79 160.82 3.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 119.126 -1.03 . . . . 73.51 109.506 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 12' ' ' VAL . 7.1 t -101.38 173.19 6.55 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 106.56 -1.644 . . . . 70.35 106.56 174.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -43.8 -59.43 2.24 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.528 0.518 . . . . 72.55 111.373 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 40.8 ttmt -143.09 94.15 6.4 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 109.753 -0.462 . . . . 75.31 109.753 173.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.529 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.7 Cg_endo -52.99 -85.61 0.01 OUTLIER 'Trans proline' 0 CA--C 1.556 1.617 0 C-N-CA 124.138 3.226 . . . . 52.2 117.58 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.04 149.46 42.26 Favored Pre-proline 0 C--O 1.207 -1.161 0 O-C-N 121.73 -0.606 . . . . 73.13 110.4 -174.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.22 144.97 99.07 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.54 2.16 . . . . 74.22 112.29 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.16 1.75 79.06 Favored Glycine 0 CA--C 1.502 -0.743 0 CA-C-N 115.848 -0.614 . . . . 63.24 112.748 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -80.13 -23.2 41.32 Favored 'General case' 0 N--CA 1.408 -2.565 0 CA-C-O 121.04 0.447 . . . . 72.41 110.553 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.422 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 37.3 pt -101.89 13.01 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.879 -0.513 . . . . 75.51 111.78 -177.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.5 p -98.82 137.7 25.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.511 0.672 . . . . 63.31 111.908 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -89.45 -54.46 4.08 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.43 1.092 . . . . 73.33 108.588 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -139.33 164.02 30.95 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.393 -0.965 . . . . 71.32 108.393 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -140.84 160.5 39.93 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.594 -0.521 . . . . 72.41 109.594 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.419 ' HB2' HG21 ' A' ' 40' ' ' VAL . 38.5 m80 -135.81 127.06 28.25 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.368 -1.345 . . . . 74.45 107.368 173.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -92.67 122.38 35.02 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.488 -0.93 . . . . 75.33 108.488 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.4 mm? -116.18 126.24 53.39 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 120.861 0.362 . . . . 74.01 111.651 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.7 mt -129.26 172.84 11.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.165 -1.05 . . . . 64.03 108.165 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 32.0 mt -74.63 -18.11 16.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.827 -1.175 . . . . 65.31 107.827 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -61.7 -32.8 73.03 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.93 -1.032 . . . . 72.42 109.455 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.27 -38.99 71.84 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.001 -0.545 . . . . 73.42 109.562 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.1 -50.93 0.54 Allowed Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 115.507 -0.77 . . . . 44.52 112.765 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 71.1 m -67.43 132.73 48.21 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.835 0.35 . . . . 61.31 110.888 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.42 ' HA ' HG12 ' A' ' 30' ' ' ILE . 86.7 mtt180 -80.48 22.77 0.54 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.03 0.752 . . . . 72.4 113.03 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -126.77 96.03 36.12 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 108.908 -0.775 . . . . 74.34 108.908 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -85.24 129.65 3.84 Favored 'Trans proline' 0 N--CA 1.443 -1.441 0 C-N-CA 121.902 1.734 . . . . 75.33 112.354 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.495 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -174.77 166.34 3.7 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.087 -0.961 . . . . 74.33 108.696 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.85 130.95 60.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.555 -1.276 . . . . 63.42 107.555 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 6.8 m -96.3 128.08 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.83 0 C-N-CA 119.576 -0.849 . . . . 74.12 109.583 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 28.8 m-85 -99.65 121.51 41.32 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.592 -0.731 . . . . 73.53 110.839 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.3 m -85.93 97.99 10.55 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.137 -1.431 . . . . 74.33 107.137 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.6 p -70.14 169.74 12.94 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.65 -0.25 . . . . 73.04 111.053 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 91.2 mt -60.33 -26.84 66.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.352 0.596 . . . . 62.44 109.87 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -61.58 -28.87 69.66 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.438 1.095 . . . . 74.23 110.678 175.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.34 9.32 58.03 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 111.834 -0.506 . . . . 75.45 111.834 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -103.76 136.21 43.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.708 -1.59 . . . . 74.11 106.708 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 27.6 mt-30 -92.19 130.5 37.89 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 121.122 -0.231 . . . . 71.22 110.413 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 7.2 mp -119.62 147.08 44.95 Favored 'General case' 0 CA--C 1.475 -1.909 0 CA-C-N 116.406 -0.361 . . . . 74.11 111.0 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.1 m -86.1 125.24 33.32 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.075 -0.966 . . . . 72.03 109.18 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.529 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.41 152.45 76.4 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 118.016 0.371 . . . . 71.11 111.736 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 87.9 Cg_endo -71.09 108.14 2.26 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.329 2.686 . . . . 71.2 114.243 -174.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 40.9 Cg_endo -67.95 -13.54 38.62 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.489 2.126 . . . . 65.44 111.245 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.67 -27.71 50.94 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.574 -1.194 . . . . 74.12 111.687 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -85.99 142.06 36.01 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 113.513 0.931 . . . . 70.21 113.513 -173.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.22 -38.07 92.67 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.603 2.869 . . . . 71.4 113.451 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.43 ' O ' HG12 ' A' ' 61' ' ' ILE . 39.4 p-90 -63.44 -27.73 69.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.961 0.41 . . . . 74.44 110.304 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 62' ' ' ILE . 53.1 t -78.97 -46.89 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 116.0 -0.545 . . . . 71.22 111.756 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -25.37 67.09 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 119.549 -0.86 . . . . 74.11 109.719 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -59.65 -56.35 22.93 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.51 -1.223 . . . . 74.55 108.895 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 57' ' ' TRP . 12.0 pt -74.55 -32.21 29.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.967 -1.015 . . . . 74.22 113.598 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 58' ' ' VAL . 64.1 mt -54.95 -55.74 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 123.254 0.347 . . . . 71.44 111.178 176.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.54 -38.9 92.91 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 112.42 0.526 . . . . 73.11 112.42 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -62.17 -42.47 99.3 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.667 -0.697 . . . . 74.5 112.021 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 tt -72.94 -31.72 64.78 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.179 -0.674 . . . . 74.11 109.179 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 79.9 mt-30 -48.87 -39.6 26.41 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 120.812 0.339 . . . . 75.41 111.383 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 . . . . . 0 C--N 1.313 -1.014 0 CA-C-N 115.784 -0.644 . . . . 73.44 112.286 -177.031 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.496 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 29.1 p . . . . . 0 CA--C 1.505 -0.774 0 N-CA-C 110.338 -0.245 . . . . 72.34 110.338 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.517 ' SG ' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -65.45 125.53 25.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.987 -0.552 . . . . 61.01 112.454 -172.207 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.442 ' O ' HG21 ' A' ' 36' ' ' VAL . 76.1 mt -50.6 -54.62 21.27 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.785 1.634 . . . . 71.41 114.586 -172.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.6 p -174.38 142.57 0.79 Allowed 'General case' 0 CA--C 1.486 -1.505 0 C-N-CA 120.085 -0.646 . . . . 75.1 109.734 -174.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 13' ' ' THR . 1.2 m -98.5 162.65 2.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.127 -1.064 . . . . 70.53 108.127 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 12' ' ' VAL . 15.4 t -105.18 178.18 4.63 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 107.115 -1.439 . . . . 72.23 107.115 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -41.43 -57.97 2.03 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.51 0.724 . . . . 72.24 110.696 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 ttpt -146.96 97.1 4.21 Favored Pre-proline 0 N--CA 1.431 -1.421 0 N-CA-C 108.7 -0.852 . . . . 75.33 108.7 170.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.531 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 5.4 Cg_endo -44.99 -73.03 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.915 3.077 . . . . 74.52 115.997 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.84 163.72 34.16 Favored Pre-proline 0 C--N 1.317 -0.824 0 O-C-N 122.153 -0.342 . . . . 75.31 110.269 -176.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.564 ' O ' HG12 ' A' ' 21' ' ' ILE . 71.2 Cg_exo -55.49 129.09 33.24 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.446 2.097 . . . . 63.41 110.186 171.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.424 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -77.79 -4.34 85.23 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.953 -0.642 . . . . 74.34 114.377 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -96.19 2.6 53.18 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.331 -0.511 . . . . 75.41 111.816 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 18' ' ' PRO . 32.6 pt -106.75 12.39 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 120.077 -0.649 . . . . 72.44 110.654 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.484 HG22 ' CD1' ' A' ' 41' ' ' PHE . 2.2 p -95.55 133.26 37.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.651 0.738 . . . . 71.34 112.407 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.589 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 1.2 tmt_? -93.62 -49.2 5.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.595 -1.184 . . . . 65.32 108.556 -174.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.589 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 16.1 m120 -135.5 154.05 51.53 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.891 -0.781 . . . . 74.3 108.891 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.9 143.91 41.07 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.209 -0.596 . . . . 74.11 109.699 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.425 ' HB2' HG21 ' A' ' 40' ' ' VAL . 43.9 m170 -118.72 132.32 56.15 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.363 -1.717 . . . . 62.13 106.363 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -99.77 102.83 14.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.487 -0.56 . . . . 72.23 109.487 -174.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.496 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.1 mm? -102.26 120.37 40.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.872 -0.603 . . . . 75.03 111.049 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.0 mt -131.87 168.75 17.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.29 0.567 . . . . 74.22 110.603 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mt -77.89 -17.33 14.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 107.696 -1.224 . . . . 74.21 107.696 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.07 -31.91 71.57 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 114.967 -1.015 . . . . 75.35 109.417 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -76.66 -54.45 6.64 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.073 -1.084 . . . . 41.05 108.073 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.13 89.13 0.23 Allowed Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.413 -0.812 . . . . 62.41 112.518 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.5 t -171.59 -176.08 1.72 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.63 -0.878 . . . . 51.03 108.63 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -81.55 -43.02 19.31 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.808 0.443 . . . . 75.13 111.846 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 10' ' ' LEU . 2.8 p -130.84 128.24 22.35 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 113.609 0.966 . . . . 64.23 113.609 -172.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -88.82 132.18 2.38 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 123.029 2.486 . . . . 64.42 112.553 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -175.06 153.41 1.62 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.855 0.862 . . . . 74.42 108.794 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -99.1 132.64 44.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.672 -1.233 . . . . 75.33 107.672 176.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.517 HG13 ' SG ' ' A' ' 9' ' ' CYS . 5.9 m -93.38 122.75 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 C-N-CA 119.346 -0.942 . . . . 74.01 109.225 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.484 ' CD1' HG22 ' A' ' 22' ' ' VAL . 8.8 m-85 -94.77 115.91 28.08 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 115.333 -0.849 . . . . 73.35 110.56 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.1 m -85.47 104.77 15.56 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.362 -0.977 . . . . 73.34 108.362 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.0 p -71.15 178.4 3.3 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.166 -0.47 . . . . 74.44 111.448 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.5 mt -66.11 -25.18 66.87 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.778 0.799 . . . . 73.43 109.926 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -71.93 -16.31 62.1 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.787 -1.097 . . . . 74.23 110.656 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.63 16.01 57.4 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.863 -0.684 . . . . 74.03 111.579 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -97.91 135.34 39.78 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 120.739 0.304 . . . . 72.0 111.753 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -97.56 114.56 26.48 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.168 -0.924 . . . . 73.11 109.481 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.1 mp -116.53 148.42 40.85 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 116.497 -0.32 . . . . 75.45 111.603 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.8 m -77.75 122.29 25.18 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.436 -0.802 . . . . 72.43 110.667 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.531 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.54 151.71 73.34 Favored Pre-proline 0 C--O 1.242 0.704 0 C-N-CA 121.101 -0.24 . . . . 64.3 111.535 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.27 110.87 3.18 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 123.284 2.656 . . . . 74.04 114.407 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.18 -18.69 51.02 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.391 2.061 . . . . 75.52 112.948 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -87.54 -19.93 27.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.072 0.767 . . . . 64.44 113.072 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.99 139.02 39.77 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 114.08 1.141 . . . . 75.34 114.08 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.07 -39.92 69.29 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 124.608 3.538 . . . . 65.43 114.753 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.1 p-90 -59.47 -31.87 69.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.714 -0.395 . . . . 75.11 111.025 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 62' ' ' ILE . 78.2 t -77.56 -42.95 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.935 -0.575 . . . . 71.05 111.599 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -25.25 66.04 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.961 -0.696 . . . . 75.14 112.176 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.441 ' HD3' ' OE1' ' A' ' 63' ' ' GLN . 37.0 mmt180 -71.37 -34.91 70.88 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.795 -0.639 . . . . 74.34 112.547 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.424 HG21 ' HA3' ' A' ' 19' ' ' GLY . 10.6 pt -85.33 -34.16 8.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 120.718 -0.393 . . . . 75.31 111.8 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 58' ' ' VAL . 59.2 mt -56.74 -49.42 78.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-N 116.034 -0.53 . . . . 75.3 111.232 173.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.441 ' OE1' ' HD3' ' A' ' 60' ' ' ARG . 4.1 pt20 -59.08 -39.68 82.91 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.043 0.449 . . . . 73.0 111.221 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -60.76 -51.3 69.93 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.987 -1.006 . . . . 74.02 110.332 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.437 HD12 HG13 ' A' ' 22' ' ' VAL . 82.5 mt -66.26 -26.4 67.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.057 0.391 . . . . 73.42 112.057 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 55.9 mt-30 -63.24 -20.48 65.49 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 120.803 0.335 . . . . 71.34 111.822 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 . . . . . 0 C--N 1.314 -0.941 0 CA-C-O 121.098 0.475 . . . . 75.11 110.227 178.108 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.431 -1.408 0 N-CA-C 110.16 -0.311 . . . . 44.14 110.16 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.429 ' HB2' HG13 ' A' ' 40' ' ' VAL . 1.2 t -94.18 -179.39 4.93 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.801 -0.76 . . . . 74.11 111.676 -169.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.22 -66.92 0.83 Allowed 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.044 0.538 . . . . 74.34 110.434 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 p -176.4 150.09 0.87 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.113 -1.44 . . . . 75.45 107.113 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 m -98.49 161.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 118.812 -1.155 . . . . 74.03 109.276 -177.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 t -104.13 177.72 4.76 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.661 -1.607 . . . . 75.44 106.661 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -51.44 -58.5 6.1 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.148 0.431 . . . . 65.41 110.124 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -137.42 99.83 9.53 Favored Pre-proline 0 N--CA 1.424 -1.732 0 C-N-CA 120.014 -0.675 . . . . 74.1 111.654 172.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.533 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 19.1 Cg_endo -67.48 -164.09 0.09 OUTLIER 'Trans proline' 0 CA--C 1.567 2.148 0 C-N-CA 122.84 2.36 . . . . 75.15 114.167 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.33 156.76 5.45 Favored Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 125.436 1.495 . . . . 72.53 113.363 -175.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -73.65 149.09 42.98 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.63 2.22 . . . . 73.34 112.527 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.81 1.54 67.47 Favored Glycine 0 N--CA 1.459 0.216 0 CA-C-N 115.788 -0.642 . . . . 38.88 113.488 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -82.97 -23.69 33.27 Favored 'General case' 0 C--N 1.285 -2.232 0 O-C-N 122.259 -0.553 . . . . 74.4 111.522 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.4 pt -100.9 12.26 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.111 0.481 . . . . 74.32 111.904 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 4.3 p -97.94 136.79 27.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.04 -0.527 . . . . 61.55 111.394 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -55.82 3.49 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.437 -1.32 . . . . 75.4 107.437 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -142.33 163.91 31.58 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.636 -0.876 . . . . 52.03 108.636 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -132.51 157.47 44.58 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.964 -0.294 . . . . 72.12 110.28 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.409 ' HB2' HG21 ' A' ' 40' ' ' VAL . 37.8 m80 -125.54 113.56 17.6 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.668 -1.234 . . . . 72.03 107.668 172.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -82.68 100.78 10.43 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.523 -0.762 . . . . 74.3 109.235 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.5 mt -112.06 143.15 43.55 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.691 -0.686 . . . . 74.02 111.846 -175.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 98.1 mt -141.3 -177.61 5.21 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.046 -0.979 . . . . 70.54 109.842 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 57.9 mt -74.93 -29.42 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.442 -1.318 . . . . 73.52 107.442 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.02 -20.54 64.04 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.911 -1.04 . . . . 72.52 110.907 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -79.66 -49.55 11.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.553 -1.277 . . . . 64.11 107.553 174.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.33 51.15 0.06 OUTLIER Glycine 0 C--O 1.24 0.523 0 C-N-CA 120.621 -0.799 . . . . 38.88 114.1 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 87.3 m -145.5 144.74 30.74 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.764 -1.199 . . . . 75.53 107.764 174.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -63.81 -30.96 71.99 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.159 0.504 . . . . 74.43 111.03 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -100.32 112.96 65.2 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-N 115.432 -0.804 . . . . 74.13 111.572 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.8 130.33 3.66 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 122.191 1.928 . . . . 61.44 109.953 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -170.65 146.26 2.65 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.885 -0.413 . . . . 73.13 109.885 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.41 126.14 51.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.061 -1.459 . . . . 74.23 107.061 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 9' ' ' CYS . 13.1 m -90.1 128.32 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 C-N-CA 119.523 -0.871 . . . . 74.11 109.448 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -96.62 114.0 25.61 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 115.362 -0.835 . . . . 72.02 109.385 174.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.6 m -84.74 104.83 15.05 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.442 -1.318 . . . . 65.5 107.442 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 64.5 p -70.06 175.3 4.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 112.706 0.632 . . . . 55.51 112.706 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.01 -27.36 68.27 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.472 0.709 . . . . 75.54 110.672 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -79.69 -13.96 59.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.706 -0.679 . . . . 73.23 110.488 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.07 16.67 43.39 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.203 -0.999 . . . . 42.33 112.602 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -96.06 138.64 33.39 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 122.747 -0.267 . . . . 74.13 110.631 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -93.12 125.18 37.58 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 123.909 0.756 . . . . 64.31 109.304 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 50' ' ' CYS . 1.2 tm? -127.95 141.95 51.39 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.944 -1.132 . . . . 73.04 107.944 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.526 ' N ' HD12 ' A' ' 49' ' ' LEU . 4.2 m -81.51 122.88 28.1 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.098 0.559 . . . . 75.41 111.15 -174.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.533 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.03 152.76 76.14 Favored Pre-proline 0 C--O 1.245 0.82 0 C-N-CA 120.237 -0.585 . . . . 62.45 111.51 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.38 112.36 3.51 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.791 2.327 . . . . 73.2 113.564 -173.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.57 -9.63 24.26 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.204 1.936 . . . . 70.25 111.681 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.21 -17.98 24.08 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.125 -0.943 . . . . 54.22 111.45 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -89.7 133.08 34.92 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 112.889 0.7 . . . . 74.14 112.889 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.535 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 94.6 Cg_exo -44.81 -45.19 13.89 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 124.738 3.625 . . . . 75.21 115.771 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -58.16 -36.78 73.52 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.656 0.265 . . . . 70.13 111.606 -175.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 62' ' ' ILE . 71.0 t -68.59 -42.23 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 116.247 -0.433 . . . . 74.33 110.342 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.535 ' OE1' ' HA ' ' A' ' 56' ' ' PRO . 40.7 mt-10 -56.43 -33.22 65.64 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.878 -0.601 . . . . 71.32 111.029 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HD3' ' O ' ' A' ' 56' ' ' PRO . 9.3 mpt_? -77.54 -43.39 32.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.97 -0.559 . . . . 74.45 112.449 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 pt -70.77 -32.07 47.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 112.872 0.693 . . . . 74.12 112.872 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 58' ' ' VAL . 70.4 mt -54.12 -42.68 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 109.55 -0.537 . . . . 70.34 109.55 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 79.6 mm-40 -57.78 -45.55 85.83 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.642 -0.708 . . . . 74.13 110.731 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -61.43 -41.47 97.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.134 -0.485 . . . . 63.41 111.85 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.426 HD12 ' CG1' ' A' ' 22' ' ' VAL . 86.3 mt -72.4 -35.74 68.49 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.014 -0.674 . . . . 74.44 111.474 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 51.4 mt-30 -66.5 -45.75 78.54 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.116 -0.633 . . . . 72.42 111.618 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 . . . . . 0 C--O 1.22 -0.467 0 C-N-CA 120.755 -0.378 . . . . 72.55 111.837 -178.027 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.415 ' HA ' HD13 ' A' ' 28' ' ' LEU . 45.5 t . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 104.496 -2.409 . . . . 64.14 104.496 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 10' ' ' LEU . 38.9 t -123.74 173.45 8.13 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 119.372 0.987 . . . . 74.23 111.11 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 80.7 mt -89.21 -55.14 3.79 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 108.54 -0.911 . . . . 74.43 108.54 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.9 t -176.94 165.13 2.39 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.493 -0.928 . . . . 63.31 108.493 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.503 HG11 ' CB ' ' A' ' 50' ' ' CYS . 1.5 m -126.0 152.77 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 105.882 -1.895 . . . . 65.44 105.882 174.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.4 t -93.46 176.58 6.33 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.166 -1.42 . . . . 65.23 107.166 174.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -58.21 -43.97 87.93 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 118.537 0.608 . . . . 75.42 112.15 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 1.3 tmmm? -144.05 87.27 8.03 Favored Pre-proline 0 N--CA 1.414 -2.272 0 N-CA-C 108.049 -1.093 . . . . 71.22 108.049 171.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.526 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.0 Cg_endo -51.39 -80.11 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 124.216 3.277 . . . . 72.44 117.55 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.32 170.19 9.08 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 109.912 -0.403 . . . . 74.43 109.912 -171.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.562 ' O ' HG12 ' A' ' 21' ' ' ILE . 44.6 Cg_exo -60.52 132.24 42.28 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.208 1.939 . . . . 61.43 111.442 175.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.439 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -79.48 2.29 72.94 Favored Glycine 0 C--N 1.299 -1.522 0 CA-C-N 115.981 -0.554 . . . . 53.43 113.798 -176.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -98.75 -5.25 31.72 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.6 0.593 . . . . 75.54 112.6 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.562 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.9 pt -93.71 3.56 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 121.612 0.72 . . . . 71.44 110.527 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.442 HG13 HD12 ' A' ' 65' ' ' LEU . 2.7 p -88.73 137.83 20.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.133 -0.94 . . . . 72.13 111.334 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.31 -55.97 3.57 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.324 -1.361 . . . . 75.03 107.324 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -143.43 162.84 34.73 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 124.132 0.973 . . . . 71.24 108.896 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -132.63 161.6 33.5 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.7 -0.4 . . . . 74.13 110.014 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.419 ' HB2' HG21 ' A' ' 40' ' ' VAL . 42.1 m80 -127.42 112.68 15.26 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.629 -0.878 . . . . 73.25 108.629 172.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -85.65 105.85 16.51 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.41 -0.814 . . . . 72.53 109.115 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 8' ' ' CYS . 8.7 tt -119.93 133.17 55.65 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-O 121.218 0.532 . . . . 70.4 110.647 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.4 mt -127.51 -177.7 4.18 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.661 -0.699 . . . . 73.04 109.423 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 58.8 mt -72.38 -20.39 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.149 -1.056 . . . . 74.4 108.149 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -62.91 -31.88 73.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.835 -1.075 . . . . 72.04 109.434 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.6 -57.34 5.88 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.583 -0.895 . . . . 63.03 108.583 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.65 71.5 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.333 -0.937 . . . . 62.14 112.877 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 35.6 t -173.1 140.85 0.91 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.794 -1.928 . . . . 75.4 105.794 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -73.18 -19.92 61.0 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.882 1.068 . . . . 72.14 113.882 -173.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.24 102.31 31.95 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-O 121.314 0.578 . . . . 74.31 110.823 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.3 130.34 6.24 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.391 2.061 . . . . 74.2 110.792 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.49 148.64 7.96 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 120.873 0.368 . . . . 75.34 110.472 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.25 119.95 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.017 0 N-CA-C 107.939 -1.134 . . . . 71.14 107.939 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.675 HG13 ' SG ' ' A' ' 50' ' ' CYS . 7.3 m -86.12 127.04 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.411 0 C-N-CA 119.854 -0.739 . . . . 74.04 109.108 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -97.6 114.8 26.8 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.584 -0.735 . . . . 74.33 110.047 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.4 m -81.2 103.35 10.93 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.194 -1.039 . . . . 74.14 108.194 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.7 p -73.77 171.52 13.17 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.282 -0.417 . . . . 73.12 111.375 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.4 mt -58.56 -28.83 65.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.537 0.735 . . . . 75.51 112.131 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -74.77 -14.45 60.71 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.403 0.681 . . . . 74.33 111.309 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.98 17.59 37.23 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 119.935 -1.126 . . . . 71.43 111.421 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -99.62 123.93 44.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 122.69 -0.3 . . . . 71.1 111.332 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -80.73 122.39 27.08 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.962 -0.755 . . . . 72.03 108.962 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 tp -136.07 126.37 26.54 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.228 -1.027 . . . . 75.21 108.228 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.675 ' SG ' HG13 ' A' ' 40' ' ' VAL . 17.3 m -87.39 149.41 24.49 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 113.713 1.005 . . . . 70.25 113.713 -171.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.526 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -134.06 162.54 57.09 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 115.058 -0.974 . . . . 75.24 109.221 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.43 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 63.2 Cg_endo -69.03 109.44 2.17 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.077 1.852 . . . . 75.14 112.298 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.04 -21.63 63.13 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.448 2.765 . . . . 73.52 115.794 -170.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -102.95 -14.3 16.56 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.977 0.418 . . . . 75.24 111.934 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.409 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.7 mm100 -68.39 141.76 93.8 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 113.51 0.93 . . . . 74.51 113.51 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.9 -39.06 24.31 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 124.78 3.654 . . . . 72.45 115.896 -176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -74.43 -31.87 62.45 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.374 -0.93 . . . . 72.14 110.791 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 62' ' ' ILE . 77.1 t -77.09 -38.77 28.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.96 -0.564 . . . . 72.31 112.308 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 11.0 pt-20 -55.9 -36.27 67.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 120.328 -0.549 . . . . 73.12 112.211 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -68.53 -51.19 45.75 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.925 0.343 . . . . 74.32 111.925 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.439 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 14.6 pt -63.4 -33.87 63.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.166 0.432 . . . . 75.42 112.166 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.509 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 66.6 mt -61.04 -46.84 95.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 N-CA-C 109.549 -0.537 . . . . 74.51 109.549 173.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 15.4 mm100 -57.67 -44.13 85.5 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.925 -0.398 . . . . 74.41 109.925 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -56.16 -48.75 75.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.247 -0.888 . . . . 74.14 110.014 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.442 HD12 HG13 ' A' ' 22' ' ' VAL . 83.1 mt -71.13 -31.56 67.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.317 -0.553 . . . . 74.33 112.236 177.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 45.0 mt-30 -66.84 -24.37 66.14 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 120.237 -0.585 . . . . 74.44 111.871 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 31.7 mmm180 . . . . . 0 C--N 1.318 -0.786 0 N-CA-C 109.709 -0.478 . . . . 75.35 109.709 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.409 -2.514 0 N-CA-C 108.439 -0.948 . . . . 64.12 108.439 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.4 ' SG ' HG13 ' A' ' 40' ' ' VAL . 51.9 m -91.62 179.1 5.74 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.944 0.72 . . . . 73.14 112.944 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.3 mt -100.71 -45.81 5.37 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.972 -1.013 . . . . 75.11 109.444 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.7 p -170.04 152.99 4.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 119.9 -0.72 . . . . 72.04 110.786 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 50' ' ' CYS . 2.2 m -112.67 146.63 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 N-CA-C 105.612 -1.996 . . . . 64.21 105.612 171.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.3 t -98.42 178.77 4.93 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 108.802 -0.814 . . . . 75.3 108.802 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -43.83 -57.95 2.99 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.293 0.637 . . . . 64.31 110.087 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -143.28 93.07 6.54 Favored Pre-proline 0 N--CA 1.421 -1.912 0 N-CA-C 108.597 -0.89 . . . . 74.33 108.597 171.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.521 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 5.1 Cg_endo -49.39 -76.12 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.857 3.038 . . . . 75.34 115.654 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.61 145.8 32.77 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 109.057 -0.72 . . . . 72.34 109.057 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.7 139.48 81.01 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.177 1.918 . . . . 75.13 111.213 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -74.04 0.63 51.72 Favored Glycine 0 C--O 1.22 -0.728 0 CA-C-O 121.471 0.484 . . . . 73.43 113.327 -177.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -80.35 -20.5 44.02 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 123.14 0.576 . . . . 73.21 110.726 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.3 pt -104.76 10.31 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.216 0.45 . . . . 73.44 112.216 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.443 HG13 HD12 ' A' ' 65' ' ' LEU . 3.7 p -97.38 139.52 19.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.814 0.34 . . . . 73.24 111.788 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.664 ' HD2' ' ND2' ' A' ' 24' ' ' ASN . 0.8 OUTLIER -95.75 -55.89 2.86 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.833 -0.803 . . . . 71.41 108.833 -177.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.664 ' ND2' ' HD2' ' A' ' 23' ' ' ARG . 49.6 m-80 -135.07 167.6 20.66 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 109.066 -0.716 . . . . 65.33 109.066 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -144.04 165.35 28.04 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.371 -0.603 . . . . 74.31 109.371 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -133.9 118.53 18.03 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.011 -1.107 . . . . 75.42 108.011 172.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -84.16 101.63 11.99 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.652 -0.704 . . . . 74.12 109.239 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.585 HD22 ' SG ' ' A' ' 34' ' ' CYS . 6.9 tt -106.54 133.35 51.36 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.369 -0.832 . . . . 72.13 110.471 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -128.63 -176.54 3.87 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.702 -0.681 . . . . 74.35 110.144 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.7 mt -72.09 -22.2 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.589 -0.893 . . . . 65.41 108.589 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -63.44 -29.92 71.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.529 -0.76 . . . . 53.25 110.747 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -67.87 -39.16 83.75 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.027 -0.731 . . . . 74.0 109.027 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.74 58.96 0.23 Allowed Glycine 0 CA--C 1.498 -1.014 0 CA-C-N 115.187 -0.915 . . . . 72.12 110.868 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.585 ' SG ' HD22 ' A' ' 28' ' ' LEU . 61.4 m -141.91 136.62 30.63 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.626 -1.25 . . . . 75.34 107.626 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -76.06 -10.94 59.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.478 0.656 . . . . 75.32 110.647 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 p -121.36 101.39 43.94 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.372 -0.831 . . . . 75.15 109.903 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.14 130.17 10.98 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.797 1.665 . . . . 72.44 109.624 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 50' ' ' CYS . . . -168.11 148.72 4.97 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.73 0.3 . . . . 63.44 110.921 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.76 126.96 53.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.351 -0.611 . . . . 74.02 109.351 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.626 HG13 ' SG ' ' A' ' 50' ' ' CYS . 10.5 m -84.5 127.56 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 C-N-CA 120.171 -0.612 . . . . 64.41 109.464 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.436 ' CD1' HG22 ' A' ' 22' ' ' VAL . 9.3 m-85 -99.74 121.06 40.7 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.646 -0.707 . . . . 74.22 109.809 174.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.5 m -90.5 104.96 17.48 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.455 -0.942 . . . . 74.35 108.455 174.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 55.6 p -70.62 171.02 11.03 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.395 -0.366 . . . . 74.41 111.605 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.99 -25.8 65.59 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.601 0.715 . . . . 74.42 109.106 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -64.62 -32.45 74.12 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.8 -1.091 . . . . 74.22 109.611 172.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.11 16.42 15.12 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 115.757 -0.656 . . . . 74.1 112.914 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -94.08 134.73 36.19 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.241 0.521 . . . . 75.53 110.951 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -90.77 116.46 28.64 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 107.37 -1.344 . . . . 72.11 107.37 170.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 50' ' ' CYS . 1.6 tm? -138.02 143.86 40.77 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.695 -1.224 . . . . 71.44 107.695 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.626 ' SG ' HG13 ' A' ' 40' ' ' VAL . 30.8 m -94.69 143.2 26.63 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 115.19 1.552 . . . . 73.2 115.19 -177.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.521 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -125.6 163.09 40.95 Favored Pre-proline 0 N--CA 1.434 -1.265 0 CA-C-N 114.65 -1.159 . . . . 73.45 109.142 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 57.0 Cg_endo -70.76 110.38 2.74 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.123 1.882 . . . . 71.12 112.985 -174.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.75 -9.87 26.63 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 123.19 2.593 . . . . 72.12 114.676 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -101.04 -20.83 15.21 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.105 0.478 . . . . 65.31 111.308 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -69.3 130.12 91.25 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 112.795 0.665 . . . . 74.04 112.795 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.2 -36.21 36.13 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.109 3.206 . . . . 74.23 114.247 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.419 ' CE2' HG23 ' A' ' 58' ' ' VAL . 28.3 p-90 -64.8 -27.58 68.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 119.224 -0.991 . . . . 72.45 109.921 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 62' ' ' ILE . 69.7 t -86.16 -48.86 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.642 -0.708 . . . . 72.04 111.614 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.357 0.3 OUTLIER -61.9 -29.39 70.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.101 1.149 . . . . 73.44 114.101 -176.63 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -68.86 -43.09 76.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.765 0.317 . . . . 74.4 111.276 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.43 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.9 pt -71.72 -30.73 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 O-C-N 122.124 -0.36 . . . . 75.04 111.628 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.549 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 62.8 mt -56.76 -46.87 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.159 -0.473 . . . . 74.42 109.943 173.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -56.88 -41.9 78.87 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.114 0.566 . . . . 74.24 109.544 179.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 98.3 mtt180 -62.47 -38.93 91.74 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.58 -0.737 . . . . 71.22 111.492 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.443 HD12 HG13 ' A' ' 22' ' ' VAL . 84.5 mt -81.26 -26.06 36.1 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.676 0.251 . . . . 72.23 111.676 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 98.3 mt-30 -58.22 -20.53 42.38 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.59 0.959 . . . . 73.01 113.59 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 16.9 ptm180 . . . . . 0 CA--C 1.555 1.136 0 O-C-N 123.103 0.252 . . . . 75.31 111.298 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.455 ' HA ' HD11 ' A' ' 28' ' ' LEU . 27.2 p . . . . . 0 N--CA 1.412 -2.326 0 N-CA-C 106.593 -1.632 . . . . 72.12 106.593 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -101.98 175.23 5.61 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 118.436 -1.306 . . . . 70.42 110.625 -176.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.0 -64.86 1.06 Allowed 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.416 -0.587 . . . . 73.1 109.416 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -176.03 160.21 2.25 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 106.218 -1.771 . . . . 74.23 106.218 -178.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -98.87 160.04 3.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 118.722 -1.191 . . . . 71.31 109.422 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.0 t -106.15 179.47 4.26 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.416 -0.587 . . . . 63.14 109.416 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -40.48 -50.15 2.91 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.288 1.435 . . . . 74.3 110.458 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -159.97 98.47 1.49 Allowed Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 107.662 -1.236 . . . . 75.1 107.662 169.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.555 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -42.36 -73.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.379 3.386 . . . . 55.11 116.622 -175.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.69 167.86 14.36 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.219 -0.66 . . . . 72.53 109.219 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.508 ' O ' HG12 ' A' ' 21' ' ' ILE . 38.6 Cg_exo -62.21 128.71 24.68 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.704 1.603 . . . . 71.14 109.495 171.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.427 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -71.49 1.33 28.86 Favored Glycine 0 C--N 1.301 -1.376 0 N-CA-C 114.336 0.494 . . . . 72.32 114.336 -175.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -94.35 -13.48 26.33 Favored 'General case' 0 C--N 1.285 -2.222 0 O-C-N 122.509 -0.406 . . . . 74.44 111.544 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 18' ' ' PRO . 38.9 pt -95.52 9.47 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.191 0.519 . . . . 75.02 111.205 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.574 HG22 ' CD1' ' A' ' 41' ' ' PHE . 3.1 p -96.9 141.27 15.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 115.949 -0.568 . . . . 74.04 111.842 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.484 ' HD2' ' ND2' ' A' ' 24' ' ' ASN . 1.3 tmt_? -105.44 -54.32 2.5 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.483 -0.932 . . . . 72.32 108.483 -178.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.484 ' ND2' ' HD2' ' A' ' 23' ' ' ARG . 53.6 m-80 -123.88 160.55 27.22 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.126 -0.694 . . . . 63.01 109.126 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.455 ' CZ ' HG22 ' A' ' 62' ' ' ILE . 42.1 p90 -141.53 155.0 45.82 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.324 -0.991 . . . . 75.41 108.324 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -137.26 128.42 27.81 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.601 -0.518 . . . . 72.43 109.601 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -79.24 101.31 7.93 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 109.272 -0.64 . . . . 73.32 109.272 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' A' ' 8' ' ' CYS . 43.6 mt -98.92 131.0 45.33 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-O 121.665 0.745 . . . . 74.02 109.855 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.9 mt -132.59 178.23 7.01 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 114.877 -1.056 . . . . 73.52 108.815 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 25.3 mt -76.55 -29.5 18.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.442 -0.947 . . . . 61.12 108.442 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -67.83 -15.63 63.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.223 -0.899 . . . . 74.42 109.777 174.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -89.14 -43.2 11.21 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.924 -1.139 . . . . 75.44 107.924 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.8 -90.14 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 119.721 -1.228 . . . . 74.33 115.122 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 58.2 m -75.89 157.56 33.11 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.077 0.399 . . . . 72.15 112.077 -172.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -72.8 29.25 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.474 1.11 . . . . 71.42 113.702 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.4 p -137.4 102.9 8.74 Favored Pre-proline 0 C--N 1.3 -1.568 0 CA-C-O 121.395 0.617 . . . . 63.33 110.181 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -86.85 130.18 3.06 Favored 'Trans proline' 0 N--CA 1.438 -1.75 0 C-N-CA 121.941 1.76 . . . . 73.11 111.772 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.29 157.73 9.43 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.529 -0.759 . . . . 74.11 109.087 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.85 126.31 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 108.334 -0.987 . . . . 72.1 108.334 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 20.1 m -94.01 129.29 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.98 0 CA-C-O 121.609 0.718 . . . . 70.01 110.534 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 22' ' ' VAL . 7.2 m-85 -93.86 118.16 31.08 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 114.958 -1.019 . . . . 75.14 111.897 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.4 m -81.36 105.45 12.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.436 -0.949 . . . . 74.45 108.436 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.1 p -76.11 174.28 10.25 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.699 0.285 . . . . 72.35 111.363 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 88.1 mt -62.52 -28.39 69.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.185 0.594 . . . . 71.31 110.307 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -69.52 -30.21 67.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.546 -0.752 . . . . 75.55 109.414 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.57 8.69 45.64 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.66 -0.7 . . . . 72.11 111.949 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -95.22 133.49 39.03 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 105.605 -1.998 . . . . 64.31 105.605 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 39.1 mt-30 -96.79 143.57 27.59 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.477 -0.935 . . . . 71.11 108.477 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 37.4 tp -135.91 150.35 49.3 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.215 -0.594 . . . . 73.52 109.881 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.2 m -77.47 122.18 24.86 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 123.547 0.53 . . . . 73.51 109.72 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.555 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.28 151.76 72.74 Favored Pre-proline 0 C--N 1.311 -1.083 0 C-N-CA 120.288 -0.565 . . . . 72.32 110.1 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.98 110.31 3.09 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.778 2.319 . . . . 74.15 113.859 -173.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -67.94 -17.33 46.46 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.328 2.018 . . . . 65.03 111.887 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.96 -17.05 34.03 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.777 -0.647 . . . . 74.13 111.729 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -84.81 127.49 64.79 Favored Pre-proline 0 C--N 1.317 -0.827 0 O-C-N 122.162 -0.336 . . . . 74.24 111.277 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -46.76 -37.87 21.81 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.608 3.539 . . . . 62.03 115.125 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.431 ' O ' HG12 ' A' ' 61' ' ' ILE . 41.8 p-90 -61.25 -35.4 77.17 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 120.784 -0.366 . . . . 75.45 110.752 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 62' ' ' ILE . 76.6 t -70.64 -41.65 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.806 -0.634 . . . . 75.41 111.244 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.2 mt-10 -58.09 -47.5 83.02 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 111.681 0.252 . . . . 62.33 111.681 -178.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -64.03 -40.29 95.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.695 1.369 . . . . 71.21 114.695 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 57' ' ' TRP . 10.7 pt -69.79 -35.69 66.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.34 -0.544 . . . . 73.33 111.507 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.455 HG22 ' CZ ' ' A' ' 25' ' ' PHE . 56.9 mt -59.26 -49.55 83.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.356 -0.384 . . . . 75.14 110.517 173.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 18.5 mm-40 -56.19 -37.65 69.92 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.155 0.582 . . . . 72.34 110.125 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.557 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 20.2 ttm180 -68.08 -36.71 80.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.657 -0.701 . . . . 74.22 110.856 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.457 HD12 HG13 ' A' ' 22' ' ' VAL . 87.2 mt -76.13 -35.61 59.18 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 122.097 -0.377 . . . . 74.14 111.091 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -58.08 -19.15 29.8 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.983 1.475 . . . . 75.44 114.983 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 39.6 ptt180 . . . . . 0 C--N 1.319 -0.719 0 C-N-CA 120.232 -0.587 . . . . 74.12 111.731 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.472 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 24.6 p . . . . . 0 N--CA 1.434 -1.247 0 N-CA-C 107.039 -1.467 . . . . 73.31 107.039 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.519 ' SG ' HG13 ' A' ' 40' ' ' VAL . 1.7 t -121.87 -178.89 3.96 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 117.999 -1.48 . . . . 71.53 107.89 174.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tt -88.48 -67.74 0.81 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.117 -0.697 . . . . 73.52 109.117 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.7 m -168.55 149.07 4.65 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.215 -1.031 . . . . 62.11 108.215 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.49 158.66 4.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 119.144 -1.022 . . . . 75.21 108.323 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.1 t -103.21 178.47 4.55 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.077 -0.712 . . . . 73.13 109.077 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -46.64 -41.16 14.33 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.398 0.679 . . . . 70.4 111.544 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.5 ttpt -162.04 100.61 1.15 Allowed Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 107.249 -1.389 . . . . 75.3 107.249 170.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.588 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.5 Cg_endo -51.52 -82.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.889 3.059 . . . . 54.41 117.634 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.08 159.98 59.68 Favored Pre-proline 0 C--N 1.316 -0.878 0 O-C-N 121.964 -0.46 . . . . 55.44 110.257 -173.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.547 ' O ' HG12 ' A' ' 21' ' ' ILE . 78.1 Cg_exo -55.2 128.49 30.75 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.566 2.178 . . . . 75.42 110.691 173.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.452 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -79.71 0.46 81.79 Favored Glycine 0 C--N 1.307 -1.028 0 N-CA-C 115.15 0.82 . . . . 72.45 115.15 -174.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -99.17 -0.16 42.16 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.147 0.795 . . . . 71.55 113.147 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 18' ' ' PRO . 36.9 pt -101.27 10.25 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.667 0.746 . . . . 72.12 110.074 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.448 ' CG1' HD12 ' A' ' 65' ' ' LEU . 3.1 p -94.44 138.98 19.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.287 -0.869 . . . . 72.53 111.336 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.09 -47.2 7.38 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.786 -0.82 . . . . 74.51 108.786 -175.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -149.93 160.5 43.55 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.048 -1.093 . . . . 73.54 108.048 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.3 168.26 19.51 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 117.973 0.352 . . . . 74.41 110.519 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.477 ' HB2' HG21 ' A' ' 40' ' ' VAL . 40.7 m80 -135.46 112.41 10.27 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.377 -1.342 . . . . 73.13 107.377 171.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -79.45 99.29 7.15 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.339 -1.356 . . . . 65.23 107.339 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.472 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -111.73 117.55 33.18 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.761 -0.654 . . . . 75.45 110.288 -170.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.8 mt -104.82 -176.07 2.97 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.497 -0.557 . . . . 74.25 109.497 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 63.3 mt -67.04 -36.24 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.909 0.862 . . . . 73.45 109.16 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -64.29 -24.17 67.56 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.484 -1.234 . . . . 72.52 110.276 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.48 -28.39 16.85 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.828 -0.624 . . . . 53.43 110.514 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.96 -106.76 0.65 Allowed Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 119.626 -1.273 . . . . 73.4 115.884 -173.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 33.6 m -118.32 179.68 4.04 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.993 -0.604 . . . . 73.32 109.496 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -55.22 -19.38 7.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.35 1.06 . . . . 74.35 112.377 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -103.14 106.79 52.85 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 121.114 0.483 . . . . 75.25 111.34 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -87.19 144.21 6.92 Favored 'Trans proline' 0 C--O 1.251 1.143 0 C-N-CA 122.576 2.184 . . . . 72.33 110.848 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -174.43 153.47 1.91 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.92 -0.4 . . . . 63.53 109.92 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.49 122.59 50.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.178 -1.416 . . . . 71.25 107.178 175.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.519 HG13 ' SG ' ' A' ' 9' ' ' CYS . 8.0 m -89.16 127.72 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.859 0 C-N-CA 119.566 -0.854 . . . . 71.55 109.426 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -98.13 121.54 40.18 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 115.302 -0.863 . . . . 73.33 110.702 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.0 m -86.35 103.42 14.91 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.819 -1.178 . . . . 75.34 107.819 174.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 50.0 p -70.97 171.69 10.36 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 116.201 -0.454 . . . . 64.32 110.833 -177.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 98.4 mt -60.96 -26.93 67.88 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.356 0.598 . . . . 70.51 109.775 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -71.65 -15.15 62.22 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 114.972 -1.013 . . . . 61.44 111.018 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.04 8.66 61.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.004 -0.617 . . . . 63.54 112.731 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -93.41 140.59 29.4 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 122.869 -0.195 . . . . 73.23 110.84 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -99.88 117.76 34.87 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.52 -0.918 . . . . 74.23 108.52 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.52 HD12 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -120.95 143.39 49.02 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.633 -0.877 . . . . 73.02 108.633 -174.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.52 ' N ' HD12 ' A' ' 49' ' ' LEU . 6.3 m -80.15 126.14 30.71 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 122.993 0.517 . . . . 74.13 111.17 -174.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.588 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -128.26 153.27 78.84 Favored Pre-proline 0 C--O 1.245 0.859 0 C-N-CA 120.907 -0.317 . . . . 74.12 110.989 175.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 72.0 Cg_endo -68.47 113.28 3.08 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.204 2.603 . . . . 73.33 113.024 -175.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 60.1 Cg_endo -72.24 -8.02 22.01 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.551 2.167 . . . . 73.15 114.205 -175.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -109.73 -0.51 18.48 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.3 0.572 . . . . 73.5 111.616 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -86.34 135.97 36.02 Favored Pre-proline 0 C--N 1.314 -0.942 0 O-C-N 121.52 -0.737 . . . . 75.23 112.233 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.76 -36.76 26.7 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 124.697 3.598 . . . . 75.5 115.051 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -68.77 -32.48 72.26 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 120.343 -0.543 . . . . 60.42 110.685 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.639 ' O ' HG12 ' A' ' 62' ' ' ILE . 72.4 t -71.7 -48.99 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.831 -0.622 . . . . 74.13 111.997 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 9.3 pt-20 -55.69 -30.36 60.97 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.575 0.583 . . . . 73.15 112.575 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -73.02 -45.09 59.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.563 -0.29 . . . . 75.15 111.301 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.452 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 12.9 pt -71.71 -29.02 32.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 111.89 0.33 . . . . 75.4 111.89 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.639 HG12 ' O ' ' A' ' 58' ' ' VAL . 46.9 mm -56.49 -44.89 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.892 -0.781 . . . . 75.25 108.892 172.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 15.5 mm100 -59.1 -42.51 90.67 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.806 -0.634 . . . . 74.52 110.58 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -60.86 -46.59 90.0 Favored 'General case' 0 C--O 1.206 -1.201 0 O-C-N 124.143 0.902 . . . . 75.14 111.002 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.448 HD12 ' CG1' ' A' ' 22' ' ' VAL . 86.8 mt -72.47 -34.11 67.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.253 -0.579 . . . . 72.25 111.897 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 43.7 mt-30 -61.5 -19.59 62.23 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 113.466 0.914 . . . . 74.24 113.466 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 120.945 0.403 . . . . 73.34 110.122 179.208 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.432 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 46.5 t . . . . . 0 N--CA 1.437 -1.113 0 N-CA-C 106.351 -1.722 . . . . 74.44 106.351 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' A' ' 10' ' ' LEU . 11.9 t -118.9 178.32 4.53 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 120.071 -0.652 . . . . 74.15 111.637 -173.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.403 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 83.4 mt -94.36 -53.9 3.75 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.105 -1.072 . . . . 75.03 108.105 174.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.9 t -177.19 -173.97 0.48 Allowed 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.131 -1.063 . . . . 63.23 108.131 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.78 167.67 25.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 106.939 -1.504 . . . . 75.44 106.939 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.2 t -105.52 178.28 4.61 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.781 -0.822 . . . . 75.1 108.781 175.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -53.02 -38.26 62.21 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.172 0.511 . . . . 74.41 111.139 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 ttmt -159.2 93.42 1.82 Allowed Pre-proline 0 N--CA 1.425 -1.707 0 N-CA-C 108.014 -1.106 . . . . 75.4 108.014 173.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.2 Cg_endo -54.07 -86.24 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.882 3.055 . . . . 65.42 117.945 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.39 163.18 50.65 Favored Pre-proline 0 C--N 1.32 -0.698 0 O-C-N 121.865 -0.522 . . . . 72.35 110.565 -172.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.524 ' O ' HG12 ' A' ' 21' ' ' ILE . 38.0 Cg_exo -62.03 130.05 29.45 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.165 1.91 . . . . 74.13 110.853 175.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.461 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -71.95 1.6 30.85 Favored Glycine 0 C--N 1.307 -1.042 0 N-CA-C 114.32 0.488 . . . . 45.21 114.32 -177.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -87.32 -22.16 25.28 Favored 'General case' 0 N--CA 1.416 -2.128 0 O-C-N 122.529 -0.395 . . . . 74.43 110.692 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.5 pt -90.7 8.66 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 120.206 -0.598 . . . . 71.45 111.887 -176.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 65' ' ' LEU . 2.6 p -92.94 132.51 36.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.22 0.533 . . . . 71.1 111.753 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -55.33 3.63 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.004 -1.11 . . . . 74.33 108.004 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -135.24 158.33 44.63 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.279 -1.008 . . . . 71.41 108.279 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -139.71 155.06 47.57 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.153 -0.619 . . . . 74.55 110.634 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -122.27 112.59 18.33 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.666 -1.235 . . . . 64.14 107.666 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -83.46 99.58 10.19 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.064 -0.717 . . . . 75.14 109.064 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 88.3 mt -106.58 143.26 34.95 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.8 -0.636 . . . . 74.51 111.798 -176.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.6 mt -140.45 175.85 9.26 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.876 -1.056 . . . . 62.41 109.639 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 46.4 mt -76.41 -19.79 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.961 -1.126 . . . . 72.22 107.961 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -60.82 -36.58 79.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.467 -1.242 . . . . 74.51 109.276 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.99 -41.06 78.33 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.595 -0.729 . . . . 70.03 109.274 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.96 -36.91 1.29 Allowed Glycine 0 CA--C 1.495 -1.197 0 C-N-CA 120.741 -0.742 . . . . 74.42 112.361 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 49.3 t -69.56 127.94 34.76 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.002 -1.11 . . . . 74.43 108.002 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -84.43 1.62 44.59 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.902 1.445 . . . . 73.14 114.902 -170.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -110.29 95.85 23.85 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 108.598 -0.89 . . . . 74.31 108.598 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -76.52 129.11 10.76 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 121.643 1.562 . . . . 72.15 111.415 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.492 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -171.0 151.3 3.25 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.231 -0.895 . . . . 74.11 109.728 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.22 119.6 47.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.463 -1.31 . . . . 75.34 107.463 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.426 HG13 ' SG ' ' A' ' 50' ' ' CYS . 2.6 m -83.46 119.35 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.565 0 C-N-CA 119.294 -0.963 . . . . 71.43 108.529 -178.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.401 ' CD1' HG22 ' A' ' 22' ' ' VAL . 11.1 m-85 -91.28 111.53 23.05 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.377 -0.828 . . . . 75.22 110.643 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.4 m -80.13 100.4 8.22 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 106.99 -1.485 . . . . 73.54 106.99 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 49.5 p -68.1 173.94 4.25 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.964 -0.562 . . . . 74.43 111.357 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.5 mt -61.26 -29.46 69.86 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.282 0.563 . . . . 71.32 110.728 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -73.14 -16.61 61.44 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.378 -0.828 . . . . 74.24 110.227 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.6 -8.39 66.21 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 116.247 -0.433 . . . . 54.24 112.25 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -77.34 127.77 33.15 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 107.128 -1.434 . . . . 71.32 107.128 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -85.15 123.77 31.05 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.723 -0.843 . . . . 71.24 108.723 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 50' ' ' CYS . 4.3 tt -135.54 133.53 38.5 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 106.727 -1.583 . . . . 74.0 106.727 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.489 ' N ' HD22 ' A' ' 49' ' ' LEU . 21.4 m -94.94 145.43 24.93 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 114.21 1.189 . . . . 72.44 114.21 -169.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.552 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -125.64 158.73 63.91 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 115.113 -0.949 . . . . 71.22 110.515 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.441 ' HB2' ' OE1' ' A' ' 55' ' ' GLN . 66.7 Cg_endo -69.49 108.11 1.96 Allowed 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.421 2.08 . . . . 65.2 112.569 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 71.7 Cg_endo -74.22 -10.37 22.49 Favored 'Trans proline' 0 N--CA 1.473 0.274 0 C-N-CA 123.113 2.542 . . . . 73.14 113.824 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -96.32 -16.19 21.46 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.571 0.701 . . . . 75.11 109.617 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.441 ' OE1' ' HB2' ' A' ' 52' ' ' PRO . 1.8 mp0 -82.08 144.44 50.97 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 113.497 0.925 . . . . 53.02 113.497 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.96 -39.97 81.76 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 124.548 3.498 . . . . 73.45 115.013 -174.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -65.31 -26.7 68.17 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.231 -0.587 . . . . 72.43 110.473 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 62' ' ' ILE . 71.8 t -81.22 -40.11 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.823 -0.626 . . . . 75.3 111.852 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 13.4 pt-20 -61.26 -37.07 81.8 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.775 0.657 . . . . 72.52 112.775 -176.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.409 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 3.2 mpt_? -69.26 -38.84 78.62 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 120.19 -0.604 . . . . 64.2 112.165 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.461 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 12.6 pt -71.42 -33.22 49.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 120.804 -0.358 . . . . 73.33 111.829 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 58' ' ' VAL . 67.7 mt -61.88 -47.02 95.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 N-CA-C 109.292 -0.633 . . . . 75.23 109.292 172.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 84.1 mm-40 -58.34 -41.25 84.2 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.167 -0.47 . . . . 74.23 111.42 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -60.23 -41.27 92.76 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.035 -0.529 . . . . 74.31 111.191 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.467 HD12 HG13 ' A' ' 22' ' ' VAL . 90.6 mt -75.25 -28.83 60.01 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.27 -0.572 . . . . 74.51 111.043 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.1 -35.09 71.67 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 112.011 0.374 . . . . 61.24 112.011 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? . . . . . 0 N--CA 1.433 -1.305 0 C-N-CA 124.128 0.971 . . . . 74.23 111.867 -177.727 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.447 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 4.9 p . . . . . 0 N--CA 1.43 -1.463 0 N-CA-C 110.138 -0.319 . . . . 74.33 110.138 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.539 ' SG ' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -93.37 -175.75 3.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.505 -0.924 . . . . 73.02 108.505 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.07 -59.06 1.94 Allowed 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.476 0.547 . . . . 63.1 112.476 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.8 m -162.27 141.71 9.52 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.838 -0.43 . . . . 75.42 109.838 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.7 m -98.94 152.03 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.255 -1.017 . . . . 74.33 108.255 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 t -94.15 178.39 5.66 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.161 -0.681 . . . . 75.5 109.161 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -45.27 -46.48 12.62 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.948 0.899 . . . . 64.33 110.597 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.493 ' HB2' ' HZ1' ' A' ' 15' ' ' LYS . 5.0 ttmp? -160.2 99.2 1.43 Allowed Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.017 -1.105 . . . . 70.54 108.017 169.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.5 Cg_endo -51.51 -81.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.351 0 C-N-CA 123.46 2.774 . . . . 51.4 116.785 -175.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.403 HD13 ' HB2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -147.95 152.46 40.37 Favored Pre-proline 0 C--N 1.322 -0.628 0 O-C-N 121.943 -0.473 . . . . 75.43 110.611 -174.116 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.453 ' O ' HG12 ' A' ' 21' ' ' ILE . 18.7 Cg_endo -61.97 141.2 88.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.444 2.096 . . . . 74.12 111.32 174.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.86 1.46 78.78 Favored Glycine 0 C--N 1.309 -0.952 0 C-N-CA 121.434 -0.413 . . . . 74.34 113.568 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.427 ' CE1' ' HG2' ' A' ' 64' ' ' ARG . 98.4 m-85 -94.6 -0.6 54.36 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 122.226 -0.573 . . . . 71.31 111.553 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 35.4 pt -112.41 5.13 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.279 0.561 . . . . 74.32 110.728 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 p -90.78 135.04 27.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.997 -0.547 . . . . 63.24 111.261 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.39 -55.6 3.82 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.775 -0.824 . . . . 72.12 108.775 -175.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -140.45 164.33 30.43 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.361 0.664 . . . . 73.12 109.626 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 8.6 p90 -143.85 167.98 21.03 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.743 0.306 . . . . 75.32 110.51 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -141.96 137.09 30.99 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.155 -1.054 . . . . 65.32 108.155 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -98.6 103.87 15.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 123.448 0.467 . . . . 72.41 109.868 -173.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 2.3 mm? -103.74 128.55 51.1 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.921 -0.77 . . . . 73.44 108.921 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.9 mt -131.95 179.59 5.99 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.225 0.536 . . . . 70.34 111.278 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.7 mt -77.99 -19.0 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.689 -1.226 . . . . 74.15 107.689 173.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.49 -34.33 72.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.07 -0.968 . . . . 61.34 109.845 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -68.16 -34.22 75.92 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.424 -0.807 . . . . 71.21 109.927 176.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.34 -17.51 3.54 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.356 -0.838 . . . . 75.12 112.471 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.22 161.69 26.61 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.675 1.361 . . . . 75.45 114.675 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -81.33 -15.49 55.2 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.939 -1.028 . . . . 74.51 111.282 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -134.12 123.81 17.04 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-O 120.971 0.415 . . . . 75.31 111.958 -174.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -85.94 129.39 3.43 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 121.794 1.663 . . . . 74.34 109.556 172.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -162.77 136.86 6.27 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.121 -0.49 . . . . 63.13 109.742 -176.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.99 124.51 52.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.305 -1.369 . . . . 74.44 107.305 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.539 HG13 ' SG ' ' A' ' 9' ' ' CYS . 18.8 m -84.79 123.17 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.548 0 CA-C-O 121.854 0.835 . . . . 73.45 110.178 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.403 ' HB2' HD13 ' A' ' 17' ' ' ILE . 15.1 m-85 -97.97 117.88 33.3 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 114.757 -1.111 . . . . 75.41 109.804 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 94.4 m -87.1 102.08 14.1 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.746 -0.835 . . . . 75.44 108.746 174.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.5 p -70.97 166.79 20.53 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.373 -0.376 . . . . 75.34 110.511 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 90.0 mt -60.47 -25.58 66.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.525 0.678 . . . . 72.0 110.353 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -62.75 -24.85 67.9 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.127 -0.942 . . . . 73.0 110.644 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.44 15.97 36.07 Favored Glycine 0 CA--C 1.505 -0.551 0 C-N-CA 121.288 -0.482 . . . . 72.15 111.911 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 42' ' ' THR . 34.3 mmt180 -99.56 139.21 35.54 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 120.665 0.269 . . . . 75.51 111.007 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -95.79 129.41 43.03 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.996 -1.853 . . . . 71.33 105.996 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.2 tp -137.57 144.62 42.13 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.463 -0.495 . . . . 60.12 110.148 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 9.7 m -80.16 128.57 33.67 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 123.494 0.496 . . . . 72.45 110.632 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.47 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -131.86 154.78 81.86 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 109.208 -0.664 . . . . 65.43 109.208 172.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.31 107.82 2.48 Favored 'Trans proline' 0 CA--C 1.559 1.758 0 C-N-CA 122.643 2.229 . . . . 72.21 113.924 -173.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.9 Cg_endo -68.61 -19.8 41.62 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.135 2.557 . . . . 72.22 114.882 -173.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -96.87 2.7 52.04 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.601 0.715 . . . . 73.42 110.799 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -95.06 143.14 25.61 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 112.291 0.478 . . . . 74.05 112.291 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.27 -46.79 27.07 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 124.427 3.418 . . . . 74.33 114.625 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.499 ' O ' HG12 ' A' ' 61' ' ' ILE . 33.8 p-90 -63.33 -30.6 71.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 120.488 -0.485 . . . . 73.44 110.832 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 62' ' ' ILE . 72.7 t -81.56 -44.07 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.198 -0.455 . . . . 72.43 111.489 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -24.63 67.69 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 120.302 -0.559 . . . . 71.35 111.513 -177.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -79.64 -29.63 41.04 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 115.838 -0.619 . . . . 74.25 110.731 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 57' ' ' TRP . 8.3 pt -86.09 -35.31 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.703 1.001 . . . . 73.32 113.703 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 58' ' ' VAL . 67.9 mt -53.01 -41.63 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 120.741 0.305 . . . . 74.33 110.809 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -59.99 -35.33 74.79 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.942 0.719 . . . . 74.13 112.942 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 7.1 mpt_? -57.31 -45.98 83.67 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.05 0.452 . . . . 60.02 110.316 174.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 3.5 mm? -68.1 -43.35 78.66 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.697 -0.683 . . . . 74.32 110.252 176.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -59.91 -41.71 92.3 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 115.61 -0.723 . . . . 74.23 112.268 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . 0.263 4.2 ppt_? . . . . . 0 C--O 1.217 -0.641 0 N-CA-C 113.365 0.876 . . . . 73.14 113.365 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 N--CA 1.411 -2.381 0 CA-C-O 120.783 0.325 . . . . 73.55 110.534 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.647 ' SG ' ' HB1' ' A' ' 38' ' ' ALA . 75.6 m -61.0 145.86 49.19 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 115.74 1.756 . . . . 44.24 115.74 -171.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -90.81 -54.51 3.94 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 105.315 -2.106 . . . . 65.04 105.315 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.3 m -165.6 174.65 9.63 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 108.469 -0.937 . . . . 63.12 108.469 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.404 HG11 ' CB ' ' A' ' 50' ' ' CYS . 2.2 m -135.01 157.57 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.389 -1.708 . . . . 74.13 106.389 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.434 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 10.1 t -102.3 177.45 4.87 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.315 -1.365 . . . . 64.4 107.315 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -47.3 -67.02 0.32 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.596 0.634 . . . . 75.3 111.739 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 40.2 ttmt -132.49 85.91 46.79 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 119.749 -0.78 . . . . 72.42 109.166 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.491 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 6.7 Cg_endo -47.01 -80.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 124.75 3.633 . . . . 54.54 118.166 -175.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.45 156.83 73.2 Favored Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 121.916 -0.49 . . . . 75.34 111.634 -172.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.444 ' O ' HG12 ' A' ' 21' ' ' ILE . 27.0 Cg_endo -64.99 136.61 49.13 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.722 2.281 . . . . 73.44 111.486 174.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.0 1.45 63.32 Favored Glycine 0 C--N 1.31 -0.909 0 CA-C-N 115.936 -0.575 . . . . 64.51 113.631 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -83.73 -24.84 31.0 Favored 'General case' 0 N--CA 1.414 -2.24 0 O-C-N 122.301 -0.529 . . . . 75.33 110.933 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 18' ' ' PRO . 36.5 pt -90.15 2.01 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 120.353 -0.539 . . . . 75.23 111.699 -177.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.44 HG13 HD12 ' A' ' 65' ' ' LEU . 3.0 p -93.24 134.01 32.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 121.207 0.527 . . . . 53.1 111.526 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.08 -47.35 7.88 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.542 -0.91 . . . . 72.13 108.542 -175.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 42' ' ' THR . 10.3 p30 -145.84 157.99 43.88 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.417 -0.957 . . . . 75.51 108.417 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -128.58 152.47 48.28 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.941 -0.763 . . . . 73.2 108.941 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.426 ' HB2' HG21 ' A' ' 40' ' ' VAL . 27.9 m170 -120.63 112.34 18.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.218 -1.401 . . . . 74.42 107.218 172.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -84.39 103.47 13.58 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.675 -0.861 . . . . 75.4 108.675 -175.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.5 mt -109.39 137.93 46.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.45 0.643 . . . . 73.14 111.939 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.1 mt -141.6 178.75 7.24 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.14 -0.936 . . . . 74.12 110.142 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 34' ' ' CYS . 49.0 mt -77.79 -30.27 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.541 -1.281 . . . . 75.11 107.541 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -61.52 -25.92 67.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.051 -0.977 . . . . 72.05 109.999 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -83.78 -56.3 3.78 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.375 -1.342 . . . . 75.32 107.375 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.6 71.72 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.373 -0.918 . . . . 62.41 113.65 173.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.421 ' O ' HG12 ' A' ' 30' ' ' ILE . 49.9 t -161.18 151.97 18.26 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.77 -1.567 . . . . 74.2 106.77 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -74.93 -24.42 58.49 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.885 0.374 . . . . 74.23 111.995 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.53 108.08 47.9 Favored Pre-proline 0 C--N 1.3 -1.568 0 CA-C-O 121.429 0.633 . . . . 73.41 111.223 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -84.98 130.68 4.18 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.388 2.058 . . . . 64.2 111.628 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.647 ' HB1' ' SG ' ' A' ' 9' ' ' CYS . . . -176.42 164.12 2.56 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 124.046 0.938 . . . . 65.1 108.862 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.34 127.98 56.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 109.758 -0.46 . . . . 75.3 109.758 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.681 HG13 ' SG ' ' A' ' 50' ' ' CYS . 3.2 m -88.81 127.9 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 N-CA-C 108.254 -1.017 . . . . 62.13 108.254 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -97.94 113.0 24.72 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 116.08 -0.509 . . . . 75.3 110.601 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 24' ' ' ASN . 96.9 m -80.48 101.91 9.37 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.484 -0.78 . . . . 73.23 108.962 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.6 p -73.43 170.52 14.93 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.328 -0.396 . . . . 74.43 110.873 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.3 mt -57.87 -27.98 63.75 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.289 0.636 . . . . 75.22 112.622 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.3 tpp180 -73.02 -20.79 60.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.915 0.388 . . . . 74.42 110.707 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.96 40.42 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.902 -0.879 . . . . 72.52 110.902 -176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -98.57 133.05 43.46 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.634 -1.617 . . . . 73.22 106.634 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -99.44 130.5 45.71 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.943 -0.762 . . . . 74.15 108.943 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -136.8 138.61 41.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.903 -1.517 . . . . 72.01 106.903 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.681 ' SG ' HG13 ' A' ' 40' ' ' VAL . 91.0 m -94.83 147.59 23.2 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 114.872 1.434 . . . . 73.43 114.872 -173.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.491 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -130.24 163.03 50.63 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-N 114.908 -1.042 . . . . 62.21 109.847 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.72 109.85 2.69 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 122.171 1.914 . . . . 74.44 113.018 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.04 -18.62 35.6 Favored 'Trans proline' 0 N--CA 1.483 0.886 0 C-N-CA 122.924 2.416 . . . . 75.45 113.232 -174.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.18 -7.98 54.54 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.439 0.638 . . . . 71.34 109.865 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -90.08 135.21 30.32 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-O 121.17 0.51 . . . . 73.21 111.309 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.433 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 11.8 Cg_endo -54.89 -35.85 90.17 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 124.341 3.361 . . . . 74.21 115.32 -175.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.456 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 37.9 p-90 -63.1 -30.49 71.63 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.88 0.371 . . . . 74.51 111.047 -177.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 62' ' ' ILE . 69.1 t -76.59 -36.62 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.076 -0.511 . . . . 64.13 110.89 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 56' ' ' PRO . 38.3 mt-10 -56.36 -45.02 80.66 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.035 0.445 . . . . 62.4 110.551 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.548 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 4.1 mmp_? -57.68 -51.07 71.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.246 -0.888 . . . . 75.53 111.423 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 pt -70.46 -33.2 52.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 113.335 0.865 . . . . 62.32 113.335 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 58' ' ' VAL . 60.1 mt -60.43 -45.56 96.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 109.459 -0.571 . . . . 71.32 109.459 173.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -57.6 -42.27 82.9 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.313 -0.403 . . . . 61.31 111.322 176.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 60' ' ' ARG . 89.4 mtt180 -59.23 -38.8 80.86 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.92 -0.582 . . . . 73.51 111.718 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.44 HD12 HG13 ' A' ' 22' ' ' VAL . 89.2 mt -79.41 -33.89 42.29 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.309 0.485 . . . . 75.43 112.309 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -68.79 -41.5 78.65 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 120.452 -0.499 . . . . 71.52 112.065 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 121.041 0.448 . . . . 64.22 110.833 179.714 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 N--CA 1.403 -2.812 0 N-CA-C 104.349 -2.463 . . . . 65.21 104.349 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.24 -175.75 3.76 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 117.796 -1.562 . . . . 73.22 110.227 -175.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.2 mt -98.41 -64.69 1.02 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 120.903 0.382 . . . . 72.4 110.709 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.1 t -176.03 153.07 1.26 Allowed 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.146 -1.428 . . . . 70.14 107.146 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -106.98 160.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 119.154 -1.019 . . . . 75.04 110.021 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -106.24 179.59 4.22 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.567 -0.901 . . . . 72.52 108.567 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -42.62 -57.27 2.77 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.904 0.881 . . . . 75.3 109.677 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.42 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 ttpt -145.85 97.59 4.55 Favored Pre-proline 0 N--CA 1.428 -1.543 0 N-CA-C 108.4 -0.963 . . . . 74.43 108.4 170.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 2.6 Cg_endo -39.62 -73.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.712 3.608 . . . . 72.14 116.015 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.38 158.02 61.66 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 107.448 -1.316 . . . . 72.14 107.448 -177.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.483 ' O ' HG12 ' A' ' 21' ' ' ILE . 17.9 Cg_endo -63.12 130.78 29.99 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 121.649 1.566 . . . . 72.34 110.558 174.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.506 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -72.26 2.01 30.95 Favored Glycine 0 C--N 1.303 -1.264 0 N-CA-C 115.029 0.772 . . . . 62.43 115.029 -174.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.76 -3.71 38.49 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 112.495 0.554 . . . . 75.25 112.495 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.511 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 39.6 pt -103.81 6.4 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 121.379 0.609 . . . . 72.5 110.378 177.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.56 HG22 ' CD1' ' A' ' 41' ' ' PHE . 5.1 p -91.63 143.46 11.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.794 -0.639 . . . . 75.22 111.582 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HE ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -99.88 -56.46 2.37 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.949 -1.13 . . . . 73.03 107.949 -178.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -134.21 166.03 23.74 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.738 -0.838 . . . . 74.04 108.738 -176.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -143.61 161.13 39.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.821 -0.437 . . . . 71.42 109.821 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -137.68 122.58 18.91 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 110.145 -0.316 . . . . 74.13 110.145 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -75.8 98.19 4.09 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 123.236 0.335 . . . . 74.12 110.16 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.5 mt -97.14 134.2 40.79 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-O 121.887 0.851 . . . . 75.55 110.249 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.6 mt -125.93 -178.53 4.32 Favored 'General case' 0 C--N 1.256 -3.471 0 N-CA-C 106.725 -1.583 . . . . 74.05 106.725 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.2 mt -63.85 -37.88 80.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 120.312 -0.555 . . . . 72.04 109.798 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -59.87 -31.88 70.19 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 114.264 1.209 . . . . 74.03 114.264 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -111.92 -5.35 14.35 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.962 0.41 . . . . 73.45 111.259 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.77 -124.32 3.43 Favored Glycine 0 N--CA 1.417 -2.609 0 CA-C-N 115.857 -0.611 . . . . 43.11 112.726 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 84.7 m -118.01 -87.24 0.63 Allowed 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.398 -0.401 . . . . 73.14 110.404 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -143.23 15.18 1.86 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.175 0.988 . . . . 73.4 108.824 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 p -127.83 117.85 20.94 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 115.302 -0.863 . . . . 72.02 110.265 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.97 130.17 2.1 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 121.929 1.753 . . . . 60.52 110.491 174.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -171.52 154.79 3.9 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.94 -0.763 . . . . 73.13 108.94 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.25 125.43 52.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.5 -0.926 . . . . 74.34 108.5 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 m -90.12 128.35 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.008 0 C-N-CA 119.643 -0.823 . . . . 73.02 109.308 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.56 ' CD1' HG22 ' A' ' 22' ' ' VAL . 15.3 m-85 -95.58 125.52 40.23 Favored 'General case' 0 C--N 1.272 -2.788 0 CA-C-N 115.358 -0.837 . . . . 73.11 110.177 175.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.4 m -93.45 103.65 15.84 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.922 -1.14 . . . . 74.24 107.922 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 71.1 p -70.0 174.36 5.45 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.35 -0.386 . . . . 73.4 111.248 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 95.3 mt -61.2 -27.39 68.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.52 0.676 . . . . 75.35 109.724 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -67.57 -28.4 67.74 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.718 1.207 . . . . 71.24 110.904 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.08 16.59 40.53 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 120.79 -0.719 . . . . 65.21 111.424 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.62 138.39 31.55 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.436 -1.32 . . . . 64.45 107.436 -177.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -91.97 121.18 33.32 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.79 -1.189 . . . . 75.41 107.79 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 50' ' ' CYS . 0.5 OUTLIER -129.67 141.51 50.9 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.363 -0.977 . . . . 73.2 108.363 -178.095 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.444 ' N ' HD12 ' A' ' 49' ' ' LEU . 7.9 m -78.06 129.97 35.87 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.998 0.519 . . . . 64.41 111.081 -173.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.539 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -136.98 157.3 74.94 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 110.037 -0.357 . . . . 63.05 110.037 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.8 109.27 1.97 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.376 2.051 . . . . 75.41 112.798 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.0 -18.76 52.11 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.833 2.355 . . . . 75.24 113.91 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -96.51 3.66 52.56 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.465 -0.494 . . . . 72.2 112.286 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -97.57 139.24 21.27 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 120.42 -0.512 . . . . 74.4 112.315 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.36 -42.81 27.63 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 124.441 3.427 . . . . 75.22 114.55 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -62.52 -27.3 69.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.357 -0.537 . . . . 64.2 110.86 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 62' ' ' ILE . 75.4 t -81.75 -50.22 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.878 -0.601 . . . . 75.3 111.264 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -27.01 61.64 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.832 0.678 . . . . 64.21 112.832 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -73.04 -49.66 27.45 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.746 -0.661 . . . . 74.51 110.33 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.506 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.2 pt -71.7 -28.08 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.911 -0.586 . . . . 74.44 111.663 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 58' ' ' VAL . 41.0 mm -54.45 -52.76 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.851 -0.613 . . . . 72.14 109.902 173.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -56.58 -38.05 71.46 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.386 0.612 . . . . 71.41 110.3 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.26 -38.4 90.19 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.954 -1.021 . . . . 73.44 109.146 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.431 HD12 ' CG1' ' A' ' 22' ' ' VAL . 88.3 mt -79.73 -36.94 36.61 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 116.63 -0.259 . . . . 73.52 111.149 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -55.84 -20.28 14.79 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 114.054 1.131 . . . . 74.51 114.054 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 . . . . . 0 CA--C 1.555 1.139 0 N-CA-C 109.539 -0.541 . . . . 71.43 109.539 178.337 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.511 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 27.9 p . . . . . 0 N--CA 1.431 -1.412 0 N-CA-C 112.474 0.546 . . . . 72.43 112.474 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.569 ' SG ' HG13 ' A' ' 40' ' ' VAL . 91.6 m -57.86 150.81 19.35 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 116.47 2.026 . . . . 62.52 116.47 -174.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -84.25 -63.98 1.24 Allowed 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.867 -1.515 . . . . 75.13 108.13 172.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -167.15 175.72 7.29 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 106.124 -1.806 . . . . 73.43 106.124 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 13' ' ' THR . 2.2 m -133.91 161.25 41.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.485 -1.302 . . . . 73.12 107.485 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.7 t -98.78 178.06 5.09 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.127 -1.064 . . . . 73.13 108.127 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -50.5 -60.73 2.72 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.007 0.523 . . . . 72.33 110.769 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.547 ' HZ1' ' HB2' ' A' ' 15' ' ' LYS . 4.8 ttmp? -139.85 86.54 13.46 Favored Pre-proline 0 N--CA 1.428 -1.548 0 N-CA-C 109.367 -0.605 . . . . 73.24 109.367 174.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.538 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 7.5 Cg_endo -47.94 -78.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.463 0 C-N-CA 124.565 3.51 . . . . 74.3 117.303 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.32 162.83 45.43 Favored Pre-proline 0 C--N 1.32 -0.701 0 O-C-N 121.791 -0.568 . . . . 75.41 110.365 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.586 ' O ' HG12 ' A' ' 21' ' ' ILE . 36.8 Cg_exo -63.05 130.21 28.28 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.135 1.89 . . . . 60.23 110.704 174.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -73.69 2.04 42.17 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 116.339 -0.391 . . . . 73.11 113.946 -176.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -98.23 0.12 45.14 Favored 'General case' 0 N--CA 1.417 -2.121 0 O-C-N 122.133 -0.628 . . . . 73.1 111.52 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 18' ' ' PRO . 33.7 pt -106.71 9.22 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.452 0.644 . . . . 71.22 110.136 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 65' ' ' LEU . 2.9 p -96.59 134.94 32.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.733 -0.667 . . . . 74.31 111.817 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.554 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -91.15 -56.02 3.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.73 -0.841 . . . . 75.43 108.73 -176.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.554 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 18.1 m120 -130.17 157.43 42.48 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-N 115.89 -0.596 . . . . 71.31 109.445 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -139.65 152.31 46.65 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.19 -0.67 . . . . 71.31 109.19 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -122.97 121.72 36.79 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.049 -1.463 . . . . 73.34 107.049 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -93.93 114.3 26.49 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 109.607 -0.516 . . . . 74.4 109.607 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.511 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 4.0 mm? -110.23 126.92 54.65 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 116.262 -0.426 . . . . 74.25 111.608 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.7 mt -126.83 176.96 6.89 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.833 -0.802 . . . . 72.2 108.833 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 57.1 mt -74.11 -20.07 17.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 107.701 -1.222 . . . . 75.33 107.701 176.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -58.79 -30.42 67.57 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.726 -1.124 . . . . 73.23 110.071 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.05 -42.45 47.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.597 -0.729 . . . . 74.03 109.988 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.54 -44.89 0.64 Allowed Glycine 0 CA--C 1.503 -0.709 0 C-N-CA 120.458 -0.877 . . . . 74.13 113.039 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 63.4 m -66.86 141.47 57.66 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 110.263 -0.273 . . . . 62.1 110.263 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -79.23 3.44 17.9 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.194 0.521 . . . . 73.34 112.057 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.31 97.94 49.44 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.821 -0.627 . . . . 74.45 110.251 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -80.65 128.96 7.06 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 121.255 1.303 . . . . 63.22 110.137 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -173.83 161.85 3.88 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.145 0.578 . . . . 62.43 109.825 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 50' ' ' CYS . 7.9 p -108.59 128.23 64.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 109.381 -0.6 . . . . 75.22 109.381 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.569 HG13 ' SG ' ' A' ' 9' ' ' CYS . 1.4 m -86.3 129.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 107.303 -1.369 . . . . 64.52 107.303 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -104.68 116.65 32.42 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 116.567 -0.288 . . . . 75.21 111.331 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.5 m -85.24 101.57 12.62 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.284 -1.006 . . . . 74.02 108.284 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.4 p -73.97 168.67 19.01 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.258 -0.428 . . . . 72.11 110.981 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 92.2 mt -59.52 -29.05 67.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.121 0.568 . . . . 74.4 111.117 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -71.24 -16.37 62.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.493 -0.776 . . . . 71.53 110.78 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.75 15.83 44.52 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.261 -0.495 . . . . 72.43 112.306 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -94.87 140.06 30.45 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 110.523 -0.177 . . . . 74.31 110.523 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -104.12 109.83 21.78 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.89 -0.595 . . . . 73.12 109.503 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.4 tp -130.03 129.82 44.16 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.756 -0.657 . . . . 73.24 109.263 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.568 ' SG ' HG13 ' A' ' 40' ' ' VAL . 75.4 m -84.48 147.41 27.1 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 113.682 0.993 . . . . 71.35 113.682 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.31 160.55 57.07 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 115.103 -0.953 . . . . 75.42 110.169 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 72.9 Cg_endo -71.98 108.11 2.38 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.194 1.929 . . . . 75.52 111.936 -175.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.523 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 67.3 Cg_endo -68.35 -30.41 30.14 Favored 'Trans proline' 0 N--CA 1.473 0.265 0 C-N-CA 123.089 2.526 . . . . 64.45 113.388 -171.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -78.4 -26.59 46.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.228 -0.442 . . . . 72.53 111.386 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 16.0 mm100 -66.34 138.25 95.79 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 116.122 -0.49 . . . . 73.24 112.146 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.471 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 78.0 Cg_exo -53.45 -38.66 83.24 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 124.011 3.141 . . . . 54.3 114.699 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.456 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 37.0 p-90 -64.86 -29.96 70.94 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 120.469 -0.493 . . . . 74.13 111.116 -175.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 62' ' ' ILE . 72.3 t -80.07 -30.12 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 116.115 -0.493 . . . . 75.33 111.109 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.9 mt-10 -56.71 -49.73 74.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.562 -0.29 . . . . 74.53 110.715 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -61.52 -45.52 93.86 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.179 -0.464 . . . . 73.31 112.208 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.433 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 18.0 pt -69.2 -33.8 60.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 113.145 0.794 . . . . 72.3 113.145 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 58' ' ' VAL . 65.3 mt -61.66 -46.93 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.411 -0.589 . . . . 74.12 109.411 174.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 13.0 mm100 -60.05 -40.96 91.23 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.776 -0.647 . . . . 65.33 109.475 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -57.95 -51.49 69.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.234 -0.894 . . . . 73.44 109.627 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.467 HD12 HG13 ' A' ' 22' ' ' VAL . 73.7 mt -67.52 -28.97 68.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.727 0.64 . . . . 73.02 112.727 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -69.0 -32.31 71.77 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.368 -0.933 . . . . 75.43 110.767 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 31.8 mmt180 . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 116.486 -0.325 . . . . 62.52 110.787 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.424 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 14.7 p . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 109.904 -0.406 . . . . 51.53 109.904 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.82 -171.58 3.48 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.835 -0.746 . . . . 74.31 111.665 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.0 -68.05 0.82 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.395 -0.594 . . . . 72.34 109.395 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -168.04 153.83 7.17 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.259 -1.015 . . . . 75.21 108.259 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 50' ' ' CYS . 1.9 m -115.8 162.09 14.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 119.839 -0.744 . . . . 71.12 109.973 -175.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -105.75 177.64 4.79 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.012 -1.477 . . . . 74.41 107.012 172.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -53.82 -50.03 67.07 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 118.656 0.662 . . . . 74.44 111.53 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.503 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 87.4 tttt -143.6 83.7 10.49 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-O 121.0 0.429 . . . . 64.12 110.153 175.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.5 Cg_endo -47.38 -77.77 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.456 3.438 . . . . 71.33 117.429 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.15 166.3 30.23 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 110.058 -0.349 . . . . 73.34 110.058 -173.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.576 ' O ' HG12 ' A' ' 21' ' ' ILE . 44.7 Cg_exo -61.26 127.92 23.48 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.253 1.968 . . . . 73.13 111.004 175.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.459 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -80.65 0.17 86.38 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 114.594 0.598 . . . . 64.4 114.594 -175.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.53 -1.16 39.05 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 122.034 -0.686 . . . . 73.44 112.841 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 18' ' ' PRO . 34.8 pt -100.21 7.46 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.633 0.73 . . . . 74.1 110.36 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.401 HG13 HD12 ' A' ' 65' ' ' LEU . 2.5 p -89.25 136.12 24.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.33 -0.85 . . . . 74.44 111.75 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.421 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 1.0 OUTLIER -86.16 -55.68 3.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.031 -1.1 . . . . 73.13 108.031 -176.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 17.5 m120 -141.65 160.31 40.43 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.281 1.032 . . . . 73.31 108.713 177.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -131.97 156.8 45.55 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.694 -0.403 . . . . 70.05 110.068 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.441 ' HB2' HG21 ' A' ' 40' ' ' VAL . 28.0 m170 -123.56 112.54 17.57 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.299 -1.371 . . . . 73.44 107.299 172.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -82.91 99.8 10.0 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.513 -1.291 . . . . 74.11 107.513 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 77.4 mt -112.58 134.72 53.96 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.54 0.686 . . . . 73.42 111.803 -173.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 94.6 mt -142.32 169.71 17.08 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.043 -0.98 . . . . 72.35 110.755 -173.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.9 mt -77.97 -30.36 16.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 106.629 -1.619 . . . . 63.32 106.629 171.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -56.22 -39.5 72.6 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.571 -1.195 . . . . 75.13 110.368 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.94 -57.6 3.8 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.981 -1.118 . . . . 74.22 107.981 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.44 85.96 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.973 -1.108 . . . . 72.42 114.299 174.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.1 t -168.54 172.52 8.1 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 105.691 -1.966 . . . . 73.4 105.691 174.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -88.17 -3.05 58.93 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.228 1.195 . . . . 74.33 114.228 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 p -148.95 122.77 4.66 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-O 120.972 0.415 . . . . 70.22 111.256 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -87.28 130.15 2.85 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.473 2.115 . . . . 72.2 112.546 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -176.25 150.05 0.9 Allowed 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.481 -0.933 . . . . 75.41 108.481 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -98.41 127.41 50.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.401 -1.333 . . . . 74.45 107.401 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 26' ' ' HIS . 6.2 m -92.3 125.12 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.15 0 C-N-CA 119.307 -0.957 . . . . 75.51 108.849 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -99.26 113.16 25.29 Favored 'General case' 0 C--N 1.272 -2.79 0 CA-C-N 115.459 -0.791 . . . . 72.13 109.729 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 77.2 m -80.69 102.43 9.88 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.895 -0.78 . . . . 72.31 108.895 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.1 p -69.23 167.83 15.43 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.123 -0.489 . . . . 71.12 110.811 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 93.7 mt -59.13 -29.09 67.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.205 0.526 . . . . 65.13 110.26 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -64.75 -26.6 68.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.078 -0.964 . . . . 74.14 111.055 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.69 17.18 19.93 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.22 -0.991 . . . . 44.15 112.145 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -103.36 125.89 50.23 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 122.684 -0.304 . . . . 72.22 111.244 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.08 112.82 19.49 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.69 -1.226 . . . . 75.33 107.69 172.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 50' ' ' CYS . 0.9 OUTLIER -115.09 141.55 47.85 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.679 -0.86 . . . . 75.31 108.679 -176.074 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.507 ' N ' HD12 ' A' ' 49' ' ' LEU . 9.4 m -79.15 119.73 22.66 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 123.061 0.545 . . . . 64.53 111.13 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.539 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -122.85 155.55 63.42 Favored Pre-proline 0 C--O 1.243 0.733 0 C-N-CA 120.346 -0.541 . . . . 74.43 111.944 174.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -78.08 110.85 2.97 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.646 2.231 . . . . 71.53 114.427 -172.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.05 -1.19 8.3 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.752 2.301 . . . . 62.2 112.556 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -103.3 -3.29 25.82 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.493 -0.321 . . . . 74.53 111.08 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -103.82 132.8 20.69 Favored Pre-proline 0 C--N 1.311 -1.106 0 C-N-CA 120.309 -0.556 . . . . 63.22 112.435 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -49.07 -32.62 24.38 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 124.552 3.501 . . . . 74.5 115.046 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.503 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 31.0 p-90 -68.18 -30.19 69.23 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.4 -0.52 . . . . 75.41 109.902 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 62' ' ' ILE . 70.9 t -78.94 -40.97 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.212 -0.662 . . . . 73.21 109.212 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.4 mt-10 -59.68 -25.05 64.44 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.341 -0.845 . . . . 75.42 112.411 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -83.34 -43.39 16.01 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.294 0.479 . . . . 74.01 112.294 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.459 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.2 pt -70.89 -33.73 53.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 112.867 0.691 . . . . 75.21 112.867 -177.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 58' ' ' VAL . 64.3 mt -57.11 -40.82 75.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 116.064 -0.516 . . . . 75.53 110.062 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 78.8 mm-40 -59.28 -43.1 92.55 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.1 -0.5 . . . . 63.31 111.328 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -59.47 -52.29 66.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.522 0.514 . . . . 73.23 110.862 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.401 HD12 HG13 ' A' ' 22' ' ' VAL . 86.3 mt -67.95 -26.36 65.91 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.254 -0.578 . . . . 75.51 112.472 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 27.8 mt-30 -67.59 -21.77 65.41 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 121.965 -0.459 . . . . 71.41 111.917 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.541 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--N 1.314 -0.944 0 N-CA-C 109.538 -0.542 . . . . 73.54 109.538 177.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.8 p . . . . . 0 N--CA 1.428 -1.559 0 N-CA-C 107.817 -1.179 . . . . 62.44 107.817 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.466 ' HB2' HG13 ' A' ' 40' ' ' VAL . 4.4 t -76.74 142.14 40.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.027 -0.731 . . . . 74.4 109.027 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.476 ' O ' HG21 ' A' ' 36' ' ' VAL . 73.7 mt -68.89 -44.64 72.82 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 116.828 2.158 . . . . 65.34 116.828 -170.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.8 m -164.49 137.18 4.82 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.759 -0.776 . . . . 74.12 111.293 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 13' ' ' THR . 1.0 OUTLIER -102.05 161.21 3.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.459 -0.941 . . . . 64.03 108.459 -178.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.9 t -105.54 178.76 4.47 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.098 -1.075 . . . . 72.51 108.098 175.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -49.17 -40.61 33.65 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.615 0.766 . . . . 64.15 111.069 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -157.7 92.1 2.24 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 109.078 -0.712 . . . . 74.22 109.078 171.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.533 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.2 Cg_endo -40.07 -67.16 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.765 3.644 . . . . 72.54 116.688 -178.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.03 166.25 16.79 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 75.32 109.695 -176.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.529 ' O ' HG12 ' A' ' 21' ' ' ILE . 32.1 Cg_exo -60.4 128.6 26.63 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.068 1.845 . . . . 74.25 109.632 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.444 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -73.47 0.89 46.65 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 115.887 1.115 . . . . 62.34 115.887 -172.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -98.46 -7.51 28.4 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 117.772 0.786 . . . . 72.55 112.417 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.4 pt -92.84 3.94 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.58 0.705 . . . . 72.04 111.098 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.555 HG22 ' CD1' ' A' ' 41' ' ' PHE . 2.2 p -88.12 135.82 24.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.292 -0.867 . . . . 74.22 112.411 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -86.44 -56.07 3.6 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.434 1.094 . . . . 75.44 108.523 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -146.97 170.15 17.69 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.811 -1.086 . . . . 75.43 108.59 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.593 ' CZ ' HG22 ' A' ' 62' ' ' ILE . 47.2 p90 -141.68 155.94 45.66 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.978 -0.378 . . . . 74.13 109.978 -175.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -133.82 121.95 22.54 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.627 -0.509 . . . . 75.34 109.627 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.408 ' OH ' HG21 ' A' ' 62' ' ' ILE . 54.1 m-85 -78.31 103.89 8.55 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 123.208 0.318 . . . . 74.42 110.168 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -108.76 131.55 54.84 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.484 -0.887 . . . . 75.22 110.983 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.4 mt -133.94 -177.98 4.81 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.142 -0.936 . . . . 70.53 109.131 -174.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 63.1 mt -71.67 -24.15 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 120.477 -0.489 . . . . 71.25 109.777 176.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.634 ' HE3' ' C ' ' A' ' 31' ' ' LYS 0.364 0.0 OUTLIER -67.26 -10.02 46.47 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.687 0.995 . . . . 74.33 113.687 176.415 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.507 ' N ' ' HE3' ' A' ' 31' ' ' LYS . 22.2 m-20 -83.76 -5.42 59.19 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.352 0.596 . . . . 73.21 109.733 171.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.37 43.2 8.72 Favored Glycine 0 N--CA 1.434 -1.489 0 CA-C-N 115.089 -0.96 . . . . 38.13 111.464 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 11.1 t -135.56 155.37 50.59 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.09 -1.818 . . . . 74.02 106.09 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -92.75 14.52 16.99 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.501 1.667 . . . . 74.24 115.501 -168.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 10' ' ' LEU . 3.7 p -153.11 116.3 2.78 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-O 121.328 0.585 . . . . 74.52 112.544 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -83.84 134.93 6.47 Favored 'Trans proline' 0 C--O 1.252 1.181 0 C-N-CA 122.645 2.23 . . . . 74.24 112.898 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -176.18 153.94 1.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.183 0.993 . . . . 74.13 108.562 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -99.11 128.28 50.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.355 -1.35 . . . . 70.03 107.355 175.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.466 HG13 ' HB2' ' A' ' 9' ' ' CYS . 14.8 m -91.55 127.98 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.491 0 C-N-CA 119.299 -0.96 . . . . 74.1 110.083 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.555 ' CD1' HG22 ' A' ' 22' ' ' VAL . 4.9 m-85 -91.29 116.87 29.18 Favored 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 115.099 -0.955 . . . . 74.44 109.79 173.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 99.0 m -89.78 106.79 18.7 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 107.721 -1.214 . . . . 74.31 107.721 176.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 69.5 p -69.73 174.18 5.41 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 123.19 0.306 . . . . 73.13 111.321 -177.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 91.6 mt -58.0 -33.23 68.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.214 0.531 . . . . 71.43 110.73 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -69.58 -18.93 63.67 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.617 -0.719 . . . . 70.02 110.882 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.58 16.71 33.26 Favored Glycine 0 CA--C 1.499 -0.956 0 C-N-CA 120.536 -0.84 . . . . 74.41 111.729 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.558 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 1.8 mmp_? -95.87 144.24 26.38 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-O 120.693 0.282 . . . . 74.31 110.668 -177.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -105.6 131.09 53.41 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.505 -0.77 . . . . 61.34 110.151 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.3 tp -132.87 150.89 52.12 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.886 -0.783 . . . . 73.51 108.886 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.401 ' HB3' HG11 ' A' ' 12' ' ' VAL . 4.9 m -77.68 123.9 27.26 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 110.087 -0.338 . . . . 70.04 110.087 -175.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.533 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -132.66 157.57 77.98 Favored Pre-proline 0 C--O 1.243 0.747 0 CA-C-N 118.31 0.505 . . . . 53.02 109.933 174.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.34 109.34 2.3 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.055 1.837 . . . . 72.3 113.46 -174.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.74 -12.78 31.54 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 122.779 2.319 . . . . 71.21 113.685 -174.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -96.12 -20.44 18.63 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.232 -0.44 . . . . 74.22 111.385 -176.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -80.06 145.22 60.51 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 113.938 1.088 . . . . 71.23 113.938 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -51.24 -43.47 48.76 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.812 3.675 . . . . 73.3 115.734 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.431 ' O ' HG12 ' A' ' 61' ' ' ILE . 39.5 p-90 -64.53 -36.29 83.74 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.137 -0.625 . . . . 74.45 111.289 -175.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 62' ' ' ILE . 76.6 t -69.53 -47.29 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.849 -0.614 . . . . 70.21 111.765 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.442 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 10.1 pt-20 -61.62 -32.83 72.98 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.314 0.487 . . . . 64.23 112.314 -177.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.442 ' HE ' ' HG3' ' A' ' 59' ' ' GLU . 5.6 mmp_? -66.15 -51.93 53.18 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.094 0.473 . . . . 75.24 110.648 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.444 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 8.0 pt -64.58 -34.69 71.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.735 -0.666 . . . . 72.0 111.989 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.593 HG22 ' CZ ' ' A' ' 25' ' ' PHE . 39.8 mt -57.4 -43.98 83.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.315 -0.402 . . . . 71.54 111.382 173.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 63' ' ' GLN . 13.7 mm-40 -63.54 -36.72 84.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.973 0.416 . . . . 75.2 110.709 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 29.7 mmt180 -64.82 -34.08 77.52 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.618 -0.719 . . . . 72.41 111.011 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.424 HD12 HG13 ' A' ' 22' ' ' VAL . 90.4 mt -77.31 -34.93 55.32 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.767 -0.373 . . . . 75.14 110.992 176.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -76.78 -18.75 58.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.241 0.83 . . . . 72.21 113.241 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 40.7 ptt180 . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 112.712 0.634 . . . . 74.34 112.712 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.526 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 49.3 t . . . . . 0 N--CA 1.433 -1.304 0 CA-C-O 120.803 0.335 . . . . 74.03 111.025 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.418 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 97.4 m -84.44 166.18 17.52 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.744 0.818 . . . . 54.31 112.761 -177.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.51 -53.01 2.88 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.189 -1.411 . . . . 74.12 107.189 172.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.1 m -167.64 178.57 5.27 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.063 -1.458 . . . . 62.54 107.063 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.414 HG11 ' CB ' ' A' ' 50' ' ' CYS . 3.1 m -133.64 148.79 30.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.055 -1.461 . . . . 74.03 107.055 173.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.438 ' CG2' ' HA ' ' A' ' 16' ' ' PRO . 10.9 t -92.11 178.76 5.77 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.262 -1.014 . . . . 65.33 108.262 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -47.53 -69.89 0.11 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.532 0.733 . . . . 75.44 111.38 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -132.74 80.87 60.35 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 109.477 -0.564 . . . . 75.43 109.477 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.9 Cg_endo -43.64 -83.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 125.277 3.985 . . . . 74.33 118.935 -172.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.28 157.96 71.68 Favored Pre-proline 0 C--N 1.32 -0.713 0 O-C-N 122.164 -0.335 . . . . 73.13 110.451 -173.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.27 136.77 45.02 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.501 2.134 . . . . 65.33 111.354 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.467 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -77.57 1.22 67.28 Favored Glycine 0 C--O 1.218 -0.878 0 CA-C-O 121.868 0.705 . . . . 41.11 112.006 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -77.04 -28.12 54.72 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.051 -0.575 . . . . 73.12 110.6 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.1 pt -98.67 8.63 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 120.691 -0.404 . . . . 72.31 112.011 -176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.405 ' CG1' HD12 ' A' ' 65' ' ' LEU . 7.7 p -95.39 138.27 21.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.106 0.479 . . . . 70.11 111.115 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.9 -56.06 3.23 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.461 -0.94 . . . . 73.41 108.461 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -145.91 174.31 11.37 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.232 1.013 . . . . 73.31 108.602 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -140.57 169.29 17.92 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.518 -0.473 . . . . 73.24 110.357 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -129.1 129.03 44.69 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.137 -2.171 . . . . 75.02 105.137 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -97.46 109.38 22.15 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 107.906 -1.146 . . . . 64.55 107.906 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.3 mm? -98.1 117.83 33.34 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.0 0.428 . . . . 63.04 111.342 -174.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.9 mt -124.93 -179.09 4.39 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.538 -0.912 . . . . 75.32 108.538 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 52.2 mt -71.11 -21.01 21.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.544 -0.91 . . . . 75.05 108.544 176.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -59.04 -32.88 70.15 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.983 -1.008 . . . . 73.02 109.834 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.3 -6.41 57.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.664 -0.698 . . . . 71.22 110.6 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.08 34.33 12.99 Favored Glycine 0 CA--C 1.498 -1.02 0 C-N-CA 121.108 -0.568 . . . . 38.49 112.246 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 46.3 t -123.08 145.95 48.12 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.649 -0.871 . . . . 71.34 108.649 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.597 ' HD3' ' O ' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -79.79 -36.02 37.65 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.534 -0.543 . . . . 72.11 109.534 -177.524 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.7 p -98.04 103.89 19.71 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 121.132 0.491 . . . . 74.44 111.438 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 35' ' ' ARG . 92.7 Cg_endo -84.0 130.11 4.81 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 121.707 1.605 . . . . 74.54 111.588 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.406 ' HA ' ' HG3' ' A' ' 53' ' ' PRO . . . -172.65 -179.78 2.23 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 124.212 1.005 . . . . 63.42 108.857 -177.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -119.04 130.03 74.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 120.228 -0.589 . . . . 74.4 110.077 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.763 HG13 ' SG ' ' A' ' 50' ' ' CYS . 4.4 m -89.26 130.94 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 108.186 -1.042 . . . . 74.4 108.186 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -98.32 114.82 27.26 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 109.633 -0.506 . . . . 74.05 109.633 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 86.2 m -84.34 102.19 12.52 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.203 -1.036 . . . . 64.44 108.203 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 51.5 p -72.03 169.93 14.93 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.488 -0.324 . . . . 64.02 111.31 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.67 -25.46 66.37 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.492 0.717 . . . . 75.32 112.334 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -83.27 -4.04 58.04 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.227 0.537 . . . . 71.02 110.89 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.13 16.13 56.35 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 120.802 -0.713 . . . . 61.52 112.319 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.42 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 36.1 mmt180 -99.64 130.24 45.85 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 112.521 0.563 . . . . 74.42 112.521 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -95.92 122.02 38.27 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.157 -0.928 . . . . 72.22 109.545 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 50' ' ' CYS . 1.7 tm? -134.92 138.24 43.9 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.407 -1.701 . . . . 64.54 106.407 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.763 ' SG ' HG13 ' A' ' 40' ' ' VAL . 73.5 m -98.0 147.35 24.59 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 114.828 1.418 . . . . 73.44 114.828 -172.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.505 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -128.84 159.1 70.14 Favored Pre-proline 0 C--O 1.243 0.752 0 CA-C-N 115.227 -0.897 . . . . 73.11 110.999 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.445 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 55.6 Cg_endo -64.88 108.88 1.17 Allowed 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.185 2.59 . . . . 60.21 113.226 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HG3' ' HA ' ' A' ' 38' ' ' ALA . 64.1 Cg_endo -67.71 -9.8 26.67 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 C-N-CA 123.024 2.483 . . . . 74.15 114.054 -175.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.49 -22.69 17.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.932 0.396 . . . . 75.25 111.292 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -76.08 130.34 78.29 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 112.801 0.667 . . . . 74.14 112.801 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.38 -41.63 17.68 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.915 3.744 . . . . 73.13 114.809 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -63.3 -26.89 68.98 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 120.93 0.395 . . . . 74.41 110.897 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 62' ' ' ILE . 74.9 t -82.86 -42.39 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.93 -0.577 . . . . 74.42 111.869 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.305 0.2 OUTLIER -66.34 -30.88 71.37 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.929 1.085 . . . . 73.45 113.929 -174.477 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -61.32 -49.94 74.97 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.041 0.448 . . . . 74.13 110.672 176.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.467 HG21 ' HA3' ' A' ' 19' ' ' GLY . 10.7 pt -69.12 -31.63 50.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.904 -0.589 . . . . 74.03 112.173 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 58' ' ' VAL . 56.4 mt -59.13 -50.08 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 110.156 -0.312 . . . . 75.22 110.156 171.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 29.7 mm-40 -62.58 -36.78 83.78 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.14 0.495 . . . . 74.13 109.947 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.442 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 38.8 ttm180 -57.96 -48.25 80.51 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.7 -1.136 . . . . 74.12 110.817 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.405 HD12 ' CG1' ' A' ' 22' ' ' VAL . 82.8 mt -70.71 -30.39 66.94 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 116.543 -0.299 . . . . 73.31 110.699 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -55.86 -18.92 9.92 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 114.424 1.268 . . . . 75.22 114.424 177.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 15.4 ptm180 . . . . . 0 CA--C 1.55 0.961 0 CA-C-O 120.731 0.3 . . . . 65.53 110.643 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.563 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 74.6 m . . . . . 0 N--CA 1.402 -2.839 0 N-CA-C 110.381 -0.229 . . . . 62.31 110.381 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.431 ' SG ' HG13 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -107.1 -179.92 4.07 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.063 -0.655 . . . . 74.3 109.574 -176.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -118.13 -51.83 2.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.711 1.374 . . . . 74.02 114.711 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.6 p -153.21 136.3 15.59 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.142 -0.623 . . . . 72.32 111.615 -171.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -102.76 153.72 5.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 119.539 -0.864 . . . . 73.1 108.879 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.6 t -99.59 179.01 4.68 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.111 -0.699 . . . . 64.11 109.111 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -39.36 -51.52 2.07 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.591 1.157 . . . . 71.44 111.628 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -159.55 94.53 1.7 Allowed Pre-proline 0 N--CA 1.427 -1.622 0 N-CA-C 108.254 -1.017 . . . . 75.51 108.254 171.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.513 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.6 Cg_endo -39.44 -82.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.738 3.625 . . . . 73.24 117.837 -173.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.72 161.4 46.58 Favored Pre-proline 0 N--CA 1.475 0.816 0 N-CA-C 109.452 -0.573 . . . . 75.12 109.452 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.494 ' O ' HG12 ' A' ' 21' ' ' ILE . 19.5 Cg_endo -61.74 129.24 26.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.845 1.696 . . . . 75.15 110.443 172.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.522 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -74.0 2.19 43.9 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 114.79 0.676 . . . . 74.01 114.79 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -93.64 -9.4 38.09 Favored 'General case' 0 C--N 1.281 -2.383 0 O-C-N 121.953 -0.733 . . . . 73.3 112.298 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 18' ' ' PRO . 39.5 pt -96.89 0.58 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.508 0.67 . . . . 64.44 111.039 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.478 HG13 HD12 ' A' ' 65' ' ' LEU . 2.6 p -87.46 133.4 30.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.542 -0.753 . . . . 75.23 111.102 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.508 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -84.78 -53.76 5.13 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.882 -1.155 . . . . 71.44 107.882 -176.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.513 ' O ' ' HB ' ' A' ' 42' ' ' THR . 18.6 m120 -139.73 147.85 41.46 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-N 115.115 -0.948 . . . . 73.4 108.844 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.436 ' CZ ' HG22 ' A' ' 62' ' ' ILE . 43.1 p90 -114.65 152.69 31.48 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.509 -0.922 . . . . 73.2 108.509 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.491 ' HB2' HG21 ' A' ' 40' ' ' VAL . 28.8 m170 -118.52 128.64 54.78 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.3 -1.741 . . . . 72.15 106.3 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -97.33 109.48 22.22 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.684 -0.858 . . . . 75.33 108.684 -175.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.563 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 2.4 mm? -103.11 122.09 43.96 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.318 -0.401 . . . . 72.24 110.115 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.7 mt -128.8 172.33 11.39 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.457 -0.338 . . . . 74.21 110.272 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 47.7 mt -77.72 -20.89 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.096 -1.446 . . . . 73.15 107.096 176.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -63.94 -27.12 68.93 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.212 -1.358 . . . . 74.2 109.165 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.53 -12.05 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.475 -0.784 . . . . 73.2 110.488 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.61 -47.31 1.03 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.187 -0.53 . . . . 54.32 114.316 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 71.0 m -62.48 137.55 58.28 Favored 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 112.366 0.506 . . . . 64.1 112.366 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -71.13 -20.19 62.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 73.43 111.874 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.05 106.91 58.53 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-O 121.203 0.525 . . . . 74.14 111.159 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -85.57 130.21 3.76 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.282 1.988 . . . . 65.12 111.655 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -171.72 153.5 3.38 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.867 -0.79 . . . . 74.32 108.867 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.04 131.72 46.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.201 -1.037 . . . . 73.11 108.201 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG21 ' HB2' ' A' ' 26' ' ' HIS . 16.8 m -98.99 129.78 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.798 0 C-N-CA 119.535 -0.866 . . . . 73.21 109.492 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -96.44 115.44 27.43 Favored 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 115.234 -0.894 . . . . 73.25 110.903 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 24' ' ' ASN . 53.2 m -85.74 105.13 16.05 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 123.786 0.679 . . . . 73.42 109.412 175.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.1 p -71.78 173.28 8.41 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.977 -0.556 . . . . 60.21 111.002 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.25 -28.39 69.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.373 0.606 . . . . 74.23 110.062 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -64.83 -32.99 74.95 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.252 -0.886 . . . . 75.53 110.321 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.26 -3.85 25.23 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 120.77 -0.729 . . . . 72.52 112.048 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 42' ' ' THR . 27.1 mmt180 -75.69 137.82 40.9 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 111.84 0.311 . . . . 73.24 111.84 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -103.95 112.51 25.51 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.875 -1.157 . . . . 72.53 107.875 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 24.0 tp -114.76 145.35 42.2 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.263 -0.575 . . . . 64.21 109.653 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.7 m -78.03 133.41 37.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.784 -0.45 . . . . 73.2 109.784 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.513 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -137.6 155.65 75.13 Favored Pre-proline 0 C--N 1.312 -1.065 0 N-CA-C 109.811 -0.44 . . . . 73.24 109.811 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.24 111.32 3.06 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.993 2.462 . . . . 72.32 112.824 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.9 Cg_endo -70.23 -12.45 32.03 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.691 2.261 . . . . 74.32 114.328 -173.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -113.08 9.73 18.63 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.531 0.567 . . . . 74.14 112.531 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 25.1 mm-40 -91.54 139.05 25.02 Favored Pre-proline 0 C--N 1.32 -0.683 0 O-C-N 122.313 -0.242 . . . . 71.35 110.999 176.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.83 -43.16 42.06 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 124.086 3.191 . . . . 74.25 114.714 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.507 ' O ' HG12 ' A' ' 61' ' ' ILE . 40.3 p-90 -62.92 -37.46 87.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.307 -0.557 . . . . 74.34 110.518 -177.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 62' ' ' ILE . 78.6 t -72.81 -43.67 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.707 -0.679 . . . . 63.03 110.602 178.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 43.7 mt-10 -53.07 -41.54 64.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.094 0.473 . . . . 73.13 110.88 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -72.97 -41.46 64.36 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.695 0.628 . . . . 75.34 112.695 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.522 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.7 pt -71.56 -32.69 46.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 112.561 0.578 . . . . 75.43 112.561 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 58' ' ' VAL . 59.0 mt -57.69 -50.28 77.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.152 -0.684 . . . . 74.32 109.152 171.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -61.8 -40.93 96.96 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.925 -0.579 . . . . 71.13 110.423 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -54.33 -50.29 67.75 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.727 -0.67 . . . . 74.2 109.688 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.478 HD12 HG13 ' A' ' 22' ' ' VAL . 80.9 mt -70.1 -30.45 67.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.356 0.502 . . . . 73.24 112.356 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 48.5 mt-30 -71.85 -27.42 62.87 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.549 -0.86 . . . . 75.23 111.419 177.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.748 0.309 . . . . 73.44 110.666 175.514 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.415 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 6.6 p . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 110.251 -0.277 . . . . 63.21 110.251 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -84.16 128.0 34.28 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.525 -0.87 . . . . 60.51 110.684 -171.041 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.473 HD11 ' H ' ' A' ' 10' ' ' LEU . 6.2 mp -43.96 -62.44 1.13 Allowed 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 125.367 1.467 . . . . 72.43 114.265 -175.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 p -173.01 143.42 1.16 Allowed 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 120.259 -0.576 . . . . 63.54 109.633 -172.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 13' ' ' THR . 1.1 m -99.48 152.58 4.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.009 -1.108 . . . . 73.24 108.009 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 12' ' ' VAL . 9.0 t -89.54 174.44 7.77 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.274 -1.38 . . . . 73.44 107.274 175.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -53.37 -39.65 64.35 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.273 0.488 . . . . 63.03 112.12 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 ttpt -155.15 93.8 2.69 Favored Pre-proline 0 N--CA 1.429 -1.505 0 N-CA-C 108.733 -0.839 . . . . 74.35 108.733 170.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.569 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 11.8 Cg_endo -52.13 -82.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.268 3.312 . . . . 74.34 117.705 -175.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.6 162.4 53.32 Favored Pre-proline 0 C--N 1.321 -0.641 0 O-C-N 121.881 -0.512 . . . . 74.55 110.424 -173.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.595 ' O ' HG12 ' A' ' 21' ' ' ILE . 27.2 Cg_exo -63.97 132.15 33.46 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.877 1.718 . . . . 72.2 110.124 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.51 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -75.05 1.11 56.89 Favored Glycine 0 C--N 1.301 -1.382 0 N-CA-C 114.065 0.386 . . . . 63.13 114.065 -176.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -91.58 -2.38 57.14 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 122.483 -0.422 . . . . 75.11 110.88 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 18' ' ' PRO . 27.6 pt -107.1 6.76 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 120.313 -0.555 . . . . 75.24 110.819 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 41' ' ' PHE . 5.4 p -93.77 140.69 16.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.02 -0.537 . . . . 75.22 111.453 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.41 -47.0 5.06 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.776 0.83 . . . . 75.21 109.441 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -143.9 163.64 32.82 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.749 -1.204 . . . . 73.14 107.749 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.77 165.52 27.85 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.233 0.47 . . . . 72.33 110.47 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.408 ' HB2' HG21 ' A' ' 40' ' ' VAL . 36.0 m80 -134.45 112.41 10.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.695 -1.224 . . . . 71.4 107.695 170.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -83.17 94.92 7.96 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.972 -1.122 . . . . 73.34 107.972 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.415 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 63.0 mt -94.63 137.41 33.78 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.635 -0.712 . . . . 74.15 111.428 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.8 mt -142.05 169.67 17.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.035 -0.984 . . . . 75.51 110.861 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -77.9 -29.61 15.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 107.17 -1.419 . . . . 73.24 107.17 171.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.88 -30.19 70.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.023 -0.99 . . . . 73.43 109.15 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -74.33 -32.87 62.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.199 -0.91 . . . . 74.31 108.805 173.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.63 88.61 1.6 Allowed Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.178 -0.919 . . . . 53.2 113.68 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.9 t 178.84 -175.5 0.21 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.429 -1.322 . . . . 65.35 107.429 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -89.5 -41.99 11.72 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.557 0.577 . . . . 74.14 112.557 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.05 115.95 42.79 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 113.085 0.772 . . . . 65.34 113.085 -176.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -83.07 130.68 5.67 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.838 2.359 . . . . 73.04 111.655 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.66 153.42 2.26 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.269 -1.011 . . . . 55.21 108.269 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.09 130.78 47.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.81 -1.181 . . . . 63.43 107.81 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 4.5 m -92.4 131.69 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.759 0 N-CA-C 108.254 -1.017 . . . . 75.31 108.254 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.478 ' CD1' HG22 ' A' ' 22' ' ' VAL . 10.3 m-85 -103.2 115.44 30.58 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 116.108 -0.496 . . . . 74.02 110.728 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.7 m -80.69 100.39 8.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.2 -1.408 . . . . 62.45 107.2 174.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 53.2 p -72.25 175.39 6.13 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.494 0.188 . . . . 72.12 111.042 -177.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 96.8 mt -61.02 -26.74 67.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.692 -0.485 . . . . 75.14 109.692 176.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.41 ' NE ' ' HA ' ' A' ' 45' ' ' ARG . 6.5 tpm_? -63.88 -27.01 68.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.373 1.069 . . . . 73.21 110.791 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.92 8.55 59.08 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.168 -0.539 . . . . 63.43 111.878 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.61 138.93 38.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.974 -1.491 . . . . 73.22 106.974 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -95.82 118.77 33.11 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.435 -0.58 . . . . 63.53 109.435 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.1 mp -111.21 149.22 31.28 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 111.785 0.291 . . . . 74.43 111.785 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 23.3 m -80.23 123.4 27.91 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.863 -0.608 . . . . 74.32 110.241 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.569 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.74 152.52 77.11 Favored Pre-proline 0 C--O 1.246 0.882 0 O-C-N 122.356 -0.215 . . . . 75.23 110.86 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 67.3 Cg_endo -67.39 114.12 3.14 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.005 2.47 . . . . 73.21 113.844 -173.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 -15.36 28.05 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.179 1.919 . . . . 75.5 112.154 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -103.82 8.57 37.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.094 -0.503 . . . . 62.44 112.309 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.77 129.28 26.12 Favored Pre-proline 0 C--N 1.315 -0.924 0 C-N-CA 119.88 -0.728 . . . . 72.44 111.654 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.03 -36.5 28.03 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.289 3.326 . . . . 74.34 115.296 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -62.32 -27.03 68.76 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 120.086 -0.646 . . . . 75.31 110.961 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.516 ' O ' HG13 ' A' ' 62' ' ' ILE . 67.7 t -79.69 -42.38 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 116.0 -0.546 . . . . 73.5 112.386 -178.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -63.46 -25.54 68.31 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.931 1.086 . . . . 72.32 113.931 -174.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -80.59 -41.24 24.33 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 116.468 -0.333 . . . . 75.21 111.073 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.51 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 10.8 pt -71.9 -31.08 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 111.932 0.345 . . . . 75.32 111.932 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 58' ' ' VAL . 61.4 mt -55.54 -41.38 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.209 -0.45 . . . . 72.55 109.961 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 76.4 mm-40 -61.3 -42.17 98.21 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.981 -0.554 . . . . 72.33 110.372 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -58.51 -43.85 89.26 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.896 -0.593 . . . . 75.35 110.244 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.411 HD12 ' CG1' ' A' ' 22' ' ' VAL . 85.9 mt -68.53 -39.13 81.28 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.819 -0.628 . . . . 73.21 111.623 178.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -64.47 -43.35 94.47 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.694 -0.402 . . . . 75.4 111.223 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 63' ' ' GLN . 70.2 mtp180 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.18 0.514 . . . . 75.31 111.266 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.531 ' SG ' HD12 ' A' ' 28' ' ' LEU . 71.7 m . . . . . 0 N--CA 1.416 -2.148 0 N-CA-C 109.843 -0.428 . . . . 51.33 109.843 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.698 ' SG ' HG13 ' A' ' 40' ' ' VAL . 75.3 m -85.46 177.73 7.67 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.412 0.625 . . . . 74.44 111.709 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.44 -38.86 6.33 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 114.892 -1.049 . . . . 74.31 109.141 176.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.5 m -163.7 168.48 19.74 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 110.127 -0.323 . . . . 63.03 110.127 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 13' ' ' THR . 1.3 m -132.35 156.65 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 N-CA-C 104.481 -2.414 . . . . 65.12 104.481 172.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.8 t -96.9 178.02 5.43 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 108.192 -1.04 . . . . 74.11 108.192 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -50.65 -49.6 56.64 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.142 0.496 . . . . 74.2 111.103 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 37.0 ttpt -149.42 84.83 5.98 Favored Pre-proline 0 N--CA 1.421 -1.894 0 N-CA-C 108.976 -0.75 . . . . 73.32 108.976 175.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.515 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.2 Cg_endo -46.54 -81.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.786 3.658 . . . . 74.33 117.861 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.09 160.07 68.57 Favored Pre-proline 0 C--N 1.311 -1.091 0 O-C-N 121.857 -0.527 . . . . 71.23 110.612 -172.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.573 ' O ' HG12 ' A' ' 21' ' ' ILE . 19.6 Cg_endo -60.89 128.43 25.46 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.829 1.686 . . . . 74.45 109.791 173.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.532 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -73.72 1.72 44.12 Favored Glycine 0 C--O 1.209 -1.457 0 C-N-CA 120.98 -0.629 . . . . 44.52 114.554 -174.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -89.97 -1.54 57.99 Favored 'General case' 0 C--N 1.284 -2.276 0 O-C-N 122.198 -0.589 . . . . 71.42 111.367 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 18' ' ' PRO . 38.6 pt -104.01 7.29 10.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 120.788 -0.365 . . . . 72.24 110.959 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.413 HG13 HD12 ' A' ' 65' ' ' LEU . 3.2 p -90.93 131.68 37.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.576 0.703 . . . . 74.21 112.55 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -85.44 -55.06 4.2 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.798 -1.092 . . . . 75.13 108.124 -175.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -143.42 158.66 43.46 Favored 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 123.922 0.889 . . . . 73.33 109.099 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -132.43 163.27 29.12 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.84 -0.43 . . . . 73.45 109.84 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -135.01 136.91 42.49 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.289 -1.374 . . . . 73.24 107.289 174.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -100.1 105.9 17.58 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.103 0.478 . . . . 70.15 109.723 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.531 HD12 ' SG ' ' A' ' 8' ' ' CYS . 1.8 mm? -97.43 124.08 41.49 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 123.803 0.841 . . . . 71.32 109.529 -176.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.6 mt -121.9 176.36 5.81 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.813 -0.44 . . . . 74.35 109.813 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 45.4 mt -73.3 -17.36 17.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 121.992 0.901 . . . . 74.32 108.935 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -65.17 -28.88 69.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.587 -1.188 . . . . 71.33 109.347 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -76.86 -4.22 42.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.504 -0.771 . . . . 62.54 111.08 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.9 -9.37 59.99 Favored Glycine 0 CA--C 1.503 -0.692 0 CA-C-N 116.122 -0.49 . . . . 41.32 113.044 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.68 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 63.0 m -94.67 123.53 38.16 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.526 -0.916 . . . . 72.04 108.526 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.554 ' H ' ' HD2' ' A' ' 35' ' ' ARG 0.313 0.0 OUTLIER -77.67 1.89 18.47 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.968 1.099 . . . . 74.44 113.968 -176.15 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.8 p -109.62 98.22 31.75 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.053 -0.721 . . . . 73.42 109.053 171.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.12 129.86 9.03 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 121.627 1.551 . . . . 71.04 110.29 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 50' ' ' CYS . . . -166.13 160.44 16.28 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.226 -0.443 . . . . 71.23 110.734 -174.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 50' ' ' CYS . 7.2 p -110.37 123.15 66.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 109.083 -0.71 . . . . 74.22 109.083 176.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.698 HG13 ' SG ' ' A' ' 9' ' ' CYS . 9.2 m -80.34 125.64 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 C-N-CA 119.736 -0.786 . . . . 73.42 109.191 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -97.85 109.01 21.85 Favored 'General case' 0 C--N 1.267 -3.02 0 CA-C-N 115.672 -0.695 . . . . 74.55 109.487 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.4 m -82.42 103.72 12.18 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.477 -1.305 . . . . 71.51 107.477 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 64.8 p -69.94 167.12 18.12 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 120.895 -0.322 . . . . 75.54 111.084 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 94.9 mt -59.99 -30.74 69.33 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.093 0.557 . . . . 74.03 110.698 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -70.91 -18.23 62.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.313 -0.858 . . . . 75.33 110.109 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.57 16.6 26.26 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.881 -0.676 . . . . 75.21 113.22 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -99.8 126.05 45.82 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.95 0.375 . . . . 75.41 111.282 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -85.92 127.04 34.52 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.126 -0.694 . . . . 73.24 109.126 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.7 tp -147.67 131.03 16.59 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.229 -1.026 . . . . 74.43 108.229 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.56 ' SG ' HG13 ' A' ' 40' ' ' VAL . 55.8 m -86.78 155.17 20.42 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 114.877 1.436 . . . . 73.32 114.877 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.515 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -130.55 162.34 55.37 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-N 114.217 -1.356 . . . . 65.51 108.453 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 58.0 Cg_endo -68.67 107.52 1.67 Allowed 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 121.69 1.594 . . . . 75.03 111.617 -177.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.15 -12.46 35.16 Favored 'Trans proline' 0 N--CA 1.481 0.74 0 C-N-CA 123.171 2.58 . . . . 71.05 114.408 -170.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -96.07 -22.52 17.29 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.141 0.496 . . . . 73.3 110.733 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -73.84 138.7 76.6 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 112.902 0.705 . . . . 74.02 112.902 -174.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -50.54 -36.79 50.73 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.321 3.348 . . . . 73.11 115.037 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.467 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 34.7 p-90 -68.18 -28.0 66.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 119.863 -0.735 . . . . 64.42 110.673 -177.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 62' ' ' ILE . 73.9 t -79.77 -41.42 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 116.125 -0.489 . . . . 73.21 111.747 -177.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 11.7 pt-20 -60.74 -37.52 82.04 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.23 -0.588 . . . . 73.03 112.033 -177.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -62.21 -43.92 97.74 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.062 0.458 . . . . 72.02 111.731 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.532 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 8.5 pt -74.06 -32.49 33.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 116.052 -0.522 . . . . 74.24 111.841 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 58' ' ' VAL . 58.5 mt -60.74 -51.09 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.669 -0.493 . . . . 74.12 109.669 172.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 14.2 mm100 -59.56 -38.0 79.97 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.324 -0.398 . . . . 54.34 110.904 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.434 ' HG3' ' NH2' ' A' ' 67' ' ' ARG . 35.5 ttt180 -57.66 -47.41 82.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.865 -0.607 . . . . 74.44 110.558 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.413 HD12 HG13 ' A' ' 22' ' ' VAL . 86.8 mt -71.17 -30.16 66.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.885 0.374 . . . . 75.45 110.892 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -67.49 -22.56 65.45 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 113.037 0.754 . . . . 74.53 113.037 177.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.434 ' NH2' ' HG3' ' A' ' 64' ' ' ARG . 26.2 mtm180 . . . . . 0 C--N 1.318 -0.77 0 CA-C-O 121.41 0.624 . . . . 75.25 109.473 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.923 0 N-CA-C 110.288 -1.125 . . . . 64.14 110.288 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 t -98.09 127.58 44.12 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.681 -0.859 . . . . 70.14 108.681 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 53.59 84.11 0.06 Allowed 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.91 0.884 . . . . 63.24 111.106 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -95.55 107.07 19.22 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.717 -0.475 . . . . 62.42 109.717 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.98 -4.7 55.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.805 -0.634 . . . . 73.5 111.27 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -131.88 164.97 24.91 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.336 -0.847 . . . . 73.44 109.104 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -96.37 -21.55 17.71 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 112.561 0.578 . . . . 71.32 112.561 -174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.478 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 25.7 p -99.5 175.11 5.95 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.821 -0.752 . . . . 72.05 112.959 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.39 -171.04 3.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.966 -0.561 . . . . 71.44 109.659 -175.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.28 -64.02 1.09 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.06 -0.348 . . . . 70.24 110.06 -176.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -175.03 153.39 1.63 Allowed 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.307 -1.368 . . . . 71.14 107.307 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.96 150.53 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 C-N-CA 119.862 -0.735 . . . . 64.24 109.59 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.439 ' CG2' ' HA ' ' A' ' 16' ' ' PRO . 10.0 t -91.74 177.65 6.14 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.286 -1.005 . . . . 73.5 108.286 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -44.87 -63.49 0.91 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.388 0.675 . . . . 72.31 110.912 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -142.55 91.91 7.41 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 106.9 -1.518 . . . . 74.34 106.9 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.551 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.0 Cg_endo -46.98 -87.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.507 3.472 . . . . 62.43 118.321 -172.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.412 HD11 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -131.59 160.87 65.47 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 109.628 -0.508 . . . . 75.22 109.628 -173.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 21' ' ' ILE . 51.2 Cg_exo -60.16 128.41 26.33 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.181 1.921 . . . . 73.31 110.719 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.49 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -76.24 -0.88 67.49 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 116.023 -0.535 . . . . 72.32 113.454 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -95.67 -3.75 45.54 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 113.149 0.796 . . . . 75.03 113.149 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 18' ' ' PRO . 40.8 pt -103.74 9.79 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.539 0.685 . . . . 74.52 110.538 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -93.96 132.42 38.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.683 -0.689 . . . . 70.11 111.794 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -84.32 -47.99 10.17 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.657 1.183 . . . . 74.33 111.479 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.412 ' O ' ' HB ' ' A' ' 42' ' ' THR . 28.0 t-20 -150.39 156.57 41.75 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.6 -0.889 . . . . 64.45 108.6 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.404 ' CZ ' HG22 ' A' ' 62' ' ' ILE . 34.9 p90 -129.14 159.98 34.32 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.016 0.436 . . . . 64.41 109.896 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.51 ' HB2' HG21 ' A' ' 40' ' ' VAL . 3.7 m170 -127.16 125.67 41.55 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 104.907 -2.257 . . . . 74.31 104.907 175.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -95.88 100.61 12.29 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.981 -0.377 . . . . 73.04 109.981 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.478 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.4 mm? -97.99 120.28 38.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.066 0.546 . . . . 64.35 111.375 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.7 mt -130.0 176.03 8.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.069 0.461 . . . . 74.05 110.719 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.6 mt -73.52 -22.13 18.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.268 -1.012 . . . . 72.23 108.268 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -58.38 -42.59 87.37 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.623 -1.171 . . . . 64.11 108.781 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.79 -48.03 60.66 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.984 -1.007 . . . . 75.44 108.586 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.74 87.85 0.4 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 115.104 -0.953 . . . . 50.01 112.469 175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 46.9 t -171.12 161.93 6.89 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.928 -1.138 . . . . 64.2 107.928 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -87.54 -25.92 23.41 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.928 0.394 . . . . 62.24 110.388 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.6 109.2 58.09 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-O 121.123 0.487 . . . . 74.13 111.371 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -81.86 129.73 6.38 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 121.401 1.401 . . . . 72.44 109.752 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.49 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -166.49 147.76 6.36 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.164 -0.471 . . . . 75.14 110.091 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.33 128.24 51.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 107.577 -1.268 . . . . 64.55 107.577 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 26' ' ' HIS . 11.9 m -93.37 129.71 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 C-N-CA 119.42 -0.912 . . . . 75.24 109.378 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 14.7 m-85 -99.76 113.47 25.99 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.419 -0.81 . . . . 70.55 111.312 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 24' ' ' ASN . 99.4 m -83.03 104.49 13.28 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.383 -0.969 . . . . 72.14 108.383 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 66.5 p -72.64 178.47 4.1 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 112.321 0.489 . . . . 73.34 112.321 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.435 HD21 ' HG2' ' A' ' 23' ' ' ARG . 77.0 mt -60.69 -31.74 70.98 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.807 0.843 . . . . 74.32 110.947 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -75.93 -14.55 60.25 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.711 -0.677 . . . . 73.34 111.01 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.66 16.2 43.38 Favored Glycine 0 CA--C 1.506 -0.471 0 C-N-CA 120.571 -0.823 . . . . 71.11 112.243 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -100.54 130.49 46.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 110.379 -0.23 . . . . 74.42 110.379 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.515 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -95.67 144.03 26.43 Favored 'General case' 0 N--CA 1.426 -1.649 0 C-N-CA 120.173 -0.611 . . . . 75.11 111.412 175.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -139.42 146.33 39.99 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.445 -1.317 . . . . 63.52 107.445 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.515 ' N ' HD12 ' A' ' 49' ' ' LEU . 3.7 m -80.71 126.19 30.98 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.148 0.28 . . . . 60.23 110.286 -175.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.551 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.12 156.27 74.73 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 122.016 -0.427 . . . . 53.14 110.877 175.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HG3' ' OE1' ' A' ' 55' ' ' GLN . 90.3 Cg_endo -72.93 116.8 4.85 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.758 2.305 . . . . 73.43 113.961 -172.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.6 Cg_endo -74.38 -9.74 21.82 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.255 1.97 . . . . 65.45 112.57 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -89.94 -38.04 13.95 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.915 -0.314 . . . . 74.24 111.192 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.49 ' OE1' ' HG3' ' A' ' 52' ' ' PRO . 52.0 mt-30 -63.99 137.73 97.19 Favored Pre-proline 0 C--O 1.239 0.523 0 N-CA-C 113.535 0.939 . . . . 74.15 113.535 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 68.5 Cg_exo -57.27 -34.53 98.0 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.9 3.067 . . . . 71.5 114.245 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -61.02 -31.95 71.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.246 0.546 . . . . 73.02 110.579 -176.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 62' ' ' ILE . 70.9 t -76.65 -38.85 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 115.434 -0.803 . . . . 71.53 111.641 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.575 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.303 0.2 OUTLIER -66.83 -24.65 66.18 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 113.815 1.042 . . . . 41.55 113.815 -175.63 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -74.22 -50.77 17.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.037 0.446 . . . . 75.34 111.345 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.49 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 10.4 pt -64.15 -32.2 56.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.567 0.58 . . . . 75.43 112.567 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 58' ' ' VAL . 58.8 mt -58.09 -47.1 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.375 -0.375 . . . . 73.23 110.195 172.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 85.5 mm-40 -58.71 -42.59 89.0 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.809 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -59.59 -46.32 89.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.583 -0.735 . . . . 74.44 110.593 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.92 -34.92 74.12 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.658 -0.417 . . . . 74.32 111.24 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 27.3 mt-30 -61.88 -46.09 90.9 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 121.059 -0.256 . . . . 74.54 111.225 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -73.12 -24.12 60.58 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.542 0.942 . . . . 70.25 113.542 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.1 p -84.65 -34.51 23.03 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.056 -0.657 . . . . 71.21 111.717 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.9 p -76.09 -28.16 57.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.949 -0.569 . . . . 73.11 110.63 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.76 -18.48 43.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.072 0.949 . . . . 73.44 111.712 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -63.69 -27.22 69.07 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.937 -0.764 . . . . 64.11 108.937 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.7 tpt -106.42 98.65 8.3 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.125 -1.435 . . . . 71.34 107.125 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -81.24 -24.84 37.1 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.058 -0.519 . . . . 74.03 111.395 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -80.24 111.92 17.07 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.54 -0.541 . . . . 74.13 109.54 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -122.02 112.0 17.73 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.91 0.386 . . . . 74.11 110.948 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.5 m -96.87 -24.23 15.97 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.113 -0.494 . . . . 52.44 110.175 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 C--O 1.25 1.126 0 CA-C-O 119.026 -0.511 . . . . 73.52 109.822 177.509 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 CA-C-O 121.04 0.244 . . . . 63.25 112.582 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 57.7 m -148.8 -69.65 0.21 Allowed 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 107.461 -1.311 . . . . 74.45 107.461 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -104.9 108.77 20.45 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.649 -0.871 . . . . 73.55 108.649 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.502 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 11.7 m-20 -129.21 162.81 26.98 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.804 -0.635 . . . . 71.03 110.674 -175.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.59 -26.0 24.67 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.248 1.023 . . . . 74.51 109.916 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.502 ' OE1' ' HB3' ' A' ' 4' ' ' ASP . 1.1 pm0 -85.02 133.16 34.25 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 113.772 -1.558 . . . . 73.35 109.518 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -98.2 88.87 4.31 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 121.94 0.876 . . . . 75.14 110.205 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.402 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 47.7 t -154.92 -168.5 2.91 Favored 'General case' 0 C--N 1.265 -3.077 0 N-CA-C 106.602 -1.629 . . . . 74.44 106.602 176.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 10' ' ' LEU . 40.4 t -117.33 177.25 4.8 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 119.848 -0.741 . . . . 74.12 110.415 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 2.5 mm? -95.85 -54.2 3.42 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.913 -1.143 . . . . 75.15 107.913 175.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 p -178.05 164.17 1.81 Allowed 'General case' 0 C--O 1.251 1.141 0 N-CA-C 109.304 -0.628 . . . . 74.3 109.304 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 13' ' ' THR . 2.0 m -109.46 163.22 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 N-CA-C 105.723 -1.955 . . . . 74.53 105.723 174.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 12' ' ' VAL . 9.7 t -102.84 177.15 4.93 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.689 -1.226 . . . . 72.21 107.689 175.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -50.64 -49.17 57.54 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 123.222 0.326 . . . . 75.43 110.761 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 41.1 ttmt -144.91 97.65 4.87 Favored Pre-proline 0 N--CA 1.433 -1.314 0 N-CA-C 109.943 -0.392 . . . . 74.14 109.943 167.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.516 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 3.2 Cg_endo -48.65 -69.66 0.07 OUTLIER 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.955 3.103 . . . . 75.34 115.669 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.58 165.41 17.47 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 109.754 -0.462 . . . . 72.33 109.754 -176.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.518 ' O ' HG12 ' A' ' 21' ' ' ILE . 42.9 Cg_exo -61.15 128.83 26.35 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.966 1.778 . . . . 52.13 109.061 171.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.495 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -74.66 1.2 53.78 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 115.761 1.064 . . . . 71.34 115.761 -172.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.64 -1.22 38.59 Favored 'General case' 0 C--N 1.287 -2.136 0 O-C-N 121.826 -0.808 . . . . 75.2 112.689 176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.543 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 38.1 pt -98.21 7.06 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 121.57 0.7 . . . . 75.05 109.885 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.483 HG22 ' CD1' ' A' ' 41' ' ' PHE . 3.5 p -92.18 138.3 20.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.564 -0.744 . . . . 64.43 111.421 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.46 -56.79 2.9 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.921 -1.036 . . . . 72.13 109.205 -173.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -139.92 173.6 11.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.473 -0.936 . . . . 73.5 108.473 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -149.68 165.66 31.7 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.632 -0.427 . . . . 71.24 110.513 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.408 ' HB2' HG21 ' A' ' 40' ' ' VAL . 39.4 m170 -128.02 116.18 19.63 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.114 -1.439 . . . . 70.24 107.114 170.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -88.23 120.61 29.75 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.393 -0.595 . . . . 73.22 109.393 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 7.5 tt -132.5 133.78 44.21 Favored 'General case' 0 N--CA 1.407 -2.608 0 O-C-N 123.366 0.417 . . . . 55.1 110.281 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.426 HD13 ' HE3' ' A' ' 31' ' ' LYS . 80.8 mt -131.33 -173.3 3.07 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.309 -0.997 . . . . 73.22 108.309 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.0 mt -68.53 -29.0 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.569 -0.53 . . . . 73.13 109.569 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' A' ' 32' ' ' ASP 0.263 0.0 OUTLIER -64.72 -20.44 66.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.226 0.824 . . . . 72.13 113.226 176.168 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.447 ' N ' ' HD2' ' A' ' 31' ' ' LYS . 7.5 m-20 -80.82 -8.8 59.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.433 0.635 . . . . 75.42 109.644 174.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.71 79.13 1.39 Allowed Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.281 -0.872 . . . . 74.25 113.593 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.4 t -178.82 148.51 0.42 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.215 -1.402 . . . . 63.44 107.215 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -73.26 -31.03 63.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.508 0.559 . . . . 62.21 112.508 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.48 106.57 46.75 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-O 121.32 0.581 . . . . 70.42 111.519 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.55 129.43 4.25 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.107 1.871 . . . . 73.44 110.836 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.73 145.96 6.66 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.991 -0.549 . . . . 73.1 110.122 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.51 125.47 53.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.402 -0.962 . . . . 72.24 108.402 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.646 HG13 ' SG ' ' A' ' 50' ' ' CYS . 5.3 m -88.73 124.78 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 C-N-CA 119.409 -0.916 . . . . 75.11 109.537 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.533 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 10.6 m-85 -96.32 121.76 38.46 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.287 -0.87 . . . . 75.42 111.353 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.9 m -87.7 105.79 17.6 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.577 -1.268 . . . . 70.53 107.577 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.4 p -74.81 172.76 11.61 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.735 -0.211 . . . . 75.14 110.959 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 88.4 mt -63.98 -25.71 68.25 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.437 0.637 . . . . 75.23 109.74 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -61.02 -33.74 73.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.71 -1.132 . . . . 74.31 109.953 174.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.3 -0.14 40.63 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.643 -0.708 . . . . 54.33 111.857 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -95.44 153.19 17.82 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.06 -1.089 . . . . 73.51 108.06 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 41.4 mt-30 -110.5 138.79 46.42 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.482 -0.562 . . . . 70.35 109.482 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 47.1 tp -139.75 132.56 29.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.116 -1.068 . . . . 73.31 108.116 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.646 ' SG ' HG13 ' A' ' 40' ' ' VAL . 9.8 m -82.08 142.95 31.85 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 120.175 -0.61 . . . . 71.52 112.166 -174.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.516 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.78 158.35 68.48 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 115.465 -0.789 . . . . 54.55 110.144 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 88.3 Cg_endo -73.69 109.59 2.89 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.495 2.13 . . . . 74.04 113.281 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.45 -11.24 30.81 Favored 'Trans proline' 0 N--CA 1.482 0.799 0 C-N-CA 122.697 2.265 . . . . 73.01 112.594 -176.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -95.61 -5.8 41.68 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.479 -0.782 . . . . 75.32 111.21 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -98.06 128.69 32.91 Favored Pre-proline 0 N--CA 1.443 -0.805 0 C-N-CA 120.548 -0.461 . . . . 73.41 111.407 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.23 -34.0 23.27 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 124.28 3.32 . . . . 74.34 115.449 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -62.85 -33.32 75.01 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.135 -0.626 . . . . 74.4 109.988 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 62' ' ' ILE . 89.7 t -77.53 -40.16 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.709 -0.678 . . . . 73.33 110.275 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.04 -27.3 69.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.133 0.492 . . . . 72.4 111.422 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -72.03 -44.01 64.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.706 -0.679 . . . . 74.34 110.575 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.495 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 16.5 pt -80.32 -30.65 12.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.396 0.888 . . . . 72.33 113.396 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 58' ' ' VAL . 65.2 mt -55.34 -44.84 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 110.389 -0.226 . . . . 72.42 110.389 174.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -60.02 -40.91 90.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.079 0.466 . . . . 74.31 110.105 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.86 -42.05 88.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.258 -0.883 . . . . 75.24 109.814 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.433 HD12 ' CG1' ' A' ' 22' ' ' VAL . 82.4 mt -76.25 -35.97 58.72 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.446 0.536 . . . . 73.44 112.446 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 90.7 mt-30 -64.72 -25.75 68.07 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 120.467 -0.493 . . . . 72.22 111.836 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.538 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -84.78 -34.96 22.69 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.073 -0.651 . . . . 72.11 111.421 176.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.9 p -85.35 -36.44 20.76 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 114.439 1.274 . . . . 60.23 114.439 -175.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.3 t -86.54 -39.8 15.86 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.922 -0.581 . . . . 74.44 111.123 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 66' ' ' GLN . . . -72.78 -45.27 59.47 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 116.239 -0.437 . . . . 71.12 110.467 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -116.48 92.15 3.8 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.83 -1.174 . . . . 73.31 107.83 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -37.24 103.05 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 127.461 2.304 . . . . 75.35 115.961 -168.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -133.52 97.74 4.02 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.074 -1.421 . . . . 65.23 109.364 172.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -138.94 172.49 12.77 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.452 -0.795 . . . . 72.54 109.761 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -142.04 -148.99 0.25 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.141 -1.429 . . . . 73.4 107.141 -172.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.7 p -54.3 -34.32 60.69 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.762 0.791 . . . . 62.54 109.472 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.418 -2.063 0 N-CA-C 106.458 -1.682 . . . . 62.22 106.458 172.56 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.173 0 N-CA-C 110.323 -1.111 . . . . 73.53 110.323 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.473 ' HB ' ' CB ' ' A' ' 6' ' ' GLU . 69.2 m -83.93 145.17 28.72 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.079 -1.082 . . . . 73.21 108.079 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -58.82 151.4 21.51 Favored 'General case' 0 C--O 1.251 1.145 0 O-C-N 123.062 0.226 . . . . 75.05 110.915 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 5' ' ' ALA . 19.1 t70 74.98 -158.25 0.06 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.536 1.134 . . . . 64.53 108.182 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.449 ' H ' ' CG ' ' A' ' 4' ' ' ASP . . . -79.62 -3.55 47.63 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 121.491 -0.756 . . . . 73.32 111.581 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.473 ' CB ' ' HB ' ' A' ' 2' ' ' THR 0.332 11.8 pt-20 50.86 77.61 0.12 Allowed 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 126.657 1.983 . . . . 64.3 115.819 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -103.25 -17.93 15.11 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 114.211 -1.359 . . . . 74.45 108.811 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.469 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 73.0 m -80.85 140.91 35.13 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 106.922 -1.51 . . . . 71.23 106.922 174.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.475 ' SG ' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -95.06 175.61 6.56 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.94 -0.704 . . . . 72.23 112.705 -169.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 tt -88.2 -66.11 0.95 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.643 -0.873 . . . . 72.44 108.643 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -175.92 153.12 1.3 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.778 -1.193 . . . . 63.12 107.778 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 13' ' ' THR . 1.4 m -98.79 160.82 3.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 119.126 -1.03 . . . . 73.51 109.506 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.437 ' O ' HG23 ' A' ' 12' ' ' VAL . 7.1 t -101.38 173.19 6.55 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 106.56 -1.644 . . . . 70.35 106.56 174.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -43.8 -59.43 2.24 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.528 0.518 . . . . 72.55 111.373 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 40.8 ttmt -143.09 94.15 6.4 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 109.753 -0.462 . . . . 75.31 109.753 173.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.529 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.7 Cg_endo -52.99 -85.61 0.01 OUTLIER 'Trans proline' 0 CA--C 1.556 1.617 0 C-N-CA 124.138 3.226 . . . . 52.2 117.58 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.04 149.46 42.26 Favored Pre-proline 0 C--O 1.207 -1.161 0 O-C-N 121.73 -0.606 . . . . 73.13 110.4 -174.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.22 144.97 99.07 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.54 2.16 . . . . 74.22 112.29 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.16 1.75 79.06 Favored Glycine 0 CA--C 1.502 -0.743 0 CA-C-N 115.848 -0.614 . . . . 63.24 112.748 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -80.13 -23.2 41.32 Favored 'General case' 0 N--CA 1.408 -2.565 0 CA-C-O 121.04 0.447 . . . . 72.41 110.553 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.422 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 37.3 pt -101.89 13.01 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.879 -0.513 . . . . 75.51 111.78 -177.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.5 p -98.82 137.7 25.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.511 0.672 . . . . 63.31 111.908 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -89.45 -54.46 4.08 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.43 1.092 . . . . 73.33 108.588 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -139.33 164.02 30.95 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.393 -0.965 . . . . 71.32 108.393 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -140.84 160.5 39.93 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.594 -0.521 . . . . 72.41 109.594 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.419 ' HB2' HG21 ' A' ' 40' ' ' VAL . 38.5 m80 -135.81 127.06 28.25 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.368 -1.345 . . . . 74.45 107.368 173.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -92.67 122.38 35.02 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.488 -0.93 . . . . 75.33 108.488 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.4 mm? -116.18 126.24 53.39 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 120.861 0.362 . . . . 74.01 111.651 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.7 mt -129.26 172.84 11.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.165 -1.05 . . . . 64.03 108.165 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 32.0 mt -74.63 -18.11 16.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.827 -1.175 . . . . 65.31 107.827 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -61.7 -32.8 73.03 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.93 -1.032 . . . . 72.42 109.455 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.27 -38.99 71.84 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.001 -0.545 . . . . 73.42 109.562 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.1 -50.93 0.54 Allowed Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 115.507 -0.77 . . . . 44.52 112.765 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 71.1 m -67.43 132.73 48.21 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.835 0.35 . . . . 61.31 110.888 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.42 ' HA ' HG12 ' A' ' 30' ' ' ILE . 86.7 mtt180 -80.48 22.77 0.54 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.03 0.752 . . . . 72.4 113.03 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -126.77 96.03 36.12 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 108.908 -0.775 . . . . 74.34 108.908 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -85.24 129.65 3.84 Favored 'Trans proline' 0 N--CA 1.443 -1.441 0 C-N-CA 121.902 1.734 . . . . 75.33 112.354 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.495 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -174.77 166.34 3.7 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.087 -0.961 . . . . 74.33 108.696 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.85 130.95 60.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.555 -1.276 . . . . 63.42 107.555 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 6.8 m -96.3 128.08 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.83 0 C-N-CA 119.576 -0.849 . . . . 74.12 109.583 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 28.8 m-85 -99.65 121.51 41.32 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.592 -0.731 . . . . 73.53 110.839 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.3 m -85.93 97.99 10.55 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.137 -1.431 . . . . 74.33 107.137 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.6 p -70.14 169.74 12.94 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.65 -0.25 . . . . 73.04 111.053 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 91.2 mt -60.33 -26.84 66.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.352 0.596 . . . . 62.44 109.87 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -61.58 -28.87 69.66 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.438 1.095 . . . . 74.23 110.678 175.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.34 9.32 58.03 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 111.834 -0.506 . . . . 75.45 111.834 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -103.76 136.21 43.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.708 -1.59 . . . . 74.11 106.708 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 27.6 mt-30 -92.19 130.5 37.89 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 121.122 -0.231 . . . . 71.22 110.413 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 7.2 mp -119.62 147.08 44.95 Favored 'General case' 0 CA--C 1.475 -1.909 0 CA-C-N 116.406 -0.361 . . . . 74.11 111.0 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.1 m -86.1 125.24 33.32 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.075 -0.966 . . . . 72.03 109.18 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.529 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.41 152.45 76.4 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 118.016 0.371 . . . . 71.11 111.736 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 87.9 Cg_endo -71.09 108.14 2.26 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.329 2.686 . . . . 71.2 114.243 -174.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 40.9 Cg_endo -67.95 -13.54 38.62 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.489 2.126 . . . . 65.44 111.245 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.67 -27.71 50.94 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.574 -1.194 . . . . 74.12 111.687 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -85.99 142.06 36.01 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 113.513 0.931 . . . . 70.21 113.513 -173.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -58.22 -38.07 92.67 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.603 2.869 . . . . 71.4 113.451 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.43 ' O ' HG12 ' A' ' 61' ' ' ILE . 39.4 p-90 -63.44 -27.73 69.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.961 0.41 . . . . 74.44 110.304 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 62' ' ' ILE . 53.1 t -78.97 -46.89 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 116.0 -0.545 . . . . 71.22 111.756 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -25.37 67.09 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 119.549 -0.86 . . . . 74.11 109.719 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -59.65 -56.35 22.93 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.51 -1.223 . . . . 74.55 108.895 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 57' ' ' TRP . 12.0 pt -74.55 -32.21 29.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.967 -1.015 . . . . 74.22 113.598 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 58' ' ' VAL . 64.1 mt -54.95 -55.74 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 123.254 0.347 . . . . 71.44 111.178 176.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.54 -38.9 92.91 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 112.42 0.526 . . . . 73.11 112.42 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -62.17 -42.47 99.3 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.667 -0.697 . . . . 74.5 112.021 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 tt -72.94 -31.72 64.78 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.179 -0.674 . . . . 74.11 109.179 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 79.9 mt-30 -48.87 -39.6 26.41 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 120.812 0.339 . . . . 75.41 111.383 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -61.97 -37.47 84.91 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.784 -0.644 . . . . 73.44 112.286 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.8 t -85.97 -25.81 25.82 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.587 -0.845 . . . . 74.42 110.419 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.3 t -75.77 -25.54 56.55 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.446 -0.797 . . . . 73.01 110.578 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.94 -20.1 63.35 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.432 0.634 . . . . 54.41 110.078 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.47 175.54 5.43 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 108.735 -0.839 . . . . 74.31 108.735 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.0 ptp -128.15 146.56 50.67 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.684 -0.407 . . . . 71.21 110.345 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -72.84 -26.03 61.33 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.777 0.799 . . . . 73.52 109.757 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -91.41 102.49 15.17 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.314 -0.857 . . . . 73.12 109.19 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 66.79 93.57 0.07 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.753 0.821 . . . . 73.21 111.007 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.0 m -107.53 143.76 35.49 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.505 -0.771 . . . . 70.31 110.247 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.438 -1.053 0 N-CA-C 109.099 -0.704 . . . . 60.44 109.099 177.478 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.684 0 N-CA-C 110.54 -1.024 . . . . 44.42 110.54 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.3 m -96.43 97.05 9.14 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.63 -0.878 . . . . 74.53 108.63 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -136.3 99.11 4.01 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 115.847 -0.615 . . . . 63.25 110.257 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -158.78 176.78 11.93 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.889 -1.152 . . . . 72.34 107.889 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 9' ' ' CYS . . . -72.41 -23.29 61.07 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 113.468 0.914 . . . . 61.33 113.468 -176.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 65.16 -67.5 0.12 Allowed 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 125.875 1.67 . . . . 53.13 111.666 -174.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.33 -59.19 0.74 Allowed 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 114.819 -1.082 . . . . 53.55 109.728 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.496 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 29.1 p -100.54 134.8 42.96 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.247 -0.581 . . . . 72.34 110.338 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.517 ' SG ' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -65.45 125.53 25.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.987 -0.552 . . . . 61.01 112.454 -172.207 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.442 ' O ' HG21 ' A' ' 36' ' ' VAL . 76.1 mt -50.6 -54.62 21.27 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.785 1.634 . . . . 71.41 114.586 -172.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.6 p -174.38 142.57 0.79 Allowed 'General case' 0 CA--C 1.486 -1.505 0 C-N-CA 120.085 -0.646 . . . . 75.1 109.734 -174.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 13' ' ' THR . 1.2 m -98.5 162.65 2.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.127 -1.064 . . . . 70.53 108.127 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 12' ' ' VAL . 15.4 t -105.18 178.18 4.63 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 107.115 -1.439 . . . . 72.23 107.115 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -41.43 -57.97 2.03 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.51 0.724 . . . . 72.24 110.696 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 ttpt -146.96 97.1 4.21 Favored Pre-proline 0 N--CA 1.431 -1.421 0 N-CA-C 108.7 -0.852 . . . . 75.33 108.7 170.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.531 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 5.4 Cg_endo -44.99 -73.03 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.915 3.077 . . . . 74.52 115.997 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.84 163.72 34.16 Favored Pre-proline 0 C--N 1.317 -0.824 0 O-C-N 122.153 -0.342 . . . . 75.31 110.269 -176.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.564 ' O ' HG12 ' A' ' 21' ' ' ILE . 71.2 Cg_exo -55.49 129.09 33.24 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.446 2.097 . . . . 63.41 110.186 171.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.424 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -77.79 -4.34 85.23 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.953 -0.642 . . . . 74.34 114.377 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -96.19 2.6 53.18 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.331 -0.511 . . . . 75.41 111.816 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 18' ' ' PRO . 32.6 pt -106.75 12.39 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 120.077 -0.649 . . . . 72.44 110.654 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.484 HG22 ' CD1' ' A' ' 41' ' ' PHE . 2.2 p -95.55 133.26 37.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.651 0.738 . . . . 71.34 112.407 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.589 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 1.2 tmt_? -93.62 -49.2 5.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.595 -1.184 . . . . 65.32 108.556 -174.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.589 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 16.1 m120 -135.5 154.05 51.53 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.891 -0.781 . . . . 74.3 108.891 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.9 143.91 41.07 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.209 -0.596 . . . . 74.11 109.699 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.425 ' HB2' HG21 ' A' ' 40' ' ' VAL . 43.9 m170 -118.72 132.32 56.15 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.363 -1.717 . . . . 62.13 106.363 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -99.77 102.83 14.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.487 -0.56 . . . . 72.23 109.487 -174.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.496 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.1 mm? -102.26 120.37 40.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.872 -0.603 . . . . 75.03 111.049 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.0 mt -131.87 168.75 17.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.29 0.567 . . . . 74.22 110.603 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mt -77.89 -17.33 14.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 107.696 -1.224 . . . . 74.21 107.696 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.07 -31.91 71.57 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 114.967 -1.015 . . . . 75.35 109.417 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -76.66 -54.45 6.64 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.073 -1.084 . . . . 41.05 108.073 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.13 89.13 0.23 Allowed Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.413 -0.812 . . . . 62.41 112.518 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.5 t -171.59 -176.08 1.72 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.63 -0.878 . . . . 51.03 108.63 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -81.55 -43.02 19.31 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.808 0.443 . . . . 75.13 111.846 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 10' ' ' LEU . 2.8 p -130.84 128.24 22.35 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 113.609 0.966 . . . . 64.23 113.609 -172.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -88.82 132.18 2.38 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 123.029 2.486 . . . . 64.42 112.553 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -175.06 153.41 1.62 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.855 0.862 . . . . 74.42 108.794 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -99.1 132.64 44.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.672 -1.233 . . . . 75.33 107.672 176.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.517 HG13 ' SG ' ' A' ' 9' ' ' CYS . 5.9 m -93.38 122.75 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 C-N-CA 119.346 -0.942 . . . . 74.01 109.225 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.484 ' CD1' HG22 ' A' ' 22' ' ' VAL . 8.8 m-85 -94.77 115.91 28.08 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 115.333 -0.849 . . . . 73.35 110.56 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.1 m -85.47 104.77 15.56 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.362 -0.977 . . . . 73.34 108.362 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.0 p -71.15 178.4 3.3 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.166 -0.47 . . . . 74.44 111.448 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.5 mt -66.11 -25.18 66.87 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.778 0.799 . . . . 73.43 109.926 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -71.93 -16.31 62.1 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.787 -1.097 . . . . 74.23 110.656 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.63 16.01 57.4 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.863 -0.684 . . . . 74.03 111.579 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -97.91 135.34 39.78 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 120.739 0.304 . . . . 72.0 111.753 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -97.56 114.56 26.48 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.168 -0.924 . . . . 73.11 109.481 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.1 mp -116.53 148.42 40.85 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 116.497 -0.32 . . . . 75.45 111.603 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.8 m -77.75 122.29 25.18 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.436 -0.802 . . . . 72.43 110.667 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.531 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.54 151.71 73.34 Favored Pre-proline 0 C--O 1.242 0.704 0 C-N-CA 121.101 -0.24 . . . . 64.3 111.535 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.27 110.87 3.18 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 123.284 2.656 . . . . 74.04 114.407 -172.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.18 -18.69 51.02 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.391 2.061 . . . . 75.52 112.948 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -87.54 -19.93 27.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.072 0.767 . . . . 64.44 113.072 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.99 139.02 39.77 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 114.08 1.141 . . . . 75.34 114.08 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.07 -39.92 69.29 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 124.608 3.538 . . . . 65.43 114.753 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.1 p-90 -59.47 -31.87 69.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.714 -0.395 . . . . 75.11 111.025 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 62' ' ' ILE . 78.2 t -77.56 -42.95 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.935 -0.575 . . . . 71.05 111.599 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -25.25 66.04 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.961 -0.696 . . . . 75.14 112.176 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.441 ' HD3' ' OE1' ' A' ' 63' ' ' GLN . 37.0 mmt180 -71.37 -34.91 70.88 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.795 -0.639 . . . . 74.34 112.547 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.424 HG21 ' HA3' ' A' ' 19' ' ' GLY . 10.6 pt -85.33 -34.16 8.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 120.718 -0.393 . . . . 75.31 111.8 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 58' ' ' VAL . 59.2 mt -56.74 -49.42 78.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-N 116.034 -0.53 . . . . 75.3 111.232 173.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.441 ' OE1' ' HD3' ' A' ' 60' ' ' ARG . 4.1 pt20 -59.08 -39.68 82.91 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.043 0.449 . . . . 73.0 111.221 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -60.76 -51.3 69.93 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.987 -1.006 . . . . 74.02 110.332 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.437 HD12 HG13 ' A' ' 22' ' ' VAL . 82.5 mt -66.26 -26.4 67.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.057 0.391 . . . . 73.42 112.057 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.515 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 55.9 mt-30 -63.24 -20.48 65.49 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 120.803 0.335 . . . . 71.34 111.822 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -78.51 -32.42 48.08 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.098 0.475 . . . . 75.11 110.227 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.9 t -84.97 -22.28 29.21 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.304 -0.559 . . . . 74.22 110.84 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.515 ' OG ' ' HA ' ' A' ' 66' ' ' GLN . 78.1 p -84.56 -18.84 34.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.382 0.61 . . . . 74.52 109.647 176.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.32 80.34 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.153 -0.93 . . . . 55.22 108.846 175.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -67.3 119.6 12.44 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.586 -1.635 . . . . 75.11 106.586 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.2 tpp -60.51 104.0 0.3 Allowed 'General case' 0 C--O 1.253 1.273 0 CA-C-O 121.784 0.802 . . . . 74.24 113.073 -172.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -84.79 86.89 7.3 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.795 -1.093 . . . . 72.13 109.333 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -132.47 23.09 4.37 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 105.644 -1.984 . . . . 75.51 105.644 172.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -112.43 140.71 46.94 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.204 -1.817 . . . . 71.22 106.204 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.7 t -76.34 107.37 8.55 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.814 -0.81 . . . . 63.23 108.814 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.2 m . . . . . 0 C--N 1.311 -1.098 0 N-CA-C 109.366 -0.605 . . . . 62.35 109.366 -178.196 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.278 0 N-CA-C 112.132 -0.387 . . . . 71.13 112.132 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.8 t -147.05 114.66 6.38 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 109.592 -0.521 . . . . 71.11 109.592 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -113.11 81.41 1.49 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.552 1.316 . . . . 73.24 114.552 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.7 t70 43.34 -78.8 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 117.659 2.466 . . . . 65.33 117.659 169.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.93 -12.26 60.89 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.011 1.485 . . . . 63.53 115.011 -169.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -113.01 119.38 37.72 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 112.936 0.717 . . . . 75.4 112.936 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -96.53 -12.78 23.61 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.236 -0.893 . . . . 74.41 108.846 176.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.8 p -81.22 174.19 11.79 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.904 -1.044 . . . . 44.14 110.16 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.429 ' HB2' HG13 ' A' ' 40' ' ' VAL . 1.2 t -94.18 -179.39 4.93 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.801 -0.76 . . . . 74.11 111.676 -169.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.22 -66.92 0.83 Allowed 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.044 0.538 . . . . 74.34 110.434 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 p -176.4 150.09 0.87 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.113 -1.44 . . . . 75.45 107.113 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 m -98.49 161.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 118.812 -1.155 . . . . 74.03 109.276 -177.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 t -104.13 177.72 4.76 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.661 -1.607 . . . . 75.44 106.661 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -51.44 -58.5 6.1 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.148 0.431 . . . . 65.41 110.124 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -137.42 99.83 9.53 Favored Pre-proline 0 N--CA 1.424 -1.732 0 C-N-CA 120.014 -0.675 . . . . 74.1 111.654 172.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.533 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 19.1 Cg_endo -67.48 -164.09 0.09 OUTLIER 'Trans proline' 0 CA--C 1.567 2.148 0 C-N-CA 122.84 2.36 . . . . 75.15 114.167 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.33 156.76 5.45 Favored Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 125.436 1.495 . . . . 72.53 113.363 -175.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -73.65 149.09 42.98 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.63 2.22 . . . . 73.34 112.527 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.81 1.54 67.47 Favored Glycine 0 N--CA 1.459 0.216 0 CA-C-N 115.788 -0.642 . . . . 38.88 113.488 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -82.97 -23.69 33.27 Favored 'General case' 0 C--N 1.285 -2.232 0 O-C-N 122.259 -0.553 . . . . 74.4 111.522 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 42.4 pt -100.9 12.26 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.111 0.481 . . . . 74.32 111.904 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 4.3 p -97.94 136.79 27.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.04 -0.527 . . . . 61.55 111.394 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -55.82 3.49 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.437 -1.32 . . . . 75.4 107.437 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -142.33 163.91 31.58 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.636 -0.876 . . . . 52.03 108.636 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -132.51 157.47 44.58 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.964 -0.294 . . . . 72.12 110.28 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.409 ' HB2' HG21 ' A' ' 40' ' ' VAL . 37.8 m80 -125.54 113.56 17.6 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.668 -1.234 . . . . 72.03 107.668 172.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -82.68 100.78 10.43 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.523 -0.762 . . . . 74.3 109.235 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.5 mt -112.06 143.15 43.55 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.691 -0.686 . . . . 74.02 111.846 -175.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 98.1 mt -141.3 -177.61 5.21 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.046 -0.979 . . . . 70.54 109.842 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 57.9 mt -74.93 -29.42 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.442 -1.318 . . . . 73.52 107.442 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.02 -20.54 64.04 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.911 -1.04 . . . . 72.52 110.907 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -79.66 -49.55 11.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.553 -1.277 . . . . 64.11 107.553 174.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.33 51.15 0.06 OUTLIER Glycine 0 C--O 1.24 0.523 0 C-N-CA 120.621 -0.799 . . . . 38.88 114.1 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 87.3 m -145.5 144.74 30.74 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.764 -1.199 . . . . 75.53 107.764 174.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -63.81 -30.96 71.99 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.159 0.504 . . . . 74.43 111.03 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -100.32 112.96 65.2 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-N 115.432 -0.804 . . . . 74.13 111.572 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.8 130.33 3.66 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 122.191 1.928 . . . . 61.44 109.953 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -170.65 146.26 2.65 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.885 -0.413 . . . . 73.13 109.885 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.41 126.14 51.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.061 -1.459 . . . . 74.23 107.061 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 9' ' ' CYS . 13.1 m -90.1 128.32 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 C-N-CA 119.523 -0.871 . . . . 74.11 109.448 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -96.62 114.0 25.61 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 115.362 -0.835 . . . . 72.02 109.385 174.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.6 m -84.74 104.83 15.05 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.442 -1.318 . . . . 65.5 107.442 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 64.5 p -70.06 175.3 4.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 112.706 0.632 . . . . 55.51 112.706 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.01 -27.36 68.27 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.472 0.709 . . . . 75.54 110.672 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -79.69 -13.96 59.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.706 -0.679 . . . . 73.23 110.488 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.07 16.67 43.39 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.203 -0.999 . . . . 42.33 112.602 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -96.06 138.64 33.39 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 122.747 -0.267 . . . . 74.13 110.631 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -93.12 125.18 37.58 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 123.909 0.756 . . . . 64.31 109.304 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 50' ' ' CYS . 1.2 tm? -127.95 141.95 51.39 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.944 -1.132 . . . . 73.04 107.944 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.526 ' N ' HD12 ' A' ' 49' ' ' LEU . 4.2 m -81.51 122.88 28.1 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.098 0.559 . . . . 75.41 111.15 -174.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.533 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.03 152.76 76.14 Favored Pre-proline 0 C--O 1.245 0.82 0 C-N-CA 120.237 -0.585 . . . . 62.45 111.51 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.38 112.36 3.51 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.791 2.327 . . . . 73.2 113.564 -173.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.57 -9.63 24.26 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.204 1.936 . . . . 70.25 111.681 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.21 -17.98 24.08 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.125 -0.943 . . . . 54.22 111.45 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -89.7 133.08 34.92 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 112.889 0.7 . . . . 74.14 112.889 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.535 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 94.6 Cg_exo -44.81 -45.19 13.89 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 124.738 3.625 . . . . 75.21 115.771 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -58.16 -36.78 73.52 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.656 0.265 . . . . 70.13 111.606 -175.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 62' ' ' ILE . 71.0 t -68.59 -42.23 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 116.247 -0.433 . . . . 74.33 110.342 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.535 ' OE1' ' HA ' ' A' ' 56' ' ' PRO . 40.7 mt-10 -56.43 -33.22 65.64 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.878 -0.601 . . . . 71.32 111.029 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HD3' ' O ' ' A' ' 56' ' ' PRO . 9.3 mpt_? -77.54 -43.39 32.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.97 -0.559 . . . . 74.45 112.449 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 pt -70.77 -32.07 47.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 112.872 0.693 . . . . 74.12 112.872 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 58' ' ' VAL . 70.4 mt -54.12 -42.68 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 109.55 -0.537 . . . . 70.34 109.55 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 79.6 mm-40 -57.78 -45.55 85.83 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.642 -0.708 . . . . 74.13 110.731 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -61.43 -41.47 97.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.134 -0.485 . . . . 63.41 111.85 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.426 HD12 ' CG1' ' A' ' 22' ' ' VAL . 86.3 mt -72.4 -35.74 68.49 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.014 -0.674 . . . . 74.44 111.474 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 51.4 mt-30 -66.5 -45.75 78.54 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.116 -0.633 . . . . 72.42 111.618 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -71.75 -20.48 61.88 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 120.755 -0.378 . . . . 72.55 111.837 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 p -84.97 -31.43 23.55 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.905 -0.718 . . . . 63.15 111.083 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.9 t -67.59 -48.57 66.46 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.94 -0.763 . . . . 72.24 108.94 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.08 -19.3 58.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.938 -0.574 . . . . 63.22 110.002 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.472 ' HG3' ' H ' ' A' ' 72' ' ' MET 0.365 8.1 ptpp? 53.05 -91.01 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 115.17 1.545 . . . . 75.41 115.17 -179.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.472 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 49.6 ttm -117.62 4.8 12.35 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.504 0.668 . . . . 72.11 109.684 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -77.84 87.1 4.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.928 0.871 . . . . 75.23 110.4 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -94.05 -44.77 7.87 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.288 -1.323 . . . . 72.42 109.295 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -125.1 1.43 7.91 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.705 -1.22 . . . . 75.14 107.705 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.3 m 61.09 75.98 0.39 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.16 -1.382 . . . . 65.02 110.445 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.305 -1.328 0 CA-C-N 114.679 -1.146 . . . . 64.25 108.063 -178.31 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.321 0 N-CA-C 111.826 -0.51 . . . . 74.42 111.826 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 77.5 m -69.93 99.05 1.35 Allowed 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.484 -0.561 . . . . 71.23 109.484 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.4 t30 70.73 159.41 0.2 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.167 0.987 . . . . 60.04 109.676 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.4 t70 73.75 -46.35 0.63 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 123.873 0.869 . . . . 74.24 113.112 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.88 -4.6 50.48 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.86 0.838 . . . . 63.23 110.73 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -107.66 117.89 35.29 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.797 -1.092 . . . . 72.42 108.744 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -117.04 70.36 0.77 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.483 1.135 . . . . 55.22 111.519 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.415 ' HA ' HD13 ' A' ' 28' ' ' LEU . 45.5 t 178.14 -176.63 0.2 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 104.496 -2.409 . . . . 64.14 104.496 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 10' ' ' LEU . 38.9 t -123.74 173.45 8.13 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 119.372 0.987 . . . . 74.23 111.11 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 80.7 mt -89.21 -55.14 3.79 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 108.54 -0.911 . . . . 74.43 108.54 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.9 t -176.94 165.13 2.39 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.493 -0.928 . . . . 63.31 108.493 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.503 HG11 ' CB ' ' A' ' 50' ' ' CYS . 1.5 m -126.0 152.77 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 105.882 -1.895 . . . . 65.44 105.882 174.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.4 t -93.46 176.58 6.33 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.166 -1.42 . . . . 65.23 107.166 174.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -58.21 -43.97 87.93 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 118.537 0.608 . . . . 75.42 112.15 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 1.3 tmmm? -144.05 87.27 8.03 Favored Pre-proline 0 N--CA 1.414 -2.272 0 N-CA-C 108.049 -1.093 . . . . 71.22 108.049 171.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.526 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.0 Cg_endo -51.39 -80.11 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 124.216 3.277 . . . . 72.44 117.55 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.32 170.19 9.08 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 109.912 -0.403 . . . . 74.43 109.912 -171.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.562 ' O ' HG12 ' A' ' 21' ' ' ILE . 44.6 Cg_exo -60.52 132.24 42.28 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.208 1.939 . . . . 61.43 111.442 175.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.439 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -79.48 2.29 72.94 Favored Glycine 0 C--N 1.299 -1.522 0 CA-C-N 115.981 -0.554 . . . . 53.43 113.798 -176.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -98.75 -5.25 31.72 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.6 0.593 . . . . 75.54 112.6 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.562 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.9 pt -93.71 3.56 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 121.612 0.72 . . . . 71.44 110.527 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.442 HG13 HD12 ' A' ' 65' ' ' LEU . 2.7 p -88.73 137.83 20.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.133 -0.94 . . . . 72.13 111.334 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.31 -55.97 3.57 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.324 -1.361 . . . . 75.03 107.324 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -143.43 162.84 34.73 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 124.132 0.973 . . . . 71.24 108.896 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -132.63 161.6 33.5 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.7 -0.4 . . . . 74.13 110.014 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.419 ' HB2' HG21 ' A' ' 40' ' ' VAL . 42.1 m80 -127.42 112.68 15.26 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.629 -0.878 . . . . 73.25 108.629 172.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -85.65 105.85 16.51 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.41 -0.814 . . . . 72.53 109.115 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 8' ' ' CYS . 8.7 tt -119.93 133.17 55.65 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-O 121.218 0.532 . . . . 70.4 110.647 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.4 mt -127.51 -177.7 4.18 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.661 -0.699 . . . . 73.04 109.423 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 58.8 mt -72.38 -20.39 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.149 -1.056 . . . . 74.4 108.149 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -62.91 -31.88 73.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.835 -1.075 . . . . 72.04 109.434 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.6 -57.34 5.88 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.583 -0.895 . . . . 63.03 108.583 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.65 71.5 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.333 -0.937 . . . . 62.14 112.877 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 35.6 t -173.1 140.85 0.91 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.794 -1.928 . . . . 75.4 105.794 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -73.18 -19.92 61.0 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.882 1.068 . . . . 72.14 113.882 -173.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.24 102.31 31.95 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-O 121.314 0.578 . . . . 74.31 110.823 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.3 130.34 6.24 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.391 2.061 . . . . 74.2 110.792 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -165.49 148.64 7.96 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 120.873 0.368 . . . . 75.34 110.472 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.25 119.95 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.017 0 N-CA-C 107.939 -1.134 . . . . 71.14 107.939 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.675 HG13 ' SG ' ' A' ' 50' ' ' CYS . 7.3 m -86.12 127.04 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.411 0 C-N-CA 119.854 -0.739 . . . . 74.04 109.108 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -97.6 114.8 26.8 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.584 -0.735 . . . . 74.33 110.047 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.4 m -81.2 103.35 10.93 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.194 -1.039 . . . . 74.14 108.194 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.7 p -73.77 171.52 13.17 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.282 -0.417 . . . . 73.12 111.375 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.4 mt -58.56 -28.83 65.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.537 0.735 . . . . 75.51 112.131 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -74.77 -14.45 60.71 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.403 0.681 . . . . 74.33 111.309 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.98 17.59 37.23 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 119.935 -1.126 . . . . 71.43 111.421 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -99.62 123.93 44.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 122.69 -0.3 . . . . 71.1 111.332 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -80.73 122.39 27.08 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.962 -0.755 . . . . 72.03 108.962 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 tp -136.07 126.37 26.54 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.228 -1.027 . . . . 75.21 108.228 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.675 ' SG ' HG13 ' A' ' 40' ' ' VAL . 17.3 m -87.39 149.41 24.49 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 113.713 1.005 . . . . 70.25 113.713 -171.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.526 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -134.06 162.54 57.09 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 115.058 -0.974 . . . . 75.24 109.221 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.43 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 63.2 Cg_endo -69.03 109.44 2.17 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.077 1.852 . . . . 75.14 112.298 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.04 -21.63 63.13 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.448 2.765 . . . . 73.52 115.794 -170.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -102.95 -14.3 16.56 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.977 0.418 . . . . 75.24 111.934 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.409 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.7 mm100 -68.39 141.76 93.8 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 113.51 0.93 . . . . 74.51 113.51 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.9 -39.06 24.31 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 124.78 3.654 . . . . 72.45 115.896 -176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -74.43 -31.87 62.45 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.374 -0.93 . . . . 72.14 110.791 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 62' ' ' ILE . 77.1 t -77.09 -38.77 28.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.96 -0.564 . . . . 72.31 112.308 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 11.0 pt-20 -55.9 -36.27 67.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 120.328 -0.549 . . . . 73.12 112.211 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -68.53 -51.19 45.75 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.925 0.343 . . . . 74.32 111.925 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.439 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 14.6 pt -63.4 -33.87 63.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.166 0.432 . . . . 75.42 112.166 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.509 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 66.6 mt -61.04 -46.84 95.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 N-CA-C 109.549 -0.537 . . . . 74.51 109.549 173.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 15.4 mm100 -57.67 -44.13 85.5 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.925 -0.398 . . . . 74.41 109.925 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -56.16 -48.75 75.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.247 -0.888 . . . . 74.14 110.014 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.442 HD12 HG13 ' A' ' 22' ' ' VAL . 83.1 mt -71.13 -31.56 67.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.317 -0.553 . . . . 74.33 112.236 177.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 45.0 mt-30 -66.84 -24.37 66.14 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 120.237 -0.585 . . . . 74.44 111.871 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 31.7 mmm180 -67.39 -35.44 79.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.709 -0.478 . . . . 75.35 109.709 176.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 72' ' ' MET . 20.3 m -79.35 -19.37 50.42 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.853 0.835 . . . . 64.01 110.474 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.4 t -85.42 -27.45 25.75 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.85 -0.796 . . . . 52.12 108.85 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.99 -59.63 2.65 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.283 -1.006 . . . . 51.1 108.283 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -95.12 85.85 4.43 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 106.47 -1.678 . . . . 74.14 106.47 172.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 68' ' ' THR . 49.9 tpp -57.74 128.38 36.78 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 113.776 -1.556 . . . . 75.4 113.437 -170.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.1 tttt 62.8 -82.78 0.02 OUTLIER 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.565 -1.198 . . . . 75.23 113.056 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -137.91 -49.05 0.57 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.799 0.333 . . . . 74.55 111.874 -177.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -129.6 34.41 4.33 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.385 -0.37 . . . . 74.41 110.202 -173.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.0 m 78.11 3.32 2.82 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.001 1.32 . . . . 75.44 108.536 -173.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.413 -2.319 0 N-CA-C 103.504 -2.776 . . . . 75.34 103.504 178.611 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.012 0 N-CA-C 110.439 -1.064 . . . . 54.24 110.439 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 54.1 m 63.57 91.86 0.07 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.687 0.795 . . . . 72.23 111.564 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -155.01 -49.45 0.09 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.039 -0.528 . . . . 73.52 110.257 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.614 ' OD1' ' HG2' ' A' ' 6' ' ' GLU . 12.2 t70 -98.09 144.31 27.71 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.404 -0.591 . . . . 74.12 109.404 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.92 -10.52 59.84 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.876 1.435 . . . . 73.34 114.876 -172.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.614 ' HG2' ' OD1' ' A' ' 4' ' ' ASP . 12.2 pt-20 -98.62 150.94 21.22 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 119.428 -0.909 . . . . 74.14 110.786 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -82.76 14.5 3.16 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.211 1.005 . . . . 71.25 111.178 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.4 m -82.92 165.17 19.95 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 114.927 -1.033 . . . . 64.12 108.439 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.4 ' SG ' HG13 ' A' ' 40' ' ' VAL . 51.9 m -91.62 179.1 5.74 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.944 0.72 . . . . 73.14 112.944 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.3 mt -100.71 -45.81 5.37 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.972 -1.013 . . . . 75.11 109.444 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.7 p -170.04 152.99 4.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 119.9 -0.72 . . . . 72.04 110.786 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 50' ' ' CYS . 2.2 m -112.67 146.63 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 N-CA-C 105.612 -1.996 . . . . 64.21 105.612 171.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.3 t -98.42 178.77 4.93 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 108.802 -0.814 . . . . 75.3 108.802 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -43.83 -57.95 2.99 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.293 0.637 . . . . 64.31 110.087 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -143.28 93.07 6.54 Favored Pre-proline 0 N--CA 1.421 -1.912 0 N-CA-C 108.597 -0.89 . . . . 74.33 108.597 171.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.521 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 5.1 Cg_endo -49.39 -76.12 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.857 3.038 . . . . 75.34 115.654 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.61 145.8 32.77 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 109.057 -0.72 . . . . 72.34 109.057 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.7 139.48 81.01 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.177 1.918 . . . . 75.13 111.213 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -74.04 0.63 51.72 Favored Glycine 0 C--O 1.22 -0.728 0 CA-C-O 121.471 0.484 . . . . 73.43 113.327 -177.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -80.35 -20.5 44.02 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 123.14 0.576 . . . . 73.21 110.726 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.3 pt -104.76 10.31 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.216 0.45 . . . . 73.44 112.216 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.443 HG13 HD12 ' A' ' 65' ' ' LEU . 3.7 p -97.38 139.52 19.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.814 0.34 . . . . 73.24 111.788 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.664 ' HD2' ' ND2' ' A' ' 24' ' ' ASN . 0.8 OUTLIER -95.75 -55.89 2.86 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.833 -0.803 . . . . 71.41 108.833 -177.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.664 ' ND2' ' HD2' ' A' ' 23' ' ' ARG . 49.6 m-80 -135.07 167.6 20.66 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 109.066 -0.716 . . . . 65.33 109.066 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -144.04 165.35 28.04 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.371 -0.603 . . . . 74.31 109.371 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -133.9 118.53 18.03 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.011 -1.107 . . . . 75.42 108.011 172.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -84.16 101.63 11.99 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.652 -0.704 . . . . 74.12 109.239 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.585 HD22 ' SG ' ' A' ' 34' ' ' CYS . 6.9 tt -106.54 133.35 51.36 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.369 -0.832 . . . . 72.13 110.471 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -128.63 -176.54 3.87 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.702 -0.681 . . . . 74.35 110.144 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.7 mt -72.09 -22.2 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.589 -0.893 . . . . 65.41 108.589 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -63.44 -29.92 71.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.529 -0.76 . . . . 53.25 110.747 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -67.87 -39.16 83.75 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.027 -0.731 . . . . 74.0 109.027 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.74 58.96 0.23 Allowed Glycine 0 CA--C 1.498 -1.014 0 CA-C-N 115.187 -0.915 . . . . 72.12 110.868 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.585 ' SG ' HD22 ' A' ' 28' ' ' LEU . 61.4 m -141.91 136.62 30.63 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.626 -1.25 . . . . 75.34 107.626 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -76.06 -10.94 59.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.478 0.656 . . . . 75.32 110.647 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 p -121.36 101.39 43.94 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.372 -0.831 . . . . 75.15 109.903 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.14 130.17 10.98 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.797 1.665 . . . . 72.44 109.624 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' A' ' 50' ' ' CYS . . . -168.11 148.72 4.97 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.73 0.3 . . . . 63.44 110.921 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.76 126.96 53.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.351 -0.611 . . . . 74.02 109.351 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.626 HG13 ' SG ' ' A' ' 50' ' ' CYS . 10.5 m -84.5 127.56 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 C-N-CA 120.171 -0.612 . . . . 64.41 109.464 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.436 ' CD1' HG22 ' A' ' 22' ' ' VAL . 9.3 m-85 -99.74 121.06 40.7 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.646 -0.707 . . . . 74.22 109.809 174.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.5 m -90.5 104.96 17.48 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.455 -0.942 . . . . 74.35 108.455 174.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 55.6 p -70.62 171.02 11.03 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.395 -0.366 . . . . 74.41 111.605 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.99 -25.8 65.59 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.601 0.715 . . . . 74.42 109.106 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -64.62 -32.45 74.12 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.8 -1.091 . . . . 74.22 109.611 172.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.11 16.42 15.12 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 115.757 -0.656 . . . . 74.1 112.914 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -94.08 134.73 36.19 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.241 0.521 . . . . 75.53 110.951 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -90.77 116.46 28.64 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 107.37 -1.344 . . . . 72.11 107.37 170.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 50' ' ' CYS . 1.6 tm? -138.02 143.86 40.77 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.695 -1.224 . . . . 71.44 107.695 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.626 ' SG ' HG13 ' A' ' 40' ' ' VAL . 30.8 m -94.69 143.2 26.63 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 115.19 1.552 . . . . 73.2 115.19 -177.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.521 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -125.6 163.09 40.95 Favored Pre-proline 0 N--CA 1.434 -1.265 0 CA-C-N 114.65 -1.159 . . . . 73.45 109.142 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 57.0 Cg_endo -70.76 110.38 2.74 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.123 1.882 . . . . 71.12 112.985 -174.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.75 -9.87 26.63 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 123.19 2.593 . . . . 72.12 114.676 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -101.04 -20.83 15.21 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.105 0.478 . . . . 65.31 111.308 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -69.3 130.12 91.25 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 112.795 0.665 . . . . 74.04 112.795 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.2 -36.21 36.13 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.109 3.206 . . . . 74.23 114.247 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.419 ' CE2' HG23 ' A' ' 58' ' ' VAL . 28.3 p-90 -64.8 -27.58 68.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 119.224 -0.991 . . . . 72.45 109.921 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 62' ' ' ILE . 69.7 t -86.16 -48.86 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.642 -0.708 . . . . 72.04 111.614 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.357 0.3 OUTLIER -61.9 -29.39 70.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.101 1.149 . . . . 73.44 114.101 -176.63 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -68.86 -43.09 76.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.765 0.317 . . . . 74.4 111.276 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.43 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.9 pt -71.72 -30.73 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 O-C-N 122.124 -0.36 . . . . 75.04 111.628 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.549 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 62.8 mt -56.76 -46.87 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.159 -0.473 . . . . 74.42 109.943 173.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -56.88 -41.9 78.87 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.114 0.566 . . . . 74.24 109.544 179.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 98.3 mtt180 -62.47 -38.93 91.74 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.58 -0.737 . . . . 71.22 111.492 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.443 HD12 HG13 ' A' ' 22' ' ' VAL . 84.5 mt -81.26 -26.06 36.1 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.676 0.251 . . . . 72.23 111.676 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 98.3 mt-30 -58.22 -20.53 42.38 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.59 0.959 . . . . 73.01 113.59 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 16.9 ptm180 -58.01 -37.06 73.6 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 123.103 0.252 . . . . 75.31 111.298 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 65' ' ' LEU . 13.4 t -85.01 -18.66 33.73 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.605 0.717 . . . . 71.43 110.128 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.9 t -74.33 -15.64 60.94 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.492 -0.776 . . . . 75.03 110.002 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -31.67 71.89 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.025 -0.534 . . . . 72.3 111.566 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -93.88 105.61 17.62 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.791 0.805 . . . . 71.34 111.716 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -152.71 -173.13 4.46 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 105.839 -1.912 . . . . 62.41 105.839 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -71.24 103.46 2.82 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.483 -2.043 . . . . 74.4 105.483 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -114.36 132.42 56.21 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.376 -0.829 . . . . 74.42 111.396 -169.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -75.92 -59.78 2.61 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.671 -0.695 . . . . 72.35 109.741 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.4 m -89.15 92.85 9.36 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.623 -0.717 . . . . 54.44 110.404 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 N--CA 1.431 -1.393 0 CA-C-O 118.023 -0.989 . . . . 72.34 109.888 -179.86 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.032 0 N-CA-C 111.11 -0.796 . . . . 72.43 111.11 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.7 p -127.49 159.6 34.07 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 110.013 -0.366 . . . . 75.12 110.013 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -86.17 85.52 7.35 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.237 -1.764 . . . . 60.32 106.237 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -161.07 -171.85 3.22 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 104.756 -2.313 . . . . 74.21 104.756 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 7' ' ' ASP . . . -86.18 -33.5 20.79 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.869 -1.16 . . . . 62.45 107.869 175.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.325 11.3 pt-20 48.74 -8.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 128.339 2.656 . . . . 70.31 116.988 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 5' ' ' ALA . 36.2 t70 -83.69 76.84 9.95 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.733 1.254 . . . . 74.24 108.267 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.455 ' HA ' HD11 ' A' ' 28' ' ' LEU . 27.2 p -146.33 174.93 10.92 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 112.644 -2.071 . . . . 72.12 106.593 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -101.98 175.23 5.61 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 118.436 -1.306 . . . . 70.42 110.625 -176.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.0 -64.86 1.06 Allowed 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.416 -0.587 . . . . 73.1 109.416 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -176.03 160.21 2.25 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 106.218 -1.771 . . . . 74.23 106.218 -178.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -98.87 160.04 3.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 118.722 -1.191 . . . . 71.31 109.422 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.0 t -106.15 179.47 4.26 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.416 -0.587 . . . . 63.14 109.416 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -40.48 -50.15 2.91 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.288 1.435 . . . . 74.3 110.458 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -159.97 98.47 1.49 Allowed Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 107.662 -1.236 . . . . 75.1 107.662 169.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.555 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -42.36 -73.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.379 3.386 . . . . 55.11 116.622 -175.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.69 167.86 14.36 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.219 -0.66 . . . . 72.53 109.219 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.508 ' O ' HG12 ' A' ' 21' ' ' ILE . 38.6 Cg_exo -62.21 128.71 24.68 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.704 1.603 . . . . 71.14 109.495 171.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.427 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -71.49 1.33 28.86 Favored Glycine 0 C--N 1.301 -1.376 0 N-CA-C 114.336 0.494 . . . . 72.32 114.336 -175.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -94.35 -13.48 26.33 Favored 'General case' 0 C--N 1.285 -2.222 0 O-C-N 122.509 -0.406 . . . . 74.44 111.544 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 18' ' ' PRO . 38.9 pt -95.52 9.47 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.191 0.519 . . . . 75.02 111.205 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.574 HG22 ' CD1' ' A' ' 41' ' ' PHE . 3.1 p -96.9 141.27 15.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 115.949 -0.568 . . . . 74.04 111.842 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.484 ' HD2' ' ND2' ' A' ' 24' ' ' ASN . 1.3 tmt_? -105.44 -54.32 2.5 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.483 -0.932 . . . . 72.32 108.483 -178.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.484 ' ND2' ' HD2' ' A' ' 23' ' ' ARG . 53.6 m-80 -123.88 160.55 27.22 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.126 -0.694 . . . . 63.01 109.126 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.455 ' CZ ' HG22 ' A' ' 62' ' ' ILE . 42.1 p90 -141.53 155.0 45.82 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.324 -0.991 . . . . 75.41 108.324 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -137.26 128.42 27.81 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.601 -0.518 . . . . 72.43 109.601 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -79.24 101.31 7.93 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 109.272 -0.64 . . . . 73.32 109.272 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' A' ' 8' ' ' CYS . 43.6 mt -98.92 131.0 45.33 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-O 121.665 0.745 . . . . 74.02 109.855 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.9 mt -132.59 178.23 7.01 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 114.877 -1.056 . . . . 73.52 108.815 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 25.3 mt -76.55 -29.5 18.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.442 -0.947 . . . . 61.12 108.442 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -67.83 -15.63 63.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.223 -0.899 . . . . 74.42 109.777 174.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -89.14 -43.2 11.21 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.924 -1.139 . . . . 75.44 107.924 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.8 -90.14 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 119.721 -1.228 . . . . 74.33 115.122 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 58.2 m -75.89 157.56 33.11 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.077 0.399 . . . . 72.15 112.077 -172.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -72.8 29.25 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.474 1.11 . . . . 71.42 113.702 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.4 p -137.4 102.9 8.74 Favored Pre-proline 0 C--N 1.3 -1.568 0 CA-C-O 121.395 0.617 . . . . 63.33 110.181 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -86.85 130.18 3.06 Favored 'Trans proline' 0 N--CA 1.438 -1.75 0 C-N-CA 121.941 1.76 . . . . 73.11 111.772 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.29 157.73 9.43 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.529 -0.759 . . . . 74.11 109.087 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.85 126.31 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 108.334 -0.987 . . . . 72.1 108.334 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 20.1 m -94.01 129.29 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.98 0 CA-C-O 121.609 0.718 . . . . 70.01 110.534 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 22' ' ' VAL . 7.2 m-85 -93.86 118.16 31.08 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 114.958 -1.019 . . . . 75.14 111.897 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.4 m -81.36 105.45 12.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.436 -0.949 . . . . 74.45 108.436 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.1 p -76.11 174.28 10.25 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.699 0.285 . . . . 72.35 111.363 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 88.1 mt -62.52 -28.39 69.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.185 0.594 . . . . 71.31 110.307 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -69.52 -30.21 67.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.546 -0.752 . . . . 75.55 109.414 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.57 8.69 45.64 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.66 -0.7 . . . . 72.11 111.949 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -95.22 133.49 39.03 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 105.605 -1.998 . . . . 64.31 105.605 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 39.1 mt-30 -96.79 143.57 27.59 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.477 -0.935 . . . . 71.11 108.477 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 37.4 tp -135.91 150.35 49.3 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.215 -0.594 . . . . 73.52 109.881 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.2 m -77.47 122.18 24.86 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 123.547 0.53 . . . . 73.51 109.72 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.555 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.28 151.76 72.74 Favored Pre-proline 0 C--N 1.311 -1.083 0 C-N-CA 120.288 -0.565 . . . . 72.32 110.1 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.98 110.31 3.09 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.778 2.319 . . . . 74.15 113.859 -173.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -67.94 -17.33 46.46 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.328 2.018 . . . . 65.03 111.887 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.96 -17.05 34.03 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.777 -0.647 . . . . 74.13 111.729 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -84.81 127.49 64.79 Favored Pre-proline 0 C--N 1.317 -0.827 0 O-C-N 122.162 -0.336 . . . . 74.24 111.277 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -46.76 -37.87 21.81 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.608 3.539 . . . . 62.03 115.125 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.431 ' O ' HG12 ' A' ' 61' ' ' ILE . 41.8 p-90 -61.25 -35.4 77.17 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 120.784 -0.366 . . . . 75.45 110.752 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 62' ' ' ILE . 76.6 t -70.64 -41.65 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.806 -0.634 . . . . 75.41 111.244 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.2 mt-10 -58.09 -47.5 83.02 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 111.681 0.252 . . . . 62.33 111.681 -178.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -64.03 -40.29 95.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.695 1.369 . . . . 71.21 114.695 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 57' ' ' TRP . 10.7 pt -69.79 -35.69 66.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.34 -0.544 . . . . 73.33 111.507 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.455 HG22 ' CZ ' ' A' ' 25' ' ' PHE . 56.9 mt -59.26 -49.55 83.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.356 -0.384 . . . . 75.14 110.517 173.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 18.5 mm-40 -56.19 -37.65 69.92 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.155 0.582 . . . . 72.34 110.125 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.557 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 20.2 ttm180 -68.08 -36.71 80.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.657 -0.701 . . . . 74.22 110.856 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.457 HD12 HG13 ' A' ' 22' ' ' VAL . 87.2 mt -76.13 -35.61 59.18 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 122.097 -0.377 . . . . 74.14 111.091 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -58.08 -19.15 29.8 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.983 1.475 . . . . 75.44 114.983 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 39.6 ptt180 -64.08 -15.16 58.99 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.232 -0.587 . . . . 74.12 111.731 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.6 p -74.34 -27.56 60.74 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 121.587 0.708 . . . . 62.23 110.06 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 43.6 m -80.27 -12.2 59.64 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.114 -0.948 . . . . 74.44 109.49 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.43 -19.01 50.99 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.308 -0.86 . . . . 74.12 110.28 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -110.45 138.88 46.26 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.091 0.472 . . . . 72.14 111.59 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 54.4 ttp 57.53 85.1 0.09 Allowed 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 115.24 1.57 . . . . 72.41 115.24 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.4 tttt 63.5 1.14 0.95 Allowed 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 114.371 1.249 . . . . 75.43 114.371 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 69' ' ' SER . 73.6 ttt180 74.43 -61.16 0.5 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.012 0.925 . . . . 75.51 110.512 -175.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -122.53 107.84 12.46 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.812 -0.81 . . . . 73.04 108.812 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.8 m -109.38 100.93 9.96 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 116.084 -0.507 . . . . 74.0 109.961 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.429 -1.478 0 N-CA-C 107.832 -1.173 . . . . 73.11 107.832 -179.844 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.128 0 N-CA-C 110.995 -0.842 . . . . 73.24 110.995 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.9 m -86.49 89.05 7.77 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.795 0.807 . . . . 75.3 111.597 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -102.77 -32.53 9.78 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.926 -1.139 . . . . 74.44 107.926 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -93.44 143.49 26.23 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.085 -1.08 . . . . 73.34 108.085 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.72 -4.73 57.02 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 114.084 1.142 . . . . 63.42 114.084 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER 58.16 -161.28 0.24 Allowed 'General case' 0 CA--C 1.577 2.01 0 C-N-CA 124.236 1.014 . . . . 74.22 108.916 -178.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.507 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 15.9 m-20 -103.75 25.19 10.11 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 121.657 0.741 . . . . 75.13 110.066 177.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.472 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 24.6 p -150.6 -160.33 1.15 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.039 -1.467 . . . . 73.31 107.039 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.519 ' SG ' HG13 ' A' ' 40' ' ' VAL . 1.7 t -121.87 -178.89 3.96 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 117.999 -1.48 . . . . 71.53 107.89 174.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tt -88.48 -67.74 0.81 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.117 -0.697 . . . . 73.52 109.117 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.7 m -168.55 149.07 4.65 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.215 -1.031 . . . . 62.11 108.215 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.49 158.66 4.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 119.144 -1.022 . . . . 75.21 108.323 178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.1 t -103.21 178.47 4.55 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.077 -0.712 . . . . 73.13 109.077 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -46.64 -41.16 14.33 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.398 0.679 . . . . 70.4 111.544 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.5 ttpt -162.04 100.61 1.15 Allowed Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 107.249 -1.389 . . . . 75.3 107.249 170.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.588 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.5 Cg_endo -51.52 -82.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.889 3.059 . . . . 54.41 117.634 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.08 159.98 59.68 Favored Pre-proline 0 C--N 1.316 -0.878 0 O-C-N 121.964 -0.46 . . . . 55.44 110.257 -173.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.547 ' O ' HG12 ' A' ' 21' ' ' ILE . 78.1 Cg_exo -55.2 128.49 30.75 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.566 2.178 . . . . 75.42 110.691 173.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.452 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -79.71 0.46 81.79 Favored Glycine 0 C--N 1.307 -1.028 0 N-CA-C 115.15 0.82 . . . . 72.45 115.15 -174.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -99.17 -0.16 42.16 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.147 0.795 . . . . 71.55 113.147 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 18' ' ' PRO . 36.9 pt -101.27 10.25 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.667 0.746 . . . . 72.12 110.074 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.448 ' CG1' HD12 ' A' ' 65' ' ' LEU . 3.1 p -94.44 138.98 19.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.287 -0.869 . . . . 72.53 111.336 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.09 -47.2 7.38 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.786 -0.82 . . . . 74.51 108.786 -175.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -149.93 160.5 43.55 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.048 -1.093 . . . . 73.54 108.048 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.3 168.26 19.51 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 117.973 0.352 . . . . 74.41 110.519 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.477 ' HB2' HG21 ' A' ' 40' ' ' VAL . 40.7 m80 -135.46 112.41 10.27 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.377 -1.342 . . . . 73.13 107.377 171.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -79.45 99.29 7.15 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.339 -1.356 . . . . 65.23 107.339 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.472 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -111.73 117.55 33.18 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.761 -0.654 . . . . 75.45 110.288 -170.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.8 mt -104.82 -176.07 2.97 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.497 -0.557 . . . . 74.25 109.497 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 63.3 mt -67.04 -36.24 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.909 0.862 . . . . 73.45 109.16 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -64.29 -24.17 67.56 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.484 -1.234 . . . . 72.52 110.276 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.48 -28.39 16.85 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.828 -0.624 . . . . 53.43 110.514 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.96 -106.76 0.65 Allowed Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 119.626 -1.273 . . . . 73.4 115.884 -173.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 33.6 m -118.32 179.68 4.04 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.993 -0.604 . . . . 73.32 109.496 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -55.22 -19.38 7.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.35 1.06 . . . . 74.35 112.377 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -103.14 106.79 52.85 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 121.114 0.483 . . . . 75.25 111.34 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -87.19 144.21 6.92 Favored 'Trans proline' 0 C--O 1.251 1.143 0 C-N-CA 122.576 2.184 . . . . 72.33 110.848 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -174.43 153.47 1.91 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.92 -0.4 . . . . 63.53 109.92 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.49 122.59 50.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.178 -1.416 . . . . 71.25 107.178 175.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.519 HG13 ' SG ' ' A' ' 9' ' ' CYS . 8.0 m -89.16 127.72 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.859 0 C-N-CA 119.566 -0.854 . . . . 71.55 109.426 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -98.13 121.54 40.18 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 115.302 -0.863 . . . . 73.33 110.702 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.0 m -86.35 103.42 14.91 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.819 -1.178 . . . . 75.34 107.819 174.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 50.0 p -70.97 171.69 10.36 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 116.201 -0.454 . . . . 64.32 110.833 -177.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 98.4 mt -60.96 -26.93 67.88 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.356 0.598 . . . . 70.51 109.775 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -71.65 -15.15 62.22 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 114.972 -1.013 . . . . 61.44 111.018 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.04 8.66 61.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.004 -0.617 . . . . 63.54 112.731 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -93.41 140.59 29.4 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 122.869 -0.195 . . . . 73.23 110.84 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -99.88 117.76 34.87 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.52 -0.918 . . . . 74.23 108.52 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.52 HD12 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -120.95 143.39 49.02 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.633 -0.877 . . . . 73.02 108.633 -174.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.52 ' N ' HD12 ' A' ' 49' ' ' LEU . 6.3 m -80.15 126.14 30.71 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 122.993 0.517 . . . . 74.13 111.17 -174.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.588 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -128.26 153.27 78.84 Favored Pre-proline 0 C--O 1.245 0.859 0 C-N-CA 120.907 -0.317 . . . . 74.12 110.989 175.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 72.0 Cg_endo -68.47 113.28 3.08 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.204 2.603 . . . . 73.33 113.024 -175.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 60.1 Cg_endo -72.24 -8.02 22.01 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.551 2.167 . . . . 73.15 114.205 -175.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -109.73 -0.51 18.48 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.3 0.572 . . . . 73.5 111.616 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -86.34 135.97 36.02 Favored Pre-proline 0 C--N 1.314 -0.942 0 O-C-N 121.52 -0.737 . . . . 75.23 112.233 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.76 -36.76 26.7 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 124.697 3.598 . . . . 75.5 115.051 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -68.77 -32.48 72.26 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 120.343 -0.543 . . . . 60.42 110.685 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.639 ' O ' HG12 ' A' ' 62' ' ' ILE . 72.4 t -71.7 -48.99 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.831 -0.622 . . . . 74.13 111.997 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 9.3 pt-20 -55.69 -30.36 60.97 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.575 0.583 . . . . 73.15 112.575 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -73.02 -45.09 59.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.563 -0.29 . . . . 75.15 111.301 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.452 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 12.9 pt -71.71 -29.02 32.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 111.89 0.33 . . . . 75.4 111.89 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.639 HG12 ' O ' ' A' ' 58' ' ' VAL . 46.9 mm -56.49 -44.89 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.892 -0.781 . . . . 75.25 108.892 172.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 15.5 mm100 -59.1 -42.51 90.67 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.806 -0.634 . . . . 74.52 110.58 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -60.86 -46.59 90.0 Favored 'General case' 0 C--O 1.206 -1.201 0 O-C-N 124.143 0.902 . . . . 75.14 111.002 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.448 HD12 ' CG1' ' A' ' 22' ' ' VAL . 86.8 mt -72.47 -34.11 67.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.253 -0.579 . . . . 72.25 111.897 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 43.7 mt-30 -61.5 -19.59 62.23 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 113.466 0.914 . . . . 74.24 113.466 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -57.6 -28.21 63.43 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-O 120.945 0.403 . . . . 73.34 110.122 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.2 p -85.32 -32.79 22.3 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-O 121.378 0.609 . . . . 73.23 110.647 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.9 t -77.98 -22.29 49.62 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.94 -1.027 . . . . 61.44 110.83 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.16 -19.54 64.8 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.176 -0.465 . . . . 71.12 109.977 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 61.6 tttp 65.64 -67.81 0.13 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.743 1.617 . . . . 74.21 112.549 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.3 ptm -87.24 80.63 8.19 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 122.578 1.18 . . . . 74.0 111.604 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -93.8 89.06 6.0 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 113.826 -1.534 . . . . 70.25 107.683 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 55.55 75.84 0.3 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 114.896 -1.047 . . . . 74.31 108.355 -172.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -135.38 109.15 8.05 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.236 -0.585 . . . . 74.25 110.622 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.5 p -129.32 144.05 51.08 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.724 -0.671 . . . . 75.34 110.063 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.1 m . . . . . 0 C--N 1.3 -1.575 0 N-CA-C 109.378 -0.601 . . . . 72.14 109.378 179.675 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.428 0 N-CA-C 111.067 -0.813 . . . . 52.22 111.067 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.4 p -79.93 -28.12 39.76 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 117.321 0.561 . . . . 74.03 110.338 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.4 t30 62.25 93.06 0.05 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.021 1.328 . . . . 74.54 111.27 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -78.21 -5.34 51.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.41 -0.813 . . . . 74.02 111.253 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.85 -10.0 58.71 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.943 0.877 . . . . 74.24 110.029 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -126.75 163.44 23.53 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 114.176 -1.374 . . . . 75.51 109.443 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -133.09 97.01 3.89 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.583 0.706 . . . . 75.42 109.373 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.432 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 46.5 t -152.81 -172.36 4.22 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 106.351 -1.722 . . . . 74.44 106.351 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' A' ' 10' ' ' LEU . 11.9 t -118.9 178.32 4.53 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 120.071 -0.652 . . . . 74.15 111.637 -173.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.403 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 83.4 mt -94.36 -53.9 3.75 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.105 -1.072 . . . . 75.03 108.105 174.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.9 t -177.19 -173.97 0.48 Allowed 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.131 -1.063 . . . . 63.23 108.131 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.78 167.67 25.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 106.939 -1.504 . . . . 75.44 106.939 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.2 t -105.52 178.28 4.61 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.781 -0.822 . . . . 75.1 108.781 175.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -53.02 -38.26 62.21 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.172 0.511 . . . . 74.41 111.139 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 ttmt -159.2 93.42 1.82 Allowed Pre-proline 0 N--CA 1.425 -1.707 0 N-CA-C 108.014 -1.106 . . . . 75.4 108.014 173.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.2 Cg_endo -54.07 -86.24 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.882 3.055 . . . . 65.42 117.945 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.39 163.18 50.65 Favored Pre-proline 0 C--N 1.32 -0.698 0 O-C-N 121.865 -0.522 . . . . 72.35 110.565 -172.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.524 ' O ' HG12 ' A' ' 21' ' ' ILE . 38.0 Cg_exo -62.03 130.05 29.45 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.165 1.91 . . . . 74.13 110.853 175.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.461 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -71.95 1.6 30.85 Favored Glycine 0 C--N 1.307 -1.042 0 N-CA-C 114.32 0.488 . . . . 45.21 114.32 -177.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -87.32 -22.16 25.28 Favored 'General case' 0 N--CA 1.416 -2.128 0 O-C-N 122.529 -0.395 . . . . 74.43 110.692 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.5 pt -90.7 8.66 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 120.206 -0.598 . . . . 71.45 111.887 -176.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 65' ' ' LEU . 2.6 p -92.94 132.51 36.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.22 0.533 . . . . 71.1 111.753 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -55.33 3.63 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.004 -1.11 . . . . 74.33 108.004 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -135.24 158.33 44.63 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.279 -1.008 . . . . 71.41 108.279 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -139.71 155.06 47.57 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.153 -0.619 . . . . 74.55 110.634 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -122.27 112.59 18.33 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.666 -1.235 . . . . 64.14 107.666 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -83.46 99.58 10.19 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.064 -0.717 . . . . 75.14 109.064 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 88.3 mt -106.58 143.26 34.95 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.8 -0.636 . . . . 74.51 111.798 -176.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.6 mt -140.45 175.85 9.26 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.876 -1.056 . . . . 62.41 109.639 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 46.4 mt -76.41 -19.79 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.961 -1.126 . . . . 72.22 107.961 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -60.82 -36.58 79.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.467 -1.242 . . . . 74.51 109.276 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.99 -41.06 78.33 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.595 -0.729 . . . . 70.03 109.274 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.96 -36.91 1.29 Allowed Glycine 0 CA--C 1.495 -1.197 0 C-N-CA 120.741 -0.742 . . . . 74.42 112.361 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 49.3 t -69.56 127.94 34.76 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.002 -1.11 . . . . 74.43 108.002 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -84.43 1.62 44.59 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.902 1.445 . . . . 73.14 114.902 -170.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -110.29 95.85 23.85 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 108.598 -0.89 . . . . 74.31 108.598 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -76.52 129.11 10.76 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 121.643 1.562 . . . . 72.15 111.415 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.492 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -171.0 151.3 3.25 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.231 -0.895 . . . . 74.11 109.728 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.22 119.6 47.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.463 -1.31 . . . . 75.34 107.463 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.426 HG13 ' SG ' ' A' ' 50' ' ' CYS . 2.6 m -83.46 119.35 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.565 0 C-N-CA 119.294 -0.963 . . . . 71.43 108.529 -178.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.401 ' CD1' HG22 ' A' ' 22' ' ' VAL . 11.1 m-85 -91.28 111.53 23.05 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.377 -0.828 . . . . 75.22 110.643 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.4 m -80.13 100.4 8.22 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 106.99 -1.485 . . . . 73.54 106.99 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 49.5 p -68.1 173.94 4.25 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.964 -0.562 . . . . 74.43 111.357 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.5 mt -61.26 -29.46 69.86 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.282 0.563 . . . . 71.32 110.728 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -73.14 -16.61 61.44 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.378 -0.828 . . . . 74.24 110.227 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.6 -8.39 66.21 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 116.247 -0.433 . . . . 54.24 112.25 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -77.34 127.77 33.15 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 107.128 -1.434 . . . . 71.32 107.128 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -85.15 123.77 31.05 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.723 -0.843 . . . . 71.24 108.723 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 50' ' ' CYS . 4.3 tt -135.54 133.53 38.5 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 106.727 -1.583 . . . . 74.0 106.727 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.489 ' N ' HD22 ' A' ' 49' ' ' LEU . 21.4 m -94.94 145.43 24.93 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 114.21 1.189 . . . . 72.44 114.21 -169.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.552 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -125.64 158.73 63.91 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 115.113 -0.949 . . . . 71.22 110.515 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.441 ' HB2' ' OE1' ' A' ' 55' ' ' GLN . 66.7 Cg_endo -69.49 108.11 1.96 Allowed 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.421 2.08 . . . . 65.2 112.569 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 71.7 Cg_endo -74.22 -10.37 22.49 Favored 'Trans proline' 0 N--CA 1.473 0.274 0 C-N-CA 123.113 2.542 . . . . 73.14 113.824 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -96.32 -16.19 21.46 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.571 0.701 . . . . 75.11 109.617 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.441 ' OE1' ' HB2' ' A' ' 52' ' ' PRO . 1.8 mp0 -82.08 144.44 50.97 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 113.497 0.925 . . . . 53.02 113.497 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.96 -39.97 81.76 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 124.548 3.498 . . . . 73.45 115.013 -174.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -65.31 -26.7 68.17 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.231 -0.587 . . . . 72.43 110.473 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 62' ' ' ILE . 71.8 t -81.22 -40.11 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.823 -0.626 . . . . 75.3 111.852 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 13.4 pt-20 -61.26 -37.07 81.8 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.775 0.657 . . . . 72.52 112.775 -176.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.409 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 3.2 mpt_? -69.26 -38.84 78.62 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 120.19 -0.604 . . . . 64.2 112.165 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.461 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 12.6 pt -71.42 -33.22 49.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 120.804 -0.358 . . . . 73.33 111.829 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 58' ' ' VAL . 67.7 mt -61.88 -47.02 95.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 N-CA-C 109.292 -0.633 . . . . 75.23 109.292 172.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 84.1 mm-40 -58.34 -41.25 84.2 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.167 -0.47 . . . . 74.23 111.42 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -60.23 -41.27 92.76 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.035 -0.529 . . . . 74.31 111.191 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.467 HD12 HG13 ' A' ' 22' ' ' VAL . 90.6 mt -75.25 -28.83 60.01 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.27 -0.572 . . . . 74.51 111.043 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.1 -35.09 71.67 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 112.011 0.374 . . . . 61.24 112.011 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -50.74 -40.93 55.85 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 124.128 0.971 . . . . 74.23 111.867 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.0 p -82.68 -24.81 33.53 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.623 0.725 . . . . 74.14 111.654 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.0 t -86.49 -19.57 29.35 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.249 -0.887 . . . . 62.45 110.002 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.84 -23.93 66.78 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.601 0.761 . . . . 74.24 111.293 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.22 97.22 7.53 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 106.88 -1.526 . . . . 75.23 106.88 176.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.5 ptm -126.96 -167.26 1.71 Allowed 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 113.673 -1.603 . . . . 73.33 108.477 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 73' ' ' LYS . 3.0 mptp? -62.91 124.75 21.87 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.829 -0.804 . . . . 74.01 108.829 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -69.93 103.22 2.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.974 0.416 . . . . 71.41 110.236 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -149.88 21.95 0.88 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.125 -1.065 . . . . 73.01 108.125 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.6 m 69.47 81.87 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.269 -1.332 . . . . 73.54 110.304 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--N 1.305 -1.339 0 CA-C-N 115.396 -0.82 . . . . 63.31 108.991 179.83 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.305 0 N-CA-C 110.388 -1.085 . . . . 74.32 110.388 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.0 p -78.02 82.72 4.35 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 117.635 0.718 . . . . 73.4 110.933 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.5 t30 177.77 122.32 0.04 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 125.711 1.604 . . . . 64.41 106.719 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -85.6 120.25 26.83 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.587 -0.523 . . . . 74.21 109.587 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.0 -12.43 59.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.084 -0.507 . . . . 64.23 110.506 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 63.8 175.44 0.17 Allowed 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 126.103 1.761 . . . . 61.23 111.609 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -76.12 -30.84 58.36 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.666 0.746 . . . . 55.45 110.766 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.447 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 4.9 p -99.63 -161.87 0.9 Allowed 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 114.676 -1.147 . . . . 74.33 110.138 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.539 ' SG ' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -93.37 -175.75 3.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.505 -0.924 . . . . 73.02 108.505 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.07 -59.06 1.94 Allowed 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.476 0.547 . . . . 63.1 112.476 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.8 m -162.27 141.71 9.52 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.838 -0.43 . . . . 75.42 109.838 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.7 m -98.94 152.03 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.255 -1.017 . . . . 74.33 108.255 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 t -94.15 178.39 5.66 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.161 -0.681 . . . . 75.5 109.161 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -45.27 -46.48 12.62 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.948 0.899 . . . . 64.33 110.597 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.493 ' HB2' ' HZ1' ' A' ' 15' ' ' LYS . 5.0 ttmp? -160.2 99.2 1.43 Allowed Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.017 -1.105 . . . . 70.54 108.017 169.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.5 Cg_endo -51.51 -81.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.351 0 C-N-CA 123.46 2.774 . . . . 51.4 116.785 -175.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.403 HD13 ' HB2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -147.95 152.46 40.37 Favored Pre-proline 0 C--N 1.322 -0.628 0 O-C-N 121.943 -0.473 . . . . 75.43 110.611 -174.116 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.453 ' O ' HG12 ' A' ' 21' ' ' ILE . 18.7 Cg_endo -61.97 141.2 88.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.444 2.096 . . . . 74.12 111.32 174.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.86 1.46 78.78 Favored Glycine 0 C--N 1.309 -0.952 0 C-N-CA 121.434 -0.413 . . . . 74.34 113.568 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.427 ' CE1' ' HG2' ' A' ' 64' ' ' ARG . 98.4 m-85 -94.6 -0.6 54.36 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 122.226 -0.573 . . . . 71.31 111.553 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 35.4 pt -112.41 5.13 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.279 0.561 . . . . 74.32 110.728 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 p -90.78 135.04 27.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.997 -0.547 . . . . 63.24 111.261 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.39 -55.6 3.82 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.775 -0.824 . . . . 72.12 108.775 -175.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -140.45 164.33 30.43 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.361 0.664 . . . . 73.12 109.626 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 8.6 p90 -143.85 167.98 21.03 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.743 0.306 . . . . 75.32 110.51 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -141.96 137.09 30.99 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.155 -1.054 . . . . 65.32 108.155 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -98.6 103.87 15.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 123.448 0.467 . . . . 72.41 109.868 -173.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 2.3 mm? -103.74 128.55 51.1 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.921 -0.77 . . . . 73.44 108.921 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.9 mt -131.95 179.59 5.99 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.225 0.536 . . . . 70.34 111.278 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.7 mt -77.99 -19.0 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.689 -1.226 . . . . 74.15 107.689 173.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.49 -34.33 72.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.07 -0.968 . . . . 61.34 109.845 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -68.16 -34.22 75.92 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.424 -0.807 . . . . 71.21 109.927 176.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.34 -17.51 3.54 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.356 -0.838 . . . . 75.12 112.471 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.22 161.69 26.61 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.675 1.361 . . . . 75.45 114.675 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -81.33 -15.49 55.2 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.939 -1.028 . . . . 74.51 111.282 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -134.12 123.81 17.04 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-O 120.971 0.415 . . . . 75.31 111.958 -174.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -85.94 129.39 3.43 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 121.794 1.663 . . . . 74.34 109.556 172.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -162.77 136.86 6.27 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.121 -0.49 . . . . 63.13 109.742 -176.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.99 124.51 52.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.305 -1.369 . . . . 74.44 107.305 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.539 HG13 ' SG ' ' A' ' 9' ' ' CYS . 18.8 m -84.79 123.17 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.548 0 CA-C-O 121.854 0.835 . . . . 73.45 110.178 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.403 ' HB2' HD13 ' A' ' 17' ' ' ILE . 15.1 m-85 -97.97 117.88 33.3 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 114.757 -1.111 . . . . 75.41 109.804 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 94.4 m -87.1 102.08 14.1 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.746 -0.835 . . . . 75.44 108.746 174.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.5 p -70.97 166.79 20.53 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.373 -0.376 . . . . 75.34 110.511 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 90.0 mt -60.47 -25.58 66.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.525 0.678 . . . . 72.0 110.353 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -62.75 -24.85 67.9 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.127 -0.942 . . . . 73.0 110.644 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.44 15.97 36.07 Favored Glycine 0 CA--C 1.505 -0.551 0 C-N-CA 121.288 -0.482 . . . . 72.15 111.911 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 42' ' ' THR . 34.3 mmt180 -99.56 139.21 35.54 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 120.665 0.269 . . . . 75.51 111.007 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -95.79 129.41 43.03 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.996 -1.853 . . . . 71.33 105.996 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.2 tp -137.57 144.62 42.13 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.463 -0.495 . . . . 60.12 110.148 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 9.7 m -80.16 128.57 33.67 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 123.494 0.496 . . . . 72.45 110.632 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.47 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -131.86 154.78 81.86 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 109.208 -0.664 . . . . 65.43 109.208 172.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -77.31 107.82 2.48 Favored 'Trans proline' 0 CA--C 1.559 1.758 0 C-N-CA 122.643 2.229 . . . . 72.21 113.924 -173.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.9 Cg_endo -68.61 -19.8 41.62 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.135 2.557 . . . . 72.22 114.882 -173.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -96.87 2.7 52.04 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.601 0.715 . . . . 73.42 110.799 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -95.06 143.14 25.61 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 112.291 0.478 . . . . 74.05 112.291 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.27 -46.79 27.07 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 124.427 3.418 . . . . 74.33 114.625 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.499 ' O ' HG12 ' A' ' 61' ' ' ILE . 33.8 p-90 -63.33 -30.6 71.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 120.488 -0.485 . . . . 73.44 110.832 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 62' ' ' ILE . 72.7 t -81.56 -44.07 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.198 -0.455 . . . . 72.43 111.489 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -24.63 67.69 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 120.302 -0.559 . . . . 71.35 111.513 -177.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -79.64 -29.63 41.04 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 115.838 -0.619 . . . . 74.25 110.731 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 57' ' ' TRP . 8.3 pt -86.09 -35.31 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.703 1.001 . . . . 73.32 113.703 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 58' ' ' VAL . 67.9 mt -53.01 -41.63 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 120.741 0.305 . . . . 74.33 110.809 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -59.99 -35.33 74.79 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.942 0.719 . . . . 74.13 112.942 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 61' ' ' ILE . 7.1 mpt_? -57.31 -45.98 83.67 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.05 0.452 . . . . 60.02 110.316 174.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 3.5 mm? -68.1 -43.35 78.66 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.697 -0.683 . . . . 74.32 110.252 176.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -59.91 -41.71 92.3 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 115.61 -0.723 . . . . 74.23 112.268 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . 0.263 4.2 ppt_? -63.62 -27.62 69.36 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 113.365 0.876 . . . . 73.14 113.365 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.8 p -84.76 -22.14 29.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.441 0.639 . . . . 72.32 111.366 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.0 t -87.02 -12.53 47.13 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.194 -0.912 . . . . 70.12 109.741 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.35 -19.19 60.54 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.305 0.642 . . . . 74.52 111.538 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -75.62 137.95 41.09 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.234 -1.395 . . . . 55.4 107.234 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.1 ptp -52.36 94.48 0.01 OUTLIER 'General case' 0 C--O 1.248 1.012 0 N-CA-C 115.464 1.654 . . . . 73.14 115.464 -173.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 7.4 mmpt? -117.62 -31.74 5.09 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.247 -1.761 . . . . 71.35 106.247 172.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -147.79 -179.91 7.23 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.158 -1.423 . . . . 74.14 107.158 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.476 ' NE ' ' HA ' ' A' ' 75' ' ' ARG . 3.4 mmp_? -111.69 133.53 53.87 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.776 -0.453 . . . . 73.23 109.776 175.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.6 t -82.77 102.66 11.71 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.513 -1.291 . . . . 70.12 107.513 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.432 -1.363 0 N-CA-C 109.366 -0.605 . . . . 62.12 109.366 -175.961 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.469 0 N-CA-C 111.177 -0.769 . . . . 64.55 111.177 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.8 p -83.83 -21.92 31.9 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.799 0.809 . . . . 60.3 110.031 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -146.72 -166.97 2.63 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 104.632 -2.358 . . . . 73.42 104.632 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 76.58 -24.1 0.23 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.658 1.183 . . . . 60.54 112.487 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.62 -5.85 47.47 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 122.45 1.119 . . . . 63.32 109.239 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -138.19 128.78 26.49 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.459 -1.682 . . . . 75.11 106.459 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -91.06 -17.78 25.65 Favored 'General case' 0 CA--C 1.488 -1.442 0 CA-C-O 120.726 0.298 . . . . 72.34 110.491 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.3 p -84.45 170.05 13.92 Favored 'General case' 0 N--CA 1.411 -2.381 0 C-N-CA 119.586 -0.846 . . . . 73.55 110.534 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.647 ' SG ' ' HB1' ' A' ' 38' ' ' ALA . 75.6 m -61.0 145.86 49.19 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 115.74 1.756 . . . . 44.24 115.74 -171.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -90.81 -54.51 3.94 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 105.315 -2.106 . . . . 65.04 105.315 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.3 m -165.6 174.65 9.63 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 108.469 -0.937 . . . . 63.12 108.469 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.404 HG11 ' CB ' ' A' ' 50' ' ' CYS . 2.2 m -135.01 157.57 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.389 -1.708 . . . . 74.13 106.389 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.434 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 10.1 t -102.3 177.45 4.87 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.315 -1.365 . . . . 64.4 107.315 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -47.3 -67.02 0.32 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.596 0.634 . . . . 75.3 111.739 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.456 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 40.2 ttmt -132.49 85.91 46.79 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 119.749 -0.78 . . . . 72.42 109.166 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.491 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 6.7 Cg_endo -47.01 -80.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 124.75 3.633 . . . . 54.54 118.166 -175.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.45 156.83 73.2 Favored Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 121.916 -0.49 . . . . 75.34 111.634 -172.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.444 ' O ' HG12 ' A' ' 21' ' ' ILE . 27.0 Cg_endo -64.99 136.61 49.13 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.722 2.281 . . . . 73.44 111.486 174.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.0 1.45 63.32 Favored Glycine 0 C--N 1.31 -0.909 0 CA-C-N 115.936 -0.575 . . . . 64.51 113.631 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -83.73 -24.84 31.0 Favored 'General case' 0 N--CA 1.414 -2.24 0 O-C-N 122.301 -0.529 . . . . 75.33 110.933 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 18' ' ' PRO . 36.5 pt -90.15 2.01 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 120.353 -0.539 . . . . 75.23 111.699 -177.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.44 HG13 HD12 ' A' ' 65' ' ' LEU . 3.0 p -93.24 134.01 32.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 121.207 0.527 . . . . 53.1 111.526 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.08 -47.35 7.88 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.542 -0.91 . . . . 72.13 108.542 -175.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 42' ' ' THR . 10.3 p30 -145.84 157.99 43.88 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.417 -0.957 . . . . 75.51 108.417 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -128.58 152.47 48.28 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.941 -0.763 . . . . 73.2 108.941 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.426 ' HB2' HG21 ' A' ' 40' ' ' VAL . 27.9 m170 -120.63 112.34 18.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.218 -1.401 . . . . 74.42 107.218 172.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -84.39 103.47 13.58 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.675 -0.861 . . . . 75.4 108.675 -175.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.5 mt -109.39 137.93 46.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.45 0.643 . . . . 73.14 111.939 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.1 mt -141.6 178.75 7.24 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.14 -0.936 . . . . 74.12 110.142 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 34' ' ' CYS . 49.0 mt -77.79 -30.27 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.541 -1.281 . . . . 75.11 107.541 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -61.52 -25.92 67.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.051 -0.977 . . . . 72.05 109.999 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -83.78 -56.3 3.78 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.375 -1.342 . . . . 75.32 107.375 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.6 71.72 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.373 -0.918 . . . . 62.41 113.65 173.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.421 ' O ' HG12 ' A' ' 30' ' ' ILE . 49.9 t -161.18 151.97 18.26 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.77 -1.567 . . . . 74.2 106.77 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -74.93 -24.42 58.49 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.885 0.374 . . . . 74.23 111.995 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.53 108.08 47.9 Favored Pre-proline 0 C--N 1.3 -1.568 0 CA-C-O 121.429 0.633 . . . . 73.41 111.223 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -84.98 130.68 4.18 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.388 2.058 . . . . 64.2 111.628 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.647 ' HB1' ' SG ' ' A' ' 9' ' ' CYS . . . -176.42 164.12 2.56 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 124.046 0.938 . . . . 65.1 108.862 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.34 127.98 56.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 109.758 -0.46 . . . . 75.3 109.758 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.681 HG13 ' SG ' ' A' ' 50' ' ' CYS . 3.2 m -88.81 127.9 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 N-CA-C 108.254 -1.017 . . . . 62.13 108.254 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -97.94 113.0 24.72 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 116.08 -0.509 . . . . 75.3 110.601 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 24' ' ' ASN . 96.9 m -80.48 101.91 9.37 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.484 -0.78 . . . . 73.23 108.962 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.6 p -73.43 170.52 14.93 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.328 -0.396 . . . . 74.43 110.873 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.3 mt -57.87 -27.98 63.75 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.289 0.636 . . . . 75.22 112.622 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.3 tpp180 -73.02 -20.79 60.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.915 0.388 . . . . 74.42 110.707 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.96 40.42 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.902 -0.879 . . . . 72.52 110.902 -176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -98.57 133.05 43.46 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.634 -1.617 . . . . 73.22 106.634 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -99.44 130.5 45.71 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.943 -0.762 . . . . 74.15 108.943 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -136.8 138.61 41.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.903 -1.517 . . . . 72.01 106.903 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.681 ' SG ' HG13 ' A' ' 40' ' ' VAL . 91.0 m -94.83 147.59 23.2 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 114.872 1.434 . . . . 73.43 114.872 -173.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.491 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -130.24 163.03 50.63 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-N 114.908 -1.042 . . . . 62.21 109.847 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.72 109.85 2.69 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 122.171 1.914 . . . . 74.44 113.018 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.04 -18.62 35.6 Favored 'Trans proline' 0 N--CA 1.483 0.886 0 C-N-CA 122.924 2.416 . . . . 75.45 113.232 -174.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.18 -7.98 54.54 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.439 0.638 . . . . 71.34 109.865 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -90.08 135.21 30.32 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-O 121.17 0.51 . . . . 73.21 111.309 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.433 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 11.8 Cg_endo -54.89 -35.85 90.17 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 124.341 3.361 . . . . 74.21 115.32 -175.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.456 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 37.9 p-90 -63.1 -30.49 71.63 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.88 0.371 . . . . 74.51 111.047 -177.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 62' ' ' ILE . 69.1 t -76.59 -36.62 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.076 -0.511 . . . . 64.13 110.89 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 56' ' ' PRO . 38.3 mt-10 -56.36 -45.02 80.66 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.035 0.445 . . . . 62.4 110.551 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.548 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 4.1 mmp_? -57.68 -51.07 71.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.246 -0.888 . . . . 75.53 111.423 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 pt -70.46 -33.2 52.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 113.335 0.865 . . . . 62.32 113.335 -178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 58' ' ' VAL . 60.1 mt -60.43 -45.56 96.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 109.459 -0.571 . . . . 71.32 109.459 173.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -57.6 -42.27 82.9 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.313 -0.403 . . . . 61.31 111.322 176.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 60' ' ' ARG . 89.4 mtt180 -59.23 -38.8 80.86 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.92 -0.582 . . . . 73.51 111.718 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.44 HD12 HG13 ' A' ' 22' ' ' VAL . 89.2 mt -79.41 -33.89 42.29 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.309 0.485 . . . . 75.43 112.309 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -68.79 -41.5 78.65 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 120.452 -0.499 . . . . 71.52 112.065 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -63.64 -32.88 74.49 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.041 0.448 . . . . 64.22 110.833 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.8 p -84.35 -19.31 33.84 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.539 0.685 . . . . 74.31 111.593 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.9 t -85.85 -41.23 15.17 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.503 -0.771 . . . . 71.41 109.378 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.31 -44.53 75.22 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.904 -0.589 . . . . 74.25 110.165 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -108.55 98.77 8.24 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.23 -1.026 . . . . 74.22 108.23 173.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -87.36 132.27 34.01 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.833 -1.076 . . . . 75.23 113.13 -172.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -163.48 113.56 1.33 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.185 -0.916 . . . . 75.43 110.137 175.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -99.25 -48.44 4.82 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.821 -0.807 . . . . 74.52 108.821 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -123.51 -66.5 1.0 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.806 -0.813 . . . . 74.25 108.806 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.3 m 62.12 18.88 10.42 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.966 0.907 . . . . 74.12 111.19 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 N--CA 1.415 -2.223 0 N-CA-C 105.894 -1.891 . . . . 72.43 105.894 177.643 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.323 0 CA-C-O 121.391 0.44 . . . . 44.11 112.019 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.6 p -139.07 145.42 39.51 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.287 -1.005 . . . . 72.01 108.287 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -86.64 77.46 9.35 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 119.857 -0.737 . . . . 63.44 110.237 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -174.37 101.61 0.1 Allowed 'General case' 0 CA--C 1.496 -1.112 0 CA-C-N 114.786 -1.097 . . . . 71.12 108.411 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.9 -2.85 46.42 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.046 -0.979 . . . . 72.14 110.213 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 71.79 134.46 0.04 OUTLIER 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 126.704 2.002 . . . . 75.41 109.888 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -81.03 82.02 7.1 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-O 123.013 1.387 . . . . 72.2 110.379 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.3 p -157.68 159.69 37.19 Favored 'General case' 0 C--N 1.259 -3.347 0 N-CA-C 104.349 -2.463 . . . . 65.21 104.349 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.24 -175.75 3.76 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 117.796 -1.562 . . . . 73.22 110.227 -175.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.2 mt -98.41 -64.69 1.02 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 120.903 0.382 . . . . 72.4 110.709 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.1 t -176.03 153.07 1.26 Allowed 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.146 -1.428 . . . . 70.14 107.146 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -106.98 160.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 119.154 -1.019 . . . . 75.04 110.021 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -106.24 179.59 4.22 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.567 -0.901 . . . . 72.52 108.567 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -42.62 -57.27 2.77 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.904 0.881 . . . . 75.3 109.677 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.42 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 ttpt -145.85 97.59 4.55 Favored Pre-proline 0 N--CA 1.428 -1.543 0 N-CA-C 108.4 -0.963 . . . . 74.43 108.4 170.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 2.6 Cg_endo -39.62 -73.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.712 3.608 . . . . 72.14 116.015 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.38 158.02 61.66 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 107.448 -1.316 . . . . 72.14 107.448 -177.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.483 ' O ' HG12 ' A' ' 21' ' ' ILE . 17.9 Cg_endo -63.12 130.78 29.99 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 121.649 1.566 . . . . 72.34 110.558 174.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.506 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -72.26 2.01 30.95 Favored Glycine 0 C--N 1.303 -1.264 0 N-CA-C 115.029 0.772 . . . . 62.43 115.029 -174.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.76 -3.71 38.49 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 112.495 0.554 . . . . 75.25 112.495 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.511 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 39.6 pt -103.81 6.4 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 121.379 0.609 . . . . 72.5 110.378 177.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.56 HG22 ' CD1' ' A' ' 41' ' ' PHE . 5.1 p -91.63 143.46 11.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.794 -0.639 . . . . 75.22 111.582 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HE ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -99.88 -56.46 2.37 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.949 -1.13 . . . . 73.03 107.949 -178.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -134.21 166.03 23.74 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.738 -0.838 . . . . 74.04 108.738 -176.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -143.61 161.13 39.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.821 -0.437 . . . . 71.42 109.821 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -137.68 122.58 18.91 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 110.145 -0.316 . . . . 74.13 110.145 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -75.8 98.19 4.09 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 123.236 0.335 . . . . 74.12 110.16 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 69.5 mt -97.14 134.2 40.79 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-O 121.887 0.851 . . . . 75.55 110.249 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.6 mt -125.93 -178.53 4.32 Favored 'General case' 0 C--N 1.256 -3.471 0 N-CA-C 106.725 -1.583 . . . . 74.05 106.725 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.2 mt -63.85 -37.88 80.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 120.312 -0.555 . . . . 72.04 109.798 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -59.87 -31.88 70.19 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 114.264 1.209 . . . . 74.03 114.264 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -111.92 -5.35 14.35 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.962 0.41 . . . . 73.45 111.259 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.77 -124.32 3.43 Favored Glycine 0 N--CA 1.417 -2.609 0 CA-C-N 115.857 -0.611 . . . . 43.11 112.726 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 84.7 m -118.01 -87.24 0.63 Allowed 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.398 -0.401 . . . . 73.14 110.404 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -143.23 15.18 1.86 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.175 0.988 . . . . 73.4 108.824 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 p -127.83 117.85 20.94 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 115.302 -0.863 . . . . 72.02 110.265 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.97 130.17 2.1 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 121.929 1.753 . . . . 60.52 110.491 174.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -171.52 154.79 3.9 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.94 -0.763 . . . . 73.13 108.94 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.25 125.43 52.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.5 -0.926 . . . . 74.34 108.5 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 m -90.12 128.35 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.008 0 C-N-CA 119.643 -0.823 . . . . 73.02 109.308 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.56 ' CD1' HG22 ' A' ' 22' ' ' VAL . 15.3 m-85 -95.58 125.52 40.23 Favored 'General case' 0 C--N 1.272 -2.788 0 CA-C-N 115.358 -0.837 . . . . 73.11 110.177 175.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.4 m -93.45 103.65 15.84 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.922 -1.14 . . . . 74.24 107.922 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 71.1 p -70.0 174.36 5.45 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.35 -0.386 . . . . 73.4 111.248 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 95.3 mt -61.2 -27.39 68.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.52 0.676 . . . . 75.35 109.724 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -67.57 -28.4 67.74 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.718 1.207 . . . . 71.24 110.904 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.08 16.59 40.53 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 120.79 -0.719 . . . . 65.21 111.424 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.62 138.39 31.55 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.436 -1.32 . . . . 64.45 107.436 -177.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -91.97 121.18 33.32 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.79 -1.189 . . . . 75.41 107.79 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 50' ' ' CYS . 0.5 OUTLIER -129.67 141.51 50.9 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.363 -0.977 . . . . 73.2 108.363 -178.095 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.444 ' N ' HD12 ' A' ' 49' ' ' LEU . 7.9 m -78.06 129.97 35.87 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.998 0.519 . . . . 64.41 111.081 -173.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.539 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -136.98 157.3 74.94 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 110.037 -0.357 . . . . 63.05 110.037 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.8 109.27 1.97 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.376 2.051 . . . . 75.41 112.798 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.0 -18.76 52.11 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.833 2.355 . . . . 75.24 113.91 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -96.51 3.66 52.56 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.465 -0.494 . . . . 72.2 112.286 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -97.57 139.24 21.27 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 120.42 -0.512 . . . . 74.4 112.315 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.36 -42.81 27.63 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 124.441 3.427 . . . . 75.22 114.55 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -62.52 -27.3 69.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.357 -0.537 . . . . 64.2 110.86 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.647 ' O ' HG12 ' A' ' 62' ' ' ILE . 75.4 t -81.75 -50.22 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.878 -0.601 . . . . 75.3 111.264 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -27.01 61.64 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.832 0.678 . . . . 64.21 112.832 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -73.04 -49.66 27.45 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.746 -0.661 . . . . 74.51 110.33 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.506 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.2 pt -71.7 -28.08 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.911 -0.586 . . . . 74.44 111.663 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 58' ' ' VAL . 41.0 mm -54.45 -52.76 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.851 -0.613 . . . . 72.14 109.902 173.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -56.58 -38.05 71.46 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.386 0.612 . . . . 71.41 110.3 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.26 -38.4 90.19 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.954 -1.021 . . . . 73.44 109.146 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.431 HD12 ' CG1' ' A' ' 22' ' ' VAL . 88.3 mt -79.73 -36.94 36.61 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 116.63 -0.259 . . . . 73.52 111.149 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -55.84 -20.28 14.79 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 114.054 1.131 . . . . 74.51 114.054 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -58.81 -32.41 69.33 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 109.539 -0.541 . . . . 71.43 109.539 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.9 p -84.64 -19.57 32.7 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.517 0.675 . . . . 74.43 111.067 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.9 t -85.18 -16.95 38.66 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.763 -0.653 . . . . 73.31 109.254 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.8 -29.02 61.93 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 115.609 -0.723 . . . . 72.5 110.17 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.662 ' O ' ' HD2' ' A' ' 71' ' ' LYS 0.306 0.1 OUTLIER -78.13 90.18 4.25 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 122.809 1.29 . . . . 75.44 111.494 177.473 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.8 ptm -156.46 139.51 15.43 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.186 -1.37 . . . . 72.54 107.469 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -81.31 71.38 8.3 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.152 0.977 . . . . 75.33 111.4 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -161.88 17.81 0.1 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 105.388 -2.078 . . . . 74.31 105.388 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -150.15 100.85 2.95 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.849 -1.523 . . . . 74.0 108.911 -175.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.5 t -101.73 -41.63 6.48 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.903 -1.147 . . . . 74.23 107.903 175.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 N--CA 1.422 -1.858 0 N-CA-C 106.203 -1.777 . . . . 74.31 106.203 178.752 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.662 0 N-CA-C 111.114 -0.794 . . . . 71.05 111.114 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.8 t -89.24 134.54 34.0 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.14 0.495 . . . . 73.15 110.277 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -135.77 134.1 38.65 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.55 -0.537 . . . . 74.33 109.55 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -139.16 165.57 26.82 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.934 -1.136 . . . . 70.21 107.934 -177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.09 86.28 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.309 0.576 . . . . 73.32 110.637 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 46.54 -159.42 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 126.299 1.84 . . . . 75.43 113.929 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -81.95 -31.34 31.3 Favored 'General case' 0 CA--C 1.483 -1.613 0 CA-C-N 115.848 -0.615 . . . . 74.24 111.042 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.511 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 27.9 p -124.48 159.76 29.81 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 112.474 0.546 . . . . 72.43 112.474 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.569 ' SG ' HG13 ' A' ' 40' ' ' VAL . 91.6 m -57.86 150.81 19.35 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 116.47 2.026 . . . . 62.52 116.47 -174.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -84.25 -63.98 1.24 Allowed 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.867 -1.515 . . . . 75.13 108.13 172.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -167.15 175.72 7.29 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 106.124 -1.806 . . . . 73.43 106.124 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 13' ' ' THR . 2.2 m -133.91 161.25 41.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.485 -1.302 . . . . 73.12 107.485 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.434 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.7 t -98.78 178.06 5.09 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.127 -1.064 . . . . 73.13 108.127 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -50.5 -60.73 2.72 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.007 0.523 . . . . 72.33 110.769 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.547 ' HZ1' ' HB2' ' A' ' 15' ' ' LYS . 4.8 ttmp? -139.85 86.54 13.46 Favored Pre-proline 0 N--CA 1.428 -1.548 0 N-CA-C 109.367 -0.605 . . . . 73.24 109.367 174.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.538 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 7.5 Cg_endo -47.94 -78.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.463 0 C-N-CA 124.565 3.51 . . . . 74.3 117.303 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.32 162.83 45.43 Favored Pre-proline 0 C--N 1.32 -0.701 0 O-C-N 121.791 -0.568 . . . . 75.41 110.365 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.586 ' O ' HG12 ' A' ' 21' ' ' ILE . 36.8 Cg_exo -63.05 130.21 28.28 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.135 1.89 . . . . 60.23 110.704 174.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -73.69 2.04 42.17 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 116.339 -0.391 . . . . 73.11 113.946 -176.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -98.23 0.12 45.14 Favored 'General case' 0 N--CA 1.417 -2.121 0 O-C-N 122.133 -0.628 . . . . 73.1 111.52 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 18' ' ' PRO . 33.7 pt -106.71 9.22 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.452 0.644 . . . . 71.22 110.136 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG13 HD12 ' A' ' 65' ' ' LEU . 2.9 p -96.59 134.94 32.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.733 -0.667 . . . . 74.31 111.817 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.554 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -91.15 -56.02 3.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.73 -0.841 . . . . 75.43 108.73 -176.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.554 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 18.1 m120 -130.17 157.43 42.48 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-N 115.89 -0.596 . . . . 71.31 109.445 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -139.65 152.31 46.65 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.19 -0.67 . . . . 71.31 109.19 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -122.97 121.72 36.79 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.049 -1.463 . . . . 73.34 107.049 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -93.93 114.3 26.49 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 109.607 -0.516 . . . . 74.4 109.607 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.511 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 4.0 mm? -110.23 126.92 54.65 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 116.262 -0.426 . . . . 74.25 111.608 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.7 mt -126.83 176.96 6.89 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.833 -0.802 . . . . 72.2 108.833 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 57.1 mt -74.11 -20.07 17.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 107.701 -1.222 . . . . 75.33 107.701 176.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -58.79 -30.42 67.57 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.726 -1.124 . . . . 73.23 110.071 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.05 -42.45 47.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.597 -0.729 . . . . 74.03 109.988 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.54 -44.89 0.64 Allowed Glycine 0 CA--C 1.503 -0.709 0 C-N-CA 120.458 -0.877 . . . . 74.13 113.039 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 63.4 m -66.86 141.47 57.66 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 110.263 -0.273 . . . . 62.1 110.263 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -79.23 3.44 17.9 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.194 0.521 . . . . 73.34 112.057 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.31 97.94 49.44 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.821 -0.627 . . . . 74.45 110.251 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -80.65 128.96 7.06 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 121.255 1.303 . . . . 63.22 110.137 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -173.83 161.85 3.88 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.145 0.578 . . . . 62.43 109.825 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 50' ' ' CYS . 7.9 p -108.59 128.23 64.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 109.381 -0.6 . . . . 75.22 109.381 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.569 HG13 ' SG ' ' A' ' 9' ' ' CYS . 1.4 m -86.3 129.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 107.303 -1.369 . . . . 64.52 107.303 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -104.68 116.65 32.42 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 116.567 -0.288 . . . . 75.21 111.331 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.5 m -85.24 101.57 12.62 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.284 -1.006 . . . . 74.02 108.284 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 63.4 p -73.97 168.67 19.01 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.258 -0.428 . . . . 72.11 110.981 -177.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 92.2 mt -59.52 -29.05 67.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.121 0.568 . . . . 74.4 111.117 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -71.24 -16.37 62.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.493 -0.776 . . . . 71.53 110.78 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.75 15.83 44.52 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.261 -0.495 . . . . 72.43 112.306 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -94.87 140.06 30.45 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 110.523 -0.177 . . . . 74.31 110.523 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -104.12 109.83 21.78 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.89 -0.595 . . . . 73.12 109.503 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.4 tp -130.03 129.82 44.16 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.756 -0.657 . . . . 73.24 109.263 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.568 ' SG ' HG13 ' A' ' 40' ' ' VAL . 75.4 m -84.48 147.41 27.1 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 113.682 0.993 . . . . 71.35 113.682 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.31 160.55 57.07 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 115.103 -0.953 . . . . 75.42 110.169 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 72.9 Cg_endo -71.98 108.11 2.38 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.194 1.929 . . . . 75.52 111.936 -175.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.523 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 67.3 Cg_endo -68.35 -30.41 30.14 Favored 'Trans proline' 0 N--CA 1.473 0.265 0 C-N-CA 123.089 2.526 . . . . 64.45 113.388 -171.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -78.4 -26.59 46.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.228 -0.442 . . . . 72.53 111.386 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 16.0 mm100 -66.34 138.25 95.79 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 116.122 -0.49 . . . . 73.24 112.146 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.471 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 78.0 Cg_exo -53.45 -38.66 83.24 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 124.011 3.141 . . . . 54.3 114.699 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.456 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 37.0 p-90 -64.86 -29.96 70.94 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 120.469 -0.493 . . . . 74.13 111.116 -175.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 62' ' ' ILE . 72.3 t -80.07 -30.12 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 116.115 -0.493 . . . . 75.33 111.109 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.9 mt-10 -56.71 -49.73 74.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.562 -0.29 . . . . 74.53 110.715 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -61.52 -45.52 93.86 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.179 -0.464 . . . . 73.31 112.208 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.433 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 18.0 pt -69.2 -33.8 60.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 113.145 0.794 . . . . 72.3 113.145 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 58' ' ' VAL . 65.3 mt -61.66 -46.93 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.411 -0.589 . . . . 74.12 109.411 174.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 13.0 mm100 -60.05 -40.96 91.23 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.776 -0.647 . . . . 65.33 109.475 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -57.95 -51.49 69.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.234 -0.894 . . . . 73.44 109.627 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.467 HD12 HG13 ' A' ' 22' ' ' VAL . 73.7 mt -67.52 -28.97 68.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.727 0.64 . . . . 73.02 112.727 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -69.0 -32.31 71.77 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.368 -0.933 . . . . 75.43 110.767 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 71' ' ' LYS . 31.8 mmt180 -73.04 -37.87 66.71 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.486 -0.325 . . . . 62.52 110.787 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.4 p -69.42 -34.36 74.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.451 0.643 . . . . 75.53 110.203 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.3 t -70.35 -34.76 73.02 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.778 -1.101 . . . . 75.4 109.401 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.04 -40.56 82.84 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.137 -0.483 . . . . 53.13 110.549 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 67' ' ' ARG . 75.4 mmtt -68.19 -32.11 72.11 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.387 0.613 . . . . 72.23 109.743 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.6 ttt -70.25 -20.32 63.07 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.247 -0.888 . . . . 74.11 109.945 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -89.91 138.21 31.69 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.736 -1.579 . . . . 70.31 106.736 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -73.85 -7.46 52.31 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 111.982 0.364 . . . . 73.44 111.982 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 64.49 98.52 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.463 1.105 . . . . 74.15 111.892 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 m -129.48 -16.64 3.85 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-O 121.973 0.892 . . . . 71.35 108.965 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 106.571 -1.64 . . . . 73.31 106.571 176.783 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.988 0 N-CA-C 110.985 -0.846 . . . . 64.15 110.985 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.3 p -66.22 117.59 8.72 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 120.992 0.425 . . . . 74.23 110.99 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -127.21 100.71 6.19 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.681 -0.691 . . . . 72.23 109.42 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -99.63 117.25 33.6 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.743 -0.662 . . . . 71.31 110.238 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.21 -8.5 32.82 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.349 -0.841 . . . . 71.44 110.104 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.47 144.06 51.54 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.597 -1.183 . . . . 71.33 112.124 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.43 -33.48 71.38 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.14 -0.936 . . . . 74.5 108.82 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.424 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 14.7 p -83.24 -176.41 6.31 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.824 -1.08 . . . . 51.53 109.904 174.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.82 -171.58 3.48 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.835 -0.746 . . . . 74.31 111.665 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.0 -68.05 0.82 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.395 -0.594 . . . . 72.34 109.395 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -168.04 153.83 7.17 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.259 -1.015 . . . . 75.21 108.259 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 50' ' ' CYS . 1.9 m -115.8 162.09 14.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 119.839 -0.744 . . . . 71.12 109.973 -175.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -105.75 177.64 4.79 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.012 -1.477 . . . . 74.41 107.012 172.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -53.82 -50.03 67.07 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 118.656 0.662 . . . . 74.44 111.53 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.503 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 87.4 tttt -143.6 83.7 10.49 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-O 121.0 0.429 . . . . 64.12 110.153 175.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.5 Cg_endo -47.38 -77.77 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.456 3.438 . . . . 71.33 117.429 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.15 166.3 30.23 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 110.058 -0.349 . . . . 73.34 110.058 -173.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.576 ' O ' HG12 ' A' ' 21' ' ' ILE . 44.7 Cg_exo -61.26 127.92 23.48 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.253 1.968 . . . . 73.13 111.004 175.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.459 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -80.65 0.17 86.38 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 114.594 0.598 . . . . 64.4 114.594 -175.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.53 -1.16 39.05 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 122.034 -0.686 . . . . 73.44 112.841 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 18' ' ' PRO . 34.8 pt -100.21 7.46 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.633 0.73 . . . . 74.1 110.36 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.401 HG13 HD12 ' A' ' 65' ' ' LEU . 2.5 p -89.25 136.12 24.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.33 -0.85 . . . . 74.44 111.75 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.421 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 1.0 OUTLIER -86.16 -55.68 3.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.031 -1.1 . . . . 73.13 108.031 -176.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 17.5 m120 -141.65 160.31 40.43 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.281 1.032 . . . . 73.31 108.713 177.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -131.97 156.8 45.55 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.694 -0.403 . . . . 70.05 110.068 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.441 ' HB2' HG21 ' A' ' 40' ' ' VAL . 28.0 m170 -123.56 112.54 17.57 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.299 -1.371 . . . . 73.44 107.299 172.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -82.91 99.8 10.0 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.513 -1.291 . . . . 74.11 107.513 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 77.4 mt -112.58 134.72 53.96 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.54 0.686 . . . . 73.42 111.803 -173.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 94.6 mt -142.32 169.71 17.08 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.043 -0.98 . . . . 72.35 110.755 -173.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.9 mt -77.97 -30.36 16.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 106.629 -1.619 . . . . 63.32 106.629 171.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -56.22 -39.5 72.6 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.571 -1.195 . . . . 75.13 110.368 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.94 -57.6 3.8 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.981 -1.118 . . . . 74.22 107.981 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.44 85.96 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.973 -1.108 . . . . 72.42 114.299 174.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.1 t -168.54 172.52 8.1 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 105.691 -1.966 . . . . 73.4 105.691 174.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -88.17 -3.05 58.93 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.228 1.195 . . . . 74.33 114.228 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 p -148.95 122.77 4.66 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-O 120.972 0.415 . . . . 70.22 111.256 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -87.28 130.15 2.85 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.473 2.115 . . . . 72.2 112.546 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -176.25 150.05 0.9 Allowed 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.481 -0.933 . . . . 75.41 108.481 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -98.41 127.41 50.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.401 -1.333 . . . . 74.45 107.401 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 26' ' ' HIS . 6.2 m -92.3 125.12 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.15 0 C-N-CA 119.307 -0.957 . . . . 75.51 108.849 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -99.26 113.16 25.29 Favored 'General case' 0 C--N 1.272 -2.79 0 CA-C-N 115.459 -0.791 . . . . 72.13 109.729 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 77.2 m -80.69 102.43 9.88 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.895 -0.78 . . . . 72.31 108.895 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.1 p -69.23 167.83 15.43 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.123 -0.489 . . . . 71.12 110.811 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 93.7 mt -59.13 -29.09 67.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.205 0.526 . . . . 65.13 110.26 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -64.75 -26.6 68.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.078 -0.964 . . . . 74.14 111.055 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.69 17.18 19.93 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.22 -0.991 . . . . 44.15 112.145 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -103.36 125.89 50.23 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 122.684 -0.304 . . . . 72.22 111.244 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.08 112.82 19.49 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.69 -1.226 . . . . 75.33 107.69 172.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 50' ' ' CYS . 0.9 OUTLIER -115.09 141.55 47.85 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.679 -0.86 . . . . 75.31 108.679 -176.074 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.507 ' N ' HD12 ' A' ' 49' ' ' LEU . 9.4 m -79.15 119.73 22.66 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 123.061 0.545 . . . . 64.53 111.13 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.539 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -122.85 155.55 63.42 Favored Pre-proline 0 C--O 1.243 0.733 0 C-N-CA 120.346 -0.541 . . . . 74.43 111.944 174.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -78.08 110.85 2.97 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.646 2.231 . . . . 71.53 114.427 -172.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.05 -1.19 8.3 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.752 2.301 . . . . 62.2 112.556 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -103.3 -3.29 25.82 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.493 -0.321 . . . . 74.53 111.08 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -103.82 132.8 20.69 Favored Pre-proline 0 C--N 1.311 -1.106 0 C-N-CA 120.309 -0.556 . . . . 63.22 112.435 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -49.07 -32.62 24.38 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 124.552 3.501 . . . . 74.5 115.046 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.503 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 31.0 p-90 -68.18 -30.19 69.23 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.4 -0.52 . . . . 75.41 109.902 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 62' ' ' ILE . 70.9 t -78.94 -40.97 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.212 -0.662 . . . . 73.21 109.212 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.4 mt-10 -59.68 -25.05 64.44 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.341 -0.845 . . . . 75.42 112.411 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -83.34 -43.39 16.01 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.294 0.479 . . . . 74.01 112.294 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.459 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.2 pt -70.89 -33.73 53.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 112.867 0.691 . . . . 75.21 112.867 -177.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 58' ' ' VAL . 64.3 mt -57.11 -40.82 75.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 116.064 -0.516 . . . . 75.53 110.062 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 78.8 mm-40 -59.28 -43.1 92.55 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.1 -0.5 . . . . 63.31 111.328 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -59.47 -52.29 66.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.522 0.514 . . . . 73.23 110.862 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.401 HD12 HG13 ' A' ' 22' ' ' VAL . 86.3 mt -67.95 -26.36 65.91 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.254 -0.578 . . . . 75.51 112.472 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 27.8 mt-30 -67.59 -21.77 65.41 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 121.965 -0.459 . . . . 71.41 111.917 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.541 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -72.62 -37.84 67.95 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.538 -0.542 . . . . 73.54 109.538 177.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.5 p -82.3 -36.57 26.86 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.018 -0.537 . . . . 73.52 111.763 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.1 m -71.81 -18.22 62.11 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.82 -0.627 . . . . 74.12 111.397 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.55 -32.85 64.4 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.979 0.418 . . . . 62.14 110.657 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -121.03 79.8 1.56 Allowed 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 122.287 1.041 . . . . 71.2 109.165 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.7 tpt 179.38 165.6 1.03 Allowed 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 104.854 -2.276 . . . . 74.42 104.854 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -66.81 131.24 45.52 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.975 -0.75 . . . . 74.33 108.975 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -77.48 139.63 39.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.324 0.583 . . . . 55.14 111.303 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -84.92 -35.81 21.87 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.658 -0.701 . . . . 74.23 112.757 -172.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.1 m -75.82 2.21 12.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 113.459 0.911 . . . . 71.04 113.459 -175.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.295 -0.86 . . . . 74.4 110.22 177.616 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.631 0 N-CA-C 111.061 -0.816 . . . . 44.14 111.061 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.6 m -135.31 78.71 1.74 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.755 0.788 . . . . 74.13 110.014 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -140.36 88.1 2.18 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.299 -1.371 . . . . 74.1 107.299 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -88.9 102.32 14.93 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.668 -0.696 . . . . 72.33 110.464 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.96 -16.24 30.31 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.682 0.753 . . . . 64.34 109.633 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.85 118.83 37.15 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.586 -1.188 . . . . 70.24 110.361 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.36 -57.78 3.02 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.813 -0.81 . . . . 73.05 108.813 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.8 p -86.87 147.65 25.71 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 107.817 -1.179 . . . . 62.44 107.817 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.466 ' HB2' HG13 ' A' ' 40' ' ' VAL . 4.4 t -76.74 142.14 40.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.027 -0.731 . . . . 74.4 109.027 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.476 ' O ' HG21 ' A' ' 36' ' ' VAL . 73.7 mt -68.89 -44.64 72.82 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 116.828 2.158 . . . . 65.34 116.828 -170.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.8 m -164.49 137.18 4.82 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.759 -0.776 . . . . 74.12 111.293 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 13' ' ' THR . 1.0 OUTLIER -102.05 161.21 3.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.459 -0.941 . . . . 64.03 108.459 -178.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.9 t -105.54 178.76 4.47 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.098 -1.075 . . . . 72.51 108.098 175.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -49.17 -40.61 33.65 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.615 0.766 . . . . 64.15 111.069 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -157.7 92.1 2.24 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 109.078 -0.712 . . . . 74.22 109.078 171.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.533 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.2 Cg_endo -40.07 -67.16 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.765 3.644 . . . . 72.54 116.688 -178.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.03 166.25 16.79 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 75.32 109.695 -176.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.529 ' O ' HG12 ' A' ' 21' ' ' ILE . 32.1 Cg_exo -60.4 128.6 26.63 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.068 1.845 . . . . 74.25 109.632 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.444 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -73.47 0.89 46.65 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 115.887 1.115 . . . . 62.34 115.887 -172.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -98.46 -7.51 28.4 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 117.772 0.786 . . . . 72.55 112.417 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.4 pt -92.84 3.94 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.58 0.705 . . . . 72.04 111.098 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.555 HG22 ' CD1' ' A' ' 41' ' ' PHE . 2.2 p -88.12 135.82 24.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.292 -0.867 . . . . 74.22 112.411 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -86.44 -56.07 3.6 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.434 1.094 . . . . 75.44 108.523 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -146.97 170.15 17.69 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.811 -1.086 . . . . 75.43 108.59 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.593 ' CZ ' HG22 ' A' ' 62' ' ' ILE . 47.2 p90 -141.68 155.94 45.66 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.978 -0.378 . . . . 74.13 109.978 -175.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -133.82 121.95 22.54 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.627 -0.509 . . . . 75.34 109.627 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.408 ' OH ' HG21 ' A' ' 62' ' ' ILE . 54.1 m-85 -78.31 103.89 8.55 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 123.208 0.318 . . . . 74.42 110.168 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -108.76 131.55 54.84 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.484 -0.887 . . . . 75.22 110.983 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.4 mt -133.94 -177.98 4.81 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.142 -0.936 . . . . 70.53 109.131 -174.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 63.1 mt -71.67 -24.15 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 120.477 -0.489 . . . . 71.25 109.777 176.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.634 ' HE3' ' C ' ' A' ' 31' ' ' LYS 0.364 0.0 OUTLIER -67.26 -10.02 46.47 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.687 0.995 . . . . 74.33 113.687 176.415 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.507 ' N ' ' HE3' ' A' ' 31' ' ' LYS . 22.2 m-20 -83.76 -5.42 59.19 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.352 0.596 . . . . 73.21 109.733 171.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.37 43.2 8.72 Favored Glycine 0 N--CA 1.434 -1.489 0 CA-C-N 115.089 -0.96 . . . . 38.13 111.464 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 11.1 t -135.56 155.37 50.59 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.09 -1.818 . . . . 74.02 106.09 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -92.75 14.52 16.99 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.501 1.667 . . . . 74.24 115.501 -168.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 10' ' ' LEU . 3.7 p -153.11 116.3 2.78 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-O 121.328 0.585 . . . . 74.52 112.544 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -83.84 134.93 6.47 Favored 'Trans proline' 0 C--O 1.252 1.181 0 C-N-CA 122.645 2.23 . . . . 74.24 112.898 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -176.18 153.94 1.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.183 0.993 . . . . 74.13 108.562 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -99.11 128.28 50.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.355 -1.35 . . . . 70.03 107.355 175.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.466 HG13 ' HB2' ' A' ' 9' ' ' CYS . 14.8 m -91.55 127.98 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.491 0 C-N-CA 119.299 -0.96 . . . . 74.1 110.083 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.555 ' CD1' HG22 ' A' ' 22' ' ' VAL . 4.9 m-85 -91.29 116.87 29.18 Favored 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 115.099 -0.955 . . . . 74.44 109.79 173.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 99.0 m -89.78 106.79 18.7 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 107.721 -1.214 . . . . 74.31 107.721 176.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 69.5 p -69.73 174.18 5.41 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 123.19 0.306 . . . . 73.13 111.321 -177.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 91.6 mt -58.0 -33.23 68.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.214 0.531 . . . . 71.43 110.73 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -69.58 -18.93 63.67 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.617 -0.719 . . . . 70.02 110.882 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.58 16.71 33.26 Favored Glycine 0 CA--C 1.499 -0.956 0 C-N-CA 120.536 -0.84 . . . . 74.41 111.729 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.558 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 1.8 mmp_? -95.87 144.24 26.38 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-O 120.693 0.282 . . . . 74.31 110.668 -177.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -105.6 131.09 53.41 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.505 -0.77 . . . . 61.34 110.151 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.3 tp -132.87 150.89 52.12 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.886 -0.783 . . . . 73.51 108.886 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.401 ' HB3' HG11 ' A' ' 12' ' ' VAL . 4.9 m -77.68 123.9 27.26 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 110.087 -0.338 . . . . 70.04 110.087 -175.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.533 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -132.66 157.57 77.98 Favored Pre-proline 0 C--O 1.243 0.747 0 CA-C-N 118.31 0.505 . . . . 53.02 109.933 174.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.34 109.34 2.3 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.055 1.837 . . . . 72.3 113.46 -174.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -70.74 -12.78 31.54 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 122.779 2.319 . . . . 71.21 113.685 -174.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -96.12 -20.44 18.63 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.232 -0.44 . . . . 74.22 111.385 -176.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -80.06 145.22 60.51 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 113.938 1.088 . . . . 71.23 113.938 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -51.24 -43.47 48.76 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.812 3.675 . . . . 73.3 115.734 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.431 ' O ' HG12 ' A' ' 61' ' ' ILE . 39.5 p-90 -64.53 -36.29 83.74 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.137 -0.625 . . . . 74.45 111.289 -175.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 62' ' ' ILE . 76.6 t -69.53 -47.29 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.849 -0.614 . . . . 70.21 111.765 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.442 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 10.1 pt-20 -61.62 -32.83 72.98 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.314 0.487 . . . . 64.23 112.314 -177.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.442 ' HE ' ' HG3' ' A' ' 59' ' ' GLU . 5.6 mmp_? -66.15 -51.93 53.18 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.094 0.473 . . . . 75.24 110.648 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.444 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 8.0 pt -64.58 -34.69 71.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.735 -0.666 . . . . 72.0 111.989 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.593 HG22 ' CZ ' ' A' ' 25' ' ' PHE . 39.8 mt -57.4 -43.98 83.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.315 -0.402 . . . . 71.54 111.382 173.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 63' ' ' GLN . 13.7 mm-40 -63.54 -36.72 84.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.973 0.416 . . . . 75.2 110.709 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 29.7 mmt180 -64.82 -34.08 77.52 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.618 -0.719 . . . . 72.41 111.011 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.424 HD12 HG13 ' A' ' 22' ' ' VAL . 90.4 mt -77.31 -34.93 55.32 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.767 -0.373 . . . . 75.14 110.992 176.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -76.78 -18.75 58.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.241 0.83 . . . . 72.21 113.241 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 40.7 ptt180 -65.34 -6.69 10.64 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.712 0.634 . . . . 74.34 112.712 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.5 p -62.73 -28.34 69.89 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 122.085 0.945 . . . . 71.44 109.754 174.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.0 m -76.03 -13.7 60.22 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 114.569 -1.196 . . . . 72.44 111.246 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.52 -21.86 48.21 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.177 -0.675 . . . . 64.44 109.177 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -80.35 -17.51 51.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.138 -0.937 . . . . 52.13 108.512 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 49.0 ttm -80.03 150.72 30.28 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.348 -0.842 . . . . 72.1 108.989 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -75.03 100.62 4.23 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.943 -0.762 . . . . 75.12 108.943 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -135.55 146.66 48.25 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.639 -1.245 . . . . 73.22 107.639 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 64.45 93.5 0.06 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 123.766 0.666 . . . . 73.31 110.44 -174.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.9 t -79.31 -31.76 43.29 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.217 -0.447 . . . . 71.43 110.579 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.432 -1.345 0 N-CA-C 109.344 -0.613 . . . . 54.33 109.344 179.575 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.327 0 N-CA-C 109.986 -1.246 . . . . 63.4 109.986 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.6 m 66.34 -71.82 0.09 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.864 0.866 . . . . 75.51 111.94 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -102.5 127.08 49.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.901 0.382 . . . . 72.24 110.268 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -133.44 76.77 1.69 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.833 0.825 . . . . 51.2 109.451 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.71 -4.26 44.48 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.887 -1.051 . . . . 71.52 111.289 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -106.85 146.88 30.42 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.344 -0.844 . . . . 74.34 111.269 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -138.91 10.64 2.63 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.826 -1.176 . . . . 73.42 107.826 176.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.526 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 49.3 t -102.6 -178.11 3.59 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.627 -1.169 . . . . 74.03 111.025 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.418 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 97.4 m -84.44 166.18 17.52 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.744 0.818 . . . . 54.31 112.761 -177.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.51 -53.01 2.88 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.189 -1.411 . . . . 74.12 107.189 172.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.1 m -167.64 178.57 5.27 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.063 -1.458 . . . . 62.54 107.063 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.414 HG11 ' CB ' ' A' ' 50' ' ' CYS . 3.1 m -133.64 148.79 30.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.055 -1.461 . . . . 74.03 107.055 173.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.438 ' CG2' ' HA ' ' A' ' 16' ' ' PRO . 10.9 t -92.11 178.76 5.77 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.262 -1.014 . . . . 65.33 108.262 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -47.53 -69.89 0.11 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.532 0.733 . . . . 75.44 111.38 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -132.74 80.87 60.35 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 109.477 -0.564 . . . . 75.43 109.477 174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.9 Cg_endo -43.64 -83.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 125.277 3.985 . . . . 74.33 118.935 -172.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.28 157.96 71.68 Favored Pre-proline 0 C--N 1.32 -0.713 0 O-C-N 122.164 -0.335 . . . . 73.13 110.451 -173.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.27 136.77 45.02 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.501 2.134 . . . . 65.33 111.354 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.467 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -77.57 1.22 67.28 Favored Glycine 0 C--O 1.218 -0.878 0 CA-C-O 121.868 0.705 . . . . 41.11 112.006 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -77.04 -28.12 54.72 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.051 -0.575 . . . . 73.12 110.6 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.1 pt -98.67 8.63 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 120.691 -0.404 . . . . 72.31 112.011 -176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.405 ' CG1' HD12 ' A' ' 65' ' ' LEU . 7.7 p -95.39 138.27 21.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.106 0.479 . . . . 70.11 111.115 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.9 -56.06 3.23 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.461 -0.94 . . . . 73.41 108.461 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -145.91 174.31 11.37 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.232 1.013 . . . . 73.31 108.602 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -140.57 169.29 17.92 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.518 -0.473 . . . . 73.24 110.357 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -129.1 129.03 44.69 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.137 -2.171 . . . . 75.02 105.137 171.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -97.46 109.38 22.15 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 107.906 -1.146 . . . . 64.55 107.906 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.3 mm? -98.1 117.83 33.34 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.0 0.428 . . . . 63.04 111.342 -174.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.9 mt -124.93 -179.09 4.39 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.538 -0.912 . . . . 75.32 108.538 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 52.2 mt -71.11 -21.01 21.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.544 -0.91 . . . . 75.05 108.544 176.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -59.04 -32.88 70.15 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.983 -1.008 . . . . 73.02 109.834 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.3 -6.41 57.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.664 -0.698 . . . . 71.22 110.6 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.08 34.33 12.99 Favored Glycine 0 CA--C 1.498 -1.02 0 C-N-CA 121.108 -0.568 . . . . 38.49 112.246 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 46.3 t -123.08 145.95 48.12 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.649 -0.871 . . . . 71.34 108.649 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.597 ' HD3' ' O ' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -79.79 -36.02 37.65 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.534 -0.543 . . . . 72.11 109.534 -177.524 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.7 p -98.04 103.89 19.71 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 121.132 0.491 . . . . 74.44 111.438 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 35' ' ' ARG . 92.7 Cg_endo -84.0 130.11 4.81 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 121.707 1.605 . . . . 74.54 111.588 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.406 ' HA ' ' HG3' ' A' ' 53' ' ' PRO . . . -172.65 -179.78 2.23 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 124.212 1.005 . . . . 63.42 108.857 -177.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -119.04 130.03 74.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 120.228 -0.589 . . . . 74.4 110.077 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.763 HG13 ' SG ' ' A' ' 50' ' ' CYS . 4.4 m -89.26 130.94 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 108.186 -1.042 . . . . 74.4 108.186 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -98.32 114.82 27.26 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 109.633 -0.506 . . . . 74.05 109.633 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 86.2 m -84.34 102.19 12.52 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.203 -1.036 . . . . 64.44 108.203 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 51.5 p -72.03 169.93 14.93 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.488 -0.324 . . . . 64.02 111.31 -177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.67 -25.46 66.37 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.492 0.717 . . . . 75.32 112.334 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -83.27 -4.04 58.04 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.227 0.537 . . . . 71.02 110.89 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.13 16.13 56.35 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 120.802 -0.713 . . . . 61.52 112.319 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.42 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 36.1 mmt180 -99.64 130.24 45.85 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 112.521 0.563 . . . . 74.42 112.521 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -95.92 122.02 38.27 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.157 -0.928 . . . . 72.22 109.545 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 50' ' ' CYS . 1.7 tm? -134.92 138.24 43.9 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.407 -1.701 . . . . 64.54 106.407 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.763 ' SG ' HG13 ' A' ' 40' ' ' VAL . 73.5 m -98.0 147.35 24.59 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 114.828 1.418 . . . . 73.44 114.828 -172.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.505 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -128.84 159.1 70.14 Favored Pre-proline 0 C--O 1.243 0.752 0 CA-C-N 115.227 -0.897 . . . . 73.11 110.999 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.445 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 55.6 Cg_endo -64.88 108.88 1.17 Allowed 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.185 2.59 . . . . 60.21 113.226 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HG3' ' HA ' ' A' ' 38' ' ' ALA . 64.1 Cg_endo -67.71 -9.8 26.67 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 C-N-CA 123.024 2.483 . . . . 74.15 114.054 -175.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.49 -22.69 17.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.932 0.396 . . . . 75.25 111.292 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -76.08 130.34 78.29 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 112.801 0.667 . . . . 74.14 112.801 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.38 -41.63 17.68 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.915 3.744 . . . . 73.13 114.809 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -63.3 -26.89 68.98 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 120.93 0.395 . . . . 74.41 110.897 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 62' ' ' ILE . 74.9 t -82.86 -42.39 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.93 -0.577 . . . . 74.42 111.869 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.305 0.2 OUTLIER -66.34 -30.88 71.37 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.929 1.085 . . . . 73.45 113.929 -174.477 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -61.32 -49.94 74.97 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.041 0.448 . . . . 74.13 110.672 176.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.467 HG21 ' HA3' ' A' ' 19' ' ' GLY . 10.7 pt -69.12 -31.63 50.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.904 -0.589 . . . . 74.03 112.173 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 58' ' ' VAL . 56.4 mt -59.13 -50.08 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 110.156 -0.312 . . . . 75.22 110.156 171.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 29.7 mm-40 -62.58 -36.78 83.78 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.14 0.495 . . . . 74.13 109.947 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.442 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 38.8 ttm180 -57.96 -48.25 80.51 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.7 -1.136 . . . . 74.12 110.817 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.405 HD12 ' CG1' ' A' ' 22' ' ' VAL . 82.8 mt -70.71 -30.39 66.94 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 116.543 -0.299 . . . . 73.31 110.699 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -55.86 -18.92 9.92 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 114.424 1.268 . . . . 75.22 114.424 177.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 15.4 ptm180 -53.82 -32.87 54.34 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 120.731 0.3 . . . . 65.53 110.643 176.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.3 p -73.72 -31.06 63.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.469 0.652 . . . . 63.3 110.392 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.1 t -78.97 -34.27 44.4 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.174 -0.921 . . . . 51.12 109.38 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.84 -21.56 62.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.697 0.76 . . . . 74.33 110.012 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -83.68 -23.29 31.79 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.033 -0.985 . . . . 71.41 109.21 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.7 tpt -93.02 104.39 16.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.544 -0.753 . . . . 74.24 109.865 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.01 106.83 14.23 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 116.086 -0.507 . . . . 73.45 110.141 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 73.41 100.89 0.07 Allowed 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.127 1.371 . . . . 71.3 111.109 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -102.42 142.51 33.51 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.895 -0.593 . . . . 75.34 110.144 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.7 p -96.35 76.57 2.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.493 0.664 . . . . 60.11 110.199 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--N 1.303 -1.453 0 N-CA-C 107.751 -1.203 . . . . 65.42 107.751 179.81 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.77 0 N-CA-C 111.166 -0.773 . . . . 73.41 111.166 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 t -156.65 157.57 35.46 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.394 -0.965 . . . . 73.44 108.394 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -81.71 -51.11 8.52 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.024 -1.473 . . . . 72.35 107.024 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -176.42 163.53 2.49 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.989 -1.485 . . . . 72.52 106.989 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.22 -17.42 39.91 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.261 0.553 . . . . 74.14 111.811 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -98.08 152.6 19.14 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 112.889 0.7 . . . . 74.32 112.889 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -84.59 -29.56 25.71 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.197 -1.409 . . . . 63.25 107.197 174.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.563 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 74.6 m -84.16 173.67 10.85 Favored 'General case' 0 N--CA 1.402 -2.839 0 CA-C-N 114.088 -1.414 . . . . 62.31 110.381 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.431 ' SG ' HG13 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -107.1 -179.92 4.07 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.063 -0.655 . . . . 74.3 109.574 -176.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -118.13 -51.83 2.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.711 1.374 . . . . 74.02 114.711 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.6 p -153.21 136.3 15.59 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.142 -0.623 . . . . 72.32 111.615 -171.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -102.76 153.72 5.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 119.539 -0.864 . . . . 73.1 108.879 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.6 t -99.59 179.01 4.68 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.111 -0.699 . . . . 64.11 109.111 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -39.36 -51.52 2.07 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.591 1.157 . . . . 71.44 111.628 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -159.55 94.53 1.7 Allowed Pre-proline 0 N--CA 1.427 -1.622 0 N-CA-C 108.254 -1.017 . . . . 75.51 108.254 171.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.513 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.6 Cg_endo -39.44 -82.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.738 3.625 . . . . 73.24 117.837 -173.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.72 161.4 46.58 Favored Pre-proline 0 N--CA 1.475 0.816 0 N-CA-C 109.452 -0.573 . . . . 75.12 109.452 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.494 ' O ' HG12 ' A' ' 21' ' ' ILE . 19.5 Cg_endo -61.74 129.24 26.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.845 1.696 . . . . 75.15 110.443 172.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.522 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -74.0 2.19 43.9 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 114.79 0.676 . . . . 74.01 114.79 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -93.64 -9.4 38.09 Favored 'General case' 0 C--N 1.281 -2.383 0 O-C-N 121.953 -0.733 . . . . 73.3 112.298 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 18' ' ' PRO . 39.5 pt -96.89 0.58 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.508 0.67 . . . . 64.44 111.039 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.478 HG13 HD12 ' A' ' 65' ' ' LEU . 2.6 p -87.46 133.4 30.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.542 -0.753 . . . . 75.23 111.102 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.508 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -84.78 -53.76 5.13 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.882 -1.155 . . . . 71.44 107.882 -176.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.513 ' O ' ' HB ' ' A' ' 42' ' ' THR . 18.6 m120 -139.73 147.85 41.46 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-N 115.115 -0.948 . . . . 73.4 108.844 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.436 ' CZ ' HG22 ' A' ' 62' ' ' ILE . 43.1 p90 -114.65 152.69 31.48 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.509 -0.922 . . . . 73.2 108.509 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.491 ' HB2' HG21 ' A' ' 40' ' ' VAL . 28.8 m170 -118.52 128.64 54.78 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.3 -1.741 . . . . 72.15 106.3 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -97.33 109.48 22.22 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.684 -0.858 . . . . 75.33 108.684 -175.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.563 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 2.4 mm? -103.11 122.09 43.96 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.318 -0.401 . . . . 72.24 110.115 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.7 mt -128.8 172.33 11.39 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.457 -0.338 . . . . 74.21 110.272 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 47.7 mt -77.72 -20.89 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.096 -1.446 . . . . 73.15 107.096 176.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -63.94 -27.12 68.93 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.212 -1.358 . . . . 74.2 109.165 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.53 -12.05 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.475 -0.784 . . . . 73.2 110.488 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.61 -47.31 1.03 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.187 -0.53 . . . . 54.32 114.316 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 71.0 m -62.48 137.55 58.28 Favored 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 112.366 0.506 . . . . 64.1 112.366 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -71.13 -20.19 62.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 73.43 111.874 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.05 106.91 58.53 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-O 121.203 0.525 . . . . 74.14 111.159 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -85.57 130.21 3.76 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.282 1.988 . . . . 65.12 111.655 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -171.72 153.5 3.38 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.867 -0.79 . . . . 74.32 108.867 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.04 131.72 46.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.201 -1.037 . . . . 73.11 108.201 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG21 ' HB2' ' A' ' 26' ' ' HIS . 16.8 m -98.99 129.78 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.798 0 C-N-CA 119.535 -0.866 . . . . 73.21 109.492 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -96.44 115.44 27.43 Favored 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 115.234 -0.894 . . . . 73.25 110.903 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 24' ' ' ASN . 53.2 m -85.74 105.13 16.05 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 123.786 0.679 . . . . 73.42 109.412 175.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.1 p -71.78 173.28 8.41 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.977 -0.556 . . . . 60.21 111.002 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.25 -28.39 69.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.373 0.606 . . . . 74.23 110.062 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -64.83 -32.99 74.95 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.252 -0.886 . . . . 75.53 110.321 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.26 -3.85 25.23 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 120.77 -0.729 . . . . 72.52 112.048 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 42' ' ' THR . 27.1 mmt180 -75.69 137.82 40.9 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 111.84 0.311 . . . . 73.24 111.84 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -103.95 112.51 25.51 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.875 -1.157 . . . . 72.53 107.875 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 24.0 tp -114.76 145.35 42.2 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.263 -0.575 . . . . 64.21 109.653 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.7 m -78.03 133.41 37.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.784 -0.45 . . . . 73.2 109.784 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.513 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -137.6 155.65 75.13 Favored Pre-proline 0 C--N 1.312 -1.065 0 N-CA-C 109.811 -0.44 . . . . 73.24 109.811 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.24 111.32 3.06 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.993 2.462 . . . . 72.32 112.824 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.9 Cg_endo -70.23 -12.45 32.03 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.691 2.261 . . . . 74.32 114.328 -173.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -113.08 9.73 18.63 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.531 0.567 . . . . 74.14 112.531 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 25.1 mm-40 -91.54 139.05 25.02 Favored Pre-proline 0 C--N 1.32 -0.683 0 O-C-N 122.313 -0.242 . . . . 71.35 110.999 176.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.83 -43.16 42.06 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 124.086 3.191 . . . . 74.25 114.714 -175.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.507 ' O ' HG12 ' A' ' 61' ' ' ILE . 40.3 p-90 -62.92 -37.46 87.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.307 -0.557 . . . . 74.34 110.518 -177.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 62' ' ' ILE . 78.6 t -72.81 -43.67 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.707 -0.679 . . . . 63.03 110.602 178.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 43.7 mt-10 -53.07 -41.54 64.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.094 0.473 . . . . 73.13 110.88 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -72.97 -41.46 64.36 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.695 0.628 . . . . 75.34 112.695 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.522 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.7 pt -71.56 -32.69 46.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 112.561 0.578 . . . . 75.43 112.561 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 58' ' ' VAL . 59.0 mt -57.69 -50.28 77.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.152 -0.684 . . . . 74.32 109.152 171.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -61.8 -40.93 96.96 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.925 -0.579 . . . . 71.13 110.423 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -54.33 -50.29 67.75 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.727 -0.67 . . . . 74.2 109.688 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.478 HD12 HG13 ' A' ' 22' ' ' VAL . 80.9 mt -70.1 -30.45 67.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.356 0.502 . . . . 73.24 112.356 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 48.5 mt-30 -71.85 -27.42 62.87 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.549 -0.86 . . . . 75.23 111.419 177.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -72.97 -29.01 62.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.748 0.309 . . . . 73.44 110.666 175.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 36.1 p -81.74 -19.69 40.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.891 0.853 . . . . 73.23 110.608 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 61.2 m -85.57 -11.24 54.53 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.756 -1.111 . . . . 74.3 110.96 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.46 -29.71 66.4 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.224 0.609 . . . . 61.44 111.251 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -98.63 144.86 27.46 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.386 -0.968 . . . . 75.43 108.386 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.9 tpt 63.23 27.51 15.56 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-O 122.746 1.26 . . . . 62.43 109.241 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -77.26 111.49 12.96 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.892 -1.049 . . . . 74.04 111.001 -177.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -129.82 -51.26 1.14 Allowed 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.561 -1.274 . . . . 75.23 107.561 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -155.96 103.34 2.22 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.112 -0.949 . . . . 72.52 110.115 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.7 t -106.23 77.2 1.2 Allowed 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.241 -1.763 . . . . 70.2 106.241 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.9 m . . . . . 0 C--O 1.262 1.732 0 N-CA-C 108.001 -1.111 . . . . 74.33 108.001 -176.521 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.236 0 N-CA-C 110.508 -1.037 . . . . 71.44 110.508 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.2 p -82.79 90.14 6.87 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.092 0.472 . . . . 74.43 109.79 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -116.91 109.97 17.73 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.634 -0.876 . . . . 54.04 108.634 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -71.03 152.24 43.76 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.256 -0.429 . . . . 65.04 111.283 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.06 -16.12 51.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.191 -0.459 . . . . 74.23 111.78 -177.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 52.96 -174.15 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 125.801 1.64 . . . . 73.23 114.631 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -88.86 -32.75 17.63 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 121.118 0.485 . . . . 75.13 110.805 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.415 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 6.6 p -108.62 168.95 8.97 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.87 -0.604 . . . . 63.21 110.251 174.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -84.16 128.0 34.28 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.525 -0.87 . . . . 60.51 110.684 -171.041 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.473 HD11 ' H ' ' A' ' 10' ' ' LEU . 6.2 mp -43.96 -62.44 1.13 Allowed 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 125.367 1.467 . . . . 72.43 114.265 -175.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 p -173.01 143.42 1.16 Allowed 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 120.259 -0.576 . . . . 63.54 109.633 -172.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 13' ' ' THR . 1.1 m -99.48 152.58 4.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.009 -1.108 . . . . 73.24 108.009 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 12' ' ' VAL . 9.0 t -89.54 174.44 7.77 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.274 -1.38 . . . . 73.44 107.274 175.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -53.37 -39.65 64.35 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.273 0.488 . . . . 63.03 112.12 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.0 ttpt -155.15 93.8 2.69 Favored Pre-proline 0 N--CA 1.429 -1.505 0 N-CA-C 108.733 -0.839 . . . . 74.35 108.733 170.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.569 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 11.8 Cg_endo -52.13 -82.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.268 3.312 . . . . 74.34 117.705 -175.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.6 162.4 53.32 Favored Pre-proline 0 C--N 1.321 -0.641 0 O-C-N 121.881 -0.512 . . . . 74.55 110.424 -173.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.595 ' O ' HG12 ' A' ' 21' ' ' ILE . 27.2 Cg_exo -63.97 132.15 33.46 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.877 1.718 . . . . 72.2 110.124 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.51 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -75.05 1.11 56.89 Favored Glycine 0 C--N 1.301 -1.382 0 N-CA-C 114.065 0.386 . . . . 63.13 114.065 -176.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -91.58 -2.38 57.14 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 122.483 -0.422 . . . . 75.11 110.88 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 18' ' ' PRO . 27.6 pt -107.1 6.76 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 120.313 -0.555 . . . . 75.24 110.819 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 41' ' ' PHE . 5.4 p -93.77 140.69 16.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.02 -0.537 . . . . 75.22 111.453 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.41 -47.0 5.06 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.776 0.83 . . . . 75.21 109.441 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -143.9 163.64 32.82 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.749 -1.204 . . . . 73.14 107.749 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.77 165.52 27.85 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.233 0.47 . . . . 72.33 110.47 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.408 ' HB2' HG21 ' A' ' 40' ' ' VAL . 36.0 m80 -134.45 112.41 10.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.695 -1.224 . . . . 71.4 107.695 170.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -83.17 94.92 7.96 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.972 -1.122 . . . . 73.34 107.972 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.415 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 63.0 mt -94.63 137.41 33.78 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.635 -0.712 . . . . 74.15 111.428 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.8 mt -142.05 169.67 17.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.035 -0.984 . . . . 75.51 110.861 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -77.9 -29.61 15.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 107.17 -1.419 . . . . 73.24 107.17 171.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.88 -30.19 70.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.023 -0.99 . . . . 73.43 109.15 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -74.33 -32.87 62.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.199 -0.91 . . . . 74.31 108.805 173.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.63 88.61 1.6 Allowed Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.178 -0.919 . . . . 53.2 113.68 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.9 t 178.84 -175.5 0.21 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.429 -1.322 . . . . 65.35 107.429 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -89.5 -41.99 11.72 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.557 0.577 . . . . 74.14 112.557 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.05 115.95 42.79 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 113.085 0.772 . . . . 65.34 113.085 -176.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -83.07 130.68 5.67 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.838 2.359 . . . . 73.04 111.655 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.66 153.42 2.26 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.269 -1.011 . . . . 55.21 108.269 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.09 130.78 47.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.81 -1.181 . . . . 63.43 107.81 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 4.5 m -92.4 131.69 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.759 0 N-CA-C 108.254 -1.017 . . . . 75.31 108.254 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.478 ' CD1' HG22 ' A' ' 22' ' ' VAL . 10.3 m-85 -103.2 115.44 30.58 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 116.108 -0.496 . . . . 74.02 110.728 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.7 m -80.69 100.39 8.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.2 -1.408 . . . . 62.45 107.2 174.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 53.2 p -72.25 175.39 6.13 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.494 0.188 . . . . 72.12 111.042 -177.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 96.8 mt -61.02 -26.74 67.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.692 -0.485 . . . . 75.14 109.692 176.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.41 ' NE ' ' HA ' ' A' ' 45' ' ' ARG . 6.5 tpm_? -63.88 -27.01 68.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.373 1.069 . . . . 73.21 110.791 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.92 8.55 59.08 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.168 -0.539 . . . . 63.43 111.878 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.61 138.93 38.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.974 -1.491 . . . . 73.22 106.974 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -95.82 118.77 33.11 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.435 -0.58 . . . . 63.53 109.435 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.1 mp -111.21 149.22 31.28 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 111.785 0.291 . . . . 74.43 111.785 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 23.3 m -80.23 123.4 27.91 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.863 -0.608 . . . . 74.32 110.241 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.569 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.74 152.52 77.11 Favored Pre-proline 0 C--O 1.246 0.882 0 O-C-N 122.356 -0.215 . . . . 75.23 110.86 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.41 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 67.3 Cg_endo -67.39 114.12 3.14 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.005 2.47 . . . . 73.21 113.844 -173.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 -15.36 28.05 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.179 1.919 . . . . 75.5 112.154 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -103.82 8.57 37.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.094 -0.503 . . . . 62.44 112.309 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.77 129.28 26.12 Favored Pre-proline 0 C--N 1.315 -0.924 0 C-N-CA 119.88 -0.728 . . . . 72.44 111.654 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.03 -36.5 28.03 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.289 3.326 . . . . 74.34 115.296 -177.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -62.32 -27.03 68.76 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 120.086 -0.646 . . . . 75.31 110.961 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.516 ' O ' HG13 ' A' ' 62' ' ' ILE . 67.7 t -79.69 -42.38 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 116.0 -0.546 . . . . 73.5 112.386 -178.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -63.46 -25.54 68.31 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.931 1.086 . . . . 72.32 113.931 -174.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -80.59 -41.24 24.33 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 116.468 -0.333 . . . . 75.21 111.073 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.51 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 10.8 pt -71.9 -31.08 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 111.932 0.345 . . . . 75.32 111.932 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 58' ' ' VAL . 61.4 mt -55.54 -41.38 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.209 -0.45 . . . . 72.55 109.961 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 76.4 mm-40 -61.3 -42.17 98.21 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.981 -0.554 . . . . 72.33 110.372 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -58.51 -43.85 89.26 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.896 -0.593 . . . . 75.35 110.244 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.411 HD12 ' CG1' ' A' ' 22' ' ' VAL . 85.9 mt -68.53 -39.13 81.28 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.819 -0.628 . . . . 73.21 111.623 178.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -64.47 -43.35 94.47 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.694 -0.402 . . . . 75.4 111.223 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 63' ' ' GLN . 70.2 mtp180 -63.37 -33.98 76.72 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.18 0.514 . . . . 75.31 111.266 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.8 p -84.76 -26.21 27.73 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 113.142 0.793 . . . . 73.02 113.142 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.3 t -80.31 -38.02 31.52 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.53 -0.304 . . . . 70.23 110.478 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.11 65.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.95 0.405 . . . . 73.52 112.039 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -105.77 4.54 30.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.258 0.551 . . . . 72.33 110.886 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.74 123.66 48.04 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.402 -1.333 . . . . 73.55 107.402 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -82.15 104.74 12.7 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.898 0.38 . . . . 74.51 110.989 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -162.02 171.37 17.68 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.889 -0.782 . . . . 71.33 108.889 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -75.79 122.54 24.22 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.842 -1.17 . . . . 74.23 107.842 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.1 m -80.11 101.14 8.58 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.469 -0.493 . . . . 74.2 110.867 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.5 m . . . . . 0 N--CA 1.429 -1.516 0 N-CA-C 108.428 -0.953 . . . . 70.41 108.428 177.902 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.645 0 N-CA-C 111.706 -0.558 . . . . 71.35 111.706 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.7 m -71.54 128.9 37.34 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.456 -0.572 . . . . 72.33 109.456 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.8 t30 71.16 115.32 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.442 1.097 . . . . 74.2 109.987 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -82.47 38.04 0.54 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.235 1.017 . . . . 74.45 111.541 -174.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.56 -4.0 56.91 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.975 0.893 . . . . 64.45 109.089 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.47 117.7 9.79 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.248 -1.342 . . . . 64.33 110.871 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -98.96 -13.25 20.03 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.005 0.907 . . . . 71.13 109.316 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.531 ' SG ' HD12 ' A' ' 28' ' ' LEU . 71.7 m -81.68 159.88 23.84 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.769 -1.105 . . . . 51.33 109.843 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.698 ' SG ' HG13 ' A' ' 40' ' ' VAL . 75.3 m -85.46 177.73 7.67 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.412 0.625 . . . . 74.44 111.709 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.44 -38.86 6.33 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 114.892 -1.049 . . . . 74.31 109.141 176.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.5 m -163.7 168.48 19.74 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 110.127 -0.323 . . . . 63.03 110.127 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 13' ' ' THR . 1.3 m -132.35 156.65 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 N-CA-C 104.481 -2.414 . . . . 65.12 104.481 172.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.8 t -96.9 178.02 5.43 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 108.192 -1.04 . . . . 74.11 108.192 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -50.65 -49.6 56.64 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.142 0.496 . . . . 74.2 111.103 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 37.0 ttpt -149.42 84.83 5.98 Favored Pre-proline 0 N--CA 1.421 -1.894 0 N-CA-C 108.976 -0.75 . . . . 73.32 108.976 175.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.515 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.2 Cg_endo -46.54 -81.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.786 3.658 . . . . 74.33 117.861 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.09 160.07 68.57 Favored Pre-proline 0 C--N 1.311 -1.091 0 O-C-N 121.857 -0.527 . . . . 71.23 110.612 -172.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.573 ' O ' HG12 ' A' ' 21' ' ' ILE . 19.6 Cg_endo -60.89 128.43 25.46 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.829 1.686 . . . . 74.45 109.791 173.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.532 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -73.72 1.72 44.12 Favored Glycine 0 C--O 1.209 -1.457 0 C-N-CA 120.98 -0.629 . . . . 44.52 114.554 -174.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -89.97 -1.54 57.99 Favored 'General case' 0 C--N 1.284 -2.276 0 O-C-N 122.198 -0.589 . . . . 71.42 111.367 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 18' ' ' PRO . 38.6 pt -104.01 7.29 10.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 120.788 -0.365 . . . . 72.24 110.959 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.413 HG13 HD12 ' A' ' 65' ' ' LEU . 3.2 p -90.93 131.68 37.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.576 0.703 . . . . 74.21 112.55 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -85.44 -55.06 4.2 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.798 -1.092 . . . . 75.13 108.124 -175.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -143.42 158.66 43.46 Favored 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 123.922 0.889 . . . . 73.33 109.099 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -132.43 163.27 29.12 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.84 -0.43 . . . . 73.45 109.84 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -135.01 136.91 42.49 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.289 -1.374 . . . . 73.24 107.289 174.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -100.1 105.9 17.58 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.103 0.478 . . . . 70.15 109.723 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.531 HD12 ' SG ' ' A' ' 8' ' ' CYS . 1.8 mm? -97.43 124.08 41.49 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 123.803 0.841 . . . . 71.32 109.529 -176.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.6 mt -121.9 176.36 5.81 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.813 -0.44 . . . . 74.35 109.813 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 45.4 mt -73.3 -17.36 17.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 121.992 0.901 . . . . 74.32 108.935 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -65.17 -28.88 69.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.587 -1.188 . . . . 71.33 109.347 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -76.86 -4.22 42.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.504 -0.771 . . . . 62.54 111.08 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.9 -9.37 59.99 Favored Glycine 0 CA--C 1.503 -0.692 0 CA-C-N 116.122 -0.49 . . . . 41.32 113.044 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.68 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 63.0 m -94.67 123.53 38.16 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.526 -0.916 . . . . 72.04 108.526 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.554 ' H ' ' HD2' ' A' ' 35' ' ' ARG 0.313 0.0 OUTLIER -77.67 1.89 18.47 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.968 1.099 . . . . 74.44 113.968 -176.15 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.8 p -109.62 98.22 31.75 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.053 -0.721 . . . . 73.42 109.053 171.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.12 129.86 9.03 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 121.627 1.551 . . . . 71.04 110.29 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 50' ' ' CYS . . . -166.13 160.44 16.28 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.226 -0.443 . . . . 71.23 110.734 -174.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 50' ' ' CYS . 7.2 p -110.37 123.15 66.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 109.083 -0.71 . . . . 74.22 109.083 176.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.698 HG13 ' SG ' ' A' ' 9' ' ' CYS . 9.2 m -80.34 125.64 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 C-N-CA 119.736 -0.786 . . . . 73.42 109.191 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -97.85 109.01 21.85 Favored 'General case' 0 C--N 1.267 -3.02 0 CA-C-N 115.672 -0.695 . . . . 74.55 109.487 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.4 m -82.42 103.72 12.18 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.477 -1.305 . . . . 71.51 107.477 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 64.8 p -69.94 167.12 18.12 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 120.895 -0.322 . . . . 75.54 111.084 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 94.9 mt -59.99 -30.74 69.33 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.093 0.557 . . . . 74.03 110.698 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -70.91 -18.23 62.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.313 -0.858 . . . . 75.33 110.109 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.57 16.6 26.26 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.881 -0.676 . . . . 75.21 113.22 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -99.8 126.05 45.82 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.95 0.375 . . . . 75.41 111.282 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -85.92 127.04 34.52 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.126 -0.694 . . . . 73.24 109.126 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.7 tp -147.67 131.03 16.59 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.229 -1.026 . . . . 74.43 108.229 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.56 ' SG ' HG13 ' A' ' 40' ' ' VAL . 55.8 m -86.78 155.17 20.42 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 114.877 1.436 . . . . 73.32 114.877 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.515 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -130.55 162.34 55.37 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-N 114.217 -1.356 . . . . 65.51 108.453 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 58.0 Cg_endo -68.67 107.52 1.67 Allowed 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 121.69 1.594 . . . . 75.03 111.617 -177.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.15 -12.46 35.16 Favored 'Trans proline' 0 N--CA 1.481 0.74 0 C-N-CA 123.171 2.58 . . . . 71.05 114.408 -170.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -96.07 -22.52 17.29 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.141 0.496 . . . . 73.3 110.733 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -73.84 138.7 76.6 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 112.902 0.705 . . . . 74.02 112.902 -174.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -50.54 -36.79 50.73 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.321 3.348 . . . . 73.11 115.037 -177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.467 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 34.7 p-90 -68.18 -28.0 66.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 119.863 -0.735 . . . . 64.42 110.673 -177.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 62' ' ' ILE . 73.9 t -79.77 -41.42 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 116.125 -0.489 . . . . 73.21 111.747 -177.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 11.7 pt-20 -60.74 -37.52 82.04 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.23 -0.588 . . . . 73.03 112.033 -177.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -62.21 -43.92 97.74 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.062 0.458 . . . . 72.02 111.731 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.532 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 8.5 pt -74.06 -32.49 33.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 116.052 -0.522 . . . . 74.24 111.841 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 58' ' ' VAL . 58.5 mt -60.74 -51.09 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.669 -0.493 . . . . 74.12 109.669 172.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 14.2 mm100 -59.56 -38.0 79.97 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.324 -0.398 . . . . 54.34 110.904 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.434 ' HG3' ' NH2' ' A' ' 67' ' ' ARG . 35.5 ttt180 -57.66 -47.41 82.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.865 -0.607 . . . . 74.44 110.558 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.413 HD12 HG13 ' A' ' 22' ' ' VAL . 86.8 mt -71.17 -30.16 66.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.885 0.374 . . . . 75.45 110.892 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 69' ' ' SER . 73.5 mt-30 -67.49 -22.56 65.45 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 113.037 0.754 . . . . 74.53 113.037 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.434 ' NH2' ' HG3' ' A' ' 64' ' ' ARG . 26.2 mtm180 -65.66 -45.99 80.82 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.41 0.624 . . . . 75.25 109.473 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.6 p -78.32 -20.08 52.18 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.689 -0.687 . . . . 73.35 112.101 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.411 ' HB2' ' HA ' ' A' ' 66' ' ' GLN . 67.7 m -86.45 -12.13 49.91 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.829 -0.623 . . . . 65.22 111.184 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.68 -25.52 61.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.707 0.403 . . . . 52.22 111.292 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -73.99 -26.6 60.55 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.592 -0.892 . . . . 71.2 108.592 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 49.1 ttp -95.84 -176.9 3.86 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.0 -1.482 . . . . 74.31 107.0 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 21.7 ptmt -75.6 -0.81 21.81 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 118.339 0.518 . . . . 75.11 111.747 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 73' ' ' LYS . 73.7 ttt180 72.02 131.35 0.04 OUTLIER 'General case' 0 C--N 1.359 0.995 0 C-N-CA 123.441 0.697 . . . . 74.24 110.295 -173.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -82.64 79.54 9.03 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 119.911 -0.716 . . . . 73.24 111.267 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.4 t -170.06 93.81 0.24 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 105.495 -2.039 . . . . 75.32 105.495 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--N 1.299 -1.613 0 N-CA-C 107.797 -1.186 . . . . 73.13 107.797 -175.009 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.5 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 25.7 p . . . . . 0 N--CA 1.44 -0.956 0 N-CA-C 112.959 0.726 . . . . 72.05 112.959 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.39 -171.04 3.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.966 -0.561 . . . . 53.21 109.659 -175.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.28 -64.02 1.09 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.06 -0.348 . . . . 70.24 110.06 -176.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -175.03 153.39 1.63 Allowed 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.307 -1.368 . . . . 54.25 107.307 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.96 150.53 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 C-N-CA 119.862 -0.735 . . . . 62.51 109.59 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.0 t -91.74 177.65 6.14 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.286 -1.005 . . . . 73.5 108.286 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -44.87 -63.49 0.91 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.388 0.675 . . . . 72.31 110.912 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 86.4 tttt -142.55 91.91 7.41 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 106.9 -1.518 . . . . 72.13 106.9 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.625 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.0 Cg_endo -46.98 -87.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.507 3.472 . . . . 45.13 118.321 -172.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.555 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -131.59 160.87 65.47 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 109.628 -0.508 . . . . 72.24 109.628 -173.392 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.508 ' O ' HG12 ' A' ' 21' ' ' ILE . 51.2 Cg_exo -60.16 128.41 26.33 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.181 1.921 . . . . 72.45 110.719 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.514 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -76.24 -0.88 67.49 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 116.023 -0.535 . . . . 72.32 113.454 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -95.67 -3.75 45.54 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 113.149 0.796 . . . . 74.13 113.149 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 18' ' ' PRO . 40.8 pt -103.74 9.79 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.539 0.685 . . . . 51.41 110.538 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.538 HG13 HD11 ' A' ' 65' ' ' LEU . 3.3 p -93.96 132.42 38.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.683 -0.689 . . . . 70.11 111.794 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -84.32 -47.99 10.17 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.657 1.183 . . . . 74.33 111.479 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -150.39 156.57 41.75 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.6 -0.889 . . . . 64.45 108.6 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 34.9 p90 -129.14 159.98 34.32 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.016 0.436 . . . . 62.45 109.896 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.654 ' HB2' HG22 ' A' ' 40' ' ' VAL . 3.7 m170 -127.16 125.67 41.55 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 104.907 -2.257 . . . . 74.31 104.907 175.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -95.88 100.61 12.29 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.981 -0.377 . . . . 73.03 109.981 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.4 mm? -97.99 120.28 38.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.066 0.546 . . . . 54.01 111.375 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.7 mt -130.0 176.03 8.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.069 0.461 . . . . 72.41 110.719 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.6 mt -73.52 -22.13 18.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.268 -1.012 . . . . 72.23 108.268 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -58.38 -42.59 87.37 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.623 -1.171 . . . . 64.11 108.781 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.79 -48.03 60.66 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.984 -1.007 . . . . 75.44 108.586 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.74 87.85 0.4 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 115.104 -0.953 . . . . 50.01 112.469 175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 46.9 t -171.12 161.93 6.89 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.928 -1.138 . . . . 53.43 107.928 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -87.54 -25.92 23.41 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.928 0.394 . . . . 41.13 110.388 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.6 109.2 58.09 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-O 121.123 0.487 . . . . 62.05 111.371 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -81.86 129.73 6.38 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 121.401 1.401 . . . . 72.44 109.752 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.521 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -166.49 147.76 6.36 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.164 -0.471 . . . . 75.14 110.091 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.33 128.24 51.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 107.577 -1.268 . . . . 64.55 107.577 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.654 HG22 ' HB2' ' A' ' 26' ' ' HIS . 11.9 m -93.37 129.71 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 C-N-CA 119.42 -0.912 . . . . 71.55 109.378 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 14.7 m-85 -99.76 113.47 25.99 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.419 -0.81 . . . . 70.55 111.312 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -83.03 104.49 13.28 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.383 -0.969 . . . . 72.14 108.383 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 66.5 p -72.64 178.47 4.1 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 112.321 0.489 . . . . 61.13 112.321 -175.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.486 HD23 ' HG2' ' A' ' 23' ' ' ARG . 77.0 mt -60.69 -31.74 70.98 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.807 0.843 . . . . 70.15 110.947 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -75.93 -14.55 60.25 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.711 -0.677 . . . . 70.21 111.01 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.66 16.2 43.38 Favored Glycine 0 CA--C 1.506 -0.471 0 C-N-CA 120.571 -0.823 . . . . 44.43 112.243 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -100.54 130.49 46.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 110.379 -0.23 . . . . 74.42 110.379 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -95.67 144.03 26.43 Favored 'General case' 0 N--CA 1.426 -1.649 0 C-N-CA 120.173 -0.611 . . . . 75.11 111.412 175.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.538 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -139.42 146.33 39.99 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.445 -1.317 . . . . 63.52 107.445 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.538 ' N ' HD13 ' A' ' 49' ' ' LEU . 3.7 m -80.71 126.19 30.98 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.148 0.28 . . . . 60.23 110.286 -175.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.625 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.12 156.27 74.73 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 122.016 -0.427 . . . . 41.33 110.877 175.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.497 ' HG3' ' OE1' ' A' ' 55' ' ' GLN . 90.3 Cg_endo -72.93 116.8 4.85 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.758 2.305 . . . . 73.43 113.961 -172.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.521 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.6 Cg_endo -74.38 -9.74 21.82 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.255 1.97 . . . . 65.45 112.57 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -89.94 -38.04 13.95 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.915 -0.314 . . . . 74.24 111.192 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.497 ' OE1' ' HG3' ' A' ' 52' ' ' PRO . 52.0 mt-30 -63.99 137.73 97.19 Favored Pre-proline 0 C--O 1.239 0.523 0 N-CA-C 113.535 0.939 . . . . 74.15 113.535 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 68.5 Cg_exo -57.27 -34.53 98.0 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.9 3.067 . . . . 53.55 114.245 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -61.02 -31.95 71.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.246 0.546 . . . . 73.02 110.579 -176.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 62' ' ' ILE . 70.9 t -76.65 -38.85 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 115.434 -0.803 . . . . 71.31 111.641 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.593 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.303 0.2 OUTLIER -66.83 -24.65 66.18 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 113.815 1.042 . . . . 41.55 113.815 -175.63 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -74.22 -50.77 17.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.037 0.446 . . . . 75.34 111.345 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.514 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 10.4 pt -64.15 -32.2 56.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.567 0.58 . . . . 64.2 112.567 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 58' ' ' VAL . 58.8 mt -58.09 -47.1 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.375 -0.375 . . . . 63.24 110.195 172.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 85.5 mm-40 -58.71 -42.59 89.0 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.169 -0.469 . . . . 53.02 110.809 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -59.59 -46.32 89.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.583 -0.735 . . . . 74.44 110.593 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.538 HD11 HG13 ' A' ' 22' ' ' VAL . 89.3 mt -69.92 -34.92 74.12 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.658 -0.417 . . . . 74.32 111.24 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 97.7 mt-30 -61.88 -46.09 90.9 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 121.059 -0.256 . . . . 74.54 111.225 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 . . . . . 0 C--N 1.313 -1.014 0 N-CA-C 113.542 0.942 . . . . 54.13 113.542 -178.594 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 47.7 t . . . . . 0 N--CA 1.425 -1.71 0 N-CA-C 106.602 -1.629 . . . . 74.44 106.602 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 10' ' ' LEU . 40.4 t -117.33 177.25 4.8 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 119.848 -0.741 . . . . 74.12 110.415 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 2.5 mm? -95.85 -54.2 3.42 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.913 -1.143 . . . . 75.15 107.913 175.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 p -178.05 164.17 1.81 Allowed 'General case' 0 C--O 1.251 1.141 0 N-CA-C 109.304 -0.628 . . . . 74.3 109.304 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 13' ' ' THR . 2.0 m -109.46 163.22 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 N-CA-C 105.723 -1.955 . . . . 74.53 105.723 174.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 12' ' ' VAL . 9.7 t -102.84 177.15 4.93 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.689 -1.226 . . . . 64.34 107.689 175.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -50.64 -49.17 57.54 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 123.222 0.326 . . . . 75.43 110.761 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.486 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 41.1 ttmt -144.91 97.65 4.87 Favored Pre-proline 0 N--CA 1.433 -1.314 0 N-CA-C 109.943 -0.392 . . . . 74.14 109.943 167.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 3.2 Cg_endo -48.65 -69.66 0.07 OUTLIER 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.955 3.103 . . . . 52.11 115.669 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.406 HG23 HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -150.58 165.41 17.47 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 109.754 -0.462 . . . . 72.33 109.754 -176.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.537 ' O ' HG12 ' A' ' 21' ' ' ILE . 42.9 Cg_exo -61.15 128.83 26.35 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.966 1.778 . . . . 50.04 109.061 171.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.502 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -74.66 1.2 53.78 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 115.761 1.064 . . . . 71.34 115.761 -172.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.64 -1.22 38.59 Favored 'General case' 0 C--N 1.287 -2.136 0 O-C-N 121.826 -0.808 . . . . 75.2 112.689 176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 38.1 pt -98.21 7.06 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 121.57 0.7 . . . . 71.4 109.885 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.513 HG13 HD11 ' A' ' 65' ' ' LEU . 3.5 p -92.18 138.3 20.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.564 -0.744 . . . . 61.15 111.421 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.46 -56.79 2.9 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.921 -1.036 . . . . 71.23 109.205 -173.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -139.92 173.6 11.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.473 -0.936 . . . . 73.5 108.473 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -149.68 165.66 31.7 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.632 -0.427 . . . . 71.24 110.513 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.466 ' HB2' HG22 ' A' ' 40' ' ' VAL . 39.4 m170 -128.02 116.18 19.63 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.114 -1.439 . . . . 70.24 107.114 170.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -88.23 120.61 29.75 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.393 -0.595 . . . . 72.25 109.393 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 7.5 tt -132.5 133.78 44.21 Favored 'General case' 0 N--CA 1.407 -2.608 0 O-C-N 123.366 0.417 . . . . 55.1 110.281 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.46 HD12 ' HE3' ' A' ' 31' ' ' LYS . 80.8 mt -131.33 -173.3 3.07 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.309 -0.997 . . . . 73.22 108.309 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 59.0 mt -68.53 -29.0 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.569 -0.53 . . . . 60.11 109.569 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 32' ' ' ASP 0.263 0.0 OUTLIER -64.72 -20.44 66.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.226 0.824 . . . . 72.13 113.226 176.168 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.463 ' N ' ' HD2' ' A' ' 31' ' ' LYS . 7.5 m-20 -80.82 -8.8 59.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.433 0.635 . . . . 75.42 109.644 174.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.71 79.13 1.39 Allowed Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.281 -0.872 . . . . 74.25 113.593 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 47.4 t -178.82 148.51 0.42 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.215 -1.402 . . . . 63.01 107.215 175.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -73.26 -31.03 63.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.508 0.559 . . . . 61.52 112.508 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.48 106.57 46.75 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-O 121.32 0.581 . . . . 70.42 111.519 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.55 129.43 4.25 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.107 1.871 . . . . 73.44 110.836 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 50' ' ' CYS . . . -165.73 145.96 6.66 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.991 -0.549 . . . . 64.01 110.122 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.51 125.47 53.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.402 -0.962 . . . . 71.25 108.402 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.658 HG12 ' SG ' ' A' ' 50' ' ' CYS . 5.3 m -88.73 124.78 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 C-N-CA 119.409 -0.916 . . . . 75.11 109.537 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 10.6 m-85 -96.32 121.76 38.46 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.287 -0.87 . . . . 75.42 111.353 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.9 m -87.7 105.79 17.6 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.577 -1.268 . . . . 70.53 107.577 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 61.4 p -74.81 172.76 11.61 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.735 -0.211 . . . . 75.14 110.959 -176.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 88.4 mt -63.98 -25.71 68.25 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.437 0.637 . . . . 61.1 109.74 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -61.02 -33.74 73.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.71 -1.132 . . . . 72.12 109.953 174.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.3 -0.14 40.63 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.643 -0.708 . . . . 54.33 111.857 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -95.44 153.19 17.82 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.06 -1.089 . . . . 72.12 108.06 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 41.4 mt-30 -110.5 138.79 46.42 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.482 -0.562 . . . . 65.14 109.482 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.406 HD23 HG23 ' A' ' 17' ' ' ILE . 47.1 tp -139.75 132.56 29.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.116 -1.068 . . . . 73.31 108.116 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.658 ' SG ' HG12 ' A' ' 40' ' ' VAL . 9.8 m -82.08 142.95 31.85 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 120.175 -0.61 . . . . 64.31 112.166 -174.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.58 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.78 158.35 68.48 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 115.465 -0.789 . . . . 42.01 110.144 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.484 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 88.3 Cg_endo -73.69 109.59 2.89 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.495 2.13 . . . . 71.34 113.281 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 52' ' ' PRO . 14.6 Cg_exo -69.45 -11.24 30.81 Favored 'Trans proline' 0 N--CA 1.482 0.799 0 C-N-CA 122.697 2.265 . . . . 70.55 112.594 -176.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -95.61 -5.8 41.68 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.479 -0.782 . . . . 74.42 111.21 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.404 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.3 mm100 -98.06 128.69 32.91 Favored Pre-proline 0 N--CA 1.443 -0.805 0 C-N-CA 120.548 -0.461 . . . . 73.23 111.407 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.23 -34.0 23.27 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 124.28 3.32 . . . . 74.15 115.449 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -62.85 -33.32 75.01 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.135 -0.626 . . . . 74.04 109.988 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 62' ' ' ILE . 89.7 t -77.53 -40.16 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.709 -0.678 . . . . 73.33 110.275 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.04 -27.3 69.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.133 0.492 . . . . 72.4 111.422 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -72.03 -44.01 64.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.706 -0.679 . . . . 71.2 110.575 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.502 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 16.5 pt -80.32 -30.65 12.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.396 0.888 . . . . 72.33 113.396 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 58' ' ' VAL . 65.2 mt -55.34 -44.84 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 110.389 -0.226 . . . . 72.42 110.389 174.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -60.02 -40.91 90.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.079 0.466 . . . . 74.31 110.105 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.86 -42.05 88.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.258 -0.883 . . . . 75.24 109.814 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.513 HD11 HG13 ' A' ' 22' ' ' VAL . 82.4 mt -76.25 -35.97 58.72 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.446 0.536 . . . . 71.43 112.446 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -64.72 -25.75 68.07 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 120.467 -0.493 . . . . 72.22 111.836 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.59 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--N 1.297 -1.714 0 C-N-CA 120.073 -0.651 . . . . 71.1 111.421 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.461 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 73.0 m . . . . . 0 N--CA 1.409 -2.482 0 N-CA-C 106.922 -1.51 . . . . 71.23 106.922 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -95.06 175.61 6.56 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.94 -0.704 . . . . 72.23 112.705 -169.292 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 tt -88.2 -66.11 0.95 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.643 -0.873 . . . . 64.14 108.643 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -175.92 153.12 1.3 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.778 -1.193 . . . . 63.12 107.778 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 13' ' ' THR . 1.4 m -98.79 160.82 3.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 119.126 -1.03 . . . . 73.51 109.506 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 12' ' ' VAL . 7.1 t -101.38 173.19 6.55 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 106.56 -1.644 . . . . 70.35 106.56 174.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -43.8 -59.43 2.24 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.528 0.518 . . . . 53.45 111.373 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 40.8 ttmt -143.09 94.15 6.4 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 109.753 -0.462 . . . . 75.31 109.753 173.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.614 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.7 Cg_endo -52.99 -85.61 0.01 OUTLIER 'Trans proline' 0 CA--C 1.556 1.617 0 C-N-CA 124.138 3.226 . . . . 52.2 117.58 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.406 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -145.04 149.46 42.26 Favored Pre-proline 0 C--O 1.207 -1.161 0 O-C-N 121.73 -0.606 . . . . 73.13 110.4 -174.07 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.22 144.97 99.07 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.54 2.16 . . . . 72.14 112.29 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.426 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -80.16 1.75 79.06 Favored Glycine 0 CA--C 1.502 -0.743 0 CA-C-N 115.848 -0.614 . . . . 54.41 112.748 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -80.13 -23.2 41.32 Favored 'General case' 0 N--CA 1.408 -2.565 0 CA-C-O 121.04 0.447 . . . . 72.41 110.553 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.434 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 37.3 pt -101.89 13.01 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.879 -0.513 . . . . 75.51 111.78 -177.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 19' ' ' GLY . 6.5 p -98.82 137.7 25.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.511 0.672 . . . . 63.31 111.908 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -89.45 -54.46 4.08 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.43 1.092 . . . . 73.33 108.588 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -139.33 164.02 30.95 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.393 -0.965 . . . . 71.32 108.393 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -140.84 160.5 39.93 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.594 -0.521 . . . . 72.41 109.594 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.487 ' HB2' HG22 ' A' ' 40' ' ' VAL . 38.5 m80 -135.81 127.06 28.25 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.368 -1.345 . . . . 74.45 107.368 173.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -92.67 122.38 35.02 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.488 -0.93 . . . . 75.33 108.488 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.4 mm? -116.18 126.24 53.39 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 120.861 0.362 . . . . 72.4 111.651 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.7 mt -129.26 172.84 11.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.165 -1.05 . . . . 64.03 108.165 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 35' ' ' ARG . 32.0 mt -74.63 -18.11 16.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.827 -1.175 . . . . 65.31 107.827 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -61.7 -32.8 73.03 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.93 -1.032 . . . . 72.42 109.455 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.27 -38.99 71.84 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.001 -0.545 . . . . 73.42 109.562 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.1 -50.93 0.54 Allowed Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 115.507 -0.77 . . . . 44.52 112.765 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 71.1 m -67.43 132.73 48.21 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.835 0.35 . . . . 44.41 110.888 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.471 ' HA ' HG12 ' A' ' 30' ' ' ILE . 86.7 mtt180 -80.48 22.77 0.54 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.03 0.752 . . . . 70.14 113.03 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -126.77 96.03 36.12 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 108.908 -0.775 . . . . 74.34 108.908 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -85.24 129.65 3.84 Favored 'Trans proline' 0 N--CA 1.443 -1.441 0 C-N-CA 121.902 1.734 . . . . 75.33 112.354 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.551 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -174.77 166.34 3.7 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.087 -0.961 . . . . 74.33 108.696 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.85 130.95 60.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.555 -1.276 . . . . 53.51 107.555 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 26' ' ' HIS . 6.8 m -96.3 128.08 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.83 0 C-N-CA 119.576 -0.849 . . . . 71.4 109.583 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 28.8 m-85 -99.65 121.51 41.32 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.592 -0.731 . . . . 73.53 110.839 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.3 m -85.93 97.99 10.55 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.137 -1.431 . . . . 74.33 107.137 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.6 p -70.14 169.74 12.94 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.65 -0.25 . . . . 63.35 111.053 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 91.2 mt -60.33 -26.84 66.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.352 0.596 . . . . 62.41 109.87 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -61.58 -28.87 69.66 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.438 1.095 . . . . 74.11 110.678 175.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.34 9.32 58.03 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 111.834 -0.506 . . . . 75.45 111.834 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -103.76 136.21 43.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.708 -1.59 . . . . 74.11 106.708 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 27.6 mt-30 -92.19 130.5 37.89 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 121.122 -0.231 . . . . 71.22 110.413 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 7.2 mp -119.62 147.08 44.95 Favored 'General case' 0 CA--C 1.475 -1.909 0 CA-C-N 116.406 -0.361 . . . . 73.52 111.0 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.407 ' HB3' HG12 ' A' ' 12' ' ' VAL . 5.1 m -86.1 125.24 33.32 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.075 -0.966 . . . . 72.03 109.18 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.614 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.41 152.45 76.4 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 118.016 0.371 . . . . 43.23 111.736 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.09 108.14 2.26 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.329 2.686 . . . . 71.2 114.243 -174.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 40.9 Cg_endo -67.95 -13.54 38.62 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.489 2.126 . . . . 65.44 111.245 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.67 -27.71 50.94 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.574 -1.194 . . . . 44.41 111.687 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 30.3 mm-40 -85.99 142.06 36.01 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 113.513 0.931 . . . . 65.12 113.513 -173.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 40.0 Cg_exo -58.22 -38.07 92.67 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.603 2.869 . . . . 62.31 113.451 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.422 ' O ' HG12 ' A' ' 61' ' ' ILE . 39.4 p-90 -63.44 -27.73 69.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.961 0.41 . . . . 74.44 110.304 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.554 ' O ' HG13 ' A' ' 62' ' ' ILE . 53.1 t -78.97 -46.89 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 116.0 -0.545 . . . . 71.22 111.756 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -25.37 67.09 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 119.549 -0.86 . . . . 74.11 109.719 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -59.65 -56.35 22.93 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.51 -1.223 . . . . 74.55 108.895 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.426 HG21 ' HA3' ' A' ' 19' ' ' GLY . 12.0 pt -74.55 -32.21 29.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.967 -1.015 . . . . 63.34 113.598 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 58' ' ' VAL . 64.1 mt -54.95 -55.74 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 123.254 0.347 . . . . 71.24 111.178 176.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.54 -38.9 92.91 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 112.42 0.526 . . . . 62.32 112.42 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -62.17 -42.47 99.3 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.667 -0.697 . . . . 65.11 112.021 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 tt -72.94 -31.72 64.78 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.179 -0.674 . . . . 74.11 109.179 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 28.5 mt-30 -48.87 -39.6 26.41 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 120.812 0.339 . . . . 72.44 111.383 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 . . . . . 0 C--N 1.313 -1.014 0 CA-C-N 115.784 -0.644 . . . . 73.44 112.286 -177.031 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.502 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 29.1 p . . . . . 0 CA--C 1.505 -0.774 0 N-CA-C 110.338 -0.245 . . . . 72.34 110.338 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.507 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -65.45 125.53 25.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.987 -0.552 . . . . 61.01 112.454 -172.207 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.438 ' O ' HG21 ' A' ' 36' ' ' VAL . 76.1 mt -50.6 -54.62 21.27 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.785 1.634 . . . . 65.34 114.586 -172.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.6 p -174.38 142.57 0.79 Allowed 'General case' 0 CA--C 1.486 -1.505 0 C-N-CA 120.085 -0.646 . . . . 61.23 109.734 -174.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.2 m -98.5 162.65 2.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.127 -1.064 . . . . 60.54 108.127 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 12' ' ' VAL . 15.4 t -105.18 178.18 4.63 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 107.115 -1.439 . . . . 72.23 107.115 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -41.43 -57.97 2.03 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.51 0.724 . . . . 72.24 110.696 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 ttpt -146.96 97.1 4.21 Favored Pre-proline 0 N--CA 1.431 -1.421 0 N-CA-C 108.7 -0.852 . . . . 71.14 108.7 170.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.595 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 5.4 Cg_endo -44.99 -73.03 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.915 3.077 . . . . 73.42 115.997 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.84 163.72 34.16 Favored Pre-proline 0 C--N 1.317 -0.824 0 O-C-N 122.153 -0.342 . . . . 61.34 110.269 -176.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.58 ' O ' HG12 ' A' ' 21' ' ' ILE . 71.2 Cg_exo -55.49 129.09 33.24 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.446 2.097 . . . . 63.41 110.186 171.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.496 ' HA3' HD13 ' A' ' 61' ' ' ILE . . . -77.79 -4.34 85.23 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.953 -0.642 . . . . 74.34 114.377 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -96.19 2.6 53.18 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.331 -0.511 . . . . 75.41 111.816 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 18' ' ' PRO . 32.6 pt -106.75 12.39 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 120.077 -0.649 . . . . 70.21 110.654 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.604 HG13 HD11 ' A' ' 65' ' ' LEU . 2.2 p -95.55 133.26 37.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.651 0.738 . . . . 71.34 112.407 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.596 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 1.2 tmt_? -93.62 -49.2 5.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.595 -1.184 . . . . 65.32 108.556 -174.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.596 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 16.1 m120 -135.5 154.05 51.53 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.891 -0.781 . . . . 74.3 108.891 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.9 143.91 41.07 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.209 -0.596 . . . . 72.04 109.699 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.538 ' HB2' HG22 ' A' ' 40' ' ' VAL . 43.9 m170 -118.72 132.32 56.15 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.363 -1.717 . . . . 61.34 106.363 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -99.77 102.83 14.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.487 -0.56 . . . . 71.54 109.487 -174.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.502 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.1 mm? -102.26 120.37 40.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.872 -0.603 . . . . 75.03 111.049 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.0 mt -131.87 168.75 17.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.29 0.567 . . . . 74.22 110.603 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mt -77.89 -17.33 14.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 107.696 -1.224 . . . . 64.02 107.696 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.07 -31.91 71.57 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 114.967 -1.015 . . . . 75.35 109.417 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -76.66 -54.45 6.64 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.073 -1.084 . . . . 41.05 108.073 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.13 89.13 0.23 Allowed Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.413 -0.812 . . . . 62.41 112.518 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.5 t -171.59 -176.08 1.72 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.63 -0.878 . . . . 51.03 108.63 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -81.55 -43.02 19.31 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.808 0.443 . . . . 75.13 111.846 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 10' ' ' LEU . 2.8 p -130.84 128.24 22.35 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 113.609 0.966 . . . . 64.23 113.609 -172.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 92.0 Cg_endo -88.82 132.18 2.38 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 123.029 2.486 . . . . 64.42 112.553 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 9' ' ' CYS . . . -175.06 153.41 1.62 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.855 0.862 . . . . 74.42 108.794 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -99.1 132.64 44.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.672 -1.233 . . . . 75.33 107.672 176.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.538 HG22 ' HB2' ' A' ' 26' ' ' HIS . 5.9 m -93.38 122.75 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 C-N-CA 119.346 -0.942 . . . . 74.01 109.225 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.498 ' CD1' HG21 ' A' ' 22' ' ' VAL . 8.8 m-85 -94.77 115.91 28.08 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 115.333 -0.849 . . . . 73.35 110.56 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.1 m -85.47 104.77 15.56 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.362 -0.977 . . . . 61.23 108.362 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.0 p -71.15 178.4 3.3 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.166 -0.47 . . . . 74.03 111.448 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.5 mt -66.11 -25.18 66.87 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.778 0.799 . . . . 73.43 109.926 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -71.93 -16.31 62.1 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.787 -1.097 . . . . 74.23 110.656 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.63 16.01 57.4 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.863 -0.684 . . . . 74.03 111.579 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 31.0 mmt180 -97.91 135.34 39.78 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 120.739 0.304 . . . . 63.13 111.753 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -97.56 114.56 26.48 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.168 -0.924 . . . . 73.11 109.481 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.1 mp -116.53 148.42 40.85 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 116.497 -0.32 . . . . 75.42 111.603 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.414 ' HB3' HG12 ' A' ' 12' ' ' VAL . 34.8 m -77.75 122.29 25.18 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.436 -0.802 . . . . 71.24 110.667 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.595 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.54 151.71 73.34 Favored Pre-proline 0 C--O 1.242 0.704 0 C-N-CA 121.101 -0.24 . . . . 64.3 111.535 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 83.1 Cg_endo -74.27 110.87 3.18 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 123.284 2.656 . . . . 73.35 114.407 -172.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 52' ' ' PRO . 17.7 Cg_exo -67.18 -18.69 51.02 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.391 2.061 . . . . 75.52 112.948 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -87.54 -19.93 27.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.072 0.767 . . . . 64.44 113.072 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -83.99 139.02 39.77 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 114.08 1.141 . . . . 62.4 114.08 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.459 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 9.7 Cg_endo -52.07 -39.92 69.29 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 124.608 3.538 . . . . 65.43 114.753 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.1 p-90 -59.47 -31.87 69.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.714 -0.395 . . . . 74.51 111.025 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 62' ' ' ILE . 78.2 t -77.56 -42.95 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.935 -0.575 . . . . 63.11 111.599 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -67.19 -25.25 66.04 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.961 -0.696 . . . . 75.14 112.176 -178.157 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HD3' ' OE1' ' A' ' 63' ' ' GLN . 37.0 mmt180 -71.37 -34.91 70.88 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.795 -0.639 . . . . 74.34 112.547 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.496 HD13 ' HA3' ' A' ' 19' ' ' GLY . 10.6 pt -85.33 -34.16 8.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 120.718 -0.393 . . . . 75.31 111.8 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 58' ' ' VAL . 59.2 mt -56.74 -49.42 78.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-N 116.034 -0.53 . . . . 75.3 111.232 173.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.45 ' OE1' ' HD3' ' A' ' 60' ' ' ARG . 4.1 pt20 -59.08 -39.68 82.91 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.043 0.449 . . . . 73.0 111.221 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -60.76 -51.3 69.93 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.987 -1.006 . . . . 71.21 110.332 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.604 HD11 HG13 ' A' ' 22' ' ' VAL . 82.5 mt -66.26 -26.4 67.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.057 0.391 . . . . 72.32 112.057 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 55.9 mt-30 -63.24 -20.48 65.49 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 120.803 0.335 . . . . 65.55 111.822 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 . . . . . 0 C--N 1.314 -0.941 0 CA-C-O 121.098 0.475 . . . . 75.11 110.227 178.108 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.411 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 6.8 p . . . . . 0 N--CA 1.431 -1.408 0 N-CA-C 110.16 -0.311 . . . . 44.14 110.16 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB2' HG12 ' A' ' 40' ' ' VAL . 1.2 t -94.18 -179.39 4.93 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.801 -0.76 . . . . 74.11 111.676 -169.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.22 -66.92 0.83 Allowed 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.044 0.538 . . . . 53.05 110.434 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 p -176.4 150.09 0.87 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.113 -1.44 . . . . 75.45 107.113 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.435 HG12 ' HB3' ' A' ' 50' ' ' CYS . 2.0 m -98.49 161.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 118.812 -1.155 . . . . 51.25 109.276 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 t -104.13 177.72 4.76 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.661 -1.607 . . . . 72.12 106.661 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -51.44 -58.5 6.1 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.148 0.431 . . . . 65.41 110.124 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 59.8 tttm -137.42 99.83 9.53 Favored Pre-proline 0 N--CA 1.424 -1.732 0 C-N-CA 120.014 -0.675 . . . . 73.11 111.654 172.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 19.1 Cg_endo -67.48 -164.09 0.09 OUTLIER 'Trans proline' 0 CA--C 1.567 2.148 0 C-N-CA 122.84 2.36 . . . . 75.15 114.167 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.33 156.76 5.45 Favored Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 125.436 1.495 . . . . 72.53 113.363 -175.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -73.65 149.09 42.98 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.63 2.22 . . . . 73.11 112.527 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.433 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -77.81 1.54 67.47 Favored Glycine 0 N--CA 1.459 0.216 0 CA-C-N 115.788 -0.642 . . . . 33.05 113.488 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -82.97 -23.69 33.27 Favored 'General case' 0 C--N 1.285 -2.232 0 O-C-N 122.259 -0.553 . . . . 74.4 111.522 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.412 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 42.4 pt -100.9 12.26 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.111 0.481 . . . . 74.32 111.904 -177.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.56 HG13 HD11 ' A' ' 65' ' ' LEU . 4.3 p -97.94 136.79 27.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.04 -0.527 . . . . 61.55 111.394 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -55.82 3.49 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.437 -1.32 . . . . 73.04 107.437 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -142.33 163.91 31.58 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.636 -0.876 . . . . 52.03 108.636 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.404 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 37.9 p90 -132.51 157.47 44.58 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.964 -0.294 . . . . 72.12 110.28 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.454 ' HB2' HG22 ' A' ' 40' ' ' VAL . 37.8 m80 -125.54 113.56 17.6 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.668 -1.234 . . . . 72.03 107.668 172.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -82.68 100.78 10.43 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.523 -0.762 . . . . 71.34 109.235 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 83.5 mt -112.06 143.15 43.55 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.691 -0.686 . . . . 62.43 111.846 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 98.1 mt -141.3 -177.61 5.21 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.046 -0.979 . . . . 70.54 109.842 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 57.9 mt -74.93 -29.42 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.442 -1.318 . . . . 71.2 107.442 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.02 -20.54 64.04 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.911 -1.04 . . . . 72.52 110.907 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -79.66 -49.55 11.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.553 -1.277 . . . . 54.22 107.553 174.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.33 51.15 0.06 OUTLIER Glycine 0 C--O 1.24 0.523 0 C-N-CA 120.621 -0.799 . . . . 33.32 114.1 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 87.3 m -145.5 144.74 30.74 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.764 -1.199 . . . . 75.53 107.764 174.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -63.81 -30.96 71.99 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.159 0.504 . . . . 70.23 111.03 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -100.32 112.96 65.2 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-N 115.432 -0.804 . . . . 62.02 111.572 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.8 130.33 3.66 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 122.191 1.928 . . . . 61.44 109.953 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -170.65 146.26 2.65 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.885 -0.413 . . . . 71.43 109.885 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.41 126.14 51.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.061 -1.459 . . . . 74.03 107.061 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 9' ' ' CYS . 13.1 m -90.1 128.32 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 C-N-CA 119.523 -0.871 . . . . 63.31 109.448 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -96.62 114.0 25.61 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 115.362 -0.835 . . . . 72.02 109.385 174.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.6 m -84.74 104.83 15.05 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.442 -1.318 . . . . 62.52 107.442 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 64.5 p -70.06 175.3 4.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 112.706 0.632 . . . . 54.11 112.706 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 90.7 mt -61.01 -27.36 68.27 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.472 0.709 . . . . 71.34 110.672 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -79.69 -13.96 59.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.706 -0.679 . . . . 73.23 110.488 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.07 16.67 43.39 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.203 -0.999 . . . . 42.33 112.602 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -96.06 138.64 33.39 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 122.747 -0.267 . . . . 74.13 110.631 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -93.12 125.18 37.58 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 123.909 0.756 . . . . 64.31 109.304 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.2 tm? -127.95 141.95 51.39 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.944 -1.132 . . . . 72.33 107.944 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.542 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.2 m -81.51 122.88 28.1 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.098 0.559 . . . . 75.41 111.15 -174.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.03 152.76 76.14 Favored Pre-proline 0 C--O 1.245 0.82 0 C-N-CA 120.237 -0.585 . . . . 43.21 111.51 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 93.8 Cg_endo -73.38 112.36 3.51 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.791 2.327 . . . . 70.24 113.564 -173.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.57 -9.63 24.26 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.204 1.936 . . . . 70.25 111.681 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.21 -17.98 24.08 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.125 -0.943 . . . . 54.22 111.45 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 31.3 mm-40 -89.7 133.08 34.92 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 112.889 0.7 . . . . 74.14 112.889 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.532 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 94.6 Cg_exo -44.81 -45.19 13.89 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 124.738 3.625 . . . . 75.21 115.771 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.445 ' HZ2' ' HD2' ' A' ' 16' ' ' PRO . 33.5 p-90 -58.16 -36.78 73.52 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.656 0.265 . . . . 70.13 111.606 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 62' ' ' ILE . 71.0 t -68.59 -42.23 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 116.247 -0.433 . . . . 71.33 110.342 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.532 ' OE1' ' HA ' ' A' ' 56' ' ' PRO . 40.7 mt-10 -56.43 -33.22 65.64 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.878 -0.601 . . . . 71.32 111.029 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' A' ' 56' ' ' PRO . 9.3 mpt_? -77.54 -43.39 32.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.97 -0.559 . . . . 74.45 112.449 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.433 HG21 ' HA3' ' A' ' 19' ' ' GLY . 8.8 pt -70.77 -32.07 47.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 112.872 0.693 . . . . 73.14 112.872 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 58' ' ' VAL . 70.4 mt -54.12 -42.68 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 109.55 -0.537 . . . . 63.45 109.55 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 79.6 mm-40 -57.78 -45.55 85.83 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.642 -0.708 . . . . 74.13 110.731 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -61.43 -41.47 97.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.134 -0.485 . . . . 63.41 111.85 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.56 HD11 HG13 ' A' ' 22' ' ' VAL . 86.3 mt -72.4 -35.74 68.49 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.014 -0.674 . . . . 74.44 111.474 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 51.4 mt-30 -66.5 -45.75 78.54 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.116 -0.633 . . . . 72.42 111.618 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 . . . . . 0 C--O 1.22 -0.467 0 C-N-CA 120.755 -0.378 . . . . 72.32 111.837 -178.027 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.479 ' HA ' HD13 ' A' ' 28' ' ' LEU . 45.5 t . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 104.496 -2.409 . . . . 64.14 104.496 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 10' ' ' LEU . 38.9 t -123.74 173.45 8.13 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 119.372 0.987 . . . . 71.44 111.11 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 80.7 mt -89.21 -55.14 3.79 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 108.54 -0.911 . . . . 73.42 108.54 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.9 t -176.94 165.13 2.39 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.493 -0.928 . . . . 63.31 108.493 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.514 HG12 ' CB ' ' A' ' 50' ' ' CYS . 1.5 m -126.0 152.77 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 105.882 -1.895 . . . . 53.23 105.882 174.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.4 t -93.46 176.58 6.33 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.166 -1.42 . . . . 54.11 107.166 174.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -58.21 -43.97 87.93 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 118.537 0.608 . . . . 75.42 112.15 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -144.05 87.27 8.03 Favored Pre-proline 0 N--CA 1.414 -2.272 0 N-CA-C 108.049 -1.093 . . . . 71.22 108.049 171.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.0 Cg_endo -51.39 -80.11 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 124.216 3.277 . . . . 72.44 117.55 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.463 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -143.32 170.19 9.08 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 109.912 -0.403 . . . . 52.12 109.912 -171.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.576 ' O ' HG12 ' A' ' 21' ' ' ILE . 44.6 Cg_exo -60.52 132.24 42.28 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.208 1.939 . . . . 61.43 111.442 175.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.455 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -79.48 2.29 72.94 Favored Glycine 0 C--N 1.299 -1.522 0 CA-C-N 115.981 -0.554 . . . . 53.43 113.798 -176.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -98.75 -5.25 31.72 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.6 0.593 . . . . 73.22 112.6 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.9 pt -93.71 3.56 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 121.612 0.72 . . . . 71.44 110.527 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.636 HG13 HD11 ' A' ' 65' ' ' LEU . 2.7 p -88.73 137.83 20.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.133 -0.94 . . . . 64.45 111.334 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.31 -55.97 3.57 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.324 -1.361 . . . . 75.03 107.324 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -143.43 162.84 34.73 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 124.132 0.973 . . . . 63.32 108.896 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -132.63 161.6 33.5 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.7 -0.4 . . . . 74.13 110.014 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.497 ' HB2' HG22 ' A' ' 40' ' ' VAL . 42.1 m80 -127.42 112.68 15.26 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.629 -0.878 . . . . 73.25 108.629 172.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -85.65 105.85 16.51 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.41 -0.814 . . . . 72.53 109.115 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 8' ' ' CYS . 8.7 tt -119.93 133.17 55.65 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-O 121.218 0.532 . . . . 70.4 110.647 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.4 mt -127.51 -177.7 4.18 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.661 -0.699 . . . . 73.04 109.423 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 58.8 mt -72.38 -20.39 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.149 -1.056 . . . . 74.4 108.149 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -62.91 -31.88 73.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.835 -1.075 . . . . 72.04 109.434 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.6 -57.34 5.88 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.583 -0.895 . . . . 63.03 108.583 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.65 71.5 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.333 -0.937 . . . . 52.44 112.877 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 35.6 t -173.1 140.85 0.91 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.794 -1.928 . . . . 75.4 105.794 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -73.18 -19.92 61.0 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.882 1.068 . . . . 71.01 113.882 -173.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.24 102.31 31.95 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-O 121.314 0.578 . . . . 74.14 110.823 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.3 130.34 6.24 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.391 2.061 . . . . 64.33 110.792 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 50' ' ' CYS . . . -165.49 148.64 7.96 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 120.873 0.368 . . . . 75.34 110.472 -177.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.25 119.95 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.017 0 N-CA-C 107.939 -1.134 . . . . 45.4 107.939 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.685 HG12 ' SG ' ' A' ' 50' ' ' CYS . 7.3 m -86.12 127.04 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.411 0 C-N-CA 119.854 -0.739 . . . . 63.24 109.108 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -97.6 114.8 26.8 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.584 -0.735 . . . . 74.33 110.047 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.4 m -81.2 103.35 10.93 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.194 -1.039 . . . . 74.14 108.194 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.7 p -73.77 171.52 13.17 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.282 -0.417 . . . . 71.22 111.375 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.4 mt -58.56 -28.83 65.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.537 0.735 . . . . 75.51 112.131 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -74.77 -14.45 60.71 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.403 0.681 . . . . 74.33 111.309 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.98 17.59 37.23 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 119.935 -1.126 . . . . 71.43 111.421 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -99.62 123.93 44.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 122.69 -0.3 . . . . 60.13 111.332 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -80.73 122.39 27.08 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.962 -0.755 . . . . 63.31 108.962 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 tp -136.07 126.37 26.54 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.228 -1.027 . . . . 75.21 108.228 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.685 ' SG ' HG12 ' A' ' 40' ' ' VAL . 17.3 m -87.39 149.41 24.49 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 113.713 1.005 . . . . 70.25 113.713 -171.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.587 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -134.06 162.54 57.09 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 115.058 -0.974 . . . . 75.24 109.221 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 63.2 Cg_endo -69.03 109.44 2.17 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.077 1.852 . . . . 63.02 112.298 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.04 -21.63 63.13 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.448 2.765 . . . . 73.52 115.794 -170.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -102.95 -14.3 16.56 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.977 0.418 . . . . 51.33 111.934 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.5 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.7 mm100 -68.39 141.76 93.8 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 113.51 0.93 . . . . 74.51 113.51 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 71.5 Cg_exo -46.9 -39.06 24.31 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 124.78 3.654 . . . . 61.43 115.896 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -74.43 -31.87 62.45 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.374 -0.93 . . . . 72.14 110.791 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 62' ' ' ILE . 77.1 t -77.09 -38.77 28.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.96 -0.564 . . . . 72.31 112.308 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 11.0 pt-20 -55.9 -36.27 67.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 120.328 -0.549 . . . . 73.12 112.211 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -68.53 -51.19 45.75 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.925 0.343 . . . . 74.32 111.925 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.455 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 14.6 pt -63.4 -33.87 63.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.166 0.432 . . . . 75.13 112.166 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.516 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 66.6 mt -61.04 -46.84 95.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 N-CA-C 109.549 -0.537 . . . . 74.51 109.549 173.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 15.4 mm100 -57.67 -44.13 85.5 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.925 -0.398 . . . . 74.41 109.925 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -56.16 -48.75 75.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.247 -0.888 . . . . 74.14 110.014 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.636 HD11 HG13 ' A' ' 22' ' ' VAL . 83.1 mt -71.13 -31.56 67.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.317 -0.553 . . . . 73.11 112.236 177.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 53.4 mt-30 -66.84 -24.37 66.14 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 120.237 -0.585 . . . . 74.21 111.871 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 31.7 mmm180 . . . . . 0 C--N 1.318 -0.786 0 N-CA-C 109.709 -0.478 . . . . 75.35 109.709 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.409 -2.514 0 N-CA-C 108.439 -0.948 . . . . 64.12 108.439 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.411 ' SG ' HG12 ' A' ' 40' ' ' VAL . 51.9 m -91.62 179.1 5.74 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.944 0.72 . . . . 73.14 112.944 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.3 mt -100.71 -45.81 5.37 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.972 -1.013 . . . . 74.04 109.444 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.7 p -170.04 152.99 4.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 119.9 -0.72 . . . . 72.04 110.786 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.445 HG12 ' HB3' ' A' ' 50' ' ' CYS . 2.2 m -112.67 146.63 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 N-CA-C 105.612 -1.996 . . . . 63.34 105.612 171.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 10.3 t -98.42 178.77 4.93 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 108.802 -0.814 . . . . 74.43 108.802 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -43.83 -57.95 2.99 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.293 0.637 . . . . 51.24 110.087 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 38.5 ttpt -143.28 93.07 6.54 Favored Pre-proline 0 N--CA 1.421 -1.912 0 N-CA-C 108.597 -0.89 . . . . 64.31 108.597 171.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.603 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 5.1 Cg_endo -49.39 -76.12 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.857 3.038 . . . . 75.34 115.654 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.405 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -143.61 145.8 32.77 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 109.057 -0.72 . . . . 72.34 109.057 -177.388 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.405 ' O ' HG12 ' A' ' 21' ' ' ILE . 19.8 Cg_endo -61.7 139.48 81.01 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.177 1.918 . . . . 75.13 111.213 177.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.45 ' HA3' HD12 ' A' ' 61' ' ' ILE . . . -74.04 0.63 51.72 Favored Glycine 0 C--O 1.22 -0.728 0 CA-C-O 121.471 0.484 . . . . 73.43 113.327 -177.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -80.35 -20.5 44.02 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 123.14 0.576 . . . . 73.21 110.726 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 37.3 pt -104.76 10.31 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.216 0.45 . . . . 73.44 112.216 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.569 HG13 HD11 ' A' ' 65' ' ' LEU . 3.7 p -97.38 139.52 19.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.814 0.34 . . . . 72.22 111.788 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.675 ' HD2' ' ND2' ' A' ' 24' ' ' ASN . 0.8 OUTLIER -95.75 -55.89 2.86 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.833 -0.803 . . . . 62.15 108.833 -177.242 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.675 ' ND2' ' HD2' ' A' ' 23' ' ' ARG . 49.6 m-80 -135.07 167.6 20.66 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 109.066 -0.716 . . . . 64.32 109.066 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -144.04 165.35 28.04 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.371 -0.603 . . . . 74.31 109.371 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.465 ' HB2' HG22 ' A' ' 40' ' ' VAL . 36.1 m80 -133.9 118.53 18.03 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.011 -1.107 . . . . 75.42 108.011 172.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -84.16 101.63 11.99 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.652 -0.704 . . . . 74.12 109.239 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.593 HD21 ' SG ' ' A' ' 34' ' ' CYS . 6.9 tt -106.54 133.35 51.36 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.369 -0.832 . . . . 72.13 110.471 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -128.63 -176.54 3.87 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.702 -0.681 . . . . 54.12 110.144 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.7 mt -72.09 -22.2 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.589 -0.893 . . . . 64.31 108.589 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -63.44 -29.92 71.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.529 -0.76 . . . . 53.25 110.747 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -67.87 -39.16 83.75 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.027 -0.731 . . . . 74.0 109.027 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.74 58.96 0.23 Allowed Glycine 0 CA--C 1.498 -1.014 0 CA-C-N 115.187 -0.915 . . . . 70.22 110.868 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.593 ' SG ' HD21 ' A' ' 28' ' ' LEU . 61.4 m -141.91 136.62 30.63 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.626 -1.25 . . . . 75.34 107.626 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -76.06 -10.94 59.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.478 0.656 . . . . 75.32 110.647 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 p -121.36 101.39 43.94 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.372 -0.831 . . . . 75.15 109.903 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.14 130.17 10.98 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.797 1.665 . . . . 72.44 109.624 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 50' ' ' CYS . . . -168.11 148.72 4.97 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.73 0.3 . . . . 52.03 110.921 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.76 126.96 53.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.351 -0.611 . . . . 63.33 109.351 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.627 HG12 ' SG ' ' A' ' 50' ' ' CYS . 10.5 m -84.5 127.56 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 C-N-CA 120.171 -0.612 . . . . 42.54 109.464 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.446 ' CD1' HG21 ' A' ' 22' ' ' VAL . 9.3 m-85 -99.74 121.06 40.7 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.646 -0.707 . . . . 74.22 109.809 174.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.5 m -90.5 104.96 17.48 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.455 -0.942 . . . . 74.35 108.455 174.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 55.6 p -70.62 171.02 11.03 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.395 -0.366 . . . . 74.41 111.605 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 95.4 mt -67.99 -25.8 65.59 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.601 0.715 . . . . 74.41 109.106 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -64.62 -32.45 74.12 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.8 -1.091 . . . . 71.2 109.611 172.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.11 16.42 15.12 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 115.757 -0.656 . . . . 74.1 112.914 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -94.08 134.73 36.19 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.241 0.521 . . . . 75.53 110.951 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -90.77 116.46 28.64 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 107.37 -1.344 . . . . 43.01 107.37 170.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.6 tm? -138.02 143.86 40.77 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.695 -1.224 . . . . 63.12 107.695 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.627 ' SG ' HG12 ' A' ' 40' ' ' VAL . 30.8 m -94.69 143.2 26.63 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 115.19 1.552 . . . . 72.33 115.19 -177.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.603 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -125.6 163.09 40.95 Favored Pre-proline 0 N--CA 1.434 -1.265 0 CA-C-N 114.65 -1.159 . . . . 62.01 109.142 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 57.0 Cg_endo -70.76 110.38 2.74 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.123 1.882 . . . . 63.32 112.985 -174.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.75 -9.87 26.63 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 123.19 2.593 . . . . 72.12 114.676 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -101.04 -20.83 15.21 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.105 0.478 . . . . 51.3 111.308 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -69.3 130.12 91.25 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 112.795 0.665 . . . . 64.1 112.795 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.2 -36.21 36.13 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.109 3.206 . . . . 74.23 114.247 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.417 ' CE2' HG23 ' A' ' 58' ' ' VAL . 28.3 p-90 -64.8 -27.58 68.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 119.224 -0.991 . . . . 72.45 109.921 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 62' ' ' ILE . 69.7 t -86.16 -48.86 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.642 -0.708 . . . . 70.25 111.614 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.357 0.3 OUTLIER -61.9 -29.39 70.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.101 1.149 . . . . 73.44 114.101 -176.63 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -68.86 -43.09 76.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.765 0.317 . . . . 74.4 111.276 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.45 HD12 ' HA3' ' A' ' 19' ' ' GLY . 11.9 pt -71.72 -30.73 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 O-C-N 122.124 -0.36 . . . . 75.04 111.628 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.561 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 62.8 mt -56.76 -46.87 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.159 -0.473 . . . . 74.42 109.943 173.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 18.5 mm-40 -56.88 -41.9 78.87 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.114 0.566 . . . . 74.24 109.544 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 98.3 mtt180 -62.47 -38.93 91.74 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.58 -0.737 . . . . 71.22 111.492 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.569 HD11 HG13 ' A' ' 22' ' ' VAL . 84.5 mt -81.26 -26.06 36.1 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.676 0.251 . . . . 64.23 111.676 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.561 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 98.3 mt-30 -58.22 -20.53 42.38 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.59 0.959 . . . . 73.01 113.59 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 16.9 ptm180 . . . . . 0 CA--C 1.555 1.136 0 O-C-N 123.103 0.252 . . . . 75.31 111.298 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.556 ' HA ' HD13 ' A' ' 28' ' ' LEU . 27.2 p . . . . . 0 N--CA 1.412 -2.326 0 N-CA-C 106.593 -1.632 . . . . 72.12 106.593 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -101.98 175.23 5.61 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 118.436 -1.306 . . . . 70.42 110.625 -176.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.0 -64.86 1.06 Allowed 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.416 -0.587 . . . . 73.1 109.416 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -176.03 160.21 2.25 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 106.218 -1.771 . . . . 74.23 106.218 -178.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -98.87 160.04 3.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 118.722 -1.191 . . . . 71.23 109.422 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.0 t -106.15 179.47 4.26 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.416 -0.587 . . . . 63.14 109.416 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -40.48 -50.15 2.91 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.288 1.435 . . . . 74.3 110.458 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 ttpt -159.97 98.47 1.49 Allowed Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 107.662 -1.236 . . . . 75.1 107.662 169.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.661 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -42.36 -73.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.379 3.386 . . . . 55.11 116.622 -175.149 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.432 HG23 HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -143.69 167.86 14.36 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.219 -0.66 . . . . 72.33 109.219 -177.286 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.527 ' O ' HG12 ' A' ' 21' ' ' ILE . 38.6 Cg_exo -62.21 128.71 24.68 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.704 1.603 . . . . 55.53 109.495 171.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -71.49 1.33 28.86 Favored Glycine 0 C--N 1.301 -1.376 0 N-CA-C 114.336 0.494 . . . . 63.2 114.336 -175.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -94.35 -13.48 26.33 Favored 'General case' 0 C--N 1.285 -2.222 0 O-C-N 122.509 -0.406 . . . . 74.44 111.544 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 18' ' ' PRO . 38.9 pt -95.52 9.47 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.191 0.519 . . . . 72.22 111.205 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.589 HG21 ' CD1' ' A' ' 41' ' ' PHE . 3.1 p -96.9 141.27 15.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 115.949 -0.568 . . . . 61.2 111.842 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -105.44 -54.32 2.5 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.483 -0.932 . . . . 72.24 108.483 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -123.88 160.55 27.22 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.126 -0.694 . . . . 63.01 109.126 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.465 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 42.1 p90 -141.53 155.0 45.82 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.324 -0.991 . . . . 75.41 108.324 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -137.26 128.42 27.81 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.601 -0.518 . . . . 62.42 109.601 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -79.24 101.31 7.93 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 109.272 -0.64 . . . . 65.53 109.272 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.556 HD13 ' HA ' ' A' ' 8' ' ' CYS . 43.6 mt -98.92 131.0 45.33 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-O 121.665 0.745 . . . . 73.23 109.855 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.9 mt -132.59 178.23 7.01 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 114.877 -1.056 . . . . 52.44 108.815 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 25.3 mt -76.55 -29.5 18.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.442 -0.947 . . . . 61.12 108.442 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -67.83 -15.63 63.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.223 -0.899 . . . . 73.12 109.777 174.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -89.14 -43.2 11.21 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.924 -1.139 . . . . 75.44 107.924 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.8 -90.14 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 119.721 -1.228 . . . . 74.33 115.122 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 58.2 m -75.89 157.56 33.11 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.077 0.399 . . . . 72.15 112.077 -172.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -72.8 29.25 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.474 1.11 . . . . 71.42 113.702 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.4 p -137.4 102.9 8.74 Favored Pre-proline 0 C--N 1.3 -1.568 0 CA-C-O 121.395 0.617 . . . . 63.33 110.181 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -86.85 130.18 3.06 Favored 'Trans proline' 0 N--CA 1.438 -1.75 0 C-N-CA 121.941 1.76 . . . . 73.11 111.772 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.29 157.73 9.43 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.529 -0.759 . . . . 74.11 109.087 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.85 126.31 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 108.334 -0.987 . . . . 72.1 108.334 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 20.1 m -94.01 129.29 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.98 0 CA-C-O 121.609 0.718 . . . . 63.22 110.534 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.589 ' CD1' HG21 ' A' ' 22' ' ' VAL . 7.2 m-85 -93.86 118.16 31.08 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 114.958 -1.019 . . . . 72.1 111.897 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.4 m -81.36 105.45 12.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.436 -0.949 . . . . 70.34 108.436 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.1 p -76.11 174.28 10.25 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.699 0.285 . . . . 72.35 111.363 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 88.1 mt -62.52 -28.39 69.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.185 0.594 . . . . 53.54 110.307 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -69.52 -30.21 67.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.546 -0.752 . . . . 75.55 109.414 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.57 8.69 45.64 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.66 -0.7 . . . . 71.42 111.949 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -95.22 133.49 39.03 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 105.605 -1.998 . . . . 64.31 105.605 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 39.1 mt-30 -96.79 143.57 27.59 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.477 -0.935 . . . . 54.12 108.477 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 37.4 tp -135.91 150.35 49.3 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.215 -0.594 . . . . 73.52 109.881 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.2 m -77.47 122.18 24.86 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 123.547 0.53 . . . . 73.51 109.72 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.661 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.28 151.76 72.74 Favored Pre-proline 0 C--N 1.311 -1.083 0 C-N-CA 120.288 -0.565 . . . . 72.32 110.1 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.434 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 83.0 Cg_endo -74.98 110.31 3.09 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.778 2.319 . . . . 74.15 113.859 -173.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -67.94 -17.33 46.46 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.328 2.018 . . . . 65.03 111.887 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.96 -17.05 34.03 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.777 -0.647 . . . . 74.13 111.729 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.434 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.9 mm100 -84.81 127.49 64.79 Favored Pre-proline 0 C--N 1.317 -0.827 0 O-C-N 122.162 -0.336 . . . . 74.24 111.277 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -46.76 -37.87 21.81 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.608 3.539 . . . . 62.03 115.125 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.425 ' O ' HG12 ' A' ' 61' ' ' ILE . 41.8 p-90 -61.25 -35.4 77.17 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 120.784 -0.366 . . . . 75.45 110.752 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 62' ' ' ILE . 76.6 t -70.64 -41.65 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.806 -0.634 . . . . 75.41 111.244 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.2 mt-10 -58.09 -47.5 83.02 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 111.681 0.252 . . . . 62.33 111.681 -178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -64.03 -40.29 95.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.695 1.369 . . . . 61.13 114.695 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.453 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 10.7 pt -69.79 -35.69 66.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.34 -0.544 . . . . 65.32 111.507 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.465 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 56.9 mt -59.26 -49.55 83.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.356 -0.384 . . . . 75.14 110.517 173.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 18.5 mm-40 -56.19 -37.65 69.92 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.155 0.582 . . . . 72.34 110.125 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.562 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 20.2 ttm180 -68.08 -36.71 80.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.657 -0.701 . . . . 74.22 110.856 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.576 HD11 HG13 ' A' ' 22' ' ' VAL . 87.2 mt -76.13 -35.61 59.18 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 122.097 -0.377 . . . . 74.14 111.091 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 54.1 mt-30 -58.08 -19.15 29.8 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.983 1.475 . . . . 75.44 114.983 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 39.6 ptt180 . . . . . 0 C--N 1.319 -0.719 0 C-N-CA 120.232 -0.587 . . . . 74.12 111.731 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 24.6 p . . . . . 0 N--CA 1.434 -1.247 0 N-CA-C 107.039 -1.467 . . . . 62.14 107.039 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.533 ' SG ' HG12 ' A' ' 40' ' ' VAL . 1.7 t -121.87 -178.89 3.96 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 117.999 -1.48 . . . . 71.53 107.89 174.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tt -88.48 -67.74 0.81 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.117 -0.697 . . . . 73.52 109.117 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.7 m -168.55 149.07 4.65 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.215 -1.031 . . . . 32.3 108.215 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.433 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -102.49 158.66 4.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 119.144 -1.022 . . . . 54.45 108.323 178.235 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.1 t -103.21 178.47 4.55 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.077 -0.712 . . . . 72.22 109.077 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -46.64 -41.16 14.33 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.398 0.679 . . . . 70.4 111.544 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.5 ttpt -162.04 100.61 1.15 Allowed Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 107.249 -1.389 . . . . 72.35 107.249 170.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.66 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.5 Cg_endo -51.52 -82.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.889 3.059 . . . . 54.41 117.634 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.41 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -141.08 159.98 59.68 Favored Pre-proline 0 C--N 1.316 -0.878 0 O-C-N 121.964 -0.46 . . . . 41.13 110.257 -173.18 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.565 ' O ' HG12 ' A' ' 21' ' ' ILE . 78.1 Cg_exo -55.2 128.49 30.75 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.566 2.178 . . . . 75.42 110.691 173.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.464 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -79.71 0.46 81.79 Favored Glycine 0 C--N 1.307 -1.028 0 N-CA-C 115.15 0.82 . . . . 72.45 115.15 -174.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -99.17 -0.16 42.16 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.147 0.795 . . . . 71.55 113.147 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 18' ' ' PRO . 36.9 pt -101.27 10.25 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.667 0.746 . . . . 72.12 110.074 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 65' ' ' LEU . 3.1 p -94.44 138.98 19.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.287 -0.869 . . . . 72.53 111.336 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.09 -47.2 7.38 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.786 -0.82 . . . . 72.45 108.786 -175.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -149.93 160.5 43.55 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.048 -1.093 . . . . 73.54 108.048 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.3 168.26 19.51 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 117.973 0.352 . . . . 65.32 110.519 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.574 ' HB2' HG22 ' A' ' 40' ' ' VAL . 40.7 m80 -135.46 112.41 10.27 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.377 -1.342 . . . . 73.13 107.377 171.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -79.45 99.29 7.15 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.339 -1.356 . . . . 65.23 107.339 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.505 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -111.73 117.55 33.18 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.761 -0.654 . . . . 72.43 110.288 -170.067 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.8 mt -104.82 -176.07 2.97 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.497 -0.557 . . . . 74.25 109.497 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 63.3 mt -67.04 -36.24 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.909 0.862 . . . . 73.03 109.16 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -64.29 -24.17 67.56 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.484 -1.234 . . . . 72.52 110.276 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.48 -28.39 16.85 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.828 -0.624 . . . . 53.43 110.514 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.96 -106.76 0.65 Allowed Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 119.626 -1.273 . . . . 72.44 115.884 -173.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 33.6 m -118.32 179.68 4.04 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.993 -0.604 . . . . 73.32 109.496 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -55.22 -19.38 7.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.35 1.06 . . . . 71.41 112.377 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -103.14 106.79 52.85 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 121.114 0.483 . . . . 51.31 111.34 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -87.19 144.21 6.92 Favored 'Trans proline' 0 C--O 1.251 1.143 0 C-N-CA 122.576 2.184 . . . . 72.33 110.848 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.489 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -174.43 153.47 1.91 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.92 -0.4 . . . . 23.41 109.92 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.49 122.59 50.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.178 -1.416 . . . . 71.25 107.178 175.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.574 HG22 ' HB2' ' A' ' 26' ' ' HIS . 8.0 m -89.16 127.72 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.859 0 C-N-CA 119.566 -0.854 . . . . 52.12 109.426 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -98.13 121.54 40.18 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 115.302 -0.863 . . . . 73.33 110.702 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.0 m -86.35 103.42 14.91 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.819 -1.178 . . . . 74.1 107.819 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 50.0 p -70.97 171.69 10.36 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 116.201 -0.454 . . . . 64.32 110.833 -177.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 98.4 mt -60.96 -26.93 67.88 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.356 0.598 . . . . 60.22 109.775 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -71.65 -15.15 62.22 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 114.972 -1.013 . . . . 52.41 111.018 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.04 8.66 61.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.004 -0.617 . . . . 63.54 112.731 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -93.41 140.59 29.4 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 122.869 -0.195 . . . . 73.23 110.84 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -99.88 117.76 34.87 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.52 -0.918 . . . . 64.34 108.52 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -120.95 143.39 49.02 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.633 -0.877 . . . . 71.33 108.633 -174.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.534 ' N ' HD13 ' A' ' 49' ' ' LEU . 6.3 m -80.15 126.14 30.71 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 122.993 0.517 . . . . 72.24 111.17 -174.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.66 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -128.26 153.27 78.84 Favored Pre-proline 0 C--O 1.245 0.859 0 C-N-CA 120.907 -0.317 . . . . 74.12 110.989 175.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.484 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 72.0 Cg_endo -68.47 113.28 3.08 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.204 2.603 . . . . 73.33 113.024 -175.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 60.1 Cg_endo -72.24 -8.02 22.01 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.551 2.167 . . . . 73.15 114.205 -175.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -109.73 -0.51 18.48 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.3 0.572 . . . . 71.33 111.616 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.484 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 16.0 mm100 -86.34 135.97 36.02 Favored Pre-proline 0 C--N 1.314 -0.942 0 O-C-N 121.52 -0.737 . . . . 75.23 112.233 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.76 -36.76 26.7 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 124.697 3.598 . . . . 74.41 115.051 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -68.77 -32.48 72.26 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 120.343 -0.543 . . . . 60.42 110.685 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.662 ' O ' HG12 ' A' ' 62' ' ' ILE . 72.4 t -71.7 -48.99 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.831 -0.622 . . . . 72.14 111.997 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 9.3 pt-20 -55.69 -30.36 60.97 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.575 0.583 . . . . 71.23 112.575 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -73.02 -45.09 59.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.563 -0.29 . . . . 75.15 111.301 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.464 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 12.9 pt -71.71 -29.02 32.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 111.89 0.33 . . . . 71.41 111.89 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.662 HG12 ' O ' ' A' ' 58' ' ' VAL . 46.9 mm -56.49 -44.89 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.892 -0.781 . . . . 72.53 108.892 172.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 15.5 mm100 -59.1 -42.51 90.67 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.806 -0.634 . . . . 52.53 110.58 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -60.86 -46.59 90.0 Favored 'General case' 0 C--O 1.206 -1.201 0 O-C-N 124.143 0.902 . . . . 72.32 111.002 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 22' ' ' VAL . 86.8 mt -72.47 -34.11 67.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.253 -0.579 . . . . 72.25 111.897 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 50.7 mt-30 -61.5 -19.59 62.23 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 113.466 0.914 . . . . 74.24 113.466 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 120.945 0.403 . . . . 73.34 110.122 179.208 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.473 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 46.5 t . . . . . 0 N--CA 1.437 -1.113 0 N-CA-C 106.351 -1.722 . . . . 74.44 106.351 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.419 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 11.9 t -118.9 178.32 4.53 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 120.071 -0.652 . . . . 74.15 111.637 -173.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.403 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 83.4 mt -94.36 -53.9 3.75 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.105 -1.072 . . . . 75.03 108.105 174.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.9 t -177.19 -173.97 0.48 Allowed 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.131 -1.063 . . . . 63.23 108.131 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.78 167.67 25.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 106.939 -1.504 . . . . 61.43 106.939 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.2 t -105.52 178.28 4.61 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.781 -0.822 . . . . 75.1 108.781 175.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -53.02 -38.26 62.21 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.172 0.511 . . . . 74.41 111.139 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -159.2 93.42 1.82 Allowed Pre-proline 0 N--CA 1.425 -1.707 0 N-CA-C 108.014 -1.106 . . . . 73.54 108.014 173.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.2 Cg_endo -54.07 -86.24 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.882 3.055 . . . . 64.22 117.945 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.458 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -137.39 163.18 50.65 Favored Pre-proline 0 C--N 1.32 -0.698 0 O-C-N 121.865 -0.522 . . . . 72.35 110.565 -172.37 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.545 ' O ' HG12 ' A' ' 21' ' ' ILE . 38.0 Cg_exo -62.03 130.05 29.45 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.165 1.91 . . . . 74.13 110.853 175.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -71.95 1.6 30.85 Favored Glycine 0 C--N 1.307 -1.042 0 N-CA-C 114.32 0.488 . . . . 45.21 114.32 -177.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -87.32 -22.16 25.28 Favored 'General case' 0 N--CA 1.416 -2.128 0 O-C-N 122.529 -0.395 . . . . 74.43 110.692 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.5 pt -90.7 8.66 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 120.206 -0.598 . . . . 71.45 111.887 -176.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.588 HG13 HD11 ' A' ' 65' ' ' LEU . 2.6 p -92.94 132.51 36.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.22 0.533 . . . . 71.1 111.753 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -55.33 3.63 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.004 -1.11 . . . . 61.54 108.004 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -135.24 158.33 44.63 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.279 -1.008 . . . . 62.51 108.279 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -139.71 155.06 47.57 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.153 -0.619 . . . . 74.55 110.634 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.491 ' HB2' HG22 ' A' ' 40' ' ' VAL . 63.6 m170 -122.27 112.59 18.33 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.666 -1.235 . . . . 64.14 107.666 172.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -83.46 99.58 10.19 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.064 -0.717 . . . . 75.14 109.064 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.473 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 88.3 mt -106.58 143.26 34.95 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.8 -0.636 . . . . 74.51 111.798 -176.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.6 mt -140.45 175.85 9.26 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.876 -1.056 . . . . 62.24 109.639 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 46.4 mt -76.41 -19.79 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.961 -1.126 . . . . 72.22 107.961 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -60.82 -36.58 79.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.467 -1.242 . . . . 74.51 109.276 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.99 -41.06 78.33 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.595 -0.729 . . . . 70.03 109.274 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.96 -36.91 1.29 Allowed Glycine 0 CA--C 1.495 -1.197 0 C-N-CA 120.741 -0.742 . . . . 74.42 112.361 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 49.3 t -69.56 127.94 34.76 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.002 -1.11 . . . . 74.43 108.002 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -84.43 1.62 44.59 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.902 1.445 . . . . 62.24 114.902 -170.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -110.29 95.85 23.85 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 108.598 -0.89 . . . . 70.32 108.598 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -76.52 129.11 10.76 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 121.643 1.562 . . . . 72.15 111.415 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.536 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -171.0 151.3 3.25 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.231 -0.895 . . . . 74.11 109.728 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.22 119.6 47.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.463 -1.31 . . . . 74.23 107.463 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 26' ' ' HIS . 2.6 m -83.46 119.35 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.565 0 C-N-CA 119.294 -0.963 . . . . 71.43 108.529 -178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 22' ' ' VAL . 11.1 m-85 -91.28 111.53 23.05 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.377 -0.828 . . . . 75.22 110.643 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.4 m -80.13 100.4 8.22 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 106.99 -1.485 . . . . 71.14 106.99 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 49.5 p -68.1 173.94 4.25 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.964 -0.562 . . . . 72.13 111.357 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 93.5 mt -61.26 -29.46 69.86 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.282 0.563 . . . . 71.32 110.728 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -73.14 -16.61 61.44 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.378 -0.828 . . . . 74.24 110.227 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.6 -8.39 66.21 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 116.247 -0.433 . . . . 54.24 112.25 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -77.34 127.77 33.15 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 107.128 -1.434 . . . . 71.23 107.128 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -85.15 123.77 31.05 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.723 -0.843 . . . . 71.24 108.723 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 50' ' ' CYS . 4.3 tt -135.54 133.53 38.5 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 106.727 -1.583 . . . . 74.0 106.727 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.496 ' N ' HD23 ' A' ' 49' ' ' LEU . 21.4 m -94.94 145.43 24.93 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 114.21 1.189 . . . . 72.44 114.21 -169.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -125.64 158.73 63.91 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 115.113 -0.949 . . . . 54.44 110.515 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 66.7 Cg_endo -69.49 108.11 1.96 Allowed 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.421 2.08 . . . . 65.2 112.569 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 71.7 Cg_endo -74.22 -10.37 22.49 Favored 'Trans proline' 0 N--CA 1.473 0.274 0 C-N-CA 123.113 2.542 . . . . 73.14 113.824 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -96.32 -16.19 21.46 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.571 0.701 . . . . 75.11 109.617 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.463 ' OE1' ' HB2' ' A' ' 52' ' ' PRO . 1.8 mp0 -82.08 144.44 50.97 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 113.497 0.925 . . . . 50.44 113.497 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.96 -39.97 81.76 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 124.548 3.498 . . . . 63.42 115.013 -174.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -65.31 -26.7 68.17 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.231 -0.587 . . . . 72.43 110.473 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 62' ' ' ILE . 71.8 t -81.22 -40.11 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.823 -0.626 . . . . 75.3 111.852 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.464 ' HG3' ' HD2' ' A' ' 60' ' ' ARG . 13.4 pt-20 -61.26 -37.07 81.8 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.775 0.657 . . . . 72.52 112.775 -176.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.464 ' HD2' ' HG3' ' A' ' 59' ' ' GLU . 3.2 mpt_? -69.26 -38.84 78.62 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 120.19 -0.604 . . . . 61.4 112.165 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.47 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 12.6 pt -71.42 -33.22 49.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 120.804 -0.358 . . . . 73.33 111.829 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 58' ' ' VAL . 67.7 mt -61.88 -47.02 95.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 N-CA-C 109.292 -0.633 . . . . 75.23 109.292 172.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 84.1 mm-40 -58.34 -41.25 84.2 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.167 -0.47 . . . . 74.23 111.42 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -60.23 -41.27 92.76 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.035 -0.529 . . . . 63.23 111.191 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.588 HD11 HG13 ' A' ' 22' ' ' VAL . 90.6 mt -75.25 -28.83 60.01 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.27 -0.572 . . . . 74.35 111.043 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 52.8 mt-30 -71.1 -35.09 71.67 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 112.011 0.374 . . . . 61.24 112.011 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? . . . . . 0 N--CA 1.433 -1.305 0 C-N-CA 124.128 0.971 . . . . 74.23 111.867 -177.727 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.508 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 4.9 p . . . . . 0 N--CA 1.43 -1.463 0 N-CA-C 110.138 -0.319 . . . . 74.33 110.138 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.542 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -93.37 -175.75 3.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.505 -0.924 . . . . 73.02 108.505 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.07 -59.06 1.94 Allowed 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.476 0.547 . . . . 63.1 112.476 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.8 m -162.27 141.71 9.52 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.838 -0.43 . . . . 75.42 109.838 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.7 m -98.94 152.03 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.255 -1.017 . . . . 74.33 108.255 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 t -94.15 178.39 5.66 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.161 -0.681 . . . . 74.13 109.161 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -45.27 -46.48 12.62 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.948 0.899 . . . . 64.33 110.597 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 5.0 ttmp? -160.2 99.2 1.43 Allowed Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.017 -1.105 . . . . 70.25 108.017 169.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.5 Cg_endo -51.51 -81.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.351 0 C-N-CA 123.46 2.774 . . . . 51.4 116.785 -175.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.444 HD11 ' HB2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -147.95 152.46 40.37 Favored Pre-proline 0 C--N 1.322 -0.628 0 O-C-N 121.943 -0.473 . . . . 75.43 110.611 -174.116 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.475 ' O ' HG12 ' A' ' 21' ' ' ILE . 18.7 Cg_endo -61.97 141.2 88.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.444 2.096 . . . . 74.12 111.32 174.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.411 ' HA3' HD12 ' A' ' 61' ' ' ILE . . . -79.86 1.46 78.78 Favored Glycine 0 C--N 1.309 -0.952 0 C-N-CA 121.434 -0.413 . . . . 72.15 113.568 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.45 ' CE1' ' HG2' ' A' ' 64' ' ' ARG . 98.4 m-85 -94.6 -0.6 54.36 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 122.226 -0.573 . . . . 71.11 111.553 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.507 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 35.4 pt -112.41 5.13 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.279 0.561 . . . . 74.32 110.728 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.423 HG13 HD21 ' A' ' 65' ' ' LEU . 2.7 p -90.78 135.04 27.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.997 -0.547 . . . . 63.24 111.261 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.39 -55.6 3.82 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.775 -0.824 . . . . 70.44 108.775 -175.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -140.45 164.33 30.43 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.361 0.664 . . . . 64.43 109.626 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.49 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 8.6 p90 -143.85 167.98 21.03 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.743 0.306 . . . . 73.5 110.51 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -141.96 137.09 30.99 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.155 -1.054 . . . . 65.32 108.155 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -98.6 103.87 15.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 123.448 0.467 . . . . 72.41 109.868 -173.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 2.3 mm? -103.74 128.55 51.1 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.921 -0.77 . . . . 73.44 108.921 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.9 mt -131.95 179.59 5.99 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.225 0.536 . . . . 63.52 111.278 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.7 mt -77.99 -19.0 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.689 -1.226 . . . . 71.25 107.689 173.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.49 -34.33 72.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.07 -0.968 . . . . 61.34 109.845 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -68.16 -34.22 75.92 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.424 -0.807 . . . . 71.21 109.927 176.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.34 -17.51 3.54 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.356 -0.838 . . . . 75.12 112.471 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.22 161.69 26.61 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.675 1.361 . . . . 75.45 114.675 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -81.33 -15.49 55.2 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.939 -1.028 . . . . 72.2 111.282 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -134.12 123.81 17.04 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-O 120.971 0.415 . . . . 74.2 111.958 -174.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -85.94 129.39 3.43 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 121.794 1.663 . . . . 74.34 109.556 172.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.55 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -162.77 136.86 6.27 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.121 -0.49 . . . . 54.42 109.742 -176.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.99 124.51 52.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.305 -1.369 . . . . 74.44 107.305 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.542 HG12 ' SG ' ' A' ' 9' ' ' CYS . 18.8 m -84.79 123.17 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.548 0 CA-C-O 121.854 0.835 . . . . 70.5 110.178 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.444 ' HB2' HD11 ' A' ' 17' ' ' ILE . 15.1 m-85 -97.97 117.88 33.3 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 114.757 -1.111 . . . . 75.41 109.804 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 94.4 m -87.1 102.08 14.1 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.746 -0.835 . . . . 75.44 108.746 174.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.5 p -70.97 166.79 20.53 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.373 -0.376 . . . . 75.34 110.511 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 90.0 mt -60.47 -25.58 66.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.525 0.678 . . . . 72.0 110.353 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -62.75 -24.85 67.9 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.127 -0.942 . . . . 64.1 110.644 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.44 15.97 36.07 Favored Glycine 0 CA--C 1.505 -0.551 0 C-N-CA 121.288 -0.482 . . . . 72.15 111.911 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 42' ' ' THR . 34.3 mmt180 -99.56 139.21 35.54 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 120.665 0.269 . . . . 75.51 111.007 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -95.79 129.41 43.03 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.996 -1.853 . . . . 71.33 105.996 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.2 tp -137.57 144.62 42.13 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.463 -0.495 . . . . 50.2 110.148 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 9.7 m -80.16 128.57 33.67 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 123.494 0.496 . . . . 71.22 110.632 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.539 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -131.86 154.78 81.86 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 109.208 -0.664 . . . . 54.12 109.208 172.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.421 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 95.8 Cg_endo -77.31 107.82 2.48 Favored 'Trans proline' 0 CA--C 1.559 1.758 0 C-N-CA 122.643 2.229 . . . . 72.21 113.924 -173.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.55 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.9 Cg_endo -68.61 -19.8 41.62 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.135 2.557 . . . . 72.22 114.882 -173.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -96.87 2.7 52.04 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.601 0.715 . . . . 73.42 110.799 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.421 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.3 mm100 -95.06 143.14 25.61 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 112.291 0.478 . . . . 74.05 112.291 -178.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.427 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 10.3 Cg_endo -50.27 -46.79 27.07 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 124.427 3.418 . . . . 62.0 114.625 -175.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.497 ' O ' HG12 ' A' ' 61' ' ' ILE . 33.8 p-90 -63.33 -30.6 71.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 120.488 -0.485 . . . . 73.44 110.832 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 62' ' ' ILE . 72.7 t -81.56 -44.07 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.198 -0.455 . . . . 71.13 111.489 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.427 ' HG3' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -64.47 -24.63 67.69 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 120.302 -0.559 . . . . 71.35 111.513 -177.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -79.64 -29.63 41.04 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 115.838 -0.619 . . . . 74.25 110.731 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 57' ' ' TRP . 8.3 pt -86.09 -35.31 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.703 1.001 . . . . 64.31 113.703 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 58' ' ' VAL . 67.9 mt -53.01 -41.63 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 120.741 0.305 . . . . 74.33 110.809 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -59.99 -35.33 74.79 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.942 0.719 . . . . 74.13 112.942 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.45 ' HG2' ' CE1' ' A' ' 20' ' ' TYR . 7.1 mpt_? -57.31 -45.98 83.67 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.05 0.452 . . . . 60.02 110.316 174.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.49 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 3.5 mm? -68.1 -43.35 78.66 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.697 -0.683 . . . . 74.32 110.252 176.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -59.91 -41.71 92.3 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 115.61 -0.723 . . . . 74.23 112.268 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . 0.263 4.2 ppt_? . . . . . 0 C--O 1.217 -0.641 0 N-CA-C 113.365 0.876 . . . . 71.33 113.365 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.415 ' HA ' HD12 ' A' ' 28' ' ' LEU . 26.3 p . . . . . 0 N--CA 1.411 -2.381 0 CA-C-O 120.783 0.325 . . . . 73.55 110.534 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 38' ' ' ALA . 75.6 m -61.0 145.86 49.19 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 115.74 1.756 . . . . 43.33 115.74 -171.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -90.81 -54.51 3.94 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 105.315 -2.106 . . . . 62.24 105.315 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.3 m -165.6 174.65 9.63 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 108.469 -0.937 . . . . 63.12 108.469 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.419 HG12 ' CB ' ' A' ' 50' ' ' CYS . 2.2 m -135.01 157.57 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.389 -1.708 . . . . 74.13 106.389 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.494 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 10.1 t -102.3 177.45 4.87 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.315 -1.365 . . . . 63.21 107.315 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -47.3 -67.02 0.32 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.596 0.634 . . . . 75.3 111.739 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 40.2 ttmt -132.49 85.91 46.79 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 119.749 -0.78 . . . . 72.42 109.166 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.534 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 6.7 Cg_endo -47.01 -80.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 124.75 3.633 . . . . 52.14 118.166 -175.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.429 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -138.45 156.83 73.2 Favored Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 121.916 -0.49 . . . . 70.22 111.634 -172.329 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.464 ' O ' HG12 ' A' ' 21' ' ' ILE . 27.0 Cg_endo -64.99 136.61 49.13 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.722 2.281 . . . . 73.44 111.486 174.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.454 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -77.0 1.45 63.32 Favored Glycine 0 C--N 1.31 -0.909 0 CA-C-N 115.936 -0.575 . . . . 64.51 113.631 -178.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -83.73 -24.84 31.0 Favored 'General case' 0 N--CA 1.414 -2.24 0 O-C-N 122.301 -0.529 . . . . 75.33 110.933 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 18' ' ' PRO . 36.5 pt -90.15 2.01 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 120.353 -0.539 . . . . 75.23 111.699 -177.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.574 HG13 HD11 ' A' ' 65' ' ' LEU . 3.0 p -93.24 134.01 32.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 121.207 0.527 . . . . 53.1 111.526 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.08 -47.35 7.88 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.542 -0.91 . . . . 72.13 108.542 -175.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.46 ' O ' ' HB ' ' A' ' 42' ' ' THR . 10.3 p30 -145.84 157.99 43.88 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.417 -0.957 . . . . 75.51 108.417 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -128.58 152.47 48.28 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.941 -0.763 . . . . 73.2 108.941 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.536 ' HB2' HG22 ' A' ' 40' ' ' VAL . 27.9 m170 -120.63 112.34 18.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.218 -1.401 . . . . 74.42 107.218 172.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -84.39 103.47 13.58 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.675 -0.861 . . . . 70.2 108.675 -175.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 8' ' ' CYS . 79.5 mt -109.39 137.93 46.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.45 0.643 . . . . 73.14 111.939 -175.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.1 mt -141.6 178.75 7.24 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.14 -0.936 . . . . 74.12 110.142 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 34' ' ' CYS . 49.0 mt -77.79 -30.27 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.541 -1.281 . . . . 74.55 107.541 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -61.52 -25.92 67.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.051 -0.977 . . . . 72.05 109.999 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -83.78 -56.3 3.78 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.375 -1.342 . . . . 75.32 107.375 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.6 71.72 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.373 -0.918 . . . . 62.41 113.65 173.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.438 ' O ' HG12 ' A' ' 30' ' ' ILE . 49.9 t -161.18 151.97 18.26 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.77 -1.567 . . . . 62.32 106.77 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -74.93 -24.42 58.49 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.885 0.374 . . . . 63.31 111.995 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.53 108.08 47.9 Favored Pre-proline 0 C--N 1.3 -1.568 0 CA-C-O 121.429 0.633 . . . . 65.31 111.223 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -84.98 130.68 4.18 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.388 2.058 . . . . 55.31 111.628 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.642 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -176.42 164.12 2.56 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 124.046 0.938 . . . . 65.1 108.862 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.34 127.98 56.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 109.758 -0.46 . . . . 60.3 109.758 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.689 HG12 ' SG ' ' A' ' 50' ' ' CYS . 3.2 m -88.81 127.9 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 N-CA-C 108.254 -1.017 . . . . 60.24 108.254 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -97.94 113.0 24.72 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 116.08 -0.509 . . . . 65.34 110.601 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 24' ' ' ASN . 96.9 m -80.48 101.91 9.37 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.484 -0.78 . . . . 73.23 108.962 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.6 p -73.43 170.52 14.93 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.328 -0.396 . . . . 74.43 110.873 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.3 mt -57.87 -27.98 63.75 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.289 0.636 . . . . 65.24 112.622 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.3 tpp180 -73.02 -20.79 60.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.915 0.388 . . . . 62.3 110.707 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.96 40.42 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.902 -0.879 . . . . 51.22 110.902 -176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -98.57 133.05 43.46 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.634 -1.617 . . . . 70.32 106.634 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -99.44 130.5 45.71 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.943 -0.762 . . . . 74.15 108.943 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -136.8 138.61 41.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.903 -1.517 . . . . 72.01 106.903 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.689 ' SG ' HG12 ' A' ' 40' ' ' VAL . 91.0 m -94.83 147.59 23.2 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 114.872 1.434 . . . . 73.43 114.872 -173.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.534 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -130.24 163.03 50.63 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-N 114.908 -1.042 . . . . 62.21 109.847 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 88.9 Cg_endo -78.72 109.85 2.69 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 122.171 1.914 . . . . 73.24 113.018 -175.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 65.8 Cg_endo -70.04 -18.62 35.6 Favored 'Trans proline' 0 N--CA 1.483 0.886 0 C-N-CA 122.924 2.416 . . . . 72.14 113.232 -174.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.18 -7.98 54.54 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.439 0.638 . . . . 71.34 109.865 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -90.08 135.21 30.32 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-O 121.17 0.51 . . . . 73.21 111.309 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.408 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 11.8 Cg_endo -54.89 -35.85 90.17 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 124.341 3.361 . . . . 74.21 115.32 -175.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.466 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 37.9 p-90 -63.1 -30.49 71.63 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.88 0.371 . . . . 74.51 111.047 -177.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 62' ' ' ILE . 69.1 t -76.59 -36.62 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.076 -0.511 . . . . 64.13 110.89 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 56' ' ' PRO . 38.3 mt-10 -56.36 -45.02 80.66 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.035 0.445 . . . . 53.43 110.551 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.552 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 4.1 mmp_? -57.68 -51.07 71.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.246 -0.888 . . . . 75.53 111.423 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.454 HG21 ' HA3' ' A' ' 19' ' ' GLY . 13.1 pt -70.46 -33.2 52.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 113.335 0.865 . . . . 62.32 113.335 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 58' ' ' VAL . 60.1 mt -60.43 -45.56 96.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 109.459 -0.571 . . . . 71.32 109.459 173.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -57.6 -42.27 82.9 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.313 -0.403 . . . . 61.31 111.322 176.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 60' ' ' ARG . 89.4 mtt180 -59.23 -38.8 80.86 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.92 -0.582 . . . . 73.51 111.718 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.574 HD11 HG13 ' A' ' 22' ' ' VAL . 89.2 mt -79.41 -33.89 42.29 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.309 0.485 . . . . 75.43 112.309 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -68.79 -41.5 78.65 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 120.452 -0.499 . . . . 71.52 112.065 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 121.041 0.448 . . . . 62.43 110.833 179.714 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.402 ' HA ' HD13 ' A' ' 28' ' ' LEU . 27.3 p . . . . . 0 N--CA 1.403 -2.812 0 N-CA-C 104.349 -2.463 . . . . 65.21 104.349 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.24 -175.75 3.76 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 117.796 -1.562 . . . . 73.21 110.227 -175.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.2 mt -98.41 -64.69 1.02 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 120.903 0.382 . . . . 72.4 110.709 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.1 t -176.03 153.07 1.26 Allowed 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.146 -1.428 . . . . 65.23 107.146 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.432 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -106.98 160.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 119.154 -1.019 . . . . 51.44 110.021 -176.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -106.24 179.59 4.22 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.567 -0.901 . . . . 72.52 108.567 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -42.62 -57.27 2.77 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.904 0.881 . . . . 75.3 109.677 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 ttpt -145.85 97.59 4.55 Favored Pre-proline 0 N--CA 1.428 -1.543 0 N-CA-C 108.4 -0.963 . . . . 74.41 108.4 170.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.595 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 2.6 Cg_endo -39.62 -73.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.712 3.608 . . . . 62.35 116.015 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.401 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -142.38 158.02 61.66 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 107.448 -1.316 . . . . 71.41 107.448 -177.563 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' O ' HG12 ' A' ' 21' ' ' ILE . 17.9 Cg_endo -63.12 130.78 29.99 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 121.649 1.566 . . . . 72.34 110.558 174.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.524 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -72.26 2.01 30.95 Favored Glycine 0 C--N 1.303 -1.264 0 N-CA-C 115.029 0.772 . . . . 62.43 115.029 -174.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.76 -3.71 38.49 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 112.495 0.554 . . . . 75.25 112.495 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.523 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 39.6 pt -103.81 6.4 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 121.379 0.609 . . . . 71.32 110.378 177.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 41' ' ' PHE . 5.1 p -91.63 143.46 11.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.794 -0.639 . . . . 63.52 111.582 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.409 ' HE ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -99.88 -56.46 2.37 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.949 -1.13 . . . . 65.52 107.949 -178.224 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -134.21 166.03 23.74 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.738 -0.838 . . . . 71.43 108.738 -176.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -143.61 161.13 39.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.821 -0.437 . . . . 64.51 109.821 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.429 ' HB2' HG22 ' A' ' 40' ' ' VAL . 38.4 m80 -137.68 122.58 18.91 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 110.145 -0.316 . . . . 74.13 110.145 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -75.8 98.19 4.09 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 123.236 0.335 . . . . 74.12 110.16 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 8' ' ' CYS . 69.5 mt -97.14 134.2 40.79 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-O 121.887 0.851 . . . . 72.44 110.249 177.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.6 mt -125.93 -178.53 4.32 Favored 'General case' 0 C--N 1.256 -3.471 0 N-CA-C 106.725 -1.583 . . . . 70.24 106.725 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.469 HG23 ' HA ' ' A' ' 35' ' ' ARG . 68.2 mt -63.85 -37.88 80.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 120.312 -0.555 . . . . 64.23 109.798 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.471 ' HE2' ' HB2' ' A' ' 31' ' ' LYS . 12.1 ptmm? -59.87 -31.88 70.19 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 114.264 1.209 . . . . 62.42 114.264 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -111.92 -5.35 14.35 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.962 0.41 . . . . 72.25 111.259 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.77 -124.32 3.43 Favored Glycine 0 N--CA 1.417 -2.609 0 CA-C-N 115.857 -0.611 . . . . 25.33 112.726 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 84.7 m -118.01 -87.24 0.63 Allowed 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.398 -0.401 . . . . 73.14 110.404 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.469 ' HA ' HG23 ' A' ' 30' ' ' ILE . 35.9 ttm180 -143.23 15.18 1.86 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.175 0.988 . . . . 71.24 108.824 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 p -127.83 117.85 20.94 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 115.302 -0.863 . . . . 72.02 110.265 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.97 130.17 2.1 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 121.929 1.753 . . . . 60.52 110.491 174.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -171.52 154.79 3.9 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.94 -0.763 . . . . 73.13 108.94 -177.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.25 125.43 52.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.5 -0.926 . . . . 54.33 108.5 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 26' ' ' HIS . 16.4 m -90.12 128.35 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.008 0 C-N-CA 119.643 -0.823 . . . . 73.02 109.308 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CD1' HG21 ' A' ' 22' ' ' VAL . 15.3 m-85 -95.58 125.52 40.23 Favored 'General case' 0 C--N 1.272 -2.788 0 CA-C-N 115.358 -0.837 . . . . 73.11 110.177 175.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.4 m -93.45 103.65 15.84 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.922 -1.14 . . . . 71.3 107.922 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 71.1 p -70.0 174.36 5.45 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.35 -0.386 . . . . 54.35 111.248 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 95.3 mt -61.2 -27.39 68.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.52 0.676 . . . . 52.41 109.724 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -67.57 -28.4 67.74 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.718 1.207 . . . . 55.14 110.904 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.08 16.59 40.53 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 120.79 -0.719 . . . . 65.21 111.424 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.62 138.39 31.55 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.436 -1.32 . . . . 64.45 107.436 -177.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -91.97 121.18 33.32 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.79 -1.189 . . . . 75.41 107.79 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.483 HD13 ' N ' ' A' ' 50' ' ' CYS . 0.5 OUTLIER -129.67 141.51 50.9 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.363 -0.977 . . . . 73.2 108.363 -178.095 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.483 ' N ' HD13 ' A' ' 49' ' ' LEU . 7.9 m -78.06 129.97 35.87 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.998 0.519 . . . . 64.41 111.081 -173.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.595 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -136.98 157.3 74.94 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 110.037 -0.357 . . . . 61.52 110.037 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.8 109.27 1.97 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.376 2.051 . . . . 71.12 112.798 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 42.5 Cg_endo -67.0 -18.76 52.11 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.833 2.355 . . . . 74.21 113.91 -174.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -96.51 3.66 52.56 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.465 -0.494 . . . . 72.2 112.286 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -97.57 139.24 21.27 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 120.42 -0.512 . . . . 74.4 112.315 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.508 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 83.6 Cg_exo -47.36 -42.81 27.63 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 124.441 3.427 . . . . 75.22 114.55 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -62.52 -27.3 69.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.357 -0.537 . . . . 54.12 110.86 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.667 ' O ' HG12 ' A' ' 62' ' ' ILE . 75.4 t -81.75 -50.22 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.878 -0.601 . . . . 64.1 111.264 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.508 ' HG3' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -57.23 -27.01 61.64 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.832 0.678 . . . . 64.21 112.832 -176.799 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -73.04 -49.66 27.45 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.746 -0.661 . . . . 74.51 110.33 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.524 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.2 pt -71.7 -28.08 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.911 -0.586 . . . . 73.43 111.663 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 58' ' ' VAL . 41.0 mm -54.45 -52.76 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.851 -0.613 . . . . 72.14 109.902 173.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -56.58 -38.05 71.46 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.386 0.612 . . . . 71.22 110.3 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.26 -38.4 90.19 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.954 -1.021 . . . . 61.53 109.146 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.546 HD11 HG13 ' A' ' 22' ' ' VAL . 88.3 mt -79.73 -36.94 36.61 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 116.63 -0.259 . . . . 73.52 111.149 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -55.84 -20.28 14.79 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 114.054 1.131 . . . . 74.51 114.054 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 . . . . . 0 CA--C 1.555 1.139 0 N-CA-C 109.539 -0.541 . . . . 61.04 109.539 178.337 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 27.9 p . . . . . 0 N--CA 1.431 -1.412 0 N-CA-C 112.474 0.546 . . . . 72.43 112.474 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.586 ' SG ' HG12 ' A' ' 40' ' ' VAL . 91.6 m -57.86 150.81 19.35 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 116.47 2.026 . . . . 62.52 116.47 -174.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -84.25 -63.98 1.24 Allowed 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.867 -1.515 . . . . 75.13 108.13 172.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -167.15 175.72 7.29 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 106.124 -1.806 . . . . 54.04 106.124 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 13' ' ' THR . 2.2 m -133.91 161.25 41.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.485 -1.302 . . . . 73.12 107.485 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.7 t -98.78 178.06 5.09 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.127 -1.064 . . . . 61.43 108.127 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -50.5 -60.73 2.72 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.007 0.523 . . . . 72.33 110.769 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 4.8 ttmp? -139.85 86.54 13.46 Favored Pre-proline 0 N--CA 1.428 -1.548 0 N-CA-C 109.367 -0.605 . . . . 71.22 109.367 174.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 7.5 Cg_endo -47.94 -78.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.463 0 C-N-CA 124.565 3.51 . . . . 74.3 117.303 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.405 ' H ' HD13 ' A' ' 17' ' ' ILE . 0.2 OUTLIER -141.32 162.83 45.43 Favored Pre-proline 0 C--N 1.32 -0.701 0 O-C-N 121.791 -0.568 . . . . 65.42 110.365 -175.142 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.599 ' O ' HG12 ' A' ' 21' ' ' ILE . 36.8 Cg_exo -63.05 130.21 28.28 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.135 1.89 . . . . 60.23 110.704 174.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -73.69 2.04 42.17 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 116.339 -0.391 . . . . 65.31 113.946 -176.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -98.23 0.12 45.14 Favored 'General case' 0 N--CA 1.417 -2.121 0 O-C-N 122.133 -0.628 . . . . 72.31 111.52 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 18' ' ' PRO . 33.7 pt -106.71 9.22 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.452 0.644 . . . . 71.22 110.136 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.632 HG13 HD11 ' A' ' 65' ' ' LEU . 2.9 p -96.59 134.94 32.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.733 -0.667 . . . . 74.31 111.817 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.571 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -91.15 -56.02 3.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.73 -0.841 . . . . 74.51 108.73 -176.411 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.571 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 18.1 m120 -130.17 157.43 42.48 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-N 115.89 -0.596 . . . . 71.31 109.445 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -139.65 152.31 46.65 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.19 -0.67 . . . . 71.31 109.19 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.42 ' HB2' HG22 ' A' ' 40' ' ' VAL . 34.3 m170 -122.97 121.72 36.79 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.049 -1.463 . . . . 73.34 107.049 174.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -93.93 114.3 26.49 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 109.607 -0.516 . . . . 74.4 109.607 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.579 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 4.0 mm? -110.23 126.92 54.65 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 116.262 -0.426 . . . . 74.25 111.608 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.7 mt -126.83 176.96 6.89 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.833 -0.802 . . . . 60.53 108.833 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 57.1 mt -74.11 -20.07 17.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 107.701 -1.222 . . . . 75.33 107.701 176.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -58.79 -30.42 67.57 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.726 -1.124 . . . . 73.23 110.071 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.05 -42.45 47.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.597 -0.729 . . . . 74.03 109.988 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.54 -44.89 0.64 Allowed Glycine 0 CA--C 1.503 -0.709 0 C-N-CA 120.458 -0.877 . . . . 74.13 113.039 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 63.4 m -66.86 141.47 57.66 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 110.263 -0.273 . . . . 62.1 110.263 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -79.23 3.44 17.9 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.194 0.521 . . . . 73.34 112.057 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.31 97.94 49.44 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.821 -0.627 . . . . 74.45 110.251 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -80.65 128.96 7.06 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 121.255 1.303 . . . . 63.22 110.137 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.594 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -173.83 161.85 3.88 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.145 0.578 . . . . 52.24 109.825 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 50' ' ' CYS . 7.9 p -108.59 128.23 64.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 109.381 -0.6 . . . . 75.22 109.381 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.586 HG12 ' SG ' ' A' ' 9' ' ' CYS . 1.4 m -86.3 129.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 107.303 -1.369 . . . . 63.33 107.303 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -104.68 116.65 32.42 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 116.567 -0.288 . . . . 70.21 111.331 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.5 m -85.24 101.57 12.62 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.284 -1.006 . . . . 61.24 108.284 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 63.4 p -73.97 168.67 19.01 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.258 -0.428 . . . . 65.03 110.981 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 92.2 mt -59.52 -29.05 67.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.121 0.568 . . . . 73.44 111.117 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -71.24 -16.37 62.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.493 -0.776 . . . . 71.41 110.78 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.75 15.83 44.52 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.261 -0.495 . . . . 63.11 112.306 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -94.87 140.06 30.45 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 110.523 -0.177 . . . . 74.22 110.523 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -104.12 109.83 21.78 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.89 -0.595 . . . . 73.12 109.503 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.4 tp -130.03 129.82 44.16 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.756 -0.657 . . . . 73.24 109.263 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.576 ' SG ' HG12 ' A' ' 40' ' ' VAL . 75.4 m -84.48 147.41 27.1 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 113.682 0.993 . . . . 71.35 113.682 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.589 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.31 160.55 57.07 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 115.103 -0.953 . . . . 64.33 110.169 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 72.9 Cg_endo -71.98 108.11 2.38 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.194 1.929 . . . . 75.52 111.936 -175.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.594 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 67.3 Cg_endo -68.35 -30.41 30.14 Favored 'Trans proline' 0 N--CA 1.473 0.265 0 C-N-CA 123.089 2.526 . . . . 64.45 113.388 -171.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -78.4 -26.59 46.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.228 -0.442 . . . . 72.53 111.386 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -66.34 138.25 95.79 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 116.122 -0.49 . . . . 70.42 112.146 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.443 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 78.0 Cg_exo -53.45 -38.66 83.24 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 124.011 3.141 . . . . 34.32 114.699 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.466 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 37.0 p-90 -64.86 -29.96 70.94 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 120.469 -0.493 . . . . 74.13 111.116 -175.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 62' ' ' ILE . 72.3 t -80.07 -30.12 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 116.115 -0.493 . . . . 70.31 111.109 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.9 mt-10 -56.71 -49.73 74.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.562 -0.29 . . . . 74.53 110.715 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -61.52 -45.52 93.86 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.179 -0.464 . . . . 73.31 112.208 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.5 HG21 ' HA3' ' A' ' 19' ' ' GLY . 18.0 pt -69.2 -33.8 60.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 113.145 0.794 . . . . 70.44 113.145 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 58' ' ' VAL . 65.3 mt -61.66 -46.93 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.411 -0.589 . . . . 72.21 109.411 174.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 13.0 mm100 -60.05 -40.96 91.23 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.776 -0.647 . . . . 43.42 109.475 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -57.95 -51.49 69.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.234 -0.894 . . . . 73.44 109.627 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.632 HD11 HG13 ' A' ' 22' ' ' VAL . 73.7 mt -67.52 -28.97 68.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.727 0.64 . . . . 73.02 112.727 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -69.0 -32.31 71.77 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.368 -0.933 . . . . 75.43 110.767 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 31.8 mmt180 . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 116.486 -0.325 . . . . 61.52 110.787 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.449 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 14.7 p . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 109.904 -0.406 . . . . 51.53 109.904 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.82 -171.58 3.48 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.835 -0.746 . . . . 62.43 111.665 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.0 -68.05 0.82 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.395 -0.594 . . . . 72.34 109.395 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -168.04 153.83 7.17 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.259 -1.015 . . . . 75.21 108.259 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.547 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.9 m -115.8 162.09 14.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 119.839 -0.744 . . . . 54.3 109.973 -175.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -105.75 177.64 4.79 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.012 -1.477 . . . . 71.23 107.012 172.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -53.82 -50.03 67.07 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 118.656 0.662 . . . . 51.13 111.53 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.508 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 87.4 tttt -143.6 83.7 10.49 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-O 121.0 0.429 . . . . 64.12 110.153 175.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.5 Cg_endo -47.38 -77.77 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.456 3.438 . . . . 71.33 117.429 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.48 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -134.15 166.3 30.23 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 110.058 -0.349 . . . . 73.34 110.058 -173.157 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.585 ' O ' HG12 ' A' ' 21' ' ' ILE . 44.7 Cg_exo -61.26 127.92 23.48 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.253 1.968 . . . . 51.24 111.004 175.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.48 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -80.65 0.17 86.38 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 114.594 0.598 . . . . 64.4 114.594 -175.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.53 -1.16 39.05 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 122.034 -0.686 . . . . 73.44 112.841 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 18' ' ' PRO . 34.8 pt -100.21 7.46 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.633 0.73 . . . . 73.12 110.36 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.53 HG13 HD11 ' A' ' 65' ' ' LEU . 2.5 p -89.25 136.12 24.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.33 -0.85 . . . . 61.43 111.75 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.442 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 1.0 OUTLIER -86.16 -55.68 3.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.031 -1.1 . . . . 73.13 108.031 -176.785 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.442 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 17.5 m120 -141.65 160.31 40.43 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.281 1.032 . . . . 72.0 108.713 177.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -131.97 156.8 45.55 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.694 -0.403 . . . . 65.31 110.068 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.535 ' HB2' HG22 ' A' ' 40' ' ' VAL . 28.0 m170 -123.56 112.54 17.57 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.299 -1.371 . . . . 73.44 107.299 172.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -82.91 99.8 10.0 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.513 -1.291 . . . . 72.42 107.513 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.449 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 77.4 mt -112.58 134.72 53.96 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.54 0.686 . . . . 73.42 111.803 -173.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 94.6 mt -142.32 169.71 17.08 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.043 -0.98 . . . . 72.35 110.755 -173.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.9 mt -77.97 -30.36 16.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 106.629 -1.619 . . . . 61.25 106.629 171.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -56.22 -39.5 72.6 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.571 -1.195 . . . . 73.44 110.368 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.94 -57.6 3.8 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.981 -1.118 . . . . 74.22 107.981 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.44 85.96 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.973 -1.108 . . . . 72.42 114.299 174.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.1 t -168.54 172.52 8.1 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 105.691 -1.966 . . . . 73.4 105.691 174.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -88.17 -3.05 58.93 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.228 1.195 . . . . 74.33 114.228 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 p -148.95 122.77 4.66 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-O 120.972 0.415 . . . . 70.22 111.256 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -87.28 130.15 2.85 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.473 2.115 . . . . 61.13 112.546 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -176.25 150.05 0.9 Allowed 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.481 -0.933 . . . . 60.13 108.481 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -98.41 127.41 50.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.401 -1.333 . . . . 74.45 107.401 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 26' ' ' HIS . 6.2 m -92.3 125.12 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.15 0 C-N-CA 119.307 -0.957 . . . . 75.51 108.849 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -99.26 113.16 25.29 Favored 'General case' 0 C--N 1.272 -2.79 0 CA-C-N 115.459 -0.791 . . . . 72.13 109.729 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 77.2 m -80.69 102.43 9.88 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.895 -0.78 . . . . 72.31 108.895 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.1 p -69.23 167.83 15.43 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.123 -0.489 . . . . 63.42 110.811 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 93.7 mt -59.13 -29.09 67.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.205 0.526 . . . . 53.53 110.26 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -64.75 -26.6 68.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.078 -0.964 . . . . 71.14 111.055 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.69 17.18 19.93 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.22 -0.991 . . . . 44.13 112.145 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -103.36 125.89 50.23 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 122.684 -0.304 . . . . 72.22 111.244 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.08 112.82 19.49 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.69 -1.226 . . . . 75.33 107.69 172.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 50' ' ' CYS . 0.9 OUTLIER -115.09 141.55 47.85 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.679 -0.86 . . . . 73.24 108.679 -176.074 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.547 ' HB3' HG12 ' A' ' 12' ' ' VAL . 9.4 m -79.15 119.73 22.66 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 123.061 0.545 . . . . 64.53 111.13 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.623 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -122.85 155.55 63.42 Favored Pre-proline 0 C--O 1.243 0.733 0 C-N-CA 120.346 -0.541 . . . . 74.43 111.944 174.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 98.0 Cg_endo -78.08 110.85 2.97 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.646 2.231 . . . . 71.53 114.427 -172.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.05 -1.19 8.3 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.752 2.301 . . . . 62.2 112.556 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -103.3 -3.29 25.82 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.493 -0.321 . . . . 74.53 111.08 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 29.7 mm-40 -103.82 132.8 20.69 Favored Pre-proline 0 C--N 1.311 -1.106 0 C-N-CA 120.309 -0.556 . . . . 63.22 112.435 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 98.6 Cg_exo -49.07 -32.62 24.38 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 124.552 3.501 . . . . 74.5 115.046 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.508 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 31.0 p-90 -68.18 -30.19 69.23 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.4 -0.52 . . . . 75.41 109.902 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 62' ' ' ILE . 70.9 t -78.94 -40.97 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.212 -0.662 . . . . 60.14 109.212 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.4 mt-10 -59.68 -25.05 64.44 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.341 -0.845 . . . . 75.42 112.411 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -83.34 -43.39 16.01 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.294 0.479 . . . . 65.41 112.294 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.48 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.2 pt -70.89 -33.73 53.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 112.867 0.691 . . . . 74.33 112.867 -177.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 58' ' ' VAL . 64.3 mt -57.11 -40.82 75.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 116.064 -0.516 . . . . 75.53 110.062 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 78.8 mm-40 -59.28 -43.1 92.55 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.1 -0.5 . . . . 63.31 111.328 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -59.47 -52.29 66.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.522 0.514 . . . . 73.23 110.862 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.53 HD11 HG13 ' A' ' 22' ' ' VAL . 86.3 mt -67.95 -26.36 65.91 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.254 -0.578 . . . . 71.04 112.472 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 93.2 mt-30 -67.59 -21.77 65.41 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 121.965 -0.459 . . . . 54.13 111.917 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.639 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--N 1.314 -0.944 0 N-CA-C 109.538 -0.542 . . . . 73.54 109.538 177.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.8 p . . . . . 0 N--CA 1.428 -1.559 0 N-CA-C 107.817 -1.179 . . . . 62.44 107.817 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.578 ' HB2' HG12 ' A' ' 40' ' ' VAL . 4.4 t -76.74 142.14 40.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.027 -0.731 . . . . 74.4 109.027 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.481 ' O ' HG21 ' A' ' 36' ' ' VAL . 73.7 mt -68.89 -44.64 72.82 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 116.828 2.158 . . . . 60.03 116.828 -170.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.8 m -164.49 137.18 4.82 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.759 -0.776 . . . . 74.12 111.293 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -102.05 161.21 3.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.459 -0.941 . . . . 64.03 108.459 -178.93 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.9 t -105.54 178.76 4.47 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.098 -1.075 . . . . 72.32 108.098 175.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -49.17 -40.61 33.65 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.615 0.766 . . . . 64.15 111.069 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 38.0 ttpt -157.7 92.1 2.24 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 109.078 -0.712 . . . . 64.43 109.078 171.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.608 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.2 Cg_endo -40.07 -67.16 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.765 3.644 . . . . 72.54 116.688 -178.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.443 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -147.03 166.25 16.79 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 75.32 109.695 -176.782 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.545 ' O ' HG12 ' A' ' 21' ' ' ILE . 32.1 Cg_exo -60.4 128.6 26.63 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.068 1.845 . . . . 42.43 109.632 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -73.47 0.89 46.65 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 115.887 1.115 . . . . 52.2 115.887 -172.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -98.46 -7.51 28.4 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 117.772 0.786 . . . . 72.55 112.417 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.4 pt -92.84 3.94 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.58 0.705 . . . . 71.45 111.098 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 41' ' ' PHE . 2.2 p -88.12 135.82 24.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.292 -0.867 . . . . 74.22 112.411 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -86.44 -56.07 3.6 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.434 1.094 . . . . 65.53 108.523 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -146.97 170.15 17.69 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.811 -1.086 . . . . 72.02 108.59 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.604 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 47.2 p90 -141.68 155.94 45.66 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.978 -0.378 . . . . 74.13 109.978 -175.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.412 ' HB2' HG22 ' A' ' 40' ' ' VAL . 28.1 m170 -133.82 121.95 22.54 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.627 -0.509 . . . . 75.34 109.627 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' OH ' HG21 ' A' ' 62' ' ' ILE . 54.1 m-85 -78.31 103.89 8.55 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 123.208 0.318 . . . . 74.42 110.168 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -108.76 131.55 54.84 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.484 -0.887 . . . . 75.22 110.983 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.4 mt -133.94 -177.98 4.81 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.142 -0.936 . . . . 50.54 109.131 -174.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 63.1 mt -71.67 -24.15 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 120.477 -0.489 . . . . 71.25 109.777 176.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.642 ' HE3' ' C ' ' A' ' 31' ' ' LYS 0.364 0.0 OUTLIER -67.26 -10.02 46.47 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.687 0.995 . . . . 73.43 113.687 176.415 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.521 ' N ' ' HE3' ' A' ' 31' ' ' LYS . 22.2 m-20 -83.76 -5.42 59.19 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.352 0.596 . . . . 73.21 109.733 171.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.37 43.2 8.72 Favored Glycine 0 N--CA 1.434 -1.489 0 CA-C-N 115.089 -0.96 . . . . 33.42 111.464 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 11.1 t -135.56 155.37 50.59 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.09 -1.818 . . . . 74.02 106.09 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -92.75 14.52 16.99 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.501 1.667 . . . . 74.24 115.501 -168.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 10' ' ' LEU . 3.7 p -153.11 116.3 2.78 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-O 121.328 0.585 . . . . 73.4 112.544 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -83.84 134.93 6.47 Favored 'Trans proline' 0 C--O 1.252 1.181 0 C-N-CA 122.645 2.23 . . . . 74.24 112.898 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -176.18 153.94 1.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.183 0.993 . . . . 74.13 108.562 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 8.6 p -99.11 128.28 50.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.355 -1.35 . . . . 61.13 107.355 175.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 9' ' ' CYS . 14.8 m -91.55 127.98 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.491 0 C-N-CA 119.299 -0.96 . . . . 74.1 110.083 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CD1' HG21 ' A' ' 22' ' ' VAL . 4.9 m-85 -91.29 116.87 29.18 Favored 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 115.099 -0.955 . . . . 74.44 109.79 173.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 99.0 m -89.78 106.79 18.7 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 107.721 -1.214 . . . . 61.21 107.721 176.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 69.5 p -69.73 174.18 5.41 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 123.19 0.306 . . . . 70.3 111.321 -177.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 91.6 mt -58.0 -33.23 68.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.214 0.531 . . . . 70.0 110.73 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -69.58 -18.93 63.67 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.617 -0.719 . . . . 64.2 110.882 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.58 16.71 33.26 Favored Glycine 0 CA--C 1.499 -0.956 0 C-N-CA 120.536 -0.84 . . . . 74.41 111.729 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.564 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 1.8 mmp_? -95.87 144.24 26.38 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-O 120.693 0.282 . . . . 74.21 110.668 -177.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -105.6 131.09 53.41 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.505 -0.77 . . . . 53.14 110.151 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.402 HD23 HG23 ' A' ' 17' ' ' ILE . 31.3 tp -132.87 150.89 52.12 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.886 -0.783 . . . . 73.43 108.886 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.479 ' HB3' HG12 ' A' ' 12' ' ' VAL . 4.9 m -77.68 123.9 27.26 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 110.087 -0.338 . . . . 70.04 110.087 -175.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.608 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -132.66 157.57 77.98 Favored Pre-proline 0 C--O 1.243 0.747 0 CA-C-N 118.31 0.505 . . . . 53.02 109.933 174.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.34 109.34 2.3 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.055 1.837 . . . . 51.23 113.46 -174.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.42 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 54.8 Cg_endo -70.74 -12.78 31.54 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 122.779 2.319 . . . . 71.21 113.685 -174.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -96.12 -20.44 18.63 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.232 -0.44 . . . . 74.22 111.385 -176.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -80.06 145.22 60.51 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 113.938 1.088 . . . . 71.23 113.938 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -51.24 -43.47 48.76 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.812 3.675 . . . . 73.3 115.734 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.423 ' O ' HG12 ' A' ' 61' ' ' ILE . 39.5 p-90 -64.53 -36.29 83.74 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.137 -0.625 . . . . 74.45 111.289 -175.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 62' ' ' ILE . 76.6 t -69.53 -47.29 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.849 -0.614 . . . . 70.01 111.765 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.532 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 10.1 pt-20 -61.62 -32.83 72.98 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.314 0.487 . . . . 64.23 112.314 -177.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.532 ' HE ' ' HG3' ' A' ' 59' ' ' GLU . 5.6 mmp_? -66.15 -51.93 53.18 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.094 0.473 . . . . 75.24 110.648 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.465 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 8.0 pt -64.58 -34.69 71.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.735 -0.666 . . . . 72.0 111.989 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.604 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 39.8 mt -57.4 -43.98 83.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.315 -0.402 . . . . 71.54 111.382 173.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.436 ' HA ' ' OE1' ' A' ' 63' ' ' GLN . 13.7 mm-40 -63.54 -36.72 84.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.973 0.416 . . . . 73.14 110.709 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 29.7 mmt180 -64.82 -34.08 77.52 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.618 -0.719 . . . . 72.41 111.011 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.521 HD11 HG13 ' A' ' 22' ' ' VAL . 90.4 mt -77.31 -34.93 55.32 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.767 -0.373 . . . . 75.14 110.992 176.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -76.78 -18.75 58.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.241 0.83 . . . . 72.21 113.241 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 40.7 ptt180 . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 112.712 0.634 . . . . 54.42 112.712 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.616 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 49.3 t . . . . . 0 N--CA 1.433 -1.304 0 CA-C-O 120.803 0.335 . . . . 74.03 111.025 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.418 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 97.4 m -84.44 166.18 17.52 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.744 0.818 . . . . 54.31 112.761 -177.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.51 -53.01 2.88 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.189 -1.411 . . . . 74.12 107.189 172.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.1 m -167.64 178.57 5.27 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.063 -1.458 . . . . 61.41 107.063 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.427 HG12 ' CB ' ' A' ' 50' ' ' CYS . 3.1 m -133.64 148.79 30.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.055 -1.461 . . . . 72.15 107.055 173.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 10.9 t -92.11 178.76 5.77 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.262 -1.014 . . . . 53.51 108.262 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -47.53 -69.89 0.11 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.532 0.733 . . . . 74.24 111.38 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 61.1 mtpt -132.74 80.87 60.35 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 109.477 -0.564 . . . . 71.53 109.477 174.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.9 Cg_endo -43.64 -83.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 125.277 3.985 . . . . 70.11 118.935 -172.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -138.28 157.96 71.68 Favored Pre-proline 0 C--N 1.32 -0.713 0 O-C-N 122.164 -0.335 . . . . 72.33 110.451 -173.076 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.27 136.77 45.02 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.501 2.134 . . . . 62.1 111.354 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.542 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -77.57 1.22 67.28 Favored Glycine 0 C--O 1.218 -0.878 0 CA-C-O 121.868 0.705 . . . . 41.11 112.006 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -77.04 -28.12 54.72 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.051 -0.575 . . . . 73.12 110.6 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.1 pt -98.67 8.63 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 120.691 -0.404 . . . . 72.31 112.011 -176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.431 HG13 HD11 ' A' ' 65' ' ' LEU . 7.7 p -95.39 138.27 21.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.106 0.479 . . . . 70.11 111.115 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.9 -56.06 3.23 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.461 -0.94 . . . . 71.22 108.461 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -145.91 174.31 11.37 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.232 1.013 . . . . 73.31 108.602 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -140.57 169.29 17.92 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.518 -0.473 . . . . 71.2 110.357 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.482 ' HB2' HG22 ' A' ' 40' ' ' VAL . 34.0 m80 -129.1 129.03 44.69 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.137 -2.171 . . . . 72.1 105.137 171.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -97.46 109.38 22.15 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 107.906 -1.146 . . . . 64.55 107.906 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.616 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.3 mm? -98.1 117.83 33.34 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.0 0.428 . . . . 63.04 111.342 -174.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.9 mt -124.93 -179.09 4.39 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.538 -0.912 . . . . 75.32 108.538 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 52.2 mt -71.11 -21.01 21.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.544 -0.91 . . . . 53.0 108.544 176.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -59.04 -32.88 70.15 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.983 -1.008 . . . . 71.24 109.834 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.3 -6.41 57.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.664 -0.698 . . . . 60.12 110.6 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.08 34.33 12.99 Favored Glycine 0 CA--C 1.498 -1.02 0 C-N-CA 121.108 -0.568 . . . . 33.44 112.246 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 46.3 t -123.08 145.95 48.12 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.649 -0.871 . . . . 71.34 108.649 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.607 ' O ' ' HD3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -79.79 -36.02 37.65 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.534 -0.543 . . . . 63.44 109.534 -177.524 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.7 p -98.04 103.89 19.71 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 121.132 0.491 . . . . 74.4 111.438 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 35' ' ' ARG . 92.7 Cg_endo -84.0 130.11 4.81 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 121.707 1.605 . . . . 62.44 111.588 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HA ' ' HG3' ' A' ' 53' ' ' PRO . . . -172.65 -179.78 2.23 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 124.212 1.005 . . . . 53.44 108.857 -177.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -119.04 130.03 74.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 120.228 -0.589 . . . . 71.45 110.077 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.777 HG12 ' SG ' ' A' ' 50' ' ' CYS . 4.4 m -89.26 130.94 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 108.186 -1.042 . . . . 65.11 108.186 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -98.32 114.82 27.26 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 109.633 -0.506 . . . . 74.05 109.633 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 86.2 m -84.34 102.19 12.52 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.203 -1.036 . . . . 63.13 108.203 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 51.5 p -72.03 169.93 14.93 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.488 -0.324 . . . . 64.02 111.31 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.67 -25.46 66.37 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.492 0.717 . . . . 75.32 112.334 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -83.27 -4.04 58.04 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.227 0.537 . . . . 71.02 110.89 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.13 16.13 56.35 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 120.802 -0.713 . . . . 61.33 112.319 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 36.1 mmt180 -99.64 130.24 45.85 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 112.521 0.563 . . . . 74.42 112.521 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -95.92 122.02 38.27 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.157 -0.928 . . . . 72.22 109.545 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.7 tm? -134.92 138.24 43.9 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.407 -1.701 . . . . 64.54 106.407 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.777 ' SG ' HG12 ' A' ' 40' ' ' VAL . 73.5 m -98.0 147.35 24.59 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 114.828 1.418 . . . . 73.44 114.828 -172.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.556 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -128.84 159.1 70.14 Favored Pre-proline 0 C--O 1.243 0.752 0 CA-C-N 115.227 -0.897 . . . . 63.35 110.999 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 55.6 Cg_endo -64.88 108.88 1.17 Allowed 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.185 2.59 . . . . 60.21 113.226 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HG3' ' HA ' ' A' ' 38' ' ' ALA . 64.1 Cg_endo -67.71 -9.8 26.67 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 C-N-CA 123.024 2.483 . . . . 74.15 114.054 -175.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.49 -22.69 17.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.932 0.396 . . . . 75.25 111.292 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -76.08 130.34 78.29 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 112.801 0.667 . . . . 74.14 112.801 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.38 -41.63 17.68 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.915 3.744 . . . . 64.54 114.809 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -63.3 -26.89 68.98 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 120.93 0.395 . . . . 74.41 110.897 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 62' ' ' ILE . 74.9 t -82.86 -42.39 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.93 -0.577 . . . . 71.0 111.869 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.305 0.2 OUTLIER -66.34 -30.88 71.37 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.929 1.085 . . . . 73.45 113.929 -174.477 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -61.32 -49.94 74.97 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.041 0.448 . . . . 72.15 110.672 176.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.542 HG21 ' HA3' ' A' ' 19' ' ' GLY . 10.7 pt -69.12 -31.63 50.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.904 -0.589 . . . . 74.03 112.173 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 58' ' ' VAL . 56.4 mt -59.13 -50.08 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 110.156 -0.312 . . . . 61.15 110.156 171.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 29.7 mm-40 -62.58 -36.78 83.78 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.14 0.495 . . . . 61.31 109.947 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 38.8 ttm180 -57.96 -48.25 80.51 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.7 -1.136 . . . . 53.32 110.817 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.431 HD11 HG13 ' A' ' 22' ' ' VAL . 82.8 mt -70.71 -30.39 66.94 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 116.543 -0.299 . . . . 64.24 110.699 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -55.86 -18.92 9.92 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 114.424 1.268 . . . . 75.22 114.424 177.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 15.4 ptm180 . . . . . 0 CA--C 1.55 0.961 0 CA-C-O 120.731 0.3 . . . . 55.45 110.643 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.67 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 74.6 m . . . . . 0 N--CA 1.402 -2.839 0 N-CA-C 110.381 -0.229 . . . . 62.31 110.381 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.429 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -107.1 -179.92 4.07 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.063 -0.655 . . . . 74.3 109.574 -176.823 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -118.13 -51.83 2.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.711 1.374 . . . . 74.02 114.711 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.6 p -153.21 136.3 15.59 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.142 -0.623 . . . . 72.32 111.615 -171.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -102.76 153.72 5.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 119.539 -0.864 . . . . 65.44 108.879 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.6 t -99.59 179.01 4.68 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.111 -0.699 . . . . 55.43 109.111 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -39.36 -51.52 2.07 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.591 1.157 . . . . 71.44 111.628 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 40.3 ttmt -159.55 94.53 1.7 Allowed Pre-proline 0 N--CA 1.427 -1.622 0 N-CA-C 108.254 -1.017 . . . . 70.45 108.254 171.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.6 Cg_endo -39.44 -82.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.738 3.625 . . . . 61.44 117.837 -173.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.421 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -143.72 161.4 46.58 Favored Pre-proline 0 N--CA 1.475 0.816 0 N-CA-C 109.452 -0.573 . . . . 64.43 109.452 -175.085 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.508 ' O ' HG12 ' A' ' 21' ' ' ILE . 19.5 Cg_endo -61.74 129.24 26.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.845 1.696 . . . . 72.44 110.443 172.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.532 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -74.0 2.19 43.9 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 114.79 0.676 . . . . 74.01 114.79 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -93.64 -9.4 38.09 Favored 'General case' 0 C--N 1.281 -2.383 0 O-C-N 121.953 -0.733 . . . . 73.3 112.298 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 18' ' ' PRO . 39.5 pt -96.89 0.58 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.508 0.67 . . . . 54.31 111.039 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.628 HG13 HD11 ' A' ' 65' ' ' LEU . 2.6 p -87.46 133.4 30.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.542 -0.753 . . . . 75.23 111.102 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.523 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -84.78 -53.76 5.13 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.882 -1.155 . . . . 71.14 107.882 -176.656 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.523 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 18.6 m120 -139.73 147.85 41.46 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-N 115.115 -0.948 . . . . 73.4 108.844 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.447 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 43.1 p90 -114.65 152.69 31.48 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.509 -0.922 . . . . 73.2 108.509 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.574 ' HB2' HG22 ' A' ' 40' ' ' VAL . 28.8 m170 -118.52 128.64 54.78 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.3 -1.741 . . . . 72.15 106.3 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -97.33 109.48 22.22 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.684 -0.858 . . . . 75.33 108.684 -175.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.67 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 2.4 mm? -103.11 122.09 43.96 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.318 -0.401 . . . . 61.23 110.115 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.7 mt -128.8 172.33 11.39 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.457 -0.338 . . . . 74.21 110.272 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.589 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 47.7 mt -77.72 -20.89 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.096 -1.446 . . . . 55.21 107.096 176.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -63.94 -27.12 68.93 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.212 -1.358 . . . . 71.11 109.165 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.53 -12.05 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.475 -0.784 . . . . 71.4 110.488 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.61 -47.31 1.03 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.187 -0.53 . . . . 54.32 114.316 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 71.0 m -62.48 137.55 58.28 Favored 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 112.366 0.506 . . . . 60.24 112.366 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -71.13 -20.19 62.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 73.43 111.874 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.05 106.91 58.53 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-O 121.203 0.525 . . . . 71.33 111.159 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -85.57 130.21 3.76 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.282 1.988 . . . . 65.12 111.655 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -171.72 153.5 3.38 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.867 -0.79 . . . . 74.32 108.867 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.04 131.72 46.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.201 -1.037 . . . . 73.11 108.201 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.574 HG22 ' HB2' ' A' ' 26' ' ' HIS . 16.8 m -98.99 129.78 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.798 0 C-N-CA 119.535 -0.866 . . . . 73.21 109.492 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -96.44 115.44 27.43 Favored 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 115.234 -0.894 . . . . 60.1 110.903 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 24' ' ' ASN . 53.2 m -85.74 105.13 16.05 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 123.786 0.679 . . . . 73.42 109.412 175.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.1 p -71.78 173.28 8.41 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.977 -0.556 . . . . 60.21 111.002 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.25 -28.39 69.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.373 0.606 . . . . 74.23 110.062 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -64.83 -32.99 74.95 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.252 -0.886 . . . . 73.24 110.321 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.26 -3.85 25.23 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 120.77 -0.729 . . . . 64.23 112.048 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 42' ' ' THR . 27.1 mmt180 -75.69 137.82 40.9 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 111.84 0.311 . . . . 73.24 111.84 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -103.95 112.51 25.51 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.875 -1.157 . . . . 64.14 107.875 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 24.0 tp -114.76 145.35 42.2 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.263 -0.575 . . . . 54.2 109.653 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.7 m -78.03 133.41 37.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.784 -0.45 . . . . 64.12 109.784 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.57 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -137.6 155.65 75.13 Favored Pre-proline 0 C--N 1.312 -1.065 0 N-CA-C 109.811 -0.44 . . . . 73.02 109.811 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 86.5 Cg_endo -71.24 111.32 3.06 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.993 2.462 . . . . 72.32 112.824 -175.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.9 Cg_endo -70.23 -12.45 32.03 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.691 2.261 . . . . 74.32 114.328 -173.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -113.08 9.73 18.63 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.531 0.567 . . . . 74.14 112.531 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 25.1 mm-40 -91.54 139.05 25.02 Favored Pre-proline 0 C--N 1.32 -0.683 0 O-C-N 122.313 -0.242 . . . . 71.13 110.999 176.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 83.3 Cg_exo -49.83 -43.16 42.06 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 124.086 3.191 . . . . 74.25 114.714 -175.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.5 ' O ' HG12 ' A' ' 61' ' ' ILE . 40.3 p-90 -62.92 -37.46 87.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.307 -0.557 . . . . 74.34 110.518 -177.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 62' ' ' ILE . 78.6 t -72.81 -43.67 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.707 -0.679 . . . . 63.03 110.602 178.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 43.7 mt-10 -53.07 -41.54 64.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.094 0.473 . . . . 73.13 110.88 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -72.97 -41.46 64.36 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.695 0.628 . . . . 75.34 112.695 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.532 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.7 pt -71.56 -32.69 46.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 112.561 0.578 . . . . 75.43 112.561 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.447 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 59.0 mt -57.69 -50.28 77.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.152 -0.684 . . . . 74.32 109.152 171.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 31.0 mm-40 -61.8 -40.93 96.96 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.925 -0.579 . . . . 71.13 110.423 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -54.33 -50.29 67.75 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.727 -0.67 . . . . 72.34 109.688 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.628 HD11 HG13 ' A' ' 22' ' ' VAL . 80.9 mt -70.1 -30.45 67.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.356 0.502 . . . . 53.41 112.356 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 48.5 mt-30 -71.85 -27.42 62.87 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.549 -0.86 . . . . 75.23 111.419 177.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 30.4 mmm180 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.748 0.309 . . . . 73.44 110.666 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.532 ' HA ' HD13 ' A' ' 28' ' ' LEU . 6.6 p . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 110.251 -0.277 . . . . 63.21 110.251 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.465 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -84.16 128.0 34.28 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.525 -0.87 . . . . 44.52 110.684 -171.041 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.604 ' H ' HD12 ' A' ' 10' ' ' LEU . 6.2 mp -43.96 -62.44 1.13 Allowed 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 125.367 1.467 . . . . 72.43 114.265 -175.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 p -173.01 143.42 1.16 Allowed 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 120.259 -0.576 . . . . 63.54 109.633 -172.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 13' ' ' THR . 1.1 m -99.48 152.58 4.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.009 -1.108 . . . . 63.11 108.009 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 12' ' ' VAL . 9.0 t -89.54 174.44 7.77 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.274 -1.38 . . . . 73.44 107.274 175.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -53.37 -39.65 64.35 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.273 0.488 . . . . 63.03 112.12 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -155.15 93.8 2.69 Favored Pre-proline 0 N--CA 1.429 -1.505 0 N-CA-C 108.733 -0.839 . . . . 71.11 108.733 170.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.644 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 11.8 Cg_endo -52.13 -82.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.268 3.312 . . . . 74.34 117.705 -175.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.419 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -138.6 162.4 53.32 Favored Pre-proline 0 C--N 1.321 -0.641 0 O-C-N 121.881 -0.512 . . . . 74.55 110.424 -173.224 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.61 ' O ' HG12 ' A' ' 21' ' ' ILE . 27.2 Cg_exo -63.97 132.15 33.46 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.877 1.718 . . . . 72.2 110.124 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.529 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -75.05 1.11 56.89 Favored Glycine 0 C--N 1.301 -1.382 0 N-CA-C 114.065 0.386 . . . . 50.25 114.065 -176.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -91.58 -2.38 57.14 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 122.483 -0.422 . . . . 74.32 110.88 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 18' ' ' PRO . 27.6 pt -107.1 6.76 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 120.313 -0.555 . . . . 61.35 110.819 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.491 HG21 ' CD1' ' A' ' 41' ' ' PHE . 5.4 p -93.77 140.69 16.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.02 -0.537 . . . . 73.25 111.453 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.41 -47.0 5.06 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.776 0.83 . . . . 75.21 109.441 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -143.9 163.64 32.82 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.749 -1.204 . . . . 71.15 107.749 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.77 165.52 27.85 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.233 0.47 . . . . 72.33 110.47 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.524 ' HB2' HG22 ' A' ' 40' ' ' VAL . 36.0 m80 -134.45 112.41 10.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.695 -1.224 . . . . 62.33 107.695 170.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -83.17 94.92 7.96 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.972 -1.122 . . . . 71.02 107.972 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.532 HD13 ' HA ' ' A' ' 8' ' ' CYS . 63.0 mt -94.63 137.41 33.78 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.635 -0.712 . . . . 70.23 111.428 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.42 ' H ' ' HB3' ' A' ' 32' ' ' ASP . 91.8 mt -142.05 169.67 17.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.035 -0.984 . . . . 72.33 110.861 -175.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -77.9 -29.61 15.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 107.17 -1.419 . . . . 73.24 107.17 171.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.88 -30.19 70.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.023 -0.99 . . . . 73.43 109.15 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' A' ' 29' ' ' LEU . 20.1 t70 -74.33 -32.87 62.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.199 -0.91 . . . . 74.31 108.805 173.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.63 88.61 1.6 Allowed Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.178 -0.919 . . . . 53.2 113.68 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.9 t 178.84 -175.5 0.21 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.429 -1.322 . . . . 64.54 107.429 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -89.5 -41.99 11.72 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.557 0.577 . . . . 74.11 112.557 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.05 115.95 42.79 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 113.085 0.772 . . . . 65.34 113.085 -176.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -83.07 130.68 5.67 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.838 2.359 . . . . 73.04 111.655 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.66 153.42 2.26 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.269 -1.011 . . . . 43.24 108.269 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.09 130.78 47.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.81 -1.181 . . . . 42.34 107.81 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' A' ' 26' ' ' HIS . 4.5 m -92.4 131.69 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.759 0 N-CA-C 108.254 -1.017 . . . . 75.31 108.254 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.491 ' CD1' HG21 ' A' ' 22' ' ' VAL . 10.3 m-85 -103.2 115.44 30.58 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 116.108 -0.496 . . . . 71.15 110.728 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.7 m -80.69 100.39 8.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.2 -1.408 . . . . 51.22 107.2 174.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 53.2 p -72.25 175.39 6.13 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.494 0.188 . . . . 72.12 111.042 -177.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 96.8 mt -61.02 -26.74 67.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.692 -0.485 . . . . 65.12 109.692 176.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.403 ' NE ' ' HA ' ' A' ' 45' ' ' ARG . 6.5 tpm_? -63.88 -27.01 68.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.373 1.069 . . . . 73.21 110.791 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.92 8.55 59.08 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.168 -0.539 . . . . 63.43 111.878 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.61 138.93 38.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.974 -1.491 . . . . 73.22 106.974 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -95.82 118.77 33.11 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.435 -0.58 . . . . 63.53 109.435 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.1 mp -111.21 149.22 31.28 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 111.785 0.291 . . . . 74.43 111.785 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.428 ' HB3' HG12 ' A' ' 12' ' ' VAL . 23.3 m -80.23 123.4 27.91 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.863 -0.608 . . . . 74.32 110.241 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.74 152.52 77.11 Favored Pre-proline 0 C--O 1.246 0.882 0 O-C-N 122.356 -0.215 . . . . 72.43 110.86 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.422 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 67.3 Cg_endo -67.39 114.12 3.14 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.005 2.47 . . . . 73.21 113.844 -173.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 -15.36 28.05 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.179 1.919 . . . . 75.5 112.154 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -103.82 8.57 37.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.094 -0.503 . . . . 62.44 112.309 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.77 129.28 26.12 Favored Pre-proline 0 C--N 1.315 -0.924 0 C-N-CA 119.88 -0.728 . . . . 70.41 111.654 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.405 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 83.0 Cg_exo -48.03 -36.5 28.03 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.289 3.326 . . . . 74.34 115.296 -177.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -62.32 -27.03 68.76 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 120.086 -0.646 . . . . 75.31 110.961 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 62' ' ' ILE . 67.7 t -79.69 -42.38 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 116.0 -0.546 . . . . 72.22 112.386 -178.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -63.46 -25.54 68.31 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.931 1.086 . . . . 72.32 113.931 -174.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -80.59 -41.24 24.33 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 116.468 -0.333 . . . . 74.25 111.073 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.529 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 10.8 pt -71.9 -31.08 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 111.932 0.345 . . . . 73.31 111.932 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 58' ' ' VAL . 61.4 mt -55.54 -41.38 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.209 -0.45 . . . . 61.14 109.961 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 76.4 mm-40 -61.3 -42.17 98.21 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.981 -0.554 . . . . 72.33 110.372 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -58.51 -43.85 89.26 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.896 -0.593 . . . . 71.13 110.244 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.421 HD11 ' CG1' ' A' ' 22' ' ' VAL . 85.9 mt -68.53 -39.13 81.28 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.819 -0.628 . . . . 64.32 111.623 178.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -64.47 -43.35 94.47 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.694 -0.402 . . . . 75.4 111.223 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 63' ' ' GLN . 70.2 mtp180 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.18 0.514 . . . . 75.31 111.266 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' A' ' 28' ' ' LEU . 71.7 m . . . . . 0 N--CA 1.416 -2.148 0 N-CA-C 109.843 -0.428 . . . . 51.33 109.843 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.701 ' SG ' HG12 ' A' ' 40' ' ' VAL . 75.3 m -85.46 177.73 7.67 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.412 0.625 . . . . 74.44 111.709 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.44 -38.86 6.33 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 114.892 -1.049 . . . . 71.44 109.141 176.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.5 m -163.7 168.48 19.74 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 110.127 -0.323 . . . . 42.01 110.127 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.506 HG12 ' CB ' ' A' ' 50' ' ' CYS . 1.3 m -132.35 156.65 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 N-CA-C 104.481 -2.414 . . . . 62.23 104.481 172.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.8 t -96.9 178.02 5.43 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 108.192 -1.04 . . . . 74.11 108.192 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -50.65 -49.6 56.64 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.142 0.496 . . . . 74.2 111.103 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 37.0 ttpt -149.42 84.83 5.98 Favored Pre-proline 0 N--CA 1.421 -1.894 0 N-CA-C 108.976 -0.75 . . . . 54.41 108.976 175.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.2 Cg_endo -46.54 -81.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.786 3.658 . . . . 63.14 117.861 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -136.09 160.07 68.57 Favored Pre-proline 0 C--N 1.311 -1.091 0 O-C-N 121.857 -0.527 . . . . 60.14 110.612 -172.491 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.593 ' O ' HG12 ' A' ' 21' ' ' ILE . 19.6 Cg_endo -60.89 128.43 25.46 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.829 1.686 . . . . 74.45 109.791 173.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.541 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -73.72 1.72 44.12 Favored Glycine 0 C--O 1.209 -1.457 0 C-N-CA 120.98 -0.629 . . . . 31.13 114.554 -174.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -89.97 -1.54 57.99 Favored 'General case' 0 C--N 1.284 -2.276 0 O-C-N 122.198 -0.589 . . . . 71.42 111.367 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 18' ' ' PRO . 38.6 pt -104.01 7.29 10.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 120.788 -0.365 . . . . 72.24 110.959 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.559 HG13 HD11 ' A' ' 65' ' ' LEU . 3.2 p -90.93 131.68 37.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.576 0.703 . . . . 64.21 112.55 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -85.44 -55.06 4.2 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.798 -1.092 . . . . 63.34 108.124 -175.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -143.42 158.66 43.46 Favored 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 123.922 0.889 . . . . 73.33 109.099 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -132.43 163.27 29.12 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.84 -0.43 . . . . 73.45 109.84 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.475 ' HB2' HG22 ' A' ' 40' ' ' VAL . 34.0 m170 -135.01 136.91 42.49 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.289 -1.374 . . . . 73.24 107.289 174.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.409 ' CE2' HD21 ' A' ' 29' ' ' LEU . 5.4 t80 -100.1 105.9 17.58 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.103 0.478 . . . . 64.35 109.723 -175.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.543 HD12 ' SG ' ' A' ' 8' ' ' CYS . 1.8 mm? -97.43 124.08 41.49 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 123.803 0.841 . . . . 64.32 109.529 -176.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.409 HD21 ' CE2' ' A' ' 27' ' ' TYR . 87.6 mt -121.9 176.36 5.81 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.813 -0.44 . . . . 52.54 109.813 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 45.4 mt -73.3 -17.36 17.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 121.992 0.901 . . . . 73.23 108.935 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -65.17 -28.88 69.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.587 -1.188 . . . . 71.33 109.347 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -76.86 -4.22 42.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.504 -0.771 . . . . 62.54 111.08 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.9 -9.37 59.99 Favored Glycine 0 CA--C 1.503 -0.692 0 CA-C-N 116.122 -0.49 . . . . 41.32 113.044 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.715 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 63.0 m -94.67 123.53 38.16 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.526 -0.916 . . . . 72.04 108.526 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.678 ' H ' ' HD2' ' A' ' 35' ' ' ARG 0.313 0.0 OUTLIER -77.67 1.89 18.47 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.968 1.099 . . . . 72.02 113.968 -176.15 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.8 p -109.62 98.22 31.75 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.053 -0.721 . . . . 73.42 109.053 171.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.12 129.86 9.03 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 121.627 1.551 . . . . 71.04 110.29 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 50' ' ' CYS . . . -166.13 160.44 16.28 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.226 -0.443 . . . . 71.23 110.734 -174.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.37 123.15 66.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 109.083 -0.71 . . . . 73.44 109.083 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.701 HG12 ' SG ' ' A' ' 9' ' ' CYS . 9.2 m -80.34 125.64 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 C-N-CA 119.736 -0.786 . . . . 73.42 109.191 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -97.85 109.01 21.85 Favored 'General case' 0 C--N 1.267 -3.02 0 CA-C-N 115.672 -0.695 . . . . 64.42 109.487 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.4 m -82.42 103.72 12.18 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.477 -1.305 . . . . 61.23 107.477 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 64.8 p -69.94 167.12 18.12 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 120.895 -0.322 . . . . 61.52 111.084 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 94.9 mt -59.99 -30.74 69.33 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.093 0.557 . . . . 51.54 110.698 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -70.91 -18.23 62.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.313 -0.858 . . . . 75.33 110.109 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.57 16.6 26.26 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.881 -0.676 . . . . 75.21 113.22 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -99.8 126.05 45.82 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.95 0.375 . . . . 73.41 111.282 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -85.92 127.04 34.52 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.126 -0.694 . . . . 55.3 109.126 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.7 tp -147.67 131.03 16.59 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.229 -1.026 . . . . 74.43 108.229 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.593 ' SG ' HG12 ' A' ' 40' ' ' VAL . 55.8 m -86.78 155.17 20.42 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 114.877 1.436 . . . . 73.32 114.877 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.556 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -130.55 162.34 55.37 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-N 114.217 -1.356 . . . . 63.43 108.453 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.477 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 58.0 Cg_endo -68.67 107.52 1.67 Allowed 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 121.69 1.594 . . . . 71.34 111.617 -177.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 59.6 Cg_endo -68.15 -12.46 35.16 Favored 'Trans proline' 0 N--CA 1.481 0.74 0 C-N-CA 123.171 2.58 . . . . 61.24 114.408 -170.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -96.07 -22.52 17.29 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.141 0.496 . . . . 73.3 110.733 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 15.5 mm100 -73.84 138.7 76.6 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 112.902 0.705 . . . . 71.22 112.902 -174.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 87.7 Cg_exo -50.54 -36.79 50.73 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.321 3.348 . . . . 73.11 115.037 -177.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.481 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 34.7 p-90 -68.18 -28.0 66.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 119.863 -0.735 . . . . 64.42 110.673 -177.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 62' ' ' ILE . 73.9 t -79.77 -41.42 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 116.125 -0.489 . . . . 65.23 111.747 -177.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.569 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 11.7 pt-20 -60.74 -37.52 82.04 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.23 -0.588 . . . . 73.03 112.033 -177.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -62.21 -43.92 97.74 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.062 0.458 . . . . 72.02 111.731 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.541 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 8.5 pt -74.06 -32.49 33.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 116.052 -0.522 . . . . 70.22 111.841 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 58' ' ' VAL . 58.5 mt -60.74 -51.09 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.669 -0.493 . . . . 74.12 109.669 172.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 14.2 mm100 -59.56 -38.0 79.97 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.324 -0.398 . . . . 54.34 110.904 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.441 ' HG3' ' NH2' ' A' ' 67' ' ' ARG . 35.5 ttt180 -57.66 -47.41 82.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.865 -0.607 . . . . 72.14 110.558 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.559 HD11 HG13 ' A' ' 22' ' ' VAL . 86.8 mt -71.17 -30.16 66.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.885 0.374 . . . . 75.45 110.892 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -67.49 -22.56 65.45 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 113.037 0.754 . . . . 74.53 113.037 177.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.441 ' NH2' ' HG3' ' A' ' 64' ' ' ARG . 26.2 mtm180 . . . . . 0 C--N 1.318 -0.77 0 CA-C-O 121.41 0.624 . . . . 64.31 109.473 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.923 0 N-CA-C 110.288 -1.125 . . . . 64.14 110.288 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 t -98.09 127.58 44.12 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.681 -0.859 . . . . 70.14 108.681 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 53.59 84.11 0.06 Allowed 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.91 0.884 . . . . 63.24 111.106 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -95.55 107.07 19.22 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.717 -0.475 . . . . 55.15 109.717 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.98 -4.7 55.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.805 -0.634 . . . . 73.5 111.27 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -131.88 164.97 24.91 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.336 -0.847 . . . . 73.12 109.104 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -96.37 -21.55 17.71 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 112.561 0.578 . . . . 71.3 112.561 -174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.5 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 25.7 p -99.5 175.11 5.95 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.821 -0.752 . . . . 72.05 112.959 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.39 -171.04 3.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.966 -0.561 . . . . 53.21 109.659 -175.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.28 -64.02 1.09 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.06 -0.348 . . . . 70.24 110.06 -176.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -175.03 153.39 1.63 Allowed 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.307 -1.368 . . . . 54.25 107.307 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.96 150.53 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 C-N-CA 119.862 -0.735 . . . . 62.51 109.59 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.0 t -91.74 177.65 6.14 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.286 -1.005 . . . . 73.5 108.286 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -44.87 -63.49 0.91 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.388 0.675 . . . . 72.31 110.912 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 86.4 tttt -142.55 91.91 7.41 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 106.9 -1.518 . . . . 72.13 106.9 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.625 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.0 Cg_endo -46.98 -87.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.507 3.472 . . . . 45.13 118.321 -172.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.555 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -131.59 160.87 65.47 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 109.628 -0.508 . . . . 72.24 109.628 -173.392 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.508 ' O ' HG12 ' A' ' 21' ' ' ILE . 51.2 Cg_exo -60.16 128.41 26.33 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.181 1.921 . . . . 72.45 110.719 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.514 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -76.24 -0.88 67.49 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 116.023 -0.535 . . . . 72.32 113.454 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -95.67 -3.75 45.54 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 113.149 0.796 . . . . 74.13 113.149 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 18' ' ' PRO . 40.8 pt -103.74 9.79 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.539 0.685 . . . . 51.41 110.538 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.538 HG13 HD11 ' A' ' 65' ' ' LEU . 3.3 p -93.96 132.42 38.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.683 -0.689 . . . . 70.11 111.794 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -84.32 -47.99 10.17 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.657 1.183 . . . . 74.33 111.479 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -150.39 156.57 41.75 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.6 -0.889 . . . . 64.45 108.6 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 34.9 p90 -129.14 159.98 34.32 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.016 0.436 . . . . 62.45 109.896 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.654 ' HB2' HG22 ' A' ' 40' ' ' VAL . 3.7 m170 -127.16 125.67 41.55 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 104.907 -2.257 . . . . 74.31 104.907 175.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -95.88 100.61 12.29 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.981 -0.377 . . . . 73.03 109.981 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.4 mm? -97.99 120.28 38.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.066 0.546 . . . . 54.01 111.375 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.7 mt -130.0 176.03 8.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.069 0.461 . . . . 72.41 110.719 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.6 mt -73.52 -22.13 18.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.268 -1.012 . . . . 72.23 108.268 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -58.38 -42.59 87.37 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.623 -1.171 . . . . 64.11 108.781 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.79 -48.03 60.66 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.984 -1.007 . . . . 75.44 108.586 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.74 87.85 0.4 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 115.104 -0.953 . . . . 50.01 112.469 175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 46.9 t -171.12 161.93 6.89 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.928 -1.138 . . . . 53.43 107.928 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -87.54 -25.92 23.41 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.928 0.394 . . . . 41.13 110.388 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.6 109.2 58.09 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-O 121.123 0.487 . . . . 62.05 111.371 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -81.86 129.73 6.38 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 121.401 1.401 . . . . 72.44 109.752 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.521 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -166.49 147.76 6.36 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.164 -0.471 . . . . 75.14 110.091 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.33 128.24 51.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 107.577 -1.268 . . . . 64.55 107.577 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.654 HG22 ' HB2' ' A' ' 26' ' ' HIS . 11.9 m -93.37 129.71 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 C-N-CA 119.42 -0.912 . . . . 71.55 109.378 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 14.7 m-85 -99.76 113.47 25.99 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.419 -0.81 . . . . 70.55 111.312 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -83.03 104.49 13.28 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.383 -0.969 . . . . 72.14 108.383 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 66.5 p -72.64 178.47 4.1 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 112.321 0.489 . . . . 61.13 112.321 -175.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.486 HD23 ' HG2' ' A' ' 23' ' ' ARG . 77.0 mt -60.69 -31.74 70.98 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.807 0.843 . . . . 70.15 110.947 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -75.93 -14.55 60.25 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.711 -0.677 . . . . 70.21 111.01 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.66 16.2 43.38 Favored Glycine 0 CA--C 1.506 -0.471 0 C-N-CA 120.571 -0.823 . . . . 44.43 112.243 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -100.54 130.49 46.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 110.379 -0.23 . . . . 74.42 110.379 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -95.67 144.03 26.43 Favored 'General case' 0 N--CA 1.426 -1.649 0 C-N-CA 120.173 -0.611 . . . . 75.11 111.412 175.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.538 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -139.42 146.33 39.99 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.445 -1.317 . . . . 63.52 107.445 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.538 ' N ' HD13 ' A' ' 49' ' ' LEU . 3.7 m -80.71 126.19 30.98 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.148 0.28 . . . . 60.23 110.286 -175.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.625 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.12 156.27 74.73 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 122.016 -0.427 . . . . 41.33 110.877 175.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.497 ' HG3' ' OE1' ' A' ' 55' ' ' GLN . 90.3 Cg_endo -72.93 116.8 4.85 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.758 2.305 . . . . 73.43 113.961 -172.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.521 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.6 Cg_endo -74.38 -9.74 21.82 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.255 1.97 . . . . 65.45 112.57 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -89.94 -38.04 13.95 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.915 -0.314 . . . . 74.24 111.192 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.497 ' OE1' ' HG3' ' A' ' 52' ' ' PRO . 52.0 mt-30 -63.99 137.73 97.19 Favored Pre-proline 0 C--O 1.239 0.523 0 N-CA-C 113.535 0.939 . . . . 74.15 113.535 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 68.5 Cg_exo -57.27 -34.53 98.0 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.9 3.067 . . . . 53.55 114.245 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -61.02 -31.95 71.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.246 0.546 . . . . 73.02 110.579 -176.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 62' ' ' ILE . 70.9 t -76.65 -38.85 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 115.434 -0.803 . . . . 71.31 111.641 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.593 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.303 0.2 OUTLIER -66.83 -24.65 66.18 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 113.815 1.042 . . . . 41.55 113.815 -175.63 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -74.22 -50.77 17.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.037 0.446 . . . . 75.34 111.345 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.514 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 10.4 pt -64.15 -32.2 56.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.567 0.58 . . . . 64.2 112.567 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 58' ' ' VAL . 58.8 mt -58.09 -47.1 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.375 -0.375 . . . . 63.24 110.195 172.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 85.5 mm-40 -58.71 -42.59 89.0 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.169 -0.469 . . . . 53.02 110.809 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -59.59 -46.32 89.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.583 -0.735 . . . . 74.44 110.593 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.538 HD11 HG13 ' A' ' 22' ' ' VAL . 89.3 mt -69.92 -34.92 74.12 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.658 -0.417 . . . . 74.32 111.24 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 97.7 mt-30 -61.88 -46.09 90.9 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 121.059 -0.256 . . . . 74.54 111.225 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -73.12 -24.12 60.58 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.542 0.942 . . . . 54.13 113.542 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.1 p -84.65 -34.51 23.03 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.056 -0.657 . . . . 64.42 111.717 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.9 p -76.09 -28.16 57.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.949 -0.569 . . . . 61.02 110.63 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.76 -18.48 43.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.072 0.949 . . . . 64.53 111.712 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -63.69 -27.22 69.07 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.937 -0.764 . . . . 63.32 108.937 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.7 tpt -106.42 98.65 8.3 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.125 -1.435 . . . . 71.34 107.125 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -81.24 -24.84 37.1 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.058 -0.519 . . . . 74.03 111.395 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -80.24 111.92 17.07 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.54 -0.541 . . . . 74.13 109.54 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -122.02 112.0 17.73 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.91 0.386 . . . . 72.45 110.948 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.5 m -96.87 -24.23 15.97 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.113 -0.494 . . . . 43.23 110.175 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 C--O 1.25 1.126 0 CA-C-O 119.026 -0.511 . . . . 65.01 109.822 177.509 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 CA-C-O 121.04 0.244 . . . . 63.25 112.582 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 57.7 m -148.8 -69.65 0.21 Allowed 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 107.461 -1.311 . . . . 74.45 107.461 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -104.9 108.77 20.45 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.649 -0.871 . . . . 73.55 108.649 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.51 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 11.7 m-20 -129.21 162.81 26.98 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.804 -0.635 . . . . 71.03 110.674 -175.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.59 -26.0 24.67 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.248 1.023 . . . . 73.22 109.916 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' OE1' ' HB3' ' A' ' 4' ' ' ASP . 1.1 pm0 -85.02 133.16 34.25 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 113.772 -1.558 . . . . 73.35 109.518 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -98.2 88.87 4.31 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 121.94 0.876 . . . . 75.14 110.205 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 47.7 t -154.92 -168.5 2.91 Favored 'General case' 0 C--N 1.265 -3.077 0 N-CA-C 106.602 -1.629 . . . . 74.44 106.602 176.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 10' ' ' LEU . 40.4 t -117.33 177.25 4.8 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 119.848 -0.741 . . . . 74.12 110.415 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 2.5 mm? -95.85 -54.2 3.42 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.913 -1.143 . . . . 75.15 107.913 175.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 p -178.05 164.17 1.81 Allowed 'General case' 0 C--O 1.251 1.141 0 N-CA-C 109.304 -0.628 . . . . 74.3 109.304 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 13' ' ' THR . 2.0 m -109.46 163.22 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 N-CA-C 105.723 -1.955 . . . . 74.53 105.723 174.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 12' ' ' VAL . 9.7 t -102.84 177.15 4.93 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.689 -1.226 . . . . 64.34 107.689 175.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -50.64 -49.17 57.54 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 123.222 0.326 . . . . 75.43 110.761 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.486 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 41.1 ttmt -144.91 97.65 4.87 Favored Pre-proline 0 N--CA 1.433 -1.314 0 N-CA-C 109.943 -0.392 . . . . 74.14 109.943 167.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 3.2 Cg_endo -48.65 -69.66 0.07 OUTLIER 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.955 3.103 . . . . 52.11 115.669 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.406 HG23 HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -150.58 165.41 17.47 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 109.754 -0.462 . . . . 72.33 109.754 -176.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.537 ' O ' HG12 ' A' ' 21' ' ' ILE . 42.9 Cg_exo -61.15 128.83 26.35 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.966 1.778 . . . . 50.04 109.061 171.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.502 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -74.66 1.2 53.78 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 115.761 1.064 . . . . 71.34 115.761 -172.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.64 -1.22 38.59 Favored 'General case' 0 C--N 1.287 -2.136 0 O-C-N 121.826 -0.808 . . . . 75.2 112.689 176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 38.1 pt -98.21 7.06 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 121.57 0.7 . . . . 71.4 109.885 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.513 HG13 HD11 ' A' ' 65' ' ' LEU . 3.5 p -92.18 138.3 20.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.564 -0.744 . . . . 61.15 111.421 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.46 -56.79 2.9 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.921 -1.036 . . . . 71.23 109.205 -173.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -139.92 173.6 11.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.473 -0.936 . . . . 73.5 108.473 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -149.68 165.66 31.7 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.632 -0.427 . . . . 71.24 110.513 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.466 ' HB2' HG22 ' A' ' 40' ' ' VAL . 39.4 m170 -128.02 116.18 19.63 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.114 -1.439 . . . . 70.24 107.114 170.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -88.23 120.61 29.75 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.393 -0.595 . . . . 72.25 109.393 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 7.5 tt -132.5 133.78 44.21 Favored 'General case' 0 N--CA 1.407 -2.608 0 O-C-N 123.366 0.417 . . . . 55.1 110.281 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.46 HD12 ' HE3' ' A' ' 31' ' ' LYS . 80.8 mt -131.33 -173.3 3.07 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.309 -0.997 . . . . 73.22 108.309 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 59.0 mt -68.53 -29.0 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.569 -0.53 . . . . 60.11 109.569 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 32' ' ' ASP 0.263 0.0 OUTLIER -64.72 -20.44 66.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.226 0.824 . . . . 72.13 113.226 176.168 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.463 ' N ' ' HD2' ' A' ' 31' ' ' LYS . 7.5 m-20 -80.82 -8.8 59.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.433 0.635 . . . . 75.42 109.644 174.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.71 79.13 1.39 Allowed Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.281 -0.872 . . . . 74.25 113.593 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 47.4 t -178.82 148.51 0.42 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.215 -1.402 . . . . 63.01 107.215 175.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -73.26 -31.03 63.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.508 0.559 . . . . 61.52 112.508 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.48 106.57 46.75 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-O 121.32 0.581 . . . . 70.42 111.519 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.55 129.43 4.25 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.107 1.871 . . . . 73.44 110.836 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 50' ' ' CYS . . . -165.73 145.96 6.66 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.991 -0.549 . . . . 64.01 110.122 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.51 125.47 53.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.402 -0.962 . . . . 71.25 108.402 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.658 HG12 ' SG ' ' A' ' 50' ' ' CYS . 5.3 m -88.73 124.78 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 C-N-CA 119.409 -0.916 . . . . 75.11 109.537 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 10.6 m-85 -96.32 121.76 38.46 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.287 -0.87 . . . . 75.42 111.353 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.9 m -87.7 105.79 17.6 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.577 -1.268 . . . . 70.53 107.577 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 61.4 p -74.81 172.76 11.61 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.735 -0.211 . . . . 75.14 110.959 -176.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 88.4 mt -63.98 -25.71 68.25 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.437 0.637 . . . . 61.1 109.74 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -61.02 -33.74 73.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.71 -1.132 . . . . 72.12 109.953 174.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.3 -0.14 40.63 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.643 -0.708 . . . . 54.33 111.857 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -95.44 153.19 17.82 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.06 -1.089 . . . . 72.12 108.06 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 41.4 mt-30 -110.5 138.79 46.42 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.482 -0.562 . . . . 65.14 109.482 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.406 HD23 HG23 ' A' ' 17' ' ' ILE . 47.1 tp -139.75 132.56 29.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.116 -1.068 . . . . 73.31 108.116 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.658 ' SG ' HG12 ' A' ' 40' ' ' VAL . 9.8 m -82.08 142.95 31.85 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 120.175 -0.61 . . . . 64.31 112.166 -174.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.58 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.78 158.35 68.48 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 115.465 -0.789 . . . . 42.01 110.144 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.484 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 88.3 Cg_endo -73.69 109.59 2.89 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.495 2.13 . . . . 71.34 113.281 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 52' ' ' PRO . 14.6 Cg_exo -69.45 -11.24 30.81 Favored 'Trans proline' 0 N--CA 1.482 0.799 0 C-N-CA 122.697 2.265 . . . . 70.55 112.594 -176.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -95.61 -5.8 41.68 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.479 -0.782 . . . . 74.42 111.21 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.3 mm100 -98.06 128.69 32.91 Favored Pre-proline 0 N--CA 1.443 -0.805 0 C-N-CA 120.548 -0.461 . . . . 73.23 111.407 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.23 -34.0 23.27 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 124.28 3.32 . . . . 74.15 115.449 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -62.85 -33.32 75.01 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.135 -0.626 . . . . 74.04 109.988 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 62' ' ' ILE . 89.7 t -77.53 -40.16 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.709 -0.678 . . . . 73.33 110.275 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.04 -27.3 69.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.133 0.492 . . . . 72.4 111.422 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -72.03 -44.01 64.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.706 -0.679 . . . . 71.2 110.575 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.502 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 16.5 pt -80.32 -30.65 12.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.396 0.888 . . . . 72.33 113.396 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 58' ' ' VAL . 65.2 mt -55.34 -44.84 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 110.389 -0.226 . . . . 72.42 110.389 174.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -60.02 -40.91 90.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.079 0.466 . . . . 74.31 110.105 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.86 -42.05 88.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.258 -0.883 . . . . 75.24 109.814 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.513 HD11 HG13 ' A' ' 22' ' ' VAL . 82.4 mt -76.25 -35.97 58.72 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.446 0.536 . . . . 71.43 112.446 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 90.7 mt-30 -64.72 -25.75 68.07 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 120.467 -0.493 . . . . 72.22 111.836 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.59 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -84.78 -34.96 22.69 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.073 -0.651 . . . . 71.1 111.421 176.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.9 p -85.35 -36.44 20.76 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 114.439 1.274 . . . . 60.23 114.439 -175.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.3 t -86.54 -39.8 15.86 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.922 -0.581 . . . . 74.44 111.123 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 66' ' ' GLN . . . -72.78 -45.27 59.47 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 116.239 -0.437 . . . . 62.25 110.467 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -116.48 92.15 3.8 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.83 -1.174 . . . . 54.02 107.83 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -37.24 103.05 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 127.461 2.304 . . . . 75.35 115.961 -168.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -133.52 97.74 4.02 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.074 -1.421 . . . . 65.23 109.364 172.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -138.94 172.49 12.77 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.452 -0.795 . . . . 71.14 109.761 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -142.04 -148.99 0.25 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.141 -1.429 . . . . 73.4 107.141 -172.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.7 p -54.3 -34.32 60.69 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.762 0.791 . . . . 62.54 109.472 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.418 -2.063 0 N-CA-C 106.458 -1.682 . . . . 62.22 106.458 172.56 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.173 0 N-CA-C 110.323 -1.111 . . . . 73.53 110.323 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 6' ' ' GLU . 69.2 m -83.93 145.17 28.72 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.079 -1.082 . . . . 73.21 108.079 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -58.82 151.4 21.51 Favored 'General case' 0 C--O 1.251 1.145 0 O-C-N 123.062 0.226 . . . . 60.44 110.915 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 5' ' ' ALA . 19.1 t70 74.98 -158.25 0.06 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.536 1.134 . . . . 64.53 108.182 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.409 ' H ' ' CG ' ' A' ' 4' ' ' ASP . . . -79.62 -3.55 47.63 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 121.491 -0.756 . . . . 73.32 111.581 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.496 ' HB3' ' HB ' ' A' ' 2' ' ' THR 0.332 11.8 pt-20 50.86 77.61 0.12 Allowed 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 126.657 1.983 . . . . 64.3 115.819 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -103.25 -17.93 15.11 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 114.211 -1.359 . . . . 74.45 108.811 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.461 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 73.0 m -80.85 140.91 35.13 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 106.922 -1.51 . . . . 71.23 106.922 174.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -95.06 175.61 6.56 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.94 -0.704 . . . . 72.23 112.705 -169.292 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 tt -88.2 -66.11 0.95 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.643 -0.873 . . . . 64.14 108.643 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -175.92 153.12 1.3 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.778 -1.193 . . . . 63.12 107.778 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 13' ' ' THR . 1.4 m -98.79 160.82 3.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 119.126 -1.03 . . . . 73.51 109.506 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 12' ' ' VAL . 7.1 t -101.38 173.19 6.55 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 106.56 -1.644 . . . . 70.35 106.56 174.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -43.8 -59.43 2.24 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.528 0.518 . . . . 53.45 111.373 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 40.8 ttmt -143.09 94.15 6.4 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 109.753 -0.462 . . . . 75.31 109.753 173.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.614 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.7 Cg_endo -52.99 -85.61 0.01 OUTLIER 'Trans proline' 0 CA--C 1.556 1.617 0 C-N-CA 124.138 3.226 . . . . 52.2 117.58 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.406 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -145.04 149.46 42.26 Favored Pre-proline 0 C--O 1.207 -1.161 0 O-C-N 121.73 -0.606 . . . . 73.13 110.4 -174.07 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.22 144.97 99.07 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.54 2.16 . . . . 72.14 112.29 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.426 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -80.16 1.75 79.06 Favored Glycine 0 CA--C 1.502 -0.743 0 CA-C-N 115.848 -0.614 . . . . 54.41 112.748 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -80.13 -23.2 41.32 Favored 'General case' 0 N--CA 1.408 -2.565 0 CA-C-O 121.04 0.447 . . . . 72.41 110.553 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.434 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 37.3 pt -101.89 13.01 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.879 -0.513 . . . . 75.51 111.78 -177.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 19' ' ' GLY . 6.5 p -98.82 137.7 25.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.511 0.672 . . . . 63.31 111.908 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -89.45 -54.46 4.08 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.43 1.092 . . . . 73.33 108.588 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -139.33 164.02 30.95 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.393 -0.965 . . . . 71.32 108.393 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -140.84 160.5 39.93 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.594 -0.521 . . . . 72.41 109.594 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.487 ' HB2' HG22 ' A' ' 40' ' ' VAL . 38.5 m80 -135.81 127.06 28.25 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.368 -1.345 . . . . 74.45 107.368 173.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -92.67 122.38 35.02 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.488 -0.93 . . . . 75.33 108.488 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.4 mm? -116.18 126.24 53.39 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 120.861 0.362 . . . . 72.4 111.651 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.7 mt -129.26 172.84 11.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.165 -1.05 . . . . 64.03 108.165 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 35' ' ' ARG . 32.0 mt -74.63 -18.11 16.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.827 -1.175 . . . . 65.31 107.827 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -61.7 -32.8 73.03 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.93 -1.032 . . . . 72.42 109.455 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.27 -38.99 71.84 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.001 -0.545 . . . . 73.42 109.562 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.1 -50.93 0.54 Allowed Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 115.507 -0.77 . . . . 44.52 112.765 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 71.1 m -67.43 132.73 48.21 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.835 0.35 . . . . 44.41 110.888 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.471 ' HA ' HG12 ' A' ' 30' ' ' ILE . 86.7 mtt180 -80.48 22.77 0.54 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.03 0.752 . . . . 70.14 113.03 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -126.77 96.03 36.12 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 108.908 -0.775 . . . . 74.34 108.908 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -85.24 129.65 3.84 Favored 'Trans proline' 0 N--CA 1.443 -1.441 0 C-N-CA 121.902 1.734 . . . . 75.33 112.354 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.551 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -174.77 166.34 3.7 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.087 -0.961 . . . . 74.33 108.696 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.85 130.95 60.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.555 -1.276 . . . . 53.51 107.555 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 26' ' ' HIS . 6.8 m -96.3 128.08 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.83 0 C-N-CA 119.576 -0.849 . . . . 71.4 109.583 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 28.8 m-85 -99.65 121.51 41.32 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.592 -0.731 . . . . 73.53 110.839 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.3 m -85.93 97.99 10.55 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.137 -1.431 . . . . 74.33 107.137 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.6 p -70.14 169.74 12.94 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.65 -0.25 . . . . 63.35 111.053 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 91.2 mt -60.33 -26.84 66.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.352 0.596 . . . . 62.41 109.87 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -61.58 -28.87 69.66 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.438 1.095 . . . . 74.11 110.678 175.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.34 9.32 58.03 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 111.834 -0.506 . . . . 75.45 111.834 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -103.76 136.21 43.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.708 -1.59 . . . . 74.11 106.708 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 90.8 mt-30 -92.19 130.5 37.89 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 121.122 -0.231 . . . . 71.22 110.413 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 7.2 mp -119.62 147.08 44.95 Favored 'General case' 0 CA--C 1.475 -1.909 0 CA-C-N 116.406 -0.361 . . . . 73.52 111.0 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.407 ' HB3' HG12 ' A' ' 12' ' ' VAL . 5.1 m -86.1 125.24 33.32 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.075 -0.966 . . . . 72.03 109.18 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.614 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.41 152.45 76.4 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 118.016 0.371 . . . . 43.23 111.736 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.09 108.14 2.26 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.329 2.686 . . . . 71.2 114.243 -174.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 40.9 Cg_endo -67.95 -13.54 38.62 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.489 2.126 . . . . 65.44 111.245 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.67 -27.71 50.94 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.574 -1.194 . . . . 44.41 111.687 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 30.3 mm-40 -85.99 142.06 36.01 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 113.513 0.931 . . . . 65.12 113.513 -173.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 40.0 Cg_exo -58.22 -38.07 92.67 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.603 2.869 . . . . 62.31 113.451 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.422 ' O ' HG12 ' A' ' 61' ' ' ILE . 39.4 p-90 -63.44 -27.73 69.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.961 0.41 . . . . 74.44 110.304 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.554 ' O ' HG13 ' A' ' 62' ' ' ILE . 53.1 t -78.97 -46.89 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 116.0 -0.545 . . . . 71.22 111.756 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -25.37 67.09 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 119.549 -0.86 . . . . 74.11 109.719 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -59.65 -56.35 22.93 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.51 -1.223 . . . . 74.55 108.895 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.426 HG21 ' HA3' ' A' ' 19' ' ' GLY . 12.0 pt -74.55 -32.21 29.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.967 -1.015 . . . . 63.34 113.598 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 58' ' ' VAL . 64.1 mt -54.95 -55.74 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 123.254 0.347 . . . . 71.24 111.178 176.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.54 -38.9 92.91 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 112.42 0.526 . . . . 62.32 112.42 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -62.17 -42.47 99.3 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.667 -0.697 . . . . 65.11 112.021 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 tt -72.94 -31.72 64.78 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.179 -0.674 . . . . 74.11 109.179 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 28.5 mt-30 -48.87 -39.6 26.41 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 120.812 0.339 . . . . 72.44 111.383 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -61.97 -37.47 84.91 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.784 -0.644 . . . . 73.44 112.286 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.8 t -85.97 -25.81 25.82 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.587 -0.845 . . . . 74.42 110.419 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.3 t -75.77 -25.54 56.55 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.446 -0.797 . . . . 73.01 110.578 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.94 -20.1 63.35 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.432 0.634 . . . . 54.41 110.078 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.47 175.54 5.43 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 108.735 -0.839 . . . . 54.33 108.735 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.0 ptp -128.15 146.56 50.67 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.684 -0.407 . . . . 71.21 110.345 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -72.84 -26.03 61.33 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.777 0.799 . . . . 73.43 109.757 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -91.41 102.49 15.17 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.314 -0.857 . . . . 71.32 109.19 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 66.79 93.57 0.07 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.753 0.821 . . . . 73.21 111.007 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.0 m -107.53 143.76 35.49 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.505 -0.771 . . . . 65.13 110.247 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.438 -1.053 0 N-CA-C 109.099 -0.704 . . . . 60.44 109.099 177.478 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.684 0 N-CA-C 110.54 -1.024 . . . . 44.42 110.54 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.3 m -96.43 97.05 9.14 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.63 -0.878 . . . . 74.53 108.63 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -136.3 99.11 4.01 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 115.847 -0.615 . . . . 63.25 110.257 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -158.78 176.78 11.93 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.889 -1.152 . . . . 72.34 107.889 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 9' ' ' CYS . . . -72.41 -23.29 61.07 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 113.468 0.914 . . . . 45.51 113.468 -176.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 65.16 -67.5 0.12 Allowed 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 125.875 1.67 . . . . 53.13 111.666 -174.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.33 -59.19 0.74 Allowed 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 114.819 -1.082 . . . . 53.55 109.728 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.502 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 29.1 p -100.54 134.8 42.96 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.247 -0.581 . . . . 72.34 110.338 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.507 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -65.45 125.53 25.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.987 -0.552 . . . . 61.01 112.454 -172.207 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.438 ' O ' HG21 ' A' ' 36' ' ' VAL . 76.1 mt -50.6 -54.62 21.27 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.785 1.634 . . . . 65.34 114.586 -172.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.6 p -174.38 142.57 0.79 Allowed 'General case' 0 CA--C 1.486 -1.505 0 C-N-CA 120.085 -0.646 . . . . 61.23 109.734 -174.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.2 m -98.5 162.65 2.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.127 -1.064 . . . . 60.54 108.127 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 12' ' ' VAL . 15.4 t -105.18 178.18 4.63 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 107.115 -1.439 . . . . 72.23 107.115 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -41.43 -57.97 2.03 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.51 0.724 . . . . 72.24 110.696 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 ttpt -146.96 97.1 4.21 Favored Pre-proline 0 N--CA 1.431 -1.421 0 N-CA-C 108.7 -0.852 . . . . 71.14 108.7 170.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.595 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 5.4 Cg_endo -44.99 -73.03 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.915 3.077 . . . . 73.42 115.997 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.84 163.72 34.16 Favored Pre-proline 0 C--N 1.317 -0.824 0 O-C-N 122.153 -0.342 . . . . 61.34 110.269 -176.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.58 ' O ' HG12 ' A' ' 21' ' ' ILE . 71.2 Cg_exo -55.49 129.09 33.24 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.446 2.097 . . . . 63.41 110.186 171.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.496 ' HA3' HD13 ' A' ' 61' ' ' ILE . . . -77.79 -4.34 85.23 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.953 -0.642 . . . . 74.34 114.377 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -96.19 2.6 53.18 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.331 -0.511 . . . . 75.41 111.816 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 18' ' ' PRO . 32.6 pt -106.75 12.39 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 120.077 -0.649 . . . . 70.21 110.654 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.604 HG13 HD11 ' A' ' 65' ' ' LEU . 2.2 p -95.55 133.26 37.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.651 0.738 . . . . 71.34 112.407 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.596 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 1.2 tmt_? -93.62 -49.2 5.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.595 -1.184 . . . . 65.32 108.556 -174.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.596 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 16.1 m120 -135.5 154.05 51.53 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.891 -0.781 . . . . 74.3 108.891 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.9 143.91 41.07 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.209 -0.596 . . . . 72.04 109.699 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.538 ' HB2' HG22 ' A' ' 40' ' ' VAL . 43.9 m170 -118.72 132.32 56.15 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.363 -1.717 . . . . 61.34 106.363 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -99.77 102.83 14.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.487 -0.56 . . . . 71.54 109.487 -174.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.502 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.1 mm? -102.26 120.37 40.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.872 -0.603 . . . . 75.03 111.049 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.0 mt -131.87 168.75 17.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.29 0.567 . . . . 74.22 110.603 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mt -77.89 -17.33 14.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 107.696 -1.224 . . . . 64.02 107.696 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.07 -31.91 71.57 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 114.967 -1.015 . . . . 75.35 109.417 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -76.66 -54.45 6.64 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.073 -1.084 . . . . 41.05 108.073 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.13 89.13 0.23 Allowed Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.413 -0.812 . . . . 62.41 112.518 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.5 t -171.59 -176.08 1.72 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.63 -0.878 . . . . 51.03 108.63 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -81.55 -43.02 19.31 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.808 0.443 . . . . 75.13 111.846 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 10' ' ' LEU . 2.8 p -130.84 128.24 22.35 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 113.609 0.966 . . . . 64.23 113.609 -172.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 92.0 Cg_endo -88.82 132.18 2.38 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 123.029 2.486 . . . . 64.42 112.553 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 9' ' ' CYS . . . -175.06 153.41 1.62 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.855 0.862 . . . . 74.42 108.794 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -99.1 132.64 44.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.672 -1.233 . . . . 75.33 107.672 176.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.538 HG22 ' HB2' ' A' ' 26' ' ' HIS . 5.9 m -93.38 122.75 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 C-N-CA 119.346 -0.942 . . . . 74.01 109.225 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.498 ' CD1' HG21 ' A' ' 22' ' ' VAL . 8.8 m-85 -94.77 115.91 28.08 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 115.333 -0.849 . . . . 73.35 110.56 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.1 m -85.47 104.77 15.56 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.362 -0.977 . . . . 61.23 108.362 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.0 p -71.15 178.4 3.3 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.166 -0.47 . . . . 74.03 111.448 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.5 mt -66.11 -25.18 66.87 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.778 0.799 . . . . 73.43 109.926 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -71.93 -16.31 62.1 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.787 -1.097 . . . . 74.23 110.656 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.63 16.01 57.4 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.863 -0.684 . . . . 74.03 111.579 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 31.0 mmt180 -97.91 135.34 39.78 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 120.739 0.304 . . . . 63.13 111.753 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -97.56 114.56 26.48 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.168 -0.924 . . . . 73.11 109.481 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.1 mp -116.53 148.42 40.85 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 116.497 -0.32 . . . . 75.42 111.603 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.414 ' HB3' HG12 ' A' ' 12' ' ' VAL . 34.8 m -77.75 122.29 25.18 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.436 -0.802 . . . . 71.24 110.667 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.595 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.54 151.71 73.34 Favored Pre-proline 0 C--O 1.242 0.704 0 C-N-CA 121.101 -0.24 . . . . 64.3 111.535 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 83.1 Cg_endo -74.27 110.87 3.18 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 123.284 2.656 . . . . 73.35 114.407 -172.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 52' ' ' PRO . 17.7 Cg_exo -67.18 -18.69 51.02 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.391 2.061 . . . . 75.52 112.948 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -87.54 -19.93 27.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.072 0.767 . . . . 64.44 113.072 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -83.99 139.02 39.77 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 114.08 1.141 . . . . 62.4 114.08 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.459 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 9.7 Cg_endo -52.07 -39.92 69.29 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 124.608 3.538 . . . . 65.43 114.753 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.1 p-90 -59.47 -31.87 69.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.714 -0.395 . . . . 74.51 111.025 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 62' ' ' ILE . 78.2 t -77.56 -42.95 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.935 -0.575 . . . . 63.11 111.599 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -67.19 -25.25 66.04 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.961 -0.696 . . . . 75.14 112.176 -178.157 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HD3' ' OE1' ' A' ' 63' ' ' GLN . 37.0 mmt180 -71.37 -34.91 70.88 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.795 -0.639 . . . . 74.34 112.547 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.496 HD13 ' HA3' ' A' ' 19' ' ' GLY . 10.6 pt -85.33 -34.16 8.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 120.718 -0.393 . . . . 75.31 111.8 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 58' ' ' VAL . 59.2 mt -56.74 -49.42 78.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-N 116.034 -0.53 . . . . 75.3 111.232 173.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.45 ' OE1' ' HD3' ' A' ' 60' ' ' ARG . 4.1 pt20 -59.08 -39.68 82.91 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.043 0.449 . . . . 73.0 111.221 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -60.76 -51.3 69.93 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.987 -1.006 . . . . 71.21 110.332 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.604 HD11 HG13 ' A' ' 22' ' ' VAL . 82.5 mt -66.26 -26.4 67.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.057 0.391 . . . . 72.32 112.057 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.51 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 55.9 mt-30 -63.24 -20.48 65.49 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 120.803 0.335 . . . . 65.55 111.822 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -78.51 -32.42 48.08 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.098 0.475 . . . . 75.11 110.227 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.404 HG22 ' HA ' ' A' ' 65' ' ' LEU . 8.9 t -84.97 -22.28 29.21 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.304 -0.559 . . . . 74.22 110.84 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.51 ' OG ' ' HA ' ' A' ' 66' ' ' GLN . 78.1 p -84.56 -18.84 34.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.382 0.61 . . . . 61.22 109.647 176.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.32 80.34 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.153 -0.93 . . . . 55.22 108.846 175.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -67.3 119.6 12.44 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.586 -1.635 . . . . 71.2 106.586 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.2 tpp -60.51 104.0 0.3 Allowed 'General case' 0 C--O 1.253 1.273 0 CA-C-O 121.784 0.802 . . . . 74.24 113.073 -172.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -84.79 86.89 7.3 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.795 -1.093 . . . . 72.13 109.333 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -132.47 23.09 4.37 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 105.644 -1.984 . . . . 75.51 105.644 172.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -112.43 140.71 46.94 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.204 -1.817 . . . . 65.04 106.204 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.7 t -76.34 107.37 8.55 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.814 -0.81 . . . . 62.33 108.814 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.2 m . . . . . 0 C--N 1.311 -1.098 0 N-CA-C 109.366 -0.605 . . . . 37.01 109.366 -178.196 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.278 0 N-CA-C 112.132 -0.387 . . . . 71.13 112.132 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.8 t -147.05 114.66 6.38 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 109.592 -0.521 . . . . 71.11 109.592 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -113.11 81.41 1.49 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.552 1.316 . . . . 73.13 114.552 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.7 t70 43.34 -78.8 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 117.659 2.466 . . . . 65.33 117.659 169.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.93 -12.26 60.89 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.011 1.485 . . . . 61.11 115.011 -169.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -113.01 119.38 37.72 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 112.936 0.717 . . . . 75.4 112.936 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -96.53 -12.78 23.61 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.236 -0.893 . . . . 74.41 108.846 176.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.411 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 6.8 p -81.22 174.19 11.79 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.904 -1.044 . . . . 44.14 110.16 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB2' HG12 ' A' ' 40' ' ' VAL . 1.2 t -94.18 -179.39 4.93 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.801 -0.76 . . . . 74.11 111.676 -169.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.22 -66.92 0.83 Allowed 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.044 0.538 . . . . 53.05 110.434 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 p -176.4 150.09 0.87 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.113 -1.44 . . . . 75.45 107.113 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.435 HG12 ' HB3' ' A' ' 50' ' ' CYS . 2.0 m -98.49 161.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 118.812 -1.155 . . . . 51.25 109.276 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 t -104.13 177.72 4.76 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.661 -1.607 . . . . 72.12 106.661 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -51.44 -58.5 6.1 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.148 0.431 . . . . 65.41 110.124 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 59.8 tttm -137.42 99.83 9.53 Favored Pre-proline 0 N--CA 1.424 -1.732 0 C-N-CA 120.014 -0.675 . . . . 73.11 111.654 172.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 19.1 Cg_endo -67.48 -164.09 0.09 OUTLIER 'Trans proline' 0 CA--C 1.567 2.148 0 C-N-CA 122.84 2.36 . . . . 75.15 114.167 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.33 156.76 5.45 Favored Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 125.436 1.495 . . . . 72.53 113.363 -175.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -73.65 149.09 42.98 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.63 2.22 . . . . 73.11 112.527 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.433 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -77.81 1.54 67.47 Favored Glycine 0 N--CA 1.459 0.216 0 CA-C-N 115.788 -0.642 . . . . 33.05 113.488 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -82.97 -23.69 33.27 Favored 'General case' 0 C--N 1.285 -2.232 0 O-C-N 122.259 -0.553 . . . . 74.4 111.522 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.412 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 42.4 pt -100.9 12.26 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.111 0.481 . . . . 74.32 111.904 -177.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.56 HG13 HD11 ' A' ' 65' ' ' LEU . 4.3 p -97.94 136.79 27.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.04 -0.527 . . . . 61.55 111.394 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -55.82 3.49 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.437 -1.32 . . . . 73.04 107.437 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -142.33 163.91 31.58 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.636 -0.876 . . . . 52.03 108.636 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.404 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 37.9 p90 -132.51 157.47 44.58 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.964 -0.294 . . . . 72.12 110.28 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.454 ' HB2' HG22 ' A' ' 40' ' ' VAL . 37.8 m80 -125.54 113.56 17.6 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.668 -1.234 . . . . 72.03 107.668 172.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -82.68 100.78 10.43 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.523 -0.762 . . . . 71.34 109.235 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 83.5 mt -112.06 143.15 43.55 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.691 -0.686 . . . . 62.43 111.846 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 98.1 mt -141.3 -177.61 5.21 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.046 -0.979 . . . . 70.54 109.842 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 57.9 mt -74.93 -29.42 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.442 -1.318 . . . . 71.2 107.442 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.02 -20.54 64.04 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.911 -1.04 . . . . 72.52 110.907 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -79.66 -49.55 11.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.553 -1.277 . . . . 54.22 107.553 174.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.33 51.15 0.06 OUTLIER Glycine 0 C--O 1.24 0.523 0 C-N-CA 120.621 -0.799 . . . . 33.32 114.1 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 87.3 m -145.5 144.74 30.74 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.764 -1.199 . . . . 75.53 107.764 174.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -63.81 -30.96 71.99 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.159 0.504 . . . . 70.23 111.03 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -100.32 112.96 65.2 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-N 115.432 -0.804 . . . . 62.02 111.572 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.8 130.33 3.66 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 122.191 1.928 . . . . 61.44 109.953 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -170.65 146.26 2.65 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.885 -0.413 . . . . 71.43 109.885 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.41 126.14 51.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.061 -1.459 . . . . 74.03 107.061 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 9' ' ' CYS . 13.1 m -90.1 128.32 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 C-N-CA 119.523 -0.871 . . . . 63.31 109.448 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -96.62 114.0 25.61 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 115.362 -0.835 . . . . 72.02 109.385 174.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.6 m -84.74 104.83 15.05 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.442 -1.318 . . . . 62.52 107.442 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 64.5 p -70.06 175.3 4.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 112.706 0.632 . . . . 54.11 112.706 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 90.7 mt -61.01 -27.36 68.27 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.472 0.709 . . . . 71.34 110.672 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -79.69 -13.96 59.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.706 -0.679 . . . . 73.23 110.488 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.07 16.67 43.39 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.203 -0.999 . . . . 42.33 112.602 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -96.06 138.64 33.39 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 122.747 -0.267 . . . . 74.13 110.631 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -93.12 125.18 37.58 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 123.909 0.756 . . . . 64.31 109.304 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.2 tm? -127.95 141.95 51.39 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.944 -1.132 . . . . 72.33 107.944 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.542 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.2 m -81.51 122.88 28.1 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.098 0.559 . . . . 75.41 111.15 -174.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.03 152.76 76.14 Favored Pre-proline 0 C--O 1.245 0.82 0 C-N-CA 120.237 -0.585 . . . . 43.21 111.51 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 93.8 Cg_endo -73.38 112.36 3.51 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.791 2.327 . . . . 70.24 113.564 -173.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.57 -9.63 24.26 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.204 1.936 . . . . 70.25 111.681 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.21 -17.98 24.08 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.125 -0.943 . . . . 54.22 111.45 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 31.3 mm-40 -89.7 133.08 34.92 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 112.889 0.7 . . . . 74.14 112.889 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.532 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 94.6 Cg_exo -44.81 -45.19 13.89 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 124.738 3.625 . . . . 75.21 115.771 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.445 ' HZ2' ' HD2' ' A' ' 16' ' ' PRO . 33.5 p-90 -58.16 -36.78 73.52 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.656 0.265 . . . . 70.13 111.606 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 62' ' ' ILE . 71.0 t -68.59 -42.23 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 116.247 -0.433 . . . . 71.33 110.342 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.532 ' OE1' ' HA ' ' A' ' 56' ' ' PRO . 40.7 mt-10 -56.43 -33.22 65.64 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.878 -0.601 . . . . 71.32 111.029 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' A' ' 56' ' ' PRO . 9.3 mpt_? -77.54 -43.39 32.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.97 -0.559 . . . . 74.45 112.449 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.433 HG21 ' HA3' ' A' ' 19' ' ' GLY . 8.8 pt -70.77 -32.07 47.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 112.872 0.693 . . . . 73.14 112.872 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 58' ' ' VAL . 70.4 mt -54.12 -42.68 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 109.55 -0.537 . . . . 63.45 109.55 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 79.6 mm-40 -57.78 -45.55 85.83 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.642 -0.708 . . . . 74.13 110.731 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -61.43 -41.47 97.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.134 -0.485 . . . . 63.41 111.85 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.56 HD11 HG13 ' A' ' 22' ' ' VAL . 86.3 mt -72.4 -35.74 68.49 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.014 -0.674 . . . . 74.44 111.474 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 51.4 mt-30 -66.5 -45.75 78.54 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.116 -0.633 . . . . 72.42 111.618 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -71.75 -20.48 61.88 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 120.755 -0.378 . . . . 72.32 111.837 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 p -84.97 -31.43 23.55 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.905 -0.718 . . . . 63.15 111.083 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.9 t -67.59 -48.57 66.46 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.94 -0.763 . . . . 72.24 108.94 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.08 -19.3 58.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.938 -0.574 . . . . 63.22 110.002 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.475 ' HG3' ' H ' ' A' ' 72' ' ' MET 0.365 8.1 ptpp? 53.05 -91.01 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 115.17 1.545 . . . . 75.41 115.17 -179.773 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.475 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 49.6 ttm -117.62 4.8 12.35 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.504 0.668 . . . . 72.11 109.684 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -77.84 87.1 4.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.928 0.871 . . . . 72.25 110.4 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -94.05 -44.77 7.87 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.288 -1.323 . . . . 65.33 109.295 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -125.1 1.43 7.91 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.705 -1.22 . . . . 72.01 107.705 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.3 m 61.09 75.98 0.39 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.16 -1.382 . . . . 63.44 110.445 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.305 -1.328 0 CA-C-N 114.679 -1.146 . . . . 64.25 108.063 -178.31 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.321 0 N-CA-C 111.826 -0.51 . . . . 74.42 111.826 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 77.5 m -69.93 99.05 1.35 Allowed 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.484 -0.561 . . . . 64.54 109.484 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.4 t30 70.73 159.41 0.2 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.167 0.987 . . . . 60.04 109.676 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.4 t70 73.75 -46.35 0.63 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 123.873 0.869 . . . . 74.24 113.112 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.88 -4.6 50.48 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.86 0.838 . . . . 63.23 110.73 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -107.66 117.89 35.29 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.797 -1.092 . . . . 72.42 108.744 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -117.04 70.36 0.77 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.483 1.135 . . . . 51.13 111.519 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.479 ' HA ' HD13 ' A' ' 28' ' ' LEU . 45.5 t 178.14 -176.63 0.2 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 104.496 -2.409 . . . . 64.14 104.496 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 10' ' ' LEU . 38.9 t -123.74 173.45 8.13 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 119.372 0.987 . . . . 71.44 111.11 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 80.7 mt -89.21 -55.14 3.79 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 108.54 -0.911 . . . . 73.42 108.54 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.9 t -176.94 165.13 2.39 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.493 -0.928 . . . . 63.31 108.493 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.514 HG12 ' CB ' ' A' ' 50' ' ' CYS . 1.5 m -126.0 152.77 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 105.882 -1.895 . . . . 53.23 105.882 174.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.4 t -93.46 176.58 6.33 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.166 -1.42 . . . . 54.11 107.166 174.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -58.21 -43.97 87.93 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 118.537 0.608 . . . . 75.42 112.15 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -144.05 87.27 8.03 Favored Pre-proline 0 N--CA 1.414 -2.272 0 N-CA-C 108.049 -1.093 . . . . 71.22 108.049 171.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.0 Cg_endo -51.39 -80.11 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 124.216 3.277 . . . . 72.44 117.55 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.463 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -143.32 170.19 9.08 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 109.912 -0.403 . . . . 52.12 109.912 -171.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.576 ' O ' HG12 ' A' ' 21' ' ' ILE . 44.6 Cg_exo -60.52 132.24 42.28 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.208 1.939 . . . . 61.43 111.442 175.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.455 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -79.48 2.29 72.94 Favored Glycine 0 C--N 1.299 -1.522 0 CA-C-N 115.981 -0.554 . . . . 53.43 113.798 -176.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -98.75 -5.25 31.72 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.6 0.593 . . . . 73.22 112.6 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.9 pt -93.71 3.56 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 121.612 0.72 . . . . 71.44 110.527 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.636 HG13 HD11 ' A' ' 65' ' ' LEU . 2.7 p -88.73 137.83 20.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.133 -0.94 . . . . 64.45 111.334 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.31 -55.97 3.57 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.324 -1.361 . . . . 75.03 107.324 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -143.43 162.84 34.73 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 124.132 0.973 . . . . 63.32 108.896 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -132.63 161.6 33.5 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.7 -0.4 . . . . 74.13 110.014 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.497 ' HB2' HG22 ' A' ' 40' ' ' VAL . 42.1 m80 -127.42 112.68 15.26 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.629 -0.878 . . . . 73.25 108.629 172.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -85.65 105.85 16.51 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.41 -0.814 . . . . 72.53 109.115 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 8' ' ' CYS . 8.7 tt -119.93 133.17 55.65 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-O 121.218 0.532 . . . . 70.4 110.647 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.4 mt -127.51 -177.7 4.18 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.661 -0.699 . . . . 73.04 109.423 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 58.8 mt -72.38 -20.39 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.149 -1.056 . . . . 74.4 108.149 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -62.91 -31.88 73.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.835 -1.075 . . . . 72.04 109.434 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.6 -57.34 5.88 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.583 -0.895 . . . . 63.03 108.583 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.65 71.5 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.333 -0.937 . . . . 52.44 112.877 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 35.6 t -173.1 140.85 0.91 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.794 -1.928 . . . . 75.4 105.794 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -73.18 -19.92 61.0 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.882 1.068 . . . . 71.01 113.882 -173.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.24 102.31 31.95 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-O 121.314 0.578 . . . . 74.14 110.823 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.3 130.34 6.24 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.391 2.061 . . . . 64.33 110.792 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 50' ' ' CYS . . . -165.49 148.64 7.96 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 120.873 0.368 . . . . 75.34 110.472 -177.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.25 119.95 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.017 0 N-CA-C 107.939 -1.134 . . . . 45.4 107.939 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.685 HG12 ' SG ' ' A' ' 50' ' ' CYS . 7.3 m -86.12 127.04 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.411 0 C-N-CA 119.854 -0.739 . . . . 63.24 109.108 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -97.6 114.8 26.8 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.584 -0.735 . . . . 74.33 110.047 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.4 m -81.2 103.35 10.93 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.194 -1.039 . . . . 74.14 108.194 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.7 p -73.77 171.52 13.17 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.282 -0.417 . . . . 71.22 111.375 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.4 mt -58.56 -28.83 65.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.537 0.735 . . . . 75.51 112.131 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -74.77 -14.45 60.71 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.403 0.681 . . . . 74.33 111.309 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.98 17.59 37.23 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 119.935 -1.126 . . . . 71.43 111.421 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -99.62 123.93 44.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 122.69 -0.3 . . . . 60.13 111.332 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -80.73 122.39 27.08 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.962 -0.755 . . . . 63.31 108.962 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 tp -136.07 126.37 26.54 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.228 -1.027 . . . . 75.21 108.228 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.685 ' SG ' HG12 ' A' ' 40' ' ' VAL . 17.3 m -87.39 149.41 24.49 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 113.713 1.005 . . . . 70.25 113.713 -171.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.587 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -134.06 162.54 57.09 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 115.058 -0.974 . . . . 75.24 109.221 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 63.2 Cg_endo -69.03 109.44 2.17 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.077 1.852 . . . . 63.02 112.298 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.04 -21.63 63.13 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.448 2.765 . . . . 73.52 115.794 -170.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -102.95 -14.3 16.56 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.977 0.418 . . . . 51.33 111.934 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.5 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.7 mm100 -68.39 141.76 93.8 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 113.51 0.93 . . . . 74.51 113.51 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 71.5 Cg_exo -46.9 -39.06 24.31 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 124.78 3.654 . . . . 61.43 115.896 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -74.43 -31.87 62.45 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.374 -0.93 . . . . 72.14 110.791 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 62' ' ' ILE . 77.1 t -77.09 -38.77 28.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.96 -0.564 . . . . 72.31 112.308 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 11.0 pt-20 -55.9 -36.27 67.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 120.328 -0.549 . . . . 73.12 112.211 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -68.53 -51.19 45.75 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.925 0.343 . . . . 74.32 111.925 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.455 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 14.6 pt -63.4 -33.87 63.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.166 0.432 . . . . 75.13 112.166 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.516 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 66.6 mt -61.04 -46.84 95.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 N-CA-C 109.549 -0.537 . . . . 74.51 109.549 173.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 15.4 mm100 -57.67 -44.13 85.5 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.925 -0.398 . . . . 74.41 109.925 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -56.16 -48.75 75.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.247 -0.888 . . . . 74.14 110.014 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.636 HD11 HG13 ' A' ' 22' ' ' VAL . 83.1 mt -71.13 -31.56 67.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.317 -0.553 . . . . 73.11 112.236 177.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 53.4 mt-30 -66.84 -24.37 66.14 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 120.237 -0.585 . . . . 74.21 111.871 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 31.7 mmm180 -67.39 -35.44 79.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.709 -0.478 . . . . 75.35 109.709 176.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 72' ' ' MET . 20.3 m -79.35 -19.37 50.42 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.853 0.835 . . . . 64.01 110.474 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.4 t -85.42 -27.45 25.75 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.85 -0.796 . . . . 52.12 108.85 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.99 -59.63 2.65 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.283 -1.006 . . . . 51.1 108.283 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -95.12 85.85 4.43 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 106.47 -1.678 . . . . 74.14 106.47 172.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 68' ' ' THR . 49.9 tpp -57.74 128.38 36.78 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 113.776 -1.556 . . . . 75.4 113.437 -170.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.1 tttt 62.8 -82.78 0.02 OUTLIER 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.565 -1.198 . . . . 75.23 113.056 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -137.91 -49.05 0.57 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.799 0.333 . . . . 74.25 111.874 -177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -129.6 34.41 4.33 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.385 -0.37 . . . . 74.41 110.202 -173.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.0 m 78.11 3.32 2.82 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.001 1.32 . . . . 75.44 108.536 -173.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.413 -2.319 0 N-CA-C 103.504 -2.776 . . . . 64.41 103.504 178.611 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.012 0 N-CA-C 110.439 -1.064 . . . . 54.24 110.439 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 54.1 m 63.57 91.86 0.07 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.687 0.795 . . . . 72.23 111.564 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -155.01 -49.45 0.09 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.039 -0.528 . . . . 73.52 110.257 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.627 ' OD1' ' HG2' ' A' ' 6' ' ' GLU . 12.2 t70 -98.09 144.31 27.71 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.404 -0.591 . . . . 70.13 109.404 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.92 -10.52 59.84 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.876 1.435 . . . . 73.34 114.876 -172.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.627 ' HG2' ' OD1' ' A' ' 4' ' ' ASP . 12.2 pt-20 -98.62 150.94 21.22 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 119.428 -0.909 . . . . 74.14 110.786 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -82.76 14.5 3.16 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.211 1.005 . . . . 71.25 111.178 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.4 m -82.92 165.17 19.95 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 114.927 -1.033 . . . . 64.12 108.439 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.411 ' SG ' HG12 ' A' ' 40' ' ' VAL . 51.9 m -91.62 179.1 5.74 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.944 0.72 . . . . 73.14 112.944 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.3 mt -100.71 -45.81 5.37 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.972 -1.013 . . . . 74.04 109.444 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.7 p -170.04 152.99 4.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 119.9 -0.72 . . . . 72.04 110.786 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.445 HG12 ' HB3' ' A' ' 50' ' ' CYS . 2.2 m -112.67 146.63 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 N-CA-C 105.612 -1.996 . . . . 63.34 105.612 171.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 10.3 t -98.42 178.77 4.93 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 108.802 -0.814 . . . . 74.43 108.802 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -43.83 -57.95 2.99 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.293 0.637 . . . . 51.24 110.087 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 38.5 ttpt -143.28 93.07 6.54 Favored Pre-proline 0 N--CA 1.421 -1.912 0 N-CA-C 108.597 -0.89 . . . . 64.31 108.597 171.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.603 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 5.1 Cg_endo -49.39 -76.12 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.857 3.038 . . . . 75.34 115.654 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.405 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -143.61 145.8 32.77 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 109.057 -0.72 . . . . 72.34 109.057 -177.388 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.405 ' O ' HG12 ' A' ' 21' ' ' ILE . 19.8 Cg_endo -61.7 139.48 81.01 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.177 1.918 . . . . 75.13 111.213 177.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.45 ' HA3' HD12 ' A' ' 61' ' ' ILE . . . -74.04 0.63 51.72 Favored Glycine 0 C--O 1.22 -0.728 0 CA-C-O 121.471 0.484 . . . . 73.43 113.327 -177.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -80.35 -20.5 44.02 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 123.14 0.576 . . . . 73.21 110.726 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 37.3 pt -104.76 10.31 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.216 0.45 . . . . 73.44 112.216 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.569 HG13 HD11 ' A' ' 65' ' ' LEU . 3.7 p -97.38 139.52 19.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.814 0.34 . . . . 72.22 111.788 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.675 ' HD2' ' ND2' ' A' ' 24' ' ' ASN . 0.8 OUTLIER -95.75 -55.89 2.86 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.833 -0.803 . . . . 62.15 108.833 -177.242 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.675 ' ND2' ' HD2' ' A' ' 23' ' ' ARG . 49.6 m-80 -135.07 167.6 20.66 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 109.066 -0.716 . . . . 64.32 109.066 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -144.04 165.35 28.04 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.371 -0.603 . . . . 74.31 109.371 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.465 ' HB2' HG22 ' A' ' 40' ' ' VAL . 36.1 m80 -133.9 118.53 18.03 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.011 -1.107 . . . . 75.42 108.011 172.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -84.16 101.63 11.99 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.652 -0.704 . . . . 74.12 109.239 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.593 HD21 ' SG ' ' A' ' 34' ' ' CYS . 6.9 tt -106.54 133.35 51.36 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.369 -0.832 . . . . 72.13 110.471 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -128.63 -176.54 3.87 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.702 -0.681 . . . . 54.12 110.144 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.7 mt -72.09 -22.2 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.589 -0.893 . . . . 64.31 108.589 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -63.44 -29.92 71.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.529 -0.76 . . . . 53.25 110.747 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -67.87 -39.16 83.75 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.027 -0.731 . . . . 74.0 109.027 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.74 58.96 0.23 Allowed Glycine 0 CA--C 1.498 -1.014 0 CA-C-N 115.187 -0.915 . . . . 70.22 110.868 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.593 ' SG ' HD21 ' A' ' 28' ' ' LEU . 61.4 m -141.91 136.62 30.63 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.626 -1.25 . . . . 75.34 107.626 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -76.06 -10.94 59.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.478 0.656 . . . . 75.32 110.647 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 p -121.36 101.39 43.94 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.372 -0.831 . . . . 75.15 109.903 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.14 130.17 10.98 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.797 1.665 . . . . 72.44 109.624 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 50' ' ' CYS . . . -168.11 148.72 4.97 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.73 0.3 . . . . 52.03 110.921 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.76 126.96 53.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.351 -0.611 . . . . 63.33 109.351 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.627 HG12 ' SG ' ' A' ' 50' ' ' CYS . 10.5 m -84.5 127.56 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 C-N-CA 120.171 -0.612 . . . . 42.54 109.464 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.446 ' CD1' HG21 ' A' ' 22' ' ' VAL . 9.3 m-85 -99.74 121.06 40.7 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.646 -0.707 . . . . 74.22 109.809 174.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.5 m -90.5 104.96 17.48 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.455 -0.942 . . . . 74.35 108.455 174.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 55.6 p -70.62 171.02 11.03 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.395 -0.366 . . . . 74.41 111.605 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 95.4 mt -67.99 -25.8 65.59 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.601 0.715 . . . . 74.41 109.106 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -64.62 -32.45 74.12 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.8 -1.091 . . . . 71.2 109.611 172.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.11 16.42 15.12 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 115.757 -0.656 . . . . 74.1 112.914 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -94.08 134.73 36.19 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.241 0.521 . . . . 75.53 110.951 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -90.77 116.46 28.64 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 107.37 -1.344 . . . . 43.01 107.37 170.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.6 tm? -138.02 143.86 40.77 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.695 -1.224 . . . . 63.12 107.695 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.627 ' SG ' HG12 ' A' ' 40' ' ' VAL . 30.8 m -94.69 143.2 26.63 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 115.19 1.552 . . . . 72.33 115.19 -177.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.603 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -125.6 163.09 40.95 Favored Pre-proline 0 N--CA 1.434 -1.265 0 CA-C-N 114.65 -1.159 . . . . 62.01 109.142 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 57.0 Cg_endo -70.76 110.38 2.74 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.123 1.882 . . . . 63.32 112.985 -174.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.75 -9.87 26.63 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 123.19 2.593 . . . . 72.12 114.676 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -101.04 -20.83 15.21 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.105 0.478 . . . . 51.3 111.308 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -69.3 130.12 91.25 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 112.795 0.665 . . . . 64.1 112.795 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.2 -36.21 36.13 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.109 3.206 . . . . 74.23 114.247 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.417 ' CE2' HG23 ' A' ' 58' ' ' VAL . 28.3 p-90 -64.8 -27.58 68.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 119.224 -0.991 . . . . 72.45 109.921 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 62' ' ' ILE . 69.7 t -86.16 -48.86 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.642 -0.708 . . . . 70.25 111.614 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.357 0.3 OUTLIER -61.9 -29.39 70.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.101 1.149 . . . . 73.44 114.101 -176.63 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -68.86 -43.09 76.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.765 0.317 . . . . 74.4 111.276 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.45 HD12 ' HA3' ' A' ' 19' ' ' GLY . 11.9 pt -71.72 -30.73 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 O-C-N 122.124 -0.36 . . . . 75.04 111.628 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.561 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 62.8 mt -56.76 -46.87 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.159 -0.473 . . . . 74.42 109.943 173.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 18.5 mm-40 -56.88 -41.9 78.87 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.114 0.566 . . . . 74.24 109.544 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 98.3 mtt180 -62.47 -38.93 91.74 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.58 -0.737 . . . . 71.22 111.492 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.569 HD11 HG13 ' A' ' 22' ' ' VAL . 84.5 mt -81.26 -26.06 36.1 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.676 0.251 . . . . 64.23 111.676 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.561 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 98.3 mt-30 -58.22 -20.53 42.38 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.59 0.959 . . . . 73.01 113.59 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 16.9 ptm180 -58.01 -37.06 73.6 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 123.103 0.252 . . . . 75.31 111.298 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 65' ' ' LEU . 13.4 t -85.01 -18.66 33.73 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.605 0.717 . . . . 63.23 110.128 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.9 t -74.33 -15.64 60.94 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.492 -0.776 . . . . 75.03 110.002 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -31.67 71.89 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.025 -0.534 . . . . 34.15 111.566 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -93.88 105.61 17.62 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.791 0.805 . . . . 71.34 111.716 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -152.71 -173.13 4.46 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 105.839 -1.912 . . . . 52.12 105.839 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -71.24 103.46 2.82 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.483 -2.043 . . . . 74.4 105.483 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -114.36 132.42 56.21 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.376 -0.829 . . . . 74.42 111.396 -169.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -75.92 -59.78 2.61 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.671 -0.695 . . . . 72.35 109.741 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.4 m -89.15 92.85 9.36 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.623 -0.717 . . . . 54.44 110.404 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 N--CA 1.431 -1.393 0 CA-C-O 118.023 -0.989 . . . . 71.23 109.888 -179.86 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.032 0 N-CA-C 111.11 -0.796 . . . . 72.43 111.11 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.7 p -127.49 159.6 34.07 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 110.013 -0.366 . . . . 75.12 110.013 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -86.17 85.52 7.35 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.237 -1.764 . . . . 60.32 106.237 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -161.07 -171.85 3.22 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 104.756 -2.313 . . . . 74.21 104.756 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.449 ' C ' ' H ' ' A' ' 7' ' ' ASP . . . -86.18 -33.5 20.79 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.869 -1.16 . . . . 62.45 107.869 175.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.325 11.3 pt-20 48.74 -8.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 128.339 2.656 . . . . 70.31 116.988 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' A' ' 5' ' ' ALA . 36.2 t70 -83.69 76.84 9.95 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.733 1.254 . . . . 74.24 108.267 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.556 ' HA ' HD13 ' A' ' 28' ' ' LEU . 27.2 p -146.33 174.93 10.92 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 112.644 -2.071 . . . . 72.12 106.593 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -101.98 175.23 5.61 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 118.436 -1.306 . . . . 70.42 110.625 -176.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.0 -64.86 1.06 Allowed 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.416 -0.587 . . . . 73.1 109.416 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -176.03 160.21 2.25 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 106.218 -1.771 . . . . 74.23 106.218 -178.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -98.87 160.04 3.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 118.722 -1.191 . . . . 71.23 109.422 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.0 t -106.15 179.47 4.26 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.416 -0.587 . . . . 63.14 109.416 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -40.48 -50.15 2.91 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.288 1.435 . . . . 74.3 110.458 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 ttpt -159.97 98.47 1.49 Allowed Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 107.662 -1.236 . . . . 75.1 107.662 169.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.661 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -42.36 -73.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.379 3.386 . . . . 55.11 116.622 -175.149 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.432 HG23 HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -143.69 167.86 14.36 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.219 -0.66 . . . . 72.33 109.219 -177.286 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.527 ' O ' HG12 ' A' ' 21' ' ' ILE . 38.6 Cg_exo -62.21 128.71 24.68 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.704 1.603 . . . . 55.53 109.495 171.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -71.49 1.33 28.86 Favored Glycine 0 C--N 1.301 -1.376 0 N-CA-C 114.336 0.494 . . . . 63.2 114.336 -175.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -94.35 -13.48 26.33 Favored 'General case' 0 C--N 1.285 -2.222 0 O-C-N 122.509 -0.406 . . . . 74.44 111.544 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 18' ' ' PRO . 38.9 pt -95.52 9.47 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.191 0.519 . . . . 72.22 111.205 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.589 HG21 ' CD1' ' A' ' 41' ' ' PHE . 3.1 p -96.9 141.27 15.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 115.949 -0.568 . . . . 61.2 111.842 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -105.44 -54.32 2.5 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.483 -0.932 . . . . 72.24 108.483 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -123.88 160.55 27.22 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.126 -0.694 . . . . 63.01 109.126 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.465 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 42.1 p90 -141.53 155.0 45.82 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.324 -0.991 . . . . 75.41 108.324 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -137.26 128.42 27.81 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.601 -0.518 . . . . 62.42 109.601 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -79.24 101.31 7.93 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 109.272 -0.64 . . . . 65.53 109.272 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.556 HD13 ' HA ' ' A' ' 8' ' ' CYS . 43.6 mt -98.92 131.0 45.33 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-O 121.665 0.745 . . . . 73.23 109.855 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.9 mt -132.59 178.23 7.01 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 114.877 -1.056 . . . . 52.44 108.815 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 25.3 mt -76.55 -29.5 18.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.442 -0.947 . . . . 61.12 108.442 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -67.83 -15.63 63.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.223 -0.899 . . . . 73.12 109.777 174.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -89.14 -43.2 11.21 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.924 -1.139 . . . . 75.44 107.924 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.8 -90.14 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 119.721 -1.228 . . . . 74.33 115.122 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 58.2 m -75.89 157.56 33.11 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.077 0.399 . . . . 72.15 112.077 -172.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -72.8 29.25 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.474 1.11 . . . . 71.42 113.702 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.4 p -137.4 102.9 8.74 Favored Pre-proline 0 C--N 1.3 -1.568 0 CA-C-O 121.395 0.617 . . . . 63.33 110.181 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -86.85 130.18 3.06 Favored 'Trans proline' 0 N--CA 1.438 -1.75 0 C-N-CA 121.941 1.76 . . . . 73.11 111.772 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.29 157.73 9.43 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.529 -0.759 . . . . 74.11 109.087 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.85 126.31 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 108.334 -0.987 . . . . 72.1 108.334 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 20.1 m -94.01 129.29 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.98 0 CA-C-O 121.609 0.718 . . . . 63.22 110.534 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.589 ' CD1' HG21 ' A' ' 22' ' ' VAL . 7.2 m-85 -93.86 118.16 31.08 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 114.958 -1.019 . . . . 72.1 111.897 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.4 m -81.36 105.45 12.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.436 -0.949 . . . . 70.34 108.436 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.1 p -76.11 174.28 10.25 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.699 0.285 . . . . 72.35 111.363 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 88.1 mt -62.52 -28.39 69.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.185 0.594 . . . . 53.54 110.307 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -69.52 -30.21 67.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.546 -0.752 . . . . 75.55 109.414 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.57 8.69 45.64 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.66 -0.7 . . . . 71.42 111.949 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -95.22 133.49 39.03 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 105.605 -1.998 . . . . 64.31 105.605 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 39.1 mt-30 -96.79 143.57 27.59 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.477 -0.935 . . . . 54.12 108.477 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 37.4 tp -135.91 150.35 49.3 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.215 -0.594 . . . . 73.52 109.881 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.2 m -77.47 122.18 24.86 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 123.547 0.53 . . . . 73.51 109.72 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.661 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.28 151.76 72.74 Favored Pre-proline 0 C--N 1.311 -1.083 0 C-N-CA 120.288 -0.565 . . . . 72.32 110.1 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.434 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 83.0 Cg_endo -74.98 110.31 3.09 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.778 2.319 . . . . 74.15 113.859 -173.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -67.94 -17.33 46.46 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.328 2.018 . . . . 65.03 111.887 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.96 -17.05 34.03 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.777 -0.647 . . . . 74.13 111.729 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.434 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.9 mm100 -84.81 127.49 64.79 Favored Pre-proline 0 C--N 1.317 -0.827 0 O-C-N 122.162 -0.336 . . . . 74.24 111.277 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -46.76 -37.87 21.81 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.608 3.539 . . . . 62.03 115.125 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.425 ' O ' HG12 ' A' ' 61' ' ' ILE . 41.8 p-90 -61.25 -35.4 77.17 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 120.784 -0.366 . . . . 75.45 110.752 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 62' ' ' ILE . 76.6 t -70.64 -41.65 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.806 -0.634 . . . . 75.41 111.244 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.2 mt-10 -58.09 -47.5 83.02 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 111.681 0.252 . . . . 62.33 111.681 -178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -64.03 -40.29 95.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.695 1.369 . . . . 61.13 114.695 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.453 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 10.7 pt -69.79 -35.69 66.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.34 -0.544 . . . . 65.32 111.507 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.465 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 56.9 mt -59.26 -49.55 83.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.356 -0.384 . . . . 75.14 110.517 173.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 18.5 mm-40 -56.19 -37.65 69.92 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.155 0.582 . . . . 72.34 110.125 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.562 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 20.2 ttm180 -68.08 -36.71 80.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.657 -0.701 . . . . 74.22 110.856 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.576 HD11 HG13 ' A' ' 22' ' ' VAL . 87.2 mt -76.13 -35.61 59.18 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 122.097 -0.377 . . . . 74.14 111.091 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 54.1 mt-30 -58.08 -19.15 29.8 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.983 1.475 . . . . 75.44 114.983 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 39.6 ptt180 -64.08 -15.16 58.99 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.232 -0.587 . . . . 74.12 111.731 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.6 p -74.34 -27.56 60.74 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 121.587 0.708 . . . . 62.23 110.06 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 43.6 m -80.27 -12.2 59.64 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.114 -0.948 . . . . 74.44 109.49 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.43 -19.01 50.99 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.308 -0.86 . . . . 74.12 110.28 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -110.45 138.88 46.26 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.091 0.472 . . . . 72.14 111.59 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 54.4 ttp 57.53 85.1 0.09 Allowed 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 115.24 1.57 . . . . 62.54 115.24 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.4 tttt 63.5 1.14 0.95 Allowed 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 114.371 1.249 . . . . 73.33 114.371 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 69' ' ' SER . 73.6 ttt180 74.43 -61.16 0.5 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.012 0.925 . . . . 75.51 110.512 -175.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -122.53 107.84 12.46 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.812 -0.81 . . . . 73.04 108.812 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.8 m -109.38 100.93 9.96 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 116.084 -0.507 . . . . 73.33 109.961 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.429 -1.478 0 N-CA-C 107.832 -1.173 . . . . 37.24 107.832 -179.844 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.128 0 N-CA-C 110.995 -0.842 . . . . 73.24 110.995 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.9 m -86.49 89.05 7.77 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.795 0.807 . . . . 75.3 111.597 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -102.77 -32.53 9.78 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.926 -1.139 . . . . 74.34 107.926 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -93.44 143.49 26.23 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.085 -1.08 . . . . 73.34 108.085 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.72 -4.73 57.02 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 114.084 1.142 . . . . 63.42 114.084 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.525 ' CD ' ' H ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER 58.16 -161.28 0.24 Allowed 'General case' 0 CA--C 1.577 2.01 0 C-N-CA 124.236 1.014 . . . . 74.22 108.916 -178.524 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.525 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 15.9 m-20 -103.75 25.19 10.11 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 121.657 0.741 . . . . 75.13 110.066 177.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 24.6 p -150.6 -160.33 1.15 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.039 -1.467 . . . . 62.14 107.039 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.533 ' SG ' HG12 ' A' ' 40' ' ' VAL . 1.7 t -121.87 -178.89 3.96 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 117.999 -1.48 . . . . 71.53 107.89 174.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tt -88.48 -67.74 0.81 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.117 -0.697 . . . . 73.52 109.117 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.7 m -168.55 149.07 4.65 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.215 -1.031 . . . . 32.3 108.215 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.433 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -102.49 158.66 4.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 119.144 -1.022 . . . . 54.45 108.323 178.235 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.1 t -103.21 178.47 4.55 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.077 -0.712 . . . . 72.22 109.077 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -46.64 -41.16 14.33 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.398 0.679 . . . . 70.4 111.544 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.5 ttpt -162.04 100.61 1.15 Allowed Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 107.249 -1.389 . . . . 72.35 107.249 170.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.66 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.5 Cg_endo -51.52 -82.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.889 3.059 . . . . 54.41 117.634 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.41 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -141.08 159.98 59.68 Favored Pre-proline 0 C--N 1.316 -0.878 0 O-C-N 121.964 -0.46 . . . . 41.13 110.257 -173.18 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.565 ' O ' HG12 ' A' ' 21' ' ' ILE . 78.1 Cg_exo -55.2 128.49 30.75 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.566 2.178 . . . . 75.42 110.691 173.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.464 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -79.71 0.46 81.79 Favored Glycine 0 C--N 1.307 -1.028 0 N-CA-C 115.15 0.82 . . . . 72.45 115.15 -174.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -99.17 -0.16 42.16 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.147 0.795 . . . . 71.55 113.147 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 18' ' ' PRO . 36.9 pt -101.27 10.25 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.667 0.746 . . . . 72.12 110.074 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 65' ' ' LEU . 3.1 p -94.44 138.98 19.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.287 -0.869 . . . . 72.53 111.336 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.09 -47.2 7.38 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.786 -0.82 . . . . 72.45 108.786 -175.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -149.93 160.5 43.55 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.048 -1.093 . . . . 73.54 108.048 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.3 168.26 19.51 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 117.973 0.352 . . . . 65.32 110.519 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.574 ' HB2' HG22 ' A' ' 40' ' ' VAL . 40.7 m80 -135.46 112.41 10.27 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.377 -1.342 . . . . 73.13 107.377 171.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -79.45 99.29 7.15 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.339 -1.356 . . . . 65.23 107.339 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.505 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -111.73 117.55 33.18 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.761 -0.654 . . . . 72.43 110.288 -170.067 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.8 mt -104.82 -176.07 2.97 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.497 -0.557 . . . . 74.25 109.497 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 63.3 mt -67.04 -36.24 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.909 0.862 . . . . 73.03 109.16 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -64.29 -24.17 67.56 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.484 -1.234 . . . . 72.52 110.276 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.48 -28.39 16.85 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.828 -0.624 . . . . 53.43 110.514 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.96 -106.76 0.65 Allowed Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 119.626 -1.273 . . . . 72.44 115.884 -173.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 33.6 m -118.32 179.68 4.04 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.993 -0.604 . . . . 73.32 109.496 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -55.22 -19.38 7.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.35 1.06 . . . . 71.41 112.377 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -103.14 106.79 52.85 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 121.114 0.483 . . . . 51.31 111.34 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -87.19 144.21 6.92 Favored 'Trans proline' 0 C--O 1.251 1.143 0 C-N-CA 122.576 2.184 . . . . 72.33 110.848 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.489 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -174.43 153.47 1.91 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.92 -0.4 . . . . 23.41 109.92 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.49 122.59 50.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.178 -1.416 . . . . 71.25 107.178 175.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.574 HG22 ' HB2' ' A' ' 26' ' ' HIS . 8.0 m -89.16 127.72 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.859 0 C-N-CA 119.566 -0.854 . . . . 52.12 109.426 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -98.13 121.54 40.18 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 115.302 -0.863 . . . . 73.33 110.702 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.0 m -86.35 103.42 14.91 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.819 -1.178 . . . . 74.1 107.819 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 50.0 p -70.97 171.69 10.36 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 116.201 -0.454 . . . . 64.32 110.833 -177.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 98.4 mt -60.96 -26.93 67.88 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.356 0.598 . . . . 60.22 109.775 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -71.65 -15.15 62.22 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 114.972 -1.013 . . . . 52.41 111.018 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.04 8.66 61.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.004 -0.617 . . . . 63.54 112.731 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -93.41 140.59 29.4 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 122.869 -0.195 . . . . 73.23 110.84 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -99.88 117.76 34.87 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.52 -0.918 . . . . 64.34 108.52 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -120.95 143.39 49.02 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.633 -0.877 . . . . 71.33 108.633 -174.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.534 ' N ' HD13 ' A' ' 49' ' ' LEU . 6.3 m -80.15 126.14 30.71 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 122.993 0.517 . . . . 72.24 111.17 -174.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.66 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -128.26 153.27 78.84 Favored Pre-proline 0 C--O 1.245 0.859 0 C-N-CA 120.907 -0.317 . . . . 74.12 110.989 175.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.484 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 72.0 Cg_endo -68.47 113.28 3.08 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.204 2.603 . . . . 73.33 113.024 -175.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 60.1 Cg_endo -72.24 -8.02 22.01 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.551 2.167 . . . . 73.15 114.205 -175.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -109.73 -0.51 18.48 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.3 0.572 . . . . 71.33 111.616 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.484 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 16.0 mm100 -86.34 135.97 36.02 Favored Pre-proline 0 C--N 1.314 -0.942 0 O-C-N 121.52 -0.737 . . . . 75.23 112.233 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.76 -36.76 26.7 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 124.697 3.598 . . . . 74.41 115.051 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -68.77 -32.48 72.26 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 120.343 -0.543 . . . . 60.42 110.685 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.662 ' O ' HG12 ' A' ' 62' ' ' ILE . 72.4 t -71.7 -48.99 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.831 -0.622 . . . . 72.14 111.997 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 9.3 pt-20 -55.69 -30.36 60.97 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.575 0.583 . . . . 71.23 112.575 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -73.02 -45.09 59.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.563 -0.29 . . . . 75.15 111.301 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.464 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 12.9 pt -71.71 -29.02 32.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 111.89 0.33 . . . . 71.41 111.89 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.662 HG12 ' O ' ' A' ' 58' ' ' VAL . 46.9 mm -56.49 -44.89 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.892 -0.781 . . . . 72.53 108.892 172.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 15.5 mm100 -59.1 -42.51 90.67 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.806 -0.634 . . . . 52.53 110.58 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -60.86 -46.59 90.0 Favored 'General case' 0 C--O 1.206 -1.201 0 O-C-N 124.143 0.902 . . . . 72.32 111.002 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 22' ' ' VAL . 86.8 mt -72.47 -34.11 67.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.253 -0.579 . . . . 72.25 111.897 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 50.7 mt-30 -61.5 -19.59 62.23 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 113.466 0.914 . . . . 74.24 113.466 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -57.6 -28.21 63.43 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-O 120.945 0.403 . . . . 73.34 110.122 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.2 p -85.32 -32.79 22.3 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-O 121.378 0.609 . . . . 73.23 110.647 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.9 t -77.98 -22.29 49.62 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.94 -1.027 . . . . 61.44 110.83 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.16 -19.54 64.8 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.176 -0.465 . . . . 51.43 109.977 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 61.6 tttp 65.64 -67.81 0.13 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.743 1.617 . . . . 73.3 112.549 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.3 ptm -87.24 80.63 8.19 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 122.578 1.18 . . . . 74.0 111.604 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -93.8 89.06 6.0 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 113.826 -1.534 . . . . 70.25 107.683 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 55.55 75.84 0.3 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 114.896 -1.047 . . . . 74.22 108.355 -172.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -135.38 109.15 8.05 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.236 -0.585 . . . . 64.32 110.622 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.5 p -129.32 144.05 51.08 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.724 -0.671 . . . . 53.21 110.063 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.1 m . . . . . 0 C--N 1.3 -1.575 0 N-CA-C 109.378 -0.601 . . . . 72.14 109.378 179.675 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.428 0 N-CA-C 111.067 -0.813 . . . . 52.22 111.067 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.4 p -79.93 -28.12 39.76 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 117.321 0.561 . . . . 74.03 110.338 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.4 t30 62.25 93.06 0.05 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.021 1.328 . . . . 74.54 111.27 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -78.21 -5.34 51.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.41 -0.813 . . . . 74.02 111.253 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.85 -10.0 58.71 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.943 0.877 . . . . 74.24 110.029 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -126.75 163.44 23.53 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 114.176 -1.374 . . . . 75.51 109.443 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -133.09 97.01 3.89 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.583 0.706 . . . . 71.22 109.373 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.473 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 46.5 t -152.81 -172.36 4.22 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 106.351 -1.722 . . . . 74.44 106.351 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.419 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 11.9 t -118.9 178.32 4.53 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 120.071 -0.652 . . . . 74.15 111.637 -173.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.403 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 83.4 mt -94.36 -53.9 3.75 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.105 -1.072 . . . . 75.03 108.105 174.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.9 t -177.19 -173.97 0.48 Allowed 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.131 -1.063 . . . . 63.23 108.131 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.78 167.67 25.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 106.939 -1.504 . . . . 61.43 106.939 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.2 t -105.52 178.28 4.61 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.781 -0.822 . . . . 75.1 108.781 175.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -53.02 -38.26 62.21 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.172 0.511 . . . . 74.41 111.139 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -159.2 93.42 1.82 Allowed Pre-proline 0 N--CA 1.425 -1.707 0 N-CA-C 108.014 -1.106 . . . . 73.54 108.014 173.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.2 Cg_endo -54.07 -86.24 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.882 3.055 . . . . 64.22 117.945 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.458 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -137.39 163.18 50.65 Favored Pre-proline 0 C--N 1.32 -0.698 0 O-C-N 121.865 -0.522 . . . . 72.35 110.565 -172.37 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.545 ' O ' HG12 ' A' ' 21' ' ' ILE . 38.0 Cg_exo -62.03 130.05 29.45 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.165 1.91 . . . . 74.13 110.853 175.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -71.95 1.6 30.85 Favored Glycine 0 C--N 1.307 -1.042 0 N-CA-C 114.32 0.488 . . . . 45.21 114.32 -177.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -87.32 -22.16 25.28 Favored 'General case' 0 N--CA 1.416 -2.128 0 O-C-N 122.529 -0.395 . . . . 74.43 110.692 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.5 pt -90.7 8.66 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 120.206 -0.598 . . . . 71.45 111.887 -176.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.588 HG13 HD11 ' A' ' 65' ' ' LEU . 2.6 p -92.94 132.51 36.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.22 0.533 . . . . 71.1 111.753 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -55.33 3.63 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.004 -1.11 . . . . 61.54 108.004 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -135.24 158.33 44.63 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.279 -1.008 . . . . 62.51 108.279 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -139.71 155.06 47.57 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.153 -0.619 . . . . 74.55 110.634 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.491 ' HB2' HG22 ' A' ' 40' ' ' VAL . 63.6 m170 -122.27 112.59 18.33 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.666 -1.235 . . . . 64.14 107.666 172.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -83.46 99.58 10.19 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.064 -0.717 . . . . 75.14 109.064 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.473 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 88.3 mt -106.58 143.26 34.95 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.8 -0.636 . . . . 74.51 111.798 -176.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.6 mt -140.45 175.85 9.26 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.876 -1.056 . . . . 62.24 109.639 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 46.4 mt -76.41 -19.79 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.961 -1.126 . . . . 72.22 107.961 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -60.82 -36.58 79.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.467 -1.242 . . . . 74.51 109.276 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.99 -41.06 78.33 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.595 -0.729 . . . . 70.03 109.274 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.96 -36.91 1.29 Allowed Glycine 0 CA--C 1.495 -1.197 0 C-N-CA 120.741 -0.742 . . . . 74.42 112.361 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 49.3 t -69.56 127.94 34.76 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.002 -1.11 . . . . 74.43 108.002 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -84.43 1.62 44.59 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.902 1.445 . . . . 62.24 114.902 -170.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -110.29 95.85 23.85 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 108.598 -0.89 . . . . 70.32 108.598 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -76.52 129.11 10.76 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 121.643 1.562 . . . . 72.15 111.415 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.536 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -171.0 151.3 3.25 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.231 -0.895 . . . . 74.11 109.728 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.22 119.6 47.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.463 -1.31 . . . . 74.23 107.463 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 26' ' ' HIS . 2.6 m -83.46 119.35 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.565 0 C-N-CA 119.294 -0.963 . . . . 71.43 108.529 -178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 22' ' ' VAL . 11.1 m-85 -91.28 111.53 23.05 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.377 -0.828 . . . . 75.22 110.643 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.4 m -80.13 100.4 8.22 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 106.99 -1.485 . . . . 71.14 106.99 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 49.5 p -68.1 173.94 4.25 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.964 -0.562 . . . . 72.13 111.357 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 93.5 mt -61.26 -29.46 69.86 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.282 0.563 . . . . 71.32 110.728 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -73.14 -16.61 61.44 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.378 -0.828 . . . . 74.24 110.227 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.6 -8.39 66.21 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 116.247 -0.433 . . . . 54.24 112.25 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -77.34 127.77 33.15 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 107.128 -1.434 . . . . 71.23 107.128 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -85.15 123.77 31.05 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.723 -0.843 . . . . 71.24 108.723 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 50' ' ' CYS . 4.3 tt -135.54 133.53 38.5 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 106.727 -1.583 . . . . 74.0 106.727 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.496 ' N ' HD23 ' A' ' 49' ' ' LEU . 21.4 m -94.94 145.43 24.93 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 114.21 1.189 . . . . 72.44 114.21 -169.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -125.64 158.73 63.91 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 115.113 -0.949 . . . . 54.44 110.515 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 66.7 Cg_endo -69.49 108.11 1.96 Allowed 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.421 2.08 . . . . 65.2 112.569 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 71.7 Cg_endo -74.22 -10.37 22.49 Favored 'Trans proline' 0 N--CA 1.473 0.274 0 C-N-CA 123.113 2.542 . . . . 73.14 113.824 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -96.32 -16.19 21.46 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.571 0.701 . . . . 75.11 109.617 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.463 ' OE1' ' HB2' ' A' ' 52' ' ' PRO . 1.8 mp0 -82.08 144.44 50.97 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 113.497 0.925 . . . . 50.44 113.497 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.96 -39.97 81.76 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 124.548 3.498 . . . . 63.42 115.013 -174.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -65.31 -26.7 68.17 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.231 -0.587 . . . . 72.43 110.473 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 62' ' ' ILE . 71.8 t -81.22 -40.11 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.823 -0.626 . . . . 75.3 111.852 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.464 ' HG3' ' HD2' ' A' ' 60' ' ' ARG . 13.4 pt-20 -61.26 -37.07 81.8 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.775 0.657 . . . . 72.52 112.775 -176.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.464 ' HD2' ' HG3' ' A' ' 59' ' ' GLU . 3.2 mpt_? -69.26 -38.84 78.62 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 120.19 -0.604 . . . . 61.4 112.165 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.47 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 12.6 pt -71.42 -33.22 49.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 120.804 -0.358 . . . . 73.33 111.829 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 58' ' ' VAL . 67.7 mt -61.88 -47.02 95.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 N-CA-C 109.292 -0.633 . . . . 75.23 109.292 172.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 84.1 mm-40 -58.34 -41.25 84.2 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.167 -0.47 . . . . 74.23 111.42 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -60.23 -41.27 92.76 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.035 -0.529 . . . . 63.23 111.191 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.588 HD11 HG13 ' A' ' 22' ' ' VAL . 90.6 mt -75.25 -28.83 60.01 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.27 -0.572 . . . . 74.35 111.043 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 52.8 mt-30 -71.1 -35.09 71.67 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 112.011 0.374 . . . . 61.24 112.011 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -50.74 -40.93 55.85 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 124.128 0.971 . . . . 74.23 111.867 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.0 p -82.68 -24.81 33.53 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.623 0.725 . . . . 72.34 111.654 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.0 t -86.49 -19.57 29.35 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.249 -0.887 . . . . 52.21 110.002 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.84 -23.93 66.78 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.601 0.761 . . . . 74.24 111.293 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.22 97.22 7.53 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 106.88 -1.526 . . . . 75.23 106.88 176.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.5 ptm -126.96 -167.26 1.71 Allowed 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 113.673 -1.603 . . . . 73.33 108.477 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.506 ' HD2' ' H ' ' A' ' 73' ' ' LYS . 3.0 mptp? -62.91 124.75 21.87 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.829 -0.804 . . . . 74.01 108.829 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -69.93 103.22 2.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.974 0.416 . . . . 71.41 110.236 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -149.88 21.95 0.88 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.125 -1.065 . . . . 71.34 108.125 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.6 m 69.47 81.87 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.269 -1.332 . . . . 73.54 110.304 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--N 1.305 -1.339 0 CA-C-N 115.396 -0.82 . . . . 63.31 108.991 179.83 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.305 0 N-CA-C 110.388 -1.085 . . . . 74.32 110.388 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.0 p -78.02 82.72 4.35 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 117.635 0.718 . . . . 72.24 110.933 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.5 t30 177.77 122.32 0.04 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 125.711 1.604 . . . . 64.13 106.719 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -85.6 120.25 26.83 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.587 -0.523 . . . . 74.21 109.587 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.0 -12.43 59.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.084 -0.507 . . . . 64.23 110.506 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 63.8 175.44 0.17 Allowed 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 126.103 1.761 . . . . 52.25 111.609 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -76.12 -30.84 58.36 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.666 0.746 . . . . 55.45 110.766 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.508 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 4.9 p -99.63 -161.87 0.9 Allowed 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 114.676 -1.147 . . . . 74.33 110.138 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.542 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -93.37 -175.75 3.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.505 -0.924 . . . . 73.02 108.505 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.07 -59.06 1.94 Allowed 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.476 0.547 . . . . 63.1 112.476 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.8 m -162.27 141.71 9.52 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.838 -0.43 . . . . 75.42 109.838 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.7 m -98.94 152.03 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.255 -1.017 . . . . 74.33 108.255 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 t -94.15 178.39 5.66 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.161 -0.681 . . . . 74.13 109.161 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -45.27 -46.48 12.62 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.948 0.899 . . . . 64.33 110.597 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 5.0 ttmp? -160.2 99.2 1.43 Allowed Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.017 -1.105 . . . . 70.25 108.017 169.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.5 Cg_endo -51.51 -81.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.351 0 C-N-CA 123.46 2.774 . . . . 51.4 116.785 -175.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.444 HD11 ' HB2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -147.95 152.46 40.37 Favored Pre-proline 0 C--N 1.322 -0.628 0 O-C-N 121.943 -0.473 . . . . 75.43 110.611 -174.116 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.475 ' O ' HG12 ' A' ' 21' ' ' ILE . 18.7 Cg_endo -61.97 141.2 88.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.444 2.096 . . . . 74.12 111.32 174.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.411 ' HA3' HD12 ' A' ' 61' ' ' ILE . . . -79.86 1.46 78.78 Favored Glycine 0 C--N 1.309 -0.952 0 C-N-CA 121.434 -0.413 . . . . 72.15 113.568 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.45 ' CE1' ' HG2' ' A' ' 64' ' ' ARG . 98.4 m-85 -94.6 -0.6 54.36 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 122.226 -0.573 . . . . 71.11 111.553 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.507 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 35.4 pt -112.41 5.13 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.279 0.561 . . . . 74.32 110.728 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.423 HG13 HD21 ' A' ' 65' ' ' LEU . 2.7 p -90.78 135.04 27.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.997 -0.547 . . . . 63.24 111.261 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.39 -55.6 3.82 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.775 -0.824 . . . . 70.44 108.775 -175.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -140.45 164.33 30.43 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.361 0.664 . . . . 64.43 109.626 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.49 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 8.6 p90 -143.85 167.98 21.03 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.743 0.306 . . . . 73.5 110.51 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -141.96 137.09 30.99 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.155 -1.054 . . . . 65.32 108.155 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -98.6 103.87 15.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 123.448 0.467 . . . . 72.41 109.868 -173.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 2.3 mm? -103.74 128.55 51.1 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.921 -0.77 . . . . 73.44 108.921 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.9 mt -131.95 179.59 5.99 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.225 0.536 . . . . 63.52 111.278 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.7 mt -77.99 -19.0 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.689 -1.226 . . . . 71.25 107.689 173.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.49 -34.33 72.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.07 -0.968 . . . . 61.34 109.845 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -68.16 -34.22 75.92 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.424 -0.807 . . . . 71.21 109.927 176.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.34 -17.51 3.54 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.356 -0.838 . . . . 75.12 112.471 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.22 161.69 26.61 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.675 1.361 . . . . 75.45 114.675 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -81.33 -15.49 55.2 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.939 -1.028 . . . . 72.2 111.282 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -134.12 123.81 17.04 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-O 120.971 0.415 . . . . 74.2 111.958 -174.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -85.94 129.39 3.43 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 121.794 1.663 . . . . 74.34 109.556 172.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.55 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -162.77 136.86 6.27 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.121 -0.49 . . . . 54.42 109.742 -176.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.99 124.51 52.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.305 -1.369 . . . . 74.44 107.305 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.542 HG12 ' SG ' ' A' ' 9' ' ' CYS . 18.8 m -84.79 123.17 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.548 0 CA-C-O 121.854 0.835 . . . . 70.5 110.178 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.444 ' HB2' HD11 ' A' ' 17' ' ' ILE . 15.1 m-85 -97.97 117.88 33.3 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 114.757 -1.111 . . . . 75.41 109.804 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 94.4 m -87.1 102.08 14.1 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.746 -0.835 . . . . 75.44 108.746 174.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.5 p -70.97 166.79 20.53 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.373 -0.376 . . . . 75.34 110.511 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 90.0 mt -60.47 -25.58 66.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.525 0.678 . . . . 72.0 110.353 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -62.75 -24.85 67.9 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.127 -0.942 . . . . 64.1 110.644 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.44 15.97 36.07 Favored Glycine 0 CA--C 1.505 -0.551 0 C-N-CA 121.288 -0.482 . . . . 72.15 111.911 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 42' ' ' THR . 34.3 mmt180 -99.56 139.21 35.54 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 120.665 0.269 . . . . 75.51 111.007 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -95.79 129.41 43.03 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.996 -1.853 . . . . 71.33 105.996 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.2 tp -137.57 144.62 42.13 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.463 -0.495 . . . . 50.2 110.148 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 9.7 m -80.16 128.57 33.67 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 123.494 0.496 . . . . 71.22 110.632 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.539 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -131.86 154.78 81.86 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 109.208 -0.664 . . . . 54.12 109.208 172.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.421 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 95.8 Cg_endo -77.31 107.82 2.48 Favored 'Trans proline' 0 CA--C 1.559 1.758 0 C-N-CA 122.643 2.229 . . . . 72.21 113.924 -173.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.55 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.9 Cg_endo -68.61 -19.8 41.62 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.135 2.557 . . . . 72.22 114.882 -173.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -96.87 2.7 52.04 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.601 0.715 . . . . 73.42 110.799 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.421 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.3 mm100 -95.06 143.14 25.61 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 112.291 0.478 . . . . 74.05 112.291 -178.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.427 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 10.3 Cg_endo -50.27 -46.79 27.07 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 124.427 3.418 . . . . 62.0 114.625 -175.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.497 ' O ' HG12 ' A' ' 61' ' ' ILE . 33.8 p-90 -63.33 -30.6 71.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 120.488 -0.485 . . . . 73.44 110.832 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 62' ' ' ILE . 72.7 t -81.56 -44.07 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.198 -0.455 . . . . 71.13 111.489 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.427 ' HG3' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -64.47 -24.63 67.69 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 120.302 -0.559 . . . . 71.35 111.513 -177.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -79.64 -29.63 41.04 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 115.838 -0.619 . . . . 74.25 110.731 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 57' ' ' TRP . 8.3 pt -86.09 -35.31 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.703 1.001 . . . . 64.31 113.703 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 58' ' ' VAL . 67.9 mt -53.01 -41.63 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 120.741 0.305 . . . . 74.33 110.809 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -59.99 -35.33 74.79 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.942 0.719 . . . . 74.13 112.942 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.45 ' HG2' ' CE1' ' A' ' 20' ' ' TYR . 7.1 mpt_? -57.31 -45.98 83.67 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.05 0.452 . . . . 60.02 110.316 174.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.49 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 3.5 mm? -68.1 -43.35 78.66 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.697 -0.683 . . . . 74.32 110.252 176.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -59.91 -41.71 92.3 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 115.61 -0.723 . . . . 74.23 112.268 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . 0.263 4.2 ppt_? -63.62 -27.62 69.36 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 113.365 0.876 . . . . 71.33 113.365 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.8 p -84.76 -22.14 29.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.441 0.639 . . . . 61.51 111.366 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.0 t -87.02 -12.53 47.13 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.194 -0.912 . . . . 70.12 109.741 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.35 -19.19 60.54 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.305 0.642 . . . . 71.22 111.538 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -75.62 137.95 41.09 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.234 -1.395 . . . . 55.4 107.234 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.1 ptp -52.36 94.48 0.01 OUTLIER 'General case' 0 C--O 1.248 1.012 0 N-CA-C 115.464 1.654 . . . . 73.0 115.464 -173.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 7.4 mmpt? -117.62 -31.74 5.09 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.247 -1.761 . . . . 71.04 106.247 172.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -147.79 -179.91 7.23 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.158 -1.423 . . . . 74.14 107.158 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.504 ' HA ' ' NE ' ' A' ' 75' ' ' ARG . 3.4 mmp_? -111.69 133.53 53.87 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.776 -0.453 . . . . 71.23 109.776 175.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.6 t -82.77 102.66 11.71 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.513 -1.291 . . . . 70.12 107.513 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.432 -1.363 0 N-CA-C 109.366 -0.605 . . . . 62.12 109.366 -175.961 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.469 0 N-CA-C 111.177 -0.769 . . . . 63.22 111.177 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.8 p -83.83 -21.92 31.9 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.799 0.809 . . . . 45.23 110.031 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -146.72 -166.97 2.63 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 104.632 -2.358 . . . . 73.42 104.632 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 76.58 -24.1 0.23 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.658 1.183 . . . . 60.54 112.487 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.62 -5.85 47.47 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 122.45 1.119 . . . . 63.32 109.239 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -138.19 128.78 26.49 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.459 -1.682 . . . . 75.11 106.459 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -91.06 -17.78 25.65 Favored 'General case' 0 CA--C 1.488 -1.442 0 CA-C-O 120.726 0.298 . . . . 72.34 110.491 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.415 ' HA ' HD12 ' A' ' 28' ' ' LEU . 26.3 p -84.45 170.05 13.92 Favored 'General case' 0 N--CA 1.411 -2.381 0 C-N-CA 119.586 -0.846 . . . . 73.55 110.534 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 38' ' ' ALA . 75.6 m -61.0 145.86 49.19 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 115.74 1.756 . . . . 43.33 115.74 -171.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -90.81 -54.51 3.94 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 105.315 -2.106 . . . . 62.24 105.315 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.3 m -165.6 174.65 9.63 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 108.469 -0.937 . . . . 63.12 108.469 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.419 HG12 ' CB ' ' A' ' 50' ' ' CYS . 2.2 m -135.01 157.57 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.389 -1.708 . . . . 74.13 106.389 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.494 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 10.1 t -102.3 177.45 4.87 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.315 -1.365 . . . . 63.21 107.315 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -47.3 -67.02 0.32 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.596 0.634 . . . . 75.3 111.739 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 40.2 ttmt -132.49 85.91 46.79 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 119.749 -0.78 . . . . 72.42 109.166 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.534 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 6.7 Cg_endo -47.01 -80.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 124.75 3.633 . . . . 52.14 118.166 -175.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.429 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -138.45 156.83 73.2 Favored Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 121.916 -0.49 . . . . 70.22 111.634 -172.329 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.464 ' O ' HG12 ' A' ' 21' ' ' ILE . 27.0 Cg_endo -64.99 136.61 49.13 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.722 2.281 . . . . 73.44 111.486 174.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.454 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -77.0 1.45 63.32 Favored Glycine 0 C--N 1.31 -0.909 0 CA-C-N 115.936 -0.575 . . . . 64.51 113.631 -178.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -83.73 -24.84 31.0 Favored 'General case' 0 N--CA 1.414 -2.24 0 O-C-N 122.301 -0.529 . . . . 75.33 110.933 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 18' ' ' PRO . 36.5 pt -90.15 2.01 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 120.353 -0.539 . . . . 75.23 111.699 -177.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.574 HG13 HD11 ' A' ' 65' ' ' LEU . 3.0 p -93.24 134.01 32.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 121.207 0.527 . . . . 53.1 111.526 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.08 -47.35 7.88 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.542 -0.91 . . . . 72.13 108.542 -175.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.46 ' O ' ' HB ' ' A' ' 42' ' ' THR . 10.3 p30 -145.84 157.99 43.88 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.417 -0.957 . . . . 75.51 108.417 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -128.58 152.47 48.28 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.941 -0.763 . . . . 73.2 108.941 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.536 ' HB2' HG22 ' A' ' 40' ' ' VAL . 27.9 m170 -120.63 112.34 18.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.218 -1.401 . . . . 74.42 107.218 172.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -84.39 103.47 13.58 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.675 -0.861 . . . . 70.2 108.675 -175.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 8' ' ' CYS . 79.5 mt -109.39 137.93 46.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.45 0.643 . . . . 73.14 111.939 -175.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.1 mt -141.6 178.75 7.24 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.14 -0.936 . . . . 74.12 110.142 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 34' ' ' CYS . 49.0 mt -77.79 -30.27 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.541 -1.281 . . . . 74.55 107.541 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -61.52 -25.92 67.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.051 -0.977 . . . . 72.05 109.999 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -83.78 -56.3 3.78 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.375 -1.342 . . . . 75.32 107.375 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.6 71.72 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.373 -0.918 . . . . 62.41 113.65 173.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.438 ' O ' HG12 ' A' ' 30' ' ' ILE . 49.9 t -161.18 151.97 18.26 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.77 -1.567 . . . . 62.32 106.77 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -74.93 -24.42 58.49 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.885 0.374 . . . . 63.31 111.995 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.53 108.08 47.9 Favored Pre-proline 0 C--N 1.3 -1.568 0 CA-C-O 121.429 0.633 . . . . 65.31 111.223 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -84.98 130.68 4.18 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.388 2.058 . . . . 55.31 111.628 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.642 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -176.42 164.12 2.56 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 124.046 0.938 . . . . 65.1 108.862 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.34 127.98 56.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 109.758 -0.46 . . . . 60.3 109.758 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.689 HG12 ' SG ' ' A' ' 50' ' ' CYS . 3.2 m -88.81 127.9 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 N-CA-C 108.254 -1.017 . . . . 60.24 108.254 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -97.94 113.0 24.72 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 116.08 -0.509 . . . . 65.34 110.601 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 24' ' ' ASN . 96.9 m -80.48 101.91 9.37 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.484 -0.78 . . . . 73.23 108.962 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.6 p -73.43 170.52 14.93 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.328 -0.396 . . . . 74.43 110.873 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.3 mt -57.87 -27.98 63.75 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.289 0.636 . . . . 65.24 112.622 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.3 tpp180 -73.02 -20.79 60.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.915 0.388 . . . . 62.3 110.707 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.96 40.42 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.902 -0.879 . . . . 51.22 110.902 -176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -98.57 133.05 43.46 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.634 -1.617 . . . . 70.32 106.634 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -99.44 130.5 45.71 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.943 -0.762 . . . . 74.15 108.943 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -136.8 138.61 41.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.903 -1.517 . . . . 72.01 106.903 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.689 ' SG ' HG12 ' A' ' 40' ' ' VAL . 91.0 m -94.83 147.59 23.2 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 114.872 1.434 . . . . 73.43 114.872 -173.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.534 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -130.24 163.03 50.63 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-N 114.908 -1.042 . . . . 62.21 109.847 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 88.9 Cg_endo -78.72 109.85 2.69 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 122.171 1.914 . . . . 73.24 113.018 -175.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 65.8 Cg_endo -70.04 -18.62 35.6 Favored 'Trans proline' 0 N--CA 1.483 0.886 0 C-N-CA 122.924 2.416 . . . . 72.14 113.232 -174.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.18 -7.98 54.54 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.439 0.638 . . . . 71.34 109.865 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -90.08 135.21 30.32 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-O 121.17 0.51 . . . . 73.21 111.309 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.408 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 11.8 Cg_endo -54.89 -35.85 90.17 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 124.341 3.361 . . . . 74.21 115.32 -175.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.466 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 37.9 p-90 -63.1 -30.49 71.63 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.88 0.371 . . . . 74.51 111.047 -177.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 62' ' ' ILE . 69.1 t -76.59 -36.62 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.076 -0.511 . . . . 64.13 110.89 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 56' ' ' PRO . 38.3 mt-10 -56.36 -45.02 80.66 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.035 0.445 . . . . 53.43 110.551 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.552 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 4.1 mmp_? -57.68 -51.07 71.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.246 -0.888 . . . . 75.53 111.423 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.454 HG21 ' HA3' ' A' ' 19' ' ' GLY . 13.1 pt -70.46 -33.2 52.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 113.335 0.865 . . . . 62.32 113.335 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 58' ' ' VAL . 60.1 mt -60.43 -45.56 96.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 109.459 -0.571 . . . . 71.32 109.459 173.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -57.6 -42.27 82.9 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.313 -0.403 . . . . 61.31 111.322 176.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 60' ' ' ARG . 89.4 mtt180 -59.23 -38.8 80.86 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.92 -0.582 . . . . 73.51 111.718 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.574 HD11 HG13 ' A' ' 22' ' ' VAL . 89.2 mt -79.41 -33.89 42.29 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.309 0.485 . . . . 75.43 112.309 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -68.79 -41.5 78.65 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 120.452 -0.499 . . . . 71.52 112.065 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -63.64 -32.88 74.49 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.041 0.448 . . . . 62.43 110.833 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.8 p -84.35 -19.31 33.84 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.539 0.685 . . . . 74.31 111.593 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.9 t -85.85 -41.23 15.17 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.503 -0.771 . . . . 71.41 109.378 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.31 -44.53 75.22 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.904 -0.589 . . . . 53.13 110.165 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -108.55 98.77 8.24 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.23 -1.026 . . . . 74.22 108.23 173.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -87.36 132.27 34.01 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.833 -1.076 . . . . 75.23 113.13 -172.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -163.48 113.56 1.33 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.185 -0.916 . . . . 75.41 110.137 175.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -99.25 -48.44 4.82 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.821 -0.807 . . . . 73.51 108.821 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -123.51 -66.5 1.0 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.806 -0.813 . . . . 53.13 108.806 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.3 m 62.12 18.88 10.42 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.966 0.907 . . . . 74.12 111.19 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 N--CA 1.415 -2.223 0 N-CA-C 105.894 -1.891 . . . . 50.42 105.894 177.643 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.323 0 CA-C-O 121.391 0.44 . . . . 44.11 112.019 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.6 p -139.07 145.42 39.51 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.287 -1.005 . . . . 72.01 108.287 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -86.64 77.46 9.35 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 119.857 -0.737 . . . . 63.44 110.237 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -174.37 101.61 0.1 Allowed 'General case' 0 CA--C 1.496 -1.112 0 CA-C-N 114.786 -1.097 . . . . 70.32 108.411 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.9 -2.85 46.42 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.046 -0.979 . . . . 62.51 110.213 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 71.79 134.46 0.04 OUTLIER 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 126.704 2.002 . . . . 75.41 109.888 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -81.03 82.02 7.1 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-O 123.013 1.387 . . . . 72.2 110.379 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.402 ' HA ' HD13 ' A' ' 28' ' ' LEU . 27.3 p -157.68 159.69 37.19 Favored 'General case' 0 C--N 1.259 -3.347 0 N-CA-C 104.349 -2.463 . . . . 65.21 104.349 175.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.24 -175.75 3.76 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 117.796 -1.562 . . . . 73.21 110.227 -175.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.2 mt -98.41 -64.69 1.02 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 120.903 0.382 . . . . 72.4 110.709 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.1 t -176.03 153.07 1.26 Allowed 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.146 -1.428 . . . . 65.23 107.146 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.432 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -106.98 160.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 119.154 -1.019 . . . . 51.44 110.021 -176.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -106.24 179.59 4.22 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.567 -0.901 . . . . 72.52 108.567 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -42.62 -57.27 2.77 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.904 0.881 . . . . 75.3 109.677 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 ttpt -145.85 97.59 4.55 Favored Pre-proline 0 N--CA 1.428 -1.543 0 N-CA-C 108.4 -0.963 . . . . 74.41 108.4 170.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.595 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 2.6 Cg_endo -39.62 -73.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.712 3.608 . . . . 62.35 116.015 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.401 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -142.38 158.02 61.66 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 107.448 -1.316 . . . . 71.41 107.448 -177.563 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' O ' HG12 ' A' ' 21' ' ' ILE . 17.9 Cg_endo -63.12 130.78 29.99 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 121.649 1.566 . . . . 72.34 110.558 174.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.524 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -72.26 2.01 30.95 Favored Glycine 0 C--N 1.303 -1.264 0 N-CA-C 115.029 0.772 . . . . 62.43 115.029 -174.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.76 -3.71 38.49 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 112.495 0.554 . . . . 75.25 112.495 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.523 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 39.6 pt -103.81 6.4 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 121.379 0.609 . . . . 71.32 110.378 177.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 41' ' ' PHE . 5.1 p -91.63 143.46 11.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.794 -0.639 . . . . 63.52 111.582 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.409 ' HE ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -99.88 -56.46 2.37 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.949 -1.13 . . . . 65.52 107.949 -178.224 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -134.21 166.03 23.74 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.738 -0.838 . . . . 71.43 108.738 -176.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -143.61 161.13 39.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.821 -0.437 . . . . 64.51 109.821 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.429 ' HB2' HG22 ' A' ' 40' ' ' VAL . 38.4 m80 -137.68 122.58 18.91 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 110.145 -0.316 . . . . 74.13 110.145 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -75.8 98.19 4.09 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 123.236 0.335 . . . . 74.12 110.16 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 8' ' ' CYS . 69.5 mt -97.14 134.2 40.79 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-O 121.887 0.851 . . . . 72.44 110.249 177.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.6 mt -125.93 -178.53 4.32 Favored 'General case' 0 C--N 1.256 -3.471 0 N-CA-C 106.725 -1.583 . . . . 70.24 106.725 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.469 HG23 ' HA ' ' A' ' 35' ' ' ARG . 68.2 mt -63.85 -37.88 80.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 120.312 -0.555 . . . . 64.23 109.798 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.471 ' HE2' ' HB2' ' A' ' 31' ' ' LYS . 12.1 ptmm? -59.87 -31.88 70.19 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 114.264 1.209 . . . . 62.42 114.264 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -111.92 -5.35 14.35 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.962 0.41 . . . . 72.25 111.259 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.77 -124.32 3.43 Favored Glycine 0 N--CA 1.417 -2.609 0 CA-C-N 115.857 -0.611 . . . . 25.33 112.726 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 84.7 m -118.01 -87.24 0.63 Allowed 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.398 -0.401 . . . . 73.14 110.404 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.469 ' HA ' HG23 ' A' ' 30' ' ' ILE . 35.9 ttm180 -143.23 15.18 1.86 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.175 0.988 . . . . 71.24 108.824 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 p -127.83 117.85 20.94 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 115.302 -0.863 . . . . 72.02 110.265 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.97 130.17 2.1 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 121.929 1.753 . . . . 60.52 110.491 174.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -171.52 154.79 3.9 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.94 -0.763 . . . . 73.13 108.94 -177.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.25 125.43 52.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.5 -0.926 . . . . 54.33 108.5 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 26' ' ' HIS . 16.4 m -90.12 128.35 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.008 0 C-N-CA 119.643 -0.823 . . . . 73.02 109.308 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CD1' HG21 ' A' ' 22' ' ' VAL . 15.3 m-85 -95.58 125.52 40.23 Favored 'General case' 0 C--N 1.272 -2.788 0 CA-C-N 115.358 -0.837 . . . . 73.11 110.177 175.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.4 m -93.45 103.65 15.84 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.922 -1.14 . . . . 71.3 107.922 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 71.1 p -70.0 174.36 5.45 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.35 -0.386 . . . . 54.35 111.248 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 95.3 mt -61.2 -27.39 68.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.52 0.676 . . . . 52.41 109.724 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -67.57 -28.4 67.74 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.718 1.207 . . . . 55.14 110.904 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.08 16.59 40.53 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 120.79 -0.719 . . . . 65.21 111.424 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.62 138.39 31.55 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.436 -1.32 . . . . 64.45 107.436 -177.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -91.97 121.18 33.32 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.79 -1.189 . . . . 75.41 107.79 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.483 HD13 ' N ' ' A' ' 50' ' ' CYS . 0.5 OUTLIER -129.67 141.51 50.9 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.363 -0.977 . . . . 73.2 108.363 -178.095 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.483 ' N ' HD13 ' A' ' 49' ' ' LEU . 7.9 m -78.06 129.97 35.87 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.998 0.519 . . . . 64.41 111.081 -173.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.595 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -136.98 157.3 74.94 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 110.037 -0.357 . . . . 61.52 110.037 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.8 109.27 1.97 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.376 2.051 . . . . 71.12 112.798 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 42.5 Cg_endo -67.0 -18.76 52.11 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.833 2.355 . . . . 74.21 113.91 -174.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -96.51 3.66 52.56 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.465 -0.494 . . . . 72.2 112.286 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -97.57 139.24 21.27 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 120.42 -0.512 . . . . 74.4 112.315 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.508 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 83.6 Cg_exo -47.36 -42.81 27.63 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 124.441 3.427 . . . . 75.22 114.55 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -62.52 -27.3 69.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.357 -0.537 . . . . 54.12 110.86 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.667 ' O ' HG12 ' A' ' 62' ' ' ILE . 75.4 t -81.75 -50.22 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.878 -0.601 . . . . 64.1 111.264 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.508 ' HG3' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -57.23 -27.01 61.64 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.832 0.678 . . . . 64.21 112.832 -176.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -73.04 -49.66 27.45 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.746 -0.661 . . . . 74.51 110.33 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.524 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.2 pt -71.7 -28.08 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.911 -0.586 . . . . 73.43 111.663 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 58' ' ' VAL . 41.0 mm -54.45 -52.76 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.851 -0.613 . . . . 72.14 109.902 173.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -56.58 -38.05 71.46 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.386 0.612 . . . . 71.22 110.3 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.26 -38.4 90.19 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.954 -1.021 . . . . 61.53 109.146 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.546 HD11 HG13 ' A' ' 22' ' ' VAL . 88.3 mt -79.73 -36.94 36.61 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 116.63 -0.259 . . . . 73.52 111.149 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -55.84 -20.28 14.79 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 114.054 1.131 . . . . 74.51 114.054 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -58.81 -32.41 69.33 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 109.539 -0.541 . . . . 61.04 109.539 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.9 p -84.64 -19.57 32.7 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.517 0.675 . . . . 65.52 111.067 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.9 t -85.18 -16.95 38.66 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.763 -0.653 . . . . 73.31 109.254 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.8 -29.02 61.93 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 115.609 -0.723 . . . . 72.1 110.17 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.674 ' HD2' ' O ' ' A' ' 71' ' ' LYS 0.306 0.1 OUTLIER -78.13 90.18 4.25 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 122.809 1.29 . . . . 75.44 111.494 177.473 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.8 ptm -156.46 139.51 15.43 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.186 -1.37 . . . . 72.54 107.469 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -81.31 71.38 8.3 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.152 0.977 . . . . 72.1 111.4 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -161.88 17.81 0.1 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 105.388 -2.078 . . . . 70.12 105.388 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -150.15 100.85 2.95 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.849 -1.523 . . . . 70.11 108.911 -175.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.5 t -101.73 -41.63 6.48 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.903 -1.147 . . . . 62.24 107.903 175.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 N--CA 1.422 -1.858 0 N-CA-C 106.203 -1.777 . . . . 74.31 106.203 178.752 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.662 0 N-CA-C 111.114 -0.794 . . . . 71.05 111.114 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.8 t -89.24 134.54 34.0 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.14 0.495 . . . . 72.45 110.277 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -135.77 134.1 38.65 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.55 -0.537 . . . . 74.33 109.55 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -139.16 165.57 26.82 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.934 -1.136 . . . . 70.21 107.934 -177.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.09 86.28 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.309 0.576 . . . . 73.32 110.637 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 46.54 -159.42 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 126.299 1.84 . . . . 64.02 113.929 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -81.95 -31.34 31.3 Favored 'General case' 0 CA--C 1.483 -1.613 0 CA-C-N 115.848 -0.615 . . . . 74.24 111.042 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 27.9 p -124.48 159.76 29.81 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 112.474 0.546 . . . . 72.43 112.474 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.586 ' SG ' HG12 ' A' ' 40' ' ' VAL . 91.6 m -57.86 150.81 19.35 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 116.47 2.026 . . . . 62.52 116.47 -174.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -84.25 -63.98 1.24 Allowed 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.867 -1.515 . . . . 75.13 108.13 172.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -167.15 175.72 7.29 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 106.124 -1.806 . . . . 54.04 106.124 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 13' ' ' THR . 2.2 m -133.91 161.25 41.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.485 -1.302 . . . . 73.12 107.485 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.7 t -98.78 178.06 5.09 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.127 -1.064 . . . . 61.43 108.127 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -50.5 -60.73 2.72 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.007 0.523 . . . . 72.33 110.769 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 4.8 ttmp? -139.85 86.54 13.46 Favored Pre-proline 0 N--CA 1.428 -1.548 0 N-CA-C 109.367 -0.605 . . . . 71.22 109.367 174.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 7.5 Cg_endo -47.94 -78.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.463 0 C-N-CA 124.565 3.51 . . . . 74.3 117.303 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.405 ' H ' HD13 ' A' ' 17' ' ' ILE . 0.2 OUTLIER -141.32 162.83 45.43 Favored Pre-proline 0 C--N 1.32 -0.701 0 O-C-N 121.791 -0.568 . . . . 65.42 110.365 -175.142 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.599 ' O ' HG12 ' A' ' 21' ' ' ILE . 36.8 Cg_exo -63.05 130.21 28.28 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.135 1.89 . . . . 60.23 110.704 174.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -73.69 2.04 42.17 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 116.339 -0.391 . . . . 65.31 113.946 -176.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -98.23 0.12 45.14 Favored 'General case' 0 N--CA 1.417 -2.121 0 O-C-N 122.133 -0.628 . . . . 72.31 111.52 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 18' ' ' PRO . 33.7 pt -106.71 9.22 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.452 0.644 . . . . 71.22 110.136 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.632 HG13 HD11 ' A' ' 65' ' ' LEU . 2.9 p -96.59 134.94 32.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.733 -0.667 . . . . 74.31 111.817 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.571 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -91.15 -56.02 3.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.73 -0.841 . . . . 74.51 108.73 -176.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.571 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 18.1 m120 -130.17 157.43 42.48 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-N 115.89 -0.596 . . . . 71.31 109.445 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -139.65 152.31 46.65 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.19 -0.67 . . . . 71.31 109.19 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.42 ' HB2' HG22 ' A' ' 40' ' ' VAL . 34.3 m170 -122.97 121.72 36.79 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.049 -1.463 . . . . 73.34 107.049 174.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -93.93 114.3 26.49 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 109.607 -0.516 . . . . 74.4 109.607 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.579 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 4.0 mm? -110.23 126.92 54.65 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 116.262 -0.426 . . . . 74.25 111.608 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.7 mt -126.83 176.96 6.89 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.833 -0.802 . . . . 60.53 108.833 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 57.1 mt -74.11 -20.07 17.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 107.701 -1.222 . . . . 75.33 107.701 176.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -58.79 -30.42 67.57 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.726 -1.124 . . . . 73.23 110.071 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.05 -42.45 47.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.597 -0.729 . . . . 74.03 109.988 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.54 -44.89 0.64 Allowed Glycine 0 CA--C 1.503 -0.709 0 C-N-CA 120.458 -0.877 . . . . 74.13 113.039 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 63.4 m -66.86 141.47 57.66 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 110.263 -0.273 . . . . 62.1 110.263 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -79.23 3.44 17.9 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.194 0.521 . . . . 73.34 112.057 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.31 97.94 49.44 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.821 -0.627 . . . . 74.45 110.251 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -80.65 128.96 7.06 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 121.255 1.303 . . . . 63.22 110.137 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.594 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -173.83 161.85 3.88 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.145 0.578 . . . . 52.24 109.825 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 50' ' ' CYS . 7.9 p -108.59 128.23 64.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 109.381 -0.6 . . . . 75.22 109.381 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.586 HG12 ' SG ' ' A' ' 9' ' ' CYS . 1.4 m -86.3 129.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 107.303 -1.369 . . . . 63.33 107.303 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -104.68 116.65 32.42 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 116.567 -0.288 . . . . 70.21 111.331 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.5 m -85.24 101.57 12.62 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.284 -1.006 . . . . 61.24 108.284 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 63.4 p -73.97 168.67 19.01 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.258 -0.428 . . . . 65.03 110.981 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 92.2 mt -59.52 -29.05 67.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.121 0.568 . . . . 73.44 111.117 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -71.24 -16.37 62.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.493 -0.776 . . . . 71.41 110.78 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.75 15.83 44.52 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.261 -0.495 . . . . 63.11 112.306 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -94.87 140.06 30.45 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 110.523 -0.177 . . . . 74.22 110.523 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -104.12 109.83 21.78 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.89 -0.595 . . . . 73.12 109.503 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.4 tp -130.03 129.82 44.16 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.756 -0.657 . . . . 73.24 109.263 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.576 ' SG ' HG12 ' A' ' 40' ' ' VAL . 75.4 m -84.48 147.41 27.1 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 113.682 0.993 . . . . 71.35 113.682 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.589 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.31 160.55 57.07 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 115.103 -0.953 . . . . 64.33 110.169 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 72.9 Cg_endo -71.98 108.11 2.38 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.194 1.929 . . . . 75.52 111.936 -175.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.594 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 67.3 Cg_endo -68.35 -30.41 30.14 Favored 'Trans proline' 0 N--CA 1.473 0.265 0 C-N-CA 123.089 2.526 . . . . 64.45 113.388 -171.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -78.4 -26.59 46.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.228 -0.442 . . . . 72.53 111.386 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -66.34 138.25 95.79 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 116.122 -0.49 . . . . 70.42 112.146 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.443 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 78.0 Cg_exo -53.45 -38.66 83.24 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 124.011 3.141 . . . . 34.32 114.699 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.466 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 37.0 p-90 -64.86 -29.96 70.94 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 120.469 -0.493 . . . . 74.13 111.116 -175.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 62' ' ' ILE . 72.3 t -80.07 -30.12 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 116.115 -0.493 . . . . 70.31 111.109 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.9 mt-10 -56.71 -49.73 74.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.562 -0.29 . . . . 74.53 110.715 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -61.52 -45.52 93.86 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.179 -0.464 . . . . 73.31 112.208 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.5 HG21 ' HA3' ' A' ' 19' ' ' GLY . 18.0 pt -69.2 -33.8 60.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 113.145 0.794 . . . . 70.44 113.145 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 58' ' ' VAL . 65.3 mt -61.66 -46.93 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.411 -0.589 . . . . 72.21 109.411 174.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 13.0 mm100 -60.05 -40.96 91.23 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.776 -0.647 . . . . 43.42 109.475 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -57.95 -51.49 69.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.234 -0.894 . . . . 73.44 109.627 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.632 HD11 HG13 ' A' ' 22' ' ' VAL . 73.7 mt -67.52 -28.97 68.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.727 0.64 . . . . 73.02 112.727 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -69.0 -32.31 71.77 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.368 -0.933 . . . . 75.43 110.767 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.475 ' O ' ' HG2' ' A' ' 71' ' ' LYS . 31.8 mmt180 -73.04 -37.87 66.71 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.486 -0.325 . . . . 61.52 110.787 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.4 p -69.42 -34.36 74.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.451 0.643 . . . . 63.1 110.203 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.3 t -70.35 -34.76 73.02 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.778 -1.101 . . . . 75.4 109.401 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.04 -40.56 82.84 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.137 -0.483 . . . . 52.42 110.549 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 67' ' ' ARG . 75.4 mmtt -68.19 -32.11 72.11 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.387 0.613 . . . . 64.05 109.743 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.6 ttt -70.25 -20.32 63.07 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.247 -0.888 . . . . 63.12 109.945 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -89.91 138.21 31.69 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.736 -1.579 . . . . 70.31 106.736 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -73.85 -7.46 52.31 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 111.982 0.364 . . . . 72.1 111.982 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 64.49 98.52 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.463 1.105 . . . . 65.3 111.892 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 m -129.48 -16.64 3.85 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-O 121.973 0.892 . . . . 64.22 108.965 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 106.571 -1.64 . . . . 73.31 106.571 176.783 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.988 0 N-CA-C 110.985 -0.846 . . . . 64.15 110.985 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.3 p -66.22 117.59 8.72 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 120.992 0.425 . . . . 74.11 110.99 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -127.21 100.71 6.19 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.681 -0.691 . . . . 71.41 109.42 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -99.63 117.25 33.6 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.743 -0.662 . . . . 71.31 110.238 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.21 -8.5 32.82 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.349 -0.841 . . . . 71.13 110.104 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.47 144.06 51.54 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.597 -1.183 . . . . 71.33 112.124 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.43 -33.48 71.38 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.14 -0.936 . . . . 74.5 108.82 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.449 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 14.7 p -83.24 -176.41 6.31 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.824 -1.08 . . . . 51.53 109.904 174.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.82 -171.58 3.48 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.835 -0.746 . . . . 62.43 111.665 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.0 -68.05 0.82 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.395 -0.594 . . . . 72.34 109.395 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -168.04 153.83 7.17 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.259 -1.015 . . . . 75.21 108.259 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.547 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.9 m -115.8 162.09 14.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 119.839 -0.744 . . . . 54.3 109.973 -175.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -105.75 177.64 4.79 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.012 -1.477 . . . . 71.23 107.012 172.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -53.82 -50.03 67.07 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 118.656 0.662 . . . . 51.13 111.53 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.508 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 87.4 tttt -143.6 83.7 10.49 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-O 121.0 0.429 . . . . 64.12 110.153 175.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.5 Cg_endo -47.38 -77.77 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.456 3.438 . . . . 71.33 117.429 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.48 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -134.15 166.3 30.23 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 110.058 -0.349 . . . . 73.34 110.058 -173.157 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.585 ' O ' HG12 ' A' ' 21' ' ' ILE . 44.7 Cg_exo -61.26 127.92 23.48 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.253 1.968 . . . . 51.24 111.004 175.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.48 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -80.65 0.17 86.38 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 114.594 0.598 . . . . 64.4 114.594 -175.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.53 -1.16 39.05 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 122.034 -0.686 . . . . 73.44 112.841 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 18' ' ' PRO . 34.8 pt -100.21 7.46 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.633 0.73 . . . . 73.12 110.36 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.53 HG13 HD11 ' A' ' 65' ' ' LEU . 2.5 p -89.25 136.12 24.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.33 -0.85 . . . . 61.43 111.75 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.442 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 1.0 OUTLIER -86.16 -55.68 3.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.031 -1.1 . . . . 73.13 108.031 -176.785 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.442 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 17.5 m120 -141.65 160.31 40.43 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.281 1.032 . . . . 72.0 108.713 177.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -131.97 156.8 45.55 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.694 -0.403 . . . . 65.31 110.068 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.535 ' HB2' HG22 ' A' ' 40' ' ' VAL . 28.0 m170 -123.56 112.54 17.57 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.299 -1.371 . . . . 73.44 107.299 172.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -82.91 99.8 10.0 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.513 -1.291 . . . . 72.42 107.513 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.449 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 77.4 mt -112.58 134.72 53.96 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.54 0.686 . . . . 73.42 111.803 -173.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 94.6 mt -142.32 169.71 17.08 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.043 -0.98 . . . . 72.35 110.755 -173.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.9 mt -77.97 -30.36 16.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 106.629 -1.619 . . . . 61.25 106.629 171.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -56.22 -39.5 72.6 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.571 -1.195 . . . . 73.44 110.368 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.94 -57.6 3.8 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.981 -1.118 . . . . 74.22 107.981 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.44 85.96 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.973 -1.108 . . . . 72.42 114.299 174.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.1 t -168.54 172.52 8.1 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 105.691 -1.966 . . . . 73.4 105.691 174.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -88.17 -3.05 58.93 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.228 1.195 . . . . 74.33 114.228 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 p -148.95 122.77 4.66 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-O 120.972 0.415 . . . . 70.22 111.256 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -87.28 130.15 2.85 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.473 2.115 . . . . 61.13 112.546 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -176.25 150.05 0.9 Allowed 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.481 -0.933 . . . . 60.13 108.481 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -98.41 127.41 50.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.401 -1.333 . . . . 74.45 107.401 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 26' ' ' HIS . 6.2 m -92.3 125.12 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.15 0 C-N-CA 119.307 -0.957 . . . . 75.51 108.849 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -99.26 113.16 25.29 Favored 'General case' 0 C--N 1.272 -2.79 0 CA-C-N 115.459 -0.791 . . . . 72.13 109.729 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 77.2 m -80.69 102.43 9.88 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.895 -0.78 . . . . 72.31 108.895 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.1 p -69.23 167.83 15.43 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.123 -0.489 . . . . 63.42 110.811 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 93.7 mt -59.13 -29.09 67.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.205 0.526 . . . . 53.53 110.26 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -64.75 -26.6 68.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.078 -0.964 . . . . 71.14 111.055 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.69 17.18 19.93 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.22 -0.991 . . . . 44.13 112.145 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -103.36 125.89 50.23 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 122.684 -0.304 . . . . 72.22 111.244 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.08 112.82 19.49 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.69 -1.226 . . . . 75.33 107.69 172.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 50' ' ' CYS . 0.9 OUTLIER -115.09 141.55 47.85 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.679 -0.86 . . . . 73.24 108.679 -176.074 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.547 ' HB3' HG12 ' A' ' 12' ' ' VAL . 9.4 m -79.15 119.73 22.66 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 123.061 0.545 . . . . 64.53 111.13 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.623 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -122.85 155.55 63.42 Favored Pre-proline 0 C--O 1.243 0.733 0 C-N-CA 120.346 -0.541 . . . . 74.43 111.944 174.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 98.0 Cg_endo -78.08 110.85 2.97 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.646 2.231 . . . . 71.53 114.427 -172.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.05 -1.19 8.3 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.752 2.301 . . . . 62.2 112.556 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -103.3 -3.29 25.82 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.493 -0.321 . . . . 74.53 111.08 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 29.7 mm-40 -103.82 132.8 20.69 Favored Pre-proline 0 C--N 1.311 -1.106 0 C-N-CA 120.309 -0.556 . . . . 63.22 112.435 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 98.6 Cg_exo -49.07 -32.62 24.38 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 124.552 3.501 . . . . 74.5 115.046 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.508 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 31.0 p-90 -68.18 -30.19 69.23 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.4 -0.52 . . . . 75.41 109.902 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 62' ' ' ILE . 70.9 t -78.94 -40.97 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.212 -0.662 . . . . 60.14 109.212 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.4 mt-10 -59.68 -25.05 64.44 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.341 -0.845 . . . . 75.42 112.411 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -83.34 -43.39 16.01 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.294 0.479 . . . . 65.41 112.294 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.48 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.2 pt -70.89 -33.73 53.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 112.867 0.691 . . . . 74.33 112.867 -177.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 58' ' ' VAL . 64.3 mt -57.11 -40.82 75.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 116.064 -0.516 . . . . 75.53 110.062 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 78.8 mm-40 -59.28 -43.1 92.55 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.1 -0.5 . . . . 63.31 111.328 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -59.47 -52.29 66.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.522 0.514 . . . . 73.23 110.862 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.53 HD11 HG13 ' A' ' 22' ' ' VAL . 86.3 mt -67.95 -26.36 65.91 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.254 -0.578 . . . . 71.04 112.472 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 93.2 mt-30 -67.59 -21.77 65.41 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 121.965 -0.459 . . . . 54.13 111.917 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.639 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -72.62 -37.84 67.95 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.538 -0.542 . . . . 73.54 109.538 177.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.5 p -82.3 -36.57 26.86 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.018 -0.537 . . . . 63.22 111.763 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.1 m -71.81 -18.22 62.11 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.82 -0.627 . . . . 73.34 111.397 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.55 -32.85 64.4 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.979 0.418 . . . . 62.14 110.657 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -121.03 79.8 1.56 Allowed 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 122.287 1.041 . . . . 71.2 109.165 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.7 tpt 179.38 165.6 1.03 Allowed 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 104.854 -2.276 . . . . 73.44 104.854 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -66.81 131.24 45.52 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.975 -0.75 . . . . 74.33 108.975 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -77.48 139.63 39.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.324 0.583 . . . . 55.14 111.303 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -84.92 -35.81 21.87 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.658 -0.701 . . . . 74.23 112.757 -172.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.1 m -75.82 2.21 12.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 113.459 0.911 . . . . 44.31 113.459 -175.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.295 -0.86 . . . . 74.4 110.22 177.616 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.631 0 N-CA-C 111.061 -0.816 . . . . 44.14 111.061 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.6 m -135.31 78.71 1.74 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.755 0.788 . . . . 73.02 110.014 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -140.36 88.1 2.18 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.299 -1.371 . . . . 71.15 107.299 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -88.9 102.32 14.93 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.668 -0.696 . . . . 72.33 110.464 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.96 -16.24 30.31 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.682 0.753 . . . . 61.24 109.633 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.85 118.83 37.15 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.586 -1.188 . . . . 70.24 110.361 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.36 -57.78 3.02 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.813 -0.81 . . . . 63.41 108.813 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.8 p -86.87 147.65 25.71 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 107.817 -1.179 . . . . 62.44 107.817 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.578 ' HB2' HG12 ' A' ' 40' ' ' VAL . 4.4 t -76.74 142.14 40.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.027 -0.731 . . . . 74.4 109.027 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.481 ' O ' HG21 ' A' ' 36' ' ' VAL . 73.7 mt -68.89 -44.64 72.82 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 116.828 2.158 . . . . 60.03 116.828 -170.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.8 m -164.49 137.18 4.82 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.759 -0.776 . . . . 74.12 111.293 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -102.05 161.21 3.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.459 -0.941 . . . . 64.03 108.459 -178.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.9 t -105.54 178.76 4.47 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.098 -1.075 . . . . 72.32 108.098 175.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -49.17 -40.61 33.65 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.615 0.766 . . . . 64.15 111.069 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 38.0 ttpt -157.7 92.1 2.24 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 109.078 -0.712 . . . . 64.43 109.078 171.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.608 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.2 Cg_endo -40.07 -67.16 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.765 3.644 . . . . 72.54 116.688 -178.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.443 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -147.03 166.25 16.79 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 75.32 109.695 -176.782 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.545 ' O ' HG12 ' A' ' 21' ' ' ILE . 32.1 Cg_exo -60.4 128.6 26.63 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.068 1.845 . . . . 42.43 109.632 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -73.47 0.89 46.65 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 115.887 1.115 . . . . 52.2 115.887 -172.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -98.46 -7.51 28.4 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 117.772 0.786 . . . . 72.55 112.417 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.4 pt -92.84 3.94 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.58 0.705 . . . . 71.45 111.098 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 41' ' ' PHE . 2.2 p -88.12 135.82 24.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.292 -0.867 . . . . 74.22 112.411 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -86.44 -56.07 3.6 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.434 1.094 . . . . 65.53 108.523 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -146.97 170.15 17.69 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.811 -1.086 . . . . 72.02 108.59 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.604 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 47.2 p90 -141.68 155.94 45.66 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.978 -0.378 . . . . 74.13 109.978 -175.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.412 ' HB2' HG22 ' A' ' 40' ' ' VAL . 28.1 m170 -133.82 121.95 22.54 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.627 -0.509 . . . . 75.34 109.627 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' OH ' HG21 ' A' ' 62' ' ' ILE . 54.1 m-85 -78.31 103.89 8.55 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 123.208 0.318 . . . . 74.42 110.168 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -108.76 131.55 54.84 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.484 -0.887 . . . . 75.22 110.983 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.4 mt -133.94 -177.98 4.81 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.142 -0.936 . . . . 50.54 109.131 -174.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 63.1 mt -71.67 -24.15 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 120.477 -0.489 . . . . 71.25 109.777 176.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.642 ' HE3' ' C ' ' A' ' 31' ' ' LYS 0.364 0.0 OUTLIER -67.26 -10.02 46.47 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.687 0.995 . . . . 73.43 113.687 176.415 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.521 ' N ' ' HE3' ' A' ' 31' ' ' LYS . 22.2 m-20 -83.76 -5.42 59.19 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.352 0.596 . . . . 73.21 109.733 171.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.37 43.2 8.72 Favored Glycine 0 N--CA 1.434 -1.489 0 CA-C-N 115.089 -0.96 . . . . 33.42 111.464 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 11.1 t -135.56 155.37 50.59 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.09 -1.818 . . . . 74.02 106.09 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -92.75 14.52 16.99 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.501 1.667 . . . . 74.24 115.501 -168.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 10' ' ' LEU . 3.7 p -153.11 116.3 2.78 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-O 121.328 0.585 . . . . 73.4 112.544 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -83.84 134.93 6.47 Favored 'Trans proline' 0 C--O 1.252 1.181 0 C-N-CA 122.645 2.23 . . . . 74.24 112.898 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -176.18 153.94 1.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.183 0.993 . . . . 74.13 108.562 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 8.6 p -99.11 128.28 50.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.355 -1.35 . . . . 61.13 107.355 175.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 9' ' ' CYS . 14.8 m -91.55 127.98 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.491 0 C-N-CA 119.299 -0.96 . . . . 74.1 110.083 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CD1' HG21 ' A' ' 22' ' ' VAL . 4.9 m-85 -91.29 116.87 29.18 Favored 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 115.099 -0.955 . . . . 74.44 109.79 173.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 99.0 m -89.78 106.79 18.7 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 107.721 -1.214 . . . . 61.21 107.721 176.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 69.5 p -69.73 174.18 5.41 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 123.19 0.306 . . . . 70.3 111.321 -177.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 91.6 mt -58.0 -33.23 68.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.214 0.531 . . . . 70.0 110.73 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -69.58 -18.93 63.67 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.617 -0.719 . . . . 64.2 110.882 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.58 16.71 33.26 Favored Glycine 0 CA--C 1.499 -0.956 0 C-N-CA 120.536 -0.84 . . . . 74.41 111.729 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.564 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 1.8 mmp_? -95.87 144.24 26.38 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-O 120.693 0.282 . . . . 74.21 110.668 -177.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -105.6 131.09 53.41 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.505 -0.77 . . . . 53.14 110.151 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.402 HD23 HG23 ' A' ' 17' ' ' ILE . 31.3 tp -132.87 150.89 52.12 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.886 -0.783 . . . . 73.43 108.886 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.479 ' HB3' HG12 ' A' ' 12' ' ' VAL . 4.9 m -77.68 123.9 27.26 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 110.087 -0.338 . . . . 70.04 110.087 -175.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.608 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -132.66 157.57 77.98 Favored Pre-proline 0 C--O 1.243 0.747 0 CA-C-N 118.31 0.505 . . . . 53.02 109.933 174.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.34 109.34 2.3 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.055 1.837 . . . . 51.23 113.46 -174.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.42 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 54.8 Cg_endo -70.74 -12.78 31.54 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 122.779 2.319 . . . . 71.21 113.685 -174.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -96.12 -20.44 18.63 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.232 -0.44 . . . . 74.22 111.385 -176.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -80.06 145.22 60.51 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 113.938 1.088 . . . . 71.23 113.938 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -51.24 -43.47 48.76 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.812 3.675 . . . . 73.3 115.734 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.423 ' O ' HG12 ' A' ' 61' ' ' ILE . 39.5 p-90 -64.53 -36.29 83.74 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.137 -0.625 . . . . 74.45 111.289 -175.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 62' ' ' ILE . 76.6 t -69.53 -47.29 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.849 -0.614 . . . . 70.01 111.765 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.532 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 10.1 pt-20 -61.62 -32.83 72.98 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.314 0.487 . . . . 64.23 112.314 -177.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.532 ' HE ' ' HG3' ' A' ' 59' ' ' GLU . 5.6 mmp_? -66.15 -51.93 53.18 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.094 0.473 . . . . 75.24 110.648 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.465 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 8.0 pt -64.58 -34.69 71.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.735 -0.666 . . . . 72.0 111.989 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.604 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 39.8 mt -57.4 -43.98 83.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.315 -0.402 . . . . 71.54 111.382 173.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.436 ' HA ' ' OE1' ' A' ' 63' ' ' GLN . 13.7 mm-40 -63.54 -36.72 84.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.973 0.416 . . . . 73.14 110.709 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 29.7 mmt180 -64.82 -34.08 77.52 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.618 -0.719 . . . . 72.41 111.011 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.521 HD11 HG13 ' A' ' 22' ' ' VAL . 90.4 mt -77.31 -34.93 55.32 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.767 -0.373 . . . . 75.14 110.992 176.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -76.78 -18.75 58.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.241 0.83 . . . . 72.21 113.241 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 40.7 ptt180 -65.34 -6.69 10.64 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.712 0.634 . . . . 54.42 112.712 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.5 p -62.73 -28.34 69.89 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 122.085 0.945 . . . . 71.44 109.754 174.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.0 m -76.03 -13.7 60.22 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 114.569 -1.196 . . . . 62.23 111.246 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.52 -21.86 48.21 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.177 -0.675 . . . . 64.44 109.177 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -80.35 -17.51 51.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.138 -0.937 . . . . 51.1 108.512 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 49.0 ttm -80.03 150.72 30.28 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.348 -0.842 . . . . 64.04 108.989 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -75.03 100.62 4.23 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.943 -0.762 . . . . 75.12 108.943 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -135.55 146.66 48.25 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.639 -1.245 . . . . 73.22 107.639 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 64.45 93.5 0.06 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 123.766 0.666 . . . . 73.31 110.44 -174.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.9 t -79.31 -31.76 43.29 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.217 -0.447 . . . . 71.43 110.579 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.432 -1.345 0 N-CA-C 109.344 -0.613 . . . . 54.33 109.344 179.575 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.327 0 N-CA-C 109.986 -1.246 . . . . 63.4 109.986 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.6 m 66.34 -71.82 0.09 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.864 0.866 . . . . 63.54 111.94 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -102.5 127.08 49.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.901 0.382 . . . . 72.24 110.268 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -133.44 76.77 1.69 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.833 0.825 . . . . 51.2 109.451 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.71 -4.26 44.48 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.887 -1.051 . . . . 71.52 111.289 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -106.85 146.88 30.42 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.344 -0.844 . . . . 74.34 111.269 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -138.91 10.64 2.63 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.826 -1.176 . . . . 73.42 107.826 176.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.616 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 49.3 t -102.6 -178.11 3.59 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.627 -1.169 . . . . 74.03 111.025 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.418 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 97.4 m -84.44 166.18 17.52 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.744 0.818 . . . . 54.31 112.761 -177.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.51 -53.01 2.88 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.189 -1.411 . . . . 74.12 107.189 172.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.1 m -167.64 178.57 5.27 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.063 -1.458 . . . . 61.41 107.063 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.427 HG12 ' CB ' ' A' ' 50' ' ' CYS . 3.1 m -133.64 148.79 30.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.055 -1.461 . . . . 72.15 107.055 173.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 10.9 t -92.11 178.76 5.77 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.262 -1.014 . . . . 53.51 108.262 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -47.53 -69.89 0.11 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.532 0.733 . . . . 74.24 111.38 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 61.1 mtpt -132.74 80.87 60.35 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 109.477 -0.564 . . . . 71.53 109.477 174.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.9 Cg_endo -43.64 -83.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 125.277 3.985 . . . . 70.11 118.935 -172.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -138.28 157.96 71.68 Favored Pre-proline 0 C--N 1.32 -0.713 0 O-C-N 122.164 -0.335 . . . . 72.33 110.451 -173.076 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.27 136.77 45.02 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.501 2.134 . . . . 62.1 111.354 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.542 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -77.57 1.22 67.28 Favored Glycine 0 C--O 1.218 -0.878 0 CA-C-O 121.868 0.705 . . . . 41.11 112.006 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -77.04 -28.12 54.72 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.051 -0.575 . . . . 73.12 110.6 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.1 pt -98.67 8.63 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 120.691 -0.404 . . . . 72.31 112.011 -176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.431 HG13 HD11 ' A' ' 65' ' ' LEU . 7.7 p -95.39 138.27 21.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.106 0.479 . . . . 70.11 111.115 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.9 -56.06 3.23 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.461 -0.94 . . . . 71.22 108.461 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -145.91 174.31 11.37 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.232 1.013 . . . . 73.31 108.602 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -140.57 169.29 17.92 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.518 -0.473 . . . . 71.2 110.357 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.482 ' HB2' HG22 ' A' ' 40' ' ' VAL . 34.0 m80 -129.1 129.03 44.69 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.137 -2.171 . . . . 72.1 105.137 171.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -97.46 109.38 22.15 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 107.906 -1.146 . . . . 64.55 107.906 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.616 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.3 mm? -98.1 117.83 33.34 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.0 0.428 . . . . 63.04 111.342 -174.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.9 mt -124.93 -179.09 4.39 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.538 -0.912 . . . . 75.32 108.538 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 52.2 mt -71.11 -21.01 21.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.544 -0.91 . . . . 53.0 108.544 176.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -59.04 -32.88 70.15 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.983 -1.008 . . . . 71.24 109.834 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.3 -6.41 57.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.664 -0.698 . . . . 60.12 110.6 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.08 34.33 12.99 Favored Glycine 0 CA--C 1.498 -1.02 0 C-N-CA 121.108 -0.568 . . . . 33.44 112.246 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 46.3 t -123.08 145.95 48.12 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.649 -0.871 . . . . 71.34 108.649 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.607 ' O ' ' HD3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -79.79 -36.02 37.65 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.534 -0.543 . . . . 63.44 109.534 -177.524 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.7 p -98.04 103.89 19.71 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 121.132 0.491 . . . . 74.4 111.438 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 35' ' ' ARG . 92.7 Cg_endo -84.0 130.11 4.81 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 121.707 1.605 . . . . 62.44 111.588 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HA ' ' HG3' ' A' ' 53' ' ' PRO . . . -172.65 -179.78 2.23 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 124.212 1.005 . . . . 53.44 108.857 -177.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -119.04 130.03 74.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 120.228 -0.589 . . . . 71.45 110.077 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.777 HG12 ' SG ' ' A' ' 50' ' ' CYS . 4.4 m -89.26 130.94 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 108.186 -1.042 . . . . 65.11 108.186 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -98.32 114.82 27.26 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 109.633 -0.506 . . . . 74.05 109.633 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 86.2 m -84.34 102.19 12.52 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.203 -1.036 . . . . 63.13 108.203 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 51.5 p -72.03 169.93 14.93 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.488 -0.324 . . . . 64.02 111.31 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.67 -25.46 66.37 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.492 0.717 . . . . 75.32 112.334 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -83.27 -4.04 58.04 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.227 0.537 . . . . 71.02 110.89 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.13 16.13 56.35 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 120.802 -0.713 . . . . 61.33 112.319 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 36.1 mmt180 -99.64 130.24 45.85 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 112.521 0.563 . . . . 74.42 112.521 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -95.92 122.02 38.27 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.157 -0.928 . . . . 72.22 109.545 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.7 tm? -134.92 138.24 43.9 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.407 -1.701 . . . . 64.54 106.407 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.777 ' SG ' HG12 ' A' ' 40' ' ' VAL . 73.5 m -98.0 147.35 24.59 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 114.828 1.418 . . . . 73.44 114.828 -172.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.556 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -128.84 159.1 70.14 Favored Pre-proline 0 C--O 1.243 0.752 0 CA-C-N 115.227 -0.897 . . . . 63.35 110.999 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 55.6 Cg_endo -64.88 108.88 1.17 Allowed 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.185 2.59 . . . . 60.21 113.226 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HG3' ' HA ' ' A' ' 38' ' ' ALA . 64.1 Cg_endo -67.71 -9.8 26.67 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 C-N-CA 123.024 2.483 . . . . 74.15 114.054 -175.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.49 -22.69 17.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.932 0.396 . . . . 75.25 111.292 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -76.08 130.34 78.29 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 112.801 0.667 . . . . 74.14 112.801 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.38 -41.63 17.68 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.915 3.744 . . . . 64.54 114.809 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -63.3 -26.89 68.98 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 120.93 0.395 . . . . 74.41 110.897 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 62' ' ' ILE . 74.9 t -82.86 -42.39 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.93 -0.577 . . . . 71.0 111.869 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.305 0.2 OUTLIER -66.34 -30.88 71.37 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.929 1.085 . . . . 73.45 113.929 -174.477 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -61.32 -49.94 74.97 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.041 0.448 . . . . 72.15 110.672 176.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.542 HG21 ' HA3' ' A' ' 19' ' ' GLY . 10.7 pt -69.12 -31.63 50.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.904 -0.589 . . . . 74.03 112.173 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 58' ' ' VAL . 56.4 mt -59.13 -50.08 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 110.156 -0.312 . . . . 61.15 110.156 171.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 29.7 mm-40 -62.58 -36.78 83.78 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.14 0.495 . . . . 61.31 109.947 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 38.8 ttm180 -57.96 -48.25 80.51 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.7 -1.136 . . . . 53.32 110.817 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.431 HD11 HG13 ' A' ' 22' ' ' VAL . 82.8 mt -70.71 -30.39 66.94 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 116.543 -0.299 . . . . 64.24 110.699 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -55.86 -18.92 9.92 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 114.424 1.268 . . . . 75.22 114.424 177.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 15.4 ptm180 -53.82 -32.87 54.34 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 120.731 0.3 . . . . 55.45 110.643 176.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.3 p -73.72 -31.06 63.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.469 0.652 . . . . 43.11 110.392 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.1 t -78.97 -34.27 44.4 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.174 -0.921 . . . . 44.0 109.38 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.84 -21.56 62.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.697 0.76 . . . . 74.33 110.012 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -83.68 -23.29 31.79 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.033 -0.985 . . . . 71.41 109.21 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.7 tpt -93.02 104.39 16.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.544 -0.753 . . . . 74.24 109.865 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.01 106.83 14.23 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 116.086 -0.507 . . . . 73.45 110.141 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 73.41 100.89 0.07 Allowed 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.127 1.371 . . . . 70.42 111.109 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -102.42 142.51 33.51 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.895 -0.593 . . . . 70.33 110.144 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.7 p -96.35 76.57 2.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.493 0.664 . . . . 60.11 110.199 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--N 1.303 -1.453 0 N-CA-C 107.751 -1.203 . . . . 65.42 107.751 179.81 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.77 0 N-CA-C 111.166 -0.773 . . . . 73.41 111.166 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 t -156.65 157.57 35.46 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.394 -0.965 . . . . 73.44 108.394 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -81.71 -51.11 8.52 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.024 -1.473 . . . . 72.35 107.024 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -176.42 163.53 2.49 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.989 -1.485 . . . . 72.52 106.989 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.22 -17.42 39.91 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.261 0.553 . . . . 71.25 111.811 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -98.08 152.6 19.14 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 112.889 0.7 . . . . 74.32 112.889 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -84.59 -29.56 25.71 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.197 -1.409 . . . . 63.25 107.197 174.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.67 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 74.6 m -84.16 173.67 10.85 Favored 'General case' 0 N--CA 1.402 -2.839 0 CA-C-N 114.088 -1.414 . . . . 62.31 110.381 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.429 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -107.1 -179.92 4.07 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.063 -0.655 . . . . 74.3 109.574 -176.823 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -118.13 -51.83 2.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.711 1.374 . . . . 74.02 114.711 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.6 p -153.21 136.3 15.59 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.142 -0.623 . . . . 72.32 111.615 -171.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -102.76 153.72 5.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 119.539 -0.864 . . . . 65.44 108.879 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.6 t -99.59 179.01 4.68 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.111 -0.699 . . . . 55.43 109.111 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -39.36 -51.52 2.07 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.591 1.157 . . . . 71.44 111.628 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 40.3 ttmt -159.55 94.53 1.7 Allowed Pre-proline 0 N--CA 1.427 -1.622 0 N-CA-C 108.254 -1.017 . . . . 70.45 108.254 171.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.6 Cg_endo -39.44 -82.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.738 3.625 . . . . 61.44 117.837 -173.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.421 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -143.72 161.4 46.58 Favored Pre-proline 0 N--CA 1.475 0.816 0 N-CA-C 109.452 -0.573 . . . . 64.43 109.452 -175.085 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.508 ' O ' HG12 ' A' ' 21' ' ' ILE . 19.5 Cg_endo -61.74 129.24 26.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.845 1.696 . . . . 72.44 110.443 172.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.532 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -74.0 2.19 43.9 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 114.79 0.676 . . . . 74.01 114.79 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -93.64 -9.4 38.09 Favored 'General case' 0 C--N 1.281 -2.383 0 O-C-N 121.953 -0.733 . . . . 73.3 112.298 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 18' ' ' PRO . 39.5 pt -96.89 0.58 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.508 0.67 . . . . 54.31 111.039 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.628 HG13 HD11 ' A' ' 65' ' ' LEU . 2.6 p -87.46 133.4 30.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.542 -0.753 . . . . 75.23 111.102 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.523 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -84.78 -53.76 5.13 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.882 -1.155 . . . . 71.14 107.882 -176.656 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.523 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 18.6 m120 -139.73 147.85 41.46 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-N 115.115 -0.948 . . . . 73.4 108.844 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.447 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 43.1 p90 -114.65 152.69 31.48 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.509 -0.922 . . . . 73.2 108.509 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.574 ' HB2' HG22 ' A' ' 40' ' ' VAL . 28.8 m170 -118.52 128.64 54.78 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.3 -1.741 . . . . 72.15 106.3 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -97.33 109.48 22.22 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.684 -0.858 . . . . 75.33 108.684 -175.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.67 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 2.4 mm? -103.11 122.09 43.96 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.318 -0.401 . . . . 61.23 110.115 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.7 mt -128.8 172.33 11.39 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.457 -0.338 . . . . 74.21 110.272 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.589 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 47.7 mt -77.72 -20.89 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.096 -1.446 . . . . 55.21 107.096 176.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -63.94 -27.12 68.93 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.212 -1.358 . . . . 71.11 109.165 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.53 -12.05 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.475 -0.784 . . . . 71.4 110.488 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.61 -47.31 1.03 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.187 -0.53 . . . . 54.32 114.316 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 71.0 m -62.48 137.55 58.28 Favored 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 112.366 0.506 . . . . 60.24 112.366 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -71.13 -20.19 62.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 73.43 111.874 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.05 106.91 58.53 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-O 121.203 0.525 . . . . 71.33 111.159 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -85.57 130.21 3.76 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.282 1.988 . . . . 65.12 111.655 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -171.72 153.5 3.38 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.867 -0.79 . . . . 74.32 108.867 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.04 131.72 46.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.201 -1.037 . . . . 73.11 108.201 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.574 HG22 ' HB2' ' A' ' 26' ' ' HIS . 16.8 m -98.99 129.78 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.798 0 C-N-CA 119.535 -0.866 . . . . 73.21 109.492 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -96.44 115.44 27.43 Favored 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 115.234 -0.894 . . . . 60.1 110.903 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 24' ' ' ASN . 53.2 m -85.74 105.13 16.05 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 123.786 0.679 . . . . 73.42 109.412 175.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.1 p -71.78 173.28 8.41 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.977 -0.556 . . . . 60.21 111.002 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.25 -28.39 69.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.373 0.606 . . . . 74.23 110.062 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -64.83 -32.99 74.95 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.252 -0.886 . . . . 73.24 110.321 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.26 -3.85 25.23 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 120.77 -0.729 . . . . 64.23 112.048 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 42' ' ' THR . 27.1 mmt180 -75.69 137.82 40.9 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 111.84 0.311 . . . . 73.24 111.84 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -103.95 112.51 25.51 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.875 -1.157 . . . . 64.14 107.875 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 24.0 tp -114.76 145.35 42.2 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.263 -0.575 . . . . 54.2 109.653 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.7 m -78.03 133.41 37.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.784 -0.45 . . . . 64.12 109.784 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.57 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -137.6 155.65 75.13 Favored Pre-proline 0 C--N 1.312 -1.065 0 N-CA-C 109.811 -0.44 . . . . 73.02 109.811 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 86.5 Cg_endo -71.24 111.32 3.06 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.993 2.462 . . . . 72.32 112.824 -175.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.9 Cg_endo -70.23 -12.45 32.03 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.691 2.261 . . . . 74.32 114.328 -173.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -113.08 9.73 18.63 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.531 0.567 . . . . 74.14 112.531 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 25.1 mm-40 -91.54 139.05 25.02 Favored Pre-proline 0 C--N 1.32 -0.683 0 O-C-N 122.313 -0.242 . . . . 71.13 110.999 176.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 83.3 Cg_exo -49.83 -43.16 42.06 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 124.086 3.191 . . . . 74.25 114.714 -175.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.5 ' O ' HG12 ' A' ' 61' ' ' ILE . 40.3 p-90 -62.92 -37.46 87.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.307 -0.557 . . . . 74.34 110.518 -177.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 62' ' ' ILE . 78.6 t -72.81 -43.67 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.707 -0.679 . . . . 63.03 110.602 178.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 43.7 mt-10 -53.07 -41.54 64.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.094 0.473 . . . . 73.13 110.88 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -72.97 -41.46 64.36 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.695 0.628 . . . . 75.34 112.695 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.532 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.7 pt -71.56 -32.69 46.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 112.561 0.578 . . . . 75.43 112.561 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.447 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 59.0 mt -57.69 -50.28 77.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.152 -0.684 . . . . 74.32 109.152 171.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 31.0 mm-40 -61.8 -40.93 96.96 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.925 -0.579 . . . . 71.13 110.423 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -54.33 -50.29 67.75 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.727 -0.67 . . . . 72.34 109.688 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.628 HD11 HG13 ' A' ' 22' ' ' VAL . 80.9 mt -70.1 -30.45 67.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.356 0.502 . . . . 53.41 112.356 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 48.5 mt-30 -71.85 -27.42 62.87 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.549 -0.86 . . . . 75.23 111.419 177.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 30.4 mmm180 -72.97 -29.01 62.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.748 0.309 . . . . 73.44 110.666 175.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 36.1 p -81.74 -19.69 40.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.891 0.853 . . . . 73.23 110.608 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 61.2 m -85.57 -11.24 54.53 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.756 -1.111 . . . . 74.3 110.96 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.46 -29.71 66.4 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.224 0.609 . . . . 61.34 111.251 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -98.63 144.86 27.46 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.386 -0.968 . . . . 75.43 108.386 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.9 tpt 63.23 27.51 15.56 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-O 122.746 1.26 . . . . 62.43 109.241 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -77.26 111.49 12.96 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.892 -1.049 . . . . 41.22 111.001 -177.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -129.82 -51.26 1.14 Allowed 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.561 -1.274 . . . . 75.23 107.561 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -155.96 103.34 2.22 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.112 -0.949 . . . . 72.52 110.115 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.7 t -106.23 77.2 1.2 Allowed 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.241 -1.763 . . . . 70.2 106.241 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.9 m . . . . . 0 C--O 1.262 1.732 0 N-CA-C 108.001 -1.111 . . . . 74.33 108.001 -176.521 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.236 0 N-CA-C 110.508 -1.037 . . . . 71.44 110.508 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.2 p -82.79 90.14 6.87 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.092 0.472 . . . . 74.43 109.79 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -116.91 109.97 17.73 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.634 -0.876 . . . . 52.24 108.634 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -71.03 152.24 43.76 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.256 -0.429 . . . . 62.22 111.283 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 10' ' ' LEU . . . -82.06 -16.12 51.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.191 -0.459 . . . . 74.23 111.78 -177.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 52.96 -174.15 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 125.801 1.64 . . . . 70.04 114.631 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -88.86 -32.75 17.63 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 121.118 0.485 . . . . 75.13 110.805 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.532 ' HA ' HD13 ' A' ' 28' ' ' LEU . 6.6 p -108.62 168.95 8.97 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.87 -0.604 . . . . 63.21 110.251 174.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.465 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -84.16 128.0 34.28 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.525 -0.87 . . . . 44.52 110.684 -171.041 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.604 ' H ' HD12 ' A' ' 10' ' ' LEU . 6.2 mp -43.96 -62.44 1.13 Allowed 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 125.367 1.467 . . . . 72.43 114.265 -175.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 p -173.01 143.42 1.16 Allowed 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 120.259 -0.576 . . . . 63.54 109.633 -172.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 13' ' ' THR . 1.1 m -99.48 152.58 4.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.009 -1.108 . . . . 63.11 108.009 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 12' ' ' VAL . 9.0 t -89.54 174.44 7.77 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.274 -1.38 . . . . 73.44 107.274 175.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -53.37 -39.65 64.35 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.273 0.488 . . . . 63.03 112.12 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -155.15 93.8 2.69 Favored Pre-proline 0 N--CA 1.429 -1.505 0 N-CA-C 108.733 -0.839 . . . . 71.11 108.733 170.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.644 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 11.8 Cg_endo -52.13 -82.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.268 3.312 . . . . 74.34 117.705 -175.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.419 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -138.6 162.4 53.32 Favored Pre-proline 0 C--N 1.321 -0.641 0 O-C-N 121.881 -0.512 . . . . 74.55 110.424 -173.224 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.61 ' O ' HG12 ' A' ' 21' ' ' ILE . 27.2 Cg_exo -63.97 132.15 33.46 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.877 1.718 . . . . 72.2 110.124 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.529 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -75.05 1.11 56.89 Favored Glycine 0 C--N 1.301 -1.382 0 N-CA-C 114.065 0.386 . . . . 50.25 114.065 -176.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -91.58 -2.38 57.14 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 122.483 -0.422 . . . . 74.32 110.88 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 18' ' ' PRO . 27.6 pt -107.1 6.76 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 120.313 -0.555 . . . . 61.35 110.819 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.491 HG21 ' CD1' ' A' ' 41' ' ' PHE . 5.4 p -93.77 140.69 16.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.02 -0.537 . . . . 73.25 111.453 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.41 -47.0 5.06 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.776 0.83 . . . . 75.21 109.441 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -143.9 163.64 32.82 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.749 -1.204 . . . . 71.15 107.749 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.77 165.52 27.85 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.233 0.47 . . . . 72.33 110.47 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.524 ' HB2' HG22 ' A' ' 40' ' ' VAL . 36.0 m80 -134.45 112.41 10.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.695 -1.224 . . . . 62.33 107.695 170.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -83.17 94.92 7.96 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.972 -1.122 . . . . 71.02 107.972 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.532 HD13 ' HA ' ' A' ' 8' ' ' CYS . 63.0 mt -94.63 137.41 33.78 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.635 -0.712 . . . . 70.23 111.428 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.42 ' H ' ' HB3' ' A' ' 32' ' ' ASP . 91.8 mt -142.05 169.67 17.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.035 -0.984 . . . . 72.33 110.861 -175.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -77.9 -29.61 15.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 107.17 -1.419 . . . . 73.24 107.17 171.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.88 -30.19 70.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.023 -0.99 . . . . 73.43 109.15 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' A' ' 29' ' ' LEU . 20.1 t70 -74.33 -32.87 62.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.199 -0.91 . . . . 74.31 108.805 173.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.63 88.61 1.6 Allowed Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.178 -0.919 . . . . 53.2 113.68 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.9 t 178.84 -175.5 0.21 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.429 -1.322 . . . . 64.54 107.429 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -89.5 -41.99 11.72 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.557 0.577 . . . . 74.11 112.557 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.05 115.95 42.79 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 113.085 0.772 . . . . 65.34 113.085 -176.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -83.07 130.68 5.67 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.838 2.359 . . . . 73.04 111.655 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.66 153.42 2.26 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.269 -1.011 . . . . 43.24 108.269 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.09 130.78 47.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.81 -1.181 . . . . 42.34 107.81 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' A' ' 26' ' ' HIS . 4.5 m -92.4 131.69 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.759 0 N-CA-C 108.254 -1.017 . . . . 75.31 108.254 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.491 ' CD1' HG21 ' A' ' 22' ' ' VAL . 10.3 m-85 -103.2 115.44 30.58 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 116.108 -0.496 . . . . 71.15 110.728 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.7 m -80.69 100.39 8.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.2 -1.408 . . . . 51.22 107.2 174.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 53.2 p -72.25 175.39 6.13 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.494 0.188 . . . . 72.12 111.042 -177.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 96.8 mt -61.02 -26.74 67.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.692 -0.485 . . . . 65.12 109.692 176.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.403 ' NE ' ' HA ' ' A' ' 45' ' ' ARG . 6.5 tpm_? -63.88 -27.01 68.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.373 1.069 . . . . 73.21 110.791 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.92 8.55 59.08 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.168 -0.539 . . . . 63.43 111.878 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.61 138.93 38.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.974 -1.491 . . . . 73.22 106.974 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -95.82 118.77 33.11 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.435 -0.58 . . . . 63.53 109.435 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.1 mp -111.21 149.22 31.28 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 111.785 0.291 . . . . 74.43 111.785 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.428 ' HB3' HG12 ' A' ' 12' ' ' VAL . 23.3 m -80.23 123.4 27.91 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.863 -0.608 . . . . 74.32 110.241 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.74 152.52 77.11 Favored Pre-proline 0 C--O 1.246 0.882 0 O-C-N 122.356 -0.215 . . . . 72.43 110.86 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.422 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 67.3 Cg_endo -67.39 114.12 3.14 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.005 2.47 . . . . 73.21 113.844 -173.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 -15.36 28.05 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.179 1.919 . . . . 75.5 112.154 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -103.82 8.57 37.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.094 -0.503 . . . . 62.44 112.309 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.77 129.28 26.12 Favored Pre-proline 0 C--N 1.315 -0.924 0 C-N-CA 119.88 -0.728 . . . . 70.41 111.654 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.405 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 83.0 Cg_exo -48.03 -36.5 28.03 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.289 3.326 . . . . 74.34 115.296 -177.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -62.32 -27.03 68.76 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 120.086 -0.646 . . . . 75.31 110.961 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 62' ' ' ILE . 67.7 t -79.69 -42.38 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 116.0 -0.546 . . . . 72.22 112.386 -178.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -63.46 -25.54 68.31 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.931 1.086 . . . . 72.32 113.931 -174.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -80.59 -41.24 24.33 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 116.468 -0.333 . . . . 74.25 111.073 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.529 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 10.8 pt -71.9 -31.08 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 111.932 0.345 . . . . 73.31 111.932 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 58' ' ' VAL . 61.4 mt -55.54 -41.38 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.209 -0.45 . . . . 61.14 109.961 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 76.4 mm-40 -61.3 -42.17 98.21 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.981 -0.554 . . . . 72.33 110.372 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -58.51 -43.85 89.26 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.896 -0.593 . . . . 71.13 110.244 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.421 HD11 ' CG1' ' A' ' 22' ' ' VAL . 85.9 mt -68.53 -39.13 81.28 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.819 -0.628 . . . . 64.32 111.623 178.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -64.47 -43.35 94.47 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.694 -0.402 . . . . 75.4 111.223 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 63' ' ' GLN . 70.2 mtp180 -63.37 -33.98 76.72 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.18 0.514 . . . . 75.31 111.266 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.8 p -84.76 -26.21 27.73 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 113.142 0.793 . . . . 73.02 113.142 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.3 t -80.31 -38.02 31.52 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.53 -0.304 . . . . 70.23 110.478 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.11 65.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.95 0.405 . . . . 72.41 112.039 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -105.77 4.54 30.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.258 0.551 . . . . 72.33 110.886 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.74 123.66 48.04 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.402 -1.333 . . . . 73.55 107.402 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -82.15 104.74 12.7 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.898 0.38 . . . . 74.51 110.989 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -162.02 171.37 17.68 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.889 -0.782 . . . . 64.53 108.889 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -75.79 122.54 24.22 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.842 -1.17 . . . . 64.42 107.842 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.1 m -80.11 101.14 8.58 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.469 -0.493 . . . . 74.2 110.867 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.5 m . . . . . 0 N--CA 1.429 -1.516 0 N-CA-C 108.428 -0.953 . . . . 70.41 108.428 177.902 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.645 0 N-CA-C 111.706 -0.558 . . . . 71.35 111.706 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.7 m -71.54 128.9 37.34 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.456 -0.572 . . . . 65.03 109.456 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.8 t30 71.16 115.32 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.442 1.097 . . . . 74.2 109.987 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -82.47 38.04 0.54 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.235 1.017 . . . . 70.42 111.541 -174.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.56 -4.0 56.91 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.975 0.893 . . . . 33.52 109.089 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.47 117.7 9.79 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.248 -1.342 . . . . 44.23 110.871 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -98.96 -13.25 20.03 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.005 0.907 . . . . 71.13 109.316 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' A' ' 28' ' ' LEU . 71.7 m -81.68 159.88 23.84 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.769 -1.105 . . . . 51.33 109.843 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.701 ' SG ' HG12 ' A' ' 40' ' ' VAL . 75.3 m -85.46 177.73 7.67 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.412 0.625 . . . . 74.44 111.709 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.44 -38.86 6.33 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 114.892 -1.049 . . . . 71.44 109.141 176.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.5 m -163.7 168.48 19.74 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 110.127 -0.323 . . . . 42.01 110.127 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.506 HG12 ' CB ' ' A' ' 50' ' ' CYS . 1.3 m -132.35 156.65 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 N-CA-C 104.481 -2.414 . . . . 62.23 104.481 172.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.8 t -96.9 178.02 5.43 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 108.192 -1.04 . . . . 74.11 108.192 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -50.65 -49.6 56.64 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.142 0.496 . . . . 74.2 111.103 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 37.0 ttpt -149.42 84.83 5.98 Favored Pre-proline 0 N--CA 1.421 -1.894 0 N-CA-C 108.976 -0.75 . . . . 54.41 108.976 175.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.2 Cg_endo -46.54 -81.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.786 3.658 . . . . 63.14 117.861 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -136.09 160.07 68.57 Favored Pre-proline 0 C--N 1.311 -1.091 0 O-C-N 121.857 -0.527 . . . . 60.14 110.612 -172.491 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.593 ' O ' HG12 ' A' ' 21' ' ' ILE . 19.6 Cg_endo -60.89 128.43 25.46 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.829 1.686 . . . . 74.45 109.791 173.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.541 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -73.72 1.72 44.12 Favored Glycine 0 C--O 1.209 -1.457 0 C-N-CA 120.98 -0.629 . . . . 31.13 114.554 -174.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -89.97 -1.54 57.99 Favored 'General case' 0 C--N 1.284 -2.276 0 O-C-N 122.198 -0.589 . . . . 71.42 111.367 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 18' ' ' PRO . 38.6 pt -104.01 7.29 10.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 120.788 -0.365 . . . . 72.24 110.959 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.559 HG13 HD11 ' A' ' 65' ' ' LEU . 3.2 p -90.93 131.68 37.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.576 0.703 . . . . 64.21 112.55 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -85.44 -55.06 4.2 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.798 -1.092 . . . . 63.34 108.124 -175.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -143.42 158.66 43.46 Favored 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 123.922 0.889 . . . . 73.33 109.099 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -132.43 163.27 29.12 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.84 -0.43 . . . . 73.45 109.84 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.475 ' HB2' HG22 ' A' ' 40' ' ' VAL . 34.0 m170 -135.01 136.91 42.49 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.289 -1.374 . . . . 73.24 107.289 174.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.409 ' CE2' HD21 ' A' ' 29' ' ' LEU . 5.4 t80 -100.1 105.9 17.58 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.103 0.478 . . . . 64.35 109.723 -175.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.543 HD12 ' SG ' ' A' ' 8' ' ' CYS . 1.8 mm? -97.43 124.08 41.49 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 123.803 0.841 . . . . 64.32 109.529 -176.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.409 HD21 ' CE2' ' A' ' 27' ' ' TYR . 87.6 mt -121.9 176.36 5.81 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.813 -0.44 . . . . 52.54 109.813 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 45.4 mt -73.3 -17.36 17.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 121.992 0.901 . . . . 73.23 108.935 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -65.17 -28.88 69.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.587 -1.188 . . . . 71.33 109.347 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -76.86 -4.22 42.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.504 -0.771 . . . . 62.54 111.08 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.9 -9.37 59.99 Favored Glycine 0 CA--C 1.503 -0.692 0 CA-C-N 116.122 -0.49 . . . . 41.32 113.044 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.715 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 63.0 m -94.67 123.53 38.16 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.526 -0.916 . . . . 72.04 108.526 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.678 ' H ' ' HD2' ' A' ' 35' ' ' ARG 0.313 0.0 OUTLIER -77.67 1.89 18.47 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.968 1.099 . . . . 72.02 113.968 -176.15 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.8 p -109.62 98.22 31.75 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.053 -0.721 . . . . 73.42 109.053 171.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.12 129.86 9.03 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 121.627 1.551 . . . . 71.04 110.29 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 50' ' ' CYS . . . -166.13 160.44 16.28 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.226 -0.443 . . . . 71.23 110.734 -174.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.37 123.15 66.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 109.083 -0.71 . . . . 73.44 109.083 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.701 HG12 ' SG ' ' A' ' 9' ' ' CYS . 9.2 m -80.34 125.64 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 C-N-CA 119.736 -0.786 . . . . 73.42 109.191 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -97.85 109.01 21.85 Favored 'General case' 0 C--N 1.267 -3.02 0 CA-C-N 115.672 -0.695 . . . . 64.42 109.487 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.4 m -82.42 103.72 12.18 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.477 -1.305 . . . . 61.23 107.477 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 64.8 p -69.94 167.12 18.12 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 120.895 -0.322 . . . . 61.52 111.084 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 94.9 mt -59.99 -30.74 69.33 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.093 0.557 . . . . 51.54 110.698 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -70.91 -18.23 62.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.313 -0.858 . . . . 75.33 110.109 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.57 16.6 26.26 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.881 -0.676 . . . . 75.21 113.22 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -99.8 126.05 45.82 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.95 0.375 . . . . 73.41 111.282 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -85.92 127.04 34.52 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.126 -0.694 . . . . 55.3 109.126 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.7 tp -147.67 131.03 16.59 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.229 -1.026 . . . . 74.43 108.229 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.593 ' SG ' HG12 ' A' ' 40' ' ' VAL . 55.8 m -86.78 155.17 20.42 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 114.877 1.436 . . . . 73.32 114.877 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.556 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -130.55 162.34 55.37 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-N 114.217 -1.356 . . . . 63.43 108.453 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.477 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 58.0 Cg_endo -68.67 107.52 1.67 Allowed 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 121.69 1.594 . . . . 71.34 111.617 -177.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 59.6 Cg_endo -68.15 -12.46 35.16 Favored 'Trans proline' 0 N--CA 1.481 0.74 0 C-N-CA 123.171 2.58 . . . . 61.24 114.408 -170.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -96.07 -22.52 17.29 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.141 0.496 . . . . 73.3 110.733 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 15.5 mm100 -73.84 138.7 76.6 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 112.902 0.705 . . . . 71.22 112.902 -174.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 87.7 Cg_exo -50.54 -36.79 50.73 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.321 3.348 . . . . 73.11 115.037 -177.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.481 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 34.7 p-90 -68.18 -28.0 66.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 119.863 -0.735 . . . . 64.42 110.673 -177.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 62' ' ' ILE . 73.9 t -79.77 -41.42 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 116.125 -0.489 . . . . 65.23 111.747 -177.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.569 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 11.7 pt-20 -60.74 -37.52 82.04 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.23 -0.588 . . . . 73.03 112.033 -177.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -62.21 -43.92 97.74 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.062 0.458 . . . . 72.02 111.731 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.541 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 8.5 pt -74.06 -32.49 33.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 116.052 -0.522 . . . . 70.22 111.841 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 58' ' ' VAL . 58.5 mt -60.74 -51.09 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.669 -0.493 . . . . 74.12 109.669 172.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 14.2 mm100 -59.56 -38.0 79.97 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.324 -0.398 . . . . 54.34 110.904 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.441 ' HG3' ' NH2' ' A' ' 67' ' ' ARG . 35.5 ttt180 -57.66 -47.41 82.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.865 -0.607 . . . . 72.14 110.558 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.559 HD11 HG13 ' A' ' 22' ' ' VAL . 86.8 mt -71.17 -30.16 66.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.885 0.374 . . . . 75.45 110.892 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 69' ' ' SER . 73.5 mt-30 -67.49 -22.56 65.45 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 113.037 0.754 . . . . 74.53 113.037 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.441 ' NH2' ' HG3' ' A' ' 64' ' ' ARG . 26.2 mtm180 -65.66 -45.99 80.82 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.41 0.624 . . . . 64.31 109.473 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.6 p -78.32 -20.08 52.18 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.689 -0.687 . . . . 73.35 112.101 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 66' ' ' GLN . 67.7 m -86.45 -12.13 49.91 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.829 -0.623 . . . . 65.22 111.184 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.68 -25.52 61.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.707 0.403 . . . . 52.22 111.292 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -73.99 -26.6 60.55 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.592 -0.892 . . . . 71.2 108.592 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.413 ' HG2' ' H ' ' A' ' 73' ' ' LYS . 49.1 ttp -95.84 -176.9 3.86 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.0 -1.482 . . . . 70.44 107.0 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 21.7 ptmt -75.6 -0.81 21.81 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 118.339 0.518 . . . . 72.13 111.747 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 73' ' ' LYS . 73.7 ttt180 72.02 131.35 0.04 OUTLIER 'General case' 0 C--N 1.359 0.995 0 C-N-CA 123.441 0.697 . . . . 74.24 110.295 -173.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 75' ' ' ARG . 38.8 mmt180 -82.64 79.54 9.03 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 119.911 -0.716 . . . . 73.24 111.267 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.4 t -170.06 93.81 0.24 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 105.495 -2.039 . . . . 75.32 105.495 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--N 1.299 -1.613 0 N-CA-C 107.797 -1.186 . . . . 62.14 107.797 -175.009 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.5 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 25.7 p . . . . . 0 N--CA 1.44 -0.956 0 N-CA-C 112.959 0.726 . . . . 72.05 112.959 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.39 -171.04 3.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.966 -0.561 . . . . 53.21 109.659 -175.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.28 -64.02 1.09 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.06 -0.348 . . . . 70.24 110.06 -176.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -175.03 153.39 1.63 Allowed 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.307 -1.368 . . . . 54.25 107.307 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.96 150.53 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 C-N-CA 119.862 -0.735 . . . . 62.51 109.59 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.0 t -91.74 177.65 6.14 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.286 -1.005 . . . . 73.5 108.286 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -44.87 -63.49 0.91 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.388 0.675 . . . . 72.31 110.912 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 86.4 tttt -142.55 91.91 7.41 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 106.9 -1.518 . . . . 72.13 106.9 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.625 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.0 Cg_endo -46.98 -87.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.507 3.472 . . . . 45.13 118.321 -172.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.555 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -131.59 160.87 65.47 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 109.628 -0.508 . . . . 72.24 109.628 -173.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.508 ' O ' HG12 ' A' ' 21' ' ' ILE . 51.2 Cg_exo -60.16 128.41 26.33 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.181 1.921 . . . . 72.45 110.719 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.514 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -76.24 -0.88 67.49 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 116.023 -0.535 . . . . 72.32 113.454 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -95.67 -3.75 45.54 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 113.149 0.796 . . . . 74.13 113.149 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 18' ' ' PRO . 40.8 pt -103.74 9.79 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.539 0.685 . . . . 51.41 110.538 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.538 HG13 HD11 ' A' ' 65' ' ' LEU . 3.3 p -93.96 132.42 38.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.683 -0.689 . . . . 70.11 111.794 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -84.32 -47.99 10.17 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.657 1.183 . . . . 74.33 111.479 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -150.39 156.57 41.75 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.6 -0.889 . . . . 64.45 108.6 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 34.9 p90 -129.14 159.98 34.32 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.016 0.436 . . . . 62.45 109.896 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.654 ' HB2' HG22 ' A' ' 40' ' ' VAL . 3.7 m170 -127.16 125.67 41.55 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 104.907 -2.257 . . . . 74.31 104.907 175.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -95.88 100.61 12.29 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.981 -0.377 . . . . 73.03 109.981 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.4 mm? -97.99 120.28 38.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.066 0.546 . . . . 54.01 111.375 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.7 mt -130.0 176.03 8.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.069 0.461 . . . . 72.41 110.719 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.6 mt -73.52 -22.13 18.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.268 -1.012 . . . . 72.23 108.268 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -58.38 -42.59 87.37 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.623 -1.171 . . . . 64.11 108.781 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.79 -48.03 60.66 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.984 -1.007 . . . . 75.44 108.586 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.74 87.85 0.4 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 115.104 -0.953 . . . . 50.01 112.469 175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 46.9 t -171.12 161.93 6.89 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.928 -1.138 . . . . 53.43 107.928 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -87.54 -25.92 23.41 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.928 0.394 . . . . 41.13 110.388 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.6 109.2 58.09 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-O 121.123 0.487 . . . . 62.05 111.371 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -81.86 129.73 6.38 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 121.401 1.401 . . . . 72.44 109.752 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.521 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -166.49 147.76 6.36 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.164 -0.471 . . . . 75.14 110.091 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.33 128.24 51.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 107.577 -1.268 . . . . 64.55 107.577 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.654 HG22 ' HB2' ' A' ' 26' ' ' HIS . 11.9 m -93.37 129.71 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 C-N-CA 119.42 -0.912 . . . . 71.55 109.378 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 14.7 m-85 -99.76 113.47 25.99 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.419 -0.81 . . . . 70.55 111.312 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -83.03 104.49 13.28 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.383 -0.969 . . . . 72.14 108.383 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 66.5 p -72.64 178.47 4.1 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 112.321 0.489 . . . . 61.13 112.321 -175.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.486 HD23 ' HG2' ' A' ' 23' ' ' ARG . 77.0 mt -60.69 -31.74 70.98 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.807 0.843 . . . . 70.15 110.947 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -75.93 -14.55 60.25 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.711 -0.677 . . . . 70.21 111.01 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.66 16.2 43.38 Favored Glycine 0 CA--C 1.506 -0.471 0 C-N-CA 120.571 -0.823 . . . . 44.43 112.243 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -100.54 130.49 46.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 110.379 -0.23 . . . . 74.42 110.379 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -95.67 144.03 26.43 Favored 'General case' 0 N--CA 1.426 -1.649 0 C-N-CA 120.173 -0.611 . . . . 75.11 111.412 175.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.538 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -139.42 146.33 39.99 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.445 -1.317 . . . . 63.52 107.445 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.538 ' N ' HD13 ' A' ' 49' ' ' LEU . 3.7 m -80.71 126.19 30.98 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.148 0.28 . . . . 60.23 110.286 -175.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.625 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.12 156.27 74.73 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 122.016 -0.427 . . . . 41.33 110.877 175.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.497 ' HG3' ' OE1' ' A' ' 55' ' ' GLN . 90.3 Cg_endo -72.93 116.8 4.85 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.758 2.305 . . . . 73.43 113.961 -172.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.521 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.6 Cg_endo -74.38 -9.74 21.82 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.255 1.97 . . . . 65.45 112.57 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -89.94 -38.04 13.95 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.915 -0.314 . . . . 74.24 111.192 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.497 ' OE1' ' HG3' ' A' ' 52' ' ' PRO . 52.0 mt-30 -63.99 137.73 97.19 Favored Pre-proline 0 C--O 1.239 0.523 0 N-CA-C 113.535 0.939 . . . . 74.15 113.535 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 68.5 Cg_exo -57.27 -34.53 98.0 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.9 3.067 . . . . 53.55 114.245 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -61.02 -31.95 71.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.246 0.546 . . . . 73.02 110.579 -176.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 62' ' ' ILE . 70.9 t -76.65 -38.85 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 115.434 -0.803 . . . . 71.31 111.641 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.593 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.303 0.2 OUTLIER -66.83 -24.65 66.18 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 113.815 1.042 . . . . 41.55 113.815 -175.63 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -74.22 -50.77 17.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.037 0.446 . . . . 75.34 111.345 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.514 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 10.4 pt -64.15 -32.2 56.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.567 0.58 . . . . 64.2 112.567 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 58' ' ' VAL . 58.8 mt -58.09 -47.1 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.375 -0.375 . . . . 63.24 110.195 172.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 85.5 mm-40 -58.71 -42.59 89.0 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.169 -0.469 . . . . 53.02 110.809 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -59.59 -46.32 89.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.583 -0.735 . . . . 74.44 110.593 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.538 HD11 HG13 ' A' ' 22' ' ' VAL . 89.3 mt -69.92 -34.92 74.12 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.658 -0.417 . . . . 74.32 111.24 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 27.3 mt-30 -61.88 -46.09 90.9 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 121.059 -0.256 . . . . 74.54 111.225 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 . . . . . 0 C--N 1.313 -1.014 0 N-CA-C 113.542 0.942 . . . . 54.13 113.542 -178.594 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 47.7 t . . . . . 0 N--CA 1.425 -1.71 0 N-CA-C 106.602 -1.629 . . . . 74.44 106.602 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 10' ' ' LEU . 40.4 t -117.33 177.25 4.8 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 119.848 -0.741 . . . . 74.12 110.415 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 2.5 mm? -95.85 -54.2 3.42 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.913 -1.143 . . . . 75.15 107.913 175.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 p -178.05 164.17 1.81 Allowed 'General case' 0 C--O 1.251 1.141 0 N-CA-C 109.304 -0.628 . . . . 74.3 109.304 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 13' ' ' THR . 2.0 m -109.46 163.22 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 N-CA-C 105.723 -1.955 . . . . 74.53 105.723 174.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 12' ' ' VAL . 9.7 t -102.84 177.15 4.93 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.689 -1.226 . . . . 64.34 107.689 175.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -50.64 -49.17 57.54 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 123.222 0.326 . . . . 75.43 110.761 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.486 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 41.1 ttmt -144.91 97.65 4.87 Favored Pre-proline 0 N--CA 1.433 -1.314 0 N-CA-C 109.943 -0.392 . . . . 74.14 109.943 167.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 3.2 Cg_endo -48.65 -69.66 0.07 OUTLIER 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.955 3.103 . . . . 52.11 115.669 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.406 HG23 HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -150.58 165.41 17.47 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 109.754 -0.462 . . . . 72.33 109.754 -176.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.537 ' O ' HG12 ' A' ' 21' ' ' ILE . 42.9 Cg_exo -61.15 128.83 26.35 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.966 1.778 . . . . 50.04 109.061 171.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.502 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -74.66 1.2 53.78 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 115.761 1.064 . . . . 71.34 115.761 -172.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.64 -1.22 38.59 Favored 'General case' 0 C--N 1.287 -2.136 0 O-C-N 121.826 -0.808 . . . . 75.2 112.689 176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 38.1 pt -98.21 7.06 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 121.57 0.7 . . . . 71.4 109.885 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.513 HG13 HD11 ' A' ' 65' ' ' LEU . 3.5 p -92.18 138.3 20.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.564 -0.744 . . . . 61.15 111.421 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.46 -56.79 2.9 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.921 -1.036 . . . . 71.23 109.205 -173.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -139.92 173.6 11.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.473 -0.936 . . . . 73.5 108.473 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -149.68 165.66 31.7 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.632 -0.427 . . . . 71.24 110.513 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.466 ' HB2' HG22 ' A' ' 40' ' ' VAL . 39.4 m170 -128.02 116.18 19.63 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.114 -1.439 . . . . 70.24 107.114 170.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -88.23 120.61 29.75 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.393 -0.595 . . . . 72.25 109.393 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 7.5 tt -132.5 133.78 44.21 Favored 'General case' 0 N--CA 1.407 -2.608 0 O-C-N 123.366 0.417 . . . . 55.1 110.281 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.46 HD12 ' HE3' ' A' ' 31' ' ' LYS . 80.8 mt -131.33 -173.3 3.07 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.309 -0.997 . . . . 73.22 108.309 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 59.0 mt -68.53 -29.0 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.569 -0.53 . . . . 60.11 109.569 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 32' ' ' ASP 0.263 0.0 OUTLIER -64.72 -20.44 66.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.226 0.824 . . . . 72.13 113.226 176.168 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.463 ' N ' ' HD2' ' A' ' 31' ' ' LYS . 7.5 m-20 -80.82 -8.8 59.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.433 0.635 . . . . 75.42 109.644 174.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.71 79.13 1.39 Allowed Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.281 -0.872 . . . . 74.25 113.593 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 47.4 t -178.82 148.51 0.42 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.215 -1.402 . . . . 63.01 107.215 175.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -73.26 -31.03 63.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.508 0.559 . . . . 61.52 112.508 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.48 106.57 46.75 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-O 121.32 0.581 . . . . 70.42 111.519 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.55 129.43 4.25 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.107 1.871 . . . . 73.44 110.836 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 50' ' ' CYS . . . -165.73 145.96 6.66 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.991 -0.549 . . . . 64.01 110.122 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.51 125.47 53.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.402 -0.962 . . . . 71.25 108.402 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.658 HG12 ' SG ' ' A' ' 50' ' ' CYS . 5.3 m -88.73 124.78 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 C-N-CA 119.409 -0.916 . . . . 75.11 109.537 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 10.6 m-85 -96.32 121.76 38.46 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.287 -0.87 . . . . 75.42 111.353 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.9 m -87.7 105.79 17.6 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.577 -1.268 . . . . 70.53 107.577 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 61.4 p -74.81 172.76 11.61 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.735 -0.211 . . . . 75.14 110.959 -176.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 88.4 mt -63.98 -25.71 68.25 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.437 0.637 . . . . 61.1 109.74 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -61.02 -33.74 73.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.71 -1.132 . . . . 72.12 109.953 174.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.3 -0.14 40.63 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.643 -0.708 . . . . 54.33 111.857 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -95.44 153.19 17.82 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.06 -1.089 . . . . 72.12 108.06 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 41.4 mt-30 -110.5 138.79 46.42 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.482 -0.562 . . . . 65.14 109.482 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.406 HD23 HG23 ' A' ' 17' ' ' ILE . 47.1 tp -139.75 132.56 29.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.116 -1.068 . . . . 73.31 108.116 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.658 ' SG ' HG12 ' A' ' 40' ' ' VAL . 9.8 m -82.08 142.95 31.85 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 120.175 -0.61 . . . . 64.31 112.166 -174.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.58 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.78 158.35 68.48 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 115.465 -0.789 . . . . 42.01 110.144 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.484 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 88.3 Cg_endo -73.69 109.59 2.89 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.495 2.13 . . . . 71.34 113.281 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 52' ' ' PRO . 14.6 Cg_exo -69.45 -11.24 30.81 Favored 'Trans proline' 0 N--CA 1.482 0.799 0 C-N-CA 122.697 2.265 . . . . 70.55 112.594 -176.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -95.61 -5.8 41.68 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.479 -0.782 . . . . 74.42 111.21 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.404 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.3 mm100 -98.06 128.69 32.91 Favored Pre-proline 0 N--CA 1.443 -0.805 0 C-N-CA 120.548 -0.461 . . . . 73.23 111.407 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.23 -34.0 23.27 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 124.28 3.32 . . . . 74.15 115.449 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -62.85 -33.32 75.01 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.135 -0.626 . . . . 74.04 109.988 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 62' ' ' ILE . 89.7 t -77.53 -40.16 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.709 -0.678 . . . . 73.33 110.275 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.04 -27.3 69.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.133 0.492 . . . . 72.4 111.422 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -72.03 -44.01 64.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.706 -0.679 . . . . 71.2 110.575 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.502 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 16.5 pt -80.32 -30.65 12.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.396 0.888 . . . . 72.33 113.396 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 58' ' ' VAL . 65.2 mt -55.34 -44.84 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 110.389 -0.226 . . . . 72.42 110.389 174.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -60.02 -40.91 90.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.079 0.466 . . . . 74.31 110.105 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.86 -42.05 88.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.258 -0.883 . . . . 75.24 109.814 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.513 HD11 HG13 ' A' ' 22' ' ' VAL . 82.4 mt -76.25 -35.97 58.72 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.446 0.536 . . . . 71.43 112.446 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -64.72 -25.75 68.07 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 120.467 -0.493 . . . . 72.22 111.836 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.59 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--N 1.297 -1.714 0 C-N-CA 120.073 -0.651 . . . . 71.1 111.421 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.461 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 73.0 m . . . . . 0 N--CA 1.409 -2.482 0 N-CA-C 106.922 -1.51 . . . . 71.23 106.922 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -95.06 175.61 6.56 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.94 -0.704 . . . . 72.23 112.705 -169.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 tt -88.2 -66.11 0.95 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.643 -0.873 . . . . 64.14 108.643 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -175.92 153.12 1.3 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.778 -1.193 . . . . 63.12 107.778 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 13' ' ' THR . 1.4 m -98.79 160.82 3.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 119.126 -1.03 . . . . 73.51 109.506 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 12' ' ' VAL . 7.1 t -101.38 173.19 6.55 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 106.56 -1.644 . . . . 70.35 106.56 174.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -43.8 -59.43 2.24 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.528 0.518 . . . . 53.45 111.373 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 40.8 ttmt -143.09 94.15 6.4 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 109.753 -0.462 . . . . 75.31 109.753 173.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.614 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.7 Cg_endo -52.99 -85.61 0.01 OUTLIER 'Trans proline' 0 CA--C 1.556 1.617 0 C-N-CA 124.138 3.226 . . . . 52.2 117.58 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.406 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -145.04 149.46 42.26 Favored Pre-proline 0 C--O 1.207 -1.161 0 O-C-N 121.73 -0.606 . . . . 73.13 110.4 -174.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.22 144.97 99.07 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.54 2.16 . . . . 72.14 112.29 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.426 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -80.16 1.75 79.06 Favored Glycine 0 CA--C 1.502 -0.743 0 CA-C-N 115.848 -0.614 . . . . 54.41 112.748 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -80.13 -23.2 41.32 Favored 'General case' 0 N--CA 1.408 -2.565 0 CA-C-O 121.04 0.447 . . . . 72.41 110.553 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.434 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 37.3 pt -101.89 13.01 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.879 -0.513 . . . . 75.51 111.78 -177.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 19' ' ' GLY . 6.5 p -98.82 137.7 25.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.511 0.672 . . . . 63.31 111.908 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -89.45 -54.46 4.08 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.43 1.092 . . . . 73.33 108.588 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -139.33 164.02 30.95 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.393 -0.965 . . . . 71.32 108.393 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -140.84 160.5 39.93 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.594 -0.521 . . . . 72.41 109.594 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.487 ' HB2' HG22 ' A' ' 40' ' ' VAL . 38.5 m80 -135.81 127.06 28.25 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.368 -1.345 . . . . 74.45 107.368 173.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -92.67 122.38 35.02 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.488 -0.93 . . . . 75.33 108.488 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.4 mm? -116.18 126.24 53.39 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 120.861 0.362 . . . . 72.4 111.651 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.7 mt -129.26 172.84 11.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.165 -1.05 . . . . 64.03 108.165 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 35' ' ' ARG . 32.0 mt -74.63 -18.11 16.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.827 -1.175 . . . . 65.31 107.827 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -61.7 -32.8 73.03 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.93 -1.032 . . . . 72.42 109.455 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.27 -38.99 71.84 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.001 -0.545 . . . . 73.42 109.562 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.1 -50.93 0.54 Allowed Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 115.507 -0.77 . . . . 44.52 112.765 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 71.1 m -67.43 132.73 48.21 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.835 0.35 . . . . 44.41 110.888 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.471 ' HA ' HG12 ' A' ' 30' ' ' ILE . 86.7 mtt180 -80.48 22.77 0.54 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.03 0.752 . . . . 70.14 113.03 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -126.77 96.03 36.12 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 108.908 -0.775 . . . . 74.34 108.908 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -85.24 129.65 3.84 Favored 'Trans proline' 0 N--CA 1.443 -1.441 0 C-N-CA 121.902 1.734 . . . . 75.33 112.354 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.551 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -174.77 166.34 3.7 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.087 -0.961 . . . . 74.33 108.696 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.85 130.95 60.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.555 -1.276 . . . . 53.51 107.555 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 26' ' ' HIS . 6.8 m -96.3 128.08 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.83 0 C-N-CA 119.576 -0.849 . . . . 71.4 109.583 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 28.8 m-85 -99.65 121.51 41.32 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.592 -0.731 . . . . 73.53 110.839 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.3 m -85.93 97.99 10.55 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.137 -1.431 . . . . 74.33 107.137 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.6 p -70.14 169.74 12.94 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.65 -0.25 . . . . 63.35 111.053 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 91.2 mt -60.33 -26.84 66.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.352 0.596 . . . . 62.41 109.87 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -61.58 -28.87 69.66 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.438 1.095 . . . . 74.11 110.678 175.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.34 9.32 58.03 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 111.834 -0.506 . . . . 75.45 111.834 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -103.76 136.21 43.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.708 -1.59 . . . . 74.11 106.708 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 27.6 mt-30 -92.19 130.5 37.89 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 121.122 -0.231 . . . . 71.22 110.413 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 7.2 mp -119.62 147.08 44.95 Favored 'General case' 0 CA--C 1.475 -1.909 0 CA-C-N 116.406 -0.361 . . . . 73.52 111.0 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.407 ' HB3' HG12 ' A' ' 12' ' ' VAL . 5.1 m -86.1 125.24 33.32 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.075 -0.966 . . . . 72.03 109.18 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.614 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.41 152.45 76.4 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 118.016 0.371 . . . . 43.23 111.736 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.09 108.14 2.26 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.329 2.686 . . . . 71.2 114.243 -174.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 40.9 Cg_endo -67.95 -13.54 38.62 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.489 2.126 . . . . 65.44 111.245 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.67 -27.71 50.94 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.574 -1.194 . . . . 44.41 111.687 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 30.3 mm-40 -85.99 142.06 36.01 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 113.513 0.931 . . . . 65.12 113.513 -173.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 40.0 Cg_exo -58.22 -38.07 92.67 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.603 2.869 . . . . 62.31 113.451 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.422 ' O ' HG12 ' A' ' 61' ' ' ILE . 39.4 p-90 -63.44 -27.73 69.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.961 0.41 . . . . 74.44 110.304 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.554 ' O ' HG13 ' A' ' 62' ' ' ILE . 53.1 t -78.97 -46.89 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 116.0 -0.545 . . . . 71.22 111.756 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -25.37 67.09 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 119.549 -0.86 . . . . 74.11 109.719 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -59.65 -56.35 22.93 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.51 -1.223 . . . . 74.55 108.895 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.426 HG21 ' HA3' ' A' ' 19' ' ' GLY . 12.0 pt -74.55 -32.21 29.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.967 -1.015 . . . . 63.34 113.598 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 58' ' ' VAL . 64.1 mt -54.95 -55.74 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 123.254 0.347 . . . . 71.24 111.178 176.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.54 -38.9 92.91 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 112.42 0.526 . . . . 62.32 112.42 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -62.17 -42.47 99.3 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.667 -0.697 . . . . 65.11 112.021 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 tt -72.94 -31.72 64.78 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.179 -0.674 . . . . 74.11 109.179 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.536 HE21 HG22 ' A' ' 62' ' ' ILE . 79.9 mt-30 -48.87 -39.6 26.41 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 120.812 0.339 . . . . 72.44 111.383 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 . . . . . 0 C--N 1.313 -1.014 0 CA-C-N 115.784 -0.644 . . . . 73.44 112.286 -177.031 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.502 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 29.1 p . . . . . 0 CA--C 1.505 -0.774 0 N-CA-C 110.338 -0.245 . . . . 72.34 110.338 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.507 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -65.45 125.53 25.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.987 -0.552 . . . . 61.01 112.454 -172.207 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.438 ' O ' HG21 ' A' ' 36' ' ' VAL . 76.1 mt -50.6 -54.62 21.27 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.785 1.634 . . . . 65.34 114.586 -172.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.6 p -174.38 142.57 0.79 Allowed 'General case' 0 CA--C 1.486 -1.505 0 C-N-CA 120.085 -0.646 . . . . 61.23 109.734 -174.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.2 m -98.5 162.65 2.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.127 -1.064 . . . . 60.54 108.127 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 12' ' ' VAL . 15.4 t -105.18 178.18 4.63 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 107.115 -1.439 . . . . 72.23 107.115 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -41.43 -57.97 2.03 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.51 0.724 . . . . 72.24 110.696 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 ttpt -146.96 97.1 4.21 Favored Pre-proline 0 N--CA 1.431 -1.421 0 N-CA-C 108.7 -0.852 . . . . 71.14 108.7 170.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.595 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 5.4 Cg_endo -44.99 -73.03 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.915 3.077 . . . . 73.42 115.997 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.84 163.72 34.16 Favored Pre-proline 0 C--N 1.317 -0.824 0 O-C-N 122.153 -0.342 . . . . 61.34 110.269 -176.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.58 ' O ' HG12 ' A' ' 21' ' ' ILE . 71.2 Cg_exo -55.49 129.09 33.24 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.446 2.097 . . . . 63.41 110.186 171.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.496 ' HA3' HD13 ' A' ' 61' ' ' ILE . . . -77.79 -4.34 85.23 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.953 -0.642 . . . . 74.34 114.377 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -96.19 2.6 53.18 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.331 -0.511 . . . . 75.41 111.816 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 18' ' ' PRO . 32.6 pt -106.75 12.39 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 120.077 -0.649 . . . . 70.21 110.654 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.604 HG13 HD11 ' A' ' 65' ' ' LEU . 2.2 p -95.55 133.26 37.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.651 0.738 . . . . 71.34 112.407 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.596 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 1.2 tmt_? -93.62 -49.2 5.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.595 -1.184 . . . . 65.32 108.556 -174.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.596 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 16.1 m120 -135.5 154.05 51.53 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.891 -0.781 . . . . 74.3 108.891 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.9 143.91 41.07 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.209 -0.596 . . . . 72.04 109.699 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.538 ' HB2' HG22 ' A' ' 40' ' ' VAL . 43.9 m170 -118.72 132.32 56.15 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.363 -1.717 . . . . 61.34 106.363 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -99.77 102.83 14.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.487 -0.56 . . . . 71.54 109.487 -174.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.502 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.1 mm? -102.26 120.37 40.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.872 -0.603 . . . . 75.03 111.049 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.0 mt -131.87 168.75 17.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.29 0.567 . . . . 74.22 110.603 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mt -77.89 -17.33 14.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 107.696 -1.224 . . . . 64.02 107.696 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.07 -31.91 71.57 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 114.967 -1.015 . . . . 75.35 109.417 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -76.66 -54.45 6.64 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.073 -1.084 . . . . 41.05 108.073 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.13 89.13 0.23 Allowed Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.413 -0.812 . . . . 62.41 112.518 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.5 t -171.59 -176.08 1.72 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.63 -0.878 . . . . 51.03 108.63 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -81.55 -43.02 19.31 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.808 0.443 . . . . 75.13 111.846 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 10' ' ' LEU . 2.8 p -130.84 128.24 22.35 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 113.609 0.966 . . . . 64.23 113.609 -172.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 92.0 Cg_endo -88.82 132.18 2.38 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 123.029 2.486 . . . . 64.42 112.553 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 9' ' ' CYS . . . -175.06 153.41 1.62 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.855 0.862 . . . . 74.42 108.794 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -99.1 132.64 44.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.672 -1.233 . . . . 75.33 107.672 176.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.538 HG22 ' HB2' ' A' ' 26' ' ' HIS . 5.9 m -93.38 122.75 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 C-N-CA 119.346 -0.942 . . . . 74.01 109.225 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.498 ' CD1' HG21 ' A' ' 22' ' ' VAL . 8.8 m-85 -94.77 115.91 28.08 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 115.333 -0.849 . . . . 73.35 110.56 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.1 m -85.47 104.77 15.56 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.362 -0.977 . . . . 61.23 108.362 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.0 p -71.15 178.4 3.3 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.166 -0.47 . . . . 74.03 111.448 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.5 mt -66.11 -25.18 66.87 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.778 0.799 . . . . 73.43 109.926 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -71.93 -16.31 62.1 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.787 -1.097 . . . . 74.23 110.656 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.63 16.01 57.4 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.863 -0.684 . . . . 74.03 111.579 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 31.0 mmt180 -97.91 135.34 39.78 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 120.739 0.304 . . . . 63.13 111.753 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -97.56 114.56 26.48 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.168 -0.924 . . . . 73.11 109.481 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.1 mp -116.53 148.42 40.85 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 116.497 -0.32 . . . . 75.42 111.603 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.414 ' HB3' HG12 ' A' ' 12' ' ' VAL . 34.8 m -77.75 122.29 25.18 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.436 -0.802 . . . . 71.24 110.667 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.595 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.54 151.71 73.34 Favored Pre-proline 0 C--O 1.242 0.704 0 C-N-CA 121.101 -0.24 . . . . 64.3 111.535 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 83.1 Cg_endo -74.27 110.87 3.18 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 123.284 2.656 . . . . 73.35 114.407 -172.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 52' ' ' PRO . 17.7 Cg_exo -67.18 -18.69 51.02 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.391 2.061 . . . . 75.52 112.948 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -87.54 -19.93 27.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.072 0.767 . . . . 64.44 113.072 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.99 139.02 39.77 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 114.08 1.141 . . . . 62.4 114.08 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.459 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 9.7 Cg_endo -52.07 -39.92 69.29 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 124.608 3.538 . . . . 65.43 114.753 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.1 p-90 -59.47 -31.87 69.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.714 -0.395 . . . . 74.51 111.025 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 62' ' ' ILE . 78.2 t -77.56 -42.95 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.935 -0.575 . . . . 63.11 111.599 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -67.19 -25.25 66.04 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.961 -0.696 . . . . 75.14 112.176 -178.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HD3' ' OE1' ' A' ' 63' ' ' GLN . 37.0 mmt180 -71.37 -34.91 70.88 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.795 -0.639 . . . . 74.34 112.547 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.496 HD13 ' HA3' ' A' ' 19' ' ' GLY . 10.6 pt -85.33 -34.16 8.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 120.718 -0.393 . . . . 75.31 111.8 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 58' ' ' VAL . 59.2 mt -56.74 -49.42 78.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-N 116.034 -0.53 . . . . 75.3 111.232 173.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.45 ' OE1' ' HD3' ' A' ' 60' ' ' ARG . 4.1 pt20 -59.08 -39.68 82.91 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.043 0.449 . . . . 73.0 111.221 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -60.76 -51.3 69.93 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.987 -1.006 . . . . 71.21 110.332 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.604 HD11 HG13 ' A' ' 22' ' ' VAL . 82.5 mt -66.26 -26.4 67.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.057 0.391 . . . . 72.32 112.057 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 55.9 mt-30 -63.24 -20.48 65.49 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 120.803 0.335 . . . . 65.55 111.822 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 . . . . . 0 C--N 1.314 -0.941 0 CA-C-O 121.098 0.475 . . . . 75.11 110.227 178.108 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.411 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 6.8 p . . . . . 0 N--CA 1.431 -1.408 0 N-CA-C 110.16 -0.311 . . . . 44.14 110.16 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB2' HG12 ' A' ' 40' ' ' VAL . 1.2 t -94.18 -179.39 4.93 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.801 -0.76 . . . . 74.11 111.676 -169.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.22 -66.92 0.83 Allowed 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.044 0.538 . . . . 53.05 110.434 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 p -176.4 150.09 0.87 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.113 -1.44 . . . . 75.45 107.113 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.435 HG12 ' HB3' ' A' ' 50' ' ' CYS . 2.0 m -98.49 161.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 118.812 -1.155 . . . . 51.25 109.276 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 t -104.13 177.72 4.76 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.661 -1.607 . . . . 72.12 106.661 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -51.44 -58.5 6.1 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.148 0.431 . . . . 65.41 110.124 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 59.8 tttm -137.42 99.83 9.53 Favored Pre-proline 0 N--CA 1.424 -1.732 0 C-N-CA 120.014 -0.675 . . . . 73.11 111.654 172.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 19.1 Cg_endo -67.48 -164.09 0.09 OUTLIER 'Trans proline' 0 CA--C 1.567 2.148 0 C-N-CA 122.84 2.36 . . . . 75.15 114.167 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.33 156.76 5.45 Favored Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 125.436 1.495 . . . . 72.53 113.363 -175.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -73.65 149.09 42.98 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.63 2.22 . . . . 73.11 112.527 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.433 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -77.81 1.54 67.47 Favored Glycine 0 N--CA 1.459 0.216 0 CA-C-N 115.788 -0.642 . . . . 33.05 113.488 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -82.97 -23.69 33.27 Favored 'General case' 0 C--N 1.285 -2.232 0 O-C-N 122.259 -0.553 . . . . 74.4 111.522 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.412 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 42.4 pt -100.9 12.26 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.111 0.481 . . . . 74.32 111.904 -177.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.56 HG13 HD11 ' A' ' 65' ' ' LEU . 4.3 p -97.94 136.79 27.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.04 -0.527 . . . . 61.55 111.394 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -55.82 3.49 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.437 -1.32 . . . . 73.04 107.437 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -142.33 163.91 31.58 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.636 -0.876 . . . . 52.03 108.636 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.404 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 37.9 p90 -132.51 157.47 44.58 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.964 -0.294 . . . . 72.12 110.28 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.454 ' HB2' HG22 ' A' ' 40' ' ' VAL . 37.8 m80 -125.54 113.56 17.6 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.668 -1.234 . . . . 72.03 107.668 172.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -82.68 100.78 10.43 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.523 -0.762 . . . . 71.34 109.235 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 83.5 mt -112.06 143.15 43.55 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.691 -0.686 . . . . 62.43 111.846 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 98.1 mt -141.3 -177.61 5.21 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.046 -0.979 . . . . 70.54 109.842 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 57.9 mt -74.93 -29.42 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.442 -1.318 . . . . 71.2 107.442 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.02 -20.54 64.04 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.911 -1.04 . . . . 72.52 110.907 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -79.66 -49.55 11.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.553 -1.277 . . . . 54.22 107.553 174.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.33 51.15 0.06 OUTLIER Glycine 0 C--O 1.24 0.523 0 C-N-CA 120.621 -0.799 . . . . 33.32 114.1 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 87.3 m -145.5 144.74 30.74 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.764 -1.199 . . . . 75.53 107.764 174.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -63.81 -30.96 71.99 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.159 0.504 . . . . 70.23 111.03 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -100.32 112.96 65.2 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-N 115.432 -0.804 . . . . 62.02 111.572 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.8 130.33 3.66 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 122.191 1.928 . . . . 61.44 109.953 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -170.65 146.26 2.65 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.885 -0.413 . . . . 71.43 109.885 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.41 126.14 51.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.061 -1.459 . . . . 74.03 107.061 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 9' ' ' CYS . 13.1 m -90.1 128.32 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 C-N-CA 119.523 -0.871 . . . . 63.31 109.448 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -96.62 114.0 25.61 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 115.362 -0.835 . . . . 72.02 109.385 174.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.6 m -84.74 104.83 15.05 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.442 -1.318 . . . . 62.52 107.442 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 64.5 p -70.06 175.3 4.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 112.706 0.632 . . . . 54.11 112.706 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 90.7 mt -61.01 -27.36 68.27 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.472 0.709 . . . . 71.34 110.672 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -79.69 -13.96 59.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.706 -0.679 . . . . 73.23 110.488 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.07 16.67 43.39 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.203 -0.999 . . . . 42.33 112.602 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -96.06 138.64 33.39 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 122.747 -0.267 . . . . 74.13 110.631 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -93.12 125.18 37.58 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 123.909 0.756 . . . . 64.31 109.304 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.2 tm? -127.95 141.95 51.39 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.944 -1.132 . . . . 72.33 107.944 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.542 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.2 m -81.51 122.88 28.1 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.098 0.559 . . . . 75.41 111.15 -174.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.03 152.76 76.14 Favored Pre-proline 0 C--O 1.245 0.82 0 C-N-CA 120.237 -0.585 . . . . 43.21 111.51 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 93.8 Cg_endo -73.38 112.36 3.51 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.791 2.327 . . . . 70.24 113.564 -173.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.57 -9.63 24.26 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.204 1.936 . . . . 70.25 111.681 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.21 -17.98 24.08 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.125 -0.943 . . . . 54.22 111.45 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 31.3 mm-40 -89.7 133.08 34.92 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 112.889 0.7 . . . . 74.14 112.889 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.532 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 94.6 Cg_exo -44.81 -45.19 13.89 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 124.738 3.625 . . . . 75.21 115.771 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.445 ' HZ2' ' HD2' ' A' ' 16' ' ' PRO . 33.5 p-90 -58.16 -36.78 73.52 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.656 0.265 . . . . 70.13 111.606 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 62' ' ' ILE . 71.0 t -68.59 -42.23 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 116.247 -0.433 . . . . 71.33 110.342 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.532 ' OE1' ' HA ' ' A' ' 56' ' ' PRO . 40.7 mt-10 -56.43 -33.22 65.64 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.878 -0.601 . . . . 71.32 111.029 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' A' ' 56' ' ' PRO . 9.3 mpt_? -77.54 -43.39 32.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.97 -0.559 . . . . 74.45 112.449 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.433 HG21 ' HA3' ' A' ' 19' ' ' GLY . 8.8 pt -70.77 -32.07 47.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 112.872 0.693 . . . . 73.14 112.872 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 58' ' ' VAL . 70.4 mt -54.12 -42.68 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 109.55 -0.537 . . . . 63.45 109.55 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 79.6 mm-40 -57.78 -45.55 85.83 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.642 -0.708 . . . . 74.13 110.731 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -61.43 -41.47 97.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.134 -0.485 . . . . 63.41 111.85 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.56 HD11 HG13 ' A' ' 22' ' ' VAL . 86.3 mt -72.4 -35.74 68.49 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.014 -0.674 . . . . 74.44 111.474 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 51.4 mt-30 -66.5 -45.75 78.54 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.116 -0.633 . . . . 72.42 111.618 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 . . . . . 0 C--O 1.22 -0.467 0 C-N-CA 120.755 -0.378 . . . . 72.32 111.837 -178.027 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.479 ' HA ' HD13 ' A' ' 28' ' ' LEU . 45.5 t . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 104.496 -2.409 . . . . 64.14 104.496 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 10' ' ' LEU . 38.9 t -123.74 173.45 8.13 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 119.372 0.987 . . . . 71.44 111.11 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 80.7 mt -89.21 -55.14 3.79 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 108.54 -0.911 . . . . 73.42 108.54 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.9 t -176.94 165.13 2.39 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.493 -0.928 . . . . 63.31 108.493 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.514 HG12 ' CB ' ' A' ' 50' ' ' CYS . 1.5 m -126.0 152.77 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 105.882 -1.895 . . . . 53.23 105.882 174.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.4 t -93.46 176.58 6.33 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.166 -1.42 . . . . 54.11 107.166 174.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -58.21 -43.97 87.93 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 118.537 0.608 . . . . 75.42 112.15 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -144.05 87.27 8.03 Favored Pre-proline 0 N--CA 1.414 -2.272 0 N-CA-C 108.049 -1.093 . . . . 71.22 108.049 171.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.0 Cg_endo -51.39 -80.11 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 124.216 3.277 . . . . 72.44 117.55 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.463 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -143.32 170.19 9.08 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 109.912 -0.403 . . . . 52.12 109.912 -171.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.576 ' O ' HG12 ' A' ' 21' ' ' ILE . 44.6 Cg_exo -60.52 132.24 42.28 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.208 1.939 . . . . 61.43 111.442 175.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.455 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -79.48 2.29 72.94 Favored Glycine 0 C--N 1.299 -1.522 0 CA-C-N 115.981 -0.554 . . . . 53.43 113.798 -176.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -98.75 -5.25 31.72 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.6 0.593 . . . . 73.22 112.6 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.9 pt -93.71 3.56 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 121.612 0.72 . . . . 71.44 110.527 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.636 HG13 HD11 ' A' ' 65' ' ' LEU . 2.7 p -88.73 137.83 20.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.133 -0.94 . . . . 64.45 111.334 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.31 -55.97 3.57 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.324 -1.361 . . . . 75.03 107.324 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -143.43 162.84 34.73 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 124.132 0.973 . . . . 63.32 108.896 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -132.63 161.6 33.5 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.7 -0.4 . . . . 74.13 110.014 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.497 ' HB2' HG22 ' A' ' 40' ' ' VAL . 42.1 m80 -127.42 112.68 15.26 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.629 -0.878 . . . . 73.25 108.629 172.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -85.65 105.85 16.51 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.41 -0.814 . . . . 72.53 109.115 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 8' ' ' CYS . 8.7 tt -119.93 133.17 55.65 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-O 121.218 0.532 . . . . 70.4 110.647 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.4 mt -127.51 -177.7 4.18 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.661 -0.699 . . . . 73.04 109.423 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 58.8 mt -72.38 -20.39 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.149 -1.056 . . . . 74.4 108.149 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -62.91 -31.88 73.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.835 -1.075 . . . . 72.04 109.434 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.6 -57.34 5.88 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.583 -0.895 . . . . 63.03 108.583 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.65 71.5 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.333 -0.937 . . . . 52.44 112.877 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 35.6 t -173.1 140.85 0.91 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.794 -1.928 . . . . 75.4 105.794 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -73.18 -19.92 61.0 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.882 1.068 . . . . 71.01 113.882 -173.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.24 102.31 31.95 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-O 121.314 0.578 . . . . 74.14 110.823 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.3 130.34 6.24 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.391 2.061 . . . . 64.33 110.792 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 50' ' ' CYS . . . -165.49 148.64 7.96 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 120.873 0.368 . . . . 75.34 110.472 -177.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.25 119.95 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.017 0 N-CA-C 107.939 -1.134 . . . . 45.4 107.939 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.685 HG12 ' SG ' ' A' ' 50' ' ' CYS . 7.3 m -86.12 127.04 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.411 0 C-N-CA 119.854 -0.739 . . . . 63.24 109.108 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -97.6 114.8 26.8 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.584 -0.735 . . . . 74.33 110.047 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.4 m -81.2 103.35 10.93 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.194 -1.039 . . . . 74.14 108.194 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.7 p -73.77 171.52 13.17 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.282 -0.417 . . . . 71.22 111.375 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.4 mt -58.56 -28.83 65.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.537 0.735 . . . . 75.51 112.131 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -74.77 -14.45 60.71 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.403 0.681 . . . . 74.33 111.309 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.98 17.59 37.23 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 119.935 -1.126 . . . . 71.43 111.421 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -99.62 123.93 44.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 122.69 -0.3 . . . . 60.13 111.332 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -80.73 122.39 27.08 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.962 -0.755 . . . . 63.31 108.962 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 tp -136.07 126.37 26.54 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.228 -1.027 . . . . 75.21 108.228 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.685 ' SG ' HG12 ' A' ' 40' ' ' VAL . 17.3 m -87.39 149.41 24.49 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 113.713 1.005 . . . . 70.25 113.713 -171.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.587 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -134.06 162.54 57.09 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 115.058 -0.974 . . . . 75.24 109.221 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 63.2 Cg_endo -69.03 109.44 2.17 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.077 1.852 . . . . 63.02 112.298 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.04 -21.63 63.13 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.448 2.765 . . . . 73.52 115.794 -170.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -102.95 -14.3 16.56 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.977 0.418 . . . . 51.33 111.934 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.5 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.7 mm100 -68.39 141.76 93.8 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 113.51 0.93 . . . . 74.51 113.51 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 71.5 Cg_exo -46.9 -39.06 24.31 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 124.78 3.654 . . . . 61.43 115.896 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -74.43 -31.87 62.45 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.374 -0.93 . . . . 72.14 110.791 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 62' ' ' ILE . 77.1 t -77.09 -38.77 28.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.96 -0.564 . . . . 72.31 112.308 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 11.0 pt-20 -55.9 -36.27 67.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 120.328 -0.549 . . . . 73.12 112.211 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -68.53 -51.19 45.75 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.925 0.343 . . . . 74.32 111.925 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.455 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 14.6 pt -63.4 -33.87 63.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.166 0.432 . . . . 75.13 112.166 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.516 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 66.6 mt -61.04 -46.84 95.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 N-CA-C 109.549 -0.537 . . . . 74.51 109.549 173.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 15.4 mm100 -57.67 -44.13 85.5 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.925 -0.398 . . . . 74.41 109.925 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -56.16 -48.75 75.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.247 -0.888 . . . . 74.14 110.014 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.636 HD11 HG13 ' A' ' 22' ' ' VAL . 83.1 mt -71.13 -31.56 67.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.317 -0.553 . . . . 73.11 112.236 177.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 45.0 mt-30 -66.84 -24.37 66.14 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 120.237 -0.585 . . . . 74.21 111.871 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 31.7 mmm180 . . . . . 0 C--N 1.318 -0.786 0 N-CA-C 109.709 -0.478 . . . . 75.35 109.709 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.409 -2.514 0 N-CA-C 108.439 -0.948 . . . . 64.12 108.439 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.411 ' SG ' HG12 ' A' ' 40' ' ' VAL . 51.9 m -91.62 179.1 5.74 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.944 0.72 . . . . 73.14 112.944 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.3 mt -100.71 -45.81 5.37 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.972 -1.013 . . . . 74.04 109.444 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.7 p -170.04 152.99 4.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 119.9 -0.72 . . . . 72.04 110.786 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.445 HG12 ' HB3' ' A' ' 50' ' ' CYS . 2.2 m -112.67 146.63 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 N-CA-C 105.612 -1.996 . . . . 63.34 105.612 171.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 10.3 t -98.42 178.77 4.93 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 108.802 -0.814 . . . . 74.43 108.802 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -43.83 -57.95 2.99 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.293 0.637 . . . . 51.24 110.087 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 38.5 ttpt -143.28 93.07 6.54 Favored Pre-proline 0 N--CA 1.421 -1.912 0 N-CA-C 108.597 -0.89 . . . . 64.31 108.597 171.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.603 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 5.1 Cg_endo -49.39 -76.12 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.857 3.038 . . . . 75.34 115.654 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.405 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -143.61 145.8 32.77 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 109.057 -0.72 . . . . 72.34 109.057 -177.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.405 ' O ' HG12 ' A' ' 21' ' ' ILE . 19.8 Cg_endo -61.7 139.48 81.01 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.177 1.918 . . . . 75.13 111.213 177.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.45 ' HA3' HD12 ' A' ' 61' ' ' ILE . . . -74.04 0.63 51.72 Favored Glycine 0 C--O 1.22 -0.728 0 CA-C-O 121.471 0.484 . . . . 73.43 113.327 -177.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -80.35 -20.5 44.02 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 123.14 0.576 . . . . 73.21 110.726 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 37.3 pt -104.76 10.31 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.216 0.45 . . . . 73.44 112.216 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.569 HG13 HD11 ' A' ' 65' ' ' LEU . 3.7 p -97.38 139.52 19.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.814 0.34 . . . . 72.22 111.788 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.675 ' HD2' ' ND2' ' A' ' 24' ' ' ASN . 0.8 OUTLIER -95.75 -55.89 2.86 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.833 -0.803 . . . . 62.15 108.833 -177.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.675 ' ND2' ' HD2' ' A' ' 23' ' ' ARG . 49.6 m-80 -135.07 167.6 20.66 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 109.066 -0.716 . . . . 64.32 109.066 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -144.04 165.35 28.04 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.371 -0.603 . . . . 74.31 109.371 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.465 ' HB2' HG22 ' A' ' 40' ' ' VAL . 36.1 m80 -133.9 118.53 18.03 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.011 -1.107 . . . . 75.42 108.011 172.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -84.16 101.63 11.99 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.652 -0.704 . . . . 74.12 109.239 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.593 HD21 ' SG ' ' A' ' 34' ' ' CYS . 6.9 tt -106.54 133.35 51.36 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.369 -0.832 . . . . 72.13 110.471 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -128.63 -176.54 3.87 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.702 -0.681 . . . . 54.12 110.144 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.7 mt -72.09 -22.2 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.589 -0.893 . . . . 64.31 108.589 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -63.44 -29.92 71.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.529 -0.76 . . . . 53.25 110.747 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -67.87 -39.16 83.75 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.027 -0.731 . . . . 74.0 109.027 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.74 58.96 0.23 Allowed Glycine 0 CA--C 1.498 -1.014 0 CA-C-N 115.187 -0.915 . . . . 70.22 110.868 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.593 ' SG ' HD21 ' A' ' 28' ' ' LEU . 61.4 m -141.91 136.62 30.63 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.626 -1.25 . . . . 75.34 107.626 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -76.06 -10.94 59.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.478 0.656 . . . . 75.32 110.647 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 p -121.36 101.39 43.94 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.372 -0.831 . . . . 75.15 109.903 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.14 130.17 10.98 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.797 1.665 . . . . 72.44 109.624 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 50' ' ' CYS . . . -168.11 148.72 4.97 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.73 0.3 . . . . 52.03 110.921 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.76 126.96 53.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.351 -0.611 . . . . 63.33 109.351 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.627 HG12 ' SG ' ' A' ' 50' ' ' CYS . 10.5 m -84.5 127.56 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 C-N-CA 120.171 -0.612 . . . . 42.54 109.464 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.446 ' CD1' HG21 ' A' ' 22' ' ' VAL . 9.3 m-85 -99.74 121.06 40.7 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.646 -0.707 . . . . 74.22 109.809 174.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.5 m -90.5 104.96 17.48 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.455 -0.942 . . . . 74.35 108.455 174.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 55.6 p -70.62 171.02 11.03 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.395 -0.366 . . . . 74.41 111.605 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 95.4 mt -67.99 -25.8 65.59 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.601 0.715 . . . . 74.41 109.106 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -64.62 -32.45 74.12 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.8 -1.091 . . . . 71.2 109.611 172.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.11 16.42 15.12 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 115.757 -0.656 . . . . 74.1 112.914 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -94.08 134.73 36.19 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.241 0.521 . . . . 75.53 110.951 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -90.77 116.46 28.64 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 107.37 -1.344 . . . . 43.01 107.37 170.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.6 tm? -138.02 143.86 40.77 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.695 -1.224 . . . . 63.12 107.695 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.627 ' SG ' HG12 ' A' ' 40' ' ' VAL . 30.8 m -94.69 143.2 26.63 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 115.19 1.552 . . . . 72.33 115.19 -177.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.603 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -125.6 163.09 40.95 Favored Pre-proline 0 N--CA 1.434 -1.265 0 CA-C-N 114.65 -1.159 . . . . 62.01 109.142 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 57.0 Cg_endo -70.76 110.38 2.74 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.123 1.882 . . . . 63.32 112.985 -174.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.75 -9.87 26.63 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 123.19 2.593 . . . . 72.12 114.676 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -101.04 -20.83 15.21 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.105 0.478 . . . . 51.3 111.308 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -69.3 130.12 91.25 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 112.795 0.665 . . . . 64.1 112.795 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.2 -36.21 36.13 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.109 3.206 . . . . 74.23 114.247 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.417 ' CE2' HG23 ' A' ' 58' ' ' VAL . 28.3 p-90 -64.8 -27.58 68.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 119.224 -0.991 . . . . 72.45 109.921 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 62' ' ' ILE . 69.7 t -86.16 -48.86 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.642 -0.708 . . . . 70.25 111.614 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.357 0.3 OUTLIER -61.9 -29.39 70.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.101 1.149 . . . . 73.44 114.101 -176.63 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -68.86 -43.09 76.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.765 0.317 . . . . 74.4 111.276 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.45 HD12 ' HA3' ' A' ' 19' ' ' GLY . 11.9 pt -71.72 -30.73 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 O-C-N 122.124 -0.36 . . . . 75.04 111.628 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.561 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 62.8 mt -56.76 -46.87 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.159 -0.473 . . . . 74.42 109.943 173.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -56.88 -41.9 78.87 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.114 0.566 . . . . 74.24 109.544 179.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 98.3 mtt180 -62.47 -38.93 91.74 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.58 -0.737 . . . . 71.22 111.492 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.569 HD11 HG13 ' A' ' 22' ' ' VAL . 84.5 mt -81.26 -26.06 36.1 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.676 0.251 . . . . 64.23 111.676 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.561 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 98.3 mt-30 -58.22 -20.53 42.38 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.59 0.959 . . . . 73.01 113.59 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 16.9 ptm180 . . . . . 0 CA--C 1.555 1.136 0 O-C-N 123.103 0.252 . . . . 75.31 111.298 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.556 ' HA ' HD13 ' A' ' 28' ' ' LEU . 27.2 p . . . . . 0 N--CA 1.412 -2.326 0 N-CA-C 106.593 -1.632 . . . . 72.12 106.593 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -101.98 175.23 5.61 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 118.436 -1.306 . . . . 70.42 110.625 -176.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.0 -64.86 1.06 Allowed 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.416 -0.587 . . . . 73.1 109.416 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -176.03 160.21 2.25 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 106.218 -1.771 . . . . 74.23 106.218 -178.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -98.87 160.04 3.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 118.722 -1.191 . . . . 71.23 109.422 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.0 t -106.15 179.47 4.26 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.416 -0.587 . . . . 63.14 109.416 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -40.48 -50.15 2.91 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.288 1.435 . . . . 74.3 110.458 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 ttpt -159.97 98.47 1.49 Allowed Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 107.662 -1.236 . . . . 75.1 107.662 169.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.661 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -42.36 -73.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.379 3.386 . . . . 55.11 116.622 -175.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.432 HG23 HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -143.69 167.86 14.36 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.219 -0.66 . . . . 72.33 109.219 -177.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.527 ' O ' HG12 ' A' ' 21' ' ' ILE . 38.6 Cg_exo -62.21 128.71 24.68 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.704 1.603 . . . . 55.53 109.495 171.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -71.49 1.33 28.86 Favored Glycine 0 C--N 1.301 -1.376 0 N-CA-C 114.336 0.494 . . . . 63.2 114.336 -175.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -94.35 -13.48 26.33 Favored 'General case' 0 C--N 1.285 -2.222 0 O-C-N 122.509 -0.406 . . . . 74.44 111.544 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 18' ' ' PRO . 38.9 pt -95.52 9.47 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.191 0.519 . . . . 72.22 111.205 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.589 HG21 ' CD1' ' A' ' 41' ' ' PHE . 3.1 p -96.9 141.27 15.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 115.949 -0.568 . . . . 61.2 111.842 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.502 ' HD2' ' ND2' ' A' ' 24' ' ' ASN . 1.3 tmt_? -105.44 -54.32 2.5 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.483 -0.932 . . . . 72.24 108.483 -178.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.502 ' ND2' ' HD2' ' A' ' 23' ' ' ARG . 53.6 m-80 -123.88 160.55 27.22 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.126 -0.694 . . . . 63.01 109.126 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.465 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 42.1 p90 -141.53 155.0 45.82 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.324 -0.991 . . . . 75.41 108.324 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -137.26 128.42 27.81 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.601 -0.518 . . . . 62.42 109.601 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -79.24 101.31 7.93 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 109.272 -0.64 . . . . 65.53 109.272 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.556 HD13 ' HA ' ' A' ' 8' ' ' CYS . 43.6 mt -98.92 131.0 45.33 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-O 121.665 0.745 . . . . 73.23 109.855 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.9 mt -132.59 178.23 7.01 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 114.877 -1.056 . . . . 52.44 108.815 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 25.3 mt -76.55 -29.5 18.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.442 -0.947 . . . . 61.12 108.442 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -67.83 -15.63 63.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.223 -0.899 . . . . 73.12 109.777 174.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -89.14 -43.2 11.21 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.924 -1.139 . . . . 75.44 107.924 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.8 -90.14 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 119.721 -1.228 . . . . 74.33 115.122 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 58.2 m -75.89 157.56 33.11 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.077 0.399 . . . . 72.15 112.077 -172.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -72.8 29.25 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.474 1.11 . . . . 71.42 113.702 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.4 p -137.4 102.9 8.74 Favored Pre-proline 0 C--N 1.3 -1.568 0 CA-C-O 121.395 0.617 . . . . 63.33 110.181 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -86.85 130.18 3.06 Favored 'Trans proline' 0 N--CA 1.438 -1.75 0 C-N-CA 121.941 1.76 . . . . 73.11 111.772 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.29 157.73 9.43 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.529 -0.759 . . . . 74.11 109.087 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.85 126.31 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 108.334 -0.987 . . . . 72.1 108.334 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 20.1 m -94.01 129.29 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.98 0 CA-C-O 121.609 0.718 . . . . 63.22 110.534 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.589 ' CD1' HG21 ' A' ' 22' ' ' VAL . 7.2 m-85 -93.86 118.16 31.08 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 114.958 -1.019 . . . . 72.1 111.897 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.4 m -81.36 105.45 12.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.436 -0.949 . . . . 70.34 108.436 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.1 p -76.11 174.28 10.25 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.699 0.285 . . . . 72.35 111.363 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 88.1 mt -62.52 -28.39 69.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.185 0.594 . . . . 53.54 110.307 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -69.52 -30.21 67.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.546 -0.752 . . . . 75.55 109.414 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.57 8.69 45.64 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.66 -0.7 . . . . 71.42 111.949 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -95.22 133.49 39.03 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 105.605 -1.998 . . . . 64.31 105.605 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 39.1 mt-30 -96.79 143.57 27.59 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.477 -0.935 . . . . 54.12 108.477 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 37.4 tp -135.91 150.35 49.3 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.215 -0.594 . . . . 73.52 109.881 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.2 m -77.47 122.18 24.86 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 123.547 0.53 . . . . 73.51 109.72 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.661 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.28 151.76 72.74 Favored Pre-proline 0 C--N 1.311 -1.083 0 C-N-CA 120.288 -0.565 . . . . 72.32 110.1 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.434 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 83.0 Cg_endo -74.98 110.31 3.09 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.778 2.319 . . . . 74.15 113.859 -173.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -67.94 -17.33 46.46 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.328 2.018 . . . . 65.03 111.887 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.96 -17.05 34.03 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.777 -0.647 . . . . 74.13 111.729 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.434 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.9 mm100 -84.81 127.49 64.79 Favored Pre-proline 0 C--N 1.317 -0.827 0 O-C-N 122.162 -0.336 . . . . 74.24 111.277 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -46.76 -37.87 21.81 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.608 3.539 . . . . 62.03 115.125 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.425 ' O ' HG12 ' A' ' 61' ' ' ILE . 41.8 p-90 -61.25 -35.4 77.17 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 120.784 -0.366 . . . . 75.45 110.752 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 62' ' ' ILE . 76.6 t -70.64 -41.65 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.806 -0.634 . . . . 75.41 111.244 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.2 mt-10 -58.09 -47.5 83.02 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 111.681 0.252 . . . . 62.33 111.681 -178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -64.03 -40.29 95.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.695 1.369 . . . . 61.13 114.695 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.453 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 10.7 pt -69.79 -35.69 66.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.34 -0.544 . . . . 65.32 111.507 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.465 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 56.9 mt -59.26 -49.55 83.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.356 -0.384 . . . . 75.14 110.517 173.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 18.5 mm-40 -56.19 -37.65 69.92 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.155 0.582 . . . . 72.34 110.125 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.562 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 20.2 ttm180 -68.08 -36.71 80.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.657 -0.701 . . . . 74.22 110.856 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.576 HD11 HG13 ' A' ' 22' ' ' VAL . 87.2 mt -76.13 -35.61 59.18 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 122.097 -0.377 . . . . 74.14 111.091 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 54.1 mt-30 -58.08 -19.15 29.8 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.983 1.475 . . . . 75.44 114.983 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 39.6 ptt180 . . . . . 0 C--N 1.319 -0.719 0 C-N-CA 120.232 -0.587 . . . . 74.12 111.731 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 24.6 p . . . . . 0 N--CA 1.434 -1.247 0 N-CA-C 107.039 -1.467 . . . . 62.14 107.039 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.533 ' SG ' HG12 ' A' ' 40' ' ' VAL . 1.7 t -121.87 -178.89 3.96 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 117.999 -1.48 . . . . 71.53 107.89 174.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tt -88.48 -67.74 0.81 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.117 -0.697 . . . . 73.52 109.117 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.7 m -168.55 149.07 4.65 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.215 -1.031 . . . . 32.3 108.215 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.433 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -102.49 158.66 4.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 119.144 -1.022 . . . . 54.45 108.323 178.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.1 t -103.21 178.47 4.55 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.077 -0.712 . . . . 72.22 109.077 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -46.64 -41.16 14.33 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.398 0.679 . . . . 70.4 111.544 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.5 ttpt -162.04 100.61 1.15 Allowed Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 107.249 -1.389 . . . . 72.35 107.249 170.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.66 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.5 Cg_endo -51.52 -82.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.889 3.059 . . . . 54.41 117.634 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.41 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -141.08 159.98 59.68 Favored Pre-proline 0 C--N 1.316 -0.878 0 O-C-N 121.964 -0.46 . . . . 41.13 110.257 -173.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.565 ' O ' HG12 ' A' ' 21' ' ' ILE . 78.1 Cg_exo -55.2 128.49 30.75 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.566 2.178 . . . . 75.42 110.691 173.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.464 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -79.71 0.46 81.79 Favored Glycine 0 C--N 1.307 -1.028 0 N-CA-C 115.15 0.82 . . . . 72.45 115.15 -174.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -99.17 -0.16 42.16 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.147 0.795 . . . . 71.55 113.147 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 18' ' ' PRO . 36.9 pt -101.27 10.25 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.667 0.746 . . . . 72.12 110.074 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 65' ' ' LEU . 3.1 p -94.44 138.98 19.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.287 -0.869 . . . . 72.53 111.336 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.09 -47.2 7.38 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.786 -0.82 . . . . 72.45 108.786 -175.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -149.93 160.5 43.55 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.048 -1.093 . . . . 73.54 108.048 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.3 168.26 19.51 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 117.973 0.352 . . . . 65.32 110.519 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.574 ' HB2' HG22 ' A' ' 40' ' ' VAL . 40.7 m80 -135.46 112.41 10.27 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.377 -1.342 . . . . 73.13 107.377 171.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -79.45 99.29 7.15 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.339 -1.356 . . . . 65.23 107.339 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.505 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -111.73 117.55 33.18 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.761 -0.654 . . . . 72.43 110.288 -170.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.8 mt -104.82 -176.07 2.97 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.497 -0.557 . . . . 74.25 109.497 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 63.3 mt -67.04 -36.24 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.909 0.862 . . . . 73.03 109.16 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -64.29 -24.17 67.56 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.484 -1.234 . . . . 72.52 110.276 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.48 -28.39 16.85 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.828 -0.624 . . . . 53.43 110.514 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.96 -106.76 0.65 Allowed Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 119.626 -1.273 . . . . 72.44 115.884 -173.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 33.6 m -118.32 179.68 4.04 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.993 -0.604 . . . . 73.32 109.496 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -55.22 -19.38 7.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.35 1.06 . . . . 71.41 112.377 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -103.14 106.79 52.85 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 121.114 0.483 . . . . 51.31 111.34 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -87.19 144.21 6.92 Favored 'Trans proline' 0 C--O 1.251 1.143 0 C-N-CA 122.576 2.184 . . . . 72.33 110.848 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.489 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -174.43 153.47 1.91 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.92 -0.4 . . . . 23.41 109.92 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.49 122.59 50.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.178 -1.416 . . . . 71.25 107.178 175.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.574 HG22 ' HB2' ' A' ' 26' ' ' HIS . 8.0 m -89.16 127.72 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.859 0 C-N-CA 119.566 -0.854 . . . . 52.12 109.426 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -98.13 121.54 40.18 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 115.302 -0.863 . . . . 73.33 110.702 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.0 m -86.35 103.42 14.91 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.819 -1.178 . . . . 74.1 107.819 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 50.0 p -70.97 171.69 10.36 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 116.201 -0.454 . . . . 64.32 110.833 -177.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 98.4 mt -60.96 -26.93 67.88 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.356 0.598 . . . . 60.22 109.775 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -71.65 -15.15 62.22 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 114.972 -1.013 . . . . 52.41 111.018 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.04 8.66 61.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.004 -0.617 . . . . 63.54 112.731 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -93.41 140.59 29.4 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 122.869 -0.195 . . . . 73.23 110.84 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -99.88 117.76 34.87 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.52 -0.918 . . . . 64.34 108.52 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -120.95 143.39 49.02 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.633 -0.877 . . . . 71.33 108.633 -174.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.534 ' N ' HD13 ' A' ' 49' ' ' LEU . 6.3 m -80.15 126.14 30.71 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 122.993 0.517 . . . . 72.24 111.17 -174.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.66 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -128.26 153.27 78.84 Favored Pre-proline 0 C--O 1.245 0.859 0 C-N-CA 120.907 -0.317 . . . . 74.12 110.989 175.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.484 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 72.0 Cg_endo -68.47 113.28 3.08 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.204 2.603 . . . . 73.33 113.024 -175.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 60.1 Cg_endo -72.24 -8.02 22.01 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.551 2.167 . . . . 73.15 114.205 -175.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -109.73 -0.51 18.48 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.3 0.572 . . . . 71.33 111.616 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.484 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 16.0 mm100 -86.34 135.97 36.02 Favored Pre-proline 0 C--N 1.314 -0.942 0 O-C-N 121.52 -0.737 . . . . 75.23 112.233 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.76 -36.76 26.7 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 124.697 3.598 . . . . 74.41 115.051 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -68.77 -32.48 72.26 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 120.343 -0.543 . . . . 60.42 110.685 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.662 ' O ' HG12 ' A' ' 62' ' ' ILE . 72.4 t -71.7 -48.99 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.831 -0.622 . . . . 72.14 111.997 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 9.3 pt-20 -55.69 -30.36 60.97 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.575 0.583 . . . . 71.23 112.575 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -73.02 -45.09 59.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.563 -0.29 . . . . 75.15 111.301 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.464 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 12.9 pt -71.71 -29.02 32.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 111.89 0.33 . . . . 71.41 111.89 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.662 HG12 ' O ' ' A' ' 58' ' ' VAL . 46.9 mm -56.49 -44.89 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.892 -0.781 . . . . 72.53 108.892 172.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 15.5 mm100 -59.1 -42.51 90.67 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.806 -0.634 . . . . 52.53 110.58 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -60.86 -46.59 90.0 Favored 'General case' 0 C--O 1.206 -1.201 0 O-C-N 124.143 0.902 . . . . 72.32 111.002 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 22' ' ' VAL . 86.8 mt -72.47 -34.11 67.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.253 -0.579 . . . . 72.25 111.897 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 43.7 mt-30 -61.5 -19.59 62.23 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 113.466 0.914 . . . . 74.24 113.466 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 120.945 0.403 . . . . 73.34 110.122 179.208 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.473 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 46.5 t . . . . . 0 N--CA 1.437 -1.113 0 N-CA-C 106.351 -1.722 . . . . 74.44 106.351 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.419 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 11.9 t -118.9 178.32 4.53 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 120.071 -0.652 . . . . 74.15 111.637 -173.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.403 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 83.4 mt -94.36 -53.9 3.75 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.105 -1.072 . . . . 75.03 108.105 174.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.9 t -177.19 -173.97 0.48 Allowed 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.131 -1.063 . . . . 63.23 108.131 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.78 167.67 25.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 106.939 -1.504 . . . . 61.43 106.939 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.2 t -105.52 178.28 4.61 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.781 -0.822 . . . . 75.1 108.781 175.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -53.02 -38.26 62.21 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.172 0.511 . . . . 74.41 111.139 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -159.2 93.42 1.82 Allowed Pre-proline 0 N--CA 1.425 -1.707 0 N-CA-C 108.014 -1.106 . . . . 73.54 108.014 173.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.2 Cg_endo -54.07 -86.24 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.882 3.055 . . . . 64.22 117.945 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.458 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -137.39 163.18 50.65 Favored Pre-proline 0 C--N 1.32 -0.698 0 O-C-N 121.865 -0.522 . . . . 72.35 110.565 -172.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.545 ' O ' HG12 ' A' ' 21' ' ' ILE . 38.0 Cg_exo -62.03 130.05 29.45 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.165 1.91 . . . . 74.13 110.853 175.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -71.95 1.6 30.85 Favored Glycine 0 C--N 1.307 -1.042 0 N-CA-C 114.32 0.488 . . . . 45.21 114.32 -177.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -87.32 -22.16 25.28 Favored 'General case' 0 N--CA 1.416 -2.128 0 O-C-N 122.529 -0.395 . . . . 74.43 110.692 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.5 pt -90.7 8.66 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 120.206 -0.598 . . . . 71.45 111.887 -176.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.588 HG13 HD11 ' A' ' 65' ' ' LEU . 2.6 p -92.94 132.51 36.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.22 0.533 . . . . 71.1 111.753 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -55.33 3.63 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.004 -1.11 . . . . 61.54 108.004 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -135.24 158.33 44.63 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.279 -1.008 . . . . 62.51 108.279 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -139.71 155.06 47.57 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.153 -0.619 . . . . 74.55 110.634 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.491 ' HB2' HG22 ' A' ' 40' ' ' VAL . 63.6 m170 -122.27 112.59 18.33 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.666 -1.235 . . . . 64.14 107.666 172.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -83.46 99.58 10.19 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.064 -0.717 . . . . 75.14 109.064 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.473 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 88.3 mt -106.58 143.26 34.95 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.8 -0.636 . . . . 74.51 111.798 -176.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.6 mt -140.45 175.85 9.26 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.876 -1.056 . . . . 62.24 109.639 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 46.4 mt -76.41 -19.79 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.961 -1.126 . . . . 72.22 107.961 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -60.82 -36.58 79.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.467 -1.242 . . . . 74.51 109.276 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.99 -41.06 78.33 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.595 -0.729 . . . . 70.03 109.274 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.96 -36.91 1.29 Allowed Glycine 0 CA--C 1.495 -1.197 0 C-N-CA 120.741 -0.742 . . . . 74.42 112.361 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 49.3 t -69.56 127.94 34.76 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.002 -1.11 . . . . 74.43 108.002 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -84.43 1.62 44.59 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.902 1.445 . . . . 62.24 114.902 -170.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -110.29 95.85 23.85 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 108.598 -0.89 . . . . 70.32 108.598 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -76.52 129.11 10.76 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 121.643 1.562 . . . . 72.15 111.415 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.536 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -171.0 151.3 3.25 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.231 -0.895 . . . . 74.11 109.728 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.22 119.6 47.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.463 -1.31 . . . . 74.23 107.463 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 26' ' ' HIS . 2.6 m -83.46 119.35 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.565 0 C-N-CA 119.294 -0.963 . . . . 71.43 108.529 -178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 22' ' ' VAL . 11.1 m-85 -91.28 111.53 23.05 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.377 -0.828 . . . . 75.22 110.643 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.4 m -80.13 100.4 8.22 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 106.99 -1.485 . . . . 71.14 106.99 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 49.5 p -68.1 173.94 4.25 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.964 -0.562 . . . . 72.13 111.357 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 93.5 mt -61.26 -29.46 69.86 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.282 0.563 . . . . 71.32 110.728 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -73.14 -16.61 61.44 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.378 -0.828 . . . . 74.24 110.227 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.6 -8.39 66.21 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 116.247 -0.433 . . . . 54.24 112.25 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -77.34 127.77 33.15 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 107.128 -1.434 . . . . 71.23 107.128 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -85.15 123.77 31.05 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.723 -0.843 . . . . 71.24 108.723 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 50' ' ' CYS . 4.3 tt -135.54 133.53 38.5 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 106.727 -1.583 . . . . 74.0 106.727 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.496 ' N ' HD23 ' A' ' 49' ' ' LEU . 21.4 m -94.94 145.43 24.93 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 114.21 1.189 . . . . 72.44 114.21 -169.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -125.64 158.73 63.91 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 115.113 -0.949 . . . . 54.44 110.515 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 66.7 Cg_endo -69.49 108.11 1.96 Allowed 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.421 2.08 . . . . 65.2 112.569 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 71.7 Cg_endo -74.22 -10.37 22.49 Favored 'Trans proline' 0 N--CA 1.473 0.274 0 C-N-CA 123.113 2.542 . . . . 73.14 113.824 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -96.32 -16.19 21.46 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.571 0.701 . . . . 75.11 109.617 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.463 ' OE1' ' HB2' ' A' ' 52' ' ' PRO . 1.8 mp0 -82.08 144.44 50.97 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 113.497 0.925 . . . . 50.44 113.497 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.96 -39.97 81.76 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 124.548 3.498 . . . . 63.42 115.013 -174.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -65.31 -26.7 68.17 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.231 -0.587 . . . . 72.43 110.473 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 62' ' ' ILE . 71.8 t -81.22 -40.11 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.823 -0.626 . . . . 75.3 111.852 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.464 ' HG3' ' HD2' ' A' ' 60' ' ' ARG . 13.4 pt-20 -61.26 -37.07 81.8 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.775 0.657 . . . . 72.52 112.775 -176.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.464 ' HD2' ' HG3' ' A' ' 59' ' ' GLU . 3.2 mpt_? -69.26 -38.84 78.62 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 120.19 -0.604 . . . . 61.4 112.165 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.47 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 12.6 pt -71.42 -33.22 49.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 120.804 -0.358 . . . . 73.33 111.829 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 58' ' ' VAL . 67.7 mt -61.88 -47.02 95.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 N-CA-C 109.292 -0.633 . . . . 75.23 109.292 172.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 84.1 mm-40 -58.34 -41.25 84.2 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.167 -0.47 . . . . 74.23 111.42 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -60.23 -41.27 92.76 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.035 -0.529 . . . . 63.23 111.191 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.588 HD11 HG13 ' A' ' 22' ' ' VAL . 90.6 mt -75.25 -28.83 60.01 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.27 -0.572 . . . . 74.35 111.043 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 47.0 mt-30 -71.1 -35.09 71.67 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 112.011 0.374 . . . . 61.24 112.011 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? . . . . . 0 N--CA 1.433 -1.305 0 C-N-CA 124.128 0.971 . . . . 74.23 111.867 -177.727 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.508 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 4.9 p . . . . . 0 N--CA 1.43 -1.463 0 N-CA-C 110.138 -0.319 . . . . 74.33 110.138 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.542 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -93.37 -175.75 3.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.505 -0.924 . . . . 73.02 108.505 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.07 -59.06 1.94 Allowed 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.476 0.547 . . . . 63.1 112.476 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.8 m -162.27 141.71 9.52 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.838 -0.43 . . . . 75.42 109.838 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.7 m -98.94 152.03 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.255 -1.017 . . . . 74.33 108.255 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 t -94.15 178.39 5.66 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.161 -0.681 . . . . 74.13 109.161 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -45.27 -46.48 12.62 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.948 0.899 . . . . 64.33 110.597 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 5.0 ttmp? -160.2 99.2 1.43 Allowed Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.017 -1.105 . . . . 70.25 108.017 169.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.5 Cg_endo -51.51 -81.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.351 0 C-N-CA 123.46 2.774 . . . . 51.4 116.785 -175.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.444 HD11 ' HB2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -147.95 152.46 40.37 Favored Pre-proline 0 C--N 1.322 -0.628 0 O-C-N 121.943 -0.473 . . . . 75.43 110.611 -174.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.475 ' O ' HG12 ' A' ' 21' ' ' ILE . 18.7 Cg_endo -61.97 141.2 88.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.444 2.096 . . . . 74.12 111.32 174.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.411 ' HA3' HD12 ' A' ' 61' ' ' ILE . . . -79.86 1.46 78.78 Favored Glycine 0 C--N 1.309 -0.952 0 C-N-CA 121.434 -0.413 . . . . 72.15 113.568 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.45 ' CE1' ' HG2' ' A' ' 64' ' ' ARG . 98.4 m-85 -94.6 -0.6 54.36 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 122.226 -0.573 . . . . 71.11 111.553 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.507 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 35.4 pt -112.41 5.13 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.279 0.561 . . . . 74.32 110.728 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.423 HG13 HD21 ' A' ' 65' ' ' LEU . 2.7 p -90.78 135.04 27.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.997 -0.547 . . . . 63.24 111.261 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.39 -55.6 3.82 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.775 -0.824 . . . . 70.44 108.775 -175.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -140.45 164.33 30.43 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.361 0.664 . . . . 64.43 109.626 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.49 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 8.6 p90 -143.85 167.98 21.03 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.743 0.306 . . . . 73.5 110.51 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -141.96 137.09 30.99 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.155 -1.054 . . . . 65.32 108.155 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -98.6 103.87 15.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 123.448 0.467 . . . . 72.41 109.868 -173.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 2.3 mm? -103.74 128.55 51.1 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.921 -0.77 . . . . 73.44 108.921 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.9 mt -131.95 179.59 5.99 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.225 0.536 . . . . 63.52 111.278 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.7 mt -77.99 -19.0 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.689 -1.226 . . . . 71.25 107.689 173.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.49 -34.33 72.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.07 -0.968 . . . . 61.34 109.845 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -68.16 -34.22 75.92 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.424 -0.807 . . . . 71.21 109.927 176.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.34 -17.51 3.54 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.356 -0.838 . . . . 75.12 112.471 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.22 161.69 26.61 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.675 1.361 . . . . 75.45 114.675 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -81.33 -15.49 55.2 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.939 -1.028 . . . . 72.2 111.282 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -134.12 123.81 17.04 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-O 120.971 0.415 . . . . 74.2 111.958 -174.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -85.94 129.39 3.43 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 121.794 1.663 . . . . 74.34 109.556 172.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.55 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -162.77 136.86 6.27 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.121 -0.49 . . . . 54.42 109.742 -176.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.99 124.51 52.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.305 -1.369 . . . . 74.44 107.305 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.542 HG12 ' SG ' ' A' ' 9' ' ' CYS . 18.8 m -84.79 123.17 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.548 0 CA-C-O 121.854 0.835 . . . . 70.5 110.178 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.444 ' HB2' HD11 ' A' ' 17' ' ' ILE . 15.1 m-85 -97.97 117.88 33.3 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 114.757 -1.111 . . . . 75.41 109.804 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 94.4 m -87.1 102.08 14.1 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.746 -0.835 . . . . 75.44 108.746 174.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.5 p -70.97 166.79 20.53 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.373 -0.376 . . . . 75.34 110.511 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 90.0 mt -60.47 -25.58 66.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.525 0.678 . . . . 72.0 110.353 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -62.75 -24.85 67.9 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.127 -0.942 . . . . 64.1 110.644 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.44 15.97 36.07 Favored Glycine 0 CA--C 1.505 -0.551 0 C-N-CA 121.288 -0.482 . . . . 72.15 111.911 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 42' ' ' THR . 34.3 mmt180 -99.56 139.21 35.54 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 120.665 0.269 . . . . 75.51 111.007 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -95.79 129.41 43.03 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.996 -1.853 . . . . 71.33 105.996 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.2 tp -137.57 144.62 42.13 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.463 -0.495 . . . . 50.2 110.148 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 9.7 m -80.16 128.57 33.67 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 123.494 0.496 . . . . 71.22 110.632 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.539 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -131.86 154.78 81.86 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 109.208 -0.664 . . . . 54.12 109.208 172.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.421 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 95.8 Cg_endo -77.31 107.82 2.48 Favored 'Trans proline' 0 CA--C 1.559 1.758 0 C-N-CA 122.643 2.229 . . . . 72.21 113.924 -173.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.55 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.9 Cg_endo -68.61 -19.8 41.62 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.135 2.557 . . . . 72.22 114.882 -173.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -96.87 2.7 52.04 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.601 0.715 . . . . 73.42 110.799 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.421 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.3 mm100 -95.06 143.14 25.61 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 112.291 0.478 . . . . 74.05 112.291 -178.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.427 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 10.3 Cg_endo -50.27 -46.79 27.07 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 124.427 3.418 . . . . 62.0 114.625 -175.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.497 ' O ' HG12 ' A' ' 61' ' ' ILE . 33.8 p-90 -63.33 -30.6 71.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 120.488 -0.485 . . . . 73.44 110.832 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 62' ' ' ILE . 72.7 t -81.56 -44.07 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.198 -0.455 . . . . 71.13 111.489 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.427 ' HG3' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -64.47 -24.63 67.69 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 120.302 -0.559 . . . . 71.35 111.513 -177.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -79.64 -29.63 41.04 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 115.838 -0.619 . . . . 74.25 110.731 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 57' ' ' TRP . 8.3 pt -86.09 -35.31 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.703 1.001 . . . . 64.31 113.703 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 58' ' ' VAL . 67.9 mt -53.01 -41.63 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 120.741 0.305 . . . . 74.33 110.809 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -59.99 -35.33 74.79 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.942 0.719 . . . . 74.13 112.942 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.45 ' HG2' ' CE1' ' A' ' 20' ' ' TYR . 7.1 mpt_? -57.31 -45.98 83.67 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.05 0.452 . . . . 60.02 110.316 174.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.49 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 3.5 mm? -68.1 -43.35 78.66 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.697 -0.683 . . . . 74.32 110.252 176.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -59.91 -41.71 92.3 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 115.61 -0.723 . . . . 74.23 112.268 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . 0.263 4.2 ppt_? . . . . . 0 C--O 1.217 -0.641 0 N-CA-C 113.365 0.876 . . . . 71.33 113.365 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.415 ' HA ' HD12 ' A' ' 28' ' ' LEU . 26.3 p . . . . . 0 N--CA 1.411 -2.381 0 CA-C-O 120.783 0.325 . . . . 73.55 110.534 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 38' ' ' ALA . 75.6 m -61.0 145.86 49.19 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 115.74 1.756 . . . . 43.33 115.74 -171.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -90.81 -54.51 3.94 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 105.315 -2.106 . . . . 62.24 105.315 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.3 m -165.6 174.65 9.63 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 108.469 -0.937 . . . . 63.12 108.469 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.419 HG12 ' CB ' ' A' ' 50' ' ' CYS . 2.2 m -135.01 157.57 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.389 -1.708 . . . . 74.13 106.389 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.494 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 10.1 t -102.3 177.45 4.87 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.315 -1.365 . . . . 63.21 107.315 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -47.3 -67.02 0.32 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.596 0.634 . . . . 75.3 111.739 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 40.2 ttmt -132.49 85.91 46.79 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 119.749 -0.78 . . . . 72.42 109.166 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.534 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 6.7 Cg_endo -47.01 -80.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 124.75 3.633 . . . . 52.14 118.166 -175.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.429 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -138.45 156.83 73.2 Favored Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 121.916 -0.49 . . . . 70.22 111.634 -172.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.464 ' O ' HG12 ' A' ' 21' ' ' ILE . 27.0 Cg_endo -64.99 136.61 49.13 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.722 2.281 . . . . 73.44 111.486 174.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.454 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -77.0 1.45 63.32 Favored Glycine 0 C--N 1.31 -0.909 0 CA-C-N 115.936 -0.575 . . . . 64.51 113.631 -178.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -83.73 -24.84 31.0 Favored 'General case' 0 N--CA 1.414 -2.24 0 O-C-N 122.301 -0.529 . . . . 75.33 110.933 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 18' ' ' PRO . 36.5 pt -90.15 2.01 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 120.353 -0.539 . . . . 75.23 111.699 -177.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.574 HG13 HD11 ' A' ' 65' ' ' LEU . 3.0 p -93.24 134.01 32.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 121.207 0.527 . . . . 53.1 111.526 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.08 -47.35 7.88 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.542 -0.91 . . . . 72.13 108.542 -175.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.46 ' O ' ' HB ' ' A' ' 42' ' ' THR . 10.3 p30 -145.84 157.99 43.88 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.417 -0.957 . . . . 75.51 108.417 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -128.58 152.47 48.28 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.941 -0.763 . . . . 73.2 108.941 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.536 ' HB2' HG22 ' A' ' 40' ' ' VAL . 27.9 m170 -120.63 112.34 18.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.218 -1.401 . . . . 74.42 107.218 172.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -84.39 103.47 13.58 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.675 -0.861 . . . . 70.2 108.675 -175.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 8' ' ' CYS . 79.5 mt -109.39 137.93 46.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.45 0.643 . . . . 73.14 111.939 -175.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.1 mt -141.6 178.75 7.24 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.14 -0.936 . . . . 74.12 110.142 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 34' ' ' CYS . 49.0 mt -77.79 -30.27 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.541 -1.281 . . . . 74.55 107.541 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -61.52 -25.92 67.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.051 -0.977 . . . . 72.05 109.999 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -83.78 -56.3 3.78 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.375 -1.342 . . . . 75.32 107.375 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.6 71.72 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.373 -0.918 . . . . 62.41 113.65 173.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.438 ' O ' HG12 ' A' ' 30' ' ' ILE . 49.9 t -161.18 151.97 18.26 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.77 -1.567 . . . . 62.32 106.77 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -74.93 -24.42 58.49 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.885 0.374 . . . . 63.31 111.995 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.53 108.08 47.9 Favored Pre-proline 0 C--N 1.3 -1.568 0 CA-C-O 121.429 0.633 . . . . 65.31 111.223 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -84.98 130.68 4.18 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.388 2.058 . . . . 55.31 111.628 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.642 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -176.42 164.12 2.56 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 124.046 0.938 . . . . 65.1 108.862 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.34 127.98 56.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 109.758 -0.46 . . . . 60.3 109.758 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.689 HG12 ' SG ' ' A' ' 50' ' ' CYS . 3.2 m -88.81 127.9 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 N-CA-C 108.254 -1.017 . . . . 60.24 108.254 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -97.94 113.0 24.72 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 116.08 -0.509 . . . . 65.34 110.601 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 24' ' ' ASN . 96.9 m -80.48 101.91 9.37 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.484 -0.78 . . . . 73.23 108.962 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.6 p -73.43 170.52 14.93 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.328 -0.396 . . . . 74.43 110.873 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.3 mt -57.87 -27.98 63.75 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.289 0.636 . . . . 65.24 112.622 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.3 tpp180 -73.02 -20.79 60.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.915 0.388 . . . . 62.3 110.707 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.96 40.42 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.902 -0.879 . . . . 51.22 110.902 -176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -98.57 133.05 43.46 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.634 -1.617 . . . . 70.32 106.634 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -99.44 130.5 45.71 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.943 -0.762 . . . . 74.15 108.943 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -136.8 138.61 41.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.903 -1.517 . . . . 72.01 106.903 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.689 ' SG ' HG12 ' A' ' 40' ' ' VAL . 91.0 m -94.83 147.59 23.2 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 114.872 1.434 . . . . 73.43 114.872 -173.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.534 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -130.24 163.03 50.63 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-N 114.908 -1.042 . . . . 62.21 109.847 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 88.9 Cg_endo -78.72 109.85 2.69 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 122.171 1.914 . . . . 73.24 113.018 -175.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 65.8 Cg_endo -70.04 -18.62 35.6 Favored 'Trans proline' 0 N--CA 1.483 0.886 0 C-N-CA 122.924 2.416 . . . . 72.14 113.232 -174.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.18 -7.98 54.54 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.439 0.638 . . . . 71.34 109.865 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -90.08 135.21 30.32 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-O 121.17 0.51 . . . . 73.21 111.309 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.408 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 11.8 Cg_endo -54.89 -35.85 90.17 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 124.341 3.361 . . . . 74.21 115.32 -175.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.466 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 37.9 p-90 -63.1 -30.49 71.63 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.88 0.371 . . . . 74.51 111.047 -177.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 62' ' ' ILE . 69.1 t -76.59 -36.62 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.076 -0.511 . . . . 64.13 110.89 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 56' ' ' PRO . 38.3 mt-10 -56.36 -45.02 80.66 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.035 0.445 . . . . 53.43 110.551 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.552 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 4.1 mmp_? -57.68 -51.07 71.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.246 -0.888 . . . . 75.53 111.423 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.454 HG21 ' HA3' ' A' ' 19' ' ' GLY . 13.1 pt -70.46 -33.2 52.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 113.335 0.865 . . . . 62.32 113.335 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 58' ' ' VAL . 60.1 mt -60.43 -45.56 96.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 109.459 -0.571 . . . . 71.32 109.459 173.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -57.6 -42.27 82.9 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.313 -0.403 . . . . 61.31 111.322 176.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 60' ' ' ARG . 89.4 mtt180 -59.23 -38.8 80.86 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.92 -0.582 . . . . 73.51 111.718 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.574 HD11 HG13 ' A' ' 22' ' ' VAL . 89.2 mt -79.41 -33.89 42.29 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.309 0.485 . . . . 75.43 112.309 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -68.79 -41.5 78.65 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 120.452 -0.499 . . . . 71.52 112.065 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 121.041 0.448 . . . . 62.43 110.833 179.714 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.402 ' HA ' HD13 ' A' ' 28' ' ' LEU . 27.3 p . . . . . 0 N--CA 1.403 -2.812 0 N-CA-C 104.349 -2.463 . . . . 65.21 104.349 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.24 -175.75 3.76 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 117.796 -1.562 . . . . 73.21 110.227 -175.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.2 mt -98.41 -64.69 1.02 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 120.903 0.382 . . . . 72.4 110.709 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.1 t -176.03 153.07 1.26 Allowed 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.146 -1.428 . . . . 65.23 107.146 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.432 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -106.98 160.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 119.154 -1.019 . . . . 51.44 110.021 -176.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -106.24 179.59 4.22 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.567 -0.901 . . . . 72.52 108.567 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -42.62 -57.27 2.77 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.904 0.881 . . . . 75.3 109.677 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 ttpt -145.85 97.59 4.55 Favored Pre-proline 0 N--CA 1.428 -1.543 0 N-CA-C 108.4 -0.963 . . . . 74.41 108.4 170.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.595 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 2.6 Cg_endo -39.62 -73.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.712 3.608 . . . . 62.35 116.015 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.401 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -142.38 158.02 61.66 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 107.448 -1.316 . . . . 71.41 107.448 -177.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' O ' HG12 ' A' ' 21' ' ' ILE . 17.9 Cg_endo -63.12 130.78 29.99 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 121.649 1.566 . . . . 72.34 110.558 174.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.524 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -72.26 2.01 30.95 Favored Glycine 0 C--N 1.303 -1.264 0 N-CA-C 115.029 0.772 . . . . 62.43 115.029 -174.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.76 -3.71 38.49 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 112.495 0.554 . . . . 75.25 112.495 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.523 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 39.6 pt -103.81 6.4 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 121.379 0.609 . . . . 71.32 110.378 177.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 41' ' ' PHE . 5.1 p -91.63 143.46 11.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.794 -0.639 . . . . 63.52 111.582 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.409 ' HE ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -99.88 -56.46 2.37 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.949 -1.13 . . . . 65.52 107.949 -178.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -134.21 166.03 23.74 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.738 -0.838 . . . . 71.43 108.738 -176.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -143.61 161.13 39.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.821 -0.437 . . . . 64.51 109.821 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.429 ' HB2' HG22 ' A' ' 40' ' ' VAL . 38.4 m80 -137.68 122.58 18.91 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 110.145 -0.316 . . . . 74.13 110.145 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -75.8 98.19 4.09 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 123.236 0.335 . . . . 74.12 110.16 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 8' ' ' CYS . 69.5 mt -97.14 134.2 40.79 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-O 121.887 0.851 . . . . 72.44 110.249 177.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.6 mt -125.93 -178.53 4.32 Favored 'General case' 0 C--N 1.256 -3.471 0 N-CA-C 106.725 -1.583 . . . . 70.24 106.725 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.469 HG23 ' HA ' ' A' ' 35' ' ' ARG . 68.2 mt -63.85 -37.88 80.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 120.312 -0.555 . . . . 64.23 109.798 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.471 ' HE2' ' HB2' ' A' ' 31' ' ' LYS . 12.1 ptmm? -59.87 -31.88 70.19 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 114.264 1.209 . . . . 62.42 114.264 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -111.92 -5.35 14.35 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.962 0.41 . . . . 72.25 111.259 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.77 -124.32 3.43 Favored Glycine 0 N--CA 1.417 -2.609 0 CA-C-N 115.857 -0.611 . . . . 25.33 112.726 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 84.7 m -118.01 -87.24 0.63 Allowed 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.398 -0.401 . . . . 73.14 110.404 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.469 ' HA ' HG23 ' A' ' 30' ' ' ILE . 35.9 ttm180 -143.23 15.18 1.86 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.175 0.988 . . . . 71.24 108.824 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 p -127.83 117.85 20.94 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 115.302 -0.863 . . . . 72.02 110.265 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.97 130.17 2.1 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 121.929 1.753 . . . . 60.52 110.491 174.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -171.52 154.79 3.9 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.94 -0.763 . . . . 73.13 108.94 -177.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.25 125.43 52.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.5 -0.926 . . . . 54.33 108.5 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 26' ' ' HIS . 16.4 m -90.12 128.35 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.008 0 C-N-CA 119.643 -0.823 . . . . 73.02 109.308 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CD1' HG21 ' A' ' 22' ' ' VAL . 15.3 m-85 -95.58 125.52 40.23 Favored 'General case' 0 C--N 1.272 -2.788 0 CA-C-N 115.358 -0.837 . . . . 73.11 110.177 175.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.4 m -93.45 103.65 15.84 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.922 -1.14 . . . . 71.3 107.922 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 71.1 p -70.0 174.36 5.45 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.35 -0.386 . . . . 54.35 111.248 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 95.3 mt -61.2 -27.39 68.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.52 0.676 . . . . 52.41 109.724 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -67.57 -28.4 67.74 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.718 1.207 . . . . 55.14 110.904 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.08 16.59 40.53 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 120.79 -0.719 . . . . 65.21 111.424 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.62 138.39 31.55 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.436 -1.32 . . . . 64.45 107.436 -177.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -91.97 121.18 33.32 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.79 -1.189 . . . . 75.41 107.79 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.483 HD13 ' N ' ' A' ' 50' ' ' CYS . 0.5 OUTLIER -129.67 141.51 50.9 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.363 -0.977 . . . . 73.2 108.363 -178.095 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.483 ' N ' HD13 ' A' ' 49' ' ' LEU . 7.9 m -78.06 129.97 35.87 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.998 0.519 . . . . 64.41 111.081 -173.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.595 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -136.98 157.3 74.94 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 110.037 -0.357 . . . . 61.52 110.037 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.8 109.27 1.97 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.376 2.051 . . . . 71.12 112.798 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 42.5 Cg_endo -67.0 -18.76 52.11 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.833 2.355 . . . . 74.21 113.91 -174.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -96.51 3.66 52.56 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.465 -0.494 . . . . 72.2 112.286 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -97.57 139.24 21.27 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 120.42 -0.512 . . . . 74.4 112.315 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.508 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 83.6 Cg_exo -47.36 -42.81 27.63 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 124.441 3.427 . . . . 75.22 114.55 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -62.52 -27.3 69.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.357 -0.537 . . . . 54.12 110.86 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.667 ' O ' HG12 ' A' ' 62' ' ' ILE . 75.4 t -81.75 -50.22 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.878 -0.601 . . . . 64.1 111.264 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.508 ' HG3' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -57.23 -27.01 61.64 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.832 0.678 . . . . 64.21 112.832 -176.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -73.04 -49.66 27.45 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.746 -0.661 . . . . 74.51 110.33 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.524 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.2 pt -71.7 -28.08 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.911 -0.586 . . . . 73.43 111.663 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 58' ' ' VAL . 41.0 mm -54.45 -52.76 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.851 -0.613 . . . . 72.14 109.902 173.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -56.58 -38.05 71.46 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.386 0.612 . . . . 71.22 110.3 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.26 -38.4 90.19 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.954 -1.021 . . . . 61.53 109.146 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.546 HD11 HG13 ' A' ' 22' ' ' VAL . 88.3 mt -79.73 -36.94 36.61 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 116.63 -0.259 . . . . 73.52 111.149 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -55.84 -20.28 14.79 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 114.054 1.131 . . . . 74.51 114.054 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 . . . . . 0 CA--C 1.555 1.139 0 N-CA-C 109.539 -0.541 . . . . 61.04 109.539 178.337 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 27.9 p . . . . . 0 N--CA 1.431 -1.412 0 N-CA-C 112.474 0.546 . . . . 72.43 112.474 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.586 ' SG ' HG12 ' A' ' 40' ' ' VAL . 91.6 m -57.86 150.81 19.35 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 116.47 2.026 . . . . 62.52 116.47 -174.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -84.25 -63.98 1.24 Allowed 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.867 -1.515 . . . . 75.13 108.13 172.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -167.15 175.72 7.29 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 106.124 -1.806 . . . . 54.04 106.124 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 13' ' ' THR . 2.2 m -133.91 161.25 41.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.485 -1.302 . . . . 73.12 107.485 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.7 t -98.78 178.06 5.09 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.127 -1.064 . . . . 61.43 108.127 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -50.5 -60.73 2.72 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.007 0.523 . . . . 72.33 110.769 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 4.8 ttmp? -139.85 86.54 13.46 Favored Pre-proline 0 N--CA 1.428 -1.548 0 N-CA-C 109.367 -0.605 . . . . 71.22 109.367 174.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 7.5 Cg_endo -47.94 -78.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.463 0 C-N-CA 124.565 3.51 . . . . 74.3 117.303 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.405 ' H ' HD13 ' A' ' 17' ' ' ILE . 0.2 OUTLIER -141.32 162.83 45.43 Favored Pre-proline 0 C--N 1.32 -0.701 0 O-C-N 121.791 -0.568 . . . . 65.42 110.365 -175.142 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.599 ' O ' HG12 ' A' ' 21' ' ' ILE . 36.8 Cg_exo -63.05 130.21 28.28 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.135 1.89 . . . . 60.23 110.704 174.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -73.69 2.04 42.17 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 116.339 -0.391 . . . . 65.31 113.946 -176.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -98.23 0.12 45.14 Favored 'General case' 0 N--CA 1.417 -2.121 0 O-C-N 122.133 -0.628 . . . . 72.31 111.52 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 18' ' ' PRO . 33.7 pt -106.71 9.22 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.452 0.644 . . . . 71.22 110.136 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.632 HG13 HD11 ' A' ' 65' ' ' LEU . 2.9 p -96.59 134.94 32.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.733 -0.667 . . . . 74.31 111.817 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.571 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -91.15 -56.02 3.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.73 -0.841 . . . . 74.51 108.73 -176.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.571 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 18.1 m120 -130.17 157.43 42.48 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-N 115.89 -0.596 . . . . 71.31 109.445 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -139.65 152.31 46.65 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.19 -0.67 . . . . 71.31 109.19 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.42 ' HB2' HG22 ' A' ' 40' ' ' VAL . 34.3 m170 -122.97 121.72 36.79 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.049 -1.463 . . . . 73.34 107.049 174.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -93.93 114.3 26.49 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 109.607 -0.516 . . . . 74.4 109.607 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.579 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 4.0 mm? -110.23 126.92 54.65 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 116.262 -0.426 . . . . 74.25 111.608 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.7 mt -126.83 176.96 6.89 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.833 -0.802 . . . . 60.53 108.833 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 57.1 mt -74.11 -20.07 17.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 107.701 -1.222 . . . . 75.33 107.701 176.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -58.79 -30.42 67.57 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.726 -1.124 . . . . 73.23 110.071 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.05 -42.45 47.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.597 -0.729 . . . . 74.03 109.988 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.54 -44.89 0.64 Allowed Glycine 0 CA--C 1.503 -0.709 0 C-N-CA 120.458 -0.877 . . . . 74.13 113.039 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 63.4 m -66.86 141.47 57.66 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 110.263 -0.273 . . . . 62.1 110.263 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -79.23 3.44 17.9 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.194 0.521 . . . . 73.34 112.057 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.31 97.94 49.44 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.821 -0.627 . . . . 74.45 110.251 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -80.65 128.96 7.06 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 121.255 1.303 . . . . 63.22 110.137 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.594 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -173.83 161.85 3.88 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.145 0.578 . . . . 52.24 109.825 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 50' ' ' CYS . 7.9 p -108.59 128.23 64.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 109.381 -0.6 . . . . 75.22 109.381 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.586 HG12 ' SG ' ' A' ' 9' ' ' CYS . 1.4 m -86.3 129.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 107.303 -1.369 . . . . 63.33 107.303 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -104.68 116.65 32.42 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 116.567 -0.288 . . . . 70.21 111.331 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.5 m -85.24 101.57 12.62 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.284 -1.006 . . . . 61.24 108.284 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 63.4 p -73.97 168.67 19.01 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.258 -0.428 . . . . 65.03 110.981 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 92.2 mt -59.52 -29.05 67.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.121 0.568 . . . . 73.44 111.117 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -71.24 -16.37 62.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.493 -0.776 . . . . 71.41 110.78 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.75 15.83 44.52 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.261 -0.495 . . . . 63.11 112.306 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -94.87 140.06 30.45 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 110.523 -0.177 . . . . 74.22 110.523 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -104.12 109.83 21.78 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.89 -0.595 . . . . 73.12 109.503 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.4 tp -130.03 129.82 44.16 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.756 -0.657 . . . . 73.24 109.263 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.576 ' SG ' HG12 ' A' ' 40' ' ' VAL . 75.4 m -84.48 147.41 27.1 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 113.682 0.993 . . . . 71.35 113.682 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.589 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.31 160.55 57.07 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 115.103 -0.953 . . . . 64.33 110.169 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 72.9 Cg_endo -71.98 108.11 2.38 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.194 1.929 . . . . 75.52 111.936 -175.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.594 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 67.3 Cg_endo -68.35 -30.41 30.14 Favored 'Trans proline' 0 N--CA 1.473 0.265 0 C-N-CA 123.089 2.526 . . . . 64.45 113.388 -171.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -78.4 -26.59 46.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.228 -0.442 . . . . 72.53 111.386 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -66.34 138.25 95.79 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 116.122 -0.49 . . . . 70.42 112.146 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.443 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 78.0 Cg_exo -53.45 -38.66 83.24 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 124.011 3.141 . . . . 34.32 114.699 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.466 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 37.0 p-90 -64.86 -29.96 70.94 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 120.469 -0.493 . . . . 74.13 111.116 -175.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 62' ' ' ILE . 72.3 t -80.07 -30.12 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 116.115 -0.493 . . . . 70.31 111.109 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.9 mt-10 -56.71 -49.73 74.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.562 -0.29 . . . . 74.53 110.715 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -61.52 -45.52 93.86 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.179 -0.464 . . . . 73.31 112.208 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.5 HG21 ' HA3' ' A' ' 19' ' ' GLY . 18.0 pt -69.2 -33.8 60.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 113.145 0.794 . . . . 70.44 113.145 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 58' ' ' VAL . 65.3 mt -61.66 -46.93 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.411 -0.589 . . . . 72.21 109.411 174.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 13.0 mm100 -60.05 -40.96 91.23 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.776 -0.647 . . . . 43.42 109.475 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -57.95 -51.49 69.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.234 -0.894 . . . . 73.44 109.627 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.632 HD11 HG13 ' A' ' 22' ' ' VAL . 73.7 mt -67.52 -28.97 68.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.727 0.64 . . . . 73.02 112.727 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -69.0 -32.31 71.77 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.368 -0.933 . . . . 75.43 110.767 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 31.8 mmt180 . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 116.486 -0.325 . . . . 61.52 110.787 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.449 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 14.7 p . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 109.904 -0.406 . . . . 51.53 109.904 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.82 -171.58 3.48 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.835 -0.746 . . . . 62.43 111.665 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.0 -68.05 0.82 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.395 -0.594 . . . . 72.34 109.395 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -168.04 153.83 7.17 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.259 -1.015 . . . . 75.21 108.259 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.547 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.9 m -115.8 162.09 14.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 119.839 -0.744 . . . . 54.3 109.973 -175.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -105.75 177.64 4.79 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.012 -1.477 . . . . 71.23 107.012 172.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -53.82 -50.03 67.07 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 118.656 0.662 . . . . 51.13 111.53 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.508 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 87.4 tttt -143.6 83.7 10.49 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-O 121.0 0.429 . . . . 64.12 110.153 175.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.5 Cg_endo -47.38 -77.77 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.456 3.438 . . . . 71.33 117.429 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.48 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -134.15 166.3 30.23 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 110.058 -0.349 . . . . 73.34 110.058 -173.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.585 ' O ' HG12 ' A' ' 21' ' ' ILE . 44.7 Cg_exo -61.26 127.92 23.48 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.253 1.968 . . . . 51.24 111.004 175.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.48 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -80.65 0.17 86.38 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 114.594 0.598 . . . . 64.4 114.594 -175.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.53 -1.16 39.05 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 122.034 -0.686 . . . . 73.44 112.841 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 18' ' ' PRO . 34.8 pt -100.21 7.46 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.633 0.73 . . . . 73.12 110.36 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.53 HG13 HD11 ' A' ' 65' ' ' LEU . 2.5 p -89.25 136.12 24.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.33 -0.85 . . . . 61.43 111.75 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.442 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 1.0 OUTLIER -86.16 -55.68 3.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.031 -1.1 . . . . 73.13 108.031 -176.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.442 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 17.5 m120 -141.65 160.31 40.43 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.281 1.032 . . . . 72.0 108.713 177.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -131.97 156.8 45.55 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.694 -0.403 . . . . 65.31 110.068 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.535 ' HB2' HG22 ' A' ' 40' ' ' VAL . 28.0 m170 -123.56 112.54 17.57 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.299 -1.371 . . . . 73.44 107.299 172.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -82.91 99.8 10.0 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.513 -1.291 . . . . 72.42 107.513 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.449 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 77.4 mt -112.58 134.72 53.96 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.54 0.686 . . . . 73.42 111.803 -173.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 94.6 mt -142.32 169.71 17.08 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.043 -0.98 . . . . 72.35 110.755 -173.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.9 mt -77.97 -30.36 16.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 106.629 -1.619 . . . . 61.25 106.629 171.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -56.22 -39.5 72.6 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.571 -1.195 . . . . 73.44 110.368 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.94 -57.6 3.8 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.981 -1.118 . . . . 74.22 107.981 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.44 85.96 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.973 -1.108 . . . . 72.42 114.299 174.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.1 t -168.54 172.52 8.1 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 105.691 -1.966 . . . . 73.4 105.691 174.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -88.17 -3.05 58.93 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.228 1.195 . . . . 74.33 114.228 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 p -148.95 122.77 4.66 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-O 120.972 0.415 . . . . 70.22 111.256 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -87.28 130.15 2.85 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.473 2.115 . . . . 61.13 112.546 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -176.25 150.05 0.9 Allowed 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.481 -0.933 . . . . 60.13 108.481 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -98.41 127.41 50.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.401 -1.333 . . . . 74.45 107.401 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 26' ' ' HIS . 6.2 m -92.3 125.12 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.15 0 C-N-CA 119.307 -0.957 . . . . 75.51 108.849 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -99.26 113.16 25.29 Favored 'General case' 0 C--N 1.272 -2.79 0 CA-C-N 115.459 -0.791 . . . . 72.13 109.729 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 77.2 m -80.69 102.43 9.88 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.895 -0.78 . . . . 72.31 108.895 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.1 p -69.23 167.83 15.43 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.123 -0.489 . . . . 63.42 110.811 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 93.7 mt -59.13 -29.09 67.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.205 0.526 . . . . 53.53 110.26 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -64.75 -26.6 68.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.078 -0.964 . . . . 71.14 111.055 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.69 17.18 19.93 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.22 -0.991 . . . . 44.13 112.145 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -103.36 125.89 50.23 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 122.684 -0.304 . . . . 72.22 111.244 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.08 112.82 19.49 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.69 -1.226 . . . . 75.33 107.69 172.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 50' ' ' CYS . 0.9 OUTLIER -115.09 141.55 47.85 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.679 -0.86 . . . . 73.24 108.679 -176.074 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.547 ' HB3' HG12 ' A' ' 12' ' ' VAL . 9.4 m -79.15 119.73 22.66 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 123.061 0.545 . . . . 64.53 111.13 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.623 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -122.85 155.55 63.42 Favored Pre-proline 0 C--O 1.243 0.733 0 C-N-CA 120.346 -0.541 . . . . 74.43 111.944 174.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 98.0 Cg_endo -78.08 110.85 2.97 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.646 2.231 . . . . 71.53 114.427 -172.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.05 -1.19 8.3 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.752 2.301 . . . . 62.2 112.556 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -103.3 -3.29 25.82 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.493 -0.321 . . . . 74.53 111.08 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 29.7 mm-40 -103.82 132.8 20.69 Favored Pre-proline 0 C--N 1.311 -1.106 0 C-N-CA 120.309 -0.556 . . . . 63.22 112.435 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 98.6 Cg_exo -49.07 -32.62 24.38 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 124.552 3.501 . . . . 74.5 115.046 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.508 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 31.0 p-90 -68.18 -30.19 69.23 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.4 -0.52 . . . . 75.41 109.902 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 62' ' ' ILE . 70.9 t -78.94 -40.97 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.212 -0.662 . . . . 60.14 109.212 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.4 mt-10 -59.68 -25.05 64.44 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.341 -0.845 . . . . 75.42 112.411 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -83.34 -43.39 16.01 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.294 0.479 . . . . 65.41 112.294 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.48 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.2 pt -70.89 -33.73 53.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 112.867 0.691 . . . . 74.33 112.867 -177.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 58' ' ' VAL . 64.3 mt -57.11 -40.82 75.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 116.064 -0.516 . . . . 75.53 110.062 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 78.8 mm-40 -59.28 -43.1 92.55 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.1 -0.5 . . . . 63.31 111.328 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -59.47 -52.29 66.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.522 0.514 . . . . 73.23 110.862 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.53 HD11 HG13 ' A' ' 22' ' ' VAL . 86.3 mt -67.95 -26.36 65.91 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.254 -0.578 . . . . 71.04 112.472 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 27.8 mt-30 -67.59 -21.77 65.41 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 121.965 -0.459 . . . . 54.13 111.917 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.639 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--N 1.314 -0.944 0 N-CA-C 109.538 -0.542 . . . . 73.54 109.538 177.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.8 p . . . . . 0 N--CA 1.428 -1.559 0 N-CA-C 107.817 -1.179 . . . . 62.44 107.817 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.578 ' HB2' HG12 ' A' ' 40' ' ' VAL . 4.4 t -76.74 142.14 40.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.027 -0.731 . . . . 74.4 109.027 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.481 ' O ' HG21 ' A' ' 36' ' ' VAL . 73.7 mt -68.89 -44.64 72.82 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 116.828 2.158 . . . . 60.03 116.828 -170.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.8 m -164.49 137.18 4.82 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.759 -0.776 . . . . 74.12 111.293 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -102.05 161.21 3.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.459 -0.941 . . . . 64.03 108.459 -178.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.9 t -105.54 178.76 4.47 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.098 -1.075 . . . . 72.32 108.098 175.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -49.17 -40.61 33.65 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.615 0.766 . . . . 64.15 111.069 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 38.0 ttpt -157.7 92.1 2.24 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 109.078 -0.712 . . . . 64.43 109.078 171.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.608 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.2 Cg_endo -40.07 -67.16 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.765 3.644 . . . . 72.54 116.688 -178.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.443 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -147.03 166.25 16.79 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 75.32 109.695 -176.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.545 ' O ' HG12 ' A' ' 21' ' ' ILE . 32.1 Cg_exo -60.4 128.6 26.63 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.068 1.845 . . . . 42.43 109.632 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -73.47 0.89 46.65 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 115.887 1.115 . . . . 52.2 115.887 -172.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -98.46 -7.51 28.4 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 117.772 0.786 . . . . 72.55 112.417 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.4 pt -92.84 3.94 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.58 0.705 . . . . 71.45 111.098 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 41' ' ' PHE . 2.2 p -88.12 135.82 24.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.292 -0.867 . . . . 74.22 112.411 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -86.44 -56.07 3.6 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.434 1.094 . . . . 65.53 108.523 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -146.97 170.15 17.69 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.811 -1.086 . . . . 72.02 108.59 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.604 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 47.2 p90 -141.68 155.94 45.66 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.978 -0.378 . . . . 74.13 109.978 -175.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.412 ' HB2' HG22 ' A' ' 40' ' ' VAL . 28.1 m170 -133.82 121.95 22.54 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.627 -0.509 . . . . 75.34 109.627 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' OH ' HG21 ' A' ' 62' ' ' ILE . 54.1 m-85 -78.31 103.89 8.55 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 123.208 0.318 . . . . 74.42 110.168 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -108.76 131.55 54.84 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.484 -0.887 . . . . 75.22 110.983 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.4 mt -133.94 -177.98 4.81 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.142 -0.936 . . . . 50.54 109.131 -174.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 63.1 mt -71.67 -24.15 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 120.477 -0.489 . . . . 71.25 109.777 176.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.642 ' HE3' ' C ' ' A' ' 31' ' ' LYS 0.364 0.0 OUTLIER -67.26 -10.02 46.47 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.687 0.995 . . . . 73.43 113.687 176.415 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.521 ' N ' ' HE3' ' A' ' 31' ' ' LYS . 22.2 m-20 -83.76 -5.42 59.19 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.352 0.596 . . . . 73.21 109.733 171.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.37 43.2 8.72 Favored Glycine 0 N--CA 1.434 -1.489 0 CA-C-N 115.089 -0.96 . . . . 33.42 111.464 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 11.1 t -135.56 155.37 50.59 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.09 -1.818 . . . . 74.02 106.09 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -92.75 14.52 16.99 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.501 1.667 . . . . 74.24 115.501 -168.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 10' ' ' LEU . 3.7 p -153.11 116.3 2.78 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-O 121.328 0.585 . . . . 73.4 112.544 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -83.84 134.93 6.47 Favored 'Trans proline' 0 C--O 1.252 1.181 0 C-N-CA 122.645 2.23 . . . . 74.24 112.898 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -176.18 153.94 1.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.183 0.993 . . . . 74.13 108.562 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 8.6 p -99.11 128.28 50.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.355 -1.35 . . . . 61.13 107.355 175.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 9' ' ' CYS . 14.8 m -91.55 127.98 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.491 0 C-N-CA 119.299 -0.96 . . . . 74.1 110.083 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CD1' HG21 ' A' ' 22' ' ' VAL . 4.9 m-85 -91.29 116.87 29.18 Favored 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 115.099 -0.955 . . . . 74.44 109.79 173.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 99.0 m -89.78 106.79 18.7 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 107.721 -1.214 . . . . 61.21 107.721 176.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 69.5 p -69.73 174.18 5.41 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 123.19 0.306 . . . . 70.3 111.321 -177.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 91.6 mt -58.0 -33.23 68.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.214 0.531 . . . . 70.0 110.73 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -69.58 -18.93 63.67 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.617 -0.719 . . . . 64.2 110.882 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.58 16.71 33.26 Favored Glycine 0 CA--C 1.499 -0.956 0 C-N-CA 120.536 -0.84 . . . . 74.41 111.729 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.564 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 1.8 mmp_? -95.87 144.24 26.38 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-O 120.693 0.282 . . . . 74.21 110.668 -177.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -105.6 131.09 53.41 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.505 -0.77 . . . . 53.14 110.151 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.402 HD23 HG23 ' A' ' 17' ' ' ILE . 31.3 tp -132.87 150.89 52.12 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.886 -0.783 . . . . 73.43 108.886 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.479 ' HB3' HG12 ' A' ' 12' ' ' VAL . 4.9 m -77.68 123.9 27.26 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 110.087 -0.338 . . . . 70.04 110.087 -175.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.608 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -132.66 157.57 77.98 Favored Pre-proline 0 C--O 1.243 0.747 0 CA-C-N 118.31 0.505 . . . . 53.02 109.933 174.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.34 109.34 2.3 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.055 1.837 . . . . 51.23 113.46 -174.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.42 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 54.8 Cg_endo -70.74 -12.78 31.54 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 122.779 2.319 . . . . 71.21 113.685 -174.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -96.12 -20.44 18.63 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.232 -0.44 . . . . 74.22 111.385 -176.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -80.06 145.22 60.51 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 113.938 1.088 . . . . 71.23 113.938 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -51.24 -43.47 48.76 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.812 3.675 . . . . 73.3 115.734 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.423 ' O ' HG12 ' A' ' 61' ' ' ILE . 39.5 p-90 -64.53 -36.29 83.74 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.137 -0.625 . . . . 74.45 111.289 -175.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 62' ' ' ILE . 76.6 t -69.53 -47.29 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.849 -0.614 . . . . 70.01 111.765 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.532 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 10.1 pt-20 -61.62 -32.83 72.98 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.314 0.487 . . . . 64.23 112.314 -177.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.532 ' HE ' ' HG3' ' A' ' 59' ' ' GLU . 5.6 mmp_? -66.15 -51.93 53.18 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.094 0.473 . . . . 75.24 110.648 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.465 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 8.0 pt -64.58 -34.69 71.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.735 -0.666 . . . . 72.0 111.989 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.604 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 39.8 mt -57.4 -43.98 83.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.315 -0.402 . . . . 71.54 111.382 173.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.436 ' HA ' ' OE1' ' A' ' 63' ' ' GLN . 13.7 mm-40 -63.54 -36.72 84.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.973 0.416 . . . . 73.14 110.709 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 29.7 mmt180 -64.82 -34.08 77.52 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.618 -0.719 . . . . 72.41 111.011 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.521 HD11 HG13 ' A' ' 22' ' ' VAL . 90.4 mt -77.31 -34.93 55.32 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.767 -0.373 . . . . 75.14 110.992 176.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -76.78 -18.75 58.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.241 0.83 . . . . 72.21 113.241 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 40.7 ptt180 . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 112.712 0.634 . . . . 54.42 112.712 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.616 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 49.3 t . . . . . 0 N--CA 1.433 -1.304 0 CA-C-O 120.803 0.335 . . . . 74.03 111.025 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.418 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 97.4 m -84.44 166.18 17.52 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.744 0.818 . . . . 54.31 112.761 -177.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.51 -53.01 2.88 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.189 -1.411 . . . . 74.12 107.189 172.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.1 m -167.64 178.57 5.27 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.063 -1.458 . . . . 61.41 107.063 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.427 HG12 ' CB ' ' A' ' 50' ' ' CYS . 3.1 m -133.64 148.79 30.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.055 -1.461 . . . . 72.15 107.055 173.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 10.9 t -92.11 178.76 5.77 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.262 -1.014 . . . . 53.51 108.262 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -47.53 -69.89 0.11 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.532 0.733 . . . . 74.24 111.38 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 61.1 mtpt -132.74 80.87 60.35 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 109.477 -0.564 . . . . 71.53 109.477 174.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.9 Cg_endo -43.64 -83.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 125.277 3.985 . . . . 70.11 118.935 -172.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -138.28 157.96 71.68 Favored Pre-proline 0 C--N 1.32 -0.713 0 O-C-N 122.164 -0.335 . . . . 72.33 110.451 -173.076 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.27 136.77 45.02 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.501 2.134 . . . . 62.1 111.354 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.542 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -77.57 1.22 67.28 Favored Glycine 0 C--O 1.218 -0.878 0 CA-C-O 121.868 0.705 . . . . 41.11 112.006 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -77.04 -28.12 54.72 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.051 -0.575 . . . . 73.12 110.6 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.1 pt -98.67 8.63 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 120.691 -0.404 . . . . 72.31 112.011 -176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.431 HG13 HD11 ' A' ' 65' ' ' LEU . 7.7 p -95.39 138.27 21.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.106 0.479 . . . . 70.11 111.115 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.9 -56.06 3.23 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.461 -0.94 . . . . 71.22 108.461 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -145.91 174.31 11.37 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.232 1.013 . . . . 73.31 108.602 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -140.57 169.29 17.92 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.518 -0.473 . . . . 71.2 110.357 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.482 ' HB2' HG22 ' A' ' 40' ' ' VAL . 34.0 m80 -129.1 129.03 44.69 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.137 -2.171 . . . . 72.1 105.137 171.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -97.46 109.38 22.15 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 107.906 -1.146 . . . . 64.55 107.906 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.616 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.3 mm? -98.1 117.83 33.34 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.0 0.428 . . . . 63.04 111.342 -174.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.9 mt -124.93 -179.09 4.39 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.538 -0.912 . . . . 75.32 108.538 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 52.2 mt -71.11 -21.01 21.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.544 -0.91 . . . . 53.0 108.544 176.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -59.04 -32.88 70.15 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.983 -1.008 . . . . 71.24 109.834 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.3 -6.41 57.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.664 -0.698 . . . . 60.12 110.6 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.08 34.33 12.99 Favored Glycine 0 CA--C 1.498 -1.02 0 C-N-CA 121.108 -0.568 . . . . 33.44 112.246 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 46.3 t -123.08 145.95 48.12 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.649 -0.871 . . . . 71.34 108.649 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.607 ' O ' ' HD3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -79.79 -36.02 37.65 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.534 -0.543 . . . . 63.44 109.534 -177.524 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.7 p -98.04 103.89 19.71 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 121.132 0.491 . . . . 74.4 111.438 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 35' ' ' ARG . 92.7 Cg_endo -84.0 130.11 4.81 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 121.707 1.605 . . . . 62.44 111.588 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HA ' ' HG3' ' A' ' 53' ' ' PRO . . . -172.65 -179.78 2.23 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 124.212 1.005 . . . . 53.44 108.857 -177.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -119.04 130.03 74.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 120.228 -0.589 . . . . 71.45 110.077 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.777 HG12 ' SG ' ' A' ' 50' ' ' CYS . 4.4 m -89.26 130.94 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 108.186 -1.042 . . . . 65.11 108.186 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -98.32 114.82 27.26 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 109.633 -0.506 . . . . 74.05 109.633 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 86.2 m -84.34 102.19 12.52 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.203 -1.036 . . . . 63.13 108.203 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 51.5 p -72.03 169.93 14.93 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.488 -0.324 . . . . 64.02 111.31 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.67 -25.46 66.37 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.492 0.717 . . . . 75.32 112.334 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -83.27 -4.04 58.04 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.227 0.537 . . . . 71.02 110.89 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.13 16.13 56.35 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 120.802 -0.713 . . . . 61.33 112.319 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 36.1 mmt180 -99.64 130.24 45.85 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 112.521 0.563 . . . . 74.42 112.521 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -95.92 122.02 38.27 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.157 -0.928 . . . . 72.22 109.545 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.7 tm? -134.92 138.24 43.9 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.407 -1.701 . . . . 64.54 106.407 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.777 ' SG ' HG12 ' A' ' 40' ' ' VAL . 73.5 m -98.0 147.35 24.59 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 114.828 1.418 . . . . 73.44 114.828 -172.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.556 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -128.84 159.1 70.14 Favored Pre-proline 0 C--O 1.243 0.752 0 CA-C-N 115.227 -0.897 . . . . 63.35 110.999 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 55.6 Cg_endo -64.88 108.88 1.17 Allowed 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.185 2.59 . . . . 60.21 113.226 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HG3' ' HA ' ' A' ' 38' ' ' ALA . 64.1 Cg_endo -67.71 -9.8 26.67 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 C-N-CA 123.024 2.483 . . . . 74.15 114.054 -175.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.49 -22.69 17.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.932 0.396 . . . . 75.25 111.292 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -76.08 130.34 78.29 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 112.801 0.667 . . . . 74.14 112.801 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.38 -41.63 17.68 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.915 3.744 . . . . 64.54 114.809 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -63.3 -26.89 68.98 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 120.93 0.395 . . . . 74.41 110.897 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 62' ' ' ILE . 74.9 t -82.86 -42.39 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.93 -0.577 . . . . 71.0 111.869 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.305 0.2 OUTLIER -66.34 -30.88 71.37 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.929 1.085 . . . . 73.45 113.929 -174.477 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -61.32 -49.94 74.97 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.041 0.448 . . . . 72.15 110.672 176.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.542 HG21 ' HA3' ' A' ' 19' ' ' GLY . 10.7 pt -69.12 -31.63 50.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.904 -0.589 . . . . 74.03 112.173 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 58' ' ' VAL . 56.4 mt -59.13 -50.08 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 110.156 -0.312 . . . . 61.15 110.156 171.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 29.7 mm-40 -62.58 -36.78 83.78 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.14 0.495 . . . . 61.31 109.947 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 38.8 ttm180 -57.96 -48.25 80.51 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.7 -1.136 . . . . 53.32 110.817 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.431 HD11 HG13 ' A' ' 22' ' ' VAL . 82.8 mt -70.71 -30.39 66.94 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 116.543 -0.299 . . . . 64.24 110.699 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -55.86 -18.92 9.92 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 114.424 1.268 . . . . 75.22 114.424 177.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 15.4 ptm180 . . . . . 0 CA--C 1.55 0.961 0 CA-C-O 120.731 0.3 . . . . 55.45 110.643 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.67 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 74.6 m . . . . . 0 N--CA 1.402 -2.839 0 N-CA-C 110.381 -0.229 . . . . 62.31 110.381 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.429 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -107.1 -179.92 4.07 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.063 -0.655 . . . . 74.3 109.574 -176.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -118.13 -51.83 2.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.711 1.374 . . . . 74.02 114.711 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.6 p -153.21 136.3 15.59 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.142 -0.623 . . . . 72.32 111.615 -171.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -102.76 153.72 5.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 119.539 -0.864 . . . . 65.44 108.879 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.6 t -99.59 179.01 4.68 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.111 -0.699 . . . . 55.43 109.111 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -39.36 -51.52 2.07 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.591 1.157 . . . . 71.44 111.628 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 40.3 ttmt -159.55 94.53 1.7 Allowed Pre-proline 0 N--CA 1.427 -1.622 0 N-CA-C 108.254 -1.017 . . . . 70.45 108.254 171.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.6 Cg_endo -39.44 -82.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.738 3.625 . . . . 61.44 117.837 -173.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.421 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -143.72 161.4 46.58 Favored Pre-proline 0 N--CA 1.475 0.816 0 N-CA-C 109.452 -0.573 . . . . 64.43 109.452 -175.085 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.508 ' O ' HG12 ' A' ' 21' ' ' ILE . 19.5 Cg_endo -61.74 129.24 26.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.845 1.696 . . . . 72.44 110.443 172.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.532 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -74.0 2.19 43.9 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 114.79 0.676 . . . . 74.01 114.79 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -93.64 -9.4 38.09 Favored 'General case' 0 C--N 1.281 -2.383 0 O-C-N 121.953 -0.733 . . . . 73.3 112.298 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 18' ' ' PRO . 39.5 pt -96.89 0.58 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.508 0.67 . . . . 54.31 111.039 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.628 HG13 HD11 ' A' ' 65' ' ' LEU . 2.6 p -87.46 133.4 30.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.542 -0.753 . . . . 75.23 111.102 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.523 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -84.78 -53.76 5.13 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.882 -1.155 . . . . 71.14 107.882 -176.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.523 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 18.6 m120 -139.73 147.85 41.46 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-N 115.115 -0.948 . . . . 73.4 108.844 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.447 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 43.1 p90 -114.65 152.69 31.48 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.509 -0.922 . . . . 73.2 108.509 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.574 ' HB2' HG22 ' A' ' 40' ' ' VAL . 28.8 m170 -118.52 128.64 54.78 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.3 -1.741 . . . . 72.15 106.3 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -97.33 109.48 22.22 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.684 -0.858 . . . . 75.33 108.684 -175.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.67 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 2.4 mm? -103.11 122.09 43.96 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.318 -0.401 . . . . 61.23 110.115 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.7 mt -128.8 172.33 11.39 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.457 -0.338 . . . . 74.21 110.272 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.589 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 47.7 mt -77.72 -20.89 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.096 -1.446 . . . . 55.21 107.096 176.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -63.94 -27.12 68.93 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.212 -1.358 . . . . 71.11 109.165 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.53 -12.05 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.475 -0.784 . . . . 71.4 110.488 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.61 -47.31 1.03 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.187 -0.53 . . . . 54.32 114.316 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 71.0 m -62.48 137.55 58.28 Favored 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 112.366 0.506 . . . . 60.24 112.366 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -71.13 -20.19 62.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 73.43 111.874 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.05 106.91 58.53 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-O 121.203 0.525 . . . . 71.33 111.159 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -85.57 130.21 3.76 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.282 1.988 . . . . 65.12 111.655 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -171.72 153.5 3.38 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.867 -0.79 . . . . 74.32 108.867 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.04 131.72 46.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.201 -1.037 . . . . 73.11 108.201 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.574 HG22 ' HB2' ' A' ' 26' ' ' HIS . 16.8 m -98.99 129.78 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.798 0 C-N-CA 119.535 -0.866 . . . . 73.21 109.492 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -96.44 115.44 27.43 Favored 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 115.234 -0.894 . . . . 60.1 110.903 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 24' ' ' ASN . 53.2 m -85.74 105.13 16.05 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 123.786 0.679 . . . . 73.42 109.412 175.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.1 p -71.78 173.28 8.41 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.977 -0.556 . . . . 60.21 111.002 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.25 -28.39 69.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.373 0.606 . . . . 74.23 110.062 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -64.83 -32.99 74.95 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.252 -0.886 . . . . 73.24 110.321 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.26 -3.85 25.23 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 120.77 -0.729 . . . . 64.23 112.048 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 42' ' ' THR . 27.1 mmt180 -75.69 137.82 40.9 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 111.84 0.311 . . . . 73.24 111.84 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -103.95 112.51 25.51 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.875 -1.157 . . . . 64.14 107.875 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 24.0 tp -114.76 145.35 42.2 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.263 -0.575 . . . . 54.2 109.653 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.7 m -78.03 133.41 37.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.784 -0.45 . . . . 64.12 109.784 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.57 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -137.6 155.65 75.13 Favored Pre-proline 0 C--N 1.312 -1.065 0 N-CA-C 109.811 -0.44 . . . . 73.02 109.811 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 86.5 Cg_endo -71.24 111.32 3.06 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.993 2.462 . . . . 72.32 112.824 -175.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.9 Cg_endo -70.23 -12.45 32.03 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.691 2.261 . . . . 74.32 114.328 -173.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -113.08 9.73 18.63 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.531 0.567 . . . . 74.14 112.531 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 25.1 mm-40 -91.54 139.05 25.02 Favored Pre-proline 0 C--N 1.32 -0.683 0 O-C-N 122.313 -0.242 . . . . 71.13 110.999 176.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 83.3 Cg_exo -49.83 -43.16 42.06 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 124.086 3.191 . . . . 74.25 114.714 -175.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.5 ' O ' HG12 ' A' ' 61' ' ' ILE . 40.3 p-90 -62.92 -37.46 87.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.307 -0.557 . . . . 74.34 110.518 -177.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 62' ' ' ILE . 78.6 t -72.81 -43.67 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.707 -0.679 . . . . 63.03 110.602 178.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 43.7 mt-10 -53.07 -41.54 64.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.094 0.473 . . . . 73.13 110.88 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -72.97 -41.46 64.36 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.695 0.628 . . . . 75.34 112.695 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.532 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.7 pt -71.56 -32.69 46.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 112.561 0.578 . . . . 75.43 112.561 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.447 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 59.0 mt -57.69 -50.28 77.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.152 -0.684 . . . . 74.32 109.152 171.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 31.0 mm-40 -61.8 -40.93 96.96 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.925 -0.579 . . . . 71.13 110.423 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -54.33 -50.29 67.75 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.727 -0.67 . . . . 72.34 109.688 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.628 HD11 HG13 ' A' ' 22' ' ' VAL . 80.9 mt -70.1 -30.45 67.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.356 0.502 . . . . 53.41 112.356 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 48.5 mt-30 -71.85 -27.42 62.87 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.549 -0.86 . . . . 75.23 111.419 177.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 30.4 mmm180 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.748 0.309 . . . . 73.44 110.666 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.532 ' HA ' HD13 ' A' ' 28' ' ' LEU . 6.6 p . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 110.251 -0.277 . . . . 63.21 110.251 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.465 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -84.16 128.0 34.28 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.525 -0.87 . . . . 44.52 110.684 -171.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.604 ' H ' HD12 ' A' ' 10' ' ' LEU . 6.2 mp -43.96 -62.44 1.13 Allowed 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 125.367 1.467 . . . . 72.43 114.265 -175.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 p -173.01 143.42 1.16 Allowed 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 120.259 -0.576 . . . . 63.54 109.633 -172.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 13' ' ' THR . 1.1 m -99.48 152.58 4.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.009 -1.108 . . . . 63.11 108.009 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 12' ' ' VAL . 9.0 t -89.54 174.44 7.77 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.274 -1.38 . . . . 73.44 107.274 175.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -53.37 -39.65 64.35 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.273 0.488 . . . . 63.03 112.12 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -155.15 93.8 2.69 Favored Pre-proline 0 N--CA 1.429 -1.505 0 N-CA-C 108.733 -0.839 . . . . 71.11 108.733 170.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.644 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 11.8 Cg_endo -52.13 -82.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.268 3.312 . . . . 74.34 117.705 -175.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.419 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -138.6 162.4 53.32 Favored Pre-proline 0 C--N 1.321 -0.641 0 O-C-N 121.881 -0.512 . . . . 74.55 110.424 -173.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.61 ' O ' HG12 ' A' ' 21' ' ' ILE . 27.2 Cg_exo -63.97 132.15 33.46 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.877 1.718 . . . . 72.2 110.124 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.529 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -75.05 1.11 56.89 Favored Glycine 0 C--N 1.301 -1.382 0 N-CA-C 114.065 0.386 . . . . 50.25 114.065 -176.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -91.58 -2.38 57.14 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 122.483 -0.422 . . . . 74.32 110.88 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 18' ' ' PRO . 27.6 pt -107.1 6.76 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 120.313 -0.555 . . . . 61.35 110.819 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.491 HG21 ' CD1' ' A' ' 41' ' ' PHE . 5.4 p -93.77 140.69 16.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.02 -0.537 . . . . 73.25 111.453 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.41 -47.0 5.06 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.776 0.83 . . . . 75.21 109.441 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -143.9 163.64 32.82 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.749 -1.204 . . . . 71.15 107.749 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.77 165.52 27.85 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.233 0.47 . . . . 72.33 110.47 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.524 ' HB2' HG22 ' A' ' 40' ' ' VAL . 36.0 m80 -134.45 112.41 10.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.695 -1.224 . . . . 62.33 107.695 170.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -83.17 94.92 7.96 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.972 -1.122 . . . . 71.02 107.972 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.532 HD13 ' HA ' ' A' ' 8' ' ' CYS . 63.0 mt -94.63 137.41 33.78 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.635 -0.712 . . . . 70.23 111.428 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.42 ' H ' ' HB3' ' A' ' 32' ' ' ASP . 91.8 mt -142.05 169.67 17.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.035 -0.984 . . . . 72.33 110.861 -175.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -77.9 -29.61 15.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 107.17 -1.419 . . . . 73.24 107.17 171.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.88 -30.19 70.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.023 -0.99 . . . . 73.43 109.15 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' A' ' 29' ' ' LEU . 20.1 t70 -74.33 -32.87 62.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.199 -0.91 . . . . 74.31 108.805 173.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.63 88.61 1.6 Allowed Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.178 -0.919 . . . . 53.2 113.68 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.9 t 178.84 -175.5 0.21 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.429 -1.322 . . . . 64.54 107.429 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -89.5 -41.99 11.72 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.557 0.577 . . . . 74.11 112.557 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.05 115.95 42.79 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 113.085 0.772 . . . . 65.34 113.085 -176.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -83.07 130.68 5.67 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.838 2.359 . . . . 73.04 111.655 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.66 153.42 2.26 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.269 -1.011 . . . . 43.24 108.269 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.09 130.78 47.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.81 -1.181 . . . . 42.34 107.81 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' A' ' 26' ' ' HIS . 4.5 m -92.4 131.69 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.759 0 N-CA-C 108.254 -1.017 . . . . 75.31 108.254 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.491 ' CD1' HG21 ' A' ' 22' ' ' VAL . 10.3 m-85 -103.2 115.44 30.58 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 116.108 -0.496 . . . . 71.15 110.728 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.7 m -80.69 100.39 8.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.2 -1.408 . . . . 51.22 107.2 174.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 53.2 p -72.25 175.39 6.13 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.494 0.188 . . . . 72.12 111.042 -177.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 96.8 mt -61.02 -26.74 67.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.692 -0.485 . . . . 65.12 109.692 176.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.403 ' NE ' ' HA ' ' A' ' 45' ' ' ARG . 6.5 tpm_? -63.88 -27.01 68.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.373 1.069 . . . . 73.21 110.791 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.92 8.55 59.08 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.168 -0.539 . . . . 63.43 111.878 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.61 138.93 38.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.974 -1.491 . . . . 73.22 106.974 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -95.82 118.77 33.11 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.435 -0.58 . . . . 63.53 109.435 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.1 mp -111.21 149.22 31.28 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 111.785 0.291 . . . . 74.43 111.785 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.428 ' HB3' HG12 ' A' ' 12' ' ' VAL . 23.3 m -80.23 123.4 27.91 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.863 -0.608 . . . . 74.32 110.241 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.74 152.52 77.11 Favored Pre-proline 0 C--O 1.246 0.882 0 O-C-N 122.356 -0.215 . . . . 72.43 110.86 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.422 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 67.3 Cg_endo -67.39 114.12 3.14 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.005 2.47 . . . . 73.21 113.844 -173.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 -15.36 28.05 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.179 1.919 . . . . 75.5 112.154 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -103.82 8.57 37.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.094 -0.503 . . . . 62.44 112.309 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.77 129.28 26.12 Favored Pre-proline 0 C--N 1.315 -0.924 0 C-N-CA 119.88 -0.728 . . . . 70.41 111.654 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.405 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 83.0 Cg_exo -48.03 -36.5 28.03 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.289 3.326 . . . . 74.34 115.296 -177.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -62.32 -27.03 68.76 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 120.086 -0.646 . . . . 75.31 110.961 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 62' ' ' ILE . 67.7 t -79.69 -42.38 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 116.0 -0.546 . . . . 72.22 112.386 -178.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -63.46 -25.54 68.31 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.931 1.086 . . . . 72.32 113.931 -174.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -80.59 -41.24 24.33 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 116.468 -0.333 . . . . 74.25 111.073 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.529 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 10.8 pt -71.9 -31.08 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 111.932 0.345 . . . . 73.31 111.932 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 58' ' ' VAL . 61.4 mt -55.54 -41.38 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.209 -0.45 . . . . 61.14 109.961 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 76.4 mm-40 -61.3 -42.17 98.21 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.981 -0.554 . . . . 72.33 110.372 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -58.51 -43.85 89.26 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.896 -0.593 . . . . 71.13 110.244 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.421 HD11 ' CG1' ' A' ' 22' ' ' VAL . 85.9 mt -68.53 -39.13 81.28 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.819 -0.628 . . . . 64.32 111.623 178.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -64.47 -43.35 94.47 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.694 -0.402 . . . . 75.4 111.223 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 63' ' ' GLN . 70.2 mtp180 . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.18 0.514 . . . . 75.31 111.266 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' A' ' 28' ' ' LEU . 71.7 m . . . . . 0 N--CA 1.416 -2.148 0 N-CA-C 109.843 -0.428 . . . . 51.33 109.843 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.701 ' SG ' HG12 ' A' ' 40' ' ' VAL . 75.3 m -85.46 177.73 7.67 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.412 0.625 . . . . 74.44 111.709 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.44 -38.86 6.33 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 114.892 -1.049 . . . . 71.44 109.141 176.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.5 m -163.7 168.48 19.74 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 110.127 -0.323 . . . . 42.01 110.127 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.506 HG12 ' CB ' ' A' ' 50' ' ' CYS . 1.3 m -132.35 156.65 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 N-CA-C 104.481 -2.414 . . . . 62.23 104.481 172.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.8 t -96.9 178.02 5.43 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 108.192 -1.04 . . . . 74.11 108.192 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -50.65 -49.6 56.64 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.142 0.496 . . . . 74.2 111.103 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 37.0 ttpt -149.42 84.83 5.98 Favored Pre-proline 0 N--CA 1.421 -1.894 0 N-CA-C 108.976 -0.75 . . . . 54.41 108.976 175.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.2 Cg_endo -46.54 -81.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.786 3.658 . . . . 63.14 117.861 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -136.09 160.07 68.57 Favored Pre-proline 0 C--N 1.311 -1.091 0 O-C-N 121.857 -0.527 . . . . 60.14 110.612 -172.491 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.593 ' O ' HG12 ' A' ' 21' ' ' ILE . 19.6 Cg_endo -60.89 128.43 25.46 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.829 1.686 . . . . 74.45 109.791 173.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.541 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -73.72 1.72 44.12 Favored Glycine 0 C--O 1.209 -1.457 0 C-N-CA 120.98 -0.629 . . . . 31.13 114.554 -174.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -89.97 -1.54 57.99 Favored 'General case' 0 C--N 1.284 -2.276 0 O-C-N 122.198 -0.589 . . . . 71.42 111.367 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 18' ' ' PRO . 38.6 pt -104.01 7.29 10.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 120.788 -0.365 . . . . 72.24 110.959 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.559 HG13 HD11 ' A' ' 65' ' ' LEU . 3.2 p -90.93 131.68 37.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.576 0.703 . . . . 64.21 112.55 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -85.44 -55.06 4.2 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.798 -1.092 . . . . 63.34 108.124 -175.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -143.42 158.66 43.46 Favored 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 123.922 0.889 . . . . 73.33 109.099 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -132.43 163.27 29.12 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.84 -0.43 . . . . 73.45 109.84 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.475 ' HB2' HG22 ' A' ' 40' ' ' VAL . 34.0 m170 -135.01 136.91 42.49 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.289 -1.374 . . . . 73.24 107.289 174.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.409 ' CE2' HD21 ' A' ' 29' ' ' LEU . 5.4 t80 -100.1 105.9 17.58 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.103 0.478 . . . . 64.35 109.723 -175.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.543 HD12 ' SG ' ' A' ' 8' ' ' CYS . 1.8 mm? -97.43 124.08 41.49 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 123.803 0.841 . . . . 64.32 109.529 -176.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.409 HD21 ' CE2' ' A' ' 27' ' ' TYR . 87.6 mt -121.9 176.36 5.81 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.813 -0.44 . . . . 52.54 109.813 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 45.4 mt -73.3 -17.36 17.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 121.992 0.901 . . . . 73.23 108.935 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -65.17 -28.88 69.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.587 -1.188 . . . . 71.33 109.347 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -76.86 -4.22 42.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.504 -0.771 . . . . 62.54 111.08 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.9 -9.37 59.99 Favored Glycine 0 CA--C 1.503 -0.692 0 CA-C-N 116.122 -0.49 . . . . 41.32 113.044 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.715 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 63.0 m -94.67 123.53 38.16 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.526 -0.916 . . . . 72.04 108.526 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.678 ' H ' ' HD2' ' A' ' 35' ' ' ARG 0.313 0.0 OUTLIER -77.67 1.89 18.47 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.968 1.099 . . . . 72.02 113.968 -176.15 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.8 p -109.62 98.22 31.75 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.053 -0.721 . . . . 73.42 109.053 171.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.12 129.86 9.03 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 121.627 1.551 . . . . 71.04 110.29 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 50' ' ' CYS . . . -166.13 160.44 16.28 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.226 -0.443 . . . . 71.23 110.734 -174.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.37 123.15 66.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 109.083 -0.71 . . . . 73.44 109.083 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.701 HG12 ' SG ' ' A' ' 9' ' ' CYS . 9.2 m -80.34 125.64 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 C-N-CA 119.736 -0.786 . . . . 73.42 109.191 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -97.85 109.01 21.85 Favored 'General case' 0 C--N 1.267 -3.02 0 CA-C-N 115.672 -0.695 . . . . 64.42 109.487 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.4 m -82.42 103.72 12.18 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.477 -1.305 . . . . 61.23 107.477 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 64.8 p -69.94 167.12 18.12 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 120.895 -0.322 . . . . 61.52 111.084 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 94.9 mt -59.99 -30.74 69.33 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.093 0.557 . . . . 51.54 110.698 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -70.91 -18.23 62.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.313 -0.858 . . . . 75.33 110.109 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.57 16.6 26.26 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.881 -0.676 . . . . 75.21 113.22 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -99.8 126.05 45.82 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.95 0.375 . . . . 73.41 111.282 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -85.92 127.04 34.52 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.126 -0.694 . . . . 55.3 109.126 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.7 tp -147.67 131.03 16.59 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.229 -1.026 . . . . 74.43 108.229 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.593 ' SG ' HG12 ' A' ' 40' ' ' VAL . 55.8 m -86.78 155.17 20.42 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 114.877 1.436 . . . . 73.32 114.877 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.556 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -130.55 162.34 55.37 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-N 114.217 -1.356 . . . . 63.43 108.453 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.477 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 58.0 Cg_endo -68.67 107.52 1.67 Allowed 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 121.69 1.594 . . . . 71.34 111.617 -177.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 59.6 Cg_endo -68.15 -12.46 35.16 Favored 'Trans proline' 0 N--CA 1.481 0.74 0 C-N-CA 123.171 2.58 . . . . 61.24 114.408 -170.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -96.07 -22.52 17.29 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.141 0.496 . . . . 73.3 110.733 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 15.5 mm100 -73.84 138.7 76.6 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 112.902 0.705 . . . . 71.22 112.902 -174.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 87.7 Cg_exo -50.54 -36.79 50.73 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.321 3.348 . . . . 73.11 115.037 -177.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.481 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 34.7 p-90 -68.18 -28.0 66.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 119.863 -0.735 . . . . 64.42 110.673 -177.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 62' ' ' ILE . 73.9 t -79.77 -41.42 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 116.125 -0.489 . . . . 65.23 111.747 -177.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.569 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 11.7 pt-20 -60.74 -37.52 82.04 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.23 -0.588 . . . . 73.03 112.033 -177.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -62.21 -43.92 97.74 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.062 0.458 . . . . 72.02 111.731 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.541 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 8.5 pt -74.06 -32.49 33.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 116.052 -0.522 . . . . 70.22 111.841 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 58' ' ' VAL . 58.5 mt -60.74 -51.09 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.669 -0.493 . . . . 74.12 109.669 172.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 14.2 mm100 -59.56 -38.0 79.97 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.324 -0.398 . . . . 54.34 110.904 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.441 ' HG3' ' NH2' ' A' ' 67' ' ' ARG . 35.5 ttt180 -57.66 -47.41 82.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.865 -0.607 . . . . 72.14 110.558 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.559 HD11 HG13 ' A' ' 22' ' ' VAL . 86.8 mt -71.17 -30.16 66.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.885 0.374 . . . . 75.45 110.892 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -67.49 -22.56 65.45 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 113.037 0.754 . . . . 74.53 113.037 177.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.441 ' NH2' ' HG3' ' A' ' 64' ' ' ARG . 26.2 mtm180 . . . . . 0 C--N 1.318 -0.77 0 CA-C-O 121.41 0.624 . . . . 64.31 109.473 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.923 0 N-CA-C 110.288 -1.125 . . . . 64.14 110.288 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 t -98.09 127.58 44.12 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.681 -0.859 . . . . 70.14 108.681 176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 53.59 84.11 0.06 Allowed 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.91 0.884 . . . . 63.24 111.106 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -95.55 107.07 19.22 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.717 -0.475 . . . . 55.15 109.717 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.98 -4.7 55.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.805 -0.634 . . . . 73.5 111.27 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -131.88 164.97 24.91 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.336 -0.847 . . . . 73.12 109.104 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -96.37 -21.55 17.71 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 112.561 0.578 . . . . 71.3 112.561 -174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.5 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 25.7 p -99.5 175.11 5.95 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.821 -0.752 . . . . 72.05 112.959 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.39 -171.04 3.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.966 -0.561 . . . . 53.21 109.659 -175.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -96.28 -64.02 1.09 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.06 -0.348 . . . . 70.24 110.06 -176.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -175.03 153.39 1.63 Allowed 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.307 -1.368 . . . . 54.25 107.307 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.96 150.53 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 C-N-CA 119.862 -0.735 . . . . 62.51 109.59 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.0 t -91.74 177.65 6.14 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.286 -1.005 . . . . 73.5 108.286 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -44.87 -63.49 0.91 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.388 0.675 . . . . 72.31 110.912 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 86.4 tttt -142.55 91.91 7.41 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 106.9 -1.518 . . . . 72.13 106.9 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.625 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.0 Cg_endo -46.98 -87.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.507 3.472 . . . . 45.13 118.321 -172.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.555 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -131.59 160.87 65.47 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 109.628 -0.508 . . . . 72.24 109.628 -173.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.508 ' O ' HG12 ' A' ' 21' ' ' ILE . 51.2 Cg_exo -60.16 128.41 26.33 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.181 1.921 . . . . 72.45 110.719 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.514 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -76.24 -0.88 67.49 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 116.023 -0.535 . . . . 72.32 113.454 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -95.67 -3.75 45.54 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 113.149 0.796 . . . . 74.13 113.149 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 18' ' ' PRO . 40.8 pt -103.74 9.79 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.539 0.685 . . . . 51.41 110.538 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.538 HG13 HD11 ' A' ' 65' ' ' LEU . 3.3 p -93.96 132.42 38.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.683 -0.689 . . . . 70.11 111.794 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.556 ' NE ' ' HA ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -84.32 -47.99 10.17 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.657 1.183 . . . . 74.33 111.479 179.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -150.39 156.57 41.75 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.6 -0.889 . . . . 64.45 108.6 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 34.9 p90 -129.14 159.98 34.32 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.016 0.436 . . . . 62.45 109.896 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.654 ' HB2' HG22 ' A' ' 40' ' ' VAL . 3.7 m170 -127.16 125.67 41.55 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 104.907 -2.257 . . . . 74.31 104.907 175.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -95.88 100.61 12.29 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.981 -0.377 . . . . 73.03 109.981 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.4 mm? -97.99 120.28 38.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.066 0.546 . . . . 54.01 111.375 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.7 mt -130.0 176.03 8.4 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.069 0.461 . . . . 72.41 110.719 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.6 mt -73.52 -22.13 18.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.268 -1.012 . . . . 72.23 108.268 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -58.38 -42.59 87.37 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.623 -1.171 . . . . 64.11 108.781 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.79 -48.03 60.66 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.984 -1.007 . . . . 75.44 108.586 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.74 87.85 0.4 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 115.104 -0.953 . . . . 50.01 112.469 175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 46.9 t -171.12 161.93 6.89 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.928 -1.138 . . . . 53.43 107.928 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -87.54 -25.92 23.41 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 120.928 0.394 . . . . 41.13 110.388 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.6 109.2 58.09 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-O 121.123 0.487 . . . . 62.05 111.371 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -81.86 129.73 6.38 Favored 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 121.401 1.401 . . . . 72.44 109.752 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.521 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -166.49 147.76 6.36 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.164 -0.471 . . . . 75.14 110.091 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.33 128.24 51.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 107.577 -1.268 . . . . 64.55 107.577 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.654 HG22 ' HB2' ' A' ' 26' ' ' HIS . 11.9 m -93.37 129.71 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 C-N-CA 119.42 -0.912 . . . . 71.55 109.378 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 14.7 m-85 -99.76 113.47 25.99 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.419 -0.81 . . . . 70.55 111.312 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 99.4 m -83.03 104.49 13.28 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.383 -0.969 . . . . 72.14 108.383 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 66.5 p -72.64 178.47 4.1 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 112.321 0.489 . . . . 61.13 112.321 -175.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.486 HD23 ' HG2' ' A' ' 23' ' ' ARG . 77.0 mt -60.69 -31.74 70.98 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 123.807 0.843 . . . . 70.15 110.947 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -75.93 -14.55 60.25 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.711 -0.677 . . . . 70.21 111.01 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.66 16.2 43.38 Favored Glycine 0 CA--C 1.506 -0.471 0 C-N-CA 120.571 -0.823 . . . . 44.43 112.243 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -100.54 130.49 46.61 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 110.379 -0.23 . . . . 74.42 110.379 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -95.67 144.03 26.43 Favored 'General case' 0 N--CA 1.426 -1.649 0 C-N-CA 120.173 -0.611 . . . . 75.11 111.412 175.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.538 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -139.42 146.33 39.99 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.445 -1.317 . . . . 63.52 107.445 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.538 ' N ' HD13 ' A' ' 49' ' ' LEU . 3.7 m -80.71 126.19 30.98 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.148 0.28 . . . . 60.23 110.286 -175.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.625 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.12 156.27 74.73 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 122.016 -0.427 . . . . 41.33 110.877 175.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.497 ' HG3' ' OE1' ' A' ' 55' ' ' GLN . 90.3 Cg_endo -72.93 116.8 4.85 Favored 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.758 2.305 . . . . 73.43 113.961 -172.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.521 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.6 Cg_endo -74.38 -9.74 21.82 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.255 1.97 . . . . 65.45 112.57 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -89.94 -38.04 13.95 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.915 -0.314 . . . . 74.24 111.192 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.497 ' OE1' ' HG3' ' A' ' 52' ' ' PRO . 52.0 mt-30 -63.99 137.73 97.19 Favored Pre-proline 0 C--O 1.239 0.523 0 N-CA-C 113.535 0.939 . . . . 74.15 113.535 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 68.5 Cg_exo -57.27 -34.53 98.0 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 123.9 3.067 . . . . 53.55 114.245 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -61.02 -31.95 71.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.246 0.546 . . . . 73.02 110.579 -176.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 62' ' ' ILE . 70.9 t -76.65 -38.85 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 115.434 -0.803 . . . . 71.31 111.641 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.593 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.303 0.2 OUTLIER -66.83 -24.65 66.18 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 113.815 1.042 . . . . 41.55 113.815 -175.63 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -74.22 -50.77 17.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.037 0.446 . . . . 75.34 111.345 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.514 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 10.4 pt -64.15 -32.2 56.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 112.567 0.58 . . . . 64.2 112.567 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 58' ' ' VAL . 58.8 mt -58.09 -47.1 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.375 -0.375 . . . . 63.24 110.195 172.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 85.5 mm-40 -58.71 -42.59 89.0 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.169 -0.469 . . . . 53.02 110.809 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -59.59 -46.32 89.29 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.583 -0.735 . . . . 74.44 110.593 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.538 HD11 HG13 ' A' ' 22' ' ' VAL . 89.3 mt -69.92 -34.92 74.12 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.658 -0.417 . . . . 74.32 111.24 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 27.3 mt-30 -61.88 -46.09 90.9 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 121.059 -0.256 . . . . 74.54 111.225 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -73.12 -24.12 60.58 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 113.542 0.942 . . . . 54.13 113.542 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.1 p -84.65 -34.51 23.03 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.056 -0.657 . . . . 64.42 111.717 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.9 p -76.09 -28.16 57.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.949 -0.569 . . . . 61.02 110.63 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.76 -18.48 43.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.072 0.949 . . . . 64.53 111.712 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -63.69 -27.22 69.07 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.937 -0.764 . . . . 63.32 108.937 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.7 tpt -106.42 98.65 8.3 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.125 -1.435 . . . . 71.34 107.125 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -81.24 -24.84 37.1 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.058 -0.519 . . . . 74.03 111.395 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -80.24 111.92 17.07 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.54 -0.541 . . . . 74.13 109.54 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -122.02 112.0 17.73 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 120.91 0.386 . . . . 72.45 110.948 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.5 m -96.87 -24.23 15.97 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.113 -0.494 . . . . 43.23 110.175 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.5 m . . . . . 0 C--O 1.25 1.126 0 CA-C-O 119.026 -0.511 . . . . 65.01 109.822 177.509 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 CA-C-O 121.04 0.244 . . . . 63.25 112.582 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 57.7 m -148.8 -69.65 0.21 Allowed 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 107.461 -1.311 . . . . 74.45 107.461 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -104.9 108.77 20.45 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.649 -0.871 . . . . 73.55 108.649 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.51 ' HB3' ' OE1' ' A' ' 6' ' ' GLU . 11.7 m-20 -129.21 162.81 26.98 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.804 -0.635 . . . . 71.03 110.674 -175.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.59 -26.0 24.67 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.248 1.023 . . . . 73.22 109.916 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' OE1' ' HB3' ' A' ' 4' ' ' ASP . 1.1 pm0 -85.02 133.16 34.25 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 113.772 -1.558 . . . . 73.35 109.518 175.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -98.2 88.87 4.31 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 121.94 0.876 . . . . 75.14 110.205 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 47.7 t -154.92 -168.5 2.91 Favored 'General case' 0 C--N 1.265 -3.077 0 N-CA-C 106.602 -1.629 . . . . 74.44 106.602 176.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 10' ' ' LEU . 40.4 t -117.33 177.25 4.8 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 119.848 -0.741 . . . . 74.12 110.415 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 2.5 mm? -95.85 -54.2 3.42 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.913 -1.143 . . . . 75.15 107.913 175.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.8 p -178.05 164.17 1.81 Allowed 'General case' 0 C--O 1.251 1.141 0 N-CA-C 109.304 -0.628 . . . . 74.3 109.304 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 13' ' ' THR . 2.0 m -109.46 163.22 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 N-CA-C 105.723 -1.955 . . . . 74.53 105.723 174.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 12' ' ' VAL . 9.7 t -102.84 177.15 4.93 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.689 -1.226 . . . . 64.34 107.689 175.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -50.64 -49.17 57.54 Favored 'General case' 0 C--O 1.241 0.613 0 O-C-N 123.222 0.326 . . . . 75.43 110.761 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.486 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 41.1 ttmt -144.91 97.65 4.87 Favored Pre-proline 0 N--CA 1.433 -1.314 0 N-CA-C 109.943 -0.392 . . . . 74.14 109.943 167.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 3.2 Cg_endo -48.65 -69.66 0.07 OUTLIER 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.955 3.103 . . . . 52.11 115.669 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.406 HG23 HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -150.58 165.41 17.47 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 109.754 -0.462 . . . . 72.33 109.754 -176.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.537 ' O ' HG12 ' A' ' 21' ' ' ILE . 42.9 Cg_exo -61.15 128.83 26.35 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.966 1.778 . . . . 50.04 109.061 171.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.502 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -74.66 1.2 53.78 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 115.761 1.064 . . . . 71.34 115.761 -172.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.64 -1.22 38.59 Favored 'General case' 0 C--N 1.287 -2.136 0 O-C-N 121.826 -0.808 . . . . 75.2 112.689 176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 38.1 pt -98.21 7.06 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 121.57 0.7 . . . . 71.4 109.885 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.513 HG13 HD11 ' A' ' 65' ' ' LEU . 3.5 p -92.18 138.3 20.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.564 -0.744 . . . . 61.15 111.421 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.46 -56.79 2.9 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.921 -1.036 . . . . 71.23 109.205 -173.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -139.92 173.6 11.36 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.473 -0.936 . . . . 73.5 108.473 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -149.68 165.66 31.7 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 120.632 -0.427 . . . . 71.24 110.513 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.466 ' HB2' HG22 ' A' ' 40' ' ' VAL . 39.4 m170 -128.02 116.18 19.63 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.114 -1.439 . . . . 70.24 107.114 170.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -88.23 120.61 29.75 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.393 -0.595 . . . . 72.25 109.393 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 7.5 tt -132.5 133.78 44.21 Favored 'General case' 0 N--CA 1.407 -2.608 0 O-C-N 123.366 0.417 . . . . 55.1 110.281 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.46 HD12 ' HE3' ' A' ' 31' ' ' LYS . 80.8 mt -131.33 -173.3 3.07 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.309 -0.997 . . . . 73.22 108.309 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 59.0 mt -68.53 -29.0 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.569 -0.53 . . . . 60.11 109.569 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 32' ' ' ASP 0.263 0.0 OUTLIER -64.72 -20.44 66.33 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.226 0.824 . . . . 72.13 113.226 176.168 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.463 ' N ' ' HD2' ' A' ' 31' ' ' LYS . 7.5 m-20 -80.82 -8.8 59.8 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.433 0.635 . . . . 75.42 109.644 174.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.71 79.13 1.39 Allowed Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 115.281 -0.872 . . . . 74.25 113.593 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 47.4 t -178.82 148.51 0.42 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.215 -1.402 . . . . 63.01 107.215 175.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -73.26 -31.03 63.86 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.508 0.559 . . . . 61.52 112.508 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.3 p -101.48 106.57 46.75 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-O 121.32 0.581 . . . . 70.42 111.519 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.55 129.43 4.25 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.107 1.871 . . . . 73.44 110.836 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 50' ' ' CYS . . . -165.73 145.96 6.66 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.991 -0.549 . . . . 64.01 110.122 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.51 125.47 53.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.402 -0.962 . . . . 71.25 108.402 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.658 HG12 ' SG ' ' A' ' 50' ' ' CYS . 5.3 m -88.73 124.78 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.247 0 C-N-CA 119.409 -0.916 . . . . 75.11 109.537 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 10.6 m-85 -96.32 121.76 38.46 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 115.287 -0.87 . . . . 75.42 111.353 178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.9 m -87.7 105.79 17.6 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.577 -1.268 . . . . 70.53 107.577 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 61.4 p -74.81 172.76 11.61 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.735 -0.211 . . . . 75.14 110.959 -176.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 88.4 mt -63.98 -25.71 68.25 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.437 0.637 . . . . 61.1 109.74 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -61.02 -33.74 73.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.71 -1.132 . . . . 72.12 109.953 174.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.3 -0.14 40.63 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.643 -0.708 . . . . 54.33 111.857 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -95.44 153.19 17.82 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.06 -1.089 . . . . 72.12 108.06 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 41.4 mt-30 -110.5 138.79 46.42 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.482 -0.562 . . . . 65.14 109.482 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.406 HD23 HG23 ' A' ' 17' ' ' ILE . 47.1 tp -139.75 132.56 29.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.116 -1.068 . . . . 73.31 108.116 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.658 ' SG ' HG12 ' A' ' 40' ' ' VAL . 9.8 m -82.08 142.95 31.85 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 120.175 -0.61 . . . . 64.31 112.166 -174.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.58 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.78 158.35 68.48 Favored Pre-proline 0 N--CA 1.438 -1.054 0 CA-C-N 115.465 -0.789 . . . . 42.01 110.144 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.484 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 88.3 Cg_endo -73.69 109.59 2.89 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.495 2.13 . . . . 71.34 113.281 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 52' ' ' PRO . 14.6 Cg_exo -69.45 -11.24 30.81 Favored 'Trans proline' 0 N--CA 1.482 0.799 0 C-N-CA 122.697 2.265 . . . . 70.55 112.594 -176.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -95.61 -5.8 41.68 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.479 -0.782 . . . . 74.42 111.21 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.3 mm100 -98.06 128.69 32.91 Favored Pre-proline 0 N--CA 1.443 -0.805 0 C-N-CA 120.548 -0.461 . . . . 73.23 111.407 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.23 -34.0 23.27 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 124.28 3.32 . . . . 74.15 115.449 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -62.85 -33.32 75.01 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.135 -0.626 . . . . 74.04 109.988 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 62' ' ' ILE . 89.7 t -77.53 -40.16 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.709 -0.678 . . . . 73.33 110.275 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.04 -27.3 69.31 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.133 0.492 . . . . 72.4 111.422 -178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -72.03 -44.01 64.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.706 -0.679 . . . . 71.2 110.575 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.502 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 16.5 pt -80.32 -30.65 12.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.396 0.888 . . . . 72.33 113.396 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 58' ' ' VAL . 65.2 mt -55.34 -44.84 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 110.389 -0.226 . . . . 72.42 110.389 174.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -60.02 -40.91 90.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.079 0.466 . . . . 74.31 110.105 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -58.86 -42.05 88.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.258 -0.883 . . . . 75.24 109.814 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.513 HD11 HG13 ' A' ' 22' ' ' VAL . 82.4 mt -76.25 -35.97 58.72 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.446 0.536 . . . . 71.43 112.446 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 90.7 mt-30 -64.72 -25.75 68.07 Favored 'General case' 0 C--O 1.205 -1.278 0 C-N-CA 120.467 -0.493 . . . . 72.22 111.836 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.59 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -84.78 -34.96 22.69 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.073 -0.651 . . . . 71.1 111.421 176.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.9 p -85.35 -36.44 20.76 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 114.439 1.274 . . . . 60.23 114.439 -175.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.3 t -86.54 -39.8 15.86 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.922 -0.581 . . . . 74.44 111.123 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 66' ' ' GLN . . . -72.78 -45.27 59.47 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 116.239 -0.437 . . . . 62.25 110.467 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -116.48 92.15 3.8 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.83 -1.174 . . . . 54.02 107.83 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -37.24 103.05 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 127.461 2.304 . . . . 75.35 115.961 -168.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -133.52 97.74 4.02 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.074 -1.421 . . . . 65.23 109.364 172.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -138.94 172.49 12.77 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.452 -0.795 . . . . 71.14 109.761 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -142.04 -148.99 0.25 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.141 -1.429 . . . . 73.4 107.141 -172.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.7 p -54.3 -34.32 60.69 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 121.762 0.791 . . . . 62.54 109.472 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.418 -2.063 0 N-CA-C 106.458 -1.682 . . . . 62.22 106.458 172.56 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.173 0 N-CA-C 110.323 -1.111 . . . . 73.53 110.323 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 6' ' ' GLU . 69.2 m -83.93 145.17 28.72 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.079 -1.082 . . . . 73.21 108.079 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -58.82 151.4 21.51 Favored 'General case' 0 C--O 1.251 1.145 0 O-C-N 123.062 0.226 . . . . 60.44 110.915 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 5' ' ' ALA . 19.1 t70 74.98 -158.25 0.06 Allowed 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.536 1.134 . . . . 64.53 108.182 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.409 ' H ' ' CG ' ' A' ' 4' ' ' ASP . . . -79.62 -3.55 47.63 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 121.491 -0.756 . . . . 73.32 111.581 -177.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.496 ' HB3' ' HB ' ' A' ' 2' ' ' THR 0.332 11.8 pt-20 50.86 77.61 0.12 Allowed 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 126.657 1.983 . . . . 64.3 115.819 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -103.25 -17.93 15.11 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 114.211 -1.359 . . . . 74.45 108.811 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.461 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 73.0 m -80.85 140.91 35.13 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 106.922 -1.51 . . . . 71.23 106.922 174.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.468 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -95.06 175.61 6.56 Favored 'General case' 0 C--N 1.288 -2.093 0 C-N-CA 119.94 -0.704 . . . . 72.23 112.705 -169.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 tt -88.2 -66.11 0.95 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.643 -0.873 . . . . 64.14 108.643 -177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -175.92 153.12 1.3 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 107.778 -1.193 . . . . 63.12 107.778 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 13' ' ' THR . 1.4 m -98.79 160.82 3.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 119.126 -1.03 . . . . 73.51 109.506 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 12' ' ' VAL . 7.1 t -101.38 173.19 6.55 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 106.56 -1.644 . . . . 70.35 106.56 174.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -43.8 -59.43 2.24 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.528 0.518 . . . . 53.45 111.373 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 40.8 ttmt -143.09 94.15 6.4 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 109.753 -0.462 . . . . 75.31 109.753 173.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.614 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.7 Cg_endo -52.99 -85.61 0.01 OUTLIER 'Trans proline' 0 CA--C 1.556 1.617 0 C-N-CA 124.138 3.226 . . . . 52.2 117.58 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.406 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER -145.04 149.46 42.26 Favored Pre-proline 0 C--O 1.207 -1.161 0 O-C-N 121.73 -0.606 . . . . 73.13 110.4 -174.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.22 144.97 99.07 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.54 2.16 . . . . 72.14 112.29 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.426 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -80.16 1.75 79.06 Favored Glycine 0 CA--C 1.502 -0.743 0 CA-C-N 115.848 -0.614 . . . . 54.41 112.748 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -80.13 -23.2 41.32 Favored 'General case' 0 N--CA 1.408 -2.565 0 CA-C-O 121.04 0.447 . . . . 72.41 110.553 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.434 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 37.3 pt -101.89 13.01 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.879 -0.513 . . . . 75.51 111.78 -177.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 19' ' ' GLY . 6.5 p -98.82 137.7 25.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.511 0.672 . . . . 63.31 111.908 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -89.45 -54.46 4.08 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.43 1.092 . . . . 73.33 108.588 -175.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -139.33 164.02 30.95 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.393 -0.965 . . . . 71.32 108.393 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -140.84 160.5 39.93 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.594 -0.521 . . . . 72.41 109.594 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.487 ' HB2' HG22 ' A' ' 40' ' ' VAL . 38.5 m80 -135.81 127.06 28.25 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.368 -1.345 . . . . 74.45 107.368 173.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -92.67 122.38 35.02 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.488 -0.93 . . . . 75.33 108.488 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.4 mm? -116.18 126.24 53.39 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 120.861 0.362 . . . . 72.4 111.651 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.7 mt -129.26 172.84 11.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.165 -1.05 . . . . 64.03 108.165 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 35' ' ' ARG . 32.0 mt -74.63 -18.11 16.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.827 -1.175 . . . . 65.31 107.827 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -61.7 -32.8 73.03 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 114.93 -1.032 . . . . 72.42 109.455 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.27 -38.99 71.84 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 116.001 -0.545 . . . . 73.42 109.562 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.1 -50.93 0.54 Allowed Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 115.507 -0.77 . . . . 44.52 112.765 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 71.1 m -67.43 132.73 48.21 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.835 0.35 . . . . 44.41 110.888 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.471 ' HA ' HG12 ' A' ' 30' ' ' ILE . 86.7 mtt180 -80.48 22.77 0.54 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 113.03 0.752 . . . . 70.14 113.03 -175.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -126.77 96.03 36.12 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 108.908 -0.775 . . . . 74.34 108.908 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -85.24 129.65 3.84 Favored 'Trans proline' 0 N--CA 1.443 -1.441 0 C-N-CA 121.902 1.734 . . . . 75.33 112.354 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.551 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -174.77 166.34 3.7 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.087 -0.961 . . . . 74.33 108.696 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 p -108.85 130.95 60.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.555 -1.276 . . . . 53.51 107.555 174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 26' ' ' HIS . 6.8 m -96.3 128.08 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.83 0 C-N-CA 119.576 -0.849 . . . . 71.4 109.583 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 28.8 m-85 -99.65 121.51 41.32 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.592 -0.731 . . . . 73.53 110.839 177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.3 m -85.93 97.99 10.55 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.137 -1.431 . . . . 74.33 107.137 175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.6 p -70.14 169.74 12.94 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.65 -0.25 . . . . 63.35 111.053 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 91.2 mt -60.33 -26.84 66.87 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.352 0.596 . . . . 62.41 109.87 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -61.58 -28.87 69.66 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.438 1.095 . . . . 74.11 110.678 175.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.34 9.32 58.03 Favored Glycine 0 C--N 1.332 0.316 0 N-CA-C 111.834 -0.506 . . . . 75.45 111.834 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -103.76 136.21 43.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.708 -1.59 . . . . 74.11 106.708 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 27.6 mt-30 -92.19 130.5 37.89 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 121.122 -0.231 . . . . 71.22 110.413 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 7.2 mp -119.62 147.08 44.95 Favored 'General case' 0 CA--C 1.475 -1.909 0 CA-C-N 116.406 -0.361 . . . . 73.52 111.0 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.407 ' HB3' HG12 ' A' ' 12' ' ' VAL . 5.1 m -86.1 125.24 33.32 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 115.075 -0.966 . . . . 72.03 109.18 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.614 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.41 152.45 76.4 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 118.016 0.371 . . . . 43.23 111.736 176.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.09 108.14 2.26 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.329 2.686 . . . . 71.2 114.243 -174.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 40.9 Cg_endo -67.95 -13.54 38.62 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.489 2.126 . . . . 65.44 111.245 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -77.67 -27.71 50.94 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.574 -1.194 . . . . 44.41 111.687 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 30.3 mm-40 -85.99 142.06 36.01 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 113.513 0.931 . . . . 65.12 113.513 -173.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 40.0 Cg_exo -58.22 -38.07 92.67 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.603 2.869 . . . . 62.31 113.451 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.422 ' O ' HG12 ' A' ' 61' ' ' ILE . 39.4 p-90 -63.44 -27.73 69.49 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.961 0.41 . . . . 74.44 110.304 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.554 ' O ' HG13 ' A' ' 62' ' ' ILE . 53.1 t -78.97 -46.89 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 116.0 -0.545 . . . . 71.22 111.756 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -25.37 67.09 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 119.549 -0.86 . . . . 74.11 109.719 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -59.65 -56.35 22.93 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.51 -1.223 . . . . 74.55 108.895 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.426 HG21 ' HA3' ' A' ' 19' ' ' GLY . 12.0 pt -74.55 -32.21 29.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.967 -1.015 . . . . 63.34 113.598 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 58' ' ' VAL . 64.1 mt -54.95 -55.74 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 123.254 0.347 . . . . 71.24 111.178 176.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -63.54 -38.9 92.91 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 112.42 0.526 . . . . 62.32 112.42 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -62.17 -42.47 99.3 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 115.667 -0.697 . . . . 65.11 112.021 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 tt -72.94 -31.72 64.78 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 109.179 -0.674 . . . . 74.11 109.179 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.536 HE21 HG22 ' A' ' 62' ' ' ILE . 79.9 mt-30 -48.87 -39.6 26.41 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 120.812 0.339 . . . . 72.44 111.383 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -61.97 -37.47 84.91 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.784 -0.644 . . . . 73.44 112.286 -177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.8 t -85.97 -25.81 25.82 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.587 -0.845 . . . . 74.42 110.419 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.3 t -75.77 -25.54 56.55 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.446 -0.797 . . . . 73.01 110.578 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.94 -20.1 63.35 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.432 0.634 . . . . 54.41 110.078 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.47 175.54 5.43 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 108.735 -0.839 . . . . 54.33 108.735 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.0 ptp -128.15 146.56 50.67 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.684 -0.407 . . . . 71.21 110.345 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -72.84 -26.03 61.33 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.777 0.799 . . . . 73.43 109.757 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -91.41 102.49 15.17 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.314 -0.857 . . . . 71.32 109.19 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 66.79 93.57 0.07 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.753 0.821 . . . . 73.21 111.007 -176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.0 m -107.53 143.76 35.49 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.505 -0.771 . . . . 65.13 110.247 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.438 -1.053 0 N-CA-C 109.099 -0.704 . . . . 60.44 109.099 177.478 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.684 0 N-CA-C 110.54 -1.024 . . . . 44.42 110.54 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.3 m -96.43 97.05 9.14 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.63 -0.878 . . . . 74.53 108.63 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -136.3 99.11 4.01 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 115.847 -0.615 . . . . 63.25 110.257 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -158.78 176.78 11.93 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.889 -1.152 . . . . 72.34 107.889 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 9' ' ' CYS . . . -72.41 -23.29 61.07 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 113.468 0.914 . . . . 45.51 113.468 -176.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 65.16 -67.5 0.12 Allowed 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 125.875 1.67 . . . . 53.13 111.666 -174.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -136.33 -59.19 0.74 Allowed 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 114.819 -1.082 . . . . 53.55 109.728 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.502 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 29.1 p -100.54 134.8 42.96 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 120.247 -0.581 . . . . 72.34 110.338 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.507 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -65.45 125.53 25.42 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.987 -0.552 . . . . 61.01 112.454 -172.207 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.438 ' O ' HG21 ' A' ' 36' ' ' VAL . 76.1 mt -50.6 -54.62 21.27 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.785 1.634 . . . . 65.34 114.586 -172.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.6 p -174.38 142.57 0.79 Allowed 'General case' 0 CA--C 1.486 -1.505 0 C-N-CA 120.085 -0.646 . . . . 61.23 109.734 -174.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.2 m -98.5 162.65 2.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.127 -1.064 . . . . 60.54 108.127 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 12' ' ' VAL . 15.4 t -105.18 178.18 4.63 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 107.115 -1.439 . . . . 72.23 107.115 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -41.43 -57.97 2.03 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.51 0.724 . . . . 72.24 110.696 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 ttpt -146.96 97.1 4.21 Favored Pre-proline 0 N--CA 1.431 -1.421 0 N-CA-C 108.7 -0.852 . . . . 71.14 108.7 170.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.595 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 5.4 Cg_endo -44.99 -73.03 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.915 3.077 . . . . 73.42 115.997 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.84 163.72 34.16 Favored Pre-proline 0 C--N 1.317 -0.824 0 O-C-N 122.153 -0.342 . . . . 61.34 110.269 -176.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.58 ' O ' HG12 ' A' ' 21' ' ' ILE . 71.2 Cg_exo -55.49 129.09 33.24 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.446 2.097 . . . . 63.41 110.186 171.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.496 ' HA3' HD13 ' A' ' 61' ' ' ILE . . . -77.79 -4.34 85.23 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 120.953 -0.642 . . . . 74.34 114.377 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -96.19 2.6 53.18 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.331 -0.511 . . . . 75.41 111.816 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 18' ' ' PRO . 32.6 pt -106.75 12.39 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 120.077 -0.649 . . . . 70.21 110.654 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.604 HG13 HD11 ' A' ' 65' ' ' LEU . 2.2 p -95.55 133.26 37.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.651 0.738 . . . . 71.34 112.407 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.596 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 1.2 tmt_? -93.62 -49.2 5.99 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.595 -1.184 . . . . 65.32 108.556 -174.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.596 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 16.1 m120 -135.5 154.05 51.53 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 108.891 -0.781 . . . . 74.3 108.891 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.9 143.91 41.07 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.209 -0.596 . . . . 72.04 109.699 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.538 ' HB2' HG22 ' A' ' 40' ' ' VAL . 43.9 m170 -118.72 132.32 56.15 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.363 -1.717 . . . . 61.34 106.363 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -99.77 102.83 14.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.487 -0.56 . . . . 71.54 109.487 -174.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.502 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.1 mm? -102.26 120.37 40.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.872 -0.603 . . . . 75.03 111.049 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.0 mt -131.87 168.75 17.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.29 0.567 . . . . 74.22 110.603 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.7 mt -77.89 -17.33 14.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 107.696 -1.224 . . . . 64.02 107.696 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.07 -31.91 71.57 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 114.967 -1.015 . . . . 75.35 109.417 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -76.66 -54.45 6.64 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.073 -1.084 . . . . 41.05 108.073 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.13 89.13 0.23 Allowed Glycine 0 N--CA 1.438 -1.204 0 CA-C-N 115.413 -0.812 . . . . 62.41 112.518 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.5 t -171.59 -176.08 1.72 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.63 -0.878 . . . . 51.03 108.63 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -81.55 -43.02 19.31 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 122.808 0.443 . . . . 75.13 111.846 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 10' ' ' LEU . 2.8 p -130.84 128.24 22.35 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 113.609 0.966 . . . . 64.23 113.609 -172.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 92.0 Cg_endo -88.82 132.18 2.38 Favored 'Trans proline' 0 C--O 1.248 1.014 0 C-N-CA 123.029 2.486 . . . . 64.42 112.553 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 9' ' ' CYS . . . -175.06 153.41 1.62 Allowed 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.855 0.862 . . . . 74.42 108.794 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.7 p -99.1 132.64 44.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.672 -1.233 . . . . 75.33 107.672 176.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.538 HG22 ' HB2' ' A' ' 26' ' ' HIS . 5.9 m -93.38 122.75 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.674 0 C-N-CA 119.346 -0.942 . . . . 74.01 109.225 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.498 ' CD1' HG21 ' A' ' 22' ' ' VAL . 8.8 m-85 -94.77 115.91 28.08 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 115.333 -0.849 . . . . 73.35 110.56 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.1 m -85.47 104.77 15.56 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.362 -0.977 . . . . 61.23 108.362 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 61.0 p -71.15 178.4 3.3 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.166 -0.47 . . . . 74.03 111.448 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.5 mt -66.11 -25.18 66.87 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.778 0.799 . . . . 73.43 109.926 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -71.93 -16.31 62.1 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.787 -1.097 . . . . 74.23 110.656 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.63 16.01 57.4 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.863 -0.684 . . . . 74.03 111.579 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 31.0 mmt180 -97.91 135.34 39.78 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 120.739 0.304 . . . . 63.13 111.753 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -97.56 114.56 26.48 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.168 -0.924 . . . . 73.11 109.481 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.1 mp -116.53 148.42 40.85 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 116.497 -0.32 . . . . 75.42 111.603 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.414 ' HB3' HG12 ' A' ' 12' ' ' VAL . 34.8 m -77.75 122.29 25.18 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.436 -0.802 . . . . 71.24 110.667 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.595 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.54 151.71 73.34 Favored Pre-proline 0 C--O 1.242 0.704 0 C-N-CA 121.101 -0.24 . . . . 64.3 111.535 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 83.1 Cg_endo -74.27 110.87 3.18 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 123.284 2.656 . . . . 73.35 114.407 -172.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 52' ' ' PRO . 17.7 Cg_exo -67.18 -18.69 51.02 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.391 2.061 . . . . 75.52 112.948 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -87.54 -19.93 27.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.072 0.767 . . . . 64.44 113.072 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.99 139.02 39.77 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 114.08 1.141 . . . . 62.4 114.08 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.459 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 9.7 Cg_endo -52.07 -39.92 69.29 Favored 'Trans proline' 0 C--N 1.361 1.207 0 C-N-CA 124.608 3.538 . . . . 65.43 114.753 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.1 p-90 -59.47 -31.87 69.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.714 -0.395 . . . . 74.51 111.025 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 62' ' ' ILE . 78.2 t -77.56 -42.95 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.935 -0.575 . . . . 63.11 111.599 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -67.19 -25.25 66.04 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.961 -0.696 . . . . 75.14 112.176 -178.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HD3' ' OE1' ' A' ' 63' ' ' GLN . 37.0 mmt180 -71.37 -34.91 70.88 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.795 -0.639 . . . . 74.34 112.547 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.496 HD13 ' HA3' ' A' ' 19' ' ' GLY . 10.6 pt -85.33 -34.16 8.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 C-N-CA 120.718 -0.393 . . . . 75.31 111.8 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 58' ' ' VAL . 59.2 mt -56.74 -49.42 78.4 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-N 116.034 -0.53 . . . . 75.3 111.232 173.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.45 ' OE1' ' HD3' ' A' ' 60' ' ' ARG . 4.1 pt20 -59.08 -39.68 82.91 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.043 0.449 . . . . 73.0 111.221 -178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -60.76 -51.3 69.93 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.987 -1.006 . . . . 71.21 110.332 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.604 HD11 HG13 ' A' ' 22' ' ' VAL . 82.5 mt -66.26 -26.4 67.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.057 0.391 . . . . 72.32 112.057 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.51 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 55.9 mt-30 -63.24 -20.48 65.49 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 120.803 0.335 . . . . 65.55 111.822 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -78.51 -32.42 48.08 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.098 0.475 . . . . 75.11 110.227 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.404 HG22 ' HA ' ' A' ' 65' ' ' LEU . 8.9 t -84.97 -22.28 29.21 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.304 -0.559 . . . . 74.22 110.84 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.51 ' OG ' ' HA ' ' A' ' 66' ' ' GLN . 78.1 p -84.56 -18.84 34.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.382 0.61 . . . . 61.22 109.647 176.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.01 -35.32 80.34 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.153 -0.93 . . . . 55.22 108.846 175.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -67.3 119.6 12.44 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 106.586 -1.635 . . . . 71.2 106.586 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.2 tpp -60.51 104.0 0.3 Allowed 'General case' 0 C--O 1.253 1.273 0 CA-C-O 121.784 0.802 . . . . 74.24 113.073 -172.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -84.79 86.89 7.3 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.795 -1.093 . . . . 72.13 109.333 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -132.47 23.09 4.37 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 105.644 -1.984 . . . . 75.51 105.644 172.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -112.43 140.71 46.94 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.204 -1.817 . . . . 65.04 106.204 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.7 t -76.34 107.37 8.55 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.814 -0.81 . . . . 62.33 108.814 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.2 m . . . . . 0 C--N 1.311 -1.098 0 N-CA-C 109.366 -0.605 . . . . 37.01 109.366 -178.196 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.278 0 N-CA-C 112.132 -0.387 . . . . 71.13 112.132 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.8 t -147.05 114.66 6.38 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 109.592 -0.521 . . . . 71.11 109.592 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -113.11 81.41 1.49 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.552 1.316 . . . . 73.13 114.552 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.7 t70 43.34 -78.8 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 117.659 2.466 . . . . 65.33 117.659 169.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.93 -12.26 60.89 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.011 1.485 . . . . 61.11 115.011 -169.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -113.01 119.38 37.72 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 112.936 0.717 . . . . 75.4 112.936 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -96.53 -12.78 23.61 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.236 -0.893 . . . . 74.41 108.846 176.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.411 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 6.8 p -81.22 174.19 11.79 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.904 -1.044 . . . . 44.14 110.16 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB2' HG12 ' A' ' 40' ' ' VAL . 1.2 t -94.18 -179.39 4.93 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.801 -0.76 . . . . 74.11 111.676 -169.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.0 mt -82.22 -66.92 0.83 Allowed 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 123.044 0.538 . . . . 53.05 110.434 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 p -176.4 150.09 0.87 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.113 -1.44 . . . . 75.45 107.113 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.435 HG12 ' HB3' ' A' ' 50' ' ' CYS . 2.0 m -98.49 161.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 118.812 -1.155 . . . . 51.25 109.276 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 t -104.13 177.72 4.76 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.661 -1.607 . . . . 72.12 106.661 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -51.44 -58.5 6.1 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.148 0.431 . . . . 65.41 110.124 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 59.8 tttm -137.42 99.83 9.53 Favored Pre-proline 0 N--CA 1.424 -1.732 0 C-N-CA 120.014 -0.675 . . . . 73.11 111.654 172.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 19.1 Cg_endo -67.48 -164.09 0.09 OUTLIER 'Trans proline' 0 CA--C 1.567 2.148 0 C-N-CA 122.84 2.36 . . . . 75.15 114.167 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.33 156.76 5.45 Favored Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 125.436 1.495 . . . . 72.53 113.363 -175.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -73.65 149.09 42.98 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.63 2.22 . . . . 73.11 112.527 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.433 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -77.81 1.54 67.47 Favored Glycine 0 N--CA 1.459 0.216 0 CA-C-N 115.788 -0.642 . . . . 33.05 113.488 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -82.97 -23.69 33.27 Favored 'General case' 0 C--N 1.285 -2.232 0 O-C-N 122.259 -0.553 . . . . 74.4 111.522 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.412 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 42.4 pt -100.9 12.26 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.111 0.481 . . . . 74.32 111.904 -177.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.56 HG13 HD11 ' A' ' 65' ' ' LEU . 4.3 p -97.94 136.79 27.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 116.04 -0.527 . . . . 61.55 111.394 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -55.82 3.49 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.437 -1.32 . . . . 73.04 107.437 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -142.33 163.91 31.58 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.636 -0.876 . . . . 52.03 108.636 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.404 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 37.9 p90 -132.51 157.47 44.58 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.964 -0.294 . . . . 72.12 110.28 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.454 ' HB2' HG22 ' A' ' 40' ' ' VAL . 37.8 m80 -125.54 113.56 17.6 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.668 -1.234 . . . . 72.03 107.668 172.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -82.68 100.78 10.43 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.523 -0.762 . . . . 71.34 109.235 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.411 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 83.5 mt -112.06 143.15 43.55 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.691 -0.686 . . . . 62.43 111.846 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 98.1 mt -141.3 -177.61 5.21 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.046 -0.979 . . . . 70.54 109.842 -174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 57.9 mt -74.93 -29.42 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.442 -1.318 . . . . 71.2 107.442 175.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.02 -20.54 64.04 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.911 -1.04 . . . . 72.52 110.907 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -79.66 -49.55 11.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.553 -1.277 . . . . 54.22 107.553 174.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.33 51.15 0.06 OUTLIER Glycine 0 C--O 1.24 0.523 0 C-N-CA 120.621 -0.799 . . . . 33.32 114.1 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 87.3 m -145.5 144.74 30.74 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.764 -1.199 . . . . 75.53 107.764 174.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -63.81 -30.96 71.99 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.159 0.504 . . . . 70.23 111.03 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -100.32 112.96 65.2 Favored Pre-proline 0 C--N 1.306 -1.305 0 CA-C-N 115.432 -0.804 . . . . 62.02 111.572 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.8 130.33 3.66 Favored 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 122.191 1.928 . . . . 61.44 109.953 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -170.65 146.26 2.65 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 109.885 -0.413 . . . . 71.43 109.885 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.41 126.14 51.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.061 -1.459 . . . . 74.03 107.061 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 9' ' ' CYS . 13.1 m -90.1 128.32 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.082 0 C-N-CA 119.523 -0.871 . . . . 63.31 109.448 -178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -96.62 114.0 25.61 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 115.362 -0.835 . . . . 72.02 109.385 174.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.6 m -84.74 104.83 15.05 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 107.442 -1.318 . . . . 62.52 107.442 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 64.5 p -70.06 175.3 4.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 112.706 0.632 . . . . 54.11 112.706 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 90.7 mt -61.01 -27.36 68.27 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 123.472 0.709 . . . . 71.34 110.672 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -79.69 -13.96 59.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.706 -0.679 . . . . 73.23 110.488 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.07 16.67 43.39 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.203 -0.999 . . . . 42.33 112.602 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -96.06 138.64 33.39 Favored 'General case' 0 CA--C 1.491 -1.3 0 O-C-N 122.747 -0.267 . . . . 74.13 110.631 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -93.12 125.18 37.58 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 123.909 0.756 . . . . 64.31 109.304 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.2 tm? -127.95 141.95 51.39 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.944 -1.132 . . . . 72.33 107.944 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.542 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.2 m -81.51 122.88 28.1 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.098 0.559 . . . . 75.41 111.15 -174.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.03 152.76 76.14 Favored Pre-proline 0 C--O 1.245 0.82 0 C-N-CA 120.237 -0.585 . . . . 43.21 111.51 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 93.8 Cg_endo -73.38 112.36 3.51 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.791 2.327 . . . . 70.24 113.564 -173.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.57 -9.63 24.26 Favored 'Trans proline' 0 C--O 1.24 0.593 0 C-N-CA 122.204 1.936 . . . . 70.25 111.681 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.21 -17.98 24.08 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.125 -0.943 . . . . 54.22 111.45 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 31.3 mm-40 -89.7 133.08 34.92 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 112.889 0.7 . . . . 74.14 112.889 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.532 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 94.6 Cg_exo -44.81 -45.19 13.89 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 124.738 3.625 . . . . 75.21 115.771 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.445 ' HZ2' ' HD2' ' A' ' 16' ' ' PRO . 33.5 p-90 -58.16 -36.78 73.52 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.656 0.265 . . . . 70.13 111.606 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 62' ' ' ILE . 71.0 t -68.59 -42.23 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 116.247 -0.433 . . . . 71.33 110.342 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.532 ' OE1' ' HA ' ' A' ' 56' ' ' PRO . 40.7 mt-10 -56.43 -33.22 65.64 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.878 -0.601 . . . . 71.32 111.029 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' A' ' 56' ' ' PRO . 9.3 mpt_? -77.54 -43.39 32.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.97 -0.559 . . . . 74.45 112.449 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.433 HG21 ' HA3' ' A' ' 19' ' ' GLY . 8.8 pt -70.77 -32.07 47.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 112.872 0.693 . . . . 73.14 112.872 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 58' ' ' VAL . 70.4 mt -54.12 -42.68 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 109.55 -0.537 . . . . 63.45 109.55 173.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 79.6 mm-40 -57.78 -45.55 85.83 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.642 -0.708 . . . . 74.13 110.731 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -61.43 -41.47 97.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.134 -0.485 . . . . 63.41 111.85 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.56 HD11 HG13 ' A' ' 22' ' ' VAL . 86.3 mt -72.4 -35.74 68.49 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.014 -0.674 . . . . 74.44 111.474 177.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 51.4 mt-30 -66.5 -45.75 78.54 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.116 -0.633 . . . . 72.42 111.618 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -71.75 -20.48 61.88 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 120.755 -0.378 . . . . 72.32 111.837 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 p -84.97 -31.43 23.55 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.905 -0.718 . . . . 63.15 111.083 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.9 t -67.59 -48.57 66.46 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.94 -0.763 . . . . 72.24 108.94 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.08 -19.3 58.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.938 -0.574 . . . . 63.22 110.002 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.475 ' HG3' ' H ' ' A' ' 72' ' ' MET 0.365 8.1 ptpp? 53.05 -91.01 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 115.17 1.545 . . . . 75.41 115.17 -179.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.475 ' H ' ' HG3' ' A' ' 71' ' ' LYS . 49.6 ttm -117.62 4.8 12.35 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.504 0.668 . . . . 72.11 109.684 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -77.84 87.1 4.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.928 0.871 . . . . 72.25 110.4 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -94.05 -44.77 7.87 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.288 -1.323 . . . . 65.33 109.295 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -125.1 1.43 7.91 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.705 -1.22 . . . . 72.01 107.705 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.3 m 61.09 75.98 0.39 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.16 -1.382 . . . . 63.44 110.445 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.305 -1.328 0 CA-C-N 114.679 -1.146 . . . . 64.25 108.063 -178.31 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.321 0 N-CA-C 111.826 -0.51 . . . . 74.42 111.826 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 77.5 m -69.93 99.05 1.35 Allowed 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.484 -0.561 . . . . 64.54 109.484 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.4 t30 70.73 159.41 0.2 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.167 0.987 . . . . 60.04 109.676 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.4 t70 73.75 -46.35 0.63 Allowed 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 123.873 0.869 . . . . 74.24 113.112 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.88 -4.6 50.48 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.86 0.838 . . . . 63.23 110.73 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -107.66 117.89 35.29 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.797 -1.092 . . . . 72.42 108.744 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -117.04 70.36 0.77 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.483 1.135 . . . . 51.13 111.519 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.479 ' HA ' HD13 ' A' ' 28' ' ' LEU . 45.5 t 178.14 -176.63 0.2 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 104.496 -2.409 . . . . 64.14 104.496 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 10' ' ' LEU . 38.9 t -123.74 173.45 8.13 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 119.372 0.987 . . . . 71.44 111.11 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 80.7 mt -89.21 -55.14 3.79 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 108.54 -0.911 . . . . 73.42 108.54 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.9 t -176.94 165.13 2.39 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.493 -0.928 . . . . 63.31 108.493 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.514 HG12 ' CB ' ' A' ' 50' ' ' CYS . 1.5 m -126.0 152.77 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 105.882 -1.895 . . . . 53.23 105.882 174.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.4 t -93.46 176.58 6.33 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.166 -1.42 . . . . 54.11 107.166 174.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -58.21 -43.97 87.93 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 118.537 0.608 . . . . 75.42 112.15 -174.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -144.05 87.27 8.03 Favored Pre-proline 0 N--CA 1.414 -2.272 0 N-CA-C 108.049 -1.093 . . . . 71.22 108.049 171.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.0 Cg_endo -51.39 -80.11 0.02 OUTLIER 'Trans proline' 0 CA--C 1.549 1.266 0 C-N-CA 124.216 3.277 . . . . 72.44 117.55 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.463 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -143.32 170.19 9.08 Favored Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 109.912 -0.403 . . . . 52.12 109.912 -171.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.576 ' O ' HG12 ' A' ' 21' ' ' ILE . 44.6 Cg_exo -60.52 132.24 42.28 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.208 1.939 . . . . 61.43 111.442 175.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.455 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -79.48 2.29 72.94 Favored Glycine 0 C--N 1.299 -1.522 0 CA-C-N 115.981 -0.554 . . . . 53.43 113.798 -176.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -98.75 -5.25 31.72 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.6 0.593 . . . . 73.22 112.6 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.9 pt -93.71 3.56 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 121.612 0.72 . . . . 71.44 110.527 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.636 HG13 HD11 ' A' ' 65' ' ' LEU . 2.7 p -88.73 137.83 20.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.133 -0.94 . . . . 64.45 111.334 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.31 -55.97 3.57 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.324 -1.361 . . . . 75.03 107.324 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -143.43 162.84 34.73 Favored 'General case' 0 CA--C 1.494 -1.182 0 C-N-CA 124.132 0.973 . . . . 63.32 108.896 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -132.63 161.6 33.5 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.7 -0.4 . . . . 74.13 110.014 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.497 ' HB2' HG22 ' A' ' 40' ' ' VAL . 42.1 m80 -127.42 112.68 15.26 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.629 -0.878 . . . . 73.25 108.629 172.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -85.65 105.85 16.51 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.41 -0.814 . . . . 72.53 109.115 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 8' ' ' CYS . 8.7 tt -119.93 133.17 55.65 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-O 121.218 0.532 . . . . 70.4 110.647 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.4 mt -127.51 -177.7 4.18 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.661 -0.699 . . . . 73.04 109.423 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 58.8 mt -72.38 -20.39 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.149 -1.056 . . . . 74.4 108.149 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -62.91 -31.88 73.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.835 -1.075 . . . . 72.04 109.434 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.6 -57.34 5.88 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 108.583 -0.895 . . . . 63.03 108.583 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 140.65 71.5 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.333 -0.937 . . . . 52.44 112.877 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 35.6 t -173.1 140.85 0.91 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 105.794 -1.928 . . . . 75.4 105.794 176.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -73.18 -19.92 61.0 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.882 1.068 . . . . 71.01 113.882 -173.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 p -104.24 102.31 31.95 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-O 121.314 0.578 . . . . 74.14 110.823 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.3 130.34 6.24 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.391 2.061 . . . . 64.33 110.792 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 50' ' ' CYS . . . -165.49 148.64 7.96 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 120.873 0.368 . . . . 75.34 110.472 -177.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.25 119.95 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.017 0 N-CA-C 107.939 -1.134 . . . . 45.4 107.939 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.685 HG12 ' SG ' ' A' ' 50' ' ' CYS . 7.3 m -86.12 127.04 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.411 0 C-N-CA 119.854 -0.739 . . . . 63.24 109.108 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -97.6 114.8 26.8 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.584 -0.735 . . . . 74.33 110.047 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.4 m -81.2 103.35 10.93 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.194 -1.039 . . . . 74.14 108.194 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.7 p -73.77 171.52 13.17 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.282 -0.417 . . . . 71.22 111.375 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.4 mt -58.56 -28.83 65.89 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.537 0.735 . . . . 75.51 112.131 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -74.77 -14.45 60.71 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.403 0.681 . . . . 74.33 111.309 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.98 17.59 37.23 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 119.935 -1.126 . . . . 71.43 111.421 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -99.62 123.93 44.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 122.69 -0.3 . . . . 60.13 111.332 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -80.73 122.39 27.08 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.962 -0.755 . . . . 63.31 108.962 172.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.4 tp -136.07 126.37 26.54 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.228 -1.027 . . . . 75.21 108.228 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.685 ' SG ' HG12 ' A' ' 40' ' ' VAL . 17.3 m -87.39 149.41 24.49 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 113.713 1.005 . . . . 70.25 113.713 -171.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.587 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -134.06 162.54 57.09 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 115.058 -0.974 . . . . 75.24 109.221 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 63.2 Cg_endo -69.03 109.44 2.17 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.077 1.852 . . . . 63.02 112.298 -176.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.04 -21.63 63.13 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.448 2.765 . . . . 73.52 115.794 -170.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -102.95 -14.3 16.56 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.977 0.418 . . . . 51.33 111.934 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.5 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.7 mm100 -68.39 141.76 93.8 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 113.51 0.93 . . . . 74.51 113.51 -175.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 71.5 Cg_exo -46.9 -39.06 24.31 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 124.78 3.654 . . . . 61.43 115.896 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -74.43 -31.87 62.45 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.374 -0.93 . . . . 72.14 110.791 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 62' ' ' ILE . 77.1 t -77.09 -38.77 28.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 115.96 -0.564 . . . . 72.31 112.308 -176.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 11.0 pt-20 -55.9 -36.27 67.49 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 120.328 -0.549 . . . . 73.12 112.211 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 -68.53 -51.19 45.75 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 111.925 0.343 . . . . 74.32 111.925 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.455 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 14.6 pt -63.4 -33.87 63.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.166 0.432 . . . . 75.13 112.166 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.516 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 66.6 mt -61.04 -46.84 95.88 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 N-CA-C 109.549 -0.537 . . . . 74.51 109.549 173.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 15.4 mm100 -57.67 -44.13 85.5 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.925 -0.398 . . . . 74.41 109.925 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -56.16 -48.75 75.7 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.247 -0.888 . . . . 74.14 110.014 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.636 HD11 HG13 ' A' ' 22' ' ' VAL . 83.1 mt -71.13 -31.56 67.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.317 -0.553 . . . . 73.11 112.236 177.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 45.0 mt-30 -66.84 -24.37 66.14 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 120.237 -0.585 . . . . 74.21 111.871 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 31.7 mmm180 -67.39 -35.44 79.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.709 -0.478 . . . . 75.35 109.709 176.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 72' ' ' MET . 20.3 m -79.35 -19.37 50.42 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.853 0.835 . . . . 64.01 110.474 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.4 t -85.42 -27.45 25.75 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.85 -0.796 . . . . 52.12 108.85 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.99 -59.63 2.65 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.283 -1.006 . . . . 51.1 108.283 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -95.12 85.85 4.43 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 106.47 -1.678 . . . . 74.14 106.47 172.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.516 ' HA ' ' O ' ' A' ' 68' ' ' THR . 49.9 tpp -57.74 128.38 36.78 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 113.776 -1.556 . . . . 75.4 113.437 -170.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.1 tttt 62.8 -82.78 0.02 OUTLIER 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.565 -1.198 . . . . 75.23 113.056 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -137.91 -49.05 0.57 Allowed 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.799 0.333 . . . . 74.25 111.874 -177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -129.6 34.41 4.33 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 116.385 -0.37 . . . . 74.41 110.202 -173.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.0 m 78.11 3.32 2.82 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.001 1.32 . . . . 75.44 108.536 -173.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.413 -2.319 0 N-CA-C 103.504 -2.776 . . . . 64.41 103.504 178.611 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.012 0 N-CA-C 110.439 -1.064 . . . . 54.24 110.439 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 54.1 m 63.57 91.86 0.07 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.687 0.795 . . . . 72.23 111.564 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -155.01 -49.45 0.09 Allowed 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.039 -0.528 . . . . 73.52 110.257 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.627 ' OD1' ' HG2' ' A' ' 6' ' ' GLU . 12.2 t70 -98.09 144.31 27.71 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.404 -0.591 . . . . 70.13 109.404 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.92 -10.52 59.84 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 114.876 1.435 . . . . 73.34 114.876 -172.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.627 ' HG2' ' OD1' ' A' ' 4' ' ' ASP . 12.2 pt-20 -98.62 150.94 21.22 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 119.428 -0.909 . . . . 74.14 110.786 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -82.76 14.5 3.16 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.211 1.005 . . . . 71.25 111.178 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.4 m -82.92 165.17 19.95 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 114.927 -1.033 . . . . 64.12 108.439 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.411 ' SG ' HG12 ' A' ' 40' ' ' VAL . 51.9 m -91.62 179.1 5.74 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 112.944 0.72 . . . . 73.14 112.944 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.3 mt -100.71 -45.81 5.37 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.972 -1.013 . . . . 74.04 109.444 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.7 p -170.04 152.99 4.49 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 119.9 -0.72 . . . . 72.04 110.786 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.445 HG12 ' HB3' ' A' ' 50' ' ' CYS . 2.2 m -112.67 146.63 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 N-CA-C 105.612 -1.996 . . . . 63.34 105.612 171.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 10.3 t -98.42 178.77 4.93 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 108.802 -0.814 . . . . 74.43 108.802 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -43.83 -57.95 2.99 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.293 0.637 . . . . 51.24 110.087 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 38.5 ttpt -143.28 93.07 6.54 Favored Pre-proline 0 N--CA 1.421 -1.912 0 N-CA-C 108.597 -0.89 . . . . 64.31 108.597 171.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.603 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 5.1 Cg_endo -49.39 -76.12 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.857 3.038 . . . . 75.34 115.654 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.405 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -143.61 145.8 32.77 Favored Pre-proline 0 C--N 1.315 -0.893 0 N-CA-C 109.057 -0.72 . . . . 72.34 109.057 -177.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.405 ' O ' HG12 ' A' ' 21' ' ' ILE . 19.8 Cg_endo -61.7 139.48 81.01 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.177 1.918 . . . . 75.13 111.213 177.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.45 ' HA3' HD12 ' A' ' 61' ' ' ILE . . . -74.04 0.63 51.72 Favored Glycine 0 C--O 1.22 -0.728 0 CA-C-O 121.471 0.484 . . . . 73.43 113.327 -177.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -80.35 -20.5 44.02 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 123.14 0.576 . . . . 73.21 110.726 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 37.3 pt -104.76 10.31 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 112.216 0.45 . . . . 73.44 112.216 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.569 HG13 HD11 ' A' ' 65' ' ' LEU . 3.7 p -97.38 139.52 19.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.814 0.34 . . . . 72.22 111.788 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.675 ' HD2' ' ND2' ' A' ' 24' ' ' ASN . 0.8 OUTLIER -95.75 -55.89 2.86 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.833 -0.803 . . . . 62.15 108.833 -177.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.675 ' ND2' ' HD2' ' A' ' 23' ' ' ARG . 49.6 m-80 -135.07 167.6 20.66 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 109.066 -0.716 . . . . 64.32 109.066 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -144.04 165.35 28.04 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.371 -0.603 . . . . 74.31 109.371 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.465 ' HB2' HG22 ' A' ' 40' ' ' VAL . 36.1 m80 -133.9 118.53 18.03 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.011 -1.107 . . . . 75.42 108.011 172.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -84.16 101.63 11.99 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.652 -0.704 . . . . 74.12 109.239 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.593 HD21 ' SG ' ' A' ' 34' ' ' CYS . 6.9 tt -106.54 133.35 51.36 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.369 -0.832 . . . . 72.13 110.471 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -128.63 -176.54 3.87 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.702 -0.681 . . . . 54.12 110.144 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.7 mt -72.09 -22.2 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.589 -0.893 . . . . 64.31 108.589 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -63.44 -29.92 71.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.529 -0.76 . . . . 53.25 110.747 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -67.87 -39.16 83.75 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.027 -0.731 . . . . 74.0 109.027 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.74 58.96 0.23 Allowed Glycine 0 CA--C 1.498 -1.014 0 CA-C-N 115.187 -0.915 . . . . 70.22 110.868 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.593 ' SG ' HD21 ' A' ' 28' ' ' LEU . 61.4 m -141.91 136.62 30.63 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.626 -1.25 . . . . 75.34 107.626 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -76.06 -10.94 59.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.478 0.656 . . . . 75.32 110.647 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 p -121.36 101.39 43.94 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 115.372 -0.831 . . . . 75.15 109.903 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -77.14 130.17 10.98 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.797 1.665 . . . . 72.44 109.624 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 50' ' ' CYS . . . -168.11 148.72 4.97 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.73 0.3 . . . . 52.03 110.921 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.76 126.96 53.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.351 -0.611 . . . . 63.33 109.351 177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.627 HG12 ' SG ' ' A' ' 50' ' ' CYS . 10.5 m -84.5 127.56 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 C-N-CA 120.171 -0.612 . . . . 42.54 109.464 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.446 ' CD1' HG21 ' A' ' 22' ' ' VAL . 9.3 m-85 -99.74 121.06 40.7 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 115.646 -0.707 . . . . 74.22 109.809 174.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.5 m -90.5 104.96 17.48 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.455 -0.942 . . . . 74.35 108.455 174.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 55.6 p -70.62 171.02 11.03 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.395 -0.366 . . . . 74.41 111.605 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 95.4 mt -67.99 -25.8 65.59 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 121.601 0.715 . . . . 74.41 109.106 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -64.62 -32.45 74.12 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.8 -1.091 . . . . 71.2 109.611 172.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.11 16.42 15.12 Favored Glycine 0 N--CA 1.431 -1.659 0 CA-C-N 115.757 -0.656 . . . . 74.1 112.914 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -94.08 134.73 36.19 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.241 0.521 . . . . 75.53 110.951 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -90.77 116.46 28.64 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 107.37 -1.344 . . . . 43.01 107.37 170.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.6 tm? -138.02 143.86 40.77 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.695 -1.224 . . . . 63.12 107.695 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.627 ' SG ' HG12 ' A' ' 40' ' ' VAL . 30.8 m -94.69 143.2 26.63 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 115.19 1.552 . . . . 72.33 115.19 -177.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.603 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -125.6 163.09 40.95 Favored Pre-proline 0 N--CA 1.434 -1.265 0 CA-C-N 114.65 -1.159 . . . . 62.01 109.142 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 57.0 Cg_endo -70.76 110.38 2.74 Favored 'Trans proline' 0 CA--C 1.551 1.374 0 C-N-CA 122.123 1.882 . . . . 63.32 112.985 -174.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.75 -9.87 26.63 Favored 'Trans proline' 0 N--CA 1.478 0.596 0 C-N-CA 123.19 2.593 . . . . 72.12 114.676 -171.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -101.04 -20.83 15.21 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.105 0.478 . . . . 51.3 111.308 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -69.3 130.12 91.25 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 112.795 0.665 . . . . 64.1 112.795 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.2 -36.21 36.13 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.109 3.206 . . . . 74.23 114.247 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.417 ' CE2' HG23 ' A' ' 58' ' ' VAL . 28.3 p-90 -64.8 -27.58 68.98 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 119.224 -0.991 . . . . 72.45 109.921 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 62' ' ' ILE . 69.7 t -86.16 -48.86 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.642 -0.708 . . . . 70.25 111.614 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.357 0.3 OUTLIER -61.9 -29.39 70.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.101 1.149 . . . . 73.44 114.101 -176.63 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -68.86 -43.09 76.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.765 0.317 . . . . 74.4 111.276 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.45 HD12 ' HA3' ' A' ' 19' ' ' GLY . 11.9 pt -71.72 -30.73 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 O-C-N 122.124 -0.36 . . . . 75.04 111.628 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.561 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 62.8 mt -56.76 -46.87 83.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.159 -0.473 . . . . 74.42 109.943 173.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -56.88 -41.9 78.87 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.114 0.566 . . . . 74.24 109.544 179.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 98.3 mtt180 -62.47 -38.93 91.74 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.58 -0.737 . . . . 71.22 111.492 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.569 HD11 HG13 ' A' ' 22' ' ' VAL . 84.5 mt -81.26 -26.06 36.1 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 111.676 0.251 . . . . 64.23 111.676 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.561 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 98.3 mt-30 -58.22 -20.53 42.38 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.59 0.959 . . . . 73.01 113.59 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 16.9 ptm180 -58.01 -37.06 73.6 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 123.103 0.252 . . . . 75.31 111.298 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 65' ' ' LEU . 13.4 t -85.01 -18.66 33.73 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.605 0.717 . . . . 63.23 110.128 177.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.9 t -74.33 -15.64 60.94 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.492 -0.776 . . . . 75.03 110.002 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.59 -31.67 71.89 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.025 -0.534 . . . . 34.15 111.566 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -93.88 105.61 17.62 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.791 0.805 . . . . 71.34 111.716 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -152.71 -173.13 4.46 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 105.839 -1.912 . . . . 52.12 105.839 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -71.24 103.46 2.82 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.483 -2.043 . . . . 74.4 105.483 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -114.36 132.42 56.21 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.376 -0.829 . . . . 74.42 111.396 -169.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -75.92 -59.78 2.61 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.671 -0.695 . . . . 72.35 109.741 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.4 m -89.15 92.85 9.36 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.623 -0.717 . . . . 54.44 110.404 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 N--CA 1.431 -1.393 0 CA-C-O 118.023 -0.989 . . . . 71.23 109.888 -179.86 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.032 0 N-CA-C 111.11 -0.796 . . . . 72.43 111.11 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.7 p -127.49 159.6 34.07 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 110.013 -0.366 . . . . 75.12 110.013 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -86.17 85.52 7.35 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.237 -1.764 . . . . 60.32 106.237 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -161.07 -171.85 3.22 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 104.756 -2.313 . . . . 74.21 104.756 -175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.449 ' C ' ' H ' ' A' ' 7' ' ' ASP . . . -86.18 -33.5 20.79 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.869 -1.16 . . . . 62.45 107.869 175.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.325 11.3 pt-20 48.74 -8.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 128.339 2.656 . . . . 70.31 116.988 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' A' ' 5' ' ' ALA . 36.2 t70 -83.69 76.84 9.95 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.733 1.254 . . . . 74.24 108.267 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.556 ' HA ' HD13 ' A' ' 28' ' ' LEU . 27.2 p -146.33 174.93 10.92 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 112.644 -2.071 . . . . 72.12 106.593 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -101.98 175.23 5.61 Favored 'General case' 0 N--CA 1.415 -2.223 0 C-N-CA 118.436 -1.306 . . . . 70.42 110.625 -176.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.0 -64.86 1.06 Allowed 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.416 -0.587 . . . . 73.1 109.416 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -176.03 160.21 2.25 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 106.218 -1.771 . . . . 74.23 106.218 -178.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -98.87 160.04 3.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 118.722 -1.191 . . . . 71.23 109.422 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.0 t -106.15 179.47 4.26 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 109.416 -0.587 . . . . 63.14 109.416 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -40.48 -50.15 2.91 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.288 1.435 . . . . 74.3 110.458 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.2 ttpt -159.97 98.47 1.49 Allowed Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 107.662 -1.236 . . . . 75.1 107.662 169.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.661 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -42.36 -73.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.379 3.386 . . . . 55.11 116.622 -175.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.432 HG23 HD23 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -143.69 167.86 14.36 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.219 -0.66 . . . . 72.33 109.219 -177.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.527 ' O ' HG12 ' A' ' 21' ' ' ILE . 38.6 Cg_exo -62.21 128.71 24.68 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.704 1.603 . . . . 55.53 109.495 171.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -71.49 1.33 28.86 Favored Glycine 0 C--N 1.301 -1.376 0 N-CA-C 114.336 0.494 . . . . 63.2 114.336 -175.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -94.35 -13.48 26.33 Favored 'General case' 0 C--N 1.285 -2.222 0 O-C-N 122.509 -0.406 . . . . 74.44 111.544 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 18' ' ' PRO . 38.9 pt -95.52 9.47 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.191 0.519 . . . . 72.22 111.205 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.589 HG21 ' CD1' ' A' ' 41' ' ' PHE . 3.1 p -96.9 141.27 15.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 115.949 -0.568 . . . . 61.2 111.842 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.502 ' HD2' ' ND2' ' A' ' 24' ' ' ASN . 1.3 tmt_? -105.44 -54.32 2.5 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.483 -0.932 . . . . 72.24 108.483 -178.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.502 ' ND2' ' HD2' ' A' ' 23' ' ' ARG . 53.6 m-80 -123.88 160.55 27.22 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.126 -0.694 . . . . 63.01 109.126 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.465 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 42.1 p90 -141.53 155.0 45.82 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.324 -0.991 . . . . 75.41 108.324 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -137.26 128.42 27.81 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.601 -0.518 . . . . 62.42 109.601 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -79.24 101.31 7.93 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 109.272 -0.64 . . . . 65.53 109.272 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.556 HD13 ' HA ' ' A' ' 8' ' ' CYS . 43.6 mt -98.92 131.0 45.33 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-O 121.665 0.745 . . . . 73.23 109.855 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.9 mt -132.59 178.23 7.01 Favored 'General case' 0 C--N 1.27 -2.873 0 CA-C-N 114.877 -1.056 . . . . 52.44 108.815 -172.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 25.3 mt -76.55 -29.5 18.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.442 -0.947 . . . . 61.12 108.442 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -67.83 -15.63 63.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.223 -0.899 . . . . 73.12 109.777 174.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -89.14 -43.2 11.21 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.924 -1.139 . . . . 75.44 107.924 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.8 -90.14 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 119.721 -1.228 . . . . 74.33 115.122 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 58.2 m -75.89 157.56 33.11 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.077 0.399 . . . . 72.15 112.077 -172.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -72.8 29.25 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.474 1.11 . . . . 71.42 113.702 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.4 p -137.4 102.9 8.74 Favored Pre-proline 0 C--N 1.3 -1.568 0 CA-C-O 121.395 0.617 . . . . 63.33 110.181 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -86.85 130.18 3.06 Favored 'Trans proline' 0 N--CA 1.438 -1.75 0 C-N-CA 121.941 1.76 . . . . 73.11 111.772 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.29 157.73 9.43 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.529 -0.759 . . . . 74.11 109.087 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.85 126.31 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 108.334 -0.987 . . . . 72.1 108.334 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 49' ' ' LEU . 20.1 m -94.01 129.29 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.98 0 CA-C-O 121.609 0.718 . . . . 63.22 110.534 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.589 ' CD1' HG21 ' A' ' 22' ' ' VAL . 7.2 m-85 -93.86 118.16 31.08 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 114.958 -1.019 . . . . 72.1 111.897 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.4 m -81.36 105.45 12.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.436 -0.949 . . . . 70.34 108.436 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.1 p -76.11 174.28 10.25 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.699 0.285 . . . . 72.35 111.363 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 88.1 mt -62.52 -28.39 69.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 123.185 0.594 . . . . 53.54 110.307 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -69.52 -30.21 67.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.546 -0.752 . . . . 75.55 109.414 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.57 8.69 45.64 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.66 -0.7 . . . . 71.42 111.949 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -95.22 133.49 39.03 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 105.605 -1.998 . . . . 64.31 105.605 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 39.1 mt-30 -96.79 143.57 27.59 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.477 -0.935 . . . . 54.12 108.477 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 37.4 tp -135.91 150.35 49.3 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.215 -0.594 . . . . 73.52 109.881 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 3.2 m -77.47 122.18 24.86 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 123.547 0.53 . . . . 73.51 109.72 -175.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.661 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.28 151.76 72.74 Favored Pre-proline 0 C--N 1.311 -1.083 0 C-N-CA 120.288 -0.565 . . . . 72.32 110.1 174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.434 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 83.0 Cg_endo -74.98 110.31 3.09 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 122.778 2.319 . . . . 74.15 113.859 -173.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -67.94 -17.33 46.46 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.328 2.018 . . . . 65.03 111.887 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.96 -17.05 34.03 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.777 -0.647 . . . . 74.13 111.729 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.434 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.9 mm100 -84.81 127.49 64.79 Favored Pre-proline 0 C--N 1.317 -0.827 0 O-C-N 122.162 -0.336 . . . . 74.24 111.277 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -46.76 -37.87 21.81 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.608 3.539 . . . . 62.03 115.125 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.425 ' O ' HG12 ' A' ' 61' ' ' ILE . 41.8 p-90 -61.25 -35.4 77.17 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 120.784 -0.366 . . . . 75.45 110.752 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 62' ' ' ILE . 76.6 t -70.64 -41.65 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.806 -0.634 . . . . 75.41 111.244 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.2 mt-10 -58.09 -47.5 83.02 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 111.681 0.252 . . . . 62.33 111.681 -178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -64.03 -40.29 95.99 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.695 1.369 . . . . 61.13 114.695 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.453 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 10.7 pt -69.79 -35.69 66.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.34 -0.544 . . . . 65.32 111.507 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.465 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 56.9 mt -59.26 -49.55 83.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.356 -0.384 . . . . 75.14 110.517 173.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 18.5 mm-40 -56.19 -37.65 69.92 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.155 0.582 . . . . 72.34 110.125 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.562 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 20.2 ttm180 -68.08 -36.71 80.25 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.657 -0.701 . . . . 74.22 110.856 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.576 HD11 HG13 ' A' ' 22' ' ' VAL . 87.2 mt -76.13 -35.61 59.18 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 122.097 -0.377 . . . . 74.14 111.091 177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 54.1 mt-30 -58.08 -19.15 29.8 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.983 1.475 . . . . 75.44 114.983 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 39.6 ptt180 -64.08 -15.16 58.99 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.232 -0.587 . . . . 74.12 111.731 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.6 p -74.34 -27.56 60.74 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 121.587 0.708 . . . . 62.23 110.06 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 74' ' ' ARG . 43.6 m -80.27 -12.2 59.64 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.114 -0.948 . . . . 74.44 109.49 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.43 -19.01 50.99 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.308 -0.86 . . . . 74.12 110.28 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -110.45 138.88 46.26 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.091 0.472 . . . . 72.14 111.59 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 54.4 ttp 57.53 85.1 0.09 Allowed 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 115.24 1.57 . . . . 62.54 115.24 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.4 tttt 63.5 1.14 0.95 Allowed 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 114.371 1.249 . . . . 73.33 114.371 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 69' ' ' SER . 73.6 ttt180 74.43 -61.16 0.5 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.012 0.925 . . . . 75.51 110.512 -175.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -122.53 107.84 12.46 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.812 -0.81 . . . . 73.04 108.812 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.8 m -109.38 100.93 9.96 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-N 116.084 -0.507 . . . . 73.33 109.961 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.429 -1.478 0 N-CA-C 107.832 -1.173 . . . . 37.24 107.832 -179.844 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.128 0 N-CA-C 110.995 -0.842 . . . . 73.24 110.995 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.9 m -86.49 89.05 7.77 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.795 0.807 . . . . 75.3 111.597 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -102.77 -32.53 9.78 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.926 -1.139 . . . . 74.34 107.926 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -93.44 143.49 26.23 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.085 -1.08 . . . . 73.34 108.085 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.72 -4.73 57.02 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 114.084 1.142 . . . . 63.42 114.084 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.525 ' CD ' ' H ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER 58.16 -161.28 0.24 Allowed 'General case' 0 CA--C 1.577 2.01 0 C-N-CA 124.236 1.014 . . . . 74.22 108.916 -178.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.525 ' H ' ' CD ' ' A' ' 6' ' ' GLU . 15.9 m-20 -103.75 25.19 10.11 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 121.657 0.741 . . . . 75.13 110.066 177.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 24.6 p -150.6 -160.33 1.15 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.039 -1.467 . . . . 62.14 107.039 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.533 ' SG ' HG12 ' A' ' 40' ' ' VAL . 1.7 t -121.87 -178.89 3.96 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 117.999 -1.48 . . . . 71.53 107.89 174.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tt -88.48 -67.74 0.81 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.117 -0.697 . . . . 73.52 109.117 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.7 m -168.55 149.07 4.65 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.215 -1.031 . . . . 32.3 108.215 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.433 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -102.49 158.66 4.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 119.144 -1.022 . . . . 54.45 108.323 178.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.1 t -103.21 178.47 4.55 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.077 -0.712 . . . . 72.22 109.077 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -46.64 -41.16 14.33 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.398 0.679 . . . . 70.4 111.544 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 39.5 ttpt -162.04 100.61 1.15 Allowed Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 107.249 -1.389 . . . . 72.35 107.249 170.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.66 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.5 Cg_endo -51.52 -82.59 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 123.889 3.059 . . . . 54.41 117.634 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.41 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -141.08 159.98 59.68 Favored Pre-proline 0 C--N 1.316 -0.878 0 O-C-N 121.964 -0.46 . . . . 41.13 110.257 -173.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.565 ' O ' HG12 ' A' ' 21' ' ' ILE . 78.1 Cg_exo -55.2 128.49 30.75 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.566 2.178 . . . . 75.42 110.691 173.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.464 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -79.71 0.46 81.79 Favored Glycine 0 C--N 1.307 -1.028 0 N-CA-C 115.15 0.82 . . . . 72.45 115.15 -174.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -99.17 -0.16 42.16 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.147 0.795 . . . . 71.55 113.147 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 18' ' ' PRO . 36.9 pt -101.27 10.25 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.667 0.746 . . . . 72.12 110.074 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 65' ' ' LEU . 3.1 p -94.44 138.98 19.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.287 -0.869 . . . . 72.53 111.336 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.09 -47.2 7.38 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.786 -0.82 . . . . 72.45 108.786 -175.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -149.93 160.5 43.55 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.048 -1.093 . . . . 73.54 108.048 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.3 168.26 19.51 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 117.973 0.352 . . . . 65.32 110.519 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.574 ' HB2' HG22 ' A' ' 40' ' ' VAL . 40.7 m80 -135.46 112.41 10.27 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.377 -1.342 . . . . 73.13 107.377 171.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -79.45 99.29 7.15 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.339 -1.356 . . . . 65.23 107.339 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.505 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -111.73 117.55 33.18 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.761 -0.654 . . . . 72.43 110.288 -170.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.8 mt -104.82 -176.07 2.97 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.497 -0.557 . . . . 74.25 109.497 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 63.3 mt -67.04 -36.24 76.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.909 0.862 . . . . 73.03 109.16 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -64.29 -24.17 67.56 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.484 -1.234 . . . . 72.52 110.276 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -92.48 -28.39 16.85 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.828 -0.624 . . . . 53.43 110.514 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -140.96 -106.76 0.65 Allowed Glycine 0 N--CA 1.428 -1.877 0 C-N-CA 119.626 -1.273 . . . . 72.44 115.884 -173.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 33.6 m -118.32 179.68 4.04 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 114.993 -0.604 . . . . 73.32 109.496 -172.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -55.22 -19.38 7.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.35 1.06 . . . . 71.41 112.377 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.7 p -103.14 106.79 52.85 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-O 121.114 0.483 . . . . 51.31 111.34 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -87.19 144.21 6.92 Favored 'Trans proline' 0 C--O 1.251 1.143 0 C-N-CA 122.576 2.184 . . . . 72.33 110.848 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.489 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -174.43 153.47 1.91 Allowed 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.92 -0.4 . . . . 23.41 109.92 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.49 122.59 50.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.178 -1.416 . . . . 71.25 107.178 175.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.574 HG22 ' HB2' ' A' ' 26' ' ' HIS . 8.0 m -89.16 127.72 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.859 0 C-N-CA 119.566 -0.854 . . . . 52.12 109.426 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -98.13 121.54 40.18 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 115.302 -0.863 . . . . 73.33 110.702 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 22' ' ' VAL . 95.0 m -86.35 103.42 14.91 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.819 -1.178 . . . . 74.1 107.819 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 50.0 p -70.97 171.69 10.36 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 116.201 -0.454 . . . . 64.32 110.833 -177.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 98.4 mt -60.96 -26.93 67.88 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.356 0.598 . . . . 60.22 109.775 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -71.65 -15.15 62.22 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 114.972 -1.013 . . . . 52.41 111.018 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.04 8.66 61.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.004 -0.617 . . . . 63.54 112.731 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -93.41 140.59 29.4 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 122.869 -0.195 . . . . 73.23 110.84 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -99.88 117.76 34.87 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.52 -0.918 . . . . 64.34 108.52 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -120.95 143.39 49.02 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.633 -0.877 . . . . 71.33 108.633 -174.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.534 ' N ' HD13 ' A' ' 49' ' ' LEU . 6.3 m -80.15 126.14 30.71 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 122.993 0.517 . . . . 72.24 111.17 -174.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.66 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -128.26 153.27 78.84 Favored Pre-proline 0 C--O 1.245 0.859 0 C-N-CA 120.907 -0.317 . . . . 74.12 110.989 175.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.484 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 72.0 Cg_endo -68.47 113.28 3.08 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.204 2.603 . . . . 73.33 113.024 -175.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 60.1 Cg_endo -72.24 -8.02 22.01 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.551 2.167 . . . . 73.15 114.205 -175.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -109.73 -0.51 18.48 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.3 0.572 . . . . 71.33 111.616 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.484 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 16.0 mm100 -86.34 135.97 36.02 Favored Pre-proline 0 C--N 1.314 -0.942 0 O-C-N 121.52 -0.737 . . . . 75.23 112.233 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.76 -36.76 26.7 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 124.697 3.598 . . . . 74.41 115.051 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -68.77 -32.48 72.26 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 120.343 -0.543 . . . . 60.42 110.685 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.662 ' O ' HG12 ' A' ' 62' ' ' ILE . 72.4 t -71.7 -48.99 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.831 -0.622 . . . . 72.14 111.997 -178.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 9.3 pt-20 -55.69 -30.36 60.97 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.575 0.583 . . . . 71.23 112.575 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -73.02 -45.09 59.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.563 -0.29 . . . . 75.15 111.301 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.464 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 12.9 pt -71.71 -29.02 32.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 111.89 0.33 . . . . 71.41 111.89 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.662 HG12 ' O ' ' A' ' 58' ' ' VAL . 46.9 mm -56.49 -44.89 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 108.892 -0.781 . . . . 72.53 108.892 172.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 15.5 mm100 -59.1 -42.51 90.67 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.806 -0.634 . . . . 52.53 110.58 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -60.86 -46.59 90.0 Favored 'General case' 0 C--O 1.206 -1.201 0 O-C-N 124.143 0.902 . . . . 72.32 111.002 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.541 HD11 HG13 ' A' ' 22' ' ' VAL . 86.8 mt -72.47 -34.11 67.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.253 -0.579 . . . . 72.25 111.897 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 43.7 mt-30 -61.5 -19.59 62.23 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 113.466 0.914 . . . . 74.24 113.466 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -57.6 -28.21 63.43 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-O 120.945 0.403 . . . . 73.34 110.122 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.2 p -85.32 -32.79 22.3 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-O 121.378 0.609 . . . . 73.23 110.647 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.9 t -77.98 -22.29 49.62 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.94 -1.027 . . . . 61.44 110.83 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.16 -19.54 64.8 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.176 -0.465 . . . . 51.43 109.977 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 61.6 tttp 65.64 -67.81 0.13 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.743 1.617 . . . . 73.3 112.549 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.3 ptm -87.24 80.63 8.19 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-O 122.578 1.18 . . . . 74.0 111.604 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -93.8 89.06 6.0 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 113.826 -1.534 . . . . 70.25 107.683 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 55.55 75.84 0.3 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 114.896 -1.047 . . . . 74.22 108.355 -172.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -135.38 109.15 8.05 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.236 -0.585 . . . . 64.32 110.622 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.5 p -129.32 144.05 51.08 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.724 -0.671 . . . . 53.21 110.063 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.1 m . . . . . 0 C--N 1.3 -1.575 0 N-CA-C 109.378 -0.601 . . . . 72.14 109.378 179.675 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.428 0 N-CA-C 111.067 -0.813 . . . . 52.22 111.067 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.4 p -79.93 -28.12 39.76 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 117.321 0.561 . . . . 74.03 110.338 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.4 t30 62.25 93.06 0.05 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.021 1.328 . . . . 74.54 111.27 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -78.21 -5.34 51.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.41 -0.813 . . . . 74.02 111.253 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.85 -10.0 58.71 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.943 0.877 . . . . 74.24 110.029 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -126.75 163.44 23.53 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 114.176 -1.374 . . . . 75.51 109.443 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -133.09 97.01 3.89 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.583 0.706 . . . . 71.22 109.373 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.473 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 46.5 t -152.81 -172.36 4.22 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 106.351 -1.722 . . . . 74.44 106.351 175.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.419 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 11.9 t -118.9 178.32 4.53 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 120.071 -0.652 . . . . 74.15 111.637 -173.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.403 ' N ' ' SG ' ' A' ' 9' ' ' CYS . 83.4 mt -94.36 -53.9 3.75 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.105 -1.072 . . . . 75.03 108.105 174.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.9 t -177.19 -173.97 0.48 Allowed 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.131 -1.063 . . . . 63.23 108.131 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.78 167.67 25.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 106.939 -1.504 . . . . 61.43 106.939 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.2 t -105.52 178.28 4.61 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.781 -0.822 . . . . 75.1 108.781 175.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -53.02 -38.26 62.21 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.172 0.511 . . . . 74.41 111.139 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -159.2 93.42 1.82 Allowed Pre-proline 0 N--CA 1.425 -1.707 0 N-CA-C 108.014 -1.106 . . . . 73.54 108.014 173.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.2 Cg_endo -54.07 -86.24 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.882 3.055 . . . . 64.22 117.945 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.458 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -137.39 163.18 50.65 Favored Pre-proline 0 C--N 1.32 -0.698 0 O-C-N 121.865 -0.522 . . . . 72.35 110.565 -172.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.545 ' O ' HG12 ' A' ' 21' ' ' ILE . 38.0 Cg_exo -62.03 130.05 29.45 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.165 1.91 . . . . 74.13 110.853 175.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -71.95 1.6 30.85 Favored Glycine 0 C--N 1.307 -1.042 0 N-CA-C 114.32 0.488 . . . . 45.21 114.32 -177.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -87.32 -22.16 25.28 Favored 'General case' 0 N--CA 1.416 -2.128 0 O-C-N 122.529 -0.395 . . . . 74.43 110.692 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.5 pt -90.7 8.66 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 120.206 -0.598 . . . . 71.45 111.887 -176.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.588 HG13 HD11 ' A' ' 65' ' ' LEU . 2.6 p -92.94 132.51 36.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.22 0.533 . . . . 71.1 111.753 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -55.33 3.63 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.004 -1.11 . . . . 61.54 108.004 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -135.24 158.33 44.63 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.279 -1.008 . . . . 62.51 108.279 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -139.71 155.06 47.57 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.153 -0.619 . . . . 74.55 110.634 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.491 ' HB2' HG22 ' A' ' 40' ' ' VAL . 63.6 m170 -122.27 112.59 18.33 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.666 -1.235 . . . . 64.14 107.666 172.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -83.46 99.58 10.19 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.064 -0.717 . . . . 75.14 109.064 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.473 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 88.3 mt -106.58 143.26 34.95 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.8 -0.636 . . . . 74.51 111.798 -176.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.6 mt -140.45 175.85 9.26 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.876 -1.056 . . . . 62.24 109.639 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 46.4 mt -76.41 -19.79 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 107.961 -1.126 . . . . 72.22 107.961 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -60.82 -36.58 79.45 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.467 -1.242 . . . . 74.51 109.276 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -68.99 -41.06 78.33 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.595 -0.729 . . . . 70.03 109.274 176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.96 -36.91 1.29 Allowed Glycine 0 CA--C 1.495 -1.197 0 C-N-CA 120.741 -0.742 . . . . 74.42 112.361 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 49.3 t -69.56 127.94 34.76 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.002 -1.11 . . . . 74.43 108.002 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -84.43 1.62 44.59 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 114.902 1.445 . . . . 62.24 114.902 -170.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 p -110.29 95.85 23.85 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 108.598 -0.89 . . . . 70.32 108.598 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -76.52 129.11 10.76 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 121.643 1.562 . . . . 72.15 111.415 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.536 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -171.0 151.3 3.25 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 115.231 -0.895 . . . . 74.11 109.728 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.22 119.6 47.44 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.463 -1.31 . . . . 74.23 107.463 174.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 26' ' ' HIS . 2.6 m -83.46 119.35 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.565 0 C-N-CA 119.294 -0.963 . . . . 71.43 108.529 -178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 22' ' ' VAL . 11.1 m-85 -91.28 111.53 23.05 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.377 -0.828 . . . . 75.22 110.643 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.4 m -80.13 100.4 8.22 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 106.99 -1.485 . . . . 71.14 106.99 174.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 49.5 p -68.1 173.94 4.25 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.964 -0.562 . . . . 72.13 111.357 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 93.5 mt -61.26 -29.46 69.86 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.282 0.563 . . . . 71.32 110.728 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -73.14 -16.61 61.44 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.378 -0.828 . . . . 74.24 110.227 176.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.6 -8.39 66.21 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 116.247 -0.433 . . . . 54.24 112.25 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -77.34 127.77 33.15 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 107.128 -1.434 . . . . 71.23 107.128 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.7 mp0 -85.15 123.77 31.05 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.723 -0.843 . . . . 71.24 108.723 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 50' ' ' CYS . 4.3 tt -135.54 133.53 38.5 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 106.727 -1.583 . . . . 74.0 106.727 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.496 ' N ' HD23 ' A' ' 49' ' ' LEU . 21.4 m -94.94 145.43 24.93 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 114.21 1.189 . . . . 72.44 114.21 -169.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -125.64 158.73 63.91 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 115.113 -0.949 . . . . 54.44 110.515 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 66.7 Cg_endo -69.49 108.11 1.96 Allowed 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.421 2.08 . . . . 65.2 112.569 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.536 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 71.7 Cg_endo -74.22 -10.37 22.49 Favored 'Trans proline' 0 N--CA 1.473 0.274 0 C-N-CA 123.113 2.542 . . . . 73.14 113.824 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -96.32 -16.19 21.46 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.571 0.701 . . . . 75.11 109.617 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.463 ' OE1' ' HB2' ' A' ' 52' ' ' PRO . 1.8 mp0 -82.08 144.44 50.97 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 113.497 0.925 . . . . 50.44 113.497 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.96 -39.97 81.76 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 124.548 3.498 . . . . 63.42 115.013 -174.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -65.31 -26.7 68.17 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.231 -0.587 . . . . 72.43 110.473 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 62' ' ' ILE . 71.8 t -81.22 -40.11 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.823 -0.626 . . . . 75.3 111.852 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.464 ' HG3' ' HD2' ' A' ' 60' ' ' ARG . 13.4 pt-20 -61.26 -37.07 81.8 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.775 0.657 . . . . 72.52 112.775 -176.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.464 ' HD2' ' HG3' ' A' ' 59' ' ' GLU . 3.2 mpt_? -69.26 -38.84 78.62 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 120.19 -0.604 . . . . 61.4 112.165 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.47 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 12.6 pt -71.42 -33.22 49.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 120.804 -0.358 . . . . 73.33 111.829 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 58' ' ' VAL . 67.7 mt -61.88 -47.02 95.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 N-CA-C 109.292 -0.633 . . . . 75.23 109.292 172.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 84.1 mm-40 -58.34 -41.25 84.2 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.167 -0.47 . . . . 74.23 111.42 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -60.23 -41.27 92.76 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.035 -0.529 . . . . 63.23 111.191 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.588 HD11 HG13 ' A' ' 22' ' ' VAL . 90.6 mt -75.25 -28.83 60.01 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.27 -0.572 . . . . 74.35 111.043 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 47.0 mt-30 -71.1 -35.09 71.67 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 112.011 0.374 . . . . 61.24 112.011 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -50.74 -40.93 55.85 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 124.128 0.971 . . . . 74.23 111.867 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.0 p -82.68 -24.81 33.53 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.623 0.725 . . . . 72.34 111.654 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.0 t -86.49 -19.57 29.35 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.249 -0.887 . . . . 52.21 110.002 -177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.84 -23.93 66.78 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.601 0.761 . . . . 74.24 111.293 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.22 97.22 7.53 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 106.88 -1.526 . . . . 75.23 106.88 176.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 23.5 ptm -126.96 -167.26 1.71 Allowed 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 113.673 -1.603 . . . . 73.33 108.477 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.506 ' HD2' ' H ' ' A' ' 73' ' ' LYS . 3.0 mptp? -62.91 124.75 21.87 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.829 -0.804 . . . . 74.01 108.829 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -69.93 103.22 2.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.974 0.416 . . . . 71.41 110.236 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -149.88 21.95 0.88 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.125 -1.065 . . . . 71.34 108.125 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.6 m 69.47 81.87 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.269 -1.332 . . . . 73.54 110.304 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--N 1.305 -1.339 0 CA-C-N 115.396 -0.82 . . . . 63.31 108.991 179.83 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.305 0 N-CA-C 110.388 -1.085 . . . . 74.32 110.388 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.0 p -78.02 82.72 4.35 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 117.635 0.718 . . . . 72.24 110.933 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.5 t30 177.77 122.32 0.04 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 125.711 1.604 . . . . 64.13 106.719 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -85.6 120.25 26.83 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.587 -0.523 . . . . 74.21 109.587 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.0 -12.43 59.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.084 -0.507 . . . . 64.23 110.506 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 63.8 175.44 0.17 Allowed 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 126.103 1.761 . . . . 52.25 111.609 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -76.12 -30.84 58.36 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.666 0.746 . . . . 55.45 110.766 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.508 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 4.9 p -99.63 -161.87 0.9 Allowed 'General case' 0 C--N 1.273 -2.758 0 CA-C-N 114.676 -1.147 . . . . 74.33 110.138 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.542 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -93.37 -175.75 3.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.505 -0.924 . . . . 73.02 108.505 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.07 -59.06 1.94 Allowed 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.476 0.547 . . . . 63.1 112.476 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.8 m -162.27 141.71 9.52 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.838 -0.43 . . . . 75.42 109.838 -175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.7 m -98.94 152.03 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.255 -1.017 . . . . 74.33 108.255 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 t -94.15 178.39 5.66 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.161 -0.681 . . . . 74.13 109.161 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -45.27 -46.48 12.62 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.948 0.899 . . . . 64.33 110.597 -177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 5.0 ttmp? -160.2 99.2 1.43 Allowed Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.017 -1.105 . . . . 70.25 108.017 169.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 9.5 Cg_endo -51.51 -81.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.351 0 C-N-CA 123.46 2.774 . . . . 51.4 116.785 -175.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.444 HD11 ' HB2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -147.95 152.46 40.37 Favored Pre-proline 0 C--N 1.322 -0.628 0 O-C-N 121.943 -0.473 . . . . 75.43 110.611 -174.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.475 ' O ' HG12 ' A' ' 21' ' ' ILE . 18.7 Cg_endo -61.97 141.2 88.45 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.444 2.096 . . . . 74.12 111.32 174.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.411 ' HA3' HD12 ' A' ' 61' ' ' ILE . . . -79.86 1.46 78.78 Favored Glycine 0 C--N 1.309 -0.952 0 C-N-CA 121.434 -0.413 . . . . 72.15 113.568 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.45 ' CE1' ' HG2' ' A' ' 64' ' ' ARG . 98.4 m-85 -94.6 -0.6 54.36 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 122.226 -0.573 . . . . 71.11 111.553 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.507 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 35.4 pt -112.41 5.13 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.279 0.561 . . . . 74.32 110.728 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.423 HG13 HD21 ' A' ' 65' ' ' LEU . 2.7 p -90.78 135.04 27.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.997 -0.547 . . . . 63.24 111.261 179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.39 -55.6 3.82 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.775 -0.824 . . . . 70.44 108.775 -175.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -140.45 164.33 30.43 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.361 0.664 . . . . 64.43 109.626 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.49 ' CE1' ' HB3' ' A' ' 65' ' ' LEU . 8.6 p90 -143.85 167.98 21.03 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.743 0.306 . . . . 73.5 110.51 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -141.96 137.09 30.99 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.155 -1.054 . . . . 65.32 108.155 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -98.6 103.87 15.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 123.448 0.467 . . . . 72.41 109.868 -173.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 2.3 mm? -103.74 128.55 51.1 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.921 -0.77 . . . . 73.44 108.921 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.9 mt -131.95 179.59 5.99 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.225 0.536 . . . . 63.52 111.278 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.7 mt -77.99 -19.0 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.689 -1.226 . . . . 71.25 107.689 173.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -59.49 -34.33 72.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.07 -0.968 . . . . 61.34 109.845 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -68.16 -34.22 75.92 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.424 -0.807 . . . . 71.21 109.927 176.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.34 -17.51 3.54 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.356 -0.838 . . . . 75.12 112.471 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 68.8 m -68.22 161.69 26.61 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.675 1.361 . . . . 75.45 114.675 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -81.33 -15.49 55.2 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.939 -1.028 . . . . 72.2 111.282 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -134.12 123.81 17.04 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-O 120.971 0.415 . . . . 74.2 111.958 -174.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -85.94 129.39 3.43 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 C-N-CA 121.794 1.663 . . . . 74.34 109.556 172.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.55 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -162.77 136.86 6.27 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.121 -0.49 . . . . 54.42 109.742 -176.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.99 124.51 52.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.305 -1.369 . . . . 74.44 107.305 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.542 HG12 ' SG ' ' A' ' 9' ' ' CYS . 18.8 m -84.79 123.17 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.548 0 CA-C-O 121.854 0.835 . . . . 70.5 110.178 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.444 ' HB2' HD11 ' A' ' 17' ' ' ILE . 15.1 m-85 -97.97 117.88 33.3 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 114.757 -1.111 . . . . 75.41 109.804 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 94.4 m -87.1 102.08 14.1 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.746 -0.835 . . . . 75.44 108.746 174.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.5 p -70.97 166.79 20.53 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.373 -0.376 . . . . 75.34 110.511 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 90.0 mt -60.47 -25.58 66.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.525 0.678 . . . . 72.0 110.353 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -62.75 -24.85 67.9 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.127 -0.942 . . . . 64.1 110.644 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.44 15.97 36.07 Favored Glycine 0 CA--C 1.505 -0.551 0 C-N-CA 121.288 -0.482 . . . . 72.15 111.911 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 42' ' ' THR . 34.3 mmt180 -99.56 139.21 35.54 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 120.665 0.269 . . . . 75.51 111.007 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -95.79 129.41 43.03 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 105.996 -1.853 . . . . 71.33 105.996 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 36.2 tp -137.57 144.62 42.13 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.463 -0.495 . . . . 50.2 110.148 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 9.7 m -80.16 128.57 33.67 Favored 'General case' 0 C--N 1.317 -0.805 0 O-C-N 123.494 0.496 . . . . 71.22 110.632 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.539 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -131.86 154.78 81.86 Favored Pre-proline 0 C--O 1.244 0.815 0 N-CA-C 109.208 -0.664 . . . . 54.12 109.208 172.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.421 ' HB2' ' HG2' ' A' ' 55' ' ' GLN . 95.8 Cg_endo -77.31 107.82 2.48 Favored 'Trans proline' 0 CA--C 1.559 1.758 0 C-N-CA 122.643 2.229 . . . . 72.21 113.924 -173.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.55 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.9 Cg_endo -68.61 -19.8 41.62 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.135 2.557 . . . . 72.22 114.882 -173.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -96.87 2.7 52.04 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.601 0.715 . . . . 73.42 110.799 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.421 ' HG2' ' HB2' ' A' ' 52' ' ' PRO . 15.3 mm100 -95.06 143.14 25.61 Favored Pre-proline 0 C--N 1.313 -0.996 0 N-CA-C 112.291 0.478 . . . . 74.05 112.291 -178.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.427 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 10.3 Cg_endo -50.27 -46.79 27.07 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 124.427 3.418 . . . . 62.0 114.625 -175.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.497 ' O ' HG12 ' A' ' 61' ' ' ILE . 33.8 p-90 -63.33 -30.6 71.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 120.488 -0.485 . . . . 73.44 110.832 -175.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 62' ' ' ILE . 72.7 t -81.56 -44.07 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.198 -0.455 . . . . 71.13 111.489 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.427 ' HG3' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -64.47 -24.63 67.69 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 120.302 -0.559 . . . . 71.35 111.513 -177.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.4 tpt180 -79.64 -29.63 41.04 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 115.838 -0.619 . . . . 74.25 110.731 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 57' ' ' TRP . 8.3 pt -86.09 -35.31 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 113.703 1.001 . . . . 64.31 113.703 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 58' ' ' VAL . 67.9 mt -53.01 -41.63 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-O 120.741 0.305 . . . . 74.33 110.809 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -59.99 -35.33 74.79 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.942 0.719 . . . . 74.13 112.942 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.45 ' HG2' ' CE1' ' A' ' 20' ' ' TYR . 7.1 mpt_? -57.31 -45.98 83.67 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.05 0.452 . . . . 60.02 110.316 174.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.49 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 3.5 mm? -68.1 -43.35 78.66 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.697 -0.683 . . . . 74.32 110.252 176.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -59.91 -41.71 92.3 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 115.61 -0.723 . . . . 74.23 112.268 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . 0.263 4.2 ppt_? -63.62 -27.62 69.36 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 113.365 0.876 . . . . 71.33 113.365 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.8 p -84.76 -22.14 29.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.441 0.639 . . . . 61.51 111.366 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.0 t -87.02 -12.53 47.13 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.194 -0.912 . . . . 70.12 109.741 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.35 -19.19 60.54 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.305 0.642 . . . . 71.22 111.538 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -75.62 137.95 41.09 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.234 -1.395 . . . . 55.4 107.234 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.1 ptp -52.36 94.48 0.01 OUTLIER 'General case' 0 C--O 1.248 1.012 0 N-CA-C 115.464 1.654 . . . . 73.0 115.464 -173.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 7.4 mmpt? -117.62 -31.74 5.09 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.247 -1.761 . . . . 71.04 106.247 172.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -147.79 -179.91 7.23 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.158 -1.423 . . . . 74.14 107.158 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.504 ' HA ' ' NE ' ' A' ' 75' ' ' ARG . 3.4 mmp_? -111.69 133.53 53.87 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.776 -0.453 . . . . 71.23 109.776 175.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.6 t -82.77 102.66 11.71 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.513 -1.291 . . . . 70.12 107.513 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.432 -1.363 0 N-CA-C 109.366 -0.605 . . . . 62.12 109.366 -175.961 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.469 0 N-CA-C 111.177 -0.769 . . . . 63.22 111.177 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.8 p -83.83 -21.92 31.9 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.799 0.809 . . . . 45.23 110.031 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 -146.72 -166.97 2.63 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 104.632 -2.358 . . . . 73.42 104.632 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t70 76.58 -24.1 0.23 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.658 1.183 . . . . 60.54 112.487 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.62 -5.85 47.47 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 122.45 1.119 . . . . 63.32 109.239 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -138.19 128.78 26.49 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 106.459 -1.682 . . . . 75.11 106.459 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -91.06 -17.78 25.65 Favored 'General case' 0 CA--C 1.488 -1.442 0 CA-C-O 120.726 0.298 . . . . 72.34 110.491 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.415 ' HA ' HD12 ' A' ' 28' ' ' LEU . 26.3 p -84.45 170.05 13.92 Favored 'General case' 0 N--CA 1.411 -2.381 0 C-N-CA 119.586 -0.846 . . . . 73.55 110.534 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 38' ' ' ALA . 75.6 m -61.0 145.86 49.19 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 115.74 1.756 . . . . 43.33 115.74 -171.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.1 tt -90.81 -54.51 3.94 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 105.315 -2.106 . . . . 62.24 105.315 172.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.3 m -165.6 174.65 9.63 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 108.469 -0.937 . . . . 63.12 108.469 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.419 HG12 ' CB ' ' A' ' 50' ' ' CYS . 2.2 m -135.01 157.57 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.389 -1.708 . . . . 74.13 106.389 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.494 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 10.1 t -102.3 177.45 4.87 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.315 -1.365 . . . . 63.21 107.315 175.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -47.3 -67.02 0.32 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.596 0.634 . . . . 75.3 111.739 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 40.2 ttmt -132.49 85.91 46.79 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 119.749 -0.78 . . . . 72.42 109.166 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.534 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 6.7 Cg_endo -47.01 -80.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 124.75 3.633 . . . . 52.14 118.166 -175.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.429 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -138.45 156.83 73.2 Favored Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 121.916 -0.49 . . . . 70.22 111.634 -172.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.464 ' O ' HG12 ' A' ' 21' ' ' ILE . 27.0 Cg_endo -64.99 136.61 49.13 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.722 2.281 . . . . 73.44 111.486 174.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.454 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -77.0 1.45 63.32 Favored Glycine 0 C--N 1.31 -0.909 0 CA-C-N 115.936 -0.575 . . . . 64.51 113.631 -178.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -83.73 -24.84 31.0 Favored 'General case' 0 N--CA 1.414 -2.24 0 O-C-N 122.301 -0.529 . . . . 75.33 110.933 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 18' ' ' PRO . 36.5 pt -90.15 2.01 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 120.353 -0.539 . . . . 75.23 111.699 -177.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.574 HG13 HD11 ' A' ' 65' ' ' LEU . 3.0 p -93.24 134.01 32.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 121.207 0.527 . . . . 53.1 111.526 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.08 -47.35 7.88 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.542 -0.91 . . . . 72.13 108.542 -175.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.46 ' O ' ' HB ' ' A' ' 42' ' ' THR . 10.3 p30 -145.84 157.99 43.88 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.417 -0.957 . . . . 75.51 108.417 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -128.58 152.47 48.28 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.941 -0.763 . . . . 73.2 108.941 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.536 ' HB2' HG22 ' A' ' 40' ' ' VAL . 27.9 m170 -120.63 112.34 18.78 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.218 -1.401 . . . . 74.42 107.218 172.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -84.39 103.47 13.58 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.675 -0.861 . . . . 70.2 108.675 -175.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 8' ' ' CYS . 79.5 mt -109.39 137.93 46.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.45 0.643 . . . . 73.14 111.939 -175.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.1 mt -141.6 178.75 7.24 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.14 -0.936 . . . . 74.12 110.142 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 34' ' ' CYS . 49.0 mt -77.79 -30.27 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.541 -1.281 . . . . 74.55 107.541 174.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -61.52 -25.92 67.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.051 -0.977 . . . . 72.05 109.999 174.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -83.78 -56.3 3.78 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.375 -1.342 . . . . 75.32 107.375 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.6 71.72 0.03 OUTLIER Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.373 -0.918 . . . . 62.41 113.65 173.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.438 ' O ' HG12 ' A' ' 30' ' ' ILE . 49.9 t -161.18 151.97 18.26 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.77 -1.567 . . . . 62.32 106.77 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -74.93 -24.42 58.49 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 120.885 0.374 . . . . 63.31 111.995 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.53 108.08 47.9 Favored Pre-proline 0 C--N 1.3 -1.568 0 CA-C-O 121.429 0.633 . . . . 65.31 111.223 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -84.98 130.68 4.18 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.388 2.058 . . . . 55.31 111.628 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.642 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . . . -176.42 164.12 2.56 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 124.046 0.938 . . . . 65.1 108.862 178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.34 127.98 56.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 109.758 -0.46 . . . . 60.3 109.758 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.689 HG12 ' SG ' ' A' ' 50' ' ' CYS . 3.2 m -88.81 127.9 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.152 0 N-CA-C 108.254 -1.017 . . . . 60.24 108.254 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -97.94 113.0 24.72 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 116.08 -0.509 . . . . 65.34 110.601 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 24' ' ' ASN . 96.9 m -80.48 101.91 9.37 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.484 -0.78 . . . . 73.23 108.962 176.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.6 p -73.43 170.52 14.93 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.328 -0.396 . . . . 74.43 110.873 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 90.3 mt -57.87 -27.98 63.75 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.289 0.636 . . . . 65.24 112.622 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.3 tpp180 -73.02 -20.79 60.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.915 0.388 . . . . 62.3 110.707 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.94 15.96 40.42 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.902 -0.879 . . . . 51.22 110.902 -176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -98.57 133.05 43.46 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.634 -1.617 . . . . 70.32 106.634 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -99.44 130.5 45.71 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.943 -0.762 . . . . 74.15 108.943 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.505 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.3 tm? -136.8 138.61 41.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.903 -1.517 . . . . 72.01 106.903 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.689 ' SG ' HG12 ' A' ' 40' ' ' VAL . 91.0 m -94.83 147.59 23.2 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 114.872 1.434 . . . . 73.43 114.872 -173.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.534 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -130.24 163.03 50.63 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-N 114.908 -1.042 . . . . 62.21 109.847 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 88.9 Cg_endo -78.72 109.85 2.69 Favored 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 122.171 1.914 . . . . 73.24 113.018 -175.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 65.8 Cg_endo -70.04 -18.62 35.6 Favored 'Trans proline' 0 N--CA 1.483 0.886 0 C-N-CA 122.924 2.416 . . . . 72.14 113.232 -174.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.18 -7.98 54.54 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.439 0.638 . . . . 71.34 109.865 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -90.08 135.21 30.32 Favored Pre-proline 0 N--CA 1.442 -0.847 0 CA-C-O 121.17 0.51 . . . . 73.21 111.309 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.408 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 11.8 Cg_endo -54.89 -35.85 90.17 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 124.341 3.361 . . . . 74.21 115.32 -175.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.466 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 37.9 p-90 -63.1 -30.49 71.63 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.88 0.371 . . . . 74.51 111.047 -177.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 62' ' ' ILE . 69.1 t -76.59 -36.62 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 116.076 -0.511 . . . . 64.13 110.89 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 56' ' ' PRO . 38.3 mt-10 -56.36 -45.02 80.66 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.035 0.445 . . . . 53.43 110.551 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.552 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 4.1 mmp_? -57.68 -51.07 71.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.246 -0.888 . . . . 75.53 111.423 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.454 HG21 ' HA3' ' A' ' 19' ' ' GLY . 13.1 pt -70.46 -33.2 52.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 113.335 0.865 . . . . 62.32 113.335 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 58' ' ' VAL . 60.1 mt -60.43 -45.56 96.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 109.459 -0.571 . . . . 71.32 109.459 173.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -57.6 -42.27 82.9 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.313 -0.403 . . . . 61.31 111.322 176.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 60' ' ' ARG . 89.4 mtt180 -59.23 -38.8 80.86 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.92 -0.582 . . . . 73.51 111.718 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.574 HD11 HG13 ' A' ' 22' ' ' VAL . 89.2 mt -79.41 -33.89 42.29 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.309 0.485 . . . . 75.43 112.309 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -68.79 -41.5 78.65 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 120.452 -0.499 . . . . 71.52 112.065 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -63.64 -32.88 74.49 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.041 0.448 . . . . 62.43 110.833 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.8 p -84.35 -19.31 33.84 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.539 0.685 . . . . 74.31 111.593 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.9 t -85.85 -41.23 15.17 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.503 -0.771 . . . . 71.41 109.378 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.31 -44.53 75.22 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.904 -0.589 . . . . 53.13 110.165 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -108.55 98.77 8.24 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.23 -1.026 . . . . 74.22 108.23 173.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -87.36 132.27 34.01 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.833 -1.076 . . . . 75.23 113.13 -172.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -163.48 113.56 1.33 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.185 -0.916 . . . . 75.41 110.137 175.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -99.25 -48.44 4.82 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.821 -0.807 . . . . 73.51 108.821 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -123.51 -66.5 1.0 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.806 -0.813 . . . . 53.13 108.806 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.3 m 62.12 18.88 10.42 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.966 0.907 . . . . 74.12 111.19 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 N--CA 1.415 -2.223 0 N-CA-C 105.894 -1.891 . . . . 50.42 105.894 177.643 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.323 0 CA-C-O 121.391 0.44 . . . . 44.11 112.019 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.6 p -139.07 145.42 39.51 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.287 -1.005 . . . . 72.01 108.287 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -86.64 77.46 9.35 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 119.857 -0.737 . . . . 63.44 110.237 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -174.37 101.61 0.1 Allowed 'General case' 0 CA--C 1.496 -1.112 0 CA-C-N 114.786 -1.097 . . . . 70.32 108.411 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.9 -2.85 46.42 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.046 -0.979 . . . . 62.51 110.213 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 71.79 134.46 0.04 OUTLIER 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 126.704 2.002 . . . . 75.41 109.888 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -81.03 82.02 7.1 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-O 123.013 1.387 . . . . 72.2 110.379 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.402 ' HA ' HD13 ' A' ' 28' ' ' LEU . 27.3 p -157.68 159.69 37.19 Favored 'General case' 0 C--N 1.259 -3.347 0 N-CA-C 104.349 -2.463 . . . . 65.21 104.349 175.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.24 -175.75 3.76 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 117.796 -1.562 . . . . 73.21 110.227 -175.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.2 mt -98.41 -64.69 1.02 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 120.903 0.382 . . . . 72.4 110.709 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.1 t -176.03 153.07 1.26 Allowed 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.146 -1.428 . . . . 65.23 107.146 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.432 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -106.98 160.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 C-N-CA 119.154 -1.019 . . . . 51.44 110.021 -176.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -106.24 179.59 4.22 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.567 -0.901 . . . . 72.52 108.567 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -42.62 -57.27 2.77 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.904 0.881 . . . . 75.3 109.677 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 38.2 ttpt -145.85 97.59 4.55 Favored Pre-proline 0 N--CA 1.428 -1.543 0 N-CA-C 108.4 -0.963 . . . . 74.41 108.4 170.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.595 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 2.6 Cg_endo -39.62 -73.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.712 3.608 . . . . 62.35 116.015 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.401 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -142.38 158.02 61.66 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 107.448 -1.316 . . . . 71.41 107.448 -177.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' O ' HG12 ' A' ' 21' ' ' ILE . 17.9 Cg_endo -63.12 130.78 29.99 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 121.649 1.566 . . . . 72.34 110.558 174.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.524 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -72.26 2.01 30.95 Favored Glycine 0 C--N 1.303 -1.264 0 N-CA-C 115.029 0.772 . . . . 62.43 115.029 -174.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -97.76 -3.71 38.49 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 112.495 0.554 . . . . 75.25 112.495 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.523 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 39.6 pt -103.81 6.4 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 121.379 0.609 . . . . 71.32 110.378 177.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 41' ' ' PHE . 5.1 p -91.63 143.46 11.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.794 -0.639 . . . . 63.52 111.582 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.409 ' HE ' ' C ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -99.88 -56.46 2.37 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.949 -1.13 . . . . 65.52 107.949 -178.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -134.21 166.03 23.74 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.738 -0.838 . . . . 71.43 108.738 -176.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -143.61 161.13 39.3 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.821 -0.437 . . . . 64.51 109.821 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.429 ' HB2' HG22 ' A' ' 40' ' ' VAL . 38.4 m80 -137.68 122.58 18.91 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 110.145 -0.316 . . . . 74.13 110.145 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -75.8 98.19 4.09 Favored 'General case' 0 CA--C 1.498 -1.047 0 O-C-N 123.236 0.335 . . . . 74.12 110.16 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 8' ' ' CYS . 69.5 mt -97.14 134.2 40.79 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-O 121.887 0.851 . . . . 72.44 110.249 177.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.6 mt -125.93 -178.53 4.32 Favored 'General case' 0 C--N 1.256 -3.471 0 N-CA-C 106.725 -1.583 . . . . 70.24 106.725 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.469 HG23 ' HA ' ' A' ' 35' ' ' ARG . 68.2 mt -63.85 -37.88 80.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 120.312 -0.555 . . . . 64.23 109.798 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.471 ' HE2' ' HB2' ' A' ' 31' ' ' LYS . 12.1 ptmm? -59.87 -31.88 70.19 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 114.264 1.209 . . . . 62.42 114.264 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -111.92 -5.35 14.35 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.962 0.41 . . . . 72.25 111.259 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.77 -124.32 3.43 Favored Glycine 0 N--CA 1.417 -2.609 0 CA-C-N 115.857 -0.611 . . . . 25.33 112.726 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 84.7 m -118.01 -87.24 0.63 Allowed 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.398 -0.401 . . . . 73.14 110.404 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.469 ' HA ' HG23 ' A' ' 30' ' ' ILE . 35.9 ttm180 -143.23 15.18 1.86 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.175 0.988 . . . . 71.24 108.824 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 p -127.83 117.85 20.94 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 115.302 -0.863 . . . . 72.02 110.265 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.97 130.17 2.1 Favored 'Trans proline' 0 N--CA 1.433 -2.074 0 C-N-CA 121.929 1.753 . . . . 60.52 110.491 174.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -171.52 154.79 3.9 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.94 -0.763 . . . . 73.13 108.94 -177.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.25 125.43 52.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 108.5 -0.926 . . . . 54.33 108.5 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 26' ' ' HIS . 16.4 m -90.12 128.35 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.008 0 C-N-CA 119.643 -0.823 . . . . 73.02 109.308 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CD1' HG21 ' A' ' 22' ' ' VAL . 15.3 m-85 -95.58 125.52 40.23 Favored 'General case' 0 C--N 1.272 -2.788 0 CA-C-N 115.358 -0.837 . . . . 73.11 110.177 175.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.4 m -93.45 103.65 15.84 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.922 -1.14 . . . . 71.3 107.922 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 71.1 p -70.0 174.36 5.45 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.35 -0.386 . . . . 54.35 111.248 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 95.3 mt -61.2 -27.39 68.39 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.52 0.676 . . . . 52.41 109.724 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -67.57 -28.4 67.74 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 124.718 1.207 . . . . 55.14 110.904 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.08 16.59 40.53 Favored Glycine 0 C--O 1.239 0.45 0 C-N-CA 120.79 -0.719 . . . . 65.21 111.424 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.62 138.39 31.55 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.436 -1.32 . . . . 64.45 107.436 -177.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -91.97 121.18 33.32 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.79 -1.189 . . . . 75.41 107.79 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.483 HD13 ' N ' ' A' ' 50' ' ' CYS . 0.5 OUTLIER -129.67 141.51 50.9 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.363 -0.977 . . . . 73.2 108.363 -178.095 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.483 ' N ' HD13 ' A' ' 49' ' ' LEU . 7.9 m -78.06 129.97 35.87 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.998 0.519 . . . . 64.41 111.081 -173.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.595 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -136.98 157.3 74.94 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 110.037 -0.357 . . . . 61.52 110.037 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.8 109.27 1.97 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.376 2.051 . . . . 71.12 112.798 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 42.5 Cg_endo -67.0 -18.76 52.11 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.833 2.355 . . . . 74.21 113.91 -174.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -96.51 3.66 52.56 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.465 -0.494 . . . . 72.2 112.286 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -97.57 139.24 21.27 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 120.42 -0.512 . . . . 74.4 112.315 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.508 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 83.6 Cg_exo -47.36 -42.81 27.63 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 124.441 3.427 . . . . 75.22 114.55 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -62.52 -27.3 69.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 120.357 -0.537 . . . . 54.12 110.86 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.667 ' O ' HG12 ' A' ' 62' ' ' ILE . 75.4 t -81.75 -50.22 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.878 -0.601 . . . . 64.1 111.264 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.508 ' HG3' ' HA ' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -57.23 -27.01 61.64 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.832 0.678 . . . . 64.21 112.832 -176.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -73.04 -49.66 27.45 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.746 -0.661 . . . . 74.51 110.33 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.524 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.2 pt -71.7 -28.08 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.911 -0.586 . . . . 73.43 111.663 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 58' ' ' VAL . 41.0 mm -54.45 -52.76 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 115.851 -0.613 . . . . 72.14 109.902 173.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -56.58 -38.05 71.46 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.386 0.612 . . . . 71.22 110.3 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.26 -38.4 90.19 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.954 -1.021 . . . . 61.53 109.146 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.546 HD11 HG13 ' A' ' 22' ' ' VAL . 88.3 mt -79.73 -36.94 36.61 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 116.63 -0.259 . . . . 73.52 111.149 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -55.84 -20.28 14.79 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 114.054 1.131 . . . . 74.51 114.054 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -58.81 -32.41 69.33 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 109.539 -0.541 . . . . 61.04 109.539 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 74.9 p -84.64 -19.57 32.7 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.517 0.675 . . . . 65.52 111.067 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.9 t -85.18 -16.95 38.66 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.763 -0.653 . . . . 73.31 109.254 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.8 -29.02 61.93 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 115.609 -0.723 . . . . 72.1 110.17 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.674 ' HD2' ' O ' ' A' ' 71' ' ' LYS 0.306 0.1 OUTLIER -78.13 90.18 4.25 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 122.809 1.29 . . . . 75.44 111.494 177.473 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 25.8 ptm -156.46 139.51 15.43 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.186 -1.37 . . . . 72.54 107.469 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -81.31 71.38 8.3 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.152 0.977 . . . . 72.1 111.4 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -161.88 17.81 0.1 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 105.388 -2.078 . . . . 70.12 105.388 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -150.15 100.85 2.95 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 113.849 -1.523 . . . . 70.11 108.911 -175.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.5 t -101.73 -41.63 6.48 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.903 -1.147 . . . . 62.24 107.903 175.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 N--CA 1.422 -1.858 0 N-CA-C 106.203 -1.777 . . . . 74.31 106.203 178.752 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.662 0 N-CA-C 111.114 -0.794 . . . . 71.05 111.114 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.8 t -89.24 134.54 34.0 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.14 0.495 . . . . 72.45 110.277 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -135.77 134.1 38.65 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.55 -0.537 . . . . 74.33 109.55 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -139.16 165.57 26.82 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.934 -1.136 . . . . 70.21 107.934 -177.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.31 -37.09 86.28 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.309 0.576 . . . . 73.32 110.637 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 46.54 -159.42 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 126.299 1.84 . . . . 64.02 113.929 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -81.95 -31.34 31.3 Favored 'General case' 0 CA--C 1.483 -1.613 0 CA-C-N 115.848 -0.615 . . . . 74.24 111.042 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 27.9 p -124.48 159.76 29.81 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 112.474 0.546 . . . . 72.43 112.474 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.586 ' SG ' HG12 ' A' ' 40' ' ' VAL . 91.6 m -57.86 150.81 19.35 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 116.47 2.026 . . . . 62.52 116.47 -174.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -84.25 -63.98 1.24 Allowed 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 113.867 -1.515 . . . . 75.13 108.13 172.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -167.15 175.72 7.29 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 106.124 -1.806 . . . . 54.04 106.124 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 13' ' ' THR . 2.2 m -133.91 161.25 41.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 107.485 -1.302 . . . . 73.12 107.485 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.7 t -98.78 178.06 5.09 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.127 -1.064 . . . . 61.43 108.127 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -50.5 -60.73 2.72 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.007 0.523 . . . . 72.33 110.769 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 4.8 ttmp? -139.85 86.54 13.46 Favored Pre-proline 0 N--CA 1.428 -1.548 0 N-CA-C 109.367 -0.605 . . . . 71.22 109.367 174.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 7.5 Cg_endo -47.94 -78.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.463 0 C-N-CA 124.565 3.51 . . . . 74.3 117.303 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.405 ' H ' HD13 ' A' ' 17' ' ' ILE . 0.2 OUTLIER -141.32 162.83 45.43 Favored Pre-proline 0 C--N 1.32 -0.701 0 O-C-N 121.791 -0.568 . . . . 65.42 110.365 -175.142 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.599 ' O ' HG12 ' A' ' 21' ' ' ILE . 36.8 Cg_exo -63.05 130.21 28.28 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.135 1.89 . . . . 60.23 110.704 174.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.5 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -73.69 2.04 42.17 Favored Glycine 0 C--N 1.303 -1.293 0 CA-C-N 116.339 -0.391 . . . . 65.31 113.946 -176.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -98.23 0.12 45.14 Favored 'General case' 0 N--CA 1.417 -2.121 0 O-C-N 122.133 -0.628 . . . . 72.31 111.52 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 18' ' ' PRO . 33.7 pt -106.71 9.22 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.452 0.644 . . . . 71.22 110.136 177.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.632 HG13 HD11 ' A' ' 65' ' ' LEU . 2.9 p -96.59 134.94 32.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.733 -0.667 . . . . 74.31 111.817 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.571 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -91.15 -56.02 3.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.73 -0.841 . . . . 74.51 108.73 -176.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.571 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 18.1 m120 -130.17 157.43 42.48 Favored 'General case' 0 CA--C 1.484 -1.589 0 CA-C-N 115.89 -0.596 . . . . 71.31 109.445 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -139.65 152.31 46.65 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 109.19 -0.67 . . . . 71.31 109.19 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.42 ' HB2' HG22 ' A' ' 40' ' ' VAL . 34.3 m170 -122.97 121.72 36.79 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.049 -1.463 . . . . 73.34 107.049 174.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -93.93 114.3 26.49 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 109.607 -0.516 . . . . 74.4 109.607 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.579 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 4.0 mm? -110.23 126.92 54.65 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 116.262 -0.426 . . . . 74.25 111.608 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.7 mt -126.83 176.96 6.89 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.833 -0.802 . . . . 60.53 108.833 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 57.1 mt -74.11 -20.07 17.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 107.701 -1.222 . . . . 75.33 107.701 176.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -58.79 -30.42 67.57 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.726 -1.124 . . . . 73.23 110.071 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.05 -42.45 47.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.597 -0.729 . . . . 74.03 109.988 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.54 -44.89 0.64 Allowed Glycine 0 CA--C 1.503 -0.709 0 C-N-CA 120.458 -0.877 . . . . 74.13 113.039 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 63.4 m -66.86 141.47 57.66 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 110.263 -0.273 . . . . 62.1 110.263 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -79.23 3.44 17.9 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.194 0.521 . . . . 73.34 112.057 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.31 97.94 49.44 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.821 -0.627 . . . . 74.45 110.251 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -80.65 128.96 7.06 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 121.255 1.303 . . . . 63.22 110.137 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.594 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -173.83 161.85 3.88 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 123.145 0.578 . . . . 52.24 109.825 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 50' ' ' CYS . 7.9 p -108.59 128.23 64.41 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 109.381 -0.6 . . . . 75.22 109.381 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.586 HG12 ' SG ' ' A' ' 9' ' ' CYS . 1.4 m -86.3 129.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 107.303 -1.369 . . . . 63.33 107.303 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -104.68 116.65 32.42 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 116.567 -0.288 . . . . 70.21 111.331 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.5 m -85.24 101.57 12.62 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.284 -1.006 . . . . 61.24 108.284 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 63.4 p -73.97 168.67 19.01 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 116.258 -0.428 . . . . 65.03 110.981 -177.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 92.2 mt -59.52 -29.05 67.6 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.121 0.568 . . . . 73.44 111.117 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -71.24 -16.37 62.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.493 -0.776 . . . . 71.41 110.78 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.75 15.83 44.52 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.261 -0.495 . . . . 63.11 112.306 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -94.87 140.06 30.45 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 110.523 -0.177 . . . . 74.22 110.523 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -104.12 109.83 21.78 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.89 -0.595 . . . . 73.12 109.503 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.4 tp -130.03 129.82 44.16 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.756 -0.657 . . . . 73.24 109.263 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.576 ' SG ' HG12 ' A' ' 40' ' ' VAL . 75.4 m -84.48 147.41 27.1 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 113.682 0.993 . . . . 71.35 113.682 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.589 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -126.31 160.55 57.07 Favored Pre-proline 0 N--CA 1.441 -0.911 0 CA-C-N 115.103 -0.953 . . . . 64.33 110.169 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 72.9 Cg_endo -71.98 108.11 2.38 Favored 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.194 1.929 . . . . 75.52 111.936 -175.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.594 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 67.3 Cg_endo -68.35 -30.41 30.14 Favored 'Trans proline' 0 N--CA 1.473 0.265 0 C-N-CA 123.089 2.526 . . . . 64.45 113.388 -171.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -78.4 -26.59 46.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.228 -0.442 . . . . 72.53 111.386 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -66.34 138.25 95.79 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 116.122 -0.49 . . . . 70.42 112.146 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.443 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 78.0 Cg_exo -53.45 -38.66 83.24 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 124.011 3.141 . . . . 34.32 114.699 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.466 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 37.0 p-90 -64.86 -29.96 70.94 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 120.469 -0.493 . . . . 74.13 111.116 -175.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 62' ' ' ILE . 72.3 t -80.07 -30.12 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 116.115 -0.493 . . . . 70.31 111.109 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.9 mt-10 -56.71 -49.73 74.29 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.562 -0.29 . . . . 74.53 110.715 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -61.52 -45.52 93.86 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.179 -0.464 . . . . 73.31 112.208 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.5 HG21 ' HA3' ' A' ' 19' ' ' GLY . 18.0 pt -69.2 -33.8 60.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 113.145 0.794 . . . . 70.44 113.145 -177.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 58' ' ' VAL . 65.3 mt -61.66 -46.93 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 109.411 -0.589 . . . . 72.21 109.411 174.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 13.0 mm100 -60.05 -40.96 91.23 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.776 -0.647 . . . . 43.42 109.475 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -57.95 -51.49 69.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.234 -0.894 . . . . 73.44 109.627 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.632 HD11 HG13 ' A' ' 22' ' ' VAL . 73.7 mt -67.52 -28.97 68.26 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.727 0.64 . . . . 73.02 112.727 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -69.0 -32.31 71.77 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.368 -0.933 . . . . 75.43 110.767 175.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.475 ' O ' ' HG2' ' A' ' 71' ' ' LYS . 31.8 mmt180 -73.04 -37.87 66.71 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.486 -0.325 . . . . 61.52 110.787 178.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.4 p -69.42 -34.36 74.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.451 0.643 . . . . 63.1 110.203 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.3 t -70.35 -34.76 73.02 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.778 -1.101 . . . . 75.4 109.401 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.04 -40.56 82.84 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 116.137 -0.483 . . . . 52.42 110.549 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 67' ' ' ARG . 75.4 mmtt -68.19 -32.11 72.11 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.387 0.613 . . . . 64.05 109.743 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.6 ttt -70.25 -20.32 63.07 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.247 -0.888 . . . . 63.12 109.945 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -89.91 138.21 31.69 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.736 -1.579 . . . . 70.31 106.736 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -73.85 -7.46 52.31 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 111.982 0.364 . . . . 72.1 111.982 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 64.49 98.52 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.463 1.105 . . . . 65.3 111.892 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 m -129.48 -16.64 3.85 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-O 121.973 0.892 . . . . 64.22 108.965 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 106.571 -1.64 . . . . 73.31 106.571 176.783 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.988 0 N-CA-C 110.985 -0.846 . . . . 64.15 110.985 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.3 p -66.22 117.59 8.72 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 120.992 0.425 . . . . 74.11 110.99 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -127.21 100.71 6.19 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.681 -0.691 . . . . 71.41 109.42 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -99.63 117.25 33.6 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.743 -0.662 . . . . 71.31 110.238 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.21 -8.5 32.82 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.349 -0.841 . . . . 71.13 110.104 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.47 144.06 51.54 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.597 -1.183 . . . . 71.33 112.124 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.43 -33.48 71.38 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.14 -0.936 . . . . 74.5 108.82 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.449 ' HA ' ' CD1' ' A' ' 28' ' ' LEU . 14.7 p -83.24 -176.41 6.31 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.824 -1.08 . . . . 51.53 109.904 174.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -87.82 -171.58 3.48 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.835 -0.746 . . . . 62.43 111.665 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.0 -68.05 0.82 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.395 -0.594 . . . . 72.34 109.395 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -168.04 153.83 7.17 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.259 -1.015 . . . . 75.21 108.259 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.547 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.9 m -115.8 162.09 14.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 119.839 -0.744 . . . . 54.3 109.973 -175.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -105.75 177.64 4.79 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.012 -1.477 . . . . 71.23 107.012 172.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -53.82 -50.03 67.07 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 118.656 0.662 . . . . 51.13 111.53 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.508 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 87.4 tttt -143.6 83.7 10.49 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-O 121.0 0.429 . . . . 64.12 110.153 175.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.5 Cg_endo -47.38 -77.77 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.456 3.438 . . . . 71.33 117.429 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.48 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -134.15 166.3 30.23 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 110.058 -0.349 . . . . 73.34 110.058 -173.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.585 ' O ' HG12 ' A' ' 21' ' ' ILE . 44.7 Cg_exo -61.26 127.92 23.48 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.253 1.968 . . . . 51.24 111.004 175.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.48 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -80.65 0.17 86.38 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 114.594 0.598 . . . . 64.4 114.594 -175.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.53 -1.16 39.05 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 122.034 -0.686 . . . . 73.44 112.841 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 18' ' ' PRO . 34.8 pt -100.21 7.46 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 CA-C-O 121.633 0.73 . . . . 73.12 110.36 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.53 HG13 HD11 ' A' ' 65' ' ' LEU . 2.5 p -89.25 136.12 24.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 115.33 -0.85 . . . . 61.43 111.75 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.442 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 1.0 OUTLIER -86.16 -55.68 3.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.031 -1.1 . . . . 73.13 108.031 -176.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.442 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 17.5 m120 -141.65 160.31 40.43 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 124.281 1.032 . . . . 72.0 108.713 177.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -131.97 156.8 45.55 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.694 -0.403 . . . . 65.31 110.068 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.535 ' HB2' HG22 ' A' ' 40' ' ' VAL . 28.0 m170 -123.56 112.54 17.57 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.299 -1.371 . . . . 73.44 107.299 172.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -82.91 99.8 10.0 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.513 -1.291 . . . . 72.42 107.513 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.449 ' CD1' ' HA ' ' A' ' 8' ' ' CYS . 77.4 mt -112.58 134.72 53.96 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.54 0.686 . . . . 73.42 111.803 -173.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 94.6 mt -142.32 169.71 17.08 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.043 -0.98 . . . . 72.35 110.755 -173.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.9 mt -77.97 -30.36 16.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 106.629 -1.619 . . . . 61.25 106.629 171.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -56.22 -39.5 72.6 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 114.571 -1.195 . . . . 73.44 110.368 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.94 -57.6 3.8 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.981 -1.118 . . . . 74.22 107.981 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.44 85.96 0.08 OUTLIER Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.973 -1.108 . . . . 72.42 114.299 174.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.1 t -168.54 172.52 8.1 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 105.691 -1.966 . . . . 73.4 105.691 174.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -88.17 -3.05 58.93 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.228 1.195 . . . . 74.33 114.228 -173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 p -148.95 122.77 4.66 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-O 120.972 0.415 . . . . 70.22 111.256 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -87.28 130.15 2.85 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.473 2.115 . . . . 61.13 112.546 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -176.25 150.05 0.9 Allowed 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.481 -0.933 . . . . 60.13 108.481 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -98.41 127.41 50.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.401 -1.333 . . . . 74.45 107.401 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 26' ' ' HIS . 6.2 m -92.3 125.12 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.15 0 C-N-CA 119.307 -0.957 . . . . 75.51 108.849 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -99.26 113.16 25.29 Favored 'General case' 0 C--N 1.272 -2.79 0 CA-C-N 115.459 -0.791 . . . . 72.13 109.729 175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 77.2 m -80.69 102.43 9.88 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 108.895 -0.78 . . . . 72.31 108.895 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.1 p -69.23 167.83 15.43 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.123 -0.489 . . . . 63.42 110.811 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 93.7 mt -59.13 -29.09 67.14 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.205 0.526 . . . . 53.53 110.26 178.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -64.75 -26.6 68.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.078 -0.964 . . . . 71.14 111.055 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.69 17.18 19.93 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.22 -0.991 . . . . 44.13 112.145 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -103.36 125.89 50.23 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 122.684 -0.304 . . . . 72.22 111.244 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.08 112.82 19.49 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.69 -1.226 . . . . 75.33 107.69 172.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 50' ' ' CYS . 0.9 OUTLIER -115.09 141.55 47.85 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.679 -0.86 . . . . 73.24 108.679 -176.074 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.547 ' HB3' HG12 ' A' ' 12' ' ' VAL . 9.4 m -79.15 119.73 22.66 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 123.061 0.545 . . . . 64.53 111.13 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.623 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -122.85 155.55 63.42 Favored Pre-proline 0 C--O 1.243 0.733 0 C-N-CA 120.346 -0.541 . . . . 74.43 111.944 174.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 98.0 Cg_endo -78.08 110.85 2.97 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.646 2.231 . . . . 71.53 114.427 -172.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.05 -1.19 8.3 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.752 2.301 . . . . 62.2 112.556 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -103.3 -3.29 25.82 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.493 -0.321 . . . . 74.53 111.08 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 29.7 mm-40 -103.82 132.8 20.69 Favored Pre-proline 0 C--N 1.311 -1.106 0 C-N-CA 120.309 -0.556 . . . . 63.22 112.435 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 98.6 Cg_exo -49.07 -32.62 24.38 Favored 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 124.552 3.501 . . . . 74.5 115.046 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.508 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 31.0 p-90 -68.18 -30.19 69.23 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 120.4 -0.52 . . . . 75.41 109.902 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 62' ' ' ILE . 70.9 t -78.94 -40.97 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.212 -0.662 . . . . 60.14 109.212 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 42.4 mt-10 -59.68 -25.05 64.44 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.341 -0.845 . . . . 75.42 112.411 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -83.34 -43.39 16.01 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.294 0.479 . . . . 65.41 112.294 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.48 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.2 pt -70.89 -33.73 53.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 112.867 0.691 . . . . 74.33 112.867 -177.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 58' ' ' VAL . 64.3 mt -57.11 -40.82 75.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 116.064 -0.516 . . . . 75.53 110.062 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 78.8 mm-40 -59.28 -43.1 92.55 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.1 -0.5 . . . . 63.31 111.328 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -59.47 -52.29 66.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.522 0.514 . . . . 73.23 110.862 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.53 HD11 HG13 ' A' ' 22' ' ' VAL . 86.3 mt -67.95 -26.36 65.91 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.254 -0.578 . . . . 71.04 112.472 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 27.8 mt-30 -67.59 -21.77 65.41 Favored 'General case' 0 C--O 1.215 -0.733 0 O-C-N 121.965 -0.459 . . . . 54.13 111.917 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.639 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -72.62 -37.84 67.95 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.538 -0.542 . . . . 73.54 109.538 177.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.5 p -82.3 -36.57 26.86 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.018 -0.537 . . . . 63.22 111.763 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.1 m -71.81 -18.22 62.11 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.82 -0.627 . . . . 73.34 111.397 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.55 -32.85 64.4 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.979 0.418 . . . . 62.14 110.657 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -121.03 79.8 1.56 Allowed 'General case' 0 N--CA 1.428 -1.537 0 CA-C-O 122.287 1.041 . . . . 71.2 109.165 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.7 tpt 179.38 165.6 1.03 Allowed 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 104.854 -2.276 . . . . 73.44 104.854 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -66.81 131.24 45.52 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.975 -0.75 . . . . 74.33 108.975 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -77.48 139.63 39.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.324 0.583 . . . . 55.14 111.303 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -84.92 -35.81 21.87 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.658 -0.701 . . . . 74.23 112.757 -172.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.1 m -75.82 2.21 12.89 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 113.459 0.911 . . . . 44.31 113.459 -175.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.8 m . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.295 -0.86 . . . . 74.4 110.22 177.616 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.631 0 N-CA-C 111.061 -0.816 . . . . 44.14 111.061 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.6 m -135.31 78.71 1.74 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 121.755 0.788 . . . . 73.02 110.014 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -140.36 88.1 2.18 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.299 -1.371 . . . . 71.15 107.299 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -88.9 102.32 14.93 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.668 -0.696 . . . . 72.33 110.464 -178.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.96 -16.24 30.31 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.682 0.753 . . . . 61.24 109.633 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.85 118.83 37.15 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.586 -1.188 . . . . 70.24 110.361 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.36 -57.78 3.02 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.813 -0.81 . . . . 63.41 108.813 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.8 p -86.87 147.65 25.71 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 107.817 -1.179 . . . . 62.44 107.817 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.578 ' HB2' HG12 ' A' ' 40' ' ' VAL . 4.4 t -76.74 142.14 40.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.027 -0.731 . . . . 74.4 109.027 -173.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.481 ' O ' HG21 ' A' ' 36' ' ' VAL . 73.7 mt -68.89 -44.64 72.82 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 116.828 2.158 . . . . 60.03 116.828 -170.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.8 m -164.49 137.18 4.82 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.759 -0.776 . . . . 74.12 111.293 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' A' ' 50' ' ' CYS . 1.0 OUTLIER -102.05 161.21 3.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.459 -0.941 . . . . 64.03 108.459 -178.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.9 t -105.54 178.76 4.47 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.098 -1.075 . . . . 72.32 108.098 175.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -49.17 -40.61 33.65 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.615 0.766 . . . . 64.15 111.069 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 38.0 ttpt -157.7 92.1 2.24 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 109.078 -0.712 . . . . 64.43 109.078 171.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.608 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.2 Cg_endo -40.07 -67.16 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 124.765 3.644 . . . . 72.54 116.688 -178.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.443 ' HB ' ' HD2' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -147.03 166.25 16.79 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 75.32 109.695 -176.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.545 ' O ' HG12 ' A' ' 21' ' ' ILE . 32.1 Cg_exo -60.4 128.6 26.63 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.068 1.845 . . . . 42.43 109.632 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -73.47 0.89 46.65 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 115.887 1.115 . . . . 52.2 115.887 -172.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -98.46 -7.51 28.4 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 117.772 0.786 . . . . 72.55 112.417 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 18' ' ' PRO . 35.4 pt -92.84 3.94 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 121.58 0.705 . . . . 71.45 111.098 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 41' ' ' PHE . 2.2 p -88.12 135.82 24.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.292 -0.867 . . . . 74.22 112.411 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -86.44 -56.07 3.6 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.434 1.094 . . . . 65.53 108.523 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -146.97 170.15 17.69 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.811 -1.086 . . . . 72.02 108.59 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.604 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 47.2 p90 -141.68 155.94 45.66 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.978 -0.378 . . . . 74.13 109.978 -175.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.412 ' HB2' HG22 ' A' ' 40' ' ' VAL . 28.1 m170 -133.82 121.95 22.54 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.627 -0.509 . . . . 75.34 109.627 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' OH ' HG21 ' A' ' 62' ' ' ILE . 54.1 m-85 -78.31 103.89 8.55 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 123.208 0.318 . . . . 74.42 110.168 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.1 mt -108.76 131.55 54.84 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.484 -0.887 . . . . 75.22 110.983 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.4 mt -133.94 -177.98 4.81 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.142 -0.936 . . . . 50.54 109.131 -174.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 63.1 mt -71.67 -24.15 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 120.477 -0.489 . . . . 71.25 109.777 176.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.642 ' HE3' ' C ' ' A' ' 31' ' ' LYS 0.364 0.0 OUTLIER -67.26 -10.02 46.47 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.687 0.995 . . . . 73.43 113.687 176.415 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.521 ' N ' ' HE3' ' A' ' 31' ' ' LYS . 22.2 m-20 -83.76 -5.42 59.19 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.352 0.596 . . . . 73.21 109.733 171.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.37 43.2 8.72 Favored Glycine 0 N--CA 1.434 -1.489 0 CA-C-N 115.089 -0.96 . . . . 33.42 111.464 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 11.1 t -135.56 155.37 50.59 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.09 -1.818 . . . . 74.02 106.09 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -92.75 14.52 16.99 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 115.501 1.667 . . . . 74.24 115.501 -168.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 10' ' ' LEU . 3.7 p -153.11 116.3 2.78 Favored Pre-proline 0 C--N 1.312 -1.043 0 CA-C-O 121.328 0.585 . . . . 73.4 112.544 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -83.84 134.93 6.47 Favored 'Trans proline' 0 C--O 1.252 1.181 0 C-N-CA 122.645 2.23 . . . . 74.24 112.898 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -176.18 153.94 1.33 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.183 0.993 . . . . 74.13 108.562 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 53' ' ' PRO . 8.6 p -99.11 128.28 50.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.355 -1.35 . . . . 61.13 107.355 175.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 9' ' ' CYS . 14.8 m -91.55 127.98 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.491 0 C-N-CA 119.299 -0.96 . . . . 74.1 110.083 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.572 ' CD1' HG21 ' A' ' 22' ' ' VAL . 4.9 m-85 -91.29 116.87 29.18 Favored 'General case' 0 C--N 1.273 -2.755 0 CA-C-N 115.099 -0.955 . . . . 74.44 109.79 173.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 99.0 m -89.78 106.79 18.7 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 107.721 -1.214 . . . . 61.21 107.721 176.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 69.5 p -69.73 174.18 5.41 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 123.19 0.306 . . . . 70.3 111.321 -177.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 91.6 mt -58.0 -33.23 68.7 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.214 0.531 . . . . 70.0 110.73 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -69.58 -18.93 63.67 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.617 -0.719 . . . . 64.2 110.882 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.58 16.71 33.26 Favored Glycine 0 CA--C 1.499 -0.956 0 C-N-CA 120.536 -0.84 . . . . 74.41 111.729 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.564 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 1.8 mmp_? -95.87 144.24 26.38 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-O 120.693 0.282 . . . . 74.21 110.668 -177.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -105.6 131.09 53.41 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.505 -0.77 . . . . 53.14 110.151 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.402 HD23 HG23 ' A' ' 17' ' ' ILE . 31.3 tp -132.87 150.89 52.12 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.886 -0.783 . . . . 73.43 108.886 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.479 ' HB3' HG12 ' A' ' 12' ' ' VAL . 4.9 m -77.68 123.9 27.26 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 110.087 -0.338 . . . . 70.04 110.087 -175.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.608 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -132.66 157.57 77.98 Favored Pre-proline 0 C--O 1.243 0.747 0 CA-C-N 118.31 0.505 . . . . 53.02 109.933 174.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.34 109.34 2.3 Favored 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.055 1.837 . . . . 51.23 113.46 -174.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.42 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 54.8 Cg_endo -70.74 -12.78 31.54 Favored 'Trans proline' 0 N--CA 1.483 0.855 0 C-N-CA 122.779 2.319 . . . . 71.21 113.685 -174.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -96.12 -20.44 18.63 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.232 -0.44 . . . . 74.22 111.385 -176.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -80.06 145.22 60.51 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 113.938 1.088 . . . . 71.23 113.938 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -51.24 -43.47 48.76 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.812 3.675 . . . . 73.3 115.734 -175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.423 ' O ' HG12 ' A' ' 61' ' ' ILE . 39.5 p-90 -64.53 -36.29 83.74 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.137 -0.625 . . . . 74.45 111.289 -175.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 62' ' ' ILE . 76.6 t -69.53 -47.29 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.849 -0.614 . . . . 70.01 111.765 -177.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.532 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 10.1 pt-20 -61.62 -32.83 72.98 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 112.314 0.487 . . . . 64.23 112.314 -177.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.532 ' HE ' ' HG3' ' A' ' 59' ' ' GLU . 5.6 mmp_? -66.15 -51.93 53.18 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.094 0.473 . . . . 75.24 110.648 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.465 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 8.0 pt -64.58 -34.69 71.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.735 -0.666 . . . . 72.0 111.989 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.604 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 39.8 mt -57.4 -43.98 83.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.315 -0.402 . . . . 71.54 111.382 173.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.436 ' HA ' ' OE1' ' A' ' 63' ' ' GLN . 13.7 mm-40 -63.54 -36.72 84.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.973 0.416 . . . . 73.14 110.709 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 29.7 mmt180 -64.82 -34.08 77.52 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.618 -0.719 . . . . 72.41 111.011 177.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.521 HD11 HG13 ' A' ' 22' ' ' VAL . 90.4 mt -77.31 -34.93 55.32 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.767 -0.373 . . . . 75.14 110.992 176.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -76.78 -18.75 58.25 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.241 0.83 . . . . 72.21 113.241 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 40.7 ptt180 -65.34 -6.69 10.64 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.712 0.634 . . . . 54.42 112.712 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.5 p -62.73 -28.34 69.89 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 122.085 0.945 . . . . 71.44 109.754 174.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.0 m -76.03 -13.7 60.22 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 114.569 -1.196 . . . . 62.23 111.246 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.52 -21.86 48.21 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.177 -0.675 . . . . 64.44 109.177 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -80.35 -17.51 51.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.138 -0.937 . . . . 51.1 108.512 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 49.0 ttm -80.03 150.72 30.28 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.348 -0.842 . . . . 64.04 108.989 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -75.03 100.62 4.23 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.943 -0.762 . . . . 75.12 108.943 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -135.55 146.66 48.25 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.639 -1.245 . . . . 73.22 107.639 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 64.45 93.5 0.06 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 123.766 0.666 . . . . 73.31 110.44 -174.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.9 t -79.31 -31.76 43.29 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.217 -0.447 . . . . 71.43 110.579 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.432 -1.345 0 N-CA-C 109.344 -0.613 . . . . 54.33 109.344 179.575 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.327 0 N-CA-C 109.986 -1.246 . . . . 63.4 109.986 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.6 m 66.34 -71.82 0.09 Allowed 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.864 0.866 . . . . 63.54 111.94 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -102.5 127.08 49.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.901 0.382 . . . . 72.24 110.268 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -133.44 76.77 1.69 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.833 0.825 . . . . 51.2 109.451 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.71 -4.26 44.48 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.887 -1.051 . . . . 71.52 111.289 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -106.85 146.88 30.42 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.344 -0.844 . . . . 74.34 111.269 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -138.91 10.64 2.63 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.826 -1.176 . . . . 73.42 107.826 176.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.616 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 49.3 t -102.6 -178.11 3.59 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.627 -1.169 . . . . 74.03 111.025 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.418 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 97.4 m -84.44 166.18 17.52 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.744 0.818 . . . . 54.31 112.761 -177.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.51 -53.01 2.88 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.189 -1.411 . . . . 74.12 107.189 172.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.1 m -167.64 178.57 5.27 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.063 -1.458 . . . . 61.41 107.063 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.427 HG12 ' CB ' ' A' ' 50' ' ' CYS . 3.1 m -133.64 148.79 30.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.055 -1.461 . . . . 72.15 107.055 173.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 10.9 t -92.11 178.76 5.77 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.262 -1.014 . . . . 53.51 108.262 177.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -47.53 -69.89 0.11 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.532 0.733 . . . . 74.24 111.38 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 61.1 mtpt -132.74 80.87 60.35 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 109.477 -0.564 . . . . 71.53 109.477 174.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.9 Cg_endo -43.64 -83.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 125.277 3.985 . . . . 70.11 118.935 -172.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -138.28 157.96 71.68 Favored Pre-proline 0 C--N 1.32 -0.713 0 O-C-N 122.164 -0.335 . . . . 72.33 110.451 -173.076 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.27 136.77 45.02 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.501 2.134 . . . . 62.1 111.354 178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.542 ' HA3' HG21 ' A' ' 61' ' ' ILE . . . -77.57 1.22 67.28 Favored Glycine 0 C--O 1.218 -0.878 0 CA-C-O 121.868 0.705 . . . . 41.11 112.006 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -77.04 -28.12 54.72 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-N 115.051 -0.575 . . . . 73.12 110.6 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.1 pt -98.67 8.63 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 120.691 -0.404 . . . . 72.31 112.011 -176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.431 HG13 HD11 ' A' ' 65' ' ' LEU . 7.7 p -95.39 138.27 21.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.106 0.479 . . . . 70.11 111.115 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.9 -56.06 3.23 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.461 -0.94 . . . . 71.22 108.461 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -145.91 174.31 11.37 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 124.232 1.013 . . . . 73.31 108.602 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -140.57 169.29 17.92 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.518 -0.473 . . . . 71.2 110.357 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.482 ' HB2' HG22 ' A' ' 40' ' ' VAL . 34.0 m80 -129.1 129.03 44.69 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 105.137 -2.171 . . . . 72.1 105.137 171.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -97.46 109.38 22.15 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 107.906 -1.146 . . . . 64.55 107.906 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.616 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 3.3 mm? -98.1 117.83 33.34 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.0 0.428 . . . . 63.04 111.342 -174.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.9 mt -124.93 -179.09 4.39 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.538 -0.912 . . . . 75.32 108.538 174.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 52.2 mt -71.11 -21.01 21.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.544 -0.91 . . . . 53.0 108.544 176.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -59.04 -32.88 70.15 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.983 -1.008 . . . . 71.24 109.834 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -80.3 -6.41 57.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.664 -0.698 . . . . 60.12 110.6 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.08 34.33 12.99 Favored Glycine 0 CA--C 1.498 -1.02 0 C-N-CA 121.108 -0.568 . . . . 33.44 112.246 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 46.3 t -123.08 145.95 48.12 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.649 -0.871 . . . . 71.34 108.649 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.607 ' O ' ' HD3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -79.79 -36.02 37.65 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.534 -0.543 . . . . 63.44 109.534 -177.524 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.7 p -98.04 103.89 19.71 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 121.132 0.491 . . . . 74.4 111.438 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 35' ' ' ARG . 92.7 Cg_endo -84.0 130.11 4.81 Favored 'Trans proline' 0 N--CA 1.441 -1.59 0 C-N-CA 121.707 1.605 . . . . 62.44 111.588 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HA ' ' HG3' ' A' ' 53' ' ' PRO . . . -172.65 -179.78 2.23 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 124.212 1.005 . . . . 53.44 108.857 -177.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -119.04 130.03 74.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 120.228 -0.589 . . . . 71.45 110.077 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.777 HG12 ' SG ' ' A' ' 50' ' ' CYS . 4.4 m -89.26 130.94 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.989 0 N-CA-C 108.186 -1.042 . . . . 65.11 108.186 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -98.32 114.82 27.26 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 109.633 -0.506 . . . . 74.05 109.633 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 86.2 m -84.34 102.19 12.52 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.203 -1.036 . . . . 63.13 108.203 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 51.5 p -72.03 169.93 14.93 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.488 -0.324 . . . . 64.02 111.31 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.67 -25.46 66.37 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.492 0.717 . . . . 75.32 112.334 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -83.27 -4.04 58.04 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.227 0.537 . . . . 71.02 110.89 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.13 16.13 56.35 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 120.802 -0.713 . . . . 61.33 112.319 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.466 ' HD3' ' HA ' ' A' ' 47' ' ' ARG . 36.1 mmt180 -99.64 130.24 45.85 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 112.521 0.563 . . . . 74.42 112.521 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -95.92 122.02 38.27 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.157 -0.928 . . . . 72.22 109.545 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 50' ' ' CYS . 1.7 tm? -134.92 138.24 43.9 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.407 -1.701 . . . . 64.54 106.407 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.777 ' SG ' HG12 ' A' ' 40' ' ' VAL . 73.5 m -98.0 147.35 24.59 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 114.828 1.418 . . . . 73.44 114.828 -172.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.556 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -128.84 159.1 70.14 Favored Pre-proline 0 C--O 1.243 0.752 0 CA-C-N 115.227 -0.897 . . . . 63.35 110.999 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 55.6 Cg_endo -64.88 108.88 1.17 Allowed 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.185 2.59 . . . . 60.21 113.226 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HG3' ' HA ' ' A' ' 38' ' ' ALA . 64.1 Cg_endo -67.71 -9.8 26.67 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 C-N-CA 123.024 2.483 . . . . 74.15 114.054 -175.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -95.49 -22.69 17.51 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.932 0.396 . . . . 75.25 111.292 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -76.08 130.34 78.29 Favored Pre-proline 0 C--N 1.312 -1.037 0 N-CA-C 112.801 0.667 . . . . 74.14 112.801 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.38 -41.63 17.68 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.915 3.744 . . . . 64.54 114.809 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -63.3 -26.89 68.98 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 120.93 0.395 . . . . 74.41 110.897 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 62' ' ' ILE . 74.9 t -82.86 -42.39 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.93 -0.577 . . . . 71.0 111.869 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 63' ' ' GLN 0.305 0.2 OUTLIER -66.34 -30.88 71.37 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.929 1.085 . . . . 73.45 113.929 -174.477 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -61.32 -49.94 74.97 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.041 0.448 . . . . 72.15 110.672 176.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.542 HG21 ' HA3' ' A' ' 19' ' ' GLY . 10.7 pt -69.12 -31.63 50.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.904 -0.589 . . . . 74.03 112.173 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 58' ' ' VAL . 56.4 mt -59.13 -50.08 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 110.156 -0.312 . . . . 61.15 110.156 171.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 29.7 mm-40 -62.58 -36.78 83.78 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.14 0.495 . . . . 61.31 109.947 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 38.8 ttm180 -57.96 -48.25 80.51 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.7 -1.136 . . . . 53.32 110.817 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.431 HD11 HG13 ' A' ' 22' ' ' VAL . 82.8 mt -70.71 -30.39 66.94 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 116.543 -0.299 . . . . 64.24 110.699 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -55.86 -18.92 9.92 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 114.424 1.268 . . . . 75.22 114.424 177.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 64' ' ' ARG . 15.4 ptm180 -53.82 -32.87 54.34 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 120.731 0.3 . . . . 55.45 110.643 176.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.3 p -73.72 -31.06 63.2 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.469 0.652 . . . . 43.11 110.392 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.1 t -78.97 -34.27 44.4 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.174 -0.921 . . . . 44.0 109.38 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.84 -21.56 62.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.697 0.76 . . . . 74.33 110.012 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -83.68 -23.29 31.79 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.033 -0.985 . . . . 71.41 109.21 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 16.7 tpt -93.02 104.39 16.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.544 -0.753 . . . . 74.24 109.865 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.01 106.83 14.23 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 116.086 -0.507 . . . . 73.45 110.141 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 73.41 100.89 0.07 Allowed 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.127 1.371 . . . . 70.42 111.109 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -102.42 142.51 33.51 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.895 -0.593 . . . . 70.33 110.144 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.7 p -96.35 76.57 2.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.493 0.664 . . . . 60.11 110.199 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--N 1.303 -1.453 0 N-CA-C 107.751 -1.203 . . . . 65.42 107.751 179.81 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.77 0 N-CA-C 111.166 -0.773 . . . . 73.41 111.166 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 t -156.65 157.57 35.46 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.394 -0.965 . . . . 73.44 108.394 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -81.71 -51.11 8.52 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.024 -1.473 . . . . 72.35 107.024 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -176.42 163.53 2.49 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.989 -1.485 . . . . 72.52 106.989 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.22 -17.42 39.91 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.261 0.553 . . . . 71.25 111.811 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -98.08 152.6 19.14 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 112.889 0.7 . . . . 74.32 112.889 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -84.59 -29.56 25.71 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.197 -1.409 . . . . 63.25 107.197 174.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.67 ' HA ' ' HG ' ' A' ' 28' ' ' LEU . 74.6 m -84.16 173.67 10.85 Favored 'General case' 0 N--CA 1.402 -2.839 0 CA-C-N 114.088 -1.414 . . . . 62.31 110.381 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.429 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -107.1 -179.92 4.07 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.063 -0.655 . . . . 74.3 109.574 -176.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -118.13 -51.83 2.42 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.711 1.374 . . . . 74.02 114.711 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.6 p -153.21 136.3 15.59 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.142 -0.623 . . . . 72.32 111.615 -171.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.4 m -102.76 153.72 5.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 119.539 -0.864 . . . . 65.44 108.879 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.6 t -99.59 179.01 4.68 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.111 -0.699 . . . . 55.43 109.111 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -39.36 -51.52 2.07 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.591 1.157 . . . . 71.44 111.628 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 40.3 ttmt -159.55 94.53 1.7 Allowed Pre-proline 0 N--CA 1.427 -1.622 0 N-CA-C 108.254 -1.017 . . . . 70.45 108.254 171.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 1.6 Cg_endo -39.44 -82.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.738 3.625 . . . . 61.44 117.837 -173.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.421 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -143.72 161.4 46.58 Favored Pre-proline 0 N--CA 1.475 0.816 0 N-CA-C 109.452 -0.573 . . . . 64.43 109.452 -175.085 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.508 ' O ' HG12 ' A' ' 21' ' ' ILE . 19.5 Cg_endo -61.74 129.24 26.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.845 1.696 . . . . 72.44 110.443 172.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.532 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -74.0 2.19 43.9 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 114.79 0.676 . . . . 74.01 114.79 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -93.64 -9.4 38.09 Favored 'General case' 0 C--N 1.281 -2.383 0 O-C-N 121.953 -0.733 . . . . 73.3 112.298 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 18' ' ' PRO . 39.5 pt -96.89 0.58 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.508 0.67 . . . . 54.31 111.039 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.628 HG13 HD11 ' A' ' 65' ' ' LEU . 2.6 p -87.46 133.4 30.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 115.542 -0.753 . . . . 75.23 111.102 178.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.523 ' HD2' ' OD1' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -84.78 -53.76 5.13 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.882 -1.155 . . . . 71.14 107.882 -176.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.523 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 18.6 m120 -139.73 147.85 41.46 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-N 115.115 -0.948 . . . . 73.4 108.844 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.447 ' CZ ' HG23 ' A' ' 62' ' ' ILE . 43.1 p90 -114.65 152.69 31.48 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.509 -0.922 . . . . 73.2 108.509 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.574 ' HB2' HG22 ' A' ' 40' ' ' VAL . 28.8 m170 -118.52 128.64 54.78 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.3 -1.741 . . . . 72.15 106.3 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -97.33 109.48 22.22 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.684 -0.858 . . . . 75.33 108.684 -175.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.67 ' HG ' ' HA ' ' A' ' 8' ' ' CYS . 2.4 mm? -103.11 122.09 43.96 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.318 -0.401 . . . . 61.23 110.115 -176.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.7 mt -128.8 172.33 11.39 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.457 -0.338 . . . . 74.21 110.272 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.589 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 47.7 mt -77.72 -20.89 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.096 -1.446 . . . . 55.21 107.096 176.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -63.94 -27.12 68.93 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.212 -1.358 . . . . 71.11 109.165 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.53 -12.05 41.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.475 -0.784 . . . . 71.4 110.488 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.61 -47.31 1.03 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.187 -0.53 . . . . 54.32 114.316 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 71.0 m -62.48 137.55 58.28 Favored 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 112.366 0.506 . . . . 60.24 112.366 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -71.13 -20.19 62.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 73.43 111.874 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.05 106.91 58.53 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-O 121.203 0.525 . . . . 71.33 111.159 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -85.57 130.21 3.76 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.282 1.988 . . . . 65.12 111.655 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . . . -171.72 153.5 3.38 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.867 -0.79 . . . . 74.32 108.867 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.04 131.72 46.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.201 -1.037 . . . . 73.11 108.201 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.574 HG22 ' HB2' ' A' ' 26' ' ' HIS . 16.8 m -98.99 129.78 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.798 0 C-N-CA 119.535 -0.866 . . . . 73.21 109.492 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -96.44 115.44 27.43 Favored 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 115.234 -0.894 . . . . 60.1 110.903 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 24' ' ' ASN . 53.2 m -85.74 105.13 16.05 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 123.786 0.679 . . . . 73.42 109.412 175.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.1 p -71.78 173.28 8.41 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.977 -0.556 . . . . 60.21 111.002 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 98.7 mt -63.25 -28.39 69.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 121.373 0.606 . . . . 74.23 110.062 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -64.83 -32.99 74.95 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.252 -0.886 . . . . 73.24 110.321 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.26 -3.85 25.23 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 120.77 -0.729 . . . . 64.23 112.048 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 42' ' ' THR . 27.1 mmt180 -75.69 137.82 40.9 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 111.84 0.311 . . . . 73.24 111.84 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -103.95 112.51 25.51 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.875 -1.157 . . . . 64.14 107.875 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 24.0 tp -114.76 145.35 42.2 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.263 -0.575 . . . . 54.2 109.653 -176.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 6.7 m -78.03 133.41 37.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.784 -0.45 . . . . 64.12 109.784 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.57 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -137.6 155.65 75.13 Favored Pre-proline 0 C--N 1.312 -1.065 0 N-CA-C 109.811 -0.44 . . . . 73.02 109.811 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 86.5 Cg_endo -71.24 111.32 3.06 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.993 2.462 . . . . 72.32 112.824 -175.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 57.9 Cg_endo -70.23 -12.45 32.03 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.691 2.261 . . . . 74.32 114.328 -173.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -113.08 9.73 18.63 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.531 0.567 . . . . 74.14 112.531 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 25.1 mm-40 -91.54 139.05 25.02 Favored Pre-proline 0 C--N 1.32 -0.683 0 O-C-N 122.313 -0.242 . . . . 71.13 110.999 176.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 83.3 Cg_exo -49.83 -43.16 42.06 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 124.086 3.191 . . . . 74.25 114.714 -175.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.5 ' O ' HG12 ' A' ' 61' ' ' ILE . 40.3 p-90 -62.92 -37.46 87.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.307 -0.557 . . . . 74.34 110.518 -177.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 62' ' ' ILE . 78.6 t -72.81 -43.67 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.707 -0.679 . . . . 63.03 110.602 178.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 43.7 mt-10 -53.07 -41.54 64.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.094 0.473 . . . . 73.13 110.88 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -72.97 -41.46 64.36 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.695 0.628 . . . . 75.34 112.695 -177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.532 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 11.7 pt -71.56 -32.69 46.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 112.561 0.578 . . . . 75.43 112.561 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.447 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 59.0 mt -57.69 -50.28 77.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.152 -0.684 . . . . 74.32 109.152 171.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 67' ' ' ARG . 31.0 mm-40 -61.8 -40.93 96.96 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.925 -0.579 . . . . 71.13 110.423 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -54.33 -50.29 67.75 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.727 -0.67 . . . . 72.34 109.688 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.628 HD11 HG13 ' A' ' 22' ' ' VAL . 80.9 mt -70.1 -30.45 67.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 112.356 0.502 . . . . 53.41 112.356 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 62' ' ' ILE . 48.5 mt-30 -71.85 -27.42 62.87 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.549 -0.86 . . . . 75.23 111.419 177.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 63' ' ' GLN . 30.4 mmm180 -72.97 -29.01 62.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.748 0.309 . . . . 73.44 110.666 175.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 36.1 p -81.74 -19.69 40.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.891 0.853 . . . . 73.23 110.608 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 61.2 m -85.57 -11.24 54.53 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.756 -1.111 . . . . 74.3 110.96 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.46 -29.71 66.4 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.224 0.609 . . . . 61.34 111.251 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -98.63 144.86 27.46 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.386 -0.968 . . . . 75.43 108.386 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.9 tpt 63.23 27.51 15.56 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-O 122.746 1.26 . . . . 62.43 109.241 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -77.26 111.49 12.96 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 114.892 -1.049 . . . . 41.22 111.001 -177.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -129.82 -51.26 1.14 Allowed 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.561 -1.274 . . . . 75.23 107.561 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -155.96 103.34 2.22 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.112 -0.949 . . . . 72.52 110.115 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.7 t -106.23 77.2 1.2 Allowed 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.241 -1.763 . . . . 70.2 106.241 173.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.9 m . . . . . 0 C--O 1.262 1.732 0 N-CA-C 108.001 -1.111 . . . . 74.33 108.001 -176.521 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.236 0 N-CA-C 110.508 -1.037 . . . . 71.44 110.508 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.2 p -82.79 90.14 6.87 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.092 0.472 . . . . 74.43 109.79 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -116.91 109.97 17.73 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.634 -0.876 . . . . 52.24 108.634 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -71.03 152.24 43.76 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.256 -0.429 . . . . 62.22 111.283 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 10' ' ' LEU . . . -82.06 -16.12 51.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.191 -0.459 . . . . 74.23 111.78 -177.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 52.96 -174.15 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 125.801 1.64 . . . . 70.04 114.631 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -88.86 -32.75 17.63 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 121.118 0.485 . . . . 75.13 110.805 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.532 ' HA ' HD13 ' A' ' 28' ' ' LEU . 6.6 p -108.62 168.95 8.97 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.87 -0.604 . . . . 63.21 110.251 174.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.465 ' SG ' HG12 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -84.16 128.0 34.28 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.525 -0.87 . . . . 44.52 110.684 -171.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.604 ' H ' HD12 ' A' ' 10' ' ' LEU . 6.2 mp -43.96 -62.44 1.13 Allowed 'General case' 0 CA--C 1.508 -0.667 0 C-N-CA 125.367 1.467 . . . . 72.43 114.265 -175.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 p -173.01 143.42 1.16 Allowed 'General case' 0 CA--C 1.493 -1.237 0 C-N-CA 120.259 -0.576 . . . . 63.54 109.633 -172.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 13' ' ' THR . 1.1 m -99.48 152.58 4.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.009 -1.108 . . . . 63.11 108.009 -178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 12' ' ' VAL . 9.0 t -89.54 174.44 7.77 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.274 -1.38 . . . . 73.44 107.274 175.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -53.37 -39.65 64.35 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.273 0.488 . . . . 63.03 112.12 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -155.15 93.8 2.69 Favored Pre-proline 0 N--CA 1.429 -1.505 0 N-CA-C 108.733 -0.839 . . . . 71.11 108.733 170.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.644 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 11.8 Cg_endo -52.13 -82.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.268 3.312 . . . . 74.34 117.705 -175.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.419 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -138.6 162.4 53.32 Favored Pre-proline 0 C--N 1.321 -0.641 0 O-C-N 121.881 -0.512 . . . . 74.55 110.424 -173.224 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.61 ' O ' HG12 ' A' ' 21' ' ' ILE . 27.2 Cg_exo -63.97 132.15 33.46 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.877 1.718 . . . . 72.2 110.124 174.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.529 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -75.05 1.11 56.89 Favored Glycine 0 C--N 1.301 -1.382 0 N-CA-C 114.065 0.386 . . . . 50.25 114.065 -176.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -91.58 -2.38 57.14 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 122.483 -0.422 . . . . 74.32 110.88 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 18' ' ' PRO . 27.6 pt -107.1 6.76 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 120.313 -0.555 . . . . 61.35 110.819 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.491 HG21 ' CD1' ' A' ' 41' ' ' PHE . 5.4 p -93.77 140.69 16.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 116.02 -0.537 . . . . 73.25 111.453 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.41 -47.0 5.06 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.776 0.83 . . . . 75.21 109.441 -175.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -143.9 163.64 32.82 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.749 -1.204 . . . . 71.15 107.749 -177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -144.77 165.52 27.85 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 118.233 0.47 . . . . 72.33 110.47 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.524 ' HB2' HG22 ' A' ' 40' ' ' VAL . 36.0 m80 -134.45 112.41 10.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.695 -1.224 . . . . 62.33 107.695 170.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -83.17 94.92 7.96 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.972 -1.122 . . . . 71.02 107.972 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.532 HD13 ' HA ' ' A' ' 8' ' ' CYS . 63.0 mt -94.63 137.41 33.78 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.635 -0.712 . . . . 70.23 111.428 -174.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.42 ' H ' ' HB3' ' A' ' 32' ' ' ASP . 91.8 mt -142.05 169.67 17.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.035 -0.984 . . . . 72.33 110.861 -175.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -77.9 -29.61 15.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 107.17 -1.419 . . . . 73.24 107.17 171.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -66.88 -30.19 70.29 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.023 -0.99 . . . . 73.43 109.15 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' A' ' 29' ' ' LEU . 20.1 t70 -74.33 -32.87 62.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.199 -0.91 . . . . 74.31 108.805 173.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.63 88.61 1.6 Allowed Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.178 -0.919 . . . . 53.2 113.68 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.9 t 178.84 -175.5 0.21 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.429 -1.322 . . . . 64.54 107.429 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -89.5 -41.99 11.72 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.557 0.577 . . . . 74.11 112.557 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.05 115.95 42.79 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 113.085 0.772 . . . . 65.34 113.085 -176.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -83.07 130.68 5.67 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.838 2.359 . . . . 73.04 111.655 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.66 153.42 2.26 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.269 -1.011 . . . . 43.24 108.269 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.09 130.78 47.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 107.81 -1.181 . . . . 42.34 107.81 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.524 HG22 ' HB2' ' A' ' 26' ' ' HIS . 4.5 m -92.4 131.69 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.759 0 N-CA-C 108.254 -1.017 . . . . 75.31 108.254 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.491 ' CD1' HG21 ' A' ' 22' ' ' VAL . 10.3 m-85 -103.2 115.44 30.58 Favored 'General case' 0 C--N 1.274 -2.7 0 CA-C-N 116.108 -0.496 . . . . 71.15 110.728 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 97.7 m -80.69 100.39 8.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.2 -1.408 . . . . 51.22 107.2 174.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 53.2 p -72.25 175.39 6.13 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.494 0.188 . . . . 72.12 111.042 -177.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 96.8 mt -61.02 -26.74 67.83 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.692 -0.485 . . . . 65.12 109.692 176.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.403 ' NE ' ' HA ' ' A' ' 45' ' ' ARG . 6.5 tpm_? -63.88 -27.01 68.86 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.373 1.069 . . . . 73.21 110.791 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.92 8.55 59.08 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.168 -0.539 . . . . 63.43 111.878 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.61 138.93 38.87 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.974 -1.491 . . . . 73.22 106.974 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -95.82 118.77 33.11 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.435 -0.58 . . . . 63.53 109.435 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.1 mp -111.21 149.22 31.28 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 111.785 0.291 . . . . 74.43 111.785 -177.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.428 ' HB3' HG12 ' A' ' 12' ' ' VAL . 23.3 m -80.23 123.4 27.91 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.863 -0.608 . . . . 74.32 110.241 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -127.74 152.52 77.11 Favored Pre-proline 0 C--O 1.246 0.882 0 O-C-N 122.356 -0.215 . . . . 72.43 110.86 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.422 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 67.3 Cg_endo -67.39 114.12 3.14 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 123.005 2.47 . . . . 73.21 113.844 -173.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 -15.36 28.05 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.179 1.919 . . . . 75.5 112.154 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -103.82 8.57 37.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.094 -0.503 . . . . 62.44 112.309 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -102.77 129.28 26.12 Favored Pre-proline 0 C--N 1.315 -0.924 0 C-N-CA 119.88 -0.728 . . . . 70.41 111.654 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.405 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 83.0 Cg_exo -48.03 -36.5 28.03 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 124.289 3.326 . . . . 74.34 115.296 -177.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -62.32 -27.03 68.76 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 120.086 -0.646 . . . . 75.31 110.961 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 62' ' ' ILE . 67.7 t -79.69 -42.38 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 116.0 -0.546 . . . . 72.22 112.386 -178.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -63.46 -25.54 68.31 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.931 1.086 . . . . 72.32 113.931 -174.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -80.59 -41.24 24.33 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 116.468 -0.333 . . . . 74.25 111.073 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.529 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 10.8 pt -71.9 -31.08 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 111.932 0.345 . . . . 73.31 111.932 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 58' ' ' VAL . 61.4 mt -55.54 -41.38 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.209 -0.45 . . . . 61.14 109.961 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 76.4 mm-40 -61.3 -42.17 98.21 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.981 -0.554 . . . . 72.33 110.372 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -58.51 -43.85 89.26 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.896 -0.593 . . . . 71.13 110.244 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.421 HD11 ' CG1' ' A' ' 22' ' ' VAL . 85.9 mt -68.53 -39.13 81.28 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.819 -0.628 . . . . 64.32 111.623 178.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -64.47 -43.35 94.47 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.694 -0.402 . . . . 75.4 111.223 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 63' ' ' GLN . 70.2 mtp180 -63.37 -33.98 76.72 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.18 0.514 . . . . 75.31 111.266 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.8 p -84.76 -26.21 27.73 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 113.142 0.793 . . . . 73.02 113.142 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.3 t -80.31 -38.02 31.52 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.53 -0.304 . . . . 70.23 110.478 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.11 65.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.95 0.405 . . . . 72.41 112.039 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -105.77 4.54 30.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.258 0.551 . . . . 72.33 110.886 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.74 123.66 48.04 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.402 -1.333 . . . . 73.55 107.402 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -82.15 104.74 12.7 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.898 0.38 . . . . 74.51 110.989 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -162.02 171.37 17.68 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.889 -0.782 . . . . 64.53 108.889 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -75.79 122.54 24.22 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.842 -1.17 . . . . 64.42 107.842 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.1 m -80.11 101.14 8.58 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.469 -0.493 . . . . 74.2 110.867 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.5 m . . . . . 0 N--CA 1.429 -1.516 0 N-CA-C 108.428 -0.953 . . . . 70.41 108.428 177.902 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.645 0 N-CA-C 111.706 -0.558 . . . . 71.35 111.706 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 31.7 m -71.54 128.9 37.34 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.456 -0.572 . . . . 65.03 109.456 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.8 t30 71.16 115.32 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.442 1.097 . . . . 74.2 109.987 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -82.47 38.04 0.54 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.235 1.017 . . . . 70.42 111.541 -174.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.56 -4.0 56.91 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.975 0.893 . . . . 33.52 109.089 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.47 117.7 9.79 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.248 -1.342 . . . . 44.23 110.871 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -98.96 -13.25 20.03 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.005 0.907 . . . . 71.13 109.316 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' A' ' 28' ' ' LEU . 71.7 m -81.68 159.88 23.84 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.769 -1.105 . . . . 51.33 109.843 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.701 ' SG ' HG12 ' A' ' 40' ' ' VAL . 75.3 m -85.46 177.73 7.67 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.412 0.625 . . . . 74.44 111.709 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.4 mt -105.44 -38.86 6.33 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 114.892 -1.049 . . . . 71.44 109.141 176.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.5 m -163.7 168.48 19.74 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 110.127 -0.323 . . . . 42.01 110.127 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.506 HG12 ' CB ' ' A' ' 50' ' ' CYS . 1.3 m -132.35 156.65 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 N-CA-C 104.481 -2.414 . . . . 62.23 104.481 172.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 12' ' ' VAL . 8.8 t -96.9 178.02 5.43 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 108.192 -1.04 . . . . 74.11 108.192 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -50.65 -49.6 56.64 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.142 0.496 . . . . 74.2 111.103 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HG3' ' CE2' ' A' ' 57' ' ' TRP . 37.0 ttpt -149.42 84.83 5.98 Favored Pre-proline 0 N--CA 1.421 -1.894 0 N-CA-C 108.976 -0.75 . . . . 54.41 108.976 175.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HG3' ' HA ' ' A' ' 51' ' ' ALA . 10.2 Cg_endo -46.54 -81.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.786 3.658 . . . . 63.14 117.861 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -136.09 160.07 68.57 Favored Pre-proline 0 C--N 1.311 -1.091 0 O-C-N 121.857 -0.527 . . . . 60.14 110.612 -172.491 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.593 ' O ' HG12 ' A' ' 21' ' ' ILE . 19.6 Cg_endo -60.89 128.43 25.46 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.829 1.686 . . . . 74.45 109.791 173.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.541 ' HA3' ' CD1' ' A' ' 61' ' ' ILE . . . -73.72 1.72 44.12 Favored Glycine 0 C--O 1.209 -1.457 0 C-N-CA 120.98 -0.629 . . . . 31.13 114.554 -174.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -89.97 -1.54 57.99 Favored 'General case' 0 C--N 1.284 -2.276 0 O-C-N 122.198 -0.589 . . . . 71.42 111.367 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 18' ' ' PRO . 38.6 pt -104.01 7.29 10.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 C-N-CA 120.788 -0.365 . . . . 72.24 110.959 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.559 HG13 HD11 ' A' ' 65' ' ' LEU . 3.2 p -90.93 131.68 37.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.576 0.703 . . . . 64.21 112.55 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -85.44 -55.06 4.2 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.798 -1.092 . . . . 63.34 108.124 -175.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -143.42 158.66 43.46 Favored 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 123.922 0.889 . . . . 73.33 109.099 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -132.43 163.27 29.12 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.84 -0.43 . . . . 73.45 109.84 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.475 ' HB2' HG22 ' A' ' 40' ' ' VAL . 34.0 m170 -135.01 136.91 42.49 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.289 -1.374 . . . . 73.24 107.289 174.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.409 ' CE2' HD21 ' A' ' 29' ' ' LEU . 5.4 t80 -100.1 105.9 17.58 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.103 0.478 . . . . 64.35 109.723 -175.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.543 HD12 ' SG ' ' A' ' 8' ' ' CYS . 1.8 mm? -97.43 124.08 41.49 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 123.803 0.841 . . . . 64.32 109.529 -176.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.409 HD21 ' CE2' ' A' ' 27' ' ' TYR . 87.6 mt -121.9 176.36 5.81 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.813 -0.44 . . . . 52.54 109.813 178.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 45.4 mt -73.3 -17.36 17.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 121.992 0.901 . . . . 73.23 108.935 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -65.17 -28.88 69.71 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.587 -1.188 . . . . 71.33 109.347 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -76.86 -4.22 42.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.504 -0.771 . . . . 62.54 111.08 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.9 -9.37 59.99 Favored Glycine 0 CA--C 1.503 -0.692 0 CA-C-N 116.122 -0.49 . . . . 41.32 113.044 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.715 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 63.0 m -94.67 123.53 38.16 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.526 -0.916 . . . . 72.04 108.526 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.678 ' H ' ' HD2' ' A' ' 35' ' ' ARG 0.313 0.0 OUTLIER -77.67 1.89 18.47 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 113.968 1.099 . . . . 72.02 113.968 -176.15 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.8 p -109.62 98.22 31.75 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.053 -0.721 . . . . 73.42 109.053 171.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.12 129.86 9.03 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 121.627 1.551 . . . . 71.04 110.29 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 50' ' ' CYS . . . -166.13 160.44 16.28 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.226 -0.443 . . . . 71.23 110.734 -174.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.37 123.15 66.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 109.083 -0.71 . . . . 73.44 109.083 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.701 HG12 ' SG ' ' A' ' 9' ' ' CYS . 9.2 m -80.34 125.64 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 C-N-CA 119.736 -0.786 . . . . 73.42 109.191 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -97.85 109.01 21.85 Favored 'General case' 0 C--N 1.267 -3.02 0 CA-C-N 115.672 -0.695 . . . . 64.42 109.487 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 95.4 m -82.42 103.72 12.18 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.477 -1.305 . . . . 61.23 107.477 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 64.8 p -69.94 167.12 18.12 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 120.895 -0.322 . . . . 61.52 111.084 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 21' ' ' ILE . 94.9 mt -59.99 -30.74 69.33 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.093 0.557 . . . . 51.54 110.698 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -70.91 -18.23 62.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.313 -0.858 . . . . 75.33 110.109 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.57 16.6 26.26 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.881 -0.676 . . . . 75.21 113.22 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -99.8 126.05 45.82 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.95 0.375 . . . . 73.41 111.282 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -85.92 127.04 34.52 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.126 -0.694 . . . . 55.3 109.126 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.7 tp -147.67 131.03 16.59 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.229 -1.026 . . . . 74.43 108.229 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.593 ' SG ' HG12 ' A' ' 40' ' ' VAL . 55.8 m -86.78 155.17 20.42 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 114.877 1.436 . . . . 73.32 114.877 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.556 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . . . -130.55 162.34 55.37 Favored Pre-proline 0 N--CA 1.438 -1.052 0 CA-C-N 114.217 -1.356 . . . . 63.43 108.453 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.477 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 58.0 Cg_endo -68.67 107.52 1.67 Allowed 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 121.69 1.594 . . . . 71.34 111.617 -177.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 38' ' ' ALA . 59.6 Cg_endo -68.15 -12.46 35.16 Favored 'Trans proline' 0 N--CA 1.481 0.74 0 C-N-CA 123.171 2.58 . . . . 61.24 114.408 -170.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -96.07 -22.52 17.29 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.141 0.496 . . . . 73.3 110.733 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.437 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 15.5 mm100 -73.84 138.7 76.6 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 112.902 0.705 . . . . 71.22 112.902 -174.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 55' ' ' GLN . 87.7 Cg_exo -50.54 -36.79 50.73 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.321 3.348 . . . . 73.11 115.037 -177.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.481 ' CE2' ' HG3' ' A' ' 15' ' ' LYS . 34.7 p-90 -68.18 -28.0 66.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 119.863 -0.735 . . . . 64.42 110.673 -177.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 62' ' ' ILE . 73.9 t -79.77 -41.42 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 116.125 -0.489 . . . . 65.23 111.747 -177.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.569 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 11.7 pt-20 -60.74 -37.52 82.04 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.23 -0.588 . . . . 73.03 112.033 -177.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -62.21 -43.92 97.74 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.062 0.458 . . . . 72.02 111.731 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.541 ' CD1' ' HA3' ' A' ' 19' ' ' GLY . 8.5 pt -74.06 -32.49 33.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 116.052 -0.522 . . . . 70.22 111.841 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 58' ' ' VAL . 58.5 mt -60.74 -51.09 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.669 -0.493 . . . . 74.12 109.669 172.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 14.2 mm100 -59.56 -38.0 79.97 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.324 -0.398 . . . . 54.34 110.904 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.441 ' HG3' ' NH2' ' A' ' 67' ' ' ARG . 35.5 ttt180 -57.66 -47.41 82.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.865 -0.607 . . . . 72.14 110.558 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.559 HD11 HG13 ' A' ' 22' ' ' VAL . 86.8 mt -71.17 -30.16 66.1 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.885 0.374 . . . . 75.45 110.892 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 69' ' ' SER . 73.5 mt-30 -67.49 -22.56 65.45 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 113.037 0.754 . . . . 74.53 113.037 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.441 ' NH2' ' HG3' ' A' ' 64' ' ' ARG . 26.2 mtm180 -65.66 -45.99 80.82 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.41 0.624 . . . . 64.31 109.473 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.6 p -78.32 -20.08 52.18 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.689 -0.687 . . . . 73.35 112.101 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 66' ' ' GLN . 67.7 m -86.45 -12.13 49.91 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.829 -0.623 . . . . 65.22 111.184 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.68 -25.52 61.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 122.707 0.403 . . . . 52.22 111.292 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -73.99 -26.6 60.55 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.592 -0.892 . . . . 71.2 108.592 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.413 ' HG2' ' H ' ' A' ' 73' ' ' LYS . 49.1 ttp -95.84 -176.9 3.86 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.0 -1.482 . . . . 70.44 107.0 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 21.7 ptmt -75.6 -0.81 21.81 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 118.339 0.518 . . . . 72.13 111.747 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 73' ' ' LYS . 73.7 ttt180 72.02 131.35 0.04 OUTLIER 'General case' 0 C--N 1.359 0.995 0 C-N-CA 123.441 0.697 . . . . 74.24 110.295 -173.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 75' ' ' ARG . 38.8 mmt180 -82.64 79.54 9.03 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 119.911 -0.716 . . . . 73.24 111.267 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.4 t -170.06 93.81 0.24 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 105.495 -2.039 . . . . 75.32 105.495 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--N 1.299 -1.613 0 N-CA-C 107.797 -1.186 . . . . 62.14 107.797 -175.009 . . . . . . . . 0 0 . 1 stop_ save_